data_1z2d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z2d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.6 mtmt -134.31 167.62 20.38 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.663 1.585 . . . . 0.0 107.744 169.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -136.38 132.9 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -124.84 127.94 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -125.61 104.15 8.24 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -169.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.79 147.49 45.46 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 122.026 -0.421 . . . . 0.0 109.926 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -147.5 126.36 12.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -146.88 175.57 10.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.515 0.598 . . . . 0.0 109.814 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -67.67 -11.76 58.97 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.72 -1.238 . . . . 0.0 112.972 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.16 121.1 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 49.7 t-20 -57.63 -45.16 85.78 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.637 0.775 . . . . 0.0 109.991 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m -40.07 -34.65 0.31 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 129.746 3.218 . . . . 0.0 115.175 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.1 m -112.81 -72.47 0.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.32 0.648 . . . . 0.0 111.165 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -48.28 61.58 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.348 -169.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -63.04 -45.62 91.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.288 0.494 . . . . 0.0 109.779 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -56.55 -44.7 81.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.847 -0.596 . . . . 0.0 112.368 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.2 mtm -69.83 -45.58 67.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.615 0.643 . . . . 0.0 110.333 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.72 73.79 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.93 0.786 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -61.17 -47.3 86.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.673 1.189 . . . . 0.0 110.673 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.82 95.47 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.033 -0.87 . . . . 0.0 111.676 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 98.1 m95 -65.22 -38.59 90.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.871 1.836 . . . . 0.0 110.79 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.1 82.65 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.447 -0.783 . . . . 0.0 111.604 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.48 -26.66 68.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.13 0.877 . . . . 0.0 112.348 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.53 -46.15 13.75 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.602 0.761 . . . . 0.0 109.622 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -80.9 -26.33 36.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 mt -99.08 -140.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 107.387 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -174.6 45.73 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.86 -13.91 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 113.349 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.52 -13.53 2.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.14 2.176 . . . . 0.0 111.267 169.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.447 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 8.5 m95 -133.23 162.49 31.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.965 1.706 . . . . 0.0 108.813 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.41 139.19 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 167.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.03 118.68 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.7 173.57 11.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.334 0.587 . . . . 0.0 110.413 172.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -132.24 144.22 50.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 110.175 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 179.45 6.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.055 2.142 . . . . 0.0 108.225 169.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.77 170.31 39.04 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.67 -41.64 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -142.6 179.52 6.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.521 0.729 . . . . 0.0 109.827 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.897 2.079 . . . . 0.0 107.202 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -135.57 -36.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.694 1.197 . . . . 0.0 109.238 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.89 178.57 39.44 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.98 100.79 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.93 127.85 92.23 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 117.883 -1.055 . . . . 0.0 109.257 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 -35.17 38.27 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.523 2.815 . . . . 0.0 113.946 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -59.61 -51.64 68.94 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.741 0.7 . . . . 0.0 109.886 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.35 80.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.496 0.589 . . . . 0.0 109.923 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -61.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -63.26 -40.02 96.24 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.999 0.818 . . . . 0.0 111.103 -169.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.15 83.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.583 0.753 . . . . 0.0 110.853 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -40.22 66.41 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.065 0.393 . . . . 0.0 110.715 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -68.3 -30.5 69.51 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.024 0.93 . . . . 0.0 111.287 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.47 -21.24 66.19 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.534 1.134 . . . . 0.0 111.879 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 t -89.89 -6.28 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.78 1.232 . . . . 0.0 110.193 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.57 19.97 52.83 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.764 -1.21 . . . . 0.0 112.258 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.3 mt -111.94 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.051 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -79.59 84.84 5.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.66 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.23 7.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.286 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.7 m -56.15 -25.16 45.26 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 120.667 1.576 . . . . 0.0 112.236 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.63 -20.34 59.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.696 1.198 . . . . 0.0 113.222 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.78 169.81 13.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.838 0.745 . . . . 0.0 110.511 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -145.8 155.4 42.9 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.412 1.485 . . . . 0.0 108.825 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 p -89.65 163.57 15.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.591 1.156 . . . . 0.0 110.409 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.487 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 41.2 t0 -158.15 158.78 35.28 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.818 2.047 . . . . 0.0 107.773 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.84 161.63 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.19 141.65 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 111.544 -170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -130.7 112.77 13.4 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.19 -26.88 41.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.872 1.269 . . . . 0.0 111.445 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.38 -23.03 66.86 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 125.066 1.347 . . . . 0.0 112.859 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -100.43 -42.44 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.157 0.89 . . . . 0.0 108.689 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tp -48.13 -51.73 23.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.896 1.278 . . . . 0.0 111.122 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -67.23 -13.57 62.09 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -106.82 -14.69 14.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.141 0.977 . . . . 0.0 111.281 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 148.86 47.35 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.32 -31.6 71.99 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 27.1 tp -152.73 144.37 23.48 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.763 1.225 . . . . 0.0 109.981 -169.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 135.63 58.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.71 108.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -86.29 93.18 9.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.03 -13.31 62.09 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.593 0.757 . . . . 0.0 112.328 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.3 t -144.33 145.89 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.868 1.213 . . . . 0.0 107.923 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.8 -34.77 89.69 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.568 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.22 -25.84 67.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.161 0.981 . . . . 0.0 111.402 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 -26.54 60.24 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.031 0.532 . . . . 0.0 111.841 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.65 65.72 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.78 -33.69 70.61 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.863 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -85.52 60.53 6.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.119 0.968 . . . . 0.0 110.577 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 74.7 m -120.95 74.78 27.58 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.355 1.062 . . . . 0.0 108.6 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.15 -29.08 89.52 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.126 2.551 . . . . 0.0 115.146 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.9 ptp -162.73 115.91 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 110.217 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -132.83 77.56 68.38 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.5 171.76 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.995 3.13 . . . . 0.0 112.959 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.7 -17.77 10.74 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.011 3.141 . . . . 0.0 115.795 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.53 -13.2 38.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.059 0.943 . . . . 0.0 112.419 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -127.16 159.43 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 128.81 2.844 . . . . 0.0 106.828 -169.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.1 pttt -138.48 167.7 21.36 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -127.42 153.06 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.644 0.657 . . . . 0.0 109.418 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -135.18 156.43 49.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.51 135.45 30.21 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.78 0.832 . . . . 0.0 111.766 -168.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -137.98 -170.01 2.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.472 1.909 . . . . 0.0 108.735 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.93 40.27 1.37 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.305 -0.872 . . . . 0.0 113.43 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -79.1 112.01 15.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.255 1.027 . . . . 0.0 111.978 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.62 158.39 18.35 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.983 0.913 . . . . 0.0 109.567 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.12 118.91 74.73 Favored Pre-proline 0 CA--C 1.534 0.339 0 O-C-N 121.526 -0.733 . . . . 0.0 111.142 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.98 -30.23 21.6 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.818 1.678 . . . . 0.0 112.633 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.59 -18.12 65.09 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.54 1.064 . . . . 0.0 112.408 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -99.37 -1.13 39.54 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.911 1.284 . . . . 0.0 111.618 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 146.1 36.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.03 164.39 36.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.97 0.508 . . . . 0.0 110.797 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.82 -48.58 0.66 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -165.36 166.66 18.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.243 2.217 . . . . 0.0 105.595 169.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.29 -40.82 82.97 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.726 -0.609 . . . . 0.0 110.507 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -28.35 64.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.1 -45.07 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.893 0.769 . . . . 0.0 109.105 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -56.24 -50.46 71.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.648 0.779 . . . . 0.0 109.915 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -62.3 -43.95 97.63 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.119 0.418 . . . . 0.0 110.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.39 79.83 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.886 0.766 . . . . 0.0 110.26 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.2 -40.43 97.48 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.681 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -54.85 -49.46 71.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.096 0.862 . . . . 0.0 109.352 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -61.51 -44.16 97.56 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.947 0.499 . . . . 0.0 111.282 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.47 -50.34 73.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 119.167 -0.445 . . . . 0.0 110.098 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.43 -43.73 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 117.406 -1.283 . . . . 0.0 110.164 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -61.63 -42.04 98.33 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 121.144 1.793 . . . . 0.0 111.016 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.17 -42.63 99.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.342 0.519 . . . . 0.0 110.339 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.22 -38.95 71.98 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -65.53 -40.45 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.528 1.058 . . . . 0.0 109.3 177.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.62 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -52.38 -44.37 65.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.77 0.828 . . . . 0.0 111.137 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -47.52 84.96 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 109.933 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.96 -34.91 76.1 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.167 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -49.7 76.73 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.933 0.788 . . . . 0.0 110.865 173.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.26 -52.07 66.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.18 -39.97 73.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.696 0.68 . . . . 0.0 111.388 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.8 67.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.688 0.795 . . . . 0.0 111.708 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -76.14 -43.49 42.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.049 0.94 . . . . 0.0 110.915 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.2 p -85.09 -22.33 28.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.373 1.069 . . . . 0.0 110.021 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.24 38.12 95.68 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.569 -169.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 119.8 -0.143 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -144.44 173.11 12.08 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.014 1.326 . . . . 0.0 108.567 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -131.14 142.81 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.7 141.37 46.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.868 1.267 . . . . 0.0 107.783 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.14 107.06 7.05 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.17 141.37 38.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.752 0.421 . . . . 0.0 110.083 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.81 133.81 34.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.394 1.478 . . . . 0.0 108.038 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.3 p -152.68 179.23 8.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 110.116 169.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.06 -3.68 17.57 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.85 104.43 0.21 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 54.3 t-20 -41.93 -48.16 4.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.793 1.637 . . . . 0.0 111.599 -170.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -41.89 -31.58 0.34 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.196 2.999 . . . . 0.0 115.118 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.91 -85.33 0.48 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.456 1.026 . . . . 0.0 111.185 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -45.01 95.81 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.68 -168.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -68.13 -39.24 82.76 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.997 1.272 . . . . 0.0 110.761 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -62.18 -46.2 89.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.92 0.782 . . . . 0.0 111.383 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.46 -47.86 74.68 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.88 -45.13 78.63 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.453 0.701 . . . . 0.0 110.627 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.03 -46.22 85.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.924 0.489 . . . . 0.0 110.32 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.77 97.6 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' HE2' ' A' ' 52' ' ' MET . 96.7 m95 -67.16 -38.78 86.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.321 1.561 . . . . 0.0 110.536 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.8 85.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.097 0.408 . . . . 0.0 110.771 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -57.35 -31.49 65.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.417 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.99 -59.97 2.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.612 0.642 . . . . 0.0 110.514 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -70.57 -42.8 70.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -168.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.5 mt -82.2 -37.98 25.26 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 122.315 0.246 . . . . 0.0 110.825 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.2 174.66 49.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.024 0.821 . . . . 0.0 112.072 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.48 -15.37 63.31 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.809 1.244 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.13 -27.26 19.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 110.911 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -112.28 134.46 53.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 131.65 35.29 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 168.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -111.44 142.81 22.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -140.83 167.25 22.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.851 1.26 . . . . 0.0 108.815 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.0 p -139.47 134.07 31.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.237 1.415 . . . . 0.0 108.113 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.66 -175.2 4.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.972 1.709 . . . . 0.0 108.495 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 178.05 41.97 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.05 -42.31 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.793 1.237 . . . . 0.0 108.256 172.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.41 -179.45 6.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.87 125.4 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.72 1.608 . . . . 0.0 107.026 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.87 -35.01 38.72 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.013 0.525 . . . . 0.0 109.91 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.72 -161.41 31.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.53 108.96 18.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.21 131.83 95.16 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.637 -0.696 . . . . 0.0 110.265 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.29 -32.27 33.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.975 1.784 . . . . 0.0 112.88 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.76 -38.33 83.28 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.571 1.078 . . . . 0.0 110.497 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.19 89.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.648 1.113 . . . . 0.0 109.254 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.88 -58.71 6.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.81 -47.1 82.2 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.693 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.41 81.89 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 119.096 0.862 . . . . 0.0 110.677 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.406 ' HE2' ' CD1' ' A' ' 23' ' ' TRP . 97.9 mmm -69.17 -41.68 76.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.148 0.431 . . . . 0.0 110.29 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -67.78 -27.56 66.86 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.991 0.916 . . . . 0.0 111.818 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -67.47 -18.62 65.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.518 1.127 . . . . 0.0 111.708 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.54 -13.07 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.012 0.925 . . . . 0.0 109.972 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.86 6.39 54.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.299 1.428 . . . . 0.0 112.045 -173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.61 89.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.71 78.41 2.67 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.306 1.042 . . . . 0.0 110.651 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.27 6.09 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.452 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.0 p -57.4 -24.82 57.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.601 1.546 . . . . 0.0 112.271 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.21 -19.14 60.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.568 1.147 . . . . 0.0 112.885 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.32 169.43 15.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.777 0.717 . . . . 0.0 109.939 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -145.02 161.42 39.44 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.985 1.714 . . . . 0.0 107.986 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 m -111.57 155.35 23.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 109.831 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.2 t0 -154.44 160.57 41.69 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.838 2.055 . . . . 0.0 108.484 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 pt -94.26 163.08 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.39 119.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.563 0.697 . . . . 0.0 112.825 -169.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -100.51 111.57 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -15.61 63.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.697 0.799 . . . . 0.0 112.195 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.06 -40.14 75.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.588 1.085 . . . . 0.0 111.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.9 mt -63.41 -48.35 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.88 -46.27 74.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.413 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -66.46 -5.86 12.59 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.47 3.55 3.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.078 1.308 . . . . 0.0 113.603 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 147.74 52.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.839 0.745 . . . . 0.0 109.487 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.17 -34.64 71.13 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.063 0.847 . . . . 0.0 108.932 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.0 tp -145.27 142.73 29.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.31 132.01 69.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.4 t -114.23 113.17 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.9 p -92.39 92.98 8.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.88 -10.56 54.14 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.639 -169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -147.71 162.68 38.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.979 1.718 . . . . 0.0 110.741 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.11 -55.94 27.92 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.551 1.072 . . . . 0.0 112.522 -169.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.12 -31.92 70.94 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -171.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.95 80.12 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.49 -26.43 63.42 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.68 0.792 . . . . 0.0 112.92 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.67 -38.49 80.42 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.742 0.817 . . . . 0.0 111.755 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.26 -34.47 42.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.048 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.76 114.47 4.2 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 118.155 -0.926 . . . . 0.0 108.618 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.36 173.76 10.14 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.82 2.347 . . . . 0.0 111.875 -173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 65.8 ttp -53.79 125.07 17.15 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.208 1.003 . . . . 0.0 110.994 -170.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 p -107.1 105.59 56.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.63 1.572 . . . . 0.0 107.208 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -53.89 166.59 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.719 2.946 . . . . 0.0 112.961 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.69 -28.09 36.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.438 2.759 . . . . 0.0 114.788 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -68.19 -7.49 30.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.376 1.07 . . . . 0.0 112.981 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.75 85.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.752 2.421 . . . . 0.0 105.591 -169.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.1 pttt -69.7 167.09 17.78 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.169 -0.957 . . . . 0.0 108.973 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -123.8 160.35 27.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.036 0.534 . . . . 0.0 109.85 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.68 155.03 46.6 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -143.78 137.21 27.89 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.665 0.386 . . . . 0.0 111.731 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -140.53 -172.83 3.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.869 1.668 . . . . 0.0 109.311 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.55 44.39 1.05 Allowed Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.744 -0.597 . . . . 0.0 112.954 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -76.36 114.16 14.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.852 0.826 . . . . 0.0 110.487 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.58 162.46 20.88 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.275 0.63 . . . . 0.0 109.739 169.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.32 130.65 92.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.791 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.8 -44.48 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.458 2.106 . . . . 0.0 113.106 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.42 70.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.858 0.863 . . . . 0.0 111.428 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.14 5.89 46.67 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.636 1.575 . . . . 0.0 111.507 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.71 140.07 48.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -143.36 158.65 43.46 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.687 0.795 . . . . 0.0 110.168 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.19 -51.97 0.46 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -160.41 162.06 33.18 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.57 -40.92 88.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.619 -0.675 . . . . 0.0 110.696 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.02 -29.08 67.17 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.467 -0.302 . . . . 0.0 111.069 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.93 -42.23 40.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.285 0.634 . . . . 0.0 109.994 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -54.32 -51.7 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.025 0.93 . . . . 0.0 109.639 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -60.55 -46.51 89.92 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.57 75.89 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.036 -0.415 . . . . 0.0 110.662 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.67 -37.49 87.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.667 0.787 . . . . 0.0 111.022 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -54.55 -51.74 64.25 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.118 0.872 . . . . 0.0 108.706 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.481 ' NE2' HH21 ' A' ' 124' ' ' ARG . 5.3 mm-40 -61.21 -42.72 99.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 111.666 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.27 -48.15 82.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.242 0.474 . . . . 0.0 110.113 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.1 -47.26 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 117.459 -1.257 . . . . 0.0 110.022 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.481 HH21 ' NE2' ' A' ' 121' ' ' GLN . 49.1 ptt85 -63.01 -41.65 99.62 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.898 1.681 . . . . 0.0 111.027 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.23 -42.46 98.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.21 0.459 . . . . 0.0 110.082 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -76.63 -33.76 58.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.466 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.01 -46.29 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 119.977 1.262 . . . . 0.0 107.646 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.7 -47.71 87.02 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.81 -37.91 71.84 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.8 1.24 . . . . 0.0 112.125 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -42.76 85.32 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.48 -0.763 . . . . 0.0 111.526 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 mt -68.22 -41.44 81.27 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -48.07 73.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.666 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.97 -57.9 11.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.605 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.298 5.2 p90 -68.63 -21.56 64.47 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 121.111 1.778 . . . . 0.0 112.681 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.99 64.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.38 0.991 . . . . 0.0 111.798 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -77.52 -39.58 45.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.402 1.081 . . . . 0.0 111.17 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.6 p -90.7 -22.42 21.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.932 0.893 . . . . 0.0 110.838 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.27 41.64 99.49 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.314 1.846 . . . . 0.0 111.331 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.264 0.078 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.0 mtmt -134.99 166.25 23.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.983 1.713 . . . . 0.0 106.519 169.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.0 140.16 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.2 tt -130.44 135.22 61.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.69 102.95 6.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.693 0.797 . . . . 0.0 108.981 -170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -76.91 144.96 38.53 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.205 0.602 . . . . 0.0 110.166 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 137.32 37.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.758 1.623 . . . . 0.0 108.138 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.2 p -154.76 175.23 13.98 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -67.81 -7.84 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.82 97.31 0.14 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -41.41 -40.94 1.88 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.453 1.901 . . . . 0.0 113.204 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.6 m -38.07 -36.67 0.22 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.903 3.281 . . . . 0.0 115.329 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -117.23 -74.92 0.59 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.966 0.803 . . . . 0.0 112.137 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -56.29 -50.74 70.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.738 0.699 . . . . 0.0 111.614 -169.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -70.27 -34.61 73.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.612 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -63.6 -42.22 98.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.415 0.552 . . . . 0.0 110.772 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.6 mtp -65.72 -47.54 74.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.806 0.442 . . . . 0.0 109.828 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.08 86.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.031 0.532 . . . . 0.0 110.871 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -57.86 -45.65 85.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.611 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.72 -52.44 53.09 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.074 0.845 . . . . 0.0 112.709 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -65.37 -34.57 78.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.592 1.696 . . . . 0.0 110.61 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.53 83.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.605 -0.684 . . . . 0.0 110.56 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.94 -22.11 64.1 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.223 -0.923 . . . . 0.0 112.557 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.46 -47.18 8.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.872 0.76 . . . . 0.0 110.116 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -78.92 -26.71 43.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.91 -142.78 0.25 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.46 -174.26 46.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.67 -13.74 55.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.95 -14.62 3.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.721 2.008 . . . . 0.0 111.147 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.468 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 7.8 m95 -133.18 167.06 21.04 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.021 1.728 . . . . 0.0 108.844 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -123.07 130.66 53.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 167.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.26 118.8 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.22 174.61 10.45 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.6 1.16 . . . . 0.0 108.653 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.4 p -137.59 160.41 39.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.372 0.606 . . . . 0.0 111.157 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.47 -162.25 1.49 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.496 1.518 . . . . 0.0 108.546 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.7 176.37 44.88 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -41.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.4 -179.88 6.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.596 1.159 . . . . 0.0 109.17 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.58 149.96 36.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.755 2.422 . . . . 0.0 106.156 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -13.93 1.9 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.961 0.904 . . . . 0.0 111.446 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.71 170.24 20.91 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 171.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.64 102.12 1.8 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -64.42 125.67 88.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.678 -170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.97 -35.46 50.16 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.383 2.722 . . . . 0.0 113.881 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -40.96 96.61 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.631 0.651 . . . . 0.0 110.515 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.92 -41.58 82.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.54 -55.99 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -65.25 -41.33 94.4 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 119.378 0.99 . . . . 0.0 110.664 -173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.21 71.4 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.862 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.0 mmm -86.51 -38.16 17.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.451 0.569 . . . . 0.0 111.427 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.42 -33.29 75.22 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.969 0.908 . . . . 0.0 110.3 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.77 -19.2 65.08 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 112.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.67 -10.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.221 1.008 . . . . 0.0 109.906 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.62 23.31 47.28 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.121 -0.987 . . . . 0.0 111.039 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.6 mt -114.32 91.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -78.49 74.25 5.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.991 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.03 3.32 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.322 -0.861 . . . . 0.0 112.129 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -27.12 10.38 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.497 1.044 . . . . 0.0 111.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -71.83 -19.59 61.96 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 113.852 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -78.29 170.38 16.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.963 . . . . 0.0 109.681 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.05 160.75 41.46 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.418 1.487 . . . . 0.0 108.462 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 p -101.64 153.55 19.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.419 1.088 . . . . 0.0 110.958 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -156.48 160.84 39.92 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.841 1.256 . . . . 0.0 108.944 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.09 161.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.22 129.29 18.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 123.397 0.679 . . . . 0.0 111.586 -169.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -106.59 114.84 29.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.31 1.444 . . . . 0.0 107.655 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -66.71 -23.1 66.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.63 -41.25 46.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.368 0.985 . . . . 0.0 110.268 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.67 -44.75 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.33 -48.71 65.31 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.948 0.499 . . . . 0.0 109.942 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -71.15 -14.81 62.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -94.75 -17.91 21.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.578 1.081 . . . . 0.0 111.003 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.01 150.25 49.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.164 0.438 . . . . 0.0 111.071 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.04 -32.71 51.11 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.42 141.04 29.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.562 1.145 . . . . 0.0 109.662 -174.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.74 124.67 59.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.95 118.44 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -102.66 97.34 7.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.8 mt -71.84 -3.15 20.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.903 1.681 . . . . 0.0 114.487 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.7 p -151.26 163.91 37.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.584 1.538 . . . . 0.0 110.327 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.76 -64.84 3.19 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.719 1.628 . . . . 0.0 113.338 -169.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.36 -29.25 67.93 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.712 -0.287 . . . . 0.0 111.754 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.55 66.94 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.85 64.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.45 -31.75 72.13 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.109 0.564 . . . . 0.0 112.109 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -85.36 63.17 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.319 0.647 . . . . 0.0 110.633 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -124.94 76.23 66.54 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.153 0.981 . . . . 0.0 108.401 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.51 85.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.635 2.89 . . . . 0.0 111.234 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.0 tpt 70.1 111.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.383 2.673 . . . . 0.0 111.196 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -134.55 81.71 47.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.87 171.5 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.444 2.763 . . . . 0.0 110.965 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.25 -25.47 13.47 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.43 3.42 . . . . 0.0 117.448 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -56.97 -36.93 70.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.669 1.122 . . . . 0.0 110.836 170.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.75 82.96 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.91 2.484 . . . . 0.0 106.87 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -66.63 165.27 15.09 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.49 -0.756 . . . . 0.0 108.975 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -133.77 134.07 42.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.963 0.905 . . . . 0.0 110.147 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.99 155.75 45.59 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -151.3 139.08 19.8 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -141.22 178.86 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.949 1.7 . . . . 0.0 108.537 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.22 103.82 0.4 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -135.58 143.64 45.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.668 0.787 . . . . 0.0 110.579 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -73.28 169.99 15.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -73.46 117.23 58.87 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.86 -32.08 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.677 1.585 . . . . 0.0 112.818 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.35 65.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.962 0.801 . . . . 0.0 112.209 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -101.64 2.31 38.65 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 111.786 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.41 144.98 40.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.13 165.28 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.055 0.455 . . . . 0.0 111.191 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.03 -47.65 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.54 166.41 18.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.509 2.324 . . . . 0.0 105.2 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.12 -40.57 81.58 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.533 -0.729 . . . . 0.0 110.52 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -27.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.562 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.96 -45.3 51.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.007 0.822 . . . . 0.0 109.171 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -55.69 -49.42 73.04 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.73 0.812 . . . . 0.0 109.882 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -64.68 -41.78 95.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.14 -0.35 . . . . 0.0 110.96 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.06 72.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.964 0.802 . . . . 0.0 110.62 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.78 -40.8 92.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.621 -0.674 . . . . 0.0 110.629 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.03 -45.41 83.15 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 119.191 0.905 . . . . 0.0 109.04 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.76 -50.01 75.5 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.351 0.66 . . . . 0.0 111.322 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.01 -48.78 80.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 119.488 -0.292 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.98 -45.81 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.927 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -62.3 -42.95 99.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 121.414 1.916 . . . . 0.0 110.764 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.2 -42.42 98.56 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.449 0.3 . . . . 0.0 110.696 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.44 -36.92 52.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.597 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -43.61 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.79 81.41 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.903 0.851 . . . . 0.0 112.083 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -49.41 76.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.542 0.61 . . . . 0.0 110.302 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 -43.45 70.64 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.267 0.627 . . . . 0.0 109.354 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -46.42 75.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.283 1.033 . . . . 0.0 110.934 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -60.79 -55.61 31.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.382 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.272 3.1 p90 -67.72 -24.3 65.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 121.492 1.951 . . . . 0.0 111.992 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.52 67.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.059 0.845 . . . . 0.0 111.732 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -76.58 -41.67 45.47 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.671 1.189 . . . . 0.0 111.153 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.0 p -84.92 -21.09 29.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.098 0.959 . . . . 0.0 110.343 -174.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.78 21.62 79.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.108 0.861 . . . . 0.0 111.881 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.251 1.158 0 CA-C-N 117.928 0.864 . . . . 0.0 109.673 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -126.83 164.15 22.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.629 1.972 . . . . 0.0 106.553 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -135.37 124.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -169.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tt -122.98 133.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -135.95 105.2 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -77.35 151.36 34.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 111.297 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -149.62 130.7 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.025 0.93 . . . . 0.0 108.651 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -148.69 178.68 8.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 111.01 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -66.81 -8.7 30.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 113.787 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.85 102.62 0.19 Allowed Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.1 t-20 -42.83 -46.07 5.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.222 1.809 . . . . 0.0 111.87 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -35.27 -35.95 0.05 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.148 3.379 . . . . 0.0 115.302 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.0 p -111.77 -74.06 0.65 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.362 0.983 . . . . 0.0 112.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.688 1.131 . . . . 0.0 111.95 -169.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.5 m -64.62 -36.18 83.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.223 0.465 . . . . 0.0 110.845 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.73 -44.48 90.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.535 0.607 . . . . 0.0 111.465 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.4 mtp -65.46 -48.24 73.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 109.704 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.64 84.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.233 0.613 . . . . 0.0 111.209 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.78 -45.08 90.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.026 0.53 . . . . 0.0 110.274 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.1 90.88 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.914 -0.937 . . . . 0.0 112.607 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.15 -40.46 82.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.276 1.538 . . . . 0.0 111.39 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.04 79.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.936 0.335 . . . . 0.0 111.592 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.67 -33.26 68.15 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.858 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -71.54 -58.17 3.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.422 0.555 . . . . 0.0 110.332 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.39 -39.38 68.04 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.3 mt -86.55 -39.97 15.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.174 0.443 . . . . 0.0 111.811 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.56 -173.93 55.16 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.114 0.864 . . . . 0.0 113.207 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.87 -17.01 62.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.307 1.843 . . . . 0.0 113.867 -170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -60.38 -10.94 5.43 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.242 1.417 . . . . 0.0 111.672 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -133.9 166.92 21.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.662 1.185 . . . . 0.0 110.597 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.05 137.84 51.53 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 168.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -114.42 142.42 27.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -137.82 159.43 42.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 108.636 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -137.6 124.59 21.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.24 -174.13 3.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.336 1.054 . . . . 0.0 109.109 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.84 175.03 42.2 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.18 -42.65 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -144.82 179.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.876 1.27 . . . . 0.0 109.027 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.71 44.13 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.683 1.993 . . . . 0.0 106.941 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -133.33 -30.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.005 0.922 . . . . 0.0 110.68 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 169.08 -176.64 43.13 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -76.1 104.15 6.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.28 125.77 87.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.449 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.76 -34.57 44.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.372 2.715 . . . . 0.0 113.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -42.69 96.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.693 0.679 . . . . 0.0 110.53 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.64 87.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -61.27 -56.07 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -65.76 -40.69 92.3 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.549 1.068 . . . . 0.0 110.51 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.18 -39.6 79.33 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.822 0.737 . . . . 0.0 111.871 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.3 mmm -82.37 -40.36 21.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.659 0.384 . . . . 0.0 111.093 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.99 -36.09 82.36 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.087 0.955 . . . . 0.0 110.497 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.0 -18.86 65.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.184 0.594 . . . . 0.0 111.894 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.42 -2.96 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.582 1.153 . . . . 0.0 109.934 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.36 20.91 53.64 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.898 -1.127 . . . . 0.0 111.901 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.9 mt -113.29 90.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.71 79.03 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.69 0.796 . . . . 0.0 110.627 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.09 4.57 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.008 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 m -54.18 -25.8 24.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.785 1.175 . . . . 0.0 112.592 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -78.35 -17.35 56.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.637 1.175 . . . . 0.0 113.186 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -70.69 169.25 14.82 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.863 0.756 . . . . 0.0 110.131 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 p -145.96 163.76 34.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.594 1.557 . . . . 0.0 108.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -111.37 150.85 29.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.13 0.972 . . . . 0.0 109.703 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.587 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.5 t0 -149.62 160.18 43.71 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.141 2.176 . . . . 0.0 108.746 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -89.77 164.51 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.56 139.74 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.649 0.738 . . . . 0.0 111.846 -170.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -128.64 104.71 7.81 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 107.99 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 p -57.07 -24.76 56.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.842 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.41 -22.06 66.66 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.951 1.251 . . . . 0.0 112.286 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -108.57 -45.8 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.48 -40.97 69.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.183 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.06 -15.56 63.48 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.953 1.251 . . . . 0.0 113.575 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -106.02 -6.99 18.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.522 1.129 . . . . 0.0 111.137 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.97 155.09 35.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.311 0.505 . . . . 0.0 110.101 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.05 -32.73 44.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.307 -0.871 . . . . 0.0 108.885 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -144.28 140.4 29.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.536 1.134 . . . . 0.0 109.714 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.22 134.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.21 106.94 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 p -76.54 147.89 37.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.16 2.63 13.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.868 0.467 . . . . 0.0 110.953 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -151.86 147.73 26.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.18 -45.39 96.62 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.87 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.19 -32.85 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.409 0.604 . . . . 0.0 111.662 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.8 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.31 -18.77 64.92 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.62 -35.61 81.07 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.064 0.946 . . . . 0.0 111.927 172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.26 -36.83 66.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.13 110.26 1.26 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.902 1.281 . . . . 0.0 110.938 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.552 2.834 . . . . 0.0 109.743 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -43.76 110.34 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.011 1.724 . . . . 0.0 111.765 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 p -133.16 72.49 75.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.93 168.07 12.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.479 2.786 . . . . 0.0 110.752 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -49.99 -23.79 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.53 3.487 . . . . 0.0 117.87 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -54.69 -40.86 69.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.605 1.093 . . . . 0.0 110.356 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.66 97.7 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.746 2.019 . . . . 0.0 107.556 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -72.02 159.59 33.95 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -131.22 148.51 52.71 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.386 0.675 . . . . 0.0 109.271 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.81 148.45 37.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -132.91 106.88 7.96 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -102.52 170.01 8.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.211 1.404 . . . . 0.0 108.081 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.27 106.68 0.5 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.432 -168.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -138.52 140.82 39.29 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.868 0.867 . . . . 0.0 111.73 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.79 168.99 10.43 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.546 0.738 . . . . 0.0 109.286 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -74.43 112.64 18.12 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.77 -34.07 51.38 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.547 1.498 . . . . 0.0 112.311 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.13 -15.18 62.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.029 0.831 . . . . 0.0 112.513 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -118.95 20.79 12.67 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.201 1.401 . . . . 0.0 110.979 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.1 67.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 55.07 -160.59 0.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.027 1.731 . . . . 0.0 112.237 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.95 -70.33 0.68 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -159.95 163.72 33.96 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -59.17 -40.63 86.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.828 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.05 -31.56 70.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.603 -0.237 . . . . 0.0 111.09 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -75.57 -38.02 59.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.355 0.662 . . . . 0.0 110.195 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -60.27 -50.01 75.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.154 0.982 . . . . 0.0 109.491 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -60.77 -42.9 98.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.069 0.395 . . . . 0.0 110.727 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.65 -37.51 76.13 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.919 0.488 . . . . 0.0 110.622 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.31 -35.46 76.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.56 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -54.94 -44.29 74.16 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.104 1.32 . . . . 0.0 108.485 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -60.58 -41.82 95.42 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.957 0.344 . . . . 0.0 111.197 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -64.03 -51.22 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.28 -46.45 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.784 -1.103 . . . . 0.0 109.67 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -62.73 -41.65 99.27 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.551 1.523 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.77 -44.67 96.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.001 0.364 . . . . 0.0 110.168 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.16 -42.26 76.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.275 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.06 -45.7 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.613 1.097 . . . . 0.0 108.719 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.14 94.35 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -57.28 -45.93 83.62 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.933 0.893 . . . . 0.0 111.781 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.63 -35.23 79.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.612 1.096 . . . . 0.0 111.91 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 -41.46 76.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.757 1.162 . . . . 0.0 110.816 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.63 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 110.578 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.77 -52.86 63.74 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.643 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -55.25 -46.41 76.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 120.249 1.386 . . . . 0.0 109.966 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.78 90.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.245 0.618 . . . . 0.0 111.555 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -84.52 -37.46 21.24 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.534 0.734 . . . . 0.0 111.777 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.2 p -92.88 -23.66 18.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.597 0.759 . . . . 0.0 111.081 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.9 42.43 99.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.808 2.043 . . . . 0.0 112.468 -169.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 t30 . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 110.775 -0.083 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 48.0 mtmt -134.61 169.3 17.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.846 1.659 . . . . 0.0 107.577 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.92 134.36 53.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -124.39 132.74 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -129.1 105.54 8.25 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.835 0.854 . . . . 0.0 108.714 -170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -75.59 147.54 39.52 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.941 -0.474 . . . . 0.0 110.216 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.4 127.11 15.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.95 174.52 11.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.335 0.654 . . . . 0.0 110.104 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -66.86 -12.77 60.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.73 -1.231 . . . . 0.0 112.997 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.42 122.82 1.21 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 106.326 -2.709 . . . . 0.0 106.326 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -59.69 -45.92 90.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.876 0.87 . . . . 0.0 110.744 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' HG ' ' CD2' ' A' ' 42' ' ' HIS . 3.4 m -38.18 -30.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 130.089 3.356 . . . . 0.0 117.279 -169.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.3 m -120.51 -71.21 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.431 0.693 . . . . 0.0 110.195 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -66.74 -49.77 64.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.77 -169.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -63.87 -43.99 94.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.402 0.547 . . . . 0.0 109.623 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.73 -45.88 85.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.317 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 45.1 mtm -67.29 -45.34 76.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.258 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.14 -44.6 75.24 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.715 0.689 . . . . 0.0 111.048 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.88 -44.71 94.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.586 0.754 . . . . 0.0 110.468 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.97 -50.8 53.51 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.178 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -68.21 -37.21 80.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.752 1.776 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.96 79.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.553 -0.717 . . . . 0.0 111.247 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -59.09 -32.72 70.06 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.658 -0.651 . . . . 0.0 112.072 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.82 -49.43 18.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.43 0.692 . . . . 0.0 109.359 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -79.76 -34.88 39.46 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -170.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.77 -35.54 12.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.499 0.59 . . . . 0.0 112.017 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.22 -178.72 49.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.195 0.902 . . . . 0.0 112.793 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.02 -6.04 25.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.56 -8.69 4.64 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.044 1.738 . . . . 0.0 110.729 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.418 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 4.3 m95 -138.15 157.94 45.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 108.561 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.95 142.09 44.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 168.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.8 126.83 67.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 171.11 14.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 109.668 172.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.4 m -135.52 142.34 45.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.753 1.221 . . . . 0.0 110.261 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.69 -174.72 4.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.279 1.432 . . . . 0.0 108.925 169.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.44 175.95 41.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.01 -41.87 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.23 179.34 7.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.543 0.737 . . . . 0.0 110.083 170.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.8 42.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.295 2.238 . . . . 0.0 106.306 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.47 ' CD2' ' HG ' ' A' ' 14' ' ' SER . 28.3 p80 -136.7 -19.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.58 0.752 . . . . 0.0 111.686 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.1 -178.0 40.91 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -77.75 100.72 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.57 122.77 73.29 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.33 -171.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.5 -32.01 41.6 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.183 2.588 . . . . 0.0 113.521 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -39.84 92.79 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.812 0.733 . . . . 0.0 110.801 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.84 75.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.11 -54.78 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -66.89 -41.58 86.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.588 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.53 -46.09 84.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.516 0.598 . . . . 0.0 110.818 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 84.4 mmm -73.81 -37.44 64.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.462 0.574 . . . . 0.0 111.326 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.336 -0.852 . . . . 0.0 111.342 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -66.22 -19.35 65.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.669 0.788 . . . . 0.0 112.177 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.37 -4.6 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.862 1.265 . . . . 0.0 110.374 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.76 23.03 65.24 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.763 -1.211 . . . . 0.0 111.916 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -111.98 93.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.15 86.45 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.441 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.31 5.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.275 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -57.01 -26.18 59.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.851 1.659 . . . . 0.0 112.345 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -74.77 -17.65 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.406 1.082 . . . . 0.0 112.807 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.03 170.27 14.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.59 0.756 . . . . 0.0 110.109 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 p -146.68 160.36 42.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.49 1.516 . . . . 0.0 108.554 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.9 m -108.34 151.74 25.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.049 0.94 . . . . 0.0 109.729 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.56 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.0 t0 -153.05 161.16 42.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.205 2.202 . . . . 0.0 108.378 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 pt -91.54 163.65 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.12 133.98 20.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.394 0.678 . . . . 0.0 111.942 -169.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -123.11 112.67 18.02 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 107.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.8 p -57.06 -24.21 52.25 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 111.508 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.88 -22.58 67.02 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.67 1.188 . . . . 0.0 112.873 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.82 -43.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.956 0.798 . . . . 0.0 108.937 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -48.6 -51.11 29.64 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.251 1.02 . . . . 0.0 110.782 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.1 -15.77 62.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -104.19 -16.91 15.08 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.18 0.992 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.96 58.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.775 0.43 . . . . 0.0 109.868 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.24 -33.74 76.43 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.9 tp -144.33 141.62 29.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.202 1.401 . . . . 0.0 109.702 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.35 132.3 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 109.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.08 88.24 7.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.67 -10.55 19.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.087 1.755 . . . . 0.0 114.357 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.0 t -148.66 157.71 43.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.834 1.652 . . . . 0.0 110.197 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.98 -59.29 9.59 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.259 1.885 . . . . 0.0 112.191 -170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.48 -26.9 66.59 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.536 0.334 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.29 72.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.795 0.438 . . . . 0.0 111.592 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.11 -20.11 65.07 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.05 -29.8 70.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.691 0.678 . . . . 0.0 112.277 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -77.4 -32.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 117.303 -1.332 . . . . 0.0 113.344 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -47.23 108.44 0.88 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.297 1.039 . . . . 0.0 111.031 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.17 -34.99 26.36 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.901 1.734 . . . . 0.0 113.011 -169.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 125.79 1.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.9 p -128.15 82.4 68.55 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.53 173.31 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.633 2.889 . . . . 0.0 110.79 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.21 -29.35 16.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.882 3.054 . . . . 0.0 116.104 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -68.77 -8.04 39.46 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.185 0.994 . . . . 0.0 113.064 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.31 80.95 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.945 2.498 . . . . 0.0 104.732 -170.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.7 pttt -64.94 164.99 11.59 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.736 0.779 . . . . 0.0 108.948 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -127.53 150.1 49.84 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 109.561 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.37 153.17 44.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -147.59 139.15 23.88 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -139.52 -169.27 2.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.658 1.583 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.0 41.58 1.29 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.098 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -80.34 119.17 22.7 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.958 1.379 . . . . 0.0 112.597 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.21 150.64 43.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.062 0.945 . . . . 0.0 109.603 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -74.2 121.12 84.47 Favored Pre-proline 0 C--O 1.236 0.373 0 O-C-N 121.999 -0.438 . . . . 0.0 111.858 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.43 -32.14 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.834 1.69 . . . . 0.0 112.678 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.76 65.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.767 0.712 . . . . 0.0 112.362 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -100.18 -0.96 37.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.688 1.195 . . . . 0.0 111.594 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.9 148.68 29.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -159.01 164.47 35.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.817 0.447 . . . . 0.0 110.655 -171.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.24 -48.66 0.64 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -164.99 165.68 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.277 2.231 . . . . 0.0 105.416 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.14 -40.51 81.53 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.556 -0.715 . . . . 0.0 110.638 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.38 -28.48 65.12 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.377 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.32 -44.94 58.03 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.92 0.782 . . . . 0.0 109.194 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -56.02 -50.37 71.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.588 0.755 . . . . 0.0 109.75 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.93 -44.86 95.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.989 0.359 . . . . 0.0 110.505 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.9 75.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.602 0.637 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.57 -36.92 85.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.342 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -54.95 -53.37 56.56 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.634 1.106 . . . . 0.0 108.274 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.506 ' NE2' HH21 ' A' ' 124' ' ' ARG . 6.3 mm100 -58.1 -43.22 87.01 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.864 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -61.15 -49.41 77.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.58 0.627 . . . . 0.0 110.606 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.28 -45.89 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.891 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.506 HH21 ' NE2' ' A' ' 121' ' ' GLN . 47.6 ptt85 -61.88 -40.81 96.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.44 1.927 . . . . 0.0 111.087 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.48 -44.72 95.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.25 0.477 . . . . 0.0 109.793 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.28 -32.51 61.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.045 -0.979 . . . . 0.0 112.858 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -65.32 -42.82 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.697 1.135 . . . . 0.0 108.644 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.78 -46.46 82.85 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -58.56 -36.23 73.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.303 1.041 . . . . 0.0 111.41 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -51.41 70.05 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.587 0.755 . . . . 0.0 109.379 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.8 mt -72.89 -31.78 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.251 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -51.91 67.53 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.777 0.831 . . . . 0.0 110.828 169.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.68 -49.21 75.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 119.299 0.954 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -55.32 -39.35 69.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.584 0.629 . . . . 0.0 111.055 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.43 -47.42 49.17 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.767 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.51 -37.5 71.22 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.612 1.165 . . . . 0.0 110.91 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.0 p -90.61 -22.63 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.001 0.92 . . . . 0.0 110.163 -175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.68 41.48 99.6 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.083 1.353 . . . . 0.0 111.015 -175.252 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 119.954 -0.07 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -124.69 167.74 14.13 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.724 0.81 . . . . 0.0 110.631 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.7 138.45 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tt -121.57 138.83 50.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -132.04 106.21 7.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -75.82 146.64 39.75 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.565 0.746 . . . . 0.0 110.546 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.02 130.19 20.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -148.46 171.21 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.984 0.811 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -67.58 -9.64 44.66 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.148 -0.97 . . . . 0.0 113.4 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 118.36 0.82 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 106.652 -2.579 . . . . 0.0 106.652 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.61 -43.19 99.42 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.811 0.844 . . . . 0.0 112.107 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -43.33 -22.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.06 3.344 . . . . 0.0 117.336 -169.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -128.78 -71.7 0.63 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.295 0.952 . . . . 0.0 110.947 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -58.68 -49.14 78.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.371 0.532 . . . . 0.0 111.336 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.01 -36.15 69.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.863 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -62.73 -42.07 99.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.897 0.479 . . . . 0.0 111.313 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.6 mtm -66.2 -46.62 76.66 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.693 0.679 . . . . 0.0 110.258 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.45 77.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.898 0.479 . . . . 0.0 110.64 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -57.2 -44.6 83.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.528 1.131 . . . . 0.0 110.559 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.08 90.15 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.889 -0.95 . . . . 0.0 112.59 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.61 -38.43 83.94 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.468 1.634 . . . . 0.0 110.613 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.71 85.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.652 0.381 . . . . 0.0 111.701 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -58.64 -29.12 66.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.858 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -73.67 -59.6 2.64 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.685 0.675 . . . . 0.0 110.559 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -71.28 -42.52 68.62 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.05 -39.59 33.5 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.643 0.377 . . . . 0.0 110.694 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.76 53.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.481 1.039 . . . . 0.0 112.858 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.41 -17.1 58.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.601 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.36 -21.21 5.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.595 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -127.04 161.92 27.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 110.711 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -112.0 144.43 41.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.1 t -134.21 124.52 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.3 172.59 12.6 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -141.74 154.82 45.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.71 -163.81 1.74 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.79 1.236 . . . . 0.0 108.15 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.78 175.01 44.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.86 -41.36 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.4 173.72 11.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.791 0.836 . . . . 0.0 110.163 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.35 157.14 42.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.677 1.991 . . . . 0.0 107.989 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -134.79 -32.67 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.767 1.227 . . . . 0.0 110.707 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.89 -173.41 33.9 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.47 109.63 9.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 170.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -70.03 132.79 88.22 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.64 -28.48 60.72 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.018 1.812 . . . . 0.0 112.997 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -39.13 91.54 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.972 0.806 . . . . 0.0 110.847 174.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.87 65.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.78 -59.72 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -63.32 -40.99 98.85 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.96 0.8 . . . . 0.0 110.513 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.1 -46.51 72.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 111.362 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.4 mmm -77.48 -38.58 48.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.173 0.589 . . . . 0.0 111.495 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -60.95 -34.6 74.98 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.579 -0.701 . . . . 0.0 110.051 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -68.94 -22.01 64.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.6 t -76.08 -26.2 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 119.53 1.059 . . . . 0.0 109.371 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.04 23.63 9.64 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.796 1.189 . . . . 0.0 110.511 -169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.2 mt -118.75 101.93 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.98 129.92 40.78 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.33 -2.02 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.584 0.753 . . . . 0.0 110.714 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -29.15 69.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.421 1.01 . . . . 0.0 110.695 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.67 -16.68 64.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.752 1.621 . . . . 0.0 113.537 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -75.29 176.1 7.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.952 0.901 . . . . 0.0 109.037 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -141.93 153.54 44.44 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.843 1.257 . . . . 0.0 108.744 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -107.44 147.24 30.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 109.87 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.87 158.47 40.82 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.851 1.261 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 pt -88.7 162.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 137.66 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.73 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -126.28 114.85 18.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.22 1.408 . . . . 0.0 108.058 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -56.4 -28.6 59.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.723 0.809 . . . . 0.0 111.377 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.72 0.5 8.7 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.786 1.634 . . . . 0.0 113.475 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.88 -46.99 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp -45.79 -52.76 10.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.468 1.107 . . . . 0.0 111.395 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -5.78 22.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -132.51 5.16 4.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.675 1.19 . . . . 0.0 112.541 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.7 47.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.37 -33.2 67.06 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.8 tp -143.03 142.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.062 1.345 . . . . 0.0 109.18 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.31 134.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.49 134.12 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 118.958 0.799 . . . . 0.0 108.861 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -98.53 98.27 9.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.5 -12.26 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.256 1.422 . . . . 0.0 113.598 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.65 147.37 33.0 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.34 95.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.405 0.526 . . . . 0.0 112.342 -169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.95 -25.23 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.164 0.982 . . . . 0.0 111.731 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.7 -23.96 60.94 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.284 0.634 . . . . 0.0 111.689 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.14 -20.69 66.16 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.8 -32.63 70.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.096 0.558 . . . . 0.0 111.949 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -86.79 62.09 7.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.875 0.87 . . . . 0.0 110.588 -173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 77.0 m -120.21 75.15 22.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 108.391 172.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.04 -28.48 80.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.436 2.091 . . . . 0.0 114.659 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 ttp -158.76 99.28 1.55 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.939 0.896 . . . . 0.0 109.942 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p -128.37 73.7 80.07 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.452 1.101 . . . . 0.0 108.351 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.93 171.07 10.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.3 2.666 . . . . 0.0 110.856 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.34 -21.99 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.193 3.262 . . . . 0.0 116.456 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -63.27 -11.82 24.49 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 112.897 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.3 94.39 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 128.015 2.526 . . . . 0.0 105.273 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -70.81 165.25 23.55 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 98' ' ' ARG . 3.5 mtp85 -135.47 153.81 51.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.243 0.617 . . . . 0.0 111.671 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.54 167.08 23.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.58 6.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.844 0.858 . . . . 0.0 110.369 -169.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -115.27 -174.11 2.44 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.824 1.249 . . . . 0.0 109.405 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.63 43.64 1.19 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.239 -0.913 . . . . 0.0 114.231 -168.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -84.31 108.04 16.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.261 1.03 . . . . 0.0 111.819 -172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.37 152.6 37.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.018 0.927 . . . . 0.0 109.734 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -71.5 116.43 47.46 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 122.915 0.486 . . . . 0.0 111.713 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.21 -34.42 16.45 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.089 1.86 . . . . 0.0 112.1 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.47 -16.35 64.05 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.46 0.573 . . . . 0.0 112.076 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -111.53 14.95 21.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.978 1.311 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.83 -43.8 90.74 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.651 0.659 . . . . 0.0 111.684 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 50.36 -161.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.095 1.758 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.49 -69.83 0.21 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.877 1.703 . . . . 0.0 109.122 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -154.1 156.53 37.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.29 -38.76 84.6 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.264 0.938 . . . . 0.0 111.105 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.71 -32.34 72.91 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.257 -0.277 . . . . 0.0 111.106 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.09 -42.12 60.62 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.382 0.673 . . . . 0.0 109.877 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -58.46 -50.47 73.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.367 1.467 . . . . 0.0 110.149 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -62.01 -42.57 99.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.875 0.47 . . . . 0.0 110.619 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.03 72.7 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.784 0.72 . . . . 0.0 110.813 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.86 -40.27 83.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.737 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -56.41 -46.44 80.19 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.48 -48.74 79.78 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.663 0.785 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -59.55 -50.09 75.24 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.077 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.32 -44.6 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.223 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.05 -44.09 97.43 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.992 2.178 . . . . 0.0 110.627 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.74 -43.3 99.12 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.95 -38.03 66.91 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.604 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -42.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.774 1.625 . . . . 0.0 108.617 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.78 93.72 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.43 ' ND2' HH21 ' A' ' 130' ' ' ARG . 45.5 t30 -59.23 -43.04 92.35 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.276 1.03 . . . . 0.0 112.008 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.43 HH21 ' ND2' ' A' ' 129' ' ' ASN . 4.3 mmp_? -60.84 -46.04 92.15 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.612 -0.68 . . . . 0.0 110.29 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.12 -41.11 90.96 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.258 0.481 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.34 -48.58 73.98 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.857 0.863 . . . . 0.0 110.246 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.88 -48.32 82.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.31 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.5 -44.5 85.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.873 1.215 . . . . 0.0 109.852 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.33 85.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.776 0.431 . . . . 0.0 111.148 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -82.15 -38.95 23.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.418 1.087 . . . . 0.0 111.226 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 47.5 p -94.05 -22.95 18.2 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.203 0.601 . . . . 0.0 111.115 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.57 43.0 98.0 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.964 1.706 . . . . 0.0 112.707 -169.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 119.452 -0.308 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -141.99 170.67 15.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.62 142.59 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 118.758 0.708 . . . . 0.0 109.791 -168.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.25 135.76 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.86 104.16 6.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.33 0.652 . . . . 0.0 109.38 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -77.4 149.54 35.15 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.795 0.838 . . . . 0.0 110.532 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.77 132.42 14.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -149.95 171.96 15.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.264 1.393 . . . . 0.0 110.916 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -64.18 -13.32 47.79 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.948 -1.095 . . . . 0.0 112.93 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 119.21 0.9 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 105.367 -3.093 . . . . 0.0 105.367 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.3 t-20 -56.3 -43.01 78.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.771 0.828 . . . . 0.0 110.46 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' HG ' ' CD2' ' A' ' 42' ' ' HIS . 1.0 OUTLIER -30.8 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 132.626 4.37 . . . . 0.0 118.06 -169.147 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.82 -58.83 0.76 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.654 0.661 . . . . 0.0 111.659 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -61.69 -50.54 72.04 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.025 0.83 . . . . 0.0 110.973 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -68.74 -38.28 80.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.226 0.466 . . . . 0.0 110.815 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -61.59 -43.7 98.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.776 0.716 . . . . 0.0 111.817 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 74.7 mtm -67.41 -46.85 72.01 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.27 0.486 . . . . 0.0 109.814 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.59 -42.0 74.18 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.274 0.488 . . . . 0.0 111.055 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.25 -48.15 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.051 0.54 . . . . 0.0 110.186 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.99 -50.86 53.37 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.574 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.8 m95 -67.18 -37.71 84.17 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.632 1.716 . . . . 0.0 110.851 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.05 82.72 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.219 0.918 . . . . 0.0 111.627 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -60.45 -27.17 67.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.192 0.906 . . . . 0.0 112.255 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.42 -47.1 13.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.615 0.766 . . . . 0.0 109.872 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -77.61 -28.63 51.55 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.07 -145.69 0.31 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.162 1.385 . . . . 0.0 108.297 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 -170.58 42.89 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.22 0.918 . . . . 0.0 111.857 -171.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.85 -19.07 63.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.707 1.603 . . . . 0.0 113.668 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.91 -12.12 10.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.859 1.264 . . . . 0.0 112.013 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -129.24 162.32 28.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.014 1.326 . . . . 0.0 110.782 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.2 132.13 53.05 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.15 137.05 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -137.25 163.88 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.548 0.739 . . . . 0.0 109.307 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -140.14 128.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.79 -173.11 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.757 1.223 . . . . 0.0 108.585 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.38 171.44 41.38 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.84 -41.02 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.93 179.36 7.23 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.005 0.922 . . . . 0.0 109.257 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.85 121.82 10.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.76 1.624 . . . . 0.0 106.652 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.424 ' CD2' ' HG ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -80.25 -34.78 36.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.41 -173.82 37.04 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.902 2.191 . . . . 0.0 107.693 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.28 105.29 11.44 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.93 130.87 86.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.969 -169.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.85 -34.34 75.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.53 2.82 . . . . 0.0 113.724 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.38 78.42 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.43 0.559 . . . . 0.0 111.181 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.47 63.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.42 -53.5 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -65.72 -42.88 90.56 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 119.065 0.848 . . . . 0.0 110.383 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.52 72.15 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.64 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 83.4 mmm -83.22 -37.52 23.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.713 0.688 . . . . 0.0 111.526 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -65.68 -29.83 70.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.302 -0.874 . . . . 0.0 110.934 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.53 -18.77 65.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.111 0.964 . . . . 0.0 112.248 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.12 -9.71 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.48 1.112 . . . . 0.0 109.99 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.55 21.45 56.28 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -111.75 90.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.83 77.76 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 110.245 -172.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.05 3.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 111.868 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -53.86 -26.42 24.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.462 1.105 . . . . 0.0 112.46 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -79.79 -12.04 59.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.003 1.321 . . . . 0.0 113.593 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -74.32 172.79 11.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.259 0.936 . . . . 0.0 109.238 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -146.84 161.58 40.4 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 107.783 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.2 m -104.06 151.45 23.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.643 0.777 . . . . 0.0 109.628 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.545 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -147.39 159.81 43.27 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.945 2.098 . . . . 0.0 108.496 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -89.6 165.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 142.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.037 0.935 . . . . 0.0 112.31 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -132.22 104.24 6.67 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.364 1.865 . . . . 0.0 108.383 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 p -56.9 -26.34 58.89 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -69.8 -4.86 21.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.24 1.016 . . . . 0.0 112.79 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.82 -48.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.61 -44.49 57.08 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.815 0.734 . . . . 0.0 112.158 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -3.68 17.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -135.48 10.65 3.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.984 1.314 . . . . 0.0 112.185 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.32 152.93 36.5 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.07 -36.26 79.55 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.866 1.212 . . . . 0.0 108.629 170.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.54 155.42 43.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.872 0.844 . . . . 0.0 112.28 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -113.56 138.87 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 102.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.7 p -76.08 147.96 38.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 3.13 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.01 0.524 . . . . 0.0 112.127 -169.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.81 162.19 40.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.357 0.981 . . . . 0.0 108.396 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.07 97.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.44 -35.63 73.47 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.096 0.948 . . . . 0.0 111.18 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.67 -23.66 67.23 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.066 0.546 . . . . 0.0 112.405 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.56 -29.44 59.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.466 0.707 . . . . 0.0 112.373 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.36 -32.7 74.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.209 0.604 . . . . 0.0 112.261 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -86.9 58.61 5.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.389 0.676 . . . . 0.0 110.59 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.96 81.21 12.04 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.76 -35.46 98.6 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.828 2.352 . . . . 0.0 114.384 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -159.31 125.36 4.39 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.153 0.981 . . . . 0.0 108.356 169.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -138.94 79.96 25.75 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.35 169.87 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.073 2.515 . . . . 0.0 110.846 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.66 -18.95 6.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.407 3.405 . . . . 0.0 116.378 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -61.56 -13.81 24.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.15 0.98 . . . . 0.0 112.691 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 t -127.95 109.25 19.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.177 2.191 . . . . 0.0 106.542 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.04 167.75 20.04 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -135.62 150.37 49.62 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.529 0.732 . . . . 0.0 109.846 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 153.8 43.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 169.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -138.3 84.57 2.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -169.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -79.53 176.45 9.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.943 1.297 . . . . 0.0 109.446 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.3 93.96 0.19 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.327 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -131.93 121.43 23.99 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.831 0.853 . . . . 0.0 111.131 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -64.77 152.25 43.14 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.621 1.168 . . . . 0.0 109.92 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.76 114.91 28.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.057 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -31.67 29.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.018 1.812 . . . . 0.0 112.707 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.9 -15.21 62.74 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.592 0.633 . . . . 0.0 112.053 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -115.63 22.15 13.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.617 1.567 . . . . 0.0 110.732 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.01 -27.04 69.15 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 43.51 -147.53 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.985 2.114 . . . . 0.0 113.275 -175.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.6 -73.12 1.43 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.5 166.17 16.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.534 2.334 . . . . 0.0 105.623 172.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.84 -40.21 79.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.353 0.979 . . . . 0.0 111.447 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.65 -28.97 63.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.442 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.45 -39.78 67.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.981 0.809 . . . . 0.0 109.322 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.22 -48.14 82.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 109.832 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -61.03 -43.06 99.45 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.299 0.5 . . . . 0.0 110.573 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.19 -32.9 70.33 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.597 -0.689 . . . . 0.0 110.911 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -74.75 -35.51 62.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.023 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -53.57 -45.42 69.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.96 1.254 . . . . 0.0 108.809 169.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.25 -46.92 85.09 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 123.027 0.531 . . . . 0.0 111.3 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -61.39 -50.96 70.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.949 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.21 -44.3 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.206 -1.378 . . . . 0.0 109.903 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -63.15 -43.28 98.77 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 121.565 1.984 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.38 -42.74 99.2 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.514 0.325 . . . . 0.0 110.266 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.72 -45.44 71.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.343 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -61.27 -40.7 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.034 1.288 . . . . 0.0 108.87 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.12 85.36 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -56.98 -41.5 78.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.251 1.02 . . . . 0.0 112.218 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -65.16 -41.46 94.67 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.35 -0.844 . . . . 0.0 110.174 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.76 -36.74 78.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.476 1.035 . . . . 0.0 111.475 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -49.6 76.47 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.679 0.792 . . . . 0.0 110.092 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.77 -48.32 81.18 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.757 0.708 . . . . 0.0 109.915 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.01 -38.6 70.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.212 0.915 . . . . 0.0 111.154 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.57 -45.86 61.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.49 -38.62 54.97 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.244 1.018 . . . . 0.0 111.72 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.4 p -94.35 -16.81 23.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.576 1.15 . . . . 0.0 111.05 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.06 92.0 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.906 1.283 . . . . 0.0 112.037 -169.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.473 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 42.4 mtmt -133.05 171.14 14.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.477 1.511 . . . . 0.0 108.679 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -136.1 139.28 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tt -125.76 135.48 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -130.92 111.88 12.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.87 141.01 31.62 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.562 ' CD2' ' HG ' ' A' ' 89' ' ' CYS . 6.3 mp -124.6 140.67 52.72 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -154.86 169.68 23.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.298 0.639 . . . . 0.0 109.445 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -71.03 -7.83 49.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.77 119.17 0.85 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 57.7 t-20 -77.36 72.53 3.91 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.352 1.061 . . . . 0.0 109.017 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.1 p -134.13 -30.96 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.311 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 m -134.75 -67.69 0.56 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.911 0.778 . . . . 0.0 111.63 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -57.79 -50.55 72.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.927 0.491 . . . . 0.0 111.74 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -64.43 -36.81 85.39 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.25 0.477 . . . . 0.0 111.618 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.51 -42.5 71.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.822 . . . . 0.0 110.85 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -62.06 -51.63 67.17 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.56 76.69 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.929 0.492 . . . . 0.0 110.969 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.68 -48.55 81.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.287 0.635 . . . . 0.0 109.97 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.82 -46.78 93.49 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.616 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.7 m95 -66.87 -41.87 86.55 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.065 1.433 . . . . 0.0 110.908 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.45 80.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.514 0.597 . . . . 0.0 111.055 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -57.45 -34.33 68.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.805 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.66 -58.62 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.366 0.53 . . . . 0.0 110.132 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -70.72 -36.44 73.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -169.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 42.8 mt -91.49 -36.69 13.6 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.78 -177.84 46.82 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.856 0.741 . . . . 0.0 112.723 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.54 -8.66 49.13 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.89 -9.79 2.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 110.972 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.473 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 9.6 m95 -136.36 166.42 23.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.835 1.654 . . . . 0.0 108.945 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.05 146.35 47.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 167.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.2 121.77 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -168.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.01 165.88 24.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.459 0.647 . . . . 0.0 109.841 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p -132.34 139.03 47.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.879 1.272 . . . . 0.0 108.427 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.59 -175.66 4.45 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.491 1.517 . . . . 0.0 108.565 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.04 177.19 46.39 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 121.802 -0.562 . . . . 0.0 111.891 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.53 -41.64 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.812 1.245 . . . . 0.0 108.569 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.89 177.42 8.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.82 0.848 . . . . 0.0 109.546 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.98 166.62 29.08 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.981 1.712 . . . . 0.0 108.714 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.26 -46.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.587 1.155 . . . . 0.0 108.12 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.74 25.91 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.62 122.53 14.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -74.24 141.44 77.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.661 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.11 -34.69 69.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.922 2.415 . . . . 0.0 113.715 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -35.43 78.96 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.719 0.691 . . . . 0.0 111.812 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.55 -42.1 68.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.01 -55.51 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.37 -44.41 96.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.4 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.13 88.74 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.087 0.858 . . . . 0.0 111.215 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.6 mmm -73.46 -39.93 64.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.7 0.4 . . . . 0.0 110.403 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -64.78 -33.5 76.14 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.141 0.976 . . . . 0.0 110.977 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.54 -15.29 62.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.791 1.236 . . . . 0.0 112.232 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.64 1.91 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.174 1.39 . . . . 0.0 109.781 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.29 72.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.661 -1.274 . . . . 0.0 112.299 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.57 93.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.09 77.8 5.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.46 0.704 . . . . 0.0 110.515 -172.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.4 pt -73.99 1.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.904 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -53.68 -27.94 30.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.99 1.268 . . . . 0.0 112.511 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.91 -22.37 61.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.061 1.344 . . . . 0.0 113.054 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -71.51 168.03 18.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.083 0.953 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -145.23 164.98 29.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.492 1.917 . . . . 0.0 108.115 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.2 m -108.68 158.26 17.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.531 0.681 . . . . 0.0 110.773 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 47.3 t0 -153.2 159.75 42.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.918 2.087 . . . . 0.0 107.499 172.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -88.44 166.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.02 108.52 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.152 0.981 . . . . 0.0 111.274 -170.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -94.03 114.56 26.76 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -18.76 62.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.245 1.418 . . . . 0.0 112.559 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.07 -47.7 60.83 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.121 0.873 . . . . 0.0 110.974 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.9 -42.65 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -48.85 -49.31 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.21 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -76.26 -12.96 60.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -92.75 -17.63 23.96 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.283 0.947 . . . . 0.0 110.903 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.74 50.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.168 0.44 . . . . 0.0 111.568 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 -37.5 75.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.71 162.59 39.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.931 0.872 . . . . 0.0 112.811 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.72 141.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.03 111.49 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.0 p -90.18 103.08 15.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.25 -8.97 50.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.328 0.651 . . . . 0.0 112.287 -172.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -143.6 154.21 43.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.51 95.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.26 -32.07 73.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.591 0.695 . . . . 0.0 111.557 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.75 70.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.258 0.481 . . . . 0.0 111.794 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.5 64.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.3 -31.54 72.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.568 0.622 . . . . 0.0 111.811 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.2 -28.51 57.28 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.175 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.562 ' HG ' ' CD2' ' A' ' 9' ' ' LEU . 6.3 m -47.06 108.01 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.4 1.08 . . . . 0.0 111.016 -169.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.25 -38.73 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.957 1.771 . . . . 0.0 114.526 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.7 tpt -165.74 132.01 2.64 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.316 1.046 . . . . 0.0 109.166 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.7 p -137.88 96.42 10.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.74 168.39 20.28 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.889 2.393 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -50.86 -26.17 17.39 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.037 3.158 . . . . 0.0 115.85 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -66.17 -7.14 16.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.365 1.066 . . . . 0.0 113.077 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.65 97.03 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.96 2.104 . . . . 0.0 105.58 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 163.62 27.12 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.254 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -141.84 128.53 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.45 155.67 45.34 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.072 1.349 . . . . 0.0 108.054 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -137.64 143.23 41.29 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.506 0.722 . . . . 0.0 111.665 -169.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -139.28 -170.99 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.724 1.609 . . . . 0.0 108.553 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.91 45.2 0.98 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-N 119.11 0.868 . . . . 0.0 113.379 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -80.93 122.97 27.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.062 0.931 . . . . 0.0 111.576 -173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -78.19 152.65 32.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.66 127.76 76.89 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.698 -0.626 . . . . 0.0 112.47 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.35 -34.22 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.164 1.909 . . . . 0.0 113.375 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -22.05 66.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.282 0.946 . . . . 0.0 112.235 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -100.12 -0.9 38.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.419 1.088 . . . . 0.0 111.146 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.75 152.35 23.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -160.81 164.1 31.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.29 0.636 . . . . 0.0 110.358 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.52 -49.53 0.61 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.14 166.23 19.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.051 2.14 . . . . 0.0 105.649 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.36 -40.69 82.89 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.753 -0.592 . . . . 0.0 110.579 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.94 -29.05 64.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.346 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.3 -45.05 61.68 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -56.94 -49.85 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.661 0.784 . . . . 0.0 109.964 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -61.59 -44.22 97.41 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.34 0.518 . . . . 0.0 110.398 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -40.28 80.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.321 0.509 . . . . 0.0 110.293 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -62.59 -36.92 84.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.191 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.89 -50.59 70.26 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.327 0.967 . . . . 0.0 108.595 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -61.62 -45.45 94.0 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.045 0.538 . . . . 0.0 110.834 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -59.91 -50.01 75.45 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.271 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.4 -47.41 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 117.449 -1.262 . . . . 0.0 109.945 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -61.73 -41.55 97.78 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.828 1.649 . . . . 0.0 110.806 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.74 -41.74 99.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.074 0.397 . . . . 0.0 110.017 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -76.61 -33.8 58.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.619 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.62 -42.11 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.702 1.137 . . . . 0.0 108.069 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.75 -47.11 79.06 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -53.65 -44.48 69.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.883 1.273 . . . . 0.0 111.166 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -47.49 85.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 119.249 -0.405 . . . . 0.0 110.908 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.02 -37.24 83.79 Favored 'General case' 0 C--O 1.229 -0.023 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -59.15 -49.07 79.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.782 0.833 . . . . 0.0 110.407 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.61 -45.63 82.38 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.371 0.987 . . . . 0.0 109.65 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -55.39 -38.5 68.97 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.024 0.829 . . . . 0.0 111.016 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.98 34.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.601 0.76 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.76 -38.96 73.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.762 1.225 . . . . 0.0 111.32 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 p -90.34 -16.07 29.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.856 0.862 . . . . 0.0 110.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.78 40.63 89.65 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.78 1.232 . . . . 0.0 111.789 -169.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -142.55 169.37 17.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.381 1.472 . . . . 0.0 109.026 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.3 mt -135.98 147.31 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 tt -134.64 142.9 39.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.484 1.114 . . . . 0.0 108.387 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.27 107.22 7.08 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.71 143.39 48.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.991 0.517 . . . . 0.0 109.934 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.08 143.22 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.083 1.753 . . . . 0.0 106.536 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.91 170.29 22.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 118.674 0.67 . . . . 0.0 109.53 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -66.82 -10.67 50.34 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.118 -0.989 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.98 119.82 0.93 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.4 t-20 -56.9 -46.58 81.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.632 0.773 . . . . 0.0 110.355 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 m -42.33 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 130.191 3.396 . . . . 0.0 117.733 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -119.5 -78.31 0.59 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.002 0.819 . . . . 0.0 109.499 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -61.89 -47.77 83.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.109 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -68.98 -38.25 79.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.063 0.847 . . . . 0.0 110.901 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -43.77 96.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.646 0.657 . . . . 0.0 111.484 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.4 mtp -66.18 -47.32 74.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.366 0.666 . . . . 0.0 109.546 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.9 78.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.388 0.675 . . . . 0.0 110.979 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.43 -45.85 80.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.62 0.768 . . . . 0.0 110.129 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.95 -47.29 91.41 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -69.97 -39.14 76.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.38 1.59 . . . . 0.0 111.055 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.1 79.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.744 0.417 . . . . 0.0 111.554 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.5 -33.91 64.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.82 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -74.48 -57.33 4.01 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.27 0.486 . . . . 0.0 110.603 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -73.58 -45.0 55.89 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -73.84 -35.71 64.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.486 0.584 . . . . 0.0 111.348 -169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.9 167.99 42.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.973 0.797 . . . . 0.0 111.78 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.78 -12.04 61.31 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -52.81 -31.6 39.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.384 0.611 . . . . 0.0 110.055 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -100.91 150.45 22.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -110.41 125.8 53.63 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 167.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.18 127.2 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -168.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.0 172.0 13.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.629 1.172 . . . . 0.0 108.768 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -137.47 139.67 40.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.118 0.967 . . . . 0.0 109.507 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.09 -175.15 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.344 1.458 . . . . 0.0 109.022 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.03 175.79 40.88 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -42.1 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.51 179.48 7.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.84 0.856 . . . . 0.0 109.815 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.33 151.16 37.88 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.613 1.965 . . . . 0.0 106.964 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -127.84 10.35 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.769 1.227 . . . . 0.0 111.797 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.84 -173.54 18.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 126.113 1.816 . . . . 0.0 109.035 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.76 109.3 20.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -63.49 124.55 84.86 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.286 -172.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.18 -34.16 38.44 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.288 2.658 . . . . 0.0 113.657 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -38.64 87.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.77 0.714 . . . . 0.0 110.913 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.13 75.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.61 -52.14 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -65.97 -41.89 90.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.87 0.759 . . . . 0.0 110.827 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.83 -45.58 82.24 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.839 0.745 . . . . 0.0 110.954 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.7 mmm -75.78 -38.91 57.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.467 0.307 . . . . 0.0 110.903 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.96 -34.02 77.43 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.01 -1.056 . . . . 0.0 110.993 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.84 -20.4 66.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 112.238 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.83 -10.06 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 110.281 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.15 20.05 28.98 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.629 1.109 . . . . 0.0 111.925 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.56 91.35 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -77.49 76.79 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.751 1.22 . . . . 0.0 110.089 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.69 2.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 121.381 -0.824 . . . . 0.0 112.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.68 -28.9 16.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.348 1.859 . . . . 0.0 112.802 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.22 -16.62 57.67 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.847 1.259 . . . . 0.0 112.922 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -70.67 171.83 9.71 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.826 0.85 . . . . 0.0 109.7 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -147.1 158.95 44.11 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 107.819 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -98.43 156.33 16.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 110.043 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 43.1 t0 -150.26 162.7 39.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.891 2.076 . . . . 0.0 108.088 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -94.21 160.9 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 133.23 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 112.515 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -116.89 111.64 19.93 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.559 1.944 . . . . 0.0 106.83 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -62.0 -19.56 62.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.993 0.917 . . . . 0.0 112.719 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.78 -43.42 84.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.772 1.169 . . . . 0.0 111.322 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.99 -48.7 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.81 -52.35 24.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.237 1.015 . . . . 0.0 110.409 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -68.96 -10.19 56.05 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.23 6.49 7.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.001 1.273 . . . . 0.0 112.812 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 154.0 39.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.49 -32.43 54.26 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.553 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 33.5 tp -145.43 145.84 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.153 1.381 . . . . 0.0 109.104 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -126.5 140.41 48.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.53 134.05 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.6 p -95.19 118.93 32.82 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.69 -0.76 31.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.153 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -147.22 163.03 37.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.695 1.134 . . . . 0.0 109.104 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.76 -38.99 77.11 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.852 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.52 -35.84 78.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.533 1.166 . . . . 0.0 110.925 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.72 -18.96 65.71 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.603 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.62 -23.97 65.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.935 0.789 . . . . 0.0 112.147 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.1 -34.05 76.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 111.979 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.56 63.95 8.26 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.06 0.944 . . . . 0.0 110.119 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.5 m -122.53 72.94 40.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.89 -48.43 7.52 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.08 3.186 . . . . 0.0 115.315 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 138.23 6.48 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -132.46 80.67 62.16 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.67 168.07 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.502 2.802 . . . . 0.0 110.916 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.9 -22.04 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.824 3.683 . . . . 0.0 118.655 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.21 -41.47 93.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.986 1.267 . . . . 0.0 110.615 170.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 156.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 127.785 2.434 . . . . 0.0 108.37 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.9 pttt -140.59 170.41 15.83 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.555 1.542 . . . . 0.0 107.777 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -134.02 157.07 47.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 112.417 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.97 158.39 43.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.189 2.196 . . . . 0.0 105.204 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -145.19 117.85 8.63 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.48 -0.763 . . . . 0.0 109.291 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -109.33 -174.13 2.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.019 1.327 . . . . 0.0 109.795 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.66 43.51 1.11 Allowed Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.418 -0.801 . . . . 0.0 114.534 -168.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -85.83 121.52 28.59 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.543 1.172 . . . . 0.0 111.168 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.06 155.12 40.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.78 120.89 83.75 Favored Pre-proline 0 C--O 1.235 0.318 0 O-C-N 121.833 -0.542 . . . . 0.0 111.417 -170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.85 -33.75 42.0 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.556 1.504 . . . . 0.0 112.754 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.14 -20.47 66.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.522 0.601 . . . . 0.0 112.526 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.13 -0.02 34.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.527 1.131 . . . . 0.0 111.568 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 150.18 24.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.67 164.52 33.94 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.183 0.593 . . . . 0.0 110.085 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.11 -48.21 0.69 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -164.11 162.69 23.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.904 2.082 . . . . 0.0 105.449 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.01 -40.86 86.23 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.693 -0.629 . . . . 0.0 110.495 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.22 -29.35 68.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.319 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -76.38 -40.22 51.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.988 0.813 . . . . 0.0 109.913 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.03 -51.37 69.53 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -60.21 -44.57 95.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.47 79.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -61.2 -34.84 75.73 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.97 0.805 . . . . 0.0 111.621 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -57.39 -48.46 79.02 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -61.23 -44.17 97.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.403 0.681 . . . . 0.0 111.919 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -61.27 -53.08 61.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.64 0.654 . . . . 0.0 109.578 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.23 -43.02 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.638 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -61.16 -43.87 98.21 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.941 1.7 . . . . 0.0 110.992 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.49 -43.66 96.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.35 -39.89 71.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.01 -45.24 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.565 1.075 . . . . 0.0 108.37 175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.89 95.18 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -62.19 -39.52 92.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.221 1.01 . . . . 0.0 111.719 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -38.6 85.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.98 0.809 . . . . 0.0 110.685 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.96 -38.98 66.54 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.925 -0.484 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -56.87 -47.15 81.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.119 0.968 . . . . 0.0 110.138 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.61 -52.22 66.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 117.324 -1.322 . . . . 0.0 109.519 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.02 -44.08 82.48 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.457 1.48 . . . . 0.0 110.196 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.21 92.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.264 0.626 . . . . 0.0 111.642 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.45 -37.68 22.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.994 0.918 . . . . 0.0 111.416 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 p -94.62 -22.77 17.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.592 0.757 . . . . 0.0 111.345 -170.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.249 1.05 0 C-N-CA 127.443 2.297 . . . . 0.0 112.443 -170.045 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.31 176.68 9.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.183 0.993 . . . . 0.0 109.474 169.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.9 mt -133.25 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.33 132.93 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -127.78 101.62 6.44 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.145 0.978 . . . . 0.0 108.387 -171.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -73.11 145.77 46.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.62 131.58 21.64 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HG ' ' HG2' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -151.58 -178.1 6.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.131 0.423 . . . . 0.0 111.214 172.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -7.41 36.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.713 -1.242 . . . . 0.0 114.07 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.65 129.92 2.08 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 45.4 t-20 -81.22 40.17 0.54 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.276 1.031 . . . . 0.0 112.062 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.4 p -122.46 -20.91 5.91 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 111.765 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.1 m -134.66 -73.37 0.47 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.948 0.899 . . . . 0.0 110.866 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.403 ' HG2' ' HG ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -55.69 -60.21 3.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.909 0.777 . . . . 0.0 111.038 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 m -62.68 -42.34 99.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.656 0.382 . . . . 0.0 110.468 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -61.01 -45.58 94.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.219 0.608 . . . . 0.0 111.405 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 43.2 mtm -66.77 -46.17 76.18 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.933 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.03 -44.99 79.3 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.368 0.531 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.25 -45.24 91.71 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.773 0.829 . . . . 0.0 110.082 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.48 -46.58 92.93 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.474 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -69.63 -39.82 76.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.554 1.677 . . . . 0.0 110.822 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.84 78.83 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.358 0.526 . . . . 0.0 110.844 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -57.2 -33.06 67.12 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.727 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -71.56 -57.7 4.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.465 0.575 . . . . 0.0 110.148 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -70.24 -37.81 75.04 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.93 -38.74 12.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.095 0.558 . . . . 0.0 111.839 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 177.45 48.41 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.267 0.937 . . . . 0.0 112.391 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.48 -10.15 53.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.697 1.199 . . . . 0.0 113.585 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.9 -10.69 6.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.282 1.433 . . . . 0.0 111.379 169.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.61 146.11 50.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.607 1.563 . . . . 0.0 108.095 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.76 138.46 37.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 167.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.18 127.54 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -168.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.33 169.82 16.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -134.81 143.05 46.85 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 109.766 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.26 -177.11 4.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.282 1.433 . . . . 0.0 108.838 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.91 167.36 35.92 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.64 -40.78 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.42 179.77 6.9 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.997 . . . . 0.0 109.852 170.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.11 159.43 43.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.256 1.822 . . . . 0.0 108.017 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -147.74 -31.37 0.3 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.365 0.666 . . . . 0.0 111.833 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.91 173.61 34.55 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.19 107.27 2.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -72.4 130.9 85.36 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.02 -27.09 65.92 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.866 1.711 . . . . 0.0 112.956 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -39.1 93.22 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.996 0.816 . . . . 0.0 111.2 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.37 62.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.91 -58.36 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -64.03 -39.58 94.42 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 118.644 0.656 . . . . 0.0 110.557 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.52 68.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.709 0.686 . . . . 0.0 110.935 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.72 -38.49 67.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.022 0.529 . . . . 0.0 111.108 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -68.97 -29.02 67.15 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.304 -0.873 . . . . 0.0 111.6 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.94 -18.55 65.43 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.464 1.105 . . . . 0.0 111.874 170.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.04 -2.96 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.769 1.228 . . . . 0.0 109.798 172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.27 18.93 54.55 Favored Glycine 0 CA--C 1.531 1.031 0 O-C-N 120.79 -1.194 . . . . 0.0 112.307 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 mt -114.16 95.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.07 78.69 4.55 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.279 1.032 . . . . 0.0 110.168 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -72.83 -3.21 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.44 -0.787 . . . . 0.0 112.017 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -29.2 63.33 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.815 1.189 . . . . 0.0 112.077 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -73.02 -16.02 61.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.827 1.251 . . . . 0.0 112.533 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.61 171.01 9.63 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.707 0.803 . . . . 0.0 109.027 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -138.99 162.99 33.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.88 1.272 . . . . 0.0 109.086 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 p -116.83 144.66 44.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 109.451 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.515 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -153.46 155.58 36.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.091 2.156 . . . . 0.0 107.999 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.78 164.44 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tt -54.34 134.33 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 111.265 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -128.95 112.05 13.67 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.688 1.195 . . . . 0.0 108.493 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 p -54.83 -28.75 51.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.592 0.757 . . . . 0.0 111.28 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.69 -1.23 15.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.364 1.465 . . . . 0.0 113.66 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.22 -46.54 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -45.46 -54.33 7.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.864 1.266 . . . . 0.0 111.456 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -2.15 9.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -133.56 3.76 3.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.612 1.165 . . . . 0.0 112.758 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.07 151.01 48.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.22 -34.27 75.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tp -145.66 143.14 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.117 1.367 . . . . 0.0 109.726 -171.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.58 138.13 52.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.13 111.81 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -90.97 91.26 8.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.45 -9.43 12.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.284 1.033 . . . . 0.0 113.307 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.3 133.66 21.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.8 -32.93 66.63 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.717 0.675 . . . . 0.0 112.687 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.2 -30.68 71.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.33 1.065 . . . . 0.0 111.884 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 -30.92 68.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.266 0.626 . . . . 0.0 111.576 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.79 -20.12 64.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.16 -34.49 66.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.965 0.906 . . . . 0.0 112.129 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 -32.56 61.67 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.661 -171.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.0 m -48.8 108.11 0.89 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.992 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.76 -28.01 14.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.323 2.015 . . . . 0.0 114.239 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.9 ptp -163.61 131.34 3.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.271 1.028 . . . . 0.0 110.086 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -140.23 80.48 19.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.78 169.19 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.214 3.276 . . . . 0.0 113.23 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.21 -28.12 32.62 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.463 2.776 . . . . 0.0 115.047 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.57 -7.22 30.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.262 1.025 . . . . 0.0 112.968 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.11 81.7 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.931 2.492 . . . . 0.0 105.271 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.8 pttt -65.58 166.16 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -131.68 155.07 48.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.92 0.488 . . . . 0.0 110.384 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.74 159.74 41.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 149.21 31.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.4 0.68 . . . . 0.0 112.429 -168.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -143.06 -160.2 1.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.197 1.399 . . . . 0.0 109.084 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.65 41.28 0.99 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.84 1.2 . . . . 0.0 113.874 -169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -85.65 107.88 17.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.586 1.193 . . . . 0.0 111.999 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.25 154.37 35.26 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.586 1.155 . . . . 0.0 110.105 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.98 120.67 82.48 Favored Pre-proline 0 C--O 1.236 0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.974 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.32 -32.04 27.12 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.906 1.737 . . . . 0.0 112.372 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.37 -19.86 66.13 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.371 0.987 . . . . 0.0 112.24 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.87 1.59 34.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.708 1.203 . . . . 0.0 111.3 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.442 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.14 138.87 57.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -145.75 156.28 43.5 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.27 -55.18 0.41 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 t -155.75 158.5 38.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.23 -39.0 88.64 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.569 -0.707 . . . . 0.0 110.815 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.22 -30.88 70.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.2 -0.313 . . . . 0.0 111.049 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.75 -42.55 58.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.205 0.602 . . . . 0.0 109.848 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 20.3 tttt -55.42 -52.27 64.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.702 1.201 . . . . 0.0 110.1 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -60.29 -45.2 94.17 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 117.962 0.346 . . . . 0.0 110.322 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.82 79.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.284 0.493 . . . . 0.0 110.427 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.72 -39.82 92.88 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.589 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.31 -50.57 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.037 0.835 . . . . 0.0 108.802 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -60.21 -45.08 94.43 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 122.912 0.485 . . . . 0.0 111.165 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.54 -48.86 79.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.85 0.46 . . . . 0.0 110.384 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.93 -44.69 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.021 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -60.85 -42.33 97.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 121.496 1.953 . . . . 0.0 110.753 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.03 -44.61 96.33 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.42 -31.65 62.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.526 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.91 -43.38 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.246 . . . . 0.0 108.592 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.29 88.82 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.91 -35.96 75.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.935 1.294 . . . . 0.0 111.562 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -50.98 71.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 123.614 0.766 . . . . 0.0 109.197 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.18 -32.17 66.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.004 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -52.02 67.26 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.942 0.897 . . . . 0.0 110.521 169.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.19 -47.42 79.84 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 119.609 1.095 . . . . 0.0 109.349 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -55.83 -38.6 70.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.607 -0.683 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -48.56 37.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.572 0.749 . . . . 0.0 111.611 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.97 -38.34 72.77 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.558 1.143 . . . . 0.0 111.143 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.4 p -90.97 -18.48 24.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 110.27 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.13 39.31 95.66 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -173.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm . . . . . 0 C--O 1.25 1.102 0 C-N-CA 125.158 1.383 . . . . 0.0 111.665 -171.767 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.54 175.93 10.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.457 0.703 . . . . 0.0 110.552 169.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.97 136.19 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.52 135.29 64.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -132.26 105.37 7.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -74.06 147.43 42.84 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.637 -0.665 . . . . 0.0 110.137 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.73 130.14 17.75 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.95 173.56 14.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.68 0.673 . . . . 0.0 110.093 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -66.06 -9.2 28.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.928 -1.107 . . . . 0.0 113.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.58 1.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 53.9 t-20 -62.67 -49.09 76.49 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.469 0.707 . . . . 0.0 110.786 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.1 m -41.69 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 130.321 3.448 . . . . 0.0 117.816 -168.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.8 -73.61 0.64 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.812 1.187 . . . . 0.0 110.09 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -61.65 -49.45 76.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.125 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -69.69 -38.83 77.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.655 0.661 . . . . 0.0 111.005 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -61.36 -45.28 95.04 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.836 0.744 . . . . 0.0 111.697 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -65.08 -48.69 72.83 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.45 78.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.859 0.463 . . . . 0.0 111.047 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.18 -50.93 71.29 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 109.927 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.28 -46.86 92.34 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.113 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.4 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.9 m95 -66.74 -42.39 86.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.655 1.728 . . . . 0.0 110.711 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.04 75.6 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.591 0.632 . . . . 0.0 111.313 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -57.31 -33.99 68.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.45 -57.2 5.55 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.455 0.571 . . . . 0.0 110.1 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -69.67 -34.38 73.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.66 -38.11 9.65 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.255 0.622 . . . . 0.0 112.456 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 178.97 51.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.216 0.912 . . . . 0.0 112.761 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.53 -12.32 60.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.934 1.294 . . . . 0.0 113.759 -170.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.7 -7.54 2.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.76 1.624 . . . . 0.0 112.063 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -131.55 145.39 51.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.48 1.512 . . . . 0.0 108.681 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 7.4 mmpt? -98.43 136.21 38.9 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 167.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.51 116.71 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -168.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.28 171.84 13.19 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -139.84 142.67 36.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.278 1.031 . . . . 0.0 108.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.93 -176.43 4.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.766 1.626 . . . . 0.0 108.544 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.63 173.84 40.59 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.19 -40.85 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.08 177.41 8.79 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.896 0.878 . . . . 0.0 110.099 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.04 126.3 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.847 1.659 . . . . 0.0 107.207 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -77.6 -46.12 23.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.339 0.656 . . . . 0.0 109.428 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.1 -166.7 39.37 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -78.18 99.62 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -62.68 131.01 94.11 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.64 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.71 -28.5 82.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.232 1.954 . . . . 0.0 112.891 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -58.9 -50.1 75.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.377 0.989 . . . . 0.0 109.324 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.22 -42.24 85.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.451 0.569 . . . . 0.0 110.233 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.64 -54.4 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.438 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -64.21 -46.64 82.99 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.318 0.963 . . . . 0.0 110.33 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.5 70.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.011 0.924 . . . . 0.0 111.436 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -79.97 -36.39 36.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.365 0.666 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.32 -31.72 72.95 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.918 -1.113 . . . . 0.0 109.801 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -72.79 6.72 2.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.672 1.989 . . . . 0.0 112.122 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.75 -6.68 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.795 2.038 . . . . 0.0 108.669 169.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.65 25.46 56.38 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 120.574 -1.328 . . . . 0.0 111.202 -169.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -116.76 90.49 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -78.78 80.72 5.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.578 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -75.25 6.82 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.246 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.9 m -53.98 -27.15 29.76 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.04 1.291 . . . . 0.0 112.168 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.68 -18.09 58.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.569 1.147 . . . . 0.0 113.161 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -71.81 170.72 13.04 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.878 0.763 . . . . 0.0 109.895 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 156.0 43.55 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.748 1.619 . . . . 0.0 107.648 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -102.44 151.95 21.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.75 . . . . 0.0 109.381 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.537 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.6 t0 -152.11 161.24 42.92 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.733 2.013 . . . . 0.0 108.251 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 pt -93.16 162.86 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -57.37 113.21 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.72 118.37 29.27 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 m -72.08 -22.53 61.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.539 -170.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.54 -42.75 51.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.044 0.838 . . . . 0.0 110.051 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.74 -44.88 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.88 -49.12 74.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.188 0.449 . . . . 0.0 110.281 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -65.85 -18.47 65.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -98.15 -14.81 20.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.342 0.974 . . . . 0.0 110.682 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.68 159.98 33.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 118.399 0.545 . . . . 0.0 110.946 -169.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.37 -30.59 42.65 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 168.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 tp -152.02 145.69 25.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.621 1.568 . . . . 0.0 109.872 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.6 t -123.05 140.01 48.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.51 111.47 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.5 p -90.66 94.03 9.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.11 -10.78 33.33 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.038 0.935 . . . . 0.0 112.499 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.67 135.87 23.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.92 -34.02 76.5 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.758 0.694 . . . . 0.0 112.815 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.68 -29.28 70.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.356 1.078 . . . . 0.0 111.681 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.67 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 111.531 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.43 65.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.78 -34.29 71.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.233 1.013 . . . . 0.0 112.066 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -73.66 -32.12 63.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.883 -171.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 80.8 m -46.77 107.15 0.66 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.949 1.299 . . . . 0.0 109.627 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -64.26 -44.41 12.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.553 1.502 . . . . 0.0 114.239 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.8 ttt -167.26 123.66 1.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.291 1.036 . . . . 0.0 108.527 169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -109.24 85.48 3.48 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.7 166.62 17.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.984 2.456 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.23 -19.57 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.709 3.606 . . . . 0.0 118.279 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.18 -40.22 89.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.039 1.291 . . . . 0.0 110.051 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.26 162.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 127.881 2.472 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -142.58 169.27 17.88 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.586 1.555 . . . . 0.0 107.262 169.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -132.65 145.6 51.2 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.863 0.756 . . . . 0.0 111.156 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 152.18 43.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.301 2.24 . . . . 0.0 105.115 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.17 141.12 42.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.363 0.665 . . . . 0.0 110.284 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -138.26 -166.34 1.96 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.416 1.486 . . . . 0.0 109.076 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.54 1.13 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 119.197 0.908 . . . . 0.0 112.796 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.87 112.86 12.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.867 0.833 . . . . 0.0 110.728 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -69.14 153.56 43.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.354 0.662 . . . . 0.0 109.663 169.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.19 118.2 68.81 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 111.505 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.73 -33.7 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.005 1.804 . . . . 0.0 112.385 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.1 -19.14 64.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.745 0.702 . . . . 0.0 112.072 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -100.27 -2.95 32.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.766 1.226 . . . . 0.0 111.377 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.09 136.77 58.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 168.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.07 22.3 0.66 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -168.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.34 -51.58 42.32 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -172.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -160.17 163.62 33.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.81 2.444 . . . . 0.0 104.863 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.85 -40.02 83.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.09 1.314 . . . . 0.0 111.123 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.75 -32.75 72.73 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.282 -0.261 . . . . 0.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -75.32 -37.84 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.066 0.546 . . . . 0.0 110.144 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 41.7 tttt -59.26 -51.22 70.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.769 1.228 . . . . 0.0 109.415 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -61.96 -41.69 98.28 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.803 0.274 . . . . 0.0 110.644 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.59 73.64 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.48 -0.762 . . . . 0.0 110.859 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.2 -42.07 89.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.545 0.738 . . . . 0.0 110.385 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -56.05 -47.39 77.99 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -59.7 -48.63 80.91 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.96 0.904 . . . . 0.0 111.513 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.94 -45.06 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 116.619 -1.658 . . . . 0.0 110.262 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -61.19 -44.25 97.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 121.985 2.175 . . . . 0.0 110.48 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.71 -43.71 98.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -79.93 -27.31 39.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.255 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -65.88 -42.26 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 107.883 171.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.03 90.14 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.405 ' ND2' HH22 ' A' ' 130' ' ' ARG . 58.5 t30 -57.34 -40.79 78.73 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.403 1.081 . . . . 0.0 111.14 175.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.405 HH22 ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -62.13 -46.67 87.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.744 -0.598 . . . . 0.0 111.027 175.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.66 -34.31 77.91 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.588 0.631 . . . . 0.0 111.086 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -50.55 73.6 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.89 -47.36 83.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 119.712 1.142 . . . . 0.0 109.643 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.38 -39.19 72.52 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 118.394 0.543 . . . . 0.0 110.832 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.04 -48.21 46.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.907 0.883 . . . . 0.0 111.777 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -69.47 -39.6 77.61 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.726 1.21 . . . . 0.0 111.186 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -87.35 -17.66 31.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.315 1.046 . . . . 0.0 110.122 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.53 41.36 93.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.168 1.366 . . . . 0.0 110.71 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.763 0.825 . . . . 0.0 112.207 -170.771 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -146.52 173.62 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.648 1.179 . . . . 0.0 108.358 169.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.39 142.36 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -169.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.71 135.85 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.416 1.486 . . . . 0.0 107.149 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -129.01 103.43 7.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.963 0.905 . . . . 0.0 108.727 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.58 146.19 42.74 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 122.044 -0.41 . . . . 0.0 109.933 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.92 132.25 20.66 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -148.62 173.71 12.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.292 0.637 . . . . 0.0 110.116 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -68.17 -9.11 44.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.556 -1.34 . . . . 0.0 113.689 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.19 123.7 1.3 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.25 -41.04 97.15 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.219 0.509 . . . . 0.0 111.279 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -38.57 -28.94 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.77 3.228 . . . . 0.0 116.861 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -127.93 -74.93 0.57 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.206 0.912 . . . . 0.0 112.335 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mpp_? -53.87 -50.73 65.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.21 0.914 . . . . 0.0 113.436 -168.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 p -80.26 -27.81 38.56 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.979 0.809 . . . . 0.0 111.662 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -62.1 -41.39 98.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.643 1.11 . . . . 0.0 110.943 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 79.0 mtp -65.89 -49.37 68.29 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.64 73.66 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.938 0.495 . . . . 0.0 111.357 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -56.11 -48.91 75.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.081 0.952 . . . . 0.0 109.952 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.63 99.67 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.157 -0.801 . . . . 0.0 112.823 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 94.3 m95 -68.13 -44.11 76.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.168 1.484 . . . . 0.0 110.16 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.48 83.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.618 0.367 . . . . 0.0 110.358 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -59.14 -26.1 64.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.266 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -74.07 -59.21 2.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 110.438 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -69.81 -38.15 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.6 mt -87.19 -39.37 15.54 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.249 0.619 . . . . 0.0 112.176 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.39 -178.87 49.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.092 0.853 . . . . 0.0 112.834 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.93 -15.65 62.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.291 1.436 . . . . 0.0 113.567 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.76 -16.11 3.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.905 1.282 . . . . 0.0 111.534 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -129.08 140.54 51.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 110.083 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -89.57 131.15 35.73 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.54 119.21 54.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 171.59 14.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 171.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.2 p -136.78 152.37 50.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.238 1.015 . . . . 0.0 109.356 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.89 -168.86 3.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.076 1.351 . . . . 0.0 107.572 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.23 37.82 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.52 -40.18 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.07 179.52 6.85 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.467 1.107 . . . . 0.0 109.532 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.01 157.37 43.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.424 2.29 . . . . 0.0 106.574 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -132.5 -29.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.456 1.102 . . . . 0.0 110.185 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.53 -179.25 37.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.9 tp -75.81 101.47 5.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -62.0 124.8 83.39 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.374 -171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -51.08 -33.54 43.73 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.272 2.648 . . . . 0.0 113.719 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -39.54 90.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.651 0.659 . . . . 0.0 110.691 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.35 73.56 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -58.23 -53.35 47.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -67.62 -41.59 83.7 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.778 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.08 -49.05 74.89 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 118.886 0.766 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.42 ' HE1' ' CD1' ' A' ' 23' ' ' TRP . 98.6 mmm -71.02 -40.3 71.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.076 0.55 . . . . 0.0 110.84 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -64.57 -29.96 70.99 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.195 -0.941 . . . . 0.0 111.014 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -68.99 -22.37 64.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.963 0.905 . . . . 0.0 112.06 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.03 -30.44 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.214 0.915 . . . . 0.0 109.113 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.29 14.48 11.71 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.462 1.505 . . . . 0.0 111.471 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.87 97.25 5.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.15 85.44 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.294 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.55 4.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.277 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -56.48 -26.16 53.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.891 1.678 . . . . 0.0 112.132 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -72.93 -22.07 60.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.055 1.342 . . . . 0.0 113.013 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -71.25 167.5 19.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.73 0.812 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.49 156.45 43.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.41 1.484 . . . . 0.0 108.419 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 m -102.7 153.92 19.66 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.161 0.585 . . . . 0.0 111.599 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -154.48 154.86 33.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.718 1.607 . . . . 0.0 109.056 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 pt -84.83 163.28 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.94 134.1 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.397 1.079 . . . . 0.0 110.927 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -119.88 110.18 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.427 1.491 . . . . 0.0 107.451 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 m -54.7 -24.77 23.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.152 1.381 . . . . 0.0 112.676 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.28 -45.48 63.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.07 0.85 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.06 -42.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.55 -50.21 43.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.931 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -75.89 -12.01 60.07 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -92.57 -19.89 21.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.386 0.994 . . . . 0.0 110.783 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.15 140.45 57.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.083 0.401 . . . . 0.0 110.291 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.19 -33.47 75.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.3 tp -145.44 143.88 30.3 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.238 1.415 . . . . 0.0 109.918 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.36 136.99 55.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.24 108.48 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.2 p -88.33 95.67 10.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.75 -13.48 55.14 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 50.2 t -141.99 139.67 32.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.02 -36.64 90.96 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.493 0.568 . . . . 0.0 112.59 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.72 -27.24 68.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.193 0.997 . . . . 0.0 111.659 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -24.83 61.12 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.328 0.651 . . . . 0.0 111.651 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.31 -14.91 62.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.88 -33.6 75.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.179 0.592 . . . . 0.0 111.677 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -87.59 75.46 9.07 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.471 0.709 . . . . 0.0 109.394 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.2 m -135.99 80.95 40.66 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.13 88.31 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.519 3.48 . . . . 0.0 110.882 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . 0.263 24.1 ptt? 51.57 130.62 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 131.16 3.784 . . . . 0.0 114.643 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p -137.76 84.59 21.81 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -53.87 171.85 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.67 3.58 . . . . 0.0 113.203 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.56 -27.86 26.79 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.722 2.948 . . . . 0.0 115.199 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.44 -14.13 55.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 112.853 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.28 82.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.529 2.332 . . . . 0.0 106.423 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.6 pttt -67.08 164.35 18.08 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -129.75 155.74 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.742 -0.599 . . . . 0.0 109.718 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.15 154.56 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -140.12 143.28 36.15 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.9 0.48 . . . . 0.0 111.139 -168.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -140.08 -169.88 2.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.286 1.434 . . . . 0.0 109.19 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.02 42.77 1.28 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.018 0.818 . . . . 0.0 112.992 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -77.33 101.05 6.13 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 111.455 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -60.89 158.27 13.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.372 1.069 . . . . 0.0 110.124 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.07 124.21 86.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.368 -169.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.98 -44.44 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.858 2.372 . . . . 0.0 111.84 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.59 69.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.423 0.689 . . . . 0.0 111.024 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.37 12.16 31.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.039 1.335 . . . . 0.0 111.21 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.52 72.08 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.597 0.635 . . . . 0.0 112.692 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 55.86 -176.98 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.865 2.066 . . . . 0.0 113.281 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -65.84 0.49 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 126.179 1.847 . . . . 0.0 108.784 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 t -160.92 159.88 30.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.98 -39.76 75.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.014 0.825 . . . . 0.0 111.333 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.1 -28.98 66.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.358 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.36 -41.45 69.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.732 0.697 . . . . 0.0 109.32 174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -59.41 -53.73 54.85 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -57.65 -42.1 82.8 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.528 0.517 . . . . 0.0 110.022 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.2 87.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.157 0.435 . . . . 0.0 110.295 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.91 -38.74 92.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.626 0.77 . . . . 0.0 111.144 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -58.91 -47.38 85.21 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.292 0.951 . . . . 0.0 108.721 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -61.44 -42.89 99.46 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.149 0.58 . . . . 0.0 111.149 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.47 -50.55 64.93 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.305 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.01 -44.37 99.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.191 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -44.53 97.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 121.149 1.795 . . . . 0.0 110.628 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.67 -43.02 99.65 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.84 -29.35 44.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.806 -1.093 . . . . 0.0 112.222 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.05 -44.54 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.4 -46.71 93.83 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.71 -42.18 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.848 0.824 . . . . 0.0 110.429 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -46.05 91.8 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.2 mt -72.71 -34.38 67.08 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 110.149 -175.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.65 -51.6 69.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 110.752 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.42 -49.25 76.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.982 0.81 . . . . 0.0 109.296 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.37 -39.93 67.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.686 0.675 . . . . 0.0 111.082 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.2 -46.94 54.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.745 0.818 . . . . 0.0 111.854 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.79 -38.45 67.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.606 1.163 . . . . 0.0 111.182 -173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.2 p -89.3 -22.41 22.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 110.114 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.26 44.45 97.46 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.105 1.362 . . . . 0.0 111.301 -175.488 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.4 mtmt -136.67 166.3 23.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.73 171.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.76 132.08 67.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 172.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -122.73 133.98 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -129.6 106.34 8.67 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.81 0.844 . . . . 0.0 109.155 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -75.42 146.91 40.38 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.057 -0.402 . . . . 0.0 110.084 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.95 127.51 15.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -149.44 172.84 14.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.995 0.518 . . . . 0.0 110.237 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -66.83 -10.37 47.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.885 -1.134 . . . . 0.0 113.314 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.43 118.77 0.85 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.926 -2.87 . . . . 0.0 105.926 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 56.2 t-20 -56.22 -47.48 78.35 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.611 0.764 . . . . 0.0 110.347 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -45.1 -24.61 0.26 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.679 3.192 . . . . 0.0 116.397 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 m -112.67 -88.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -60.71 -43.59 97.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.908 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -70.62 -40.56 73.07 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.914 1.234 . . . . 0.0 111.238 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.89 -44.52 96.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.079 0.854 . . . . 0.0 111.007 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.6 mtp -65.44 -45.51 83.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.78 89.41 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.316 0.647 . . . . 0.0 111.092 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -57.17 -45.46 83.62 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.79 -55.11 27.16 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.15 -0.806 . . . . 0.0 113.106 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -68.74 -36.76 78.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.911 1.856 . . . . 0.0 111.144 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.53 76.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.258 -0.902 . . . . 0.0 111.253 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.64 -35.29 70.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.623 0.647 . . . . 0.0 111.904 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.16 -49.93 25.44 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.481 0.712 . . . . 0.0 109.273 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -76.61 -31.51 57.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.22 -36.89 8.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 -171.26 49.35 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 122.116 0.842 . . . . 0.0 113.856 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.69 -14.32 57.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.746 2.019 . . . . 0.0 114.098 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.09 -10.15 2.49 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.774 1.629 . . . . 0.0 111.839 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.435 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 2.8 m95 -141.58 157.79 44.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.757 1.223 . . . . 0.0 110.261 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -109.95 139.13 45.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 167.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.02 124.94 67.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -169.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.94 170.51 15.88 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -138.65 142.2 39.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 108.507 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.92 -176.65 4.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.721 1.608 . . . . 0.0 108.466 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.16 173.69 40.19 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -41.42 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.51 179.85 6.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.814 0.846 . . . . 0.0 109.388 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.47 120.95 12.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -73.09 -38.69 66.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.642 0.777 . . . . 0.0 109.364 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.82 -167.47 35.9 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 127.961 2.696 . . . . 0.0 107.798 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.43 100.14 9.12 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -62.59 121.32 66.73 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.539 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.86 -32.82 48.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.032 2.488 . . . . 0.0 113.228 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.98 89.35 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.73 0.695 . . . . 0.0 111.035 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.47 71.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.81 -54.36 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.1 -43.12 93.08 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.127 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.68 -50.11 63.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.661 0.664 . . . . 0.0 110.431 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.4 mmm -75.42 -35.94 60.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.799 0.272 . . . . 0.0 111.578 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.68 -32.94 73.15 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -67.36 -19.85 65.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.872 0.869 . . . . 0.0 112.443 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.74 -10.68 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.504 1.047 . . . . 0.0 110.132 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.28 25.37 44.03 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.035 -1.041 . . . . 0.0 110.666 -169.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.69 89.49 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -78.6 81.44 4.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.288 -171.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.41 6.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.57 -0.728 . . . . 0.0 112.197 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 m -55.0 -27.04 41.14 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.228 1.376 . . . . 0.0 112.09 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.02 -20.72 60.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.939 1.296 . . . . 0.0 112.95 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.45 171.45 10.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.737 0.779 . . . . 0.0 109.994 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -143.65 152.41 41.32 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.539 1.536 . . . . 0.0 107.325 172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -96.12 152.51 18.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -152.06 160.51 43.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.608 1.963 . . . . 0.0 108.274 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 pt -93.96 160.5 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.64 116.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.724 0.773 . . . . 0.0 112.955 -169.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.51 113.27 25.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 m -61.43 -24.22 66.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.576 1.15 . . . . 0.0 112.56 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.15 -39.31 82.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.013 0.824 . . . . 0.0 111.222 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.0 mt -66.29 -48.19 81.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.52 -48.71 68.78 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 109.954 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.84 -2.89 8.08 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -132.96 1.43 3.57 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.535 1.516 . . . . 0.0 114.199 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.15 47.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.209 0.913 . . . . 0.0 109.599 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.27 -34.75 78.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.2 tp -147.36 144.2 28.55 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.969 1.308 . . . . 0.0 110.596 -171.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.77 136.51 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 109.82 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.4 p -88.88 101.09 13.7 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.84 -10.48 59.85 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.14 158.96 43.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.103 0.865 . . . . 0.0 109.005 169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.4 -42.67 93.73 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.104 -169.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.36 -32.39 74.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.844 0.822 . . . . 0.0 111.364 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.96 69.41 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.749 0.419 . . . . 0.0 112.053 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.41 -33.85 73.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.898 0.772 . . . . 0.0 111.599 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -89.16 59.65 5.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.404 1.082 . . . . 0.0 110.069 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.9 83.82 30.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.8 70.64 2.78 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.451 3.434 . . . . 0.0 112.134 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.6 mtt 78.55 100.18 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 129.294 3.038 . . . . 0.0 112.001 172.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -105.53 84.34 1.15 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.83 172.69 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.297 2.665 . . . . 0.0 110.775 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -49.49 -27.97 15.26 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.805 3.003 . . . . 0.0 116.365 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -68.44 -8.56 41.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.112 0.965 . . . . 0.0 113.042 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.54 86.96 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 128.421 2.688 . . . . 0.0 105.304 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -66.93 164.94 16.48 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -143.07 145.88 33.29 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.349 -0.845 . . . . 0.0 109.234 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -132.8 157.1 45.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.418 1.487 . . . . 0.0 107.576 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -141.29 138.51 33.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.843 . . . . 0.0 110.747 -168.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.52 -171.85 2.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.813 1.645 . . . . 0.0 108.43 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.63 77.68 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 O-C-N 121.174 -0.953 . . . . 0.0 113.214 -169.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.14 151.14 45.05 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.088 0.944 . . . . 0.0 111.372 170.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.51 160.32 32.65 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.444 1.898 . . . . 0.0 113.265 -169.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.85 129.36 71.0 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.096 0.959 . . . . 0.0 111.712 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.55 -30.19 4.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.188 1.925 . . . . 0.0 114.009 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.29 -13.23 57.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.27 9.65 10.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.758 1.223 . . . . 0.0 111.435 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.11 141.9 52.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.39 162.14 37.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.97 0.908 . . . . 0.0 109.708 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.54 -50.07 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.88 165.37 22.86 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.557 2.343 . . . . 0.0 105.272 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.97 -40.01 83.46 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.51 -0.744 . . . . 0.0 110.641 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.97 -29.06 66.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.411 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.06 -44.5 60.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.826 0.739 . . . . 0.0 109.128 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -56.43 -51.04 69.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.778 0.831 . . . . 0.0 109.825 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -62.85 -42.53 99.78 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.625 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.36 78.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.914 0.779 . . . . 0.0 110.142 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.37 -38.34 90.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.043 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.21 -50.9 68.22 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -60.39 -43.7 96.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.02 0.528 . . . . 0.0 111.516 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -60.52 -50.01 75.27 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.281 0.491 . . . . 0.0 110.305 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.82 -39.41 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.669 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -56.65 -51.97 66.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.696 1.134 . . . . 0.0 109.602 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.29 -41.33 96.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.456 0.702 . . . . 0.0 110.005 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.84 -26.85 44.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.618 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -45.96 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.46 -44.15 93.62 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.41 ' ND2' HH22 ' A' ' 130' ' ' ARG . 54.3 t30 -60.4 -39.65 88.12 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.205 1.402 . . . . 0.0 111.179 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.41 HH22 ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -58.0 -48.53 79.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.69 -32.69 64.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.518 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -51.42 69.81 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.226 1.011 . . . . 0.0 110.56 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.64 -47.18 82.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.557 1.071 . . . . 0.0 109.582 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.08 -39.03 71.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.403 0.547 . . . . 0.0 111.071 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.45 33.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.706 0.803 . . . . 0.0 111.624 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.76 -38.78 76.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.62 1.168 . . . . 0.0 111.183 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 31.4 p -89.14 -17.87 28.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.28 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.11 40.89 94.24 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -172.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.615 1.166 . . . . 0.0 111.702 -169.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.7 mtmt -134.41 165.74 24.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.031 1.333 . . . . 0.0 108.332 169.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.74 134.31 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.3 135.06 63.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -131.77 104.4 6.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.562 0.745 . . . . 0.0 109.53 -169.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.67 142.53 38.77 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.07 1.348 . . . . 0.0 110.141 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.92 129.49 19.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.51 175.12 11.09 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.318 0.508 . . . . 0.0 110.774 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -6.64 21.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.64 133.7 3.09 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.98 33.12 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.064 0.932 . . . . 0.0 112.23 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 m -116.21 -1.94 12.28 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.796 1.239 . . . . 0.0 110.97 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -150.27 -94.61 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.968 0.804 . . . . 0.0 111.988 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -58.08 -46.41 85.49 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.883 1.273 . . . . 0.0 112.16 -169.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.8 p -72.38 -28.08 62.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.95 0.796 . . . . 0.0 112.055 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -68.92 -42.26 77.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.882 0.764 . . . . 0.0 110.249 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.45 -46.4 80.02 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.35 81.29 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.164 0.586 . . . . 0.0 111.104 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -57.81 -47.97 81.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.334 1.054 . . . . 0.0 109.546 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.66 -50.96 60.89 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.745 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.1 m95 -64.83 -38.3 90.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.844 1.822 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.15 79.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.642 -0.661 . . . . 0.0 111.567 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.73 -27.01 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.398 0.999 . . . . 0.0 112.475 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -46.58 13.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.452 0.701 . . . . 0.0 109.586 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -78.89 -27.2 43.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.62 -140.23 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.887 1.275 . . . . 0.0 108.101 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.16 -175.79 47.8 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.85 -12.37 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -58.14 -10.99 2.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.754 2.022 . . . . 0.0 111.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 10.2 m95 -134.98 166.36 23.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.131 1.772 . . . . 0.0 108.913 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -124.59 135.68 53.32 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 167.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 118.39 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -168.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 173.25 11.91 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.48 1.112 . . . . 0.0 109.346 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.8 p -136.03 159.82 40.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.225 1.01 . . . . 0.0 110.163 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.03 -169.4 3.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.755 1.622 . . . . 0.0 107.199 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.59 173.49 42.64 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.333 -0.854 . . . . 0.0 111.221 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.97 -39.23 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.555 1.142 . . . . 0.0 108.905 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.12 -178.74 6.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 108.51 170.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.11 43.55 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.545 1.538 . . . . 0.0 108.384 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -144.76 -39.22 0.27 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.063 0.945 . . . . 0.0 110.123 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.6 140.74 2.97 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.78 114.74 2.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.821 1.31 . . . . 0.0 108.062 169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.47 157.35 80.32 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.312 -169.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.7 -36.58 73.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.703 2.935 . . . . 0.0 113.866 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -36.86 85.28 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.168 0.895 . . . . 0.0 111.325 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.98 67.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.33 -52.52 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.15 -42.1 96.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.89 0.768 . . . . 0.0 110.587 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.55 -45.62 84.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.499 0.59 . . . . 0.0 110.792 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 93.3 mmm -75.94 -37.98 58.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.503 0.138 . . . . 0.0 111.112 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -61.95 -36.42 81.37 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.88 -22.32 63.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.835 0.854 . . . . 0.0 112.509 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -77.79 -26.06 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.365 0.984 . . . . 0.0 109.601 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.97 23.62 6.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.116 1.341 . . . . 0.0 111.489 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.5 mt -124.71 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 -171.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -79.85 75.69 6.55 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.276 0.63 . . . . 0.0 110.866 -170.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -70.98 0.24 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.927 -1.035 . . . . 0.0 112.071 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -51.87 -28.03 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.208 1.367 . . . . 0.0 111.78 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.18 -20.23 64.84 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.519 1.528 . . . . 0.0 113.6 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -77.45 169.29 18.57 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.059 . . . . 0.0 109.698 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 p -143.82 167.46 22.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.584 1.953 . . . . 0.0 107.876 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.6 p -118.97 151.64 37.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.358 0.663 . . . . 0.0 111.257 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.35 154.88 35.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.724 1.61 . . . . 0.0 109.028 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.96 165.85 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 tt -57.12 106.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.186 0.994 . . . . 0.0 111.816 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -89.11 102.22 14.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -16.37 49.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.138 0.975 . . . . 0.0 112.222 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.91 -37.25 62.13 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.999 1.272 . . . . 0.0 111.871 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.07 -48.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.1 -47.46 65.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.686 0.795 . . . . 0.0 110.52 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -67.45 -8.26 31.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -128.75 3.39 5.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.274 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.33 148.1 51.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.45 -32.9 72.12 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.5 tp -147.41 144.35 28.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.225 1.41 . . . . 0.0 110.428 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.49 139.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 m -128.45 129.25 68.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -88.65 138.24 31.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.5 mt -110.62 0.7 17.65 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 112.511 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -152.19 161.79 42.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.595 1.089 . . . . 0.0 109.22 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.46 -51.43 57.81 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 123.897 0.761 . . . . 0.0 112.017 -171.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.09 -31.45 70.18 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.15 -30.01 70.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.478 0.581 . . . . 0.0 112.425 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.26 67.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.88 -38.08 89.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.045 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.59 -42.85 24.09 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.056 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.8 t -47.72 106.52 0.61 Allowed Pre-proline 0 CA--C 1.547 0.861 0 O-C-N 124.76 1.288 . . . . 0.0 110.275 -169.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.45 174.68 7.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.682 3.588 . . . . 0.0 111.461 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 99.0 mmm -58.63 135.7 57.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.152 0.581 . . . . 0.0 111.041 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 p -120.53 105.22 41.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.945 1.698 . . . . 0.0 106.675 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.27 168.88 18.13 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.813 2.342 . . . . 0.0 110.693 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.32 -24.48 15.9 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.009 3.139 . . . . 0.0 116.288 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.29 -10.34 31.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.033 0.933 . . . . 0.0 112.847 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 93.92 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 128.007 2.523 . . . . 0.0 105.621 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -70.64 164.31 25.22 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.17 144.2 31.45 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.626 0.771 . . . . 0.0 109.062 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.12 164.66 29.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -144.55 113.0 6.57 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.772 0.829 . . . . 0.0 109.283 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -115.55 169.18 9.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.662 1.585 . . . . 0.0 107.851 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.9 107.94 0.63 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.784 -169.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.87 118.86 17.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.953 0.901 . . . . 0.0 111.765 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -66.52 153.41 43.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.4 1.08 . . . . 0.0 109.542 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.64 121.36 82.19 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.522 -172.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.03 -32.92 8.14 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.837 1.691 . . . . 0.0 112.588 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 -19.93 65.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.029 0.831 . . . . 0.0 112.189 -172.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.26 -2.03 43.53 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.712 1.205 . . . . 0.0 111.811 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 142.71 45.36 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -156.51 164.69 37.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.777 0.431 . . . . 0.0 110.94 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -47.91 0.69 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -165.24 166.01 19.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.245 2.218 . . . . 0.0 105.391 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.92 -40.51 80.56 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.546 -0.721 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.09 -27.42 64.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.188 -0.434 . . . . 0.0 111.473 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.76 -44.59 55.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 109.192 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -56.63 -49.88 73.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.457 0.703 . . . . 0.0 109.892 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -64.64 -39.36 93.56 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.097 -0.377 . . . . 0.0 111.089 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.61 74.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 110.655 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -68.41 -40.56 81.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.244 0.474 . . . . 0.0 110.503 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -58.36 -39.79 80.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.712 0.687 . . . . 0.0 109.841 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -63.11 -49.71 73.34 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.576 0.625 . . . . 0.0 110.208 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -59.77 -49.96 75.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.118 0.417 . . . . 0.0 110.37 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.54 -46.24 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.099 -1.429 . . . . 0.0 110.039 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -62.54 -42.17 99.36 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 121.683 2.038 . . . . 0.0 110.916 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.87 -44.66 96.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.45 -36.04 65.82 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.065 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -63.75 -40.55 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.528 1.513 . . . . 0.0 108.984 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.64 -44.34 97.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.95 -37.1 85.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.53 1.132 . . . . 0.0 112.036 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -56.27 -52.05 65.91 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 -35.77 77.38 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 119.024 -0.513 . . . . 0.0 111.918 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -49.33 77.89 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.589 0.755 . . . . 0.0 110.477 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -61.08 -50.78 71.9 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -54.87 -41.45 70.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.222 0.609 . . . . 0.0 111.321 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.33 -47.48 56.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.007 0.923 . . . . 0.0 111.505 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -73.24 -38.34 66.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.143 0.977 . . . . 0.0 111.642 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.1 p -92.23 -21.57 20.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.381 1.073 . . . . 0.0 110.6 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.06 42.46 99.73 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.438 1.495 . . . . 0.0 111.153 -175.315 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.2 mtmt -138.12 171.47 14.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.577 1.551 . . . . 0.0 108.464 169.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.7 131.28 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.83 133.67 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.52 107.11 9.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.84 143.74 37.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.689 1.196 . . . . 0.0 110.497 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.28 127.87 17.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 108.821 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.81 169.67 16.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.848 1.259 . . . . 0.0 111.256 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -67.22 -16.42 64.29 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.133 -0.979 . . . . 0.0 113.276 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.83 112.86 0.54 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.07 -35.81 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.643 1.177 . . . . 0.0 112.337 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -41.13 -19.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.266 3.026 . . . . 0.0 118.496 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -141.59 -54.74 0.46 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.708 1.595 . . . . 0.0 113.804 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -56.59 -53.72 54.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.342 0.974 . . . . 0.0 113.456 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -36.65 78.85 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.058 0.845 . . . . 0.0 110.257 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -58.07 -43.28 86.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.785 0.721 . . . . 0.0 111.597 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -66.2 -48.06 71.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.803 0.841 . . . . 0.0 109.415 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.24 74.2 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.192 0.597 . . . . 0.0 110.769 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.04 -45.34 93.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.47 0.708 . . . . 0.0 110.289 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.93 92.82 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.223 -0.765 . . . . 0.0 112.377 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.6 m95 -66.72 -43.81 83.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.914 1.357 . . . . 0.0 110.572 176.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.81 78.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.205 0.457 . . . . 0.0 110.84 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.56 -33.35 68.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.689 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.79 -57.98 4.84 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.809 0.732 . . . . 0.0 110.023 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -69.19 -33.38 73.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.9 mt -100.09 -37.85 8.79 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.05 -173.32 48.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.074 0.845 . . . . 0.0 113.4 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.18 -14.91 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.499 1.92 . . . . 0.0 113.753 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -57.23 -11.11 1.52 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.595 1.958 . . . . 0.0 111.794 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.462 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.8 m95 -142.24 147.47 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.255 1.022 . . . . 0.0 110.922 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -92.46 140.36 29.65 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.03 125.32 64.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.73 160.41 34.39 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.827 0.851 . . . . 0.0 111.38 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -136.46 128.6 29.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.808 1.643 . . . . 0.0 108.674 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 -168.85 3.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.9 176.83 42.97 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.61 -42.79 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.807 1.243 . . . . 0.0 107.908 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -143.45 177.15 8.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.254 0.622 . . . . 0.0 110.276 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.8 43.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.574 2.35 . . . . 0.0 107.219 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -134.77 -36.33 0.85 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.286 1.035 . . . . 0.0 110.077 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.47 179.31 44.99 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.02 102.82 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -67.74 134.09 92.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.135 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.09 -33.11 72.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.199 2.6 . . . . 0.0 113.738 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -36.6 78.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.732 0.696 . . . . 0.0 111.28 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.12 71.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.17 -54.06 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.48 -43.27 90.74 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.476 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.4 82.9 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.837 0.744 . . . . 0.0 111.345 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.402 ' HE3' ' CD1' ' A' ' 23' ' ' TRP . 94.3 mmm -77.6 -40.35 42.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.172 0.442 . . . . 0.0 111.359 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -63.36 -31.75 72.99 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.422 -0.799 . . . . 0.0 110.707 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.15 -21.7 64.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.424 1.089 . . . . 0.0 112.604 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -77.52 -22.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.558 1.072 . . . . 0.0 109.55 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.39 14.78 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.741 1.162 . . . . 0.0 110.774 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.36 99.64 8.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.44 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.15 4.44 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 110.705 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -27.28 63.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.141 1.337 . . . . 0.0 111.017 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -67.15 -16.62 64.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.915 2.086 . . . . 0.0 113.614 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.87 172.57 13.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.504 1.122 . . . . 0.0 109.213 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -150.14 160.19 43.85 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.256 1.422 . . . . 0.0 108.411 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.4 m -101.08 153.63 19.4 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.13 155.49 31.1 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.809 2.044 . . . . 0.0 108.335 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.38 159.89 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.41 141.35 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.141 0.976 . . . . 0.0 112.372 -169.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -119.45 111.55 18.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.738 1.615 . . . . 0.0 107.668 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -70.75 -21.75 62.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.58 -46.39 59.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.337 0.971 . . . . 0.0 110.106 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.81 -39.52 85.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.16 -47.88 71.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.929 0.786 . . . . 0.0 110.085 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -73.67 -7.12 50.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -98.59 -21.42 16.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 111.186 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.79 142.45 58.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.193 0.451 . . . . 0.0 110.054 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.84 -32.68 73.37 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.619 -0.676 . . . . 0.0 109.295 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.7 tp -144.99 145.12 31.38 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.002 1.321 . . . . 0.0 109.625 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.19 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.78 127.79 66.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 169.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -94.23 96.85 9.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.59 -9.39 26.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.346 1.458 . . . . 0.0 114.356 -168.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 t -149.72 160.35 43.6 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 121.124 1.784 . . . . 0.0 110.352 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -44.79 -66.51 1.42 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 127.164 2.316 . . . . 0.0 113.217 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.11 -22.65 62.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.02 69.87 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.875 -0.516 . . . . 0.0 111.336 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.91 -17.46 63.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.94 -31.27 71.58 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.195 0.907 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -91.69 74.05 5.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.793 0.837 . . . . 0.0 109.175 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 p -123.16 74.25 49.45 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 0.0 109.391 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.59 74.07 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.608 3.538 . . . . 0.0 111.615 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.5 mmt 66.23 129.31 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.274 3.03 . . . . 0.0 112.412 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 p -141.44 81.58 15.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.94 171.69 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.7 3.6 . . . . 0.0 113.635 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.9 -29.84 28.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.47 2.78 . . . . 0.0 114.806 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.34 -4.83 28.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 113.171 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.74 78.38 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.55 2.34 . . . . 0.0 105.4 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -68.18 167.81 13.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -135.37 156.22 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.583 0.753 . . . . 0.0 111.879 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.79 162.7 38.7 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 169.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -153.21 119.34 5.46 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.087 -1.008 . . . . 0.0 110.337 -169.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -115.77 -174.82 2.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 0.0 110.06 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.87 44.26 1.19 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.365 0.983 . . . . 0.0 113.627 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -80.76 104.63 11.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.026 0.93 . . . . 0.0 111.342 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.87 152.31 36.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.808 0.843 . . . . 0.0 110.086 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.36 120.73 83.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.71 -33.66 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 112.784 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.15 65.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.996 0.817 . . . . 0.0 112.069 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 110' ' ' GLN . 8.0 mpt_? -104.37 9.02 35.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.976 1.31 . . . . 0.0 111.633 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.88 22.35 0.05 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.313 1.445 . . . . 0.0 114.221 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 108' ' ' ARG . 7.6 mt-30 -55.1 152.53 7.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.35 1.86 . . . . 0.0 111.825 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.89 -51.29 0.2 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -154.16 154.84 34.24 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.01 -38.29 85.53 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.505 -0.747 . . . . 0.0 110.742 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.53 -30.98 71.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.362 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -72.55 -48.34 40.95 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -53.48 -52.45 59.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 109.84 176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -64.22 -42.56 96.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.825 0.85 . . . . 0.0 111.168 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.78 72.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.992 0.815 . . . . 0.0 110.307 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -66.29 -38.19 87.18 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.564 -0.71 . . . . 0.0 111.152 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -57.45 -45.92 84.19 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.172 0.896 . . . . 0.0 108.996 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -60.1 -49.4 77.81 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.624 0.77 . . . . 0.0 110.993 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -58.68 -49.67 76.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.97 -47.65 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.328 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -64.01 -41.86 97.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 121.259 1.845 . . . . 0.0 110.673 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.32 -42.89 99.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.922 0.328 . . . . 0.0 110.259 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -75.75 -36.14 59.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.108 -0.949 . . . . 0.0 112.31 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -61.66 -46.25 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.72 92.38 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -54.82 -46.99 74.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.671 1.188 . . . . 0.0 111.879 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -39.82 88.0 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.98 -0.45 . . . . 0.0 109.904 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.74 -35.32 72.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.243 0.617 . . . . 0.0 110.99 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -60.04 -49.64 76.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.817 0.847 . . . . 0.0 110.271 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.6 -46.62 81.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.03 0.832 . . . . 0.0 109.71 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -54.3 -40.63 68.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.85 0.75 . . . . 0.0 110.916 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.77 37.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -71.82 -36.08 70.13 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.335 1.054 . . . . 0.0 111.566 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.3 p -90.28 -16.94 28.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 110.27 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.37 41.11 92.97 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.799 1.24 . . . . 0.0 111.842 -170.631 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -130.92 161.5 31.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.723 1.609 . . . . 0.0 107.107 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -136.64 130.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.82 127.03 74.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -124.8 100.11 6.46 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -169.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -73.09 147.88 44.54 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.3 143.46 37.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.313 1.845 . . . . 0.0 106.724 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.83 173.18 16.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 p -67.25 -11.52 57.7 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.326 -0.859 . . . . 0.0 113.164 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.23 116.61 0.73 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -55.36 -39.24 69.84 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.269 1.027 . . . . 0.0 111.756 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.48 -34.88 0.24 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.107 3.363 . . . . 0.0 115.777 -169.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 m -120.41 -73.92 0.63 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.069 0.547 . . . . 0.0 110.347 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -62.16 -48.52 79.73 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.211 0.604 . . . . 0.0 110.985 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -70.59 -37.17 73.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.316 -0.374 . . . . 0.0 110.741 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.38 -44.64 95.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.927 0.491 . . . . 0.0 111.127 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.3 mtm -67.0 -45.66 76.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.525 0.602 . . . . 0.0 110.287 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.71 81.47 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.748 0.704 . . . . 0.0 111.14 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -57.33 -47.04 82.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.288 1.035 . . . . 0.0 109.761 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.27 50.67 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.657 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.405 ' CD1' HG22 ' A' ' 127' ' ' ILE . 94.4 m95 -67.26 -37.49 83.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.817 1.809 . . . . 0.0 111.029 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.71 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.285 -0.884 . . . . 0.0 111.386 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.94 -24.79 67.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.957 0.799 . . . . 0.0 112.512 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.22 -46.99 12.03 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.892 0.769 . . . . 0.0 109.71 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -75.4 -30.75 60.22 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.7 -143.88 0.29 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.995 1.318 . . . . 0.0 108.091 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.2 -178.57 46.1 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.92 -13.85 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.95 -9.94 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.542 1.937 . . . . 0.0 111.642 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -125.58 161.74 26.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.376 1.87 . . . . 0.0 108.39 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.93 138.29 54.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.86 117.27 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 173.7 11.42 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -142.01 157.28 45.11 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 0.0 109.905 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.07 -163.63 1.75 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.462 1.505 . . . . 0.0 107.896 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.28 175.76 43.5 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.64 -41.8 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.05 176.43 8.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.791 0.836 . . . . 0.0 110.056 170.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.78 6.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.022 1.729 . . . . 0.0 107.139 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -74.48 -36.28 63.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.062 0.545 . . . . 0.0 109.626 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.81 -179.31 30.98 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -74.2 99.43 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -61.84 124.58 82.19 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.264 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.45 -33.51 38.26 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.269 2.646 . . . . 0.0 113.608 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -39.75 91.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.91 0.777 . . . . 0.0 110.916 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.31 75.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.95 -56.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.58 -42.06 99.32 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 119.042 0.837 . . . . 0.0 110.348 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.38 65.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.512 0.325 . . . . 0.0 110.336 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 90.1 mmm -74.44 -36.06 63.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.905 0.321 . . . . 0.0 110.873 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -61.8 -35.78 79.2 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.422 -0.799 . . . . 0.0 110.129 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.29 -24.25 63.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 112.572 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.38 -22.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.314 0.961 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.85 23.93 8.96 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.824 1.202 . . . . 0.0 111.263 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.1 mt -123.57 94.21 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -79.13 80.27 5.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -76.27 5.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.56 -0.712 . . . . 0.0 112.205 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -54.57 -26.46 32.44 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.824 1.193 . . . . 0.0 112.232 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.45 -20.06 57.42 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.99 1.316 . . . . 0.0 113.135 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.59 167.32 17.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 109.3 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -145.34 158.79 43.76 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.428 1.491 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -108.65 147.1 32.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.858 0.863 . . . . 0.0 110.103 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -155.17 159.5 40.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.026 1.331 . . . . 0.0 108.578 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.31 161.18 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.02 131.78 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.766 0.826 . . . . 0.0 111.987 -169.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.25 114.57 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.574 1.55 . . . . 0.0 107.327 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -69.37 -17.95 63.74 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.261 -171.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.06 -41.71 28.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.594 1.088 . . . . 0.0 110.504 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.42 -45.68 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -50.11 -50.85 47.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.03 0.932 . . . . 0.0 110.518 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -70.49 -19.51 62.93 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -89.94 -16.19 30.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.679 1.127 . . . . 0.0 110.976 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.53 34.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.225 0.536 . . . . 0.0 111.45 -169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.52 -33.16 36.57 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 168.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -148.44 146.68 28.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.134 1.773 . . . . 0.0 110.374 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.43 140.04 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.32 111.67 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.6 p -93.53 108.41 20.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.57 -3.82 23.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.306 -170.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 36.3 t -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 120.881 1.673 . . . . 0.0 108.748 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.87 -35.81 92.49 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 123.674 0.654 . . . . 0.0 112.413 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.27 -25.91 64.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.683 1.242 . . . . 0.0 111.517 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -18.28 58.36 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.182 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.84 67.02 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.851 0.75 . . . . 0.0 112.505 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.24 -32.59 74.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 112.033 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -86.49 57.99 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.85 0.86 . . . . 0.0 110.983 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.7 m -124.01 78.02 58.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.25 -49.93 5.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.299 3.332 . . . . 0.0 114.872 -172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.1 mtp -152.85 137.04 16.49 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.0 1.72 . . . . 0.0 107.289 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.7 p -134.4 71.09 72.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.45 164.78 24.76 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.638 2.892 . . . . 0.0 110.82 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.04 -20.44 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.798 1 C-N-CA 125.458 4.105 . . . . 0.0 119.719 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -60.05 -44.42 94.69 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.625 1.557 . . . . 0.0 109.184 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.09 156.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 127.708 2.403 . . . . 0.0 108.075 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -134.71 167.36 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 169.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -139.2 146.65 40.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.276 0.944 . . . . 0.0 110.084 -169.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -142.61 156.33 45.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.001 1.32 . . . . 0.0 107.867 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.37 140.36 30.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.246 1.019 . . . . 0.0 110.316 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -136.19 -164.7 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.678 1.591 . . . . 0.0 109.562 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.0 40.63 1.17 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.572 1.078 . . . . 0.0 114.342 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.51 116.85 22.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.509 1.155 . . . . 0.0 111.879 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.17 152.68 43.16 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.557 0.743 . . . . 0.0 109.231 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.4 123.95 88.85 Favored Pre-proline 0 C--O 1.236 0.354 0 O-C-N 121.892 -0.505 . . . . 0.0 111.904 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.28 -31.6 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.055 1.837 . . . . 0.0 112.868 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.55 -21.37 65.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.083 0.856 . . . . 0.0 112.306 -174.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -94.56 -4.41 47.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.453 1.101 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.65 57.35 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.071 0.85 . . . . 0.0 109.304 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -144.74 161.42 39.26 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.528 1.131 . . . . 0.0 109.245 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.64 -51.05 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.23 164.01 25.24 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.083 2.153 . . . . 0.0 105.51 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.23 -39.94 84.32 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.546 -0.721 . . . . 0.0 110.598 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.84 -29.21 67.49 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.344 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -74.14 -42.35 60.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.029 0.831 . . . . 0.0 109.507 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.97 -50.46 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.181 0.592 . . . . 0.0 109.773 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -63.15 -39.47 94.75 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.105 0.411 . . . . 0.0 111.036 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.88 74.79 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.38 -0.825 . . . . 0.0 110.661 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.89 -41.43 91.52 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.07 -1.019 . . . . 0.0 110.324 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -57.08 -41.78 79.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -63.82 -49.77 71.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 111.385 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.68 -51.54 68.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.433 0.561 . . . . 0.0 109.928 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.61 -37.9 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.459 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -53.06 -57.54 10.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.546 1.521 . . . . 0.0 110.638 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.34 -42.02 94.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.171 0.919 . . . . 0.0 109.821 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.75 -26.16 37.5 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.578 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.405 HG22 ' CD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -66.96 -46.22 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.445 1.475 . . . . 0.0 107.043 169.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.71 96.66 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -58.12 -41.88 84.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.937 1.295 . . . . 0.0 111.37 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -49.1 77.83 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.43 -31.13 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.017 0.527 . . . . 0.0 110.56 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -52.4 65.33 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.182 0.993 . . . . 0.0 110.229 169.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.56 -47.29 84.49 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.394 0.997 . . . . 0.0 109.021 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.74 -37.95 66.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.968 0.507 . . . . 0.0 111.187 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.75 -47.15 32.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 122.963 0.505 . . . . 0.0 111.33 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.01 -41.51 74.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.923 0.889 . . . . 0.0 111.205 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.0 p -85.31 -17.64 36.27 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.954 0.902 . . . . 0.0 110.075 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.56 40.96 93.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 124.895 1.236 . . . . 0.0 110.539 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.049 -0.976 . . . . 0.0 111.524 -172.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -123.48 165.45 17.08 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.472 1.509 . . . . 0.0 109.439 -174.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.35 138.17 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tt -127.67 136.54 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -129.85 105.86 8.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.92 141.51 42.28 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.864 0.866 . . . . 0.0 110.359 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.41 136.86 41.73 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.553 1.141 . . . . 0.0 108.499 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -156.16 171.65 19.8 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.02 0.827 . . . . 0.0 110.885 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.0 p -66.94 -11.67 57.22 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.861 -1.149 . . . . 0.0 113.177 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.96 121.92 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -58.17 -44.23 87.87 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 110.597 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -37.57 -29.15 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 C-N-CA 130.655 3.582 . . . . 0.0 117.514 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 m -125.59 -74.69 0.6 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.634 0.774 . . . . 0.0 109.859 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -60.46 -47.9 84.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.924 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -65.95 -46.53 77.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.712 0.687 . . . . 0.0 110.165 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -57.38 -42.68 82.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.953 0.501 . . . . 0.0 112.107 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.0 mtp -65.99 -48.48 71.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.623 0.769 . . . . 0.0 109.623 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.48 79.08 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.341 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.47 -45.13 89.24 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.91 0.884 . . . . 0.0 110.396 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.64 93.46 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.595 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -68.95 -43.65 74.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.312 1.556 . . . . 0.0 111.217 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.49 75.28 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.06 0.391 . . . . 0.0 110.863 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.21 -35.17 69.32 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -68.91 -57.33 5.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.497 0.59 . . . . 0.0 109.984 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.04 -35.93 79.07 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.78 -37.07 10.92 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.41 175.01 49.81 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 122.006 0.781 . . . . 0.0 113.048 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.29 -15.56 63.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.024 1.33 . . . . 0.0 114.181 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.92 -16.36 17.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.934 -0.479 . . . . 0.0 112.251 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -112.71 165.4 12.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.21 1.004 . . . . 0.0 109.068 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.1 145.34 46.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.14 119.7 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.95 169.34 17.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.485 0.659 . . . . 0.0 110.254 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -135.34 140.02 44.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.085 1.354 . . . . 0.0 109.418 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.06 -175.08 4.28 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.793 1.237 . . . . 0.0 108.801 169.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.75 176.03 42.52 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.83 -41.8 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.33 179.79 7.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 109.737 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.05 152.98 40.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.011 2.124 . . . . 0.0 106.393 171.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -129.47 -14.14 4.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.889 0.875 . . . . 0.0 111.619 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.77 -175.92 34.96 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -85.39 106.05 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -62.76 125.8 87.18 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.905 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 -34.37 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.152 2.568 . . . . 0.0 113.659 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -38.46 88.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.859 0.754 . . . . 0.0 110.768 176.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.79 73.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.85 -52.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -65.76 -42.43 90.9 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 118.951 0.796 . . . . 0.0 110.781 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.52 81.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.898 0.772 . . . . 0.0 110.993 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.8 mmm -75.86 -38.82 57.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.403 0.281 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -65.06 -33.97 77.3 Favored 'General case' 0 N--CA 1.461 0.105 0 O-C-N 121.061 -1.025 . . . . 0.0 111.036 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -65.02 -21.16 66.8 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.001 0.92 . . . . 0.0 112.158 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.71 -7.76 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.565 1.146 . . . . 0.0 110.294 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.76 21.16 34.68 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.931 -1.106 . . . . 0.0 111.987 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.21 91.83 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -78.12 85.95 4.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.198 0.523 . . . . 0.0 110.169 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -77.67 2.25 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.27 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -59.75 -23.13 62.97 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.107 1.776 . . . . 0.0 112.08 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -71.44 -18.39 62.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 112.907 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -72.52 173.28 9.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.102 0.961 . . . . 0.0 109.96 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -149.17 163.12 38.52 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.529 1.531 . . . . 0.0 108.606 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.4 m -107.08 155.4 19.88 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.179 0.992 . . . . 0.0 110.279 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.563 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -154.56 162.23 41.24 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.716 2.406 . . . . 0.0 108.411 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 pt -92.64 164.02 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.58 133.61 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 112.04 -169.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -122.42 102.56 8.17 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.011 1.724 . . . . 0.0 106.952 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -15.08 40.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.595 0.758 . . . . 0.0 112.194 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.2 -42.74 88.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.515 1.052 . . . . 0.0 111.249 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.92 -43.05 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tt -53.05 -47.15 68.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.976 0.51 . . . . 0.0 110.576 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -67.92 -18.77 64.87 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -96.53 -16.78 20.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.435 1.016 . . . . 0.0 111.484 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.61 153.91 40.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.406 0.548 . . . . 0.0 110.879 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.94 -38.2 66.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.09 166.48 30.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.243 1.02 . . . . 0.0 112.125 170.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.06 143.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.0 131.06 64.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -84.89 142.67 29.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -107.51 -1.75 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.31 0.644 . . . . 0.0 110.595 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.55 156.5 41.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.9 -38.19 88.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.3 -30.12 69.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.824 0.812 . . . . 0.0 111.933 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.66 78.35 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.146 0.43 . . . . 0.0 111.445 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.51 66.94 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.98 -39.3 93.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 111.783 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -81.96 -40.02 22.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 117.798 -1.096 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.8 m -47.6 108.11 0.84 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.565 1.146 . . . . 0.0 109.27 -173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.1 165.96 22.46 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.451 2.101 . . . . 0.0 113.289 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.9 111.45 2.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.37 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -72.89 122.46 87.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.864 1.266 . . . . 0.0 108.046 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.16 168.66 22.67 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.188 1.926 . . . . 0.0 110.356 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.03 -22.93 15.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.091 3.194 . . . . 0.0 116.017 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -68.08 -6.35 22.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.3 154.58 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.226 2.211 . . . . 0.0 106.62 -169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 173.69 9.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.355 -0.841 . . . . 0.0 110.734 169.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -127.89 155.04 44.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.256 1.422 . . . . 0.0 109.373 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.99 160.22 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 169.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -145.82 113.64 6.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -111.94 176.95 4.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.928 1.291 . . . . 0.0 109.314 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.59 94.69 0.21 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.999 -0.89 . . . . 0.0 112.439 -169.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.5 126.74 33.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.655 0.727 . . . . 0.0 111.481 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -74.34 153.23 39.4 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 169.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.93 120.83 83.28 Favored Pre-proline 0 C--O 1.236 0.395 0 O-C-N 121.915 -0.491 . . . . 0.0 111.131 -170.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.43 -32.22 20.38 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.631 1.554 . . . . 0.0 113.063 -169.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.53 -20.79 65.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -118.01 14.69 14.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 111.345 -177.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.98 144.46 45.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -142.66 156.66 45.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.527 0.731 . . . . 0.0 109.272 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.94 -56.52 0.38 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.1 p -146.09 170.14 17.29 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 127.012 2.125 . . . . 0.0 105.499 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.71 -42.38 86.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.659 -0.65 . . . . 0.0 110.994 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.47 -28.84 64.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.126 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.19 -44.35 72.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.111 0.868 . . . . 0.0 109.462 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -55.82 -52.23 64.71 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 109.94 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -59.6 -45.02 93.15 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.953 0.342 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.85 77.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.14 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.46 -37.21 80.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.675 1.125 . . . . 0.0 111.32 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -57.48 -47.94 80.55 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -60.67 -45.48 93.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.176 0.59 . . . . 0.0 111.986 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -60.12 -50.95 71.66 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.702 0.683 . . . . 0.0 109.754 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.09 -42.73 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.626 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -61.7 -43.44 98.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.638 2.017 . . . . 0.0 110.879 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.99 -44.9 95.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.93 -33.74 62.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.184 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.11 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.805 1.639 . . . . 0.0 108.36 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.8 -42.94 99.69 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.493 ' ND2' HH22 ' A' ' 130' ' ' ARG . 56.1 t30 -61.16 -43.13 99.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.258 1.023 . . . . 0.0 111.874 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.493 HH22 ' ND2' ' A' ' 129' ' ' ASN . 13.3 mmp_? -61.83 -41.55 97.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.689 -0.632 . . . . 0.0 110.214 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.0 mt -72.98 -34.74 66.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.672 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -48.56 79.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.179 0.992 . . . . 0.0 109.961 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.15 -50.62 72.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 118.936 0.789 . . . . 0.0 109.7 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.24 -38.9 71.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.493 1.042 . . . . 0.0 111.166 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.39 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.161 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.0 -38.92 31.08 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 110.934 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.5 p -89.61 -24.61 21.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.431 1.092 . . . . 0.0 110.188 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.9 97.86 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.963 -170.51 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.8 mtmt -132.51 171.58 13.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.963 1.705 . . . . 0.0 107.631 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.63 141.71 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -127.58 140.48 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -131.35 100.16 5.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.39 148.95 46.45 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.17 139.46 41.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.759 1.624 . . . . 0.0 107.422 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.22 171.78 18.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.079 0.552 . . . . 0.0 110.338 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -74.7 -5.83 45.39 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.14 95.43 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.0 t-20 -60.16 99.39 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.873 1.269 . . . . 0.0 110.095 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.6 p -160.21 -42.9 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.422 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 p -132.47 -71.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.993 0.917 . . . . 0.0 110.434 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -52.32 -50.59 61.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.349 0.977 . . . . 0.0 111.782 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.9 -42.31 97.48 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.175 0.59 . . . . 0.0 111.221 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -67.99 -39.9 83.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.841 0.857 . . . . 0.0 111.286 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 81.6 mtp -65.09 -48.6 73.11 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.394 1.078 . . . . 0.0 108.695 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.53 81.97 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.911 0.323 . . . . 0.0 110.475 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -56.85 -44.84 82.53 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.99 -47.44 88.74 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.96 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CD1' ' HE2' ' A' ' 52' ' ' MET . 94.1 m95 -66.74 -38.01 85.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.956 1.878 . . . . 0.0 110.525 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.09 82.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.291 0.496 . . . . 0.0 110.723 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.28 -26.36 66.43 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.033 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -74.95 -56.85 4.32 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.116 0.871 . . . . 0.0 110.272 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -71.37 -29.57 65.11 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -92.08 -145.08 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.285 1.434 . . . . 0.0 107.905 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.28 -164.77 38.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.33 -19.77 37.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.785 1.634 . . . . 0.0 113.419 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.97 -12.15 4.24 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.17 1.388 . . . . 0.0 111.825 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.403 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 17.3 m95 -142.77 171.54 13.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.923 1.689 . . . . 0.0 110.819 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -129.76 140.92 50.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.645 2.378 . . . . 0.0 104.785 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.71 124.97 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 170.92 15.16 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.7 p -142.61 143.26 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.523 0.729 . . . . 0.0 109.642 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -171.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.702 1.601 . . . . 0.0 109.029 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.52 173.8 40.49 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 121.681 -0.637 . . . . 0.0 111.768 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.88 -41.02 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.103 1.361 . . . . 0.0 108.225 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.77 -176.57 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.324 1.85 . . . . 0.0 106.846 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.9 165.36 25.18 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.189 1.396 . . . . 0.0 109.172 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -129.18 -36.56 1.73 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.351 0.66 . . . . 0.0 110.322 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.65 169.2 12.97 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -58.68 109.91 0.9 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -69.43 125.8 92.21 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.97 -32.78 59.26 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.555 2.17 . . . . 0.0 113.316 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -42.39 98.69 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.84 0.746 . . . . 0.0 110.458 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -39.36 71.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.94 -54.03 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -65.3 -43.29 91.56 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.51 1.05 . . . . 0.0 110.126 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.93 -45.03 67.47 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.43 0.692 . . . . 0.0 111.597 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.407 ' HE2' ' CD1' ' A' ' 23' ' ' TRP . 98.6 mmm -80.0 -38.6 31.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.543 0.737 . . . . 0.0 111.354 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.71 -31.01 71.76 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.088 -1.008 . . . . 0.0 110.821 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.89 -20.57 65.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.086 0.954 . . . . 0.0 112.109 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.15 -26.74 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.596 1.089 . . . . 0.0 109.337 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.7 15.86 12.71 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.279 1.419 . . . . 0.0 111.677 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.99 95.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -77.83 88.75 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.31 -0.92 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.247 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -27.38 66.46 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.503 1.501 . . . . 0.0 111.325 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.34 -20.4 63.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.686 1.595 . . . . 0.0 113.007 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -70.58 175.13 5.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.932 0.893 . . . . 0.0 109.853 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -141.06 148.92 40.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.088 1.355 . . . . 0.0 108.751 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -89.07 154.66 20.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 109.689 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.1 t0 -152.65 160.07 43.18 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.545 1.938 . . . . 0.0 107.317 169.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.42 161.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 132.93 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.855 0.862 . . . . 0.0 110.972 -171.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -116.97 109.78 17.45 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.813 1.645 . . . . 0.0 107.121 174.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -59.26 -20.59 55.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.206 1.002 . . . . 0.0 112.398 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.84 -45.94 69.81 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.433 1.015 . . . . 0.0 111.059 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.71 -41.1 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.91 -49.86 58.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.068 0.547 . . . . 0.0 109.868 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -68.64 -14.65 63.15 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -96.14 -20.39 18.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.502 1.046 . . . . 0.0 110.884 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.33 140.42 55.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 118.198 0.454 . . . . 0.0 110.139 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.32 -33.95 76.33 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.632 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 35.6 tp -145.32 142.32 29.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.963 1.305 . . . . 0.0 108.925 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.15 139.8 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.61 110.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -94.06 101.52 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.15 -6.45 23.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.66 159.83 42.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.24 1.382 . . . . 0.0 109.187 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.81 99.7 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.327 -169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.49 -33.53 74.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.017 0.908 . . . . 0.0 111.177 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.49 -21.12 66.6 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.308 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.53 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.849 0.75 . . . . 0.0 112.792 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.23 -30.6 66.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.309 0.504 . . . . 0.0 111.903 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.97 62.49 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 91.7 m -125.5 79.18 67.49 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -50.69 -37.3 53.52 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.588 2.858 . . . . 0.0 114.969 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 36.6 tpp -159.72 128.39 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.2 p -140.56 85.92 12.71 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.62 171.18 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.238 3.292 . . . . 0.0 112.976 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.59 -28.64 29.62 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.577 2.852 . . . . 0.0 114.84 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -70.52 -3.8 19.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.684 1.194 . . . . 0.0 113.143 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.47 79.41 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 105.531 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -68.1 163.04 23.36 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -130.34 153.88 48.24 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.08 -0.388 . . . . 0.0 110.312 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.46 157.29 46.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -143.36 140.08 30.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.665 0.786 . . . . 0.0 109.573 -169.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -137.32 -168.54 2.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.447 1.099 . . . . 0.0 108.959 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.71 39.37 1.41 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.054 -169.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -76.62 111.11 11.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.213 1.006 . . . . 0.0 110.698 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.79 153.63 39.39 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.906 0.882 . . . . 0.0 108.988 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.71 118.97 74.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 119.192 -0.432 . . . . 0.0 112.061 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.29 -31.21 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.227 1.951 . . . . 0.0 112.584 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.6 -21.3 66.13 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.017 0.826 . . . . 0.0 111.959 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -99.38 7.45 45.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.672 1.189 . . . . 0.0 111.56 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.75 15.89 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.761 1.225 . . . . 0.0 114.303 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -51.93 153.73 2.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.18 1.392 . . . . 0.0 112.627 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 -51.94 0.22 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -154.37 153.09 31.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 168.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.36 -38.12 85.81 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 121.403 -0.811 . . . . 0.0 110.781 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.07 -31.45 72.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.23 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.76 -47.66 52.15 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -54.83 -52.54 62.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 110.143 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -63.51 -42.34 98.49 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.55 0.74 . . . . 0.0 111.036 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -35.96 71.23 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.076 0.853 . . . . 0.0 110.607 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.11 -39.15 82.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.22 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.1 -46.46 79.09 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -59.91 -49.89 75.92 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.586 0.754 . . . . 0.0 111.235 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -60.17 -49.51 77.35 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.49 -45.45 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 116.691 -1.623 . . . . 0.0 110.027 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -61.05 -43.84 98.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 122.134 2.243 . . . . 0.0 110.645 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.63 -45.98 91.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.39 -33.65 63.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.21 -44.45 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.544 1.52 . . . . 0.0 108.095 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.02 -44.48 96.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.77 -40.54 96.92 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.393 1.077 . . . . 0.0 112.506 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -56.7 -48.15 78.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.524 0.73 . . . . 0.0 109.305 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.15 -40.61 64.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.98 0.512 . . . . 0.0 109.823 -171.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -56.38 -46.24 80.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.083 0.953 . . . . 0.0 110.943 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.7 -56.04 23.92 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.486 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.31 -28.23 69.57 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.675 1.579 . . . . 0.0 111.372 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.17 63.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.672 0.669 . . . . 0.0 111.633 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -85.78 -31.87 22.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -95.49 -15.24 23.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.742 0.817 . . . . 0.0 111.544 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.26 29.73 74.67 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.405 1.482 . . . . 0.0 110.638 -178.08 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.8 t30 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.4 mtmt -135.75 169.99 16.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.397 1.479 . . . . 0.0 108.608 170.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.99 130.61 48.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.37 132.08 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.6 107.1 9.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.452 0.701 . . . . 0.0 109.32 -169.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -77.16 142.21 39.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.23 135.01 35.15 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.229 1.812 . . . . 0.0 107.14 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.88 168.57 26.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.478 0.581 . . . . 0.0 110.436 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -68.03 -11.4 58.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.037 -1.039 . . . . 0.0 113.29 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 115.09 0.64 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 105.928 -2.869 . . . . 0.0 105.928 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.21 -40.48 90.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 0.0 111.831 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -38.13 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.534 3.134 . . . . 0.0 117.451 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.25 -62.64 0.79 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.341 0.973 . . . . 0.0 111.983 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -54.69 -51.7 64.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.234 0.925 . . . . 0.0 112.269 -169.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -63.24 -48.05 79.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.499 0.59 . . . . 0.0 110.475 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -60.06 -39.63 86.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.593 0.757 . . . . 0.0 112.033 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.81 -48.43 68.96 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.962 0.905 . . . . 0.0 109.562 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.15 81.55 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.134 0.425 . . . . 0.0 111.176 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.38 -48.41 80.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.0 0.92 . . . . 0.0 110.437 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.11 94.24 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.73 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.432 ' CD1' ' HE3' ' A' ' 52' ' ' MET . 94.3 m95 -67.92 -40.87 83.33 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.879 1.839 . . . . 0.0 110.551 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.91 79.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.524 0.602 . . . . 0.0 111.549 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.8 -32.75 67.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.725 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.6 -58.24 4.18 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.546 0.612 . . . . 0.0 110.096 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -71.41 -33.84 69.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 32.8 mt -95.82 -37.12 10.88 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.261 0.624 . . . . 0.0 112.679 -169.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.26 -176.34 44.61 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.001 0.81 . . . . 0.0 112.789 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 -8.96 34.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.004 1.322 . . . . 0.0 113.672 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.28 -11.26 2.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.368 1.867 . . . . 0.0 111.18 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.7 m95 -139.82 150.27 44.48 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.792 1.237 . . . . 0.0 109.642 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 5.3 mmpt? -98.43 139.42 34.21 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 167.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.83 117.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -168.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.47 170.31 16.26 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.378 0.609 . . . . 0.0 110.187 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.8 m -135.81 144.94 45.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.24 1.416 . . . . 0.0 109.441 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.91 -173.61 4.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.01 175.62 44.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.56 -40.17 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.43 175.58 10.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.287 0.635 . . . . 0.0 110.876 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.37 156.86 44.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.244 2.618 . . . . 0.0 106.628 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -135.74 -35.67 0.79 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.027 0.931 . . . . 0.0 110.246 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.2 179.04 46.45 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.45 102.14 6.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -60.4 124.7 79.47 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.964 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.95 -34.27 45.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.266 2.644 . . . . 0.0 113.711 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -39.29 91.84 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.844 0.747 . . . . 0.0 110.734 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.49 73.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.54 -54.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.13 -42.91 83.64 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.956 0.798 . . . . 0.0 110.744 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.32 -44.09 79.62 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.529 0.604 . . . . 0.0 110.799 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.432 ' HE3' ' CD1' ' A' ' 23' ' ' TRP . 98.3 mmm -76.57 -39.83 51.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.551 0.74 . . . . 0.0 111.372 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -34.18 76.77 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -67.91 -20.17 65.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.004 0.922 . . . . 0.0 112.612 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -78.07 -24.34 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.479 1.036 . . . . 0.0 109.586 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.49 19.21 11.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.108 1.337 . . . . 0.0 111.08 -169.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -117.17 92.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.23 87.58 3.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.77 4.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 117.738 -1.125 . . . . 0.0 111.92 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.6 m -58.02 -25.88 61.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.01 1.732 . . . . 0.0 112.057 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.19 -21.51 62.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 112.68 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.3 169.31 15.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.667 0.787 . . . . 0.0 109.412 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -145.92 156.14 43.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.489 1.116 . . . . 0.0 109.326 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.1 m -95.32 148.53 22.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.251 1.02 . . . . 0.0 111.123 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -156.8 159.75 38.55 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.45 1.5 . . . . 0.0 108.528 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.6 164.39 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.52 117.83 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.598 0.713 . . . . 0.0 112.395 -169.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.27 121.97 36.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -73.04 -23.8 60.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.71 0.804 . . . . 0.0 112.826 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.09 -41.21 62.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.608 0.64 . . . . 0.0 110.105 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.76 -44.63 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -48.98 71.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.332 0.515 . . . . 0.0 110.037 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -69.76 -5.48 25.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -107.02 -20.62 13.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.868 1.213 . . . . 0.0 111.946 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.9 148.22 51.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.389 0.541 . . . . 0.0 111.244 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 39.0 tp -147.0 143.37 28.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 110.072 -169.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.06 138.4 49.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.62 108.4 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.8 p -88.9 90.6 8.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.1 -9.78 34.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.952 0.901 . . . . 0.0 112.812 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.04 156.09 44.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.06 -41.87 94.89 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -170.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -31.74 72.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.608 0.704 . . . . 0.0 111.737 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.68 -27.99 69.62 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.437 0.562 . . . . 0.0 111.902 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 -14.55 62.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.57 -30.43 69.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.009 0.822 . . . . 0.0 112.108 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.27 -35.97 58.65 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 118.052 -0.975 . . . . 0.0 113.288 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.6 m -40.38 105.1 0.36 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.898 1.679 . . . . 0.0 113.48 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.58 71.6 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.056 3.171 . . . . 0.0 111.255 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.8 mtt 79.58 110.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 129.283 3.033 . . . . 0.0 111.673 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.2 p -117.67 81.2 14.51 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.94 173.16 7.41 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.479 2.786 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.4 -28.55 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.829 3.019 . . . . 0.0 116.445 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.39 -8.3 45.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.133 0.973 . . . . 0.0 113.034 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.7 t -134.91 82.95 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 128.47 2.708 . . . . 0.0 105.125 -169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.3 pttt -66.12 167.68 9.64 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -141.14 150.04 42.29 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.507 -0.745 . . . . 0.0 109.412 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -136.4 162.33 33.36 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -144.68 147.21 32.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.2 1.0 . . . . 0.0 112.006 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -142.72 -168.52 2.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 108.301 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.16 42.51 1.13 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.227 0.921 . . . . 0.0 113.848 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -78.57 115.92 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.555 1.177 . . . . 0.0 111.925 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -66.11 150.6 48.48 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.743 1.217 . . . . 0.0 109.525 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.19 116.65 51.02 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.31 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.45 -33.96 27.85 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.966 1.778 . . . . 0.0 112.661 -171.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.27 -16.68 64.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.439 0.563 . . . . 0.0 112.288 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -105.4 8.62 33.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.11 -38.8 71.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.243 0.929 . . . . 0.0 112.613 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 53.42 -170.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.887 2.075 . . . . 0.0 113.434 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.96 -65.71 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.205 1.86 . . . . 0.0 108.942 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -162.32 161.45 27.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.929 2.092 . . . . 0.0 105.579 170.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.03 -40.18 73.07 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.118 0.872 . . . . 0.0 111.243 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.17 -28.41 66.39 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.487 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.84 -39.45 66.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.863 0.756 . . . . 0.0 109.598 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -60.23 -53.16 60.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -57.83 -41.14 81.68 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.329 0.393 . . . . 0.0 110.58 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.66 77.53 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.074 -0.391 . . . . 0.0 110.878 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -74.42 -35.83 63.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.33 0.652 . . . . 0.0 111.512 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -56.18 -43.58 78.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.339 0.972 . . . . 0.0 108.689 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.47 -48.77 78.31 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.071 0.548 . . . . 0.0 111.386 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.02 -49.4 77.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.156 0.434 . . . . 0.0 110.069 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.11 -46.19 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.976 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -60.95 -43.31 98.9 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 121.776 2.08 . . . . 0.0 110.699 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.44 -45.37 94.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.31 -30.87 62.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.005 -0.997 . . . . 0.0 112.765 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -41.27 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.837 1.199 . . . . 0.0 108.712 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.73 -47.01 90.48 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -59.63 -37.05 77.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.595 1.158 . . . . 0.0 111.411 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -52.77 64.28 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.713 0.805 . . . . 0.0 109.735 173.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.73 -34.5 76.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.918 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -60.08 -49.84 76.05 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.748 0.819 . . . . 0.0 111.065 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.31 -51.37 69.83 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 119.364 0.983 . . . . 0.0 108.867 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -55.89 -39.53 71.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.283 0.633 . . . . 0.0 111.063 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.65 55.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 111.848 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.24 -39.8 65.18 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.389 -173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.6 p -92.41 -21.8 20.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.105 0.962 . . . . 0.0 110.825 -171.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.75 42.88 99.81 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 126.735 2.014 . . . . 0.0 111.16 -174.314 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -124.67 169.26 12.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.406 1.882 . . . . 0.0 108.129 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -141.95 139.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.03 137.53 55.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -132.95 105.91 7.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.015 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -80.0 149.28 30.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.913 0.485 . . . . 0.0 110.592 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.05 129.71 15.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.946 1.299 . . . . 0.0 107.543 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.94 172.63 15.38 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.983 0.913 . . . . 0.0 109.993 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -66.34 -8.91 28.38 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.649 -1.282 . . . . 0.0 113.449 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.77 125.17 1.41 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.086 -2.805 . . . . 0.0 106.086 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.2 t-20 -61.16 -46.77 89.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.099 0.56 . . . . 0.0 110.384 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -42.85 -22.37 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 130.178 3.391 . . . . 0.0 117.412 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -119.69 -84.2 0.66 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.476 1.11 . . . . 0.0 109.683 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -60.14 -46.75 88.58 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.384 1.074 . . . . 0.0 111.669 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 -40.76 76.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.098 0.863 . . . . 0.0 110.796 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -60.94 -43.84 98.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.676 0.671 . . . . 0.0 111.431 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 85.3 mtp -65.77 -48.58 71.36 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.389 0.676 . . . . 0.0 109.487 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.31 -42.13 81.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.086 0.554 . . . . 0.0 111.309 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.61 -48.55 79.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 110.044 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.61 97.99 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.616 -1.102 . . . . 0.0 112.584 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' CD1' ' HE3' ' A' ' 52' ' ' MET . 95.7 m95 -68.66 -40.84 80.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.722 1.761 . . . . 0.0 110.937 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.99 81.51 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.526 0.603 . . . . 0.0 111.417 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -57.53 -33.66 68.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.812 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.35 -58.59 3.81 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.408 0.549 . . . . 0.0 110.101 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -70.11 -37.7 75.42 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -90.31 -36.65 14.56 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -169.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 179.09 50.84 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 121.999 0.777 . . . . 0.0 112.829 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.28 -16.4 63.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.738 1.615 . . . . 0.0 113.998 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.24 -24.64 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.311 1.044 . . . . 0.0 110.875 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -120.93 140.53 51.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.243 0.617 . . . . 0.0 110.226 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -89.75 144.06 26.28 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.95 124.1 52.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 170.72 15.62 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 p -140.14 142.75 35.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.43 -174.9 4.01 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.338 1.455 . . . . 0.0 108.768 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.57 174.67 41.34 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.3 -42.02 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 170.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.65 178.36 8.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.839 0.856 . . . . 0.0 109.892 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.69 122.59 11.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.568 1.547 . . . . 0.0 107.042 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.67 -32.35 47.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.983 0.513 . . . . 0.0 109.95 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.94 -158.25 28.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -94.4 111.98 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -67.27 125.37 90.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.258 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.37 -34.38 50.08 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.163 2.575 . . . . 0.0 113.624 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -37.54 85.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.698 0.681 . . . . 0.0 110.915 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.66 75.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.17 -53.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -67.63 -41.68 83.52 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.32 -45.17 84.52 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.007 0.821 . . . . 0.0 110.784 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.425 ' HE3' ' CD1' ' A' ' 23' ' ' TRP . 98.8 mmm -73.53 -39.83 64.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.889 0.476 . . . . 0.0 110.92 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -64.5 -32.11 73.61 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.288 -0.883 . . . . 0.0 111.617 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.92 -19.59 65.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.77 0.828 . . . . 0.0 112.145 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.67 -9.39 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.469 1.108 . . . . 0.0 110.174 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 16.28 53.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.691 1.139 . . . . 0.0 111.927 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.1 mt -107.96 92.22 2.01 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -76.54 85.21 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.032 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 pt -78.13 3.47 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.269 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.6 p -61.07 -23.2 65.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 121.267 1.848 . . . . 0.0 112.202 -175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -70.67 -21.29 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.064 1.345 . . . . 0.0 112.7 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -70.05 170.18 11.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 109.57 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -145.71 161.47 39.83 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.26 1.424 . . . . 0.0 107.98 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -104.16 155.74 18.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.739 0.816 . . . . 0.0 110.116 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.538 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -150.83 161.31 42.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.12 2.168 . . . . 0.0 108.125 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 pt -92.44 164.56 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 135.43 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.591 0.756 . . . . 0.0 112.426 -169.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -127.07 110.07 12.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 108.212 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -61.08 -19.67 61.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.926 -0.483 . . . . 0.0 111.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.34 -2.66 14.26 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 113.638 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -115.97 -45.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.43 -51.64 14.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.488 1.115 . . . . 0.0 111.525 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -66.7 -5.97 13.89 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -134.36 5.47 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 112.664 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.1 155.08 40.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.939 0.791 . . . . 0.0 109.936 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.61 -33.86 73.27 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.975 -1.078 . . . . 0.0 108.389 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -147.55 143.8 28.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 109.509 -170.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.01 133.7 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.88 119.02 56.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -172.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 p -96.57 92.77 6.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -68.14 -12.6 61.19 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.538 -0.726 . . . . 0.0 112.805 -169.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.57 156.63 45.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.74 1.155 . . . . 0.0 108.174 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.81 -41.33 83.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -169.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.96 -35.88 82.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.76 0.78 . . . . 0.0 111.318 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.44 -28.84 70.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.59 -22.56 65.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.37 -32.64 74.16 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.529 0.732 . . . . 0.0 112.227 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -99.29 -22.74 15.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.8 t -55.32 106.42 0.67 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.72 174.88 3.32 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.472 2.781 . . . . 0.0 113.169 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -58.88 143.23 48.34 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.572 -0.705 . . . . 0.0 110.544 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -133.0 119.13 15.59 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.541 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 169.23 20.61 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.38 -25.79 19.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.957 3.105 . . . . 0.0 115.969 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -65.91 -9.02 25.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.956 . . . . 0.0 112.839 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 t -133.68 89.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 127.539 2.336 . . . . 0.0 105.5 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -69.11 164.3 22.82 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.299 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -126.25 148.77 49.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.577 1.151 . . . . 0.0 108.679 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -143.94 160.18 41.27 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 145.14 30.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.377 1.071 . . . . 0.0 111.717 -169.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -143.8 -170.16 3.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.405 1.882 . . . . 0.0 108.436 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.92 41.19 1.24 Allowed Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.484 -0.76 . . . . 0.0 113.241 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -76.21 114.96 15.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.354 1.077 . . . . 0.0 110.953 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -67.65 151.52 47.15 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.406 1.082 . . . . 0.0 109.926 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.32 126.72 92.55 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.48 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.88 -30.83 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.462 2.108 . . . . 0.0 114.049 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.49 -24.55 67.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.937 0.895 . . . . 0.0 112.933 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 25.43 10.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 112.557 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.75 -36.42 57.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 56.45 -168.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.373 1.869 . . . . 0.0 112.843 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.54 -61.14 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.428 1.966 . . . . 0.0 108.338 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 t -166.43 167.72 15.47 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 105.313 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.88 -40.35 84.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.386 -0.822 . . . . 0.0 110.626 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -29.94 66.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.429 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.62 -42.73 61.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.751 0.705 . . . . 0.0 109.287 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -58.29 -49.31 77.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.883 0.873 . . . . 0.0 109.814 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -61.78 -44.18 97.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.769 0.259 . . . . 0.0 110.503 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.97 75.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.457 0.571 . . . . 0.0 110.401 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.52 -39.02 93.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.187 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -55.95 -48.31 75.99 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.563 1.074 . . . . 0.0 108.859 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -60.56 -44.23 96.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.575 0.35 . . . . 0.0 111.113 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.95 -48.99 77.91 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.066 0.394 . . . . 0.0 110.519 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.13 -45.28 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 117.208 -1.377 . . . . 0.0 109.91 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -60.39 -42.38 95.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 121.395 1.907 . . . . 0.0 110.709 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.08 -45.0 95.46 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.84 -31.64 63.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.98 -41.01 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 119.847 1.203 . . . . 0.0 108.867 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.47 88.22 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.79 -35.82 75.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.12 1.368 . . . . 0.0 111.513 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -53.97 52.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.842 0.857 . . . . 0.0 109.595 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.02 -34.68 78.26 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.851 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -50.52 73.55 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.133 0.973 . . . . 0.0 111.116 173.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -61.01 -51.66 68.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 122.832 0.453 . . . . 0.0 111.163 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.78 58.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.072 0.949 . . . . 0.0 111.789 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.32 -38.13 60.39 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.865 0.866 . . . . 0.0 111.243 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.9 p -94.83 -20.85 19.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.357 1.063 . . . . 0.0 111.189 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.61 36.98 93.81 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -172.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.693 1.597 . . . . 0.0 111.353 -173.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -143.72 147.45 34.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -155.97 -38.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.794 0.838 . . . . 0.0 111.406 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.6 mtmt -134.31 167.62 20.38 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.663 1.585 . . . . 0.0 107.744 169.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -136.38 132.9 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -124.84 127.94 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -125.61 104.15 8.24 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -169.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.79 147.49 45.46 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 122.026 -0.421 . . . . 0.0 109.926 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -147.5 126.36 12.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -146.88 175.57 10.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.515 0.598 . . . . 0.0 109.814 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -67.67 -11.76 58.97 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.72 -1.238 . . . . 0.0 112.972 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.16 121.1 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 49.7 t-20 -57.63 -45.16 85.78 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.637 0.775 . . . . 0.0 109.991 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m -40.07 -34.65 0.31 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 129.746 3.218 . . . . 0.0 115.175 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.1 m -112.81 -72.47 0.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.32 0.648 . . . . 0.0 111.165 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -48.28 61.58 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.348 -169.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -63.04 -45.62 91.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.288 0.494 . . . . 0.0 109.779 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -56.55 -44.7 81.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.847 -0.596 . . . . 0.0 112.368 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.2 mtm -69.83 -45.58 67.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.615 0.643 . . . . 0.0 110.333 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.72 73.79 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.93 0.786 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -61.17 -47.3 86.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.673 1.189 . . . . 0.0 110.673 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.82 95.47 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.033 -0.87 . . . . 0.0 111.676 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 98.1 m95 -65.22 -38.59 90.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.871 1.836 . . . . 0.0 110.79 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.1 82.65 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.447 -0.783 . . . . 0.0 111.604 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.48 -26.66 68.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.13 0.877 . . . . 0.0 112.348 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.53 -46.15 13.75 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.602 0.761 . . . . 0.0 109.622 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -80.9 -26.33 36.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 mt -99.08 -140.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 107.387 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -174.6 45.73 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.86 -13.91 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 113.349 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.52 -13.53 2.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.14 2.176 . . . . 0.0 111.267 169.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.447 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 8.5 m95 -133.23 162.49 31.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.965 1.706 . . . . 0.0 108.813 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.41 139.19 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 167.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.03 118.68 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.7 173.57 11.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.334 0.587 . . . . 0.0 110.413 172.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -132.24 144.22 50.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 110.175 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 179.45 6.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.055 2.142 . . . . 0.0 108.225 169.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.77 170.31 39.04 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.67 -41.64 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -142.6 179.52 6.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.521 0.729 . . . . 0.0 109.827 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.897 2.079 . . . . 0.0 107.202 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -135.57 -36.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.694 1.197 . . . . 0.0 109.238 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.89 178.57 39.44 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.98 100.79 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.93 127.85 92.23 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 117.883 -1.055 . . . . 0.0 109.257 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 -35.17 38.27 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.523 2.815 . . . . 0.0 113.946 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -59.61 -51.64 68.94 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.741 0.7 . . . . 0.0 109.886 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.35 80.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.496 0.589 . . . . 0.0 109.923 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -61.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -63.26 -40.02 96.24 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.999 0.818 . . . . 0.0 111.103 -169.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.15 83.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.583 0.753 . . . . 0.0 110.853 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -40.22 66.41 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.065 0.393 . . . . 0.0 110.715 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -68.3 -30.5 69.51 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.024 0.93 . . . . 0.0 111.287 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.47 -21.24 66.19 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.534 1.134 . . . . 0.0 111.879 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 t -89.89 -6.28 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.78 1.232 . . . . 0.0 110.193 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.57 19.97 52.83 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.764 -1.21 . . . . 0.0 112.258 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.3 mt -111.94 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.051 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -79.59 84.84 5.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.66 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.23 7.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.286 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.7 m -56.15 -25.16 45.26 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 120.667 1.576 . . . . 0.0 112.236 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.63 -20.34 59.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.696 1.198 . . . . 0.0 113.222 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.78 169.81 13.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.838 0.745 . . . . 0.0 110.511 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -145.8 155.4 42.9 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.412 1.485 . . . . 0.0 108.825 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 p -89.65 163.57 15.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.591 1.156 . . . . 0.0 110.409 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.487 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 41.2 t0 -158.15 158.78 35.28 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.818 2.047 . . . . 0.0 107.773 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.84 161.63 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.19 141.65 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 111.544 -170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -130.7 112.77 13.4 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.19 -26.88 41.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.872 1.269 . . . . 0.0 111.445 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.38 -23.03 66.86 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 125.066 1.347 . . . . 0.0 112.859 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -100.43 -42.44 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.157 0.89 . . . . 0.0 108.689 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tp -48.13 -51.73 23.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.896 1.278 . . . . 0.0 111.122 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -67.23 -13.57 62.09 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -106.82 -14.69 14.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.141 0.977 . . . . 0.0 111.281 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 148.86 47.35 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.32 -31.6 71.99 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 27.1 tp -152.73 144.37 23.48 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.763 1.225 . . . . 0.0 109.981 -169.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 135.63 58.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.71 108.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -86.29 93.18 9.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.03 -13.31 62.09 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.593 0.757 . . . . 0.0 112.328 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.3 t -144.33 145.89 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.868 1.213 . . . . 0.0 107.923 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.8 -34.77 89.69 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.568 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.22 -25.84 67.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.161 0.981 . . . . 0.0 111.402 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 -26.54 60.24 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.031 0.532 . . . . 0.0 111.841 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.65 65.72 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.78 -33.69 70.61 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.863 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -85.52 60.53 6.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.119 0.968 . . . . 0.0 110.577 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 74.7 m -120.95 74.78 27.58 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.355 1.062 . . . . 0.0 108.6 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.15 -29.08 89.52 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.126 2.551 . . . . 0.0 115.146 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.9 ptp -162.73 115.91 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 110.217 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -132.83 77.56 68.38 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.5 171.76 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.995 3.13 . . . . 0.0 112.959 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.7 -17.77 10.74 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.011 3.141 . . . . 0.0 115.795 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.53 -13.2 38.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.059 0.943 . . . . 0.0 112.419 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -127.16 159.43 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 128.81 2.844 . . . . 0.0 106.828 -169.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.1 pttt -138.48 167.7 21.36 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -127.42 153.06 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.644 0.657 . . . . 0.0 109.418 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -135.18 156.43 49.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.51 135.45 30.21 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.78 0.832 . . . . 0.0 111.766 -168.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -137.98 -170.01 2.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.472 1.909 . . . . 0.0 108.735 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.93 40.27 1.37 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.305 -0.872 . . . . 0.0 113.43 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -79.1 112.01 15.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.255 1.027 . . . . 0.0 111.978 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.62 158.39 18.35 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.983 0.913 . . . . 0.0 109.567 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.12 118.91 74.73 Favored Pre-proline 0 CA--C 1.534 0.339 0 O-C-N 121.526 -0.733 . . . . 0.0 111.142 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.98 -30.23 21.6 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.818 1.678 . . . . 0.0 112.633 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.59 -18.12 65.09 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.54 1.064 . . . . 0.0 112.408 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -99.37 -1.13 39.54 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.911 1.284 . . . . 0.0 111.618 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 146.1 36.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.03 164.39 36.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.97 0.508 . . . . 0.0 110.797 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.82 -48.58 0.66 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -165.36 166.66 18.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.243 2.217 . . . . 0.0 105.595 169.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.29 -40.82 82.97 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.726 -0.609 . . . . 0.0 110.507 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -28.35 64.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.1 -45.07 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.893 0.769 . . . . 0.0 109.105 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -56.24 -50.46 71.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.648 0.779 . . . . 0.0 109.915 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -62.3 -43.95 97.63 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.119 0.418 . . . . 0.0 110.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.39 79.83 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.886 0.766 . . . . 0.0 110.26 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.2 -40.43 97.48 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.681 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -54.85 -49.46 71.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.096 0.862 . . . . 0.0 109.352 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -61.51 -44.16 97.56 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.947 0.499 . . . . 0.0 111.282 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.47 -50.34 73.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 119.167 -0.445 . . . . 0.0 110.098 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.43 -43.73 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 117.406 -1.283 . . . . 0.0 110.164 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -61.63 -42.04 98.33 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 121.144 1.793 . . . . 0.0 111.016 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.17 -42.63 99.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.342 0.519 . . . . 0.0 110.339 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.22 -38.95 71.98 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -65.53 -40.45 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.528 1.058 . . . . 0.0 109.3 177.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.62 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -52.38 -44.37 65.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.77 0.828 . . . . 0.0 111.137 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -47.52 84.96 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 109.933 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.96 -34.91 76.1 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.167 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -49.7 76.73 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.933 0.788 . . . . 0.0 110.865 173.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.26 -52.07 66.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.18 -39.97 73.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.696 0.68 . . . . 0.0 111.388 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.8 67.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.688 0.795 . . . . 0.0 111.708 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -76.14 -43.49 42.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.049 0.94 . . . . 0.0 110.915 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.2 p -85.09 -22.33 28.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.373 1.069 . . . . 0.0 110.021 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.24 38.12 95.68 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.569 -169.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -60.86 155.57 19.31 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.734 0.814 . . . . 0.0 111.594 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.45 -29.99 0.79 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.882 1.273 . . . . 0.0 111.096 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -144.44 173.11 12.08 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.014 1.326 . . . . 0.0 108.567 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -131.14 142.81 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.7 141.37 46.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.868 1.267 . . . . 0.0 107.783 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.14 107.06 7.05 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.17 141.37 38.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.752 0.421 . . . . 0.0 110.083 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.81 133.81 34.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.394 1.478 . . . . 0.0 108.038 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.3 p -152.68 179.23 8.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 110.116 169.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.06 -3.68 17.57 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.85 104.43 0.21 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 54.3 t-20 -41.93 -48.16 4.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.793 1.637 . . . . 0.0 111.599 -170.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -41.89 -31.58 0.34 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.196 2.999 . . . . 0.0 115.118 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.91 -85.33 0.48 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.456 1.026 . . . . 0.0 111.185 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -45.01 95.81 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.68 -168.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -68.13 -39.24 82.76 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.997 1.272 . . . . 0.0 110.761 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -62.18 -46.2 89.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.92 0.782 . . . . 0.0 111.383 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.46 -47.86 74.68 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.88 -45.13 78.63 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.453 0.701 . . . . 0.0 110.627 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.03 -46.22 85.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.924 0.489 . . . . 0.0 110.32 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.77 97.6 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' HE2' ' A' ' 52' ' ' MET . 96.7 m95 -67.16 -38.78 86.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.321 1.561 . . . . 0.0 110.536 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.8 85.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.097 0.408 . . . . 0.0 110.771 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -57.35 -31.49 65.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.417 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.99 -59.97 2.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.612 0.642 . . . . 0.0 110.514 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -70.57 -42.8 70.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -168.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.5 mt -82.2 -37.98 25.26 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 122.315 0.246 . . . . 0.0 110.825 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.2 174.66 49.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.024 0.821 . . . . 0.0 112.072 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.48 -15.37 63.31 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.809 1.244 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.13 -27.26 19.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 110.911 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -112.28 134.46 53.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 131.65 35.29 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 168.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -111.44 142.81 22.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -140.83 167.25 22.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.851 1.26 . . . . 0.0 108.815 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.0 p -139.47 134.07 31.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.237 1.415 . . . . 0.0 108.113 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.66 -175.2 4.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.972 1.709 . . . . 0.0 108.495 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 178.05 41.97 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.05 -42.31 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.793 1.237 . . . . 0.0 108.256 172.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.41 -179.45 6.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.87 125.4 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.72 1.608 . . . . 0.0 107.026 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.87 -35.01 38.72 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.013 0.525 . . . . 0.0 109.91 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.72 -161.41 31.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.53 108.96 18.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.21 131.83 95.16 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.637 -0.696 . . . . 0.0 110.265 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.29 -32.27 33.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.975 1.784 . . . . 0.0 112.88 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.76 -38.33 83.28 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.571 1.078 . . . . 0.0 110.497 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.19 89.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.648 1.113 . . . . 0.0 109.254 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.88 -58.71 6.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.81 -47.1 82.2 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.693 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.41 81.89 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 119.096 0.862 . . . . 0.0 110.677 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.406 ' HE2' ' CD1' ' A' ' 23' ' ' TRP . 97.9 mmm -69.17 -41.68 76.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.148 0.431 . . . . 0.0 110.29 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -67.78 -27.56 66.86 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.991 0.916 . . . . 0.0 111.818 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -67.47 -18.62 65.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.518 1.127 . . . . 0.0 111.708 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.54 -13.07 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.012 0.925 . . . . 0.0 109.972 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.86 6.39 54.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.299 1.428 . . . . 0.0 112.045 -173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.61 89.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.71 78.41 2.67 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.306 1.042 . . . . 0.0 110.651 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.27 6.09 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.452 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.0 p -57.4 -24.82 57.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.601 1.546 . . . . 0.0 112.271 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.21 -19.14 60.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.568 1.147 . . . . 0.0 112.885 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.32 169.43 15.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.777 0.717 . . . . 0.0 109.939 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -145.02 161.42 39.44 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.985 1.714 . . . . 0.0 107.986 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 m -111.57 155.35 23.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 109.831 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.2 t0 -154.44 160.57 41.69 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.838 2.055 . . . . 0.0 108.484 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 pt -94.26 163.08 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.39 119.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.563 0.697 . . . . 0.0 112.825 -169.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -100.51 111.57 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -15.61 63.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.697 0.799 . . . . 0.0 112.195 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.06 -40.14 75.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.588 1.085 . . . . 0.0 111.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.9 mt -63.41 -48.35 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.88 -46.27 74.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.413 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -66.46 -5.86 12.59 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.47 3.55 3.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.078 1.308 . . . . 0.0 113.603 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 147.74 52.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.839 0.745 . . . . 0.0 109.487 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.17 -34.64 71.13 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.063 0.847 . . . . 0.0 108.932 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.0 tp -145.27 142.73 29.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.31 132.01 69.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.4 t -114.23 113.17 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.9 p -92.39 92.98 8.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.88 -10.56 54.14 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.639 -169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -147.71 162.68 38.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.979 1.718 . . . . 0.0 110.741 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.11 -55.94 27.92 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.551 1.072 . . . . 0.0 112.522 -169.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.12 -31.92 70.94 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -171.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.95 80.12 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.49 -26.43 63.42 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.68 0.792 . . . . 0.0 112.92 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.67 -38.49 80.42 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.742 0.817 . . . . 0.0 111.755 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.26 -34.47 42.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.048 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.76 114.47 4.2 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 118.155 -0.926 . . . . 0.0 108.618 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.36 173.76 10.14 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.82 2.347 . . . . 0.0 111.875 -173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 65.8 ttp -53.79 125.07 17.15 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.208 1.003 . . . . 0.0 110.994 -170.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 p -107.1 105.59 56.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.63 1.572 . . . . 0.0 107.208 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -53.89 166.59 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.719 2.946 . . . . 0.0 112.961 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.69 -28.09 36.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.438 2.759 . . . . 0.0 114.788 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -68.19 -7.49 30.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.376 1.07 . . . . 0.0 112.981 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.75 85.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.752 2.421 . . . . 0.0 105.591 -169.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.1 pttt -69.7 167.09 17.78 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.169 -0.957 . . . . 0.0 108.973 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -123.8 160.35 27.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.036 0.534 . . . . 0.0 109.85 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.68 155.03 46.6 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -143.78 137.21 27.89 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.665 0.386 . . . . 0.0 111.731 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -140.53 -172.83 3.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.869 1.668 . . . . 0.0 109.311 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.55 44.39 1.05 Allowed Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.744 -0.597 . . . . 0.0 112.954 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -76.36 114.16 14.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.852 0.826 . . . . 0.0 110.487 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.58 162.46 20.88 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.275 0.63 . . . . 0.0 109.739 169.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.32 130.65 92.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.791 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.8 -44.48 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.458 2.106 . . . . 0.0 113.106 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.42 70.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.858 0.863 . . . . 0.0 111.428 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.14 5.89 46.67 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.636 1.575 . . . . 0.0 111.507 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.71 140.07 48.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -143.36 158.65 43.46 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.687 0.795 . . . . 0.0 110.168 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.19 -51.97 0.46 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -160.41 162.06 33.18 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.57 -40.92 88.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.619 -0.675 . . . . 0.0 110.696 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.02 -29.08 67.17 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.467 -0.302 . . . . 0.0 111.069 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.93 -42.23 40.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.285 0.634 . . . . 0.0 109.994 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -54.32 -51.7 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.025 0.93 . . . . 0.0 109.639 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -60.55 -46.51 89.92 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.57 75.89 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.036 -0.415 . . . . 0.0 110.662 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.67 -37.49 87.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.667 0.787 . . . . 0.0 111.022 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -54.55 -51.74 64.25 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.118 0.872 . . . . 0.0 108.706 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.481 ' NE2' HH21 ' A' ' 124' ' ' ARG . 5.3 mm-40 -61.21 -42.72 99.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 111.666 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.27 -48.15 82.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.242 0.474 . . . . 0.0 110.113 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.1 -47.26 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 117.459 -1.257 . . . . 0.0 110.022 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.481 HH21 ' NE2' ' A' ' 121' ' ' GLN . 49.1 ptt85 -63.01 -41.65 99.62 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.898 1.681 . . . . 0.0 111.027 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.23 -42.46 98.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.21 0.459 . . . . 0.0 110.082 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -76.63 -33.76 58.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.466 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.01 -46.29 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 119.977 1.262 . . . . 0.0 107.646 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.7 -47.71 87.02 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.81 -37.91 71.84 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.8 1.24 . . . . 0.0 112.125 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -42.76 85.32 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.48 -0.763 . . . . 0.0 111.526 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 mt -68.22 -41.44 81.27 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -48.07 73.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.666 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.97 -57.9 11.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.605 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.298 5.2 p90 -68.63 -21.56 64.47 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 121.111 1.778 . . . . 0.0 112.681 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.99 64.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.38 0.991 . . . . 0.0 111.798 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -77.52 -39.58 45.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.402 1.081 . . . . 0.0 111.17 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.6 p -90.7 -22.42 21.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.932 0.893 . . . . 0.0 110.838 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.27 41.64 99.49 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.314 1.846 . . . . 0.0 111.331 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -148.45 148.37 30.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -150.43 -35.78 0.15 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.362 1.065 . . . . 0.0 111.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.0 mtmt -134.99 166.25 23.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.983 1.713 . . . . 0.0 106.519 169.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.0 140.16 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.2 tt -130.44 135.22 61.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.69 102.95 6.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.693 0.797 . . . . 0.0 108.981 -170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -76.91 144.96 38.53 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.205 0.602 . . . . 0.0 110.166 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 137.32 37.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.758 1.623 . . . . 0.0 108.138 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.2 p -154.76 175.23 13.98 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -67.81 -7.84 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.82 97.31 0.14 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -41.41 -40.94 1.88 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.453 1.901 . . . . 0.0 113.204 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.6 m -38.07 -36.67 0.22 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.903 3.281 . . . . 0.0 115.329 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -117.23 -74.92 0.59 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.966 0.803 . . . . 0.0 112.137 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -56.29 -50.74 70.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.738 0.699 . . . . 0.0 111.614 -169.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -70.27 -34.61 73.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.612 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -63.6 -42.22 98.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.415 0.552 . . . . 0.0 110.772 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.6 mtp -65.72 -47.54 74.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.806 0.442 . . . . 0.0 109.828 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.08 86.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.031 0.532 . . . . 0.0 110.871 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -57.86 -45.65 85.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.611 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.72 -52.44 53.09 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.074 0.845 . . . . 0.0 112.709 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -65.37 -34.57 78.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.592 1.696 . . . . 0.0 110.61 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.53 83.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.605 -0.684 . . . . 0.0 110.56 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.94 -22.11 64.1 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.223 -0.923 . . . . 0.0 112.557 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.46 -47.18 8.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.872 0.76 . . . . 0.0 110.116 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -78.92 -26.71 43.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.91 -142.78 0.25 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.46 -174.26 46.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.67 -13.74 55.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.95 -14.62 3.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.721 2.008 . . . . 0.0 111.147 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.468 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 7.8 m95 -133.18 167.06 21.04 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.021 1.728 . . . . 0.0 108.844 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -123.07 130.66 53.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 167.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.26 118.8 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.22 174.61 10.45 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.6 1.16 . . . . 0.0 108.653 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.4 p -137.59 160.41 39.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.372 0.606 . . . . 0.0 111.157 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.47 -162.25 1.49 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.496 1.518 . . . . 0.0 108.546 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.7 176.37 44.88 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -41.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.4 -179.88 6.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.596 1.159 . . . . 0.0 109.17 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.58 149.96 36.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.755 2.422 . . . . 0.0 106.156 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -13.93 1.9 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.961 0.904 . . . . 0.0 111.446 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.71 170.24 20.91 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 171.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.64 102.12 1.8 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -64.42 125.67 88.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.678 -170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.97 -35.46 50.16 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.383 2.722 . . . . 0.0 113.881 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -40.96 96.61 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.631 0.651 . . . . 0.0 110.515 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.92 -41.58 82.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.54 -55.99 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -65.25 -41.33 94.4 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 119.378 0.99 . . . . 0.0 110.664 -173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.21 71.4 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.862 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.0 mmm -86.51 -38.16 17.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.451 0.569 . . . . 0.0 111.427 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.42 -33.29 75.22 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.969 0.908 . . . . 0.0 110.3 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.77 -19.2 65.08 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 112.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.67 -10.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.221 1.008 . . . . 0.0 109.906 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.62 23.31 47.28 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.121 -0.987 . . . . 0.0 111.039 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.6 mt -114.32 91.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -78.49 74.25 5.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.991 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.03 3.32 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.322 -0.861 . . . . 0.0 112.129 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -27.12 10.38 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.497 1.044 . . . . 0.0 111.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -71.83 -19.59 61.96 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 113.852 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -78.29 170.38 16.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.963 . . . . 0.0 109.681 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.05 160.75 41.46 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.418 1.487 . . . . 0.0 108.462 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 p -101.64 153.55 19.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.419 1.088 . . . . 0.0 110.958 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -156.48 160.84 39.92 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.841 1.256 . . . . 0.0 108.944 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.09 161.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.22 129.29 18.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 123.397 0.679 . . . . 0.0 111.586 -169.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -106.59 114.84 29.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.31 1.444 . . . . 0.0 107.655 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -66.71 -23.1 66.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.63 -41.25 46.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.368 0.985 . . . . 0.0 110.268 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.67 -44.75 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.33 -48.71 65.31 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.948 0.499 . . . . 0.0 109.942 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -71.15 -14.81 62.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -94.75 -17.91 21.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.578 1.081 . . . . 0.0 111.003 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.01 150.25 49.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.164 0.438 . . . . 0.0 111.071 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.04 -32.71 51.11 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.42 141.04 29.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.562 1.145 . . . . 0.0 109.662 -174.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.74 124.67 59.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.95 118.44 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -102.66 97.34 7.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.8 mt -71.84 -3.15 20.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.903 1.681 . . . . 0.0 114.487 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.7 p -151.26 163.91 37.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.584 1.538 . . . . 0.0 110.327 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.76 -64.84 3.19 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.719 1.628 . . . . 0.0 113.338 -169.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.36 -29.25 67.93 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.712 -0.287 . . . . 0.0 111.754 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.55 66.94 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.85 64.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.45 -31.75 72.13 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.109 0.564 . . . . 0.0 112.109 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -85.36 63.17 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.319 0.647 . . . . 0.0 110.633 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -124.94 76.23 66.54 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.153 0.981 . . . . 0.0 108.401 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.51 85.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.635 2.89 . . . . 0.0 111.234 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.0 tpt 70.1 111.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.383 2.673 . . . . 0.0 111.196 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -134.55 81.71 47.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.87 171.5 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.444 2.763 . . . . 0.0 110.965 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.25 -25.47 13.47 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.43 3.42 . . . . 0.0 117.448 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -56.97 -36.93 70.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.669 1.122 . . . . 0.0 110.836 170.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.75 82.96 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.91 2.484 . . . . 0.0 106.87 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -66.63 165.27 15.09 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.49 -0.756 . . . . 0.0 108.975 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -133.77 134.07 42.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.963 0.905 . . . . 0.0 110.147 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.99 155.75 45.59 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -151.3 139.08 19.8 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -141.22 178.86 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.949 1.7 . . . . 0.0 108.537 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.22 103.82 0.4 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -135.58 143.64 45.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.668 0.787 . . . . 0.0 110.579 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -73.28 169.99 15.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -73.46 117.23 58.87 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.86 -32.08 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.677 1.585 . . . . 0.0 112.818 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.35 65.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.962 0.801 . . . . 0.0 112.209 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -101.64 2.31 38.65 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 111.786 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.41 144.98 40.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.13 165.28 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.055 0.455 . . . . 0.0 111.191 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.03 -47.65 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.54 166.41 18.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.509 2.324 . . . . 0.0 105.2 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.12 -40.57 81.58 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.533 -0.729 . . . . 0.0 110.52 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -27.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.562 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.96 -45.3 51.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.007 0.822 . . . . 0.0 109.171 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -55.69 -49.42 73.04 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.73 0.812 . . . . 0.0 109.882 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -64.68 -41.78 95.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.14 -0.35 . . . . 0.0 110.96 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.06 72.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.964 0.802 . . . . 0.0 110.62 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.78 -40.8 92.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.621 -0.674 . . . . 0.0 110.629 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.03 -45.41 83.15 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 119.191 0.905 . . . . 0.0 109.04 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.76 -50.01 75.5 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.351 0.66 . . . . 0.0 111.322 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.01 -48.78 80.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 119.488 -0.292 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.98 -45.81 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.927 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -62.3 -42.95 99.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 121.414 1.916 . . . . 0.0 110.764 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.2 -42.42 98.56 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.449 0.3 . . . . 0.0 110.696 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.44 -36.92 52.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.597 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -43.61 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.79 81.41 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.903 0.851 . . . . 0.0 112.083 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -49.41 76.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.542 0.61 . . . . 0.0 110.302 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 -43.45 70.64 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.267 0.627 . . . . 0.0 109.354 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -46.42 75.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.283 1.033 . . . . 0.0 110.934 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -60.79 -55.61 31.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.382 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.272 3.1 p90 -67.72 -24.3 65.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 121.492 1.951 . . . . 0.0 111.992 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.52 67.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.059 0.845 . . . . 0.0 111.732 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -76.58 -41.67 45.47 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.671 1.189 . . . . 0.0 111.153 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.0 p -84.92 -21.09 29.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.098 0.959 . . . . 0.0 110.343 -174.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.78 21.62 79.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.108 0.861 . . . . 0.0 111.881 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.251 1.158 0 CA-C-N 117.928 0.864 . . . . 0.0 109.673 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -153.04 150.38 29.11 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.03 -44.66 0.11 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.292 1.037 . . . . 0.0 110.094 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -126.83 164.15 22.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.629 1.972 . . . . 0.0 106.553 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -135.37 124.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -169.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tt -122.98 133.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -135.95 105.2 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -77.35 151.36 34.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 111.297 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -149.62 130.7 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.025 0.93 . . . . 0.0 108.651 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -148.69 178.68 8.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 111.01 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -66.81 -8.7 30.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 113.787 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.85 102.62 0.19 Allowed Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.1 t-20 -42.83 -46.07 5.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.222 1.809 . . . . 0.0 111.87 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -35.27 -35.95 0.05 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.148 3.379 . . . . 0.0 115.302 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.0 p -111.77 -74.06 0.65 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.362 0.983 . . . . 0.0 112.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.688 1.131 . . . . 0.0 111.95 -169.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.5 m -64.62 -36.18 83.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.223 0.465 . . . . 0.0 110.845 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.73 -44.48 90.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.535 0.607 . . . . 0.0 111.465 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.4 mtp -65.46 -48.24 73.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 109.704 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.64 84.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.233 0.613 . . . . 0.0 111.209 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.78 -45.08 90.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.026 0.53 . . . . 0.0 110.274 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.1 90.88 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.914 -0.937 . . . . 0.0 112.607 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.15 -40.46 82.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.276 1.538 . . . . 0.0 111.39 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.04 79.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.936 0.335 . . . . 0.0 111.592 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.67 -33.26 68.15 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.858 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -71.54 -58.17 3.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.422 0.555 . . . . 0.0 110.332 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.39 -39.38 68.04 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.3 mt -86.55 -39.97 15.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.174 0.443 . . . . 0.0 111.811 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.56 -173.93 55.16 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.114 0.864 . . . . 0.0 113.207 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.87 -17.01 62.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.307 1.843 . . . . 0.0 113.867 -170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -60.38 -10.94 5.43 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.242 1.417 . . . . 0.0 111.672 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -133.9 166.92 21.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.662 1.185 . . . . 0.0 110.597 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.05 137.84 51.53 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 168.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -114.42 142.42 27.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -137.82 159.43 42.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 108.636 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -137.6 124.59 21.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.24 -174.13 3.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.336 1.054 . . . . 0.0 109.109 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.84 175.03 42.2 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.18 -42.65 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -144.82 179.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.876 1.27 . . . . 0.0 109.027 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.71 44.13 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.683 1.993 . . . . 0.0 106.941 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -133.33 -30.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.005 0.922 . . . . 0.0 110.68 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 169.08 -176.64 43.13 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -76.1 104.15 6.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.28 125.77 87.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.449 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.76 -34.57 44.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.372 2.715 . . . . 0.0 113.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -42.69 96.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.693 0.679 . . . . 0.0 110.53 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.64 87.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -61.27 -56.07 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -65.76 -40.69 92.3 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.549 1.068 . . . . 0.0 110.51 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.18 -39.6 79.33 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.822 0.737 . . . . 0.0 111.871 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.3 mmm -82.37 -40.36 21.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.659 0.384 . . . . 0.0 111.093 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.99 -36.09 82.36 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.087 0.955 . . . . 0.0 110.497 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.0 -18.86 65.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.184 0.594 . . . . 0.0 111.894 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.42 -2.96 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.582 1.153 . . . . 0.0 109.934 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.36 20.91 53.64 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.898 -1.127 . . . . 0.0 111.901 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.9 mt -113.29 90.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.71 79.03 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.69 0.796 . . . . 0.0 110.627 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.09 4.57 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.008 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 m -54.18 -25.8 24.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.785 1.175 . . . . 0.0 112.592 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -78.35 -17.35 56.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.637 1.175 . . . . 0.0 113.186 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -70.69 169.25 14.82 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.863 0.756 . . . . 0.0 110.131 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 p -145.96 163.76 34.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.594 1.557 . . . . 0.0 108.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -111.37 150.85 29.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.13 0.972 . . . . 0.0 109.703 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.587 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.5 t0 -149.62 160.18 43.71 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.141 2.176 . . . . 0.0 108.746 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -89.77 164.51 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.56 139.74 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.649 0.738 . . . . 0.0 111.846 -170.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -128.64 104.71 7.81 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 107.99 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 p -57.07 -24.76 56.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.842 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.41 -22.06 66.66 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.951 1.251 . . . . 0.0 112.286 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -108.57 -45.8 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.48 -40.97 69.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.183 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.06 -15.56 63.48 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.953 1.251 . . . . 0.0 113.575 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -106.02 -6.99 18.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.522 1.129 . . . . 0.0 111.137 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.97 155.09 35.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.311 0.505 . . . . 0.0 110.101 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.05 -32.73 44.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.307 -0.871 . . . . 0.0 108.885 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -144.28 140.4 29.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.536 1.134 . . . . 0.0 109.714 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.22 134.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.21 106.94 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 p -76.54 147.89 37.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.16 2.63 13.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.868 0.467 . . . . 0.0 110.953 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -151.86 147.73 26.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.18 -45.39 96.62 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.87 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.19 -32.85 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.409 0.604 . . . . 0.0 111.662 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.8 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.31 -18.77 64.92 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.62 -35.61 81.07 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.064 0.946 . . . . 0.0 111.927 172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.26 -36.83 66.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.13 110.26 1.26 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.902 1.281 . . . . 0.0 110.938 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.552 2.834 . . . . 0.0 109.743 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -43.76 110.34 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.011 1.724 . . . . 0.0 111.765 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 p -133.16 72.49 75.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.93 168.07 12.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.479 2.786 . . . . 0.0 110.752 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -49.99 -23.79 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.53 3.487 . . . . 0.0 117.87 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -54.69 -40.86 69.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.605 1.093 . . . . 0.0 110.356 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.66 97.7 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.746 2.019 . . . . 0.0 107.556 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -72.02 159.59 33.95 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -131.22 148.51 52.71 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.386 0.675 . . . . 0.0 109.271 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.81 148.45 37.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -132.91 106.88 7.96 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -102.52 170.01 8.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.211 1.404 . . . . 0.0 108.081 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.27 106.68 0.5 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.432 -168.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -138.52 140.82 39.29 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.868 0.867 . . . . 0.0 111.73 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.79 168.99 10.43 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.546 0.738 . . . . 0.0 109.286 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -74.43 112.64 18.12 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.77 -34.07 51.38 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.547 1.498 . . . . 0.0 112.311 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.13 -15.18 62.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.029 0.831 . . . . 0.0 112.513 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -118.95 20.79 12.67 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.201 1.401 . . . . 0.0 110.979 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.1 67.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 55.07 -160.59 0.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.027 1.731 . . . . 0.0 112.237 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.95 -70.33 0.68 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -159.95 163.72 33.96 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -59.17 -40.63 86.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.828 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.05 -31.56 70.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.603 -0.237 . . . . 0.0 111.09 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -75.57 -38.02 59.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.355 0.662 . . . . 0.0 110.195 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -60.27 -50.01 75.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.154 0.982 . . . . 0.0 109.491 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -60.77 -42.9 98.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.069 0.395 . . . . 0.0 110.727 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.65 -37.51 76.13 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.919 0.488 . . . . 0.0 110.622 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.31 -35.46 76.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.56 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -54.94 -44.29 74.16 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.104 1.32 . . . . 0.0 108.485 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -60.58 -41.82 95.42 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.957 0.344 . . . . 0.0 111.197 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -64.03 -51.22 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.28 -46.45 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.784 -1.103 . . . . 0.0 109.67 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -62.73 -41.65 99.27 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.551 1.523 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.77 -44.67 96.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.001 0.364 . . . . 0.0 110.168 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.16 -42.26 76.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.275 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.06 -45.7 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.613 1.097 . . . . 0.0 108.719 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.14 94.35 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -57.28 -45.93 83.62 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.933 0.893 . . . . 0.0 111.781 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.63 -35.23 79.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.612 1.096 . . . . 0.0 111.91 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 -41.46 76.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.757 1.162 . . . . 0.0 110.816 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.63 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 110.578 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.77 -52.86 63.74 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.643 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -55.25 -46.41 76.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 120.249 1.386 . . . . 0.0 109.966 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.78 90.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.245 0.618 . . . . 0.0 111.555 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -84.52 -37.46 21.24 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.534 0.734 . . . . 0.0 111.777 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.2 p -92.88 -23.66 18.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.597 0.759 . . . . 0.0 111.081 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.9 42.43 99.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.808 2.043 . . . . 0.0 112.468 -169.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -141.02 157.29 45.53 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 106.851 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -153.68 -43.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.445 0.698 . . . . 0.0 110.775 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 48.0 mtmt -134.61 169.3 17.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.846 1.659 . . . . 0.0 107.577 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.92 134.36 53.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -124.39 132.74 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -129.1 105.54 8.25 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.835 0.854 . . . . 0.0 108.714 -170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -75.59 147.54 39.52 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.941 -0.474 . . . . 0.0 110.216 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.4 127.11 15.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.95 174.52 11.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.335 0.654 . . . . 0.0 110.104 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -66.86 -12.77 60.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.73 -1.231 . . . . 0.0 112.997 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.42 122.82 1.21 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 106.326 -2.709 . . . . 0.0 106.326 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -59.69 -45.92 90.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.876 0.87 . . . . 0.0 110.744 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' HG ' ' CD2' ' A' ' 42' ' ' HIS . 3.4 m -38.18 -30.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 130.089 3.356 . . . . 0.0 117.279 -169.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.3 m -120.51 -71.21 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.431 0.693 . . . . 0.0 110.195 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -66.74 -49.77 64.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.77 -169.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -63.87 -43.99 94.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.402 0.547 . . . . 0.0 109.623 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.73 -45.88 85.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.317 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 45.1 mtm -67.29 -45.34 76.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.258 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.14 -44.6 75.24 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.715 0.689 . . . . 0.0 111.048 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.88 -44.71 94.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.586 0.754 . . . . 0.0 110.468 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.97 -50.8 53.51 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.178 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -68.21 -37.21 80.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.752 1.776 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.96 79.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.553 -0.717 . . . . 0.0 111.247 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -59.09 -32.72 70.06 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.658 -0.651 . . . . 0.0 112.072 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.82 -49.43 18.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.43 0.692 . . . . 0.0 109.359 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -79.76 -34.88 39.46 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -170.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.77 -35.54 12.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.499 0.59 . . . . 0.0 112.017 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.22 -178.72 49.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.195 0.902 . . . . 0.0 112.793 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.02 -6.04 25.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.56 -8.69 4.64 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.044 1.738 . . . . 0.0 110.729 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.418 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 4.3 m95 -138.15 157.94 45.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 108.561 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.95 142.09 44.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 168.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.8 126.83 67.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 171.11 14.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 109.668 172.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.4 m -135.52 142.34 45.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.753 1.221 . . . . 0.0 110.261 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.69 -174.72 4.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.279 1.432 . . . . 0.0 108.925 169.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.44 175.95 41.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.01 -41.87 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.23 179.34 7.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.543 0.737 . . . . 0.0 110.083 170.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.8 42.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.295 2.238 . . . . 0.0 106.306 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.47 ' CD2' ' HG ' ' A' ' 14' ' ' SER . 28.3 p80 -136.7 -19.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.58 0.752 . . . . 0.0 111.686 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.1 -178.0 40.91 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -77.75 100.72 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.57 122.77 73.29 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.33 -171.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.5 -32.01 41.6 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.183 2.588 . . . . 0.0 113.521 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -39.84 92.79 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.812 0.733 . . . . 0.0 110.801 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.84 75.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.11 -54.78 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -66.89 -41.58 86.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.588 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.53 -46.09 84.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.516 0.598 . . . . 0.0 110.818 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 84.4 mmm -73.81 -37.44 64.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.462 0.574 . . . . 0.0 111.326 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.336 -0.852 . . . . 0.0 111.342 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -66.22 -19.35 65.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.669 0.788 . . . . 0.0 112.177 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.37 -4.6 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.862 1.265 . . . . 0.0 110.374 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.76 23.03 65.24 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.763 -1.211 . . . . 0.0 111.916 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -111.98 93.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.15 86.45 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.441 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.31 5.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.275 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -57.01 -26.18 59.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.851 1.659 . . . . 0.0 112.345 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -74.77 -17.65 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.406 1.082 . . . . 0.0 112.807 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.03 170.27 14.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.59 0.756 . . . . 0.0 110.109 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 p -146.68 160.36 42.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.49 1.516 . . . . 0.0 108.554 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.9 m -108.34 151.74 25.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.049 0.94 . . . . 0.0 109.729 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.56 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.0 t0 -153.05 161.16 42.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.205 2.202 . . . . 0.0 108.378 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 pt -91.54 163.65 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.12 133.98 20.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.394 0.678 . . . . 0.0 111.942 -169.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -123.11 112.67 18.02 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 107.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.8 p -57.06 -24.21 52.25 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 111.508 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.88 -22.58 67.02 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.67 1.188 . . . . 0.0 112.873 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.82 -43.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.956 0.798 . . . . 0.0 108.937 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -48.6 -51.11 29.64 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.251 1.02 . . . . 0.0 110.782 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.1 -15.77 62.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -104.19 -16.91 15.08 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.18 0.992 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.96 58.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.775 0.43 . . . . 0.0 109.868 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.24 -33.74 76.43 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.9 tp -144.33 141.62 29.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.202 1.401 . . . . 0.0 109.702 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.35 132.3 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 109.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.08 88.24 7.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.67 -10.55 19.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.087 1.755 . . . . 0.0 114.357 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.0 t -148.66 157.71 43.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.834 1.652 . . . . 0.0 110.197 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.98 -59.29 9.59 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.259 1.885 . . . . 0.0 112.191 -170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.48 -26.9 66.59 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.536 0.334 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.29 72.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.795 0.438 . . . . 0.0 111.592 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.11 -20.11 65.07 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.05 -29.8 70.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.691 0.678 . . . . 0.0 112.277 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -77.4 -32.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 117.303 -1.332 . . . . 0.0 113.344 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -47.23 108.44 0.88 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.297 1.039 . . . . 0.0 111.031 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.17 -34.99 26.36 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.901 1.734 . . . . 0.0 113.011 -169.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 125.79 1.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.9 p -128.15 82.4 68.55 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.53 173.31 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.633 2.889 . . . . 0.0 110.79 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.21 -29.35 16.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.882 3.054 . . . . 0.0 116.104 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -68.77 -8.04 39.46 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.185 0.994 . . . . 0.0 113.064 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.31 80.95 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.945 2.498 . . . . 0.0 104.732 -170.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.7 pttt -64.94 164.99 11.59 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.736 0.779 . . . . 0.0 108.948 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -127.53 150.1 49.84 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 109.561 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.37 153.17 44.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -147.59 139.15 23.88 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -139.52 -169.27 2.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.658 1.583 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.0 41.58 1.29 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.098 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -80.34 119.17 22.7 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.958 1.379 . . . . 0.0 112.597 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.21 150.64 43.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.062 0.945 . . . . 0.0 109.603 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -74.2 121.12 84.47 Favored Pre-proline 0 C--O 1.236 0.373 0 O-C-N 121.999 -0.438 . . . . 0.0 111.858 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.43 -32.14 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.834 1.69 . . . . 0.0 112.678 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.76 65.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.767 0.712 . . . . 0.0 112.362 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -100.18 -0.96 37.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.688 1.195 . . . . 0.0 111.594 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.9 148.68 29.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -159.01 164.47 35.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.817 0.447 . . . . 0.0 110.655 -171.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.24 -48.66 0.64 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -164.99 165.68 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.277 2.231 . . . . 0.0 105.416 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.14 -40.51 81.53 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.556 -0.715 . . . . 0.0 110.638 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.38 -28.48 65.12 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.377 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.32 -44.94 58.03 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.92 0.782 . . . . 0.0 109.194 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -56.02 -50.37 71.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.588 0.755 . . . . 0.0 109.75 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.93 -44.86 95.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.989 0.359 . . . . 0.0 110.505 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.9 75.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.602 0.637 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.57 -36.92 85.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.342 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -54.95 -53.37 56.56 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.634 1.106 . . . . 0.0 108.274 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.506 ' NE2' HH21 ' A' ' 124' ' ' ARG . 6.3 mm100 -58.1 -43.22 87.01 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.864 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -61.15 -49.41 77.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.58 0.627 . . . . 0.0 110.606 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.28 -45.89 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.891 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.506 HH21 ' NE2' ' A' ' 121' ' ' GLN . 47.6 ptt85 -61.88 -40.81 96.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.44 1.927 . . . . 0.0 111.087 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.48 -44.72 95.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.25 0.477 . . . . 0.0 109.793 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.28 -32.51 61.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.045 -0.979 . . . . 0.0 112.858 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -65.32 -42.82 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.697 1.135 . . . . 0.0 108.644 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.78 -46.46 82.85 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -58.56 -36.23 73.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.303 1.041 . . . . 0.0 111.41 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -51.41 70.05 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.587 0.755 . . . . 0.0 109.379 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.8 mt -72.89 -31.78 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.251 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -51.91 67.53 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.777 0.831 . . . . 0.0 110.828 169.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.68 -49.21 75.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 119.299 0.954 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -55.32 -39.35 69.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.584 0.629 . . . . 0.0 111.055 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.43 -47.42 49.17 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.767 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.51 -37.5 71.22 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.612 1.165 . . . . 0.0 110.91 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.0 p -90.61 -22.63 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.001 0.92 . . . . 0.0 110.163 -175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.68 41.48 99.6 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.083 1.353 . . . . 0.0 111.015 -175.252 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.92 151.34 45.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 111.17 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -143.76 -41.24 0.28 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.994 0.918 . . . . 0.0 111.022 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -124.69 167.74 14.13 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.724 0.81 . . . . 0.0 110.631 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.7 138.45 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tt -121.57 138.83 50.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -132.04 106.21 7.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -75.82 146.64 39.75 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.565 0.746 . . . . 0.0 110.546 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.02 130.19 20.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -148.46 171.21 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.984 0.811 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -67.58 -9.64 44.66 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.148 -0.97 . . . . 0.0 113.4 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 118.36 0.82 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 106.652 -2.579 . . . . 0.0 106.652 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.61 -43.19 99.42 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.811 0.844 . . . . 0.0 112.107 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -43.33 -22.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.06 3.344 . . . . 0.0 117.336 -169.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -128.78 -71.7 0.63 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.295 0.952 . . . . 0.0 110.947 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -58.68 -49.14 78.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.371 0.532 . . . . 0.0 111.336 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.01 -36.15 69.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.863 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -62.73 -42.07 99.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.897 0.479 . . . . 0.0 111.313 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.6 mtm -66.2 -46.62 76.66 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.693 0.679 . . . . 0.0 110.258 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.45 77.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.898 0.479 . . . . 0.0 110.64 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -57.2 -44.6 83.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.528 1.131 . . . . 0.0 110.559 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.08 90.15 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.889 -0.95 . . . . 0.0 112.59 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.61 -38.43 83.94 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.468 1.634 . . . . 0.0 110.613 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.71 85.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.652 0.381 . . . . 0.0 111.701 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -58.64 -29.12 66.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.858 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -73.67 -59.6 2.64 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.685 0.675 . . . . 0.0 110.559 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -71.28 -42.52 68.62 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.05 -39.59 33.5 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.643 0.377 . . . . 0.0 110.694 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.76 53.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.481 1.039 . . . . 0.0 112.858 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.41 -17.1 58.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.601 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.36 -21.21 5.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.595 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -127.04 161.92 27.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 110.711 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -112.0 144.43 41.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.1 t -134.21 124.52 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.3 172.59 12.6 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -141.74 154.82 45.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.71 -163.81 1.74 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.79 1.236 . . . . 0.0 108.15 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.78 175.01 44.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.86 -41.36 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.4 173.72 11.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.791 0.836 . . . . 0.0 110.163 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.35 157.14 42.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.677 1.991 . . . . 0.0 107.989 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -134.79 -32.67 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.767 1.227 . . . . 0.0 110.707 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.89 -173.41 33.9 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.47 109.63 9.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 170.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -70.03 132.79 88.22 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.64 -28.48 60.72 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.018 1.812 . . . . 0.0 112.997 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -39.13 91.54 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.972 0.806 . . . . 0.0 110.847 174.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.87 65.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.78 -59.72 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -63.32 -40.99 98.85 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.96 0.8 . . . . 0.0 110.513 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.1 -46.51 72.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 111.362 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.4 mmm -77.48 -38.58 48.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.173 0.589 . . . . 0.0 111.495 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -60.95 -34.6 74.98 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.579 -0.701 . . . . 0.0 110.051 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -68.94 -22.01 64.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.6 t -76.08 -26.2 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 119.53 1.059 . . . . 0.0 109.371 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.04 23.63 9.64 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.796 1.189 . . . . 0.0 110.511 -169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.2 mt -118.75 101.93 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.98 129.92 40.78 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.33 -2.02 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.584 0.753 . . . . 0.0 110.714 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -29.15 69.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.421 1.01 . . . . 0.0 110.695 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.67 -16.68 64.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.752 1.621 . . . . 0.0 113.537 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -75.29 176.1 7.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.952 0.901 . . . . 0.0 109.037 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -141.93 153.54 44.44 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.843 1.257 . . . . 0.0 108.744 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -107.44 147.24 30.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 109.87 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.87 158.47 40.82 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.851 1.261 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 pt -88.7 162.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 137.66 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.73 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -126.28 114.85 18.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.22 1.408 . . . . 0.0 108.058 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -56.4 -28.6 59.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.723 0.809 . . . . 0.0 111.377 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.72 0.5 8.7 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.786 1.634 . . . . 0.0 113.475 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.88 -46.99 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp -45.79 -52.76 10.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.468 1.107 . . . . 0.0 111.395 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -5.78 22.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -132.51 5.16 4.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.675 1.19 . . . . 0.0 112.541 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.7 47.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.37 -33.2 67.06 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.8 tp -143.03 142.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.062 1.345 . . . . 0.0 109.18 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.31 134.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.49 134.12 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 118.958 0.799 . . . . 0.0 108.861 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -98.53 98.27 9.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.5 -12.26 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.256 1.422 . . . . 0.0 113.598 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.65 147.37 33.0 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.34 95.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.405 0.526 . . . . 0.0 112.342 -169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.95 -25.23 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.164 0.982 . . . . 0.0 111.731 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.7 -23.96 60.94 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.284 0.634 . . . . 0.0 111.689 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.14 -20.69 66.16 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.8 -32.63 70.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.096 0.558 . . . . 0.0 111.949 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -86.79 62.09 7.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.875 0.87 . . . . 0.0 110.588 -173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 77.0 m -120.21 75.15 22.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 108.391 172.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.04 -28.48 80.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.436 2.091 . . . . 0.0 114.659 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 ttp -158.76 99.28 1.55 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.939 0.896 . . . . 0.0 109.942 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p -128.37 73.7 80.07 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.452 1.101 . . . . 0.0 108.351 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.93 171.07 10.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.3 2.666 . . . . 0.0 110.856 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.34 -21.99 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.193 3.262 . . . . 0.0 116.456 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -63.27 -11.82 24.49 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 112.897 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.3 94.39 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 128.015 2.526 . . . . 0.0 105.273 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -70.81 165.25 23.55 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 98' ' ' ARG . 3.5 mtp85 -135.47 153.81 51.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.243 0.617 . . . . 0.0 111.671 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.54 167.08 23.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.58 6.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.844 0.858 . . . . 0.0 110.369 -169.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -115.27 -174.11 2.44 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.824 1.249 . . . . 0.0 109.405 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.63 43.64 1.19 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.239 -0.913 . . . . 0.0 114.231 -168.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -84.31 108.04 16.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.261 1.03 . . . . 0.0 111.819 -172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.37 152.6 37.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.018 0.927 . . . . 0.0 109.734 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -71.5 116.43 47.46 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 122.915 0.486 . . . . 0.0 111.713 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.21 -34.42 16.45 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.089 1.86 . . . . 0.0 112.1 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.47 -16.35 64.05 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.46 0.573 . . . . 0.0 112.076 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -111.53 14.95 21.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.978 1.311 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.83 -43.8 90.74 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.651 0.659 . . . . 0.0 111.684 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 50.36 -161.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.095 1.758 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.49 -69.83 0.21 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.877 1.703 . . . . 0.0 109.122 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -154.1 156.53 37.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.29 -38.76 84.6 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.264 0.938 . . . . 0.0 111.105 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.71 -32.34 72.91 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.257 -0.277 . . . . 0.0 111.106 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.09 -42.12 60.62 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.382 0.673 . . . . 0.0 109.877 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -58.46 -50.47 73.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.367 1.467 . . . . 0.0 110.149 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -62.01 -42.57 99.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.875 0.47 . . . . 0.0 110.619 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.03 72.7 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.784 0.72 . . . . 0.0 110.813 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.86 -40.27 83.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.737 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -56.41 -46.44 80.19 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.48 -48.74 79.78 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.663 0.785 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -59.55 -50.09 75.24 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.077 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.32 -44.6 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.223 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.05 -44.09 97.43 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.992 2.178 . . . . 0.0 110.627 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.74 -43.3 99.12 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.95 -38.03 66.91 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.604 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -42.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.774 1.625 . . . . 0.0 108.617 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.78 93.72 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.43 ' ND2' HH21 ' A' ' 130' ' ' ARG . 45.5 t30 -59.23 -43.04 92.35 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.276 1.03 . . . . 0.0 112.008 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.43 HH21 ' ND2' ' A' ' 129' ' ' ASN . 4.3 mmp_? -60.84 -46.04 92.15 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.612 -0.68 . . . . 0.0 110.29 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.12 -41.11 90.96 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.258 0.481 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.34 -48.58 73.98 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.857 0.863 . . . . 0.0 110.246 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.88 -48.32 82.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.31 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.5 -44.5 85.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.873 1.215 . . . . 0.0 109.852 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.33 85.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.776 0.431 . . . . 0.0 111.148 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -82.15 -38.95 23.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.418 1.087 . . . . 0.0 111.226 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 47.5 p -94.05 -22.95 18.2 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.203 0.601 . . . . 0.0 111.115 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.57 43.0 98.0 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.964 1.706 . . . . 0.0 112.707 -169.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -136.54 170.95 15.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.055 1.342 . . . . 0.0 108.234 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -144.49 -46.96 0.25 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.031 0.533 . . . . 0.0 110.687 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -141.99 170.67 15.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.62 142.59 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 118.758 0.708 . . . . 0.0 109.791 -168.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.25 135.76 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.86 104.16 6.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.33 0.652 . . . . 0.0 109.38 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -77.4 149.54 35.15 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.795 0.838 . . . . 0.0 110.532 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.77 132.42 14.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -149.95 171.96 15.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.264 1.393 . . . . 0.0 110.916 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -64.18 -13.32 47.79 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.948 -1.095 . . . . 0.0 112.93 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 119.21 0.9 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 105.367 -3.093 . . . . 0.0 105.367 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.3 t-20 -56.3 -43.01 78.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.771 0.828 . . . . 0.0 110.46 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' HG ' ' CD2' ' A' ' 42' ' ' HIS . 1.0 OUTLIER -30.8 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 132.626 4.37 . . . . 0.0 118.06 -169.147 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.82 -58.83 0.76 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.654 0.661 . . . . 0.0 111.659 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -61.69 -50.54 72.04 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.025 0.83 . . . . 0.0 110.973 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -68.74 -38.28 80.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.226 0.466 . . . . 0.0 110.815 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -61.59 -43.7 98.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.776 0.716 . . . . 0.0 111.817 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 74.7 mtm -67.41 -46.85 72.01 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.27 0.486 . . . . 0.0 109.814 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.59 -42.0 74.18 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.274 0.488 . . . . 0.0 111.055 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.25 -48.15 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.051 0.54 . . . . 0.0 110.186 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.99 -50.86 53.37 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.574 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.8 m95 -67.18 -37.71 84.17 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.632 1.716 . . . . 0.0 110.851 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.05 82.72 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.219 0.918 . . . . 0.0 111.627 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -60.45 -27.17 67.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.192 0.906 . . . . 0.0 112.255 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.42 -47.1 13.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.615 0.766 . . . . 0.0 109.872 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -77.61 -28.63 51.55 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.07 -145.69 0.31 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.162 1.385 . . . . 0.0 108.297 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 -170.58 42.89 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.22 0.918 . . . . 0.0 111.857 -171.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.85 -19.07 63.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.707 1.603 . . . . 0.0 113.668 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.91 -12.12 10.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.859 1.264 . . . . 0.0 112.013 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -129.24 162.32 28.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.014 1.326 . . . . 0.0 110.782 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.2 132.13 53.05 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.15 137.05 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -137.25 163.88 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.548 0.739 . . . . 0.0 109.307 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -140.14 128.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.79 -173.11 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.757 1.223 . . . . 0.0 108.585 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.38 171.44 41.38 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.84 -41.02 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.93 179.36 7.23 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.005 0.922 . . . . 0.0 109.257 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.85 121.82 10.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.76 1.624 . . . . 0.0 106.652 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.424 ' CD2' ' HG ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -80.25 -34.78 36.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.41 -173.82 37.04 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.902 2.191 . . . . 0.0 107.693 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.28 105.29 11.44 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.93 130.87 86.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.969 -169.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.85 -34.34 75.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.53 2.82 . . . . 0.0 113.724 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.38 78.42 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.43 0.559 . . . . 0.0 111.181 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.47 63.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.42 -53.5 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -65.72 -42.88 90.56 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 119.065 0.848 . . . . 0.0 110.383 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.52 72.15 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.64 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 83.4 mmm -83.22 -37.52 23.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.713 0.688 . . . . 0.0 111.526 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -65.68 -29.83 70.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.302 -0.874 . . . . 0.0 110.934 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.53 -18.77 65.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.111 0.964 . . . . 0.0 112.248 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.12 -9.71 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.48 1.112 . . . . 0.0 109.99 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.55 21.45 56.28 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -111.75 90.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.83 77.76 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 110.245 -172.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.05 3.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 111.868 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -53.86 -26.42 24.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.462 1.105 . . . . 0.0 112.46 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -79.79 -12.04 59.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.003 1.321 . . . . 0.0 113.593 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -74.32 172.79 11.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.259 0.936 . . . . 0.0 109.238 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -146.84 161.58 40.4 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 107.783 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.2 m -104.06 151.45 23.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.643 0.777 . . . . 0.0 109.628 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.545 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -147.39 159.81 43.27 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.945 2.098 . . . . 0.0 108.496 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -89.6 165.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 142.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.037 0.935 . . . . 0.0 112.31 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -132.22 104.24 6.67 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.364 1.865 . . . . 0.0 108.383 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 p -56.9 -26.34 58.89 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -69.8 -4.86 21.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.24 1.016 . . . . 0.0 112.79 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.82 -48.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.61 -44.49 57.08 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.815 0.734 . . . . 0.0 112.158 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -3.68 17.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -135.48 10.65 3.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.984 1.314 . . . . 0.0 112.185 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.32 152.93 36.5 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.07 -36.26 79.55 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.866 1.212 . . . . 0.0 108.629 170.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.54 155.42 43.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.872 0.844 . . . . 0.0 112.28 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -113.56 138.87 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 102.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.7 p -76.08 147.96 38.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 3.13 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.01 0.524 . . . . 0.0 112.127 -169.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.81 162.19 40.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.357 0.981 . . . . 0.0 108.396 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.07 97.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.44 -35.63 73.47 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.096 0.948 . . . . 0.0 111.18 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.67 -23.66 67.23 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.066 0.546 . . . . 0.0 112.405 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.56 -29.44 59.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.466 0.707 . . . . 0.0 112.373 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.36 -32.7 74.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.209 0.604 . . . . 0.0 112.261 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -86.9 58.61 5.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.389 0.676 . . . . 0.0 110.59 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.96 81.21 12.04 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.76 -35.46 98.6 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.828 2.352 . . . . 0.0 114.384 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -159.31 125.36 4.39 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.153 0.981 . . . . 0.0 108.356 169.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -138.94 79.96 25.75 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.35 169.87 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.073 2.515 . . . . 0.0 110.846 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.66 -18.95 6.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.407 3.405 . . . . 0.0 116.378 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -61.56 -13.81 24.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.15 0.98 . . . . 0.0 112.691 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 t -127.95 109.25 19.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.177 2.191 . . . . 0.0 106.542 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.04 167.75 20.04 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -135.62 150.37 49.62 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.529 0.732 . . . . 0.0 109.846 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 153.8 43.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 169.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -138.3 84.57 2.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -169.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -79.53 176.45 9.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.943 1.297 . . . . 0.0 109.446 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.3 93.96 0.19 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.327 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -131.93 121.43 23.99 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.831 0.853 . . . . 0.0 111.131 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -64.77 152.25 43.14 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.621 1.168 . . . . 0.0 109.92 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.76 114.91 28.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.057 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -31.67 29.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.018 1.812 . . . . 0.0 112.707 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.9 -15.21 62.74 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.592 0.633 . . . . 0.0 112.053 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -115.63 22.15 13.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.617 1.567 . . . . 0.0 110.732 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.01 -27.04 69.15 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 43.51 -147.53 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.985 2.114 . . . . 0.0 113.275 -175.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.6 -73.12 1.43 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.5 166.17 16.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.534 2.334 . . . . 0.0 105.623 172.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.84 -40.21 79.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.353 0.979 . . . . 0.0 111.447 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.65 -28.97 63.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.442 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.45 -39.78 67.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.981 0.809 . . . . 0.0 109.322 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.22 -48.14 82.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 109.832 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -61.03 -43.06 99.45 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.299 0.5 . . . . 0.0 110.573 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.19 -32.9 70.33 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.597 -0.689 . . . . 0.0 110.911 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -74.75 -35.51 62.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.023 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -53.57 -45.42 69.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.96 1.254 . . . . 0.0 108.809 169.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.25 -46.92 85.09 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 123.027 0.531 . . . . 0.0 111.3 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -61.39 -50.96 70.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.949 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.21 -44.3 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.206 -1.378 . . . . 0.0 109.903 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -63.15 -43.28 98.77 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 121.565 1.984 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.38 -42.74 99.2 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.514 0.325 . . . . 0.0 110.266 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.72 -45.44 71.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.343 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -61.27 -40.7 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.034 1.288 . . . . 0.0 108.87 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.12 85.36 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -56.98 -41.5 78.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.251 1.02 . . . . 0.0 112.218 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -65.16 -41.46 94.67 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.35 -0.844 . . . . 0.0 110.174 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.76 -36.74 78.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.476 1.035 . . . . 0.0 111.475 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -49.6 76.47 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.679 0.792 . . . . 0.0 110.092 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.77 -48.32 81.18 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.757 0.708 . . . . 0.0 109.915 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.01 -38.6 70.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.212 0.915 . . . . 0.0 111.154 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.57 -45.86 61.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.49 -38.62 54.97 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.244 1.018 . . . . 0.0 111.72 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.4 p -94.35 -16.81 23.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.576 1.15 . . . . 0.0 111.05 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.06 92.0 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.906 1.283 . . . . 0.0 112.037 -169.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.36 160.46 43.3 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.444 1.098 . . . . 0.0 108.141 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -161.3 -38.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.559 0.744 . . . . 0.0 111.825 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.473 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 42.4 mtmt -133.05 171.14 14.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.477 1.511 . . . . 0.0 108.679 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -136.1 139.28 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tt -125.76 135.48 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -130.92 111.88 12.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.87 141.01 31.62 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.562 ' CD2' ' HG ' ' A' ' 89' ' ' CYS . 6.3 mp -124.6 140.67 52.72 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -154.86 169.68 23.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.298 0.639 . . . . 0.0 109.445 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -71.03 -7.83 49.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.77 119.17 0.85 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 57.7 t-20 -77.36 72.53 3.91 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.352 1.061 . . . . 0.0 109.017 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.1 p -134.13 -30.96 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.311 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 m -134.75 -67.69 0.56 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.911 0.778 . . . . 0.0 111.63 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -57.79 -50.55 72.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.927 0.491 . . . . 0.0 111.74 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -64.43 -36.81 85.39 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.25 0.477 . . . . 0.0 111.618 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.51 -42.5 71.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.822 . . . . 0.0 110.85 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -62.06 -51.63 67.17 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.56 76.69 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.929 0.492 . . . . 0.0 110.969 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.68 -48.55 81.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.287 0.635 . . . . 0.0 109.97 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.82 -46.78 93.49 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.616 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.7 m95 -66.87 -41.87 86.55 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.065 1.433 . . . . 0.0 110.908 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.45 80.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.514 0.597 . . . . 0.0 111.055 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -57.45 -34.33 68.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.805 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.66 -58.62 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.366 0.53 . . . . 0.0 110.132 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -70.72 -36.44 73.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -169.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 42.8 mt -91.49 -36.69 13.6 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.78 -177.84 46.82 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.856 0.741 . . . . 0.0 112.723 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.54 -8.66 49.13 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.89 -9.79 2.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 110.972 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.473 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 9.6 m95 -136.36 166.42 23.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.835 1.654 . . . . 0.0 108.945 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.05 146.35 47.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 167.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.2 121.77 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -168.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.01 165.88 24.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.459 0.647 . . . . 0.0 109.841 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p -132.34 139.03 47.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.879 1.272 . . . . 0.0 108.427 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.59 -175.66 4.45 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.491 1.517 . . . . 0.0 108.565 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.04 177.19 46.39 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 121.802 -0.562 . . . . 0.0 111.891 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.53 -41.64 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.812 1.245 . . . . 0.0 108.569 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.89 177.42 8.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.82 0.848 . . . . 0.0 109.546 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.98 166.62 29.08 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.981 1.712 . . . . 0.0 108.714 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.26 -46.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.587 1.155 . . . . 0.0 108.12 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.74 25.91 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.62 122.53 14.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -74.24 141.44 77.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.661 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.11 -34.69 69.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.922 2.415 . . . . 0.0 113.715 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -35.43 78.96 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.719 0.691 . . . . 0.0 111.812 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.55 -42.1 68.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.01 -55.51 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.37 -44.41 96.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.4 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.13 88.74 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.087 0.858 . . . . 0.0 111.215 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.6 mmm -73.46 -39.93 64.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.7 0.4 . . . . 0.0 110.403 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -64.78 -33.5 76.14 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.141 0.976 . . . . 0.0 110.977 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.54 -15.29 62.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.791 1.236 . . . . 0.0 112.232 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.64 1.91 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.174 1.39 . . . . 0.0 109.781 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.29 72.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.661 -1.274 . . . . 0.0 112.299 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.57 93.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.09 77.8 5.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.46 0.704 . . . . 0.0 110.515 -172.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.4 pt -73.99 1.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.904 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -53.68 -27.94 30.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.99 1.268 . . . . 0.0 112.511 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.91 -22.37 61.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.061 1.344 . . . . 0.0 113.054 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -71.51 168.03 18.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.083 0.953 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -145.23 164.98 29.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.492 1.917 . . . . 0.0 108.115 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.2 m -108.68 158.26 17.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.531 0.681 . . . . 0.0 110.773 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 47.3 t0 -153.2 159.75 42.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.918 2.087 . . . . 0.0 107.499 172.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -88.44 166.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.02 108.52 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.152 0.981 . . . . 0.0 111.274 -170.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -94.03 114.56 26.76 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -18.76 62.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.245 1.418 . . . . 0.0 112.559 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.07 -47.7 60.83 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.121 0.873 . . . . 0.0 110.974 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.9 -42.65 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -48.85 -49.31 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.21 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -76.26 -12.96 60.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -92.75 -17.63 23.96 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.283 0.947 . . . . 0.0 110.903 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.74 50.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.168 0.44 . . . . 0.0 111.568 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 -37.5 75.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.71 162.59 39.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.931 0.872 . . . . 0.0 112.811 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.72 141.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.03 111.49 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.0 p -90.18 103.08 15.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.25 -8.97 50.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.328 0.651 . . . . 0.0 112.287 -172.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -143.6 154.21 43.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.51 95.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.26 -32.07 73.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.591 0.695 . . . . 0.0 111.557 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.75 70.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.258 0.481 . . . . 0.0 111.794 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.0 -17.5 64.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.3 -31.54 72.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.568 0.622 . . . . 0.0 111.811 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.2 -28.51 57.28 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.175 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.562 ' HG ' ' CD2' ' A' ' 9' ' ' LEU . 6.3 m -47.06 108.01 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.4 1.08 . . . . 0.0 111.016 -169.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.25 -38.73 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.957 1.771 . . . . 0.0 114.526 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.7 tpt -165.74 132.01 2.64 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.316 1.046 . . . . 0.0 109.166 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.7 p -137.88 96.42 10.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.74 168.39 20.28 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.889 2.393 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -50.86 -26.17 17.39 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.037 3.158 . . . . 0.0 115.85 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -66.17 -7.14 16.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.365 1.066 . . . . 0.0 113.077 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.65 97.03 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.96 2.104 . . . . 0.0 105.58 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 163.62 27.12 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.254 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -141.84 128.53 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.45 155.67 45.34 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.072 1.349 . . . . 0.0 108.054 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -137.64 143.23 41.29 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.506 0.722 . . . . 0.0 111.665 -169.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -139.28 -170.99 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.724 1.609 . . . . 0.0 108.553 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.91 45.2 0.98 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-N 119.11 0.868 . . . . 0.0 113.379 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -80.93 122.97 27.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.062 0.931 . . . . 0.0 111.576 -173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -78.19 152.65 32.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.66 127.76 76.89 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.698 -0.626 . . . . 0.0 112.47 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.35 -34.22 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.164 1.909 . . . . 0.0 113.375 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -22.05 66.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.282 0.946 . . . . 0.0 112.235 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -100.12 -0.9 38.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.419 1.088 . . . . 0.0 111.146 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.75 152.35 23.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -160.81 164.1 31.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.29 0.636 . . . . 0.0 110.358 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.52 -49.53 0.61 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.14 166.23 19.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.051 2.14 . . . . 0.0 105.649 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.36 -40.69 82.89 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.753 -0.592 . . . . 0.0 110.579 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.94 -29.05 64.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.346 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.3 -45.05 61.68 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -56.94 -49.85 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.661 0.784 . . . . 0.0 109.964 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -61.59 -44.22 97.41 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.34 0.518 . . . . 0.0 110.398 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -40.28 80.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.321 0.509 . . . . 0.0 110.293 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -62.59 -36.92 84.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.191 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.89 -50.59 70.26 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.327 0.967 . . . . 0.0 108.595 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -61.62 -45.45 94.0 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.045 0.538 . . . . 0.0 110.834 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -59.91 -50.01 75.45 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.271 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.4 -47.41 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 117.449 -1.262 . . . . 0.0 109.945 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -61.73 -41.55 97.78 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.828 1.649 . . . . 0.0 110.806 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.74 -41.74 99.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.074 0.397 . . . . 0.0 110.017 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -76.61 -33.8 58.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.619 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.62 -42.11 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.702 1.137 . . . . 0.0 108.069 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.75 -47.11 79.06 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -53.65 -44.48 69.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.883 1.273 . . . . 0.0 111.166 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -47.49 85.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 119.249 -0.405 . . . . 0.0 110.908 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.02 -37.24 83.79 Favored 'General case' 0 C--O 1.229 -0.023 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -59.15 -49.07 79.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.782 0.833 . . . . 0.0 110.407 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.61 -45.63 82.38 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.371 0.987 . . . . 0.0 109.65 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -55.39 -38.5 68.97 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.024 0.829 . . . . 0.0 111.016 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.98 34.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.601 0.76 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.76 -38.96 73.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.762 1.225 . . . . 0.0 111.32 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 p -90.34 -16.07 29.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.856 0.862 . . . . 0.0 110.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.78 40.63 89.65 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.78 1.232 . . . . 0.0 111.789 -169.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.78 164.28 37.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.319 1.047 . . . . 0.0 108.778 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -158.1 -36.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.464 1.506 . . . . 0.0 111.322 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -142.55 169.37 17.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.381 1.472 . . . . 0.0 109.026 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.3 mt -135.98 147.31 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 tt -134.64 142.9 39.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.484 1.114 . . . . 0.0 108.387 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.27 107.22 7.08 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.71 143.39 48.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.991 0.517 . . . . 0.0 109.934 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.08 143.22 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.083 1.753 . . . . 0.0 106.536 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -157.91 170.29 22.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 118.674 0.67 . . . . 0.0 109.53 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -66.82 -10.67 50.34 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.118 -0.989 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.98 119.82 0.93 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.4 t-20 -56.9 -46.58 81.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.632 0.773 . . . . 0.0 110.355 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 m -42.33 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 130.191 3.396 . . . . 0.0 117.733 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -119.5 -78.31 0.59 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.002 0.819 . . . . 0.0 109.499 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -61.89 -47.77 83.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.109 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -68.98 -38.25 79.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.063 0.847 . . . . 0.0 110.901 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -43.77 96.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.646 0.657 . . . . 0.0 111.484 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.4 mtp -66.18 -47.32 74.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.366 0.666 . . . . 0.0 109.546 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.9 78.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.388 0.675 . . . . 0.0 110.979 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.43 -45.85 80.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.62 0.768 . . . . 0.0 110.129 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.95 -47.29 91.41 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -69.97 -39.14 76.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.38 1.59 . . . . 0.0 111.055 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.1 79.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.744 0.417 . . . . 0.0 111.554 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.5 -33.91 64.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.82 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -74.48 -57.33 4.01 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.27 0.486 . . . . 0.0 110.603 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -73.58 -45.0 55.89 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -73.84 -35.71 64.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.486 0.584 . . . . 0.0 111.348 -169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.9 167.99 42.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.973 0.797 . . . . 0.0 111.78 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.78 -12.04 61.31 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -52.81 -31.6 39.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.384 0.611 . . . . 0.0 110.055 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -100.91 150.45 22.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -110.41 125.8 53.63 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 167.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.18 127.2 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -168.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.0 172.0 13.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.629 1.172 . . . . 0.0 108.768 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -137.47 139.67 40.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.118 0.967 . . . . 0.0 109.507 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.09 -175.15 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.344 1.458 . . . . 0.0 109.022 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.03 175.79 40.88 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -42.1 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.51 179.48 7.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.84 0.856 . . . . 0.0 109.815 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.33 151.16 37.88 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.613 1.965 . . . . 0.0 106.964 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -127.84 10.35 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.769 1.227 . . . . 0.0 111.797 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.84 -173.54 18.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 126.113 1.816 . . . . 0.0 109.035 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.76 109.3 20.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -63.49 124.55 84.86 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.286 -172.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.18 -34.16 38.44 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.288 2.658 . . . . 0.0 113.657 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -38.64 87.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.77 0.714 . . . . 0.0 110.913 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.13 75.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.61 -52.14 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -65.97 -41.89 90.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.87 0.759 . . . . 0.0 110.827 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.83 -45.58 82.24 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.839 0.745 . . . . 0.0 110.954 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.7 mmm -75.78 -38.91 57.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.467 0.307 . . . . 0.0 110.903 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.96 -34.02 77.43 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.01 -1.056 . . . . 0.0 110.993 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.84 -20.4 66.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 112.238 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.83 -10.06 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 110.281 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.15 20.05 28.98 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.629 1.109 . . . . 0.0 111.925 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.56 91.35 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -77.49 76.79 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.751 1.22 . . . . 0.0 110.089 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.69 2.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 121.381 -0.824 . . . . 0.0 112.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.68 -28.9 16.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.348 1.859 . . . . 0.0 112.802 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.22 -16.62 57.67 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.847 1.259 . . . . 0.0 112.922 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -70.67 171.83 9.71 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.826 0.85 . . . . 0.0 109.7 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -147.1 158.95 44.11 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 107.819 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -98.43 156.33 16.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 110.043 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 43.1 t0 -150.26 162.7 39.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.891 2.076 . . . . 0.0 108.088 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -94.21 160.9 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 133.23 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 112.515 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -116.89 111.64 19.93 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.559 1.944 . . . . 0.0 106.83 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -62.0 -19.56 62.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.993 0.917 . . . . 0.0 112.719 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.78 -43.42 84.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.772 1.169 . . . . 0.0 111.322 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.99 -48.7 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.81 -52.35 24.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.237 1.015 . . . . 0.0 110.409 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -68.96 -10.19 56.05 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.23 6.49 7.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.001 1.273 . . . . 0.0 112.812 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 154.0 39.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.49 -32.43 54.26 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.553 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 33.5 tp -145.43 145.84 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.153 1.381 . . . . 0.0 109.104 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -126.5 140.41 48.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.53 134.05 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.6 p -95.19 118.93 32.82 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.69 -0.76 31.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.153 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -147.22 163.03 37.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.695 1.134 . . . . 0.0 109.104 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.76 -38.99 77.11 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.852 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.52 -35.84 78.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.533 1.166 . . . . 0.0 110.925 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.72 -18.96 65.71 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.603 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.62 -23.97 65.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.935 0.789 . . . . 0.0 112.147 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.1 -34.05 76.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 111.979 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.56 63.95 8.26 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.06 0.944 . . . . 0.0 110.119 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.5 m -122.53 72.94 40.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.89 -48.43 7.52 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.08 3.186 . . . . 0.0 115.315 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 138.23 6.48 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -132.46 80.67 62.16 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.67 168.07 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.502 2.802 . . . . 0.0 110.916 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.9 -22.04 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.824 3.683 . . . . 0.0 118.655 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.21 -41.47 93.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.986 1.267 . . . . 0.0 110.615 170.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 156.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 127.785 2.434 . . . . 0.0 108.37 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.9 pttt -140.59 170.41 15.83 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.555 1.542 . . . . 0.0 107.777 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -134.02 157.07 47.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 112.417 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.97 158.39 43.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.189 2.196 . . . . 0.0 105.204 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -145.19 117.85 8.63 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.48 -0.763 . . . . 0.0 109.291 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -109.33 -174.13 2.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.019 1.327 . . . . 0.0 109.795 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.66 43.51 1.11 Allowed Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.418 -0.801 . . . . 0.0 114.534 -168.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -85.83 121.52 28.59 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.543 1.172 . . . . 0.0 111.168 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.06 155.12 40.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.78 120.89 83.75 Favored Pre-proline 0 C--O 1.235 0.318 0 O-C-N 121.833 -0.542 . . . . 0.0 111.417 -170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.85 -33.75 42.0 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.556 1.504 . . . . 0.0 112.754 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.14 -20.47 66.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.522 0.601 . . . . 0.0 112.526 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.13 -0.02 34.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.527 1.131 . . . . 0.0 111.568 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 150.18 24.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.67 164.52 33.94 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.183 0.593 . . . . 0.0 110.085 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.11 -48.21 0.69 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -164.11 162.69 23.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.904 2.082 . . . . 0.0 105.449 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.01 -40.86 86.23 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.693 -0.629 . . . . 0.0 110.495 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.22 -29.35 68.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.319 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -76.38 -40.22 51.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.988 0.813 . . . . 0.0 109.913 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.03 -51.37 69.53 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -60.21 -44.57 95.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.47 79.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -61.2 -34.84 75.73 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.97 0.805 . . . . 0.0 111.621 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -57.39 -48.46 79.02 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -61.23 -44.17 97.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.403 0.681 . . . . 0.0 111.919 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -61.27 -53.08 61.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.64 0.654 . . . . 0.0 109.578 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.23 -43.02 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.638 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -61.16 -43.87 98.21 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.941 1.7 . . . . 0.0 110.992 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.49 -43.66 96.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.35 -39.89 71.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.01 -45.24 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.565 1.075 . . . . 0.0 108.37 175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.89 95.18 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -62.19 -39.52 92.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.221 1.01 . . . . 0.0 111.719 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -38.6 85.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.98 0.809 . . . . 0.0 110.685 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.96 -38.98 66.54 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.925 -0.484 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -56.87 -47.15 81.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.119 0.968 . . . . 0.0 110.138 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.61 -52.22 66.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 117.324 -1.322 . . . . 0.0 109.519 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.02 -44.08 82.48 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.457 1.48 . . . . 0.0 110.196 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.21 92.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.264 0.626 . . . . 0.0 111.642 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.45 -37.68 22.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.994 0.918 . . . . 0.0 111.416 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 p -94.62 -22.77 17.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.592 0.757 . . . . 0.0 111.345 -170.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.249 1.05 0 C-N-CA 127.443 2.297 . . . . 0.0 112.443 -170.045 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -159.37 171.24 20.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.629 1.572 . . . . 0.0 107.544 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.59 -39.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.48 0.712 . . . . 0.0 110.176 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.31 176.68 9.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.183 0.993 . . . . 0.0 109.474 169.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.9 mt -133.25 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.33 132.93 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -127.78 101.62 6.44 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.145 0.978 . . . . 0.0 108.387 -171.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -73.11 145.77 46.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.62 131.58 21.64 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HG ' ' HG2' ' A' ' 16' ' ' ARG . 0.8 OUTLIER -151.58 -178.1 6.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.131 0.423 . . . . 0.0 111.214 172.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -7.41 36.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.713 -1.242 . . . . 0.0 114.07 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.65 129.92 2.08 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 45.4 t-20 -81.22 40.17 0.54 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.276 1.031 . . . . 0.0 112.062 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.4 p -122.46 -20.91 5.91 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 111.765 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.1 m -134.66 -73.37 0.47 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.948 0.899 . . . . 0.0 110.866 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.403 ' HG2' ' HG ' ' A' ' 10' ' ' CYS . 0.4 OUTLIER -55.69 -60.21 3.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.909 0.777 . . . . 0.0 111.038 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 m -62.68 -42.34 99.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.656 0.382 . . . . 0.0 110.468 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -61.01 -45.58 94.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.219 0.608 . . . . 0.0 111.405 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 43.2 mtm -66.77 -46.17 76.18 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.933 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.03 -44.99 79.3 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.368 0.531 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.25 -45.24 91.71 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.773 0.829 . . . . 0.0 110.082 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.48 -46.58 92.93 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.474 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -69.63 -39.82 76.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.554 1.677 . . . . 0.0 110.822 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.84 78.83 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.358 0.526 . . . . 0.0 110.844 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -57.2 -33.06 67.12 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.727 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -71.56 -57.7 4.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.465 0.575 . . . . 0.0 110.148 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -70.24 -37.81 75.04 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.93 -38.74 12.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.095 0.558 . . . . 0.0 111.839 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 177.45 48.41 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.267 0.937 . . . . 0.0 112.391 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.48 -10.15 53.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.697 1.199 . . . . 0.0 113.585 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.9 -10.69 6.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.282 1.433 . . . . 0.0 111.379 169.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.61 146.11 50.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.607 1.563 . . . . 0.0 108.095 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.76 138.46 37.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 167.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.18 127.54 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -168.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.33 169.82 16.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -134.81 143.05 46.85 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 109.766 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.26 -177.11 4.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.282 1.433 . . . . 0.0 108.838 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.91 167.36 35.92 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.64 -40.78 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.42 179.77 6.9 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.997 . . . . 0.0 109.852 170.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.11 159.43 43.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.256 1.822 . . . . 0.0 108.017 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -147.74 -31.37 0.3 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.365 0.666 . . . . 0.0 111.833 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.91 173.61 34.55 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.19 107.27 2.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -72.4 130.9 85.36 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.02 -27.09 65.92 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.866 1.711 . . . . 0.0 112.956 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -39.1 93.22 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.996 0.816 . . . . 0.0 111.2 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.37 62.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.91 -58.36 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -64.03 -39.58 94.42 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 118.644 0.656 . . . . 0.0 110.557 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.52 68.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.709 0.686 . . . . 0.0 110.935 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.72 -38.49 67.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.022 0.529 . . . . 0.0 111.108 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -68.97 -29.02 67.15 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.304 -0.873 . . . . 0.0 111.6 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.94 -18.55 65.43 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.464 1.105 . . . . 0.0 111.874 170.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.04 -2.96 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.769 1.228 . . . . 0.0 109.798 172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.27 18.93 54.55 Favored Glycine 0 CA--C 1.531 1.031 0 O-C-N 120.79 -1.194 . . . . 0.0 112.307 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 mt -114.16 95.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.07 78.69 4.55 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.279 1.032 . . . . 0.0 110.168 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -72.83 -3.21 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.44 -0.787 . . . . 0.0 112.017 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -29.2 63.33 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.815 1.189 . . . . 0.0 112.077 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -73.02 -16.02 61.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.827 1.251 . . . . 0.0 112.533 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.61 171.01 9.63 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.707 0.803 . . . . 0.0 109.027 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -138.99 162.99 33.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.88 1.272 . . . . 0.0 109.086 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 p -116.83 144.66 44.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 109.451 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.515 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -153.46 155.58 36.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.091 2.156 . . . . 0.0 107.999 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.78 164.44 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tt -54.34 134.33 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 111.265 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -128.95 112.05 13.67 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.688 1.195 . . . . 0.0 108.493 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 p -54.83 -28.75 51.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.592 0.757 . . . . 0.0 111.28 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.69 -1.23 15.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.364 1.465 . . . . 0.0 113.66 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.22 -46.54 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -45.46 -54.33 7.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.864 1.266 . . . . 0.0 111.456 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -2.15 9.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -133.56 3.76 3.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.612 1.165 . . . . 0.0 112.758 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.07 151.01 48.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.22 -34.27 75.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tp -145.66 143.14 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.117 1.367 . . . . 0.0 109.726 -171.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.58 138.13 52.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.13 111.81 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -90.97 91.26 8.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.45 -9.43 12.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.284 1.033 . . . . 0.0 113.307 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.3 133.66 21.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.8 -32.93 66.63 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.717 0.675 . . . . 0.0 112.687 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.2 -30.68 71.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.33 1.065 . . . . 0.0 111.884 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 -30.92 68.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.266 0.626 . . . . 0.0 111.576 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.79 -20.12 64.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.16 -34.49 66.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.965 0.906 . . . . 0.0 112.129 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 -32.56 61.67 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.661 -171.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.0 m -48.8 108.11 0.89 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.992 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.76 -28.01 14.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.323 2.015 . . . . 0.0 114.239 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.9 ptp -163.61 131.34 3.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.271 1.028 . . . . 0.0 110.086 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -140.23 80.48 19.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.78 169.19 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.214 3.276 . . . . 0.0 113.23 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.21 -28.12 32.62 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.463 2.776 . . . . 0.0 115.047 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.57 -7.22 30.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.262 1.025 . . . . 0.0 112.968 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.11 81.7 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.931 2.492 . . . . 0.0 105.271 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.8 pttt -65.58 166.16 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -131.68 155.07 48.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.92 0.488 . . . . 0.0 110.384 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.74 159.74 41.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 149.21 31.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.4 0.68 . . . . 0.0 112.429 -168.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -143.06 -160.2 1.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.197 1.399 . . . . 0.0 109.084 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.65 41.28 0.99 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.84 1.2 . . . . 0.0 113.874 -169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -85.65 107.88 17.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.586 1.193 . . . . 0.0 111.999 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.25 154.37 35.26 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.586 1.155 . . . . 0.0 110.105 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.98 120.67 82.48 Favored Pre-proline 0 C--O 1.236 0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.974 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.32 -32.04 27.12 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.906 1.737 . . . . 0.0 112.372 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.37 -19.86 66.13 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.371 0.987 . . . . 0.0 112.24 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.87 1.59 34.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.708 1.203 . . . . 0.0 111.3 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.442 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.14 138.87 57.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -145.75 156.28 43.5 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.27 -55.18 0.41 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 t -155.75 158.5 38.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.23 -39.0 88.64 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.569 -0.707 . . . . 0.0 110.815 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.22 -30.88 70.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.2 -0.313 . . . . 0.0 111.049 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.75 -42.55 58.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.205 0.602 . . . . 0.0 109.848 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 20.3 tttt -55.42 -52.27 64.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.702 1.201 . . . . 0.0 110.1 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -60.29 -45.2 94.17 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 117.962 0.346 . . . . 0.0 110.322 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.82 79.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.284 0.493 . . . . 0.0 110.427 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.72 -39.82 92.88 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.589 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.31 -50.57 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.037 0.835 . . . . 0.0 108.802 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -60.21 -45.08 94.43 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 122.912 0.485 . . . . 0.0 111.165 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.54 -48.86 79.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.85 0.46 . . . . 0.0 110.384 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.93 -44.69 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.021 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -60.85 -42.33 97.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 121.496 1.953 . . . . 0.0 110.753 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.03 -44.61 96.33 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.42 -31.65 62.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.526 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.91 -43.38 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.246 . . . . 0.0 108.592 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.29 88.82 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.91 -35.96 75.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.935 1.294 . . . . 0.0 111.562 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -50.98 71.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 123.614 0.766 . . . . 0.0 109.197 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.18 -32.17 66.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.004 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -52.02 67.26 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.942 0.897 . . . . 0.0 110.521 169.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.19 -47.42 79.84 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 119.609 1.095 . . . . 0.0 109.349 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -55.83 -38.6 70.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.607 -0.683 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -48.56 37.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.572 0.749 . . . . 0.0 111.611 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.97 -38.34 72.77 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.558 1.143 . . . . 0.0 111.143 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.4 p -90.97 -18.48 24.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 110.27 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.13 39.31 95.66 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -173.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm . . . . . 0 C--O 1.25 1.102 0 C-N-CA 125.158 1.383 . . . . 0.0 111.665 -171.767 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.74 166.71 32.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.612 1.565 . . . . 0.0 107.541 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -159.36 -42.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.012 0.525 . . . . 0.0 110.712 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.54 175.93 10.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.457 0.703 . . . . 0.0 110.552 169.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.97 136.19 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.52 135.29 64.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -132.26 105.37 7.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -74.06 147.43 42.84 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.637 -0.665 . . . . 0.0 110.137 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.73 130.14 17.75 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.95 173.56 14.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.68 0.673 . . . . 0.0 110.093 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -66.06 -9.2 28.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.928 -1.107 . . . . 0.0 113.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.58 1.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 53.9 t-20 -62.67 -49.09 76.49 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.469 0.707 . . . . 0.0 110.786 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.1 m -41.69 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 130.321 3.448 . . . . 0.0 117.816 -168.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.8 -73.61 0.64 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.812 1.187 . . . . 0.0 110.09 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -61.65 -49.45 76.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.125 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -69.69 -38.83 77.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.655 0.661 . . . . 0.0 111.005 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -61.36 -45.28 95.04 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.836 0.744 . . . . 0.0 111.697 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -65.08 -48.69 72.83 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.45 78.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.859 0.463 . . . . 0.0 111.047 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.18 -50.93 71.29 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 109.927 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.28 -46.86 92.34 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.113 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.4 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.9 m95 -66.74 -42.39 86.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.655 1.728 . . . . 0.0 110.711 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.04 75.6 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.591 0.632 . . . . 0.0 111.313 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -57.31 -33.99 68.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.45 -57.2 5.55 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.455 0.571 . . . . 0.0 110.1 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -69.67 -34.38 73.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.66 -38.11 9.65 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.255 0.622 . . . . 0.0 112.456 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 178.97 51.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.216 0.912 . . . . 0.0 112.761 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.53 -12.32 60.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.934 1.294 . . . . 0.0 113.759 -170.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.7 -7.54 2.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.76 1.624 . . . . 0.0 112.063 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -131.55 145.39 51.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.48 1.512 . . . . 0.0 108.681 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 7.4 mmpt? -98.43 136.21 38.9 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 167.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.51 116.71 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -168.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.28 171.84 13.19 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -139.84 142.67 36.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.278 1.031 . . . . 0.0 108.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.93 -176.43 4.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.766 1.626 . . . . 0.0 108.544 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.63 173.84 40.59 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.19 -40.85 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.08 177.41 8.79 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.896 0.878 . . . . 0.0 110.099 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.04 126.3 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.847 1.659 . . . . 0.0 107.207 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -77.6 -46.12 23.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.339 0.656 . . . . 0.0 109.428 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.1 -166.7 39.37 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -78.18 99.62 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -62.68 131.01 94.11 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.64 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.71 -28.5 82.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.232 1.954 . . . . 0.0 112.891 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -58.9 -50.1 75.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.377 0.989 . . . . 0.0 109.324 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.22 -42.24 85.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.451 0.569 . . . . 0.0 110.233 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.64 -54.4 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.438 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -64.21 -46.64 82.99 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.318 0.963 . . . . 0.0 110.33 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.5 70.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.011 0.924 . . . . 0.0 111.436 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -79.97 -36.39 36.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.365 0.666 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.32 -31.72 72.95 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.918 -1.113 . . . . 0.0 109.801 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -72.79 6.72 2.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.672 1.989 . . . . 0.0 112.122 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.75 -6.68 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.795 2.038 . . . . 0.0 108.669 169.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.65 25.46 56.38 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 120.574 -1.328 . . . . 0.0 111.202 -169.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -116.76 90.49 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -78.78 80.72 5.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.578 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -75.25 6.82 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.246 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.9 m -53.98 -27.15 29.76 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.04 1.291 . . . . 0.0 112.168 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.68 -18.09 58.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.569 1.147 . . . . 0.0 113.161 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -71.81 170.72 13.04 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.878 0.763 . . . . 0.0 109.895 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 156.0 43.55 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.748 1.619 . . . . 0.0 107.648 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -102.44 151.95 21.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.75 . . . . 0.0 109.381 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.537 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.6 t0 -152.11 161.24 42.92 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.733 2.013 . . . . 0.0 108.251 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 pt -93.16 162.86 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -57.37 113.21 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.72 118.37 29.27 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 m -72.08 -22.53 61.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.539 -170.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.54 -42.75 51.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.044 0.838 . . . . 0.0 110.051 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.74 -44.88 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.88 -49.12 74.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.188 0.449 . . . . 0.0 110.281 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -65.85 -18.47 65.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -98.15 -14.81 20.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.342 0.974 . . . . 0.0 110.682 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.68 159.98 33.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 118.399 0.545 . . . . 0.0 110.946 -169.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.37 -30.59 42.65 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 168.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 tp -152.02 145.69 25.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.621 1.568 . . . . 0.0 109.872 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.6 t -123.05 140.01 48.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.51 111.47 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.5 p -90.66 94.03 9.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.11 -10.78 33.33 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.038 0.935 . . . . 0.0 112.499 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.67 135.87 23.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.92 -34.02 76.5 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.758 0.694 . . . . 0.0 112.815 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.68 -29.28 70.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.356 1.078 . . . . 0.0 111.681 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.67 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 111.531 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.43 65.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.78 -34.29 71.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.233 1.013 . . . . 0.0 112.066 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -73.66 -32.12 63.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.883 -171.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 80.8 m -46.77 107.15 0.66 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.949 1.299 . . . . 0.0 109.627 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -64.26 -44.41 12.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.553 1.502 . . . . 0.0 114.239 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.8 ttt -167.26 123.66 1.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.291 1.036 . . . . 0.0 108.527 169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -109.24 85.48 3.48 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.7 166.62 17.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.984 2.456 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.23 -19.57 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.709 3.606 . . . . 0.0 118.279 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.18 -40.22 89.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.039 1.291 . . . . 0.0 110.051 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.26 162.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 127.881 2.472 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -142.58 169.27 17.88 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.586 1.555 . . . . 0.0 107.262 169.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -132.65 145.6 51.2 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.863 0.756 . . . . 0.0 111.156 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 152.18 43.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.301 2.24 . . . . 0.0 105.115 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.17 141.12 42.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.363 0.665 . . . . 0.0 110.284 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -138.26 -166.34 1.96 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.416 1.486 . . . . 0.0 109.076 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.54 1.13 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 119.197 0.908 . . . . 0.0 112.796 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.87 112.86 12.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.867 0.833 . . . . 0.0 110.728 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -69.14 153.56 43.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.354 0.662 . . . . 0.0 109.663 169.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.19 118.2 68.81 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 111.505 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.73 -33.7 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.005 1.804 . . . . 0.0 112.385 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.1 -19.14 64.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.745 0.702 . . . . 0.0 112.072 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -100.27 -2.95 32.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.766 1.226 . . . . 0.0 111.377 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.09 136.77 58.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 168.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.07 22.3 0.66 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -168.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.34 -51.58 42.32 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -172.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -160.17 163.62 33.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.81 2.444 . . . . 0.0 104.863 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.85 -40.02 83.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.09 1.314 . . . . 0.0 111.123 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.75 -32.75 72.73 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.282 -0.261 . . . . 0.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -75.32 -37.84 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.066 0.546 . . . . 0.0 110.144 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 41.7 tttt -59.26 -51.22 70.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.769 1.228 . . . . 0.0 109.415 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -61.96 -41.69 98.28 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.803 0.274 . . . . 0.0 110.644 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.59 73.64 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.48 -0.762 . . . . 0.0 110.859 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.2 -42.07 89.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.545 0.738 . . . . 0.0 110.385 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -56.05 -47.39 77.99 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -59.7 -48.63 80.91 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.96 0.904 . . . . 0.0 111.513 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.94 -45.06 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 116.619 -1.658 . . . . 0.0 110.262 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -61.19 -44.25 97.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 121.985 2.175 . . . . 0.0 110.48 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.71 -43.71 98.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -79.93 -27.31 39.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.255 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -65.88 -42.26 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 107.883 171.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.03 90.14 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.405 ' ND2' HH22 ' A' ' 130' ' ' ARG . 58.5 t30 -57.34 -40.79 78.73 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.403 1.081 . . . . 0.0 111.14 175.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.405 HH22 ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -62.13 -46.67 87.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.744 -0.598 . . . . 0.0 111.027 175.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.66 -34.31 77.91 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.588 0.631 . . . . 0.0 111.086 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -50.55 73.6 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.89 -47.36 83.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 119.712 1.142 . . . . 0.0 109.643 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.38 -39.19 72.52 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 118.394 0.543 . . . . 0.0 110.832 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.04 -48.21 46.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.907 0.883 . . . . 0.0 111.777 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -69.47 -39.6 77.61 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.726 1.21 . . . . 0.0 111.186 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -87.35 -17.66 31.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.315 1.046 . . . . 0.0 110.122 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.53 41.36 93.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.168 1.366 . . . . 0.0 110.71 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.763 0.825 . . . . 0.0 112.207 -170.771 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -58.96 147.46 34.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.619 0.767 . . . . 0.0 109.759 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -153.03 -51.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.364 0.666 . . . . 0.0 110.037 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -146.52 173.62 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.648 1.179 . . . . 0.0 108.358 169.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.39 142.36 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -169.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.71 135.85 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.416 1.486 . . . . 0.0 107.149 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -129.01 103.43 7.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.963 0.905 . . . . 0.0 108.727 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.58 146.19 42.74 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 122.044 -0.41 . . . . 0.0 109.933 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.92 132.25 20.66 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -148.62 173.71 12.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.292 0.637 . . . . 0.0 110.116 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -68.17 -9.11 44.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.556 -1.34 . . . . 0.0 113.689 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.19 123.7 1.3 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.25 -41.04 97.15 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.219 0.509 . . . . 0.0 111.279 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -38.57 -28.94 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.77 3.228 . . . . 0.0 116.861 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -127.93 -74.93 0.57 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.206 0.912 . . . . 0.0 112.335 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mpp_? -53.87 -50.73 65.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.21 0.914 . . . . 0.0 113.436 -168.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 p -80.26 -27.81 38.56 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.979 0.809 . . . . 0.0 111.662 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -62.1 -41.39 98.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.643 1.11 . . . . 0.0 110.943 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 79.0 mtp -65.89 -49.37 68.29 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.64 73.66 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.938 0.495 . . . . 0.0 111.357 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -56.11 -48.91 75.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.081 0.952 . . . . 0.0 109.952 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.63 99.67 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.157 -0.801 . . . . 0.0 112.823 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 94.3 m95 -68.13 -44.11 76.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.168 1.484 . . . . 0.0 110.16 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.48 83.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.618 0.367 . . . . 0.0 110.358 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -59.14 -26.1 64.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.266 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -74.07 -59.21 2.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 110.438 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -69.81 -38.15 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.6 mt -87.19 -39.37 15.54 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.249 0.619 . . . . 0.0 112.176 -169.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.39 -178.87 49.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.092 0.853 . . . . 0.0 112.834 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.93 -15.65 62.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.291 1.436 . . . . 0.0 113.567 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.76 -16.11 3.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.905 1.282 . . . . 0.0 111.534 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -129.08 140.54 51.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 110.083 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -89.57 131.15 35.73 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.54 119.21 54.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 171.59 14.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 171.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.2 p -136.78 152.37 50.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.238 1.015 . . . . 0.0 109.356 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.89 -168.86 3.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.076 1.351 . . . . 0.0 107.572 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.23 37.82 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.52 -40.18 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.07 179.52 6.85 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.467 1.107 . . . . 0.0 109.532 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.01 157.37 43.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.424 2.29 . . . . 0.0 106.574 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -132.5 -29.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.456 1.102 . . . . 0.0 110.185 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.53 -179.25 37.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.9 tp -75.81 101.47 5.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -62.0 124.8 83.39 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.374 -171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -51.08 -33.54 43.73 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.272 2.648 . . . . 0.0 113.719 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -39.54 90.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.651 0.659 . . . . 0.0 110.691 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.35 73.56 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -58.23 -53.35 47.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -67.62 -41.59 83.7 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.778 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.08 -49.05 74.89 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 118.886 0.766 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.42 ' HE1' ' CD1' ' A' ' 23' ' ' TRP . 98.6 mmm -71.02 -40.3 71.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.076 0.55 . . . . 0.0 110.84 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -64.57 -29.96 70.99 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.195 -0.941 . . . . 0.0 111.014 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -68.99 -22.37 64.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.963 0.905 . . . . 0.0 112.06 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.03 -30.44 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.214 0.915 . . . . 0.0 109.113 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.29 14.48 11.71 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.462 1.505 . . . . 0.0 111.471 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.87 97.25 5.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.15 85.44 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.294 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.55 4.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.277 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -56.48 -26.16 53.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.891 1.678 . . . . 0.0 112.132 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -72.93 -22.07 60.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.055 1.342 . . . . 0.0 113.013 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -71.25 167.5 19.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.73 0.812 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.49 156.45 43.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.41 1.484 . . . . 0.0 108.419 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 m -102.7 153.92 19.66 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.161 0.585 . . . . 0.0 111.599 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -154.48 154.86 33.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.718 1.607 . . . . 0.0 109.056 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 pt -84.83 163.28 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.94 134.1 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.397 1.079 . . . . 0.0 110.927 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -119.88 110.18 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.427 1.491 . . . . 0.0 107.451 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 m -54.7 -24.77 23.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.152 1.381 . . . . 0.0 112.676 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.28 -45.48 63.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.07 0.85 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.06 -42.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.55 -50.21 43.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.931 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -75.89 -12.01 60.07 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -92.57 -19.89 21.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.386 0.994 . . . . 0.0 110.783 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.15 140.45 57.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.083 0.401 . . . . 0.0 110.291 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.19 -33.47 75.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.3 tp -145.44 143.88 30.3 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.238 1.415 . . . . 0.0 109.918 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.36 136.99 55.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.24 108.48 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.2 p -88.33 95.67 10.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.75 -13.48 55.14 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 50.2 t -141.99 139.67 32.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.02 -36.64 90.96 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.493 0.568 . . . . 0.0 112.59 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.72 -27.24 68.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.193 0.997 . . . . 0.0 111.659 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -24.83 61.12 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.328 0.651 . . . . 0.0 111.651 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.31 -14.91 62.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.88 -33.6 75.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.179 0.592 . . . . 0.0 111.677 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -87.59 75.46 9.07 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.471 0.709 . . . . 0.0 109.394 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.2 m -135.99 80.95 40.66 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.13 88.31 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.519 3.48 . . . . 0.0 110.882 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . 0.263 24.1 ptt? 51.57 130.62 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 131.16 3.784 . . . . 0.0 114.643 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p -137.76 84.59 21.81 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -53.87 171.85 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.67 3.58 . . . . 0.0 113.203 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.56 -27.86 26.79 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.722 2.948 . . . . 0.0 115.199 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.44 -14.13 55.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 112.853 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.28 82.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.529 2.332 . . . . 0.0 106.423 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.6 pttt -67.08 164.35 18.08 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -129.75 155.74 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.742 -0.599 . . . . 0.0 109.718 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.15 154.56 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -140.12 143.28 36.15 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.9 0.48 . . . . 0.0 111.139 -168.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -140.08 -169.88 2.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.286 1.434 . . . . 0.0 109.19 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.02 42.77 1.28 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.018 0.818 . . . . 0.0 112.992 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -77.33 101.05 6.13 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 111.455 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -60.89 158.27 13.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.372 1.069 . . . . 0.0 110.124 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.07 124.21 86.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.368 -169.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.98 -44.44 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.858 2.372 . . . . 0.0 111.84 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.59 69.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.423 0.689 . . . . 0.0 111.024 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.37 12.16 31.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.039 1.335 . . . . 0.0 111.21 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.52 72.08 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.597 0.635 . . . . 0.0 112.692 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 55.86 -176.98 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.865 2.066 . . . . 0.0 113.281 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -65.84 0.49 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 126.179 1.847 . . . . 0.0 108.784 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 t -160.92 159.88 30.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.98 -39.76 75.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.014 0.825 . . . . 0.0 111.333 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.1 -28.98 66.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.358 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.36 -41.45 69.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.732 0.697 . . . . 0.0 109.32 174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -59.41 -53.73 54.85 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -57.65 -42.1 82.8 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.528 0.517 . . . . 0.0 110.022 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.2 87.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.157 0.435 . . . . 0.0 110.295 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.91 -38.74 92.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.626 0.77 . . . . 0.0 111.144 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -58.91 -47.38 85.21 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.292 0.951 . . . . 0.0 108.721 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -61.44 -42.89 99.46 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.149 0.58 . . . . 0.0 111.149 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.47 -50.55 64.93 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.305 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.01 -44.37 99.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.191 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -44.53 97.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 121.149 1.795 . . . . 0.0 110.628 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.67 -43.02 99.65 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.84 -29.35 44.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.806 -1.093 . . . . 0.0 112.222 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.05 -44.54 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.4 -46.71 93.83 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.71 -42.18 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.848 0.824 . . . . 0.0 110.429 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -46.05 91.8 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.2 mt -72.71 -34.38 67.08 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 110.149 -175.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.65 -51.6 69.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 110.752 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.42 -49.25 76.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.982 0.81 . . . . 0.0 109.296 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.37 -39.93 67.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.686 0.675 . . . . 0.0 111.082 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.2 -46.94 54.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.745 0.818 . . . . 0.0 111.854 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.79 -38.45 67.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.606 1.163 . . . . 0.0 111.182 -173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.2 p -89.3 -22.41 22.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 110.114 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.26 44.45 97.46 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.105 1.362 . . . . 0.0 111.301 -175.488 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -65.57 165.89 11.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 111.633 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -142.92 -38.68 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.4 mtmt -136.67 166.3 23.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.73 171.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.76 132.08 67.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 172.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -122.73 133.98 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -129.6 106.34 8.67 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.81 0.844 . . . . 0.0 109.155 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -75.42 146.91 40.38 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.057 -0.402 . . . . 0.0 110.084 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.95 127.51 15.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -149.44 172.84 14.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.995 0.518 . . . . 0.0 110.237 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -66.83 -10.37 47.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.885 -1.134 . . . . 0.0 113.314 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.43 118.77 0.85 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.926 -2.87 . . . . 0.0 105.926 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 56.2 t-20 -56.22 -47.48 78.35 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.611 0.764 . . . . 0.0 110.347 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -45.1 -24.61 0.26 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.679 3.192 . . . . 0.0 116.397 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 m -112.67 -88.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -60.71 -43.59 97.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.908 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -70.62 -40.56 73.07 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.914 1.234 . . . . 0.0 111.238 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.89 -44.52 96.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.079 0.854 . . . . 0.0 111.007 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.6 mtp -65.44 -45.51 83.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.78 89.41 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.316 0.647 . . . . 0.0 111.092 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -57.17 -45.46 83.62 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.79 -55.11 27.16 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.15 -0.806 . . . . 0.0 113.106 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -68.74 -36.76 78.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.911 1.856 . . . . 0.0 111.144 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.53 76.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.258 -0.902 . . . . 0.0 111.253 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.64 -35.29 70.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.623 0.647 . . . . 0.0 111.904 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.16 -49.93 25.44 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.481 0.712 . . . . 0.0 109.273 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -76.61 -31.51 57.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.22 -36.89 8.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 -171.26 49.35 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 122.116 0.842 . . . . 0.0 113.856 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.69 -14.32 57.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.746 2.019 . . . . 0.0 114.098 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.09 -10.15 2.49 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.774 1.629 . . . . 0.0 111.839 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.435 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 2.8 m95 -141.58 157.79 44.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.757 1.223 . . . . 0.0 110.261 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -109.95 139.13 45.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 167.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.02 124.94 67.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -169.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.94 170.51 15.88 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -138.65 142.2 39.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 108.507 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.92 -176.65 4.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.721 1.608 . . . . 0.0 108.466 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.16 173.69 40.19 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -41.42 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.51 179.85 6.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.814 0.846 . . . . 0.0 109.388 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.47 120.95 12.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -73.09 -38.69 66.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.642 0.777 . . . . 0.0 109.364 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.82 -167.47 35.9 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 127.961 2.696 . . . . 0.0 107.798 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.43 100.14 9.12 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -62.59 121.32 66.73 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.539 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.86 -32.82 48.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.032 2.488 . . . . 0.0 113.228 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.98 89.35 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.73 0.695 . . . . 0.0 111.035 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.47 71.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.81 -54.36 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.1 -43.12 93.08 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.127 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.68 -50.11 63.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.661 0.664 . . . . 0.0 110.431 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.4 mmm -75.42 -35.94 60.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.799 0.272 . . . . 0.0 111.578 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.68 -32.94 73.15 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -67.36 -19.85 65.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.872 0.869 . . . . 0.0 112.443 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.74 -10.68 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.504 1.047 . . . . 0.0 110.132 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.28 25.37 44.03 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.035 -1.041 . . . . 0.0 110.666 -169.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.69 89.49 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -78.6 81.44 4.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.288 -171.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.41 6.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.57 -0.728 . . . . 0.0 112.197 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 m -55.0 -27.04 41.14 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.228 1.376 . . . . 0.0 112.09 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.02 -20.72 60.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.939 1.296 . . . . 0.0 112.95 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.45 171.45 10.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.737 0.779 . . . . 0.0 109.994 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -143.65 152.41 41.32 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.539 1.536 . . . . 0.0 107.325 172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -96.12 152.51 18.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -152.06 160.51 43.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.608 1.963 . . . . 0.0 108.274 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 pt -93.96 160.5 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.64 116.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.724 0.773 . . . . 0.0 112.955 -169.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.51 113.27 25.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 m -61.43 -24.22 66.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.576 1.15 . . . . 0.0 112.56 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.15 -39.31 82.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.013 0.824 . . . . 0.0 111.222 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.0 mt -66.29 -48.19 81.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.52 -48.71 68.78 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 109.954 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.84 -2.89 8.08 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -132.96 1.43 3.57 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.535 1.516 . . . . 0.0 114.199 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.15 47.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.209 0.913 . . . . 0.0 109.599 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.27 -34.75 78.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.2 tp -147.36 144.2 28.55 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.969 1.308 . . . . 0.0 110.596 -171.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.77 136.51 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 109.82 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.4 p -88.88 101.09 13.7 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.84 -10.48 59.85 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.14 158.96 43.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.103 0.865 . . . . 0.0 109.005 169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.4 -42.67 93.73 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.104 -169.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.36 -32.39 74.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.844 0.822 . . . . 0.0 111.364 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.96 69.41 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.749 0.419 . . . . 0.0 112.053 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.41 -33.85 73.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.898 0.772 . . . . 0.0 111.599 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -89.16 59.65 5.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.404 1.082 . . . . 0.0 110.069 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.9 83.82 30.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.8 70.64 2.78 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.451 3.434 . . . . 0.0 112.134 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.6 mtt 78.55 100.18 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 129.294 3.038 . . . . 0.0 112.001 172.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -105.53 84.34 1.15 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.83 172.69 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.297 2.665 . . . . 0.0 110.775 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -49.49 -27.97 15.26 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.805 3.003 . . . . 0.0 116.365 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -68.44 -8.56 41.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.112 0.965 . . . . 0.0 113.042 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.54 86.96 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 128.421 2.688 . . . . 0.0 105.304 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -66.93 164.94 16.48 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -143.07 145.88 33.29 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.349 -0.845 . . . . 0.0 109.234 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -132.8 157.1 45.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.418 1.487 . . . . 0.0 107.576 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -141.29 138.51 33.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.843 . . . . 0.0 110.747 -168.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.52 -171.85 2.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.813 1.645 . . . . 0.0 108.43 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.63 77.68 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 O-C-N 121.174 -0.953 . . . . 0.0 113.214 -169.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.14 151.14 45.05 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.088 0.944 . . . . 0.0 111.372 170.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.51 160.32 32.65 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.444 1.898 . . . . 0.0 113.265 -169.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.85 129.36 71.0 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.096 0.959 . . . . 0.0 111.712 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.55 -30.19 4.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.188 1.925 . . . . 0.0 114.009 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.29 -13.23 57.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.27 9.65 10.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.758 1.223 . . . . 0.0 111.435 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.11 141.9 52.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.39 162.14 37.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.97 0.908 . . . . 0.0 109.708 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.54 -50.07 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.88 165.37 22.86 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.557 2.343 . . . . 0.0 105.272 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.97 -40.01 83.46 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.51 -0.744 . . . . 0.0 110.641 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.97 -29.06 66.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.411 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.06 -44.5 60.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.826 0.739 . . . . 0.0 109.128 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -56.43 -51.04 69.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.778 0.831 . . . . 0.0 109.825 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -62.85 -42.53 99.78 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.625 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.36 78.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.914 0.779 . . . . 0.0 110.142 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.37 -38.34 90.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.043 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.21 -50.9 68.22 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -60.39 -43.7 96.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.02 0.528 . . . . 0.0 111.516 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -60.52 -50.01 75.27 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.281 0.491 . . . . 0.0 110.305 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.82 -39.41 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.669 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -56.65 -51.97 66.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.696 1.134 . . . . 0.0 109.602 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.29 -41.33 96.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.456 0.702 . . . . 0.0 110.005 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.84 -26.85 44.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.618 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -45.96 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.46 -44.15 93.62 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' ND2' HH22 ' A' ' 130' ' ' ARG . 54.3 t30 -60.4 -39.65 88.12 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.205 1.402 . . . . 0.0 111.179 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.41 HH22 ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -58.0 -48.53 79.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.69 -32.69 64.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.518 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -51.42 69.81 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.226 1.011 . . . . 0.0 110.56 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.64 -47.18 82.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.557 1.071 . . . . 0.0 109.582 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.08 -39.03 71.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.403 0.547 . . . . 0.0 111.071 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.45 33.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.706 0.803 . . . . 0.0 111.624 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.76 -38.78 76.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.62 1.168 . . . . 0.0 111.183 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 31.4 p -89.14 -17.87 28.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.28 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.11 40.89 94.24 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -172.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.615 1.166 . . . . 0.0 111.702 -169.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.43 149.65 45.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -158.6 -40.97 0.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.7 mtmt -134.41 165.74 24.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.031 1.333 . . . . 0.0 108.332 169.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.74 134.31 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.3 135.06 63.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -131.77 104.4 6.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.562 0.745 . . . . 0.0 109.53 -169.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.67 142.53 38.77 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.07 1.348 . . . . 0.0 110.141 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.92 129.49 19.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.51 175.12 11.09 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.318 0.508 . . . . 0.0 110.774 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -6.64 21.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.64 133.7 3.09 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.98 33.12 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.064 0.932 . . . . 0.0 112.23 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 m -116.21 -1.94 12.28 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.796 1.239 . . . . 0.0 110.97 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -150.27 -94.61 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.968 0.804 . . . . 0.0 111.988 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -58.08 -46.41 85.49 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.883 1.273 . . . . 0.0 112.16 -169.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.8 p -72.38 -28.08 62.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.95 0.796 . . . . 0.0 112.055 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -68.92 -42.26 77.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.882 0.764 . . . . 0.0 110.249 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.45 -46.4 80.02 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.35 81.29 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.164 0.586 . . . . 0.0 111.104 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -57.81 -47.97 81.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.334 1.054 . . . . 0.0 109.546 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.66 -50.96 60.89 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.745 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.1 m95 -64.83 -38.3 90.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.844 1.822 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.15 79.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.642 -0.661 . . . . 0.0 111.567 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.73 -27.01 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.398 0.999 . . . . 0.0 112.475 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -46.58 13.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.452 0.701 . . . . 0.0 109.586 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -78.89 -27.2 43.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.62 -140.23 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.887 1.275 . . . . 0.0 108.101 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.16 -175.79 47.8 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.85 -12.37 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -58.14 -10.99 2.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.754 2.022 . . . . 0.0 111.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 10.2 m95 -134.98 166.36 23.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.131 1.772 . . . . 0.0 108.913 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -124.59 135.68 53.32 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 167.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 118.39 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -168.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 173.25 11.91 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.48 1.112 . . . . 0.0 109.346 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.8 p -136.03 159.82 40.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.225 1.01 . . . . 0.0 110.163 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.03 -169.4 3.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.755 1.622 . . . . 0.0 107.199 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.59 173.49 42.64 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.333 -0.854 . . . . 0.0 111.221 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.97 -39.23 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.555 1.142 . . . . 0.0 108.905 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.12 -178.74 6.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 108.51 170.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.11 43.55 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.545 1.538 . . . . 0.0 108.384 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -144.76 -39.22 0.27 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.063 0.945 . . . . 0.0 110.123 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.6 140.74 2.97 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.78 114.74 2.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.821 1.31 . . . . 0.0 108.062 169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.47 157.35 80.32 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.312 -169.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.7 -36.58 73.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.703 2.935 . . . . 0.0 113.866 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -36.86 85.28 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.168 0.895 . . . . 0.0 111.325 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.98 67.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.33 -52.52 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.15 -42.1 96.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.89 0.768 . . . . 0.0 110.587 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.55 -45.62 84.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.499 0.59 . . . . 0.0 110.792 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 93.3 mmm -75.94 -37.98 58.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.503 0.138 . . . . 0.0 111.112 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -61.95 -36.42 81.37 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.88 -22.32 63.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.835 0.854 . . . . 0.0 112.509 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -77.79 -26.06 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.365 0.984 . . . . 0.0 109.601 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.97 23.62 6.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.116 1.341 . . . . 0.0 111.489 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.5 mt -124.71 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 -171.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -79.85 75.69 6.55 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.276 0.63 . . . . 0.0 110.866 -170.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -70.98 0.24 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.927 -1.035 . . . . 0.0 112.071 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -51.87 -28.03 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.208 1.367 . . . . 0.0 111.78 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.18 -20.23 64.84 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.519 1.528 . . . . 0.0 113.6 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -77.45 169.29 18.57 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.059 . . . . 0.0 109.698 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 p -143.82 167.46 22.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.584 1.953 . . . . 0.0 107.876 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.6 p -118.97 151.64 37.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.358 0.663 . . . . 0.0 111.257 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.35 154.88 35.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.724 1.61 . . . . 0.0 109.028 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.96 165.85 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 tt -57.12 106.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.186 0.994 . . . . 0.0 111.816 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -89.11 102.22 14.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -16.37 49.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.138 0.975 . . . . 0.0 112.222 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.91 -37.25 62.13 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.999 1.272 . . . . 0.0 111.871 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.07 -48.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.1 -47.46 65.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.686 0.795 . . . . 0.0 110.52 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -67.45 -8.26 31.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -128.75 3.39 5.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.274 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.33 148.1 51.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.45 -32.9 72.12 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.5 tp -147.41 144.35 28.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.225 1.41 . . . . 0.0 110.428 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.49 139.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 m -128.45 129.25 68.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -88.65 138.24 31.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.5 mt -110.62 0.7 17.65 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 112.511 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -152.19 161.79 42.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.595 1.089 . . . . 0.0 109.22 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.46 -51.43 57.81 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 123.897 0.761 . . . . 0.0 112.017 -171.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.09 -31.45 70.18 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.15 -30.01 70.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.478 0.581 . . . . 0.0 112.425 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.26 67.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.88 -38.08 89.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.045 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.59 -42.85 24.09 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.056 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.8 t -47.72 106.52 0.61 Allowed Pre-proline 0 CA--C 1.547 0.861 0 O-C-N 124.76 1.288 . . . . 0.0 110.275 -169.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.45 174.68 7.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.682 3.588 . . . . 0.0 111.461 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 99.0 mmm -58.63 135.7 57.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.152 0.581 . . . . 0.0 111.041 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 p -120.53 105.22 41.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.945 1.698 . . . . 0.0 106.675 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.27 168.88 18.13 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.813 2.342 . . . . 0.0 110.693 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.32 -24.48 15.9 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.009 3.139 . . . . 0.0 116.288 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.29 -10.34 31.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.033 0.933 . . . . 0.0 112.847 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 93.92 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 128.007 2.523 . . . . 0.0 105.621 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -70.64 164.31 25.22 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.17 144.2 31.45 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.626 0.771 . . . . 0.0 109.062 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.12 164.66 29.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -144.55 113.0 6.57 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.772 0.829 . . . . 0.0 109.283 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -115.55 169.18 9.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.662 1.585 . . . . 0.0 107.851 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.9 107.94 0.63 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.784 -169.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.87 118.86 17.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.953 0.901 . . . . 0.0 111.765 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -66.52 153.41 43.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.4 1.08 . . . . 0.0 109.542 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.64 121.36 82.19 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.522 -172.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.03 -32.92 8.14 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.837 1.691 . . . . 0.0 112.588 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 -19.93 65.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.029 0.831 . . . . 0.0 112.189 -172.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.26 -2.03 43.53 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.712 1.205 . . . . 0.0 111.811 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 142.71 45.36 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -156.51 164.69 37.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.777 0.431 . . . . 0.0 110.94 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -47.91 0.69 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -165.24 166.01 19.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.245 2.218 . . . . 0.0 105.391 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.92 -40.51 80.56 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.546 -0.721 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.09 -27.42 64.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.188 -0.434 . . . . 0.0 111.473 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.76 -44.59 55.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 109.192 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -56.63 -49.88 73.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.457 0.703 . . . . 0.0 109.892 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -64.64 -39.36 93.56 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.097 -0.377 . . . . 0.0 111.089 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.61 74.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 110.655 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -68.41 -40.56 81.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.244 0.474 . . . . 0.0 110.503 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -58.36 -39.79 80.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.712 0.687 . . . . 0.0 109.841 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -63.11 -49.71 73.34 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.576 0.625 . . . . 0.0 110.208 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -59.77 -49.96 75.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.118 0.417 . . . . 0.0 110.37 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.54 -46.24 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.099 -1.429 . . . . 0.0 110.039 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -62.54 -42.17 99.36 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 121.683 2.038 . . . . 0.0 110.916 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.87 -44.66 96.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.45 -36.04 65.82 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.065 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -63.75 -40.55 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.528 1.513 . . . . 0.0 108.984 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.64 -44.34 97.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.95 -37.1 85.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.53 1.132 . . . . 0.0 112.036 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -56.27 -52.05 65.91 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 -35.77 77.38 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 119.024 -0.513 . . . . 0.0 111.918 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -49.33 77.89 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.589 0.755 . . . . 0.0 110.477 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -61.08 -50.78 71.9 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -54.87 -41.45 70.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.222 0.609 . . . . 0.0 111.321 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.33 -47.48 56.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.007 0.923 . . . . 0.0 111.505 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -73.24 -38.34 66.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.143 0.977 . . . . 0.0 111.642 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.1 p -92.23 -21.57 20.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.381 1.073 . . . . 0.0 110.6 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.06 42.46 99.73 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.438 1.495 . . . . 0.0 111.153 -175.315 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -159.2 172.77 17.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.101 1.76 . . . . 0.0 107.869 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -140.77 -44.6 0.39 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.521 0.728 . . . . 0.0 111.718 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.2 mtmt -138.12 171.47 14.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.577 1.551 . . . . 0.0 108.464 169.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.7 131.28 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.83 133.67 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.52 107.11 9.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.84 143.74 37.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.689 1.196 . . . . 0.0 110.497 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.28 127.87 17.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 108.821 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.81 169.67 16.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.848 1.259 . . . . 0.0 111.256 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -67.22 -16.42 64.29 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.133 -0.979 . . . . 0.0 113.276 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.83 112.86 0.54 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.07 -35.81 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.643 1.177 . . . . 0.0 112.337 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -41.13 -19.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.266 3.026 . . . . 0.0 118.496 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -141.59 -54.74 0.46 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.708 1.595 . . . . 0.0 113.804 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -56.59 -53.72 54.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.342 0.974 . . . . 0.0 113.456 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -36.65 78.85 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.058 0.845 . . . . 0.0 110.257 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -58.07 -43.28 86.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.785 0.721 . . . . 0.0 111.597 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -66.2 -48.06 71.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.803 0.841 . . . . 0.0 109.415 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.24 74.2 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.192 0.597 . . . . 0.0 110.769 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.04 -45.34 93.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.47 0.708 . . . . 0.0 110.289 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.93 92.82 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.223 -0.765 . . . . 0.0 112.377 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.6 m95 -66.72 -43.81 83.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.914 1.357 . . . . 0.0 110.572 176.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.81 78.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.205 0.457 . . . . 0.0 110.84 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.56 -33.35 68.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.689 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.79 -57.98 4.84 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.809 0.732 . . . . 0.0 110.023 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -69.19 -33.38 73.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.9 mt -100.09 -37.85 8.79 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.05 -173.32 48.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.074 0.845 . . . . 0.0 113.4 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.18 -14.91 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.499 1.92 . . . . 0.0 113.753 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -57.23 -11.11 1.52 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.595 1.958 . . . . 0.0 111.794 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.462 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.8 m95 -142.24 147.47 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.255 1.022 . . . . 0.0 110.922 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -92.46 140.36 29.65 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.03 125.32 64.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.73 160.41 34.39 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.827 0.851 . . . . 0.0 111.38 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -136.46 128.6 29.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.808 1.643 . . . . 0.0 108.674 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 -168.85 3.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.9 176.83 42.97 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.61 -42.79 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.807 1.243 . . . . 0.0 107.908 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -143.45 177.15 8.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.254 0.622 . . . . 0.0 110.276 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.8 43.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.574 2.35 . . . . 0.0 107.219 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -134.77 -36.33 0.85 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.286 1.035 . . . . 0.0 110.077 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.47 179.31 44.99 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.02 102.82 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -67.74 134.09 92.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.135 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.09 -33.11 72.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.199 2.6 . . . . 0.0 113.738 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -36.6 78.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.732 0.696 . . . . 0.0 111.28 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.12 71.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.17 -54.06 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.48 -43.27 90.74 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.476 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.4 82.9 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.837 0.744 . . . . 0.0 111.345 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.402 ' HE3' ' CD1' ' A' ' 23' ' ' TRP . 94.3 mmm -77.6 -40.35 42.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.172 0.442 . . . . 0.0 111.359 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -63.36 -31.75 72.99 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.422 -0.799 . . . . 0.0 110.707 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.15 -21.7 64.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.424 1.089 . . . . 0.0 112.604 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -77.52 -22.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.558 1.072 . . . . 0.0 109.55 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.39 14.78 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.741 1.162 . . . . 0.0 110.774 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.36 99.64 8.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.44 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.15 4.44 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 110.705 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -27.28 63.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.141 1.337 . . . . 0.0 111.017 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -67.15 -16.62 64.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.915 2.086 . . . . 0.0 113.614 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.87 172.57 13.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.504 1.122 . . . . 0.0 109.213 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -150.14 160.19 43.85 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.256 1.422 . . . . 0.0 108.411 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.4 m -101.08 153.63 19.4 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.13 155.49 31.1 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.809 2.044 . . . . 0.0 108.335 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.38 159.89 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.41 141.35 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.141 0.976 . . . . 0.0 112.372 -169.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -119.45 111.55 18.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.738 1.615 . . . . 0.0 107.668 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -70.75 -21.75 62.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.58 -46.39 59.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.337 0.971 . . . . 0.0 110.106 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.81 -39.52 85.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.16 -47.88 71.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.929 0.786 . . . . 0.0 110.085 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -73.67 -7.12 50.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -98.59 -21.42 16.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 111.186 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.79 142.45 58.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.193 0.451 . . . . 0.0 110.054 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.84 -32.68 73.37 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.619 -0.676 . . . . 0.0 109.295 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.7 tp -144.99 145.12 31.38 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.002 1.321 . . . . 0.0 109.625 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.19 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.78 127.79 66.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 169.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -94.23 96.85 9.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.59 -9.39 26.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.346 1.458 . . . . 0.0 114.356 -168.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 t -149.72 160.35 43.6 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 121.124 1.784 . . . . 0.0 110.352 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -44.79 -66.51 1.42 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 127.164 2.316 . . . . 0.0 113.217 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.11 -22.65 62.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.02 69.87 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.875 -0.516 . . . . 0.0 111.336 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.91 -17.46 63.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.94 -31.27 71.58 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.195 0.907 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -91.69 74.05 5.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.793 0.837 . . . . 0.0 109.175 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 p -123.16 74.25 49.45 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 0.0 109.391 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.59 74.07 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.608 3.538 . . . . 0.0 111.615 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.5 mmt 66.23 129.31 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.274 3.03 . . . . 0.0 112.412 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 p -141.44 81.58 15.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.94 171.69 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.7 3.6 . . . . 0.0 113.635 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.9 -29.84 28.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.47 2.78 . . . . 0.0 114.806 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.34 -4.83 28.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 113.171 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.74 78.38 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.55 2.34 . . . . 0.0 105.4 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -68.18 167.81 13.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -135.37 156.22 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.583 0.753 . . . . 0.0 111.879 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.79 162.7 38.7 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 169.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -153.21 119.34 5.46 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.087 -1.008 . . . . 0.0 110.337 -169.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -115.77 -174.82 2.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 0.0 110.06 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.87 44.26 1.19 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.365 0.983 . . . . 0.0 113.627 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -80.76 104.63 11.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.026 0.93 . . . . 0.0 111.342 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.87 152.31 36.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.808 0.843 . . . . 0.0 110.086 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.36 120.73 83.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.71 -33.66 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 112.784 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.15 65.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.996 0.817 . . . . 0.0 112.069 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 110' ' ' GLN . 8.0 mpt_? -104.37 9.02 35.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.976 1.31 . . . . 0.0 111.633 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.88 22.35 0.05 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.313 1.445 . . . . 0.0 114.221 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 108' ' ' ARG . 7.6 mt-30 -55.1 152.53 7.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.35 1.86 . . . . 0.0 111.825 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.89 -51.29 0.2 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -154.16 154.84 34.24 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.01 -38.29 85.53 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.505 -0.747 . . . . 0.0 110.742 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.53 -30.98 71.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.362 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -72.55 -48.34 40.95 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -53.48 -52.45 59.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 109.84 176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -64.22 -42.56 96.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.825 0.85 . . . . 0.0 111.168 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.78 72.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.992 0.815 . . . . 0.0 110.307 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -66.29 -38.19 87.18 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.564 -0.71 . . . . 0.0 111.152 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -57.45 -45.92 84.19 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.172 0.896 . . . . 0.0 108.996 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -60.1 -49.4 77.81 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.624 0.77 . . . . 0.0 110.993 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -58.68 -49.67 76.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.97 -47.65 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.328 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -64.01 -41.86 97.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 121.259 1.845 . . . . 0.0 110.673 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.32 -42.89 99.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.922 0.328 . . . . 0.0 110.259 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -75.75 -36.14 59.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.108 -0.949 . . . . 0.0 112.31 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -61.66 -46.25 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.72 92.38 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -54.82 -46.99 74.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.671 1.188 . . . . 0.0 111.879 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -39.82 88.0 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.98 -0.45 . . . . 0.0 109.904 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.74 -35.32 72.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.243 0.617 . . . . 0.0 110.99 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -60.04 -49.64 76.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.817 0.847 . . . . 0.0 110.271 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.6 -46.62 81.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.03 0.832 . . . . 0.0 109.71 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -54.3 -40.63 68.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.85 0.75 . . . . 0.0 110.916 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.77 37.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -71.82 -36.08 70.13 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.335 1.054 . . . . 0.0 111.566 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.3 p -90.28 -16.94 28.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 110.27 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.37 41.11 92.97 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.799 1.24 . . . . 0.0 111.842 -170.631 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.36 128.09 32.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.77 -41.95 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -171.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -130.92 161.5 31.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.723 1.609 . . . . 0.0 107.107 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -136.64 130.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.82 127.03 74.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -124.8 100.11 6.46 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -169.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -73.09 147.88 44.54 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.3 143.46 37.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.313 1.845 . . . . 0.0 106.724 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.83 173.18 16.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 p -67.25 -11.52 57.7 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.326 -0.859 . . . . 0.0 113.164 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.23 116.61 0.73 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -55.36 -39.24 69.84 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.269 1.027 . . . . 0.0 111.756 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.48 -34.88 0.24 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.107 3.363 . . . . 0.0 115.777 -169.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 m -120.41 -73.92 0.63 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.069 0.547 . . . . 0.0 110.347 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -62.16 -48.52 79.73 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.211 0.604 . . . . 0.0 110.985 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -70.59 -37.17 73.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.316 -0.374 . . . . 0.0 110.741 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.38 -44.64 95.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.927 0.491 . . . . 0.0 111.127 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.3 mtm -67.0 -45.66 76.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.525 0.602 . . . . 0.0 110.287 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.71 81.47 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.748 0.704 . . . . 0.0 111.14 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -57.33 -47.04 82.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.288 1.035 . . . . 0.0 109.761 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.27 50.67 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.657 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.405 ' CD1' HG22 ' A' ' 127' ' ' ILE . 94.4 m95 -67.26 -37.49 83.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.817 1.809 . . . . 0.0 111.029 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.71 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.285 -0.884 . . . . 0.0 111.386 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.94 -24.79 67.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.957 0.799 . . . . 0.0 112.512 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.22 -46.99 12.03 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.892 0.769 . . . . 0.0 109.71 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -75.4 -30.75 60.22 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.7 -143.88 0.29 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.995 1.318 . . . . 0.0 108.091 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.2 -178.57 46.1 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.92 -13.85 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.95 -9.94 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.542 1.937 . . . . 0.0 111.642 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -125.58 161.74 26.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.376 1.87 . . . . 0.0 108.39 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.93 138.29 54.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.86 117.27 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 173.7 11.42 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -142.01 157.28 45.11 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 0.0 109.905 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.07 -163.63 1.75 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.462 1.505 . . . . 0.0 107.896 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.28 175.76 43.5 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.64 -41.8 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.05 176.43 8.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.791 0.836 . . . . 0.0 110.056 170.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.78 6.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.022 1.729 . . . . 0.0 107.139 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -74.48 -36.28 63.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.062 0.545 . . . . 0.0 109.626 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.81 -179.31 30.98 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -74.2 99.43 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -61.84 124.58 82.19 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.264 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.45 -33.51 38.26 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.269 2.646 . . . . 0.0 113.608 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -39.75 91.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.91 0.777 . . . . 0.0 110.916 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.31 75.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.95 -56.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.58 -42.06 99.32 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 119.042 0.837 . . . . 0.0 110.348 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.38 65.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.512 0.325 . . . . 0.0 110.336 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 90.1 mmm -74.44 -36.06 63.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.905 0.321 . . . . 0.0 110.873 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -61.8 -35.78 79.2 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.422 -0.799 . . . . 0.0 110.129 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.29 -24.25 63.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 112.572 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.38 -22.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.314 0.961 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.85 23.93 8.96 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.824 1.202 . . . . 0.0 111.263 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.1 mt -123.57 94.21 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -79.13 80.27 5.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -76.27 5.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.56 -0.712 . . . . 0.0 112.205 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -54.57 -26.46 32.44 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.824 1.193 . . . . 0.0 112.232 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.45 -20.06 57.42 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.99 1.316 . . . . 0.0 113.135 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.59 167.32 17.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 109.3 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -145.34 158.79 43.76 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.428 1.491 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -108.65 147.1 32.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.858 0.863 . . . . 0.0 110.103 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -155.17 159.5 40.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.026 1.331 . . . . 0.0 108.578 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.31 161.18 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.02 131.78 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.766 0.826 . . . . 0.0 111.987 -169.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.25 114.57 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.574 1.55 . . . . 0.0 107.327 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -69.37 -17.95 63.74 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.261 -171.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.06 -41.71 28.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.594 1.088 . . . . 0.0 110.504 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.42 -45.68 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -50.11 -50.85 47.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.03 0.932 . . . . 0.0 110.518 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -70.49 -19.51 62.93 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -89.94 -16.19 30.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.679 1.127 . . . . 0.0 110.976 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.53 34.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.225 0.536 . . . . 0.0 111.45 -169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.52 -33.16 36.57 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 168.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -148.44 146.68 28.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.134 1.773 . . . . 0.0 110.374 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.43 140.04 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.32 111.67 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.6 p -93.53 108.41 20.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.57 -3.82 23.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.306 -170.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 36.3 t -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 120.881 1.673 . . . . 0.0 108.748 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.87 -35.81 92.49 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 123.674 0.654 . . . . 0.0 112.413 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.27 -25.91 64.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.683 1.242 . . . . 0.0 111.517 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -18.28 58.36 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.182 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.84 67.02 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.851 0.75 . . . . 0.0 112.505 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.24 -32.59 74.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 112.033 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -86.49 57.99 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.85 0.86 . . . . 0.0 110.983 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.7 m -124.01 78.02 58.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.25 -49.93 5.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.299 3.332 . . . . 0.0 114.872 -172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.1 mtp -152.85 137.04 16.49 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.0 1.72 . . . . 0.0 107.289 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.7 p -134.4 71.09 72.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.45 164.78 24.76 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.638 2.892 . . . . 0.0 110.82 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.04 -20.44 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.798 1 C-N-CA 125.458 4.105 . . . . 0.0 119.719 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -60.05 -44.42 94.69 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.625 1.557 . . . . 0.0 109.184 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.09 156.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 127.708 2.403 . . . . 0.0 108.075 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -134.71 167.36 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 169.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -139.2 146.65 40.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.276 0.944 . . . . 0.0 110.084 -169.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -142.61 156.33 45.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.001 1.32 . . . . 0.0 107.867 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.37 140.36 30.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.246 1.019 . . . . 0.0 110.316 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -136.19 -164.7 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.678 1.591 . . . . 0.0 109.562 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.0 40.63 1.17 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.572 1.078 . . . . 0.0 114.342 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.51 116.85 22.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.509 1.155 . . . . 0.0 111.879 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.17 152.68 43.16 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.557 0.743 . . . . 0.0 109.231 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.4 123.95 88.85 Favored Pre-proline 0 C--O 1.236 0.354 0 O-C-N 121.892 -0.505 . . . . 0.0 111.904 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.28 -31.6 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.055 1.837 . . . . 0.0 112.868 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.55 -21.37 65.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.083 0.856 . . . . 0.0 112.306 -174.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -94.56 -4.41 47.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.453 1.101 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.65 57.35 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.071 0.85 . . . . 0.0 109.304 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -144.74 161.42 39.26 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.528 1.131 . . . . 0.0 109.245 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.64 -51.05 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.23 164.01 25.24 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.083 2.153 . . . . 0.0 105.51 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.23 -39.94 84.32 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.546 -0.721 . . . . 0.0 110.598 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.84 -29.21 67.49 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.344 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -74.14 -42.35 60.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.029 0.831 . . . . 0.0 109.507 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.97 -50.46 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.181 0.592 . . . . 0.0 109.773 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -63.15 -39.47 94.75 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.105 0.411 . . . . 0.0 111.036 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.88 74.79 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.38 -0.825 . . . . 0.0 110.661 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.89 -41.43 91.52 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.07 -1.019 . . . . 0.0 110.324 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -57.08 -41.78 79.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -63.82 -49.77 71.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 111.385 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.68 -51.54 68.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.433 0.561 . . . . 0.0 109.928 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.61 -37.9 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.459 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -53.06 -57.54 10.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.546 1.521 . . . . 0.0 110.638 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.34 -42.02 94.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.171 0.919 . . . . 0.0 109.821 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.75 -26.16 37.5 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.578 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.405 HG22 ' CD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -66.96 -46.22 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.445 1.475 . . . . 0.0 107.043 169.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.71 96.66 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -58.12 -41.88 84.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.937 1.295 . . . . 0.0 111.37 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -49.1 77.83 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.43 -31.13 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.017 0.527 . . . . 0.0 110.56 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -52.4 65.33 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.182 0.993 . . . . 0.0 110.229 169.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.56 -47.29 84.49 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.394 0.997 . . . . 0.0 109.021 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.74 -37.95 66.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.968 0.507 . . . . 0.0 111.187 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.75 -47.15 32.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 122.963 0.505 . . . . 0.0 111.33 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.01 -41.51 74.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.923 0.889 . . . . 0.0 111.205 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.0 p -85.31 -17.64 36.27 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.954 0.902 . . . . 0.0 110.075 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.56 40.96 93.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 124.895 1.236 . . . . 0.0 110.539 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.049 -0.976 . . . . 0.0 111.524 -172.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -63.95 151.52 42.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.646 0.778 . . . . 0.0 111.585 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -145.97 -39.43 0.23 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.924 1.289 . . . . 0.0 110.446 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -123.48 165.45 17.08 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.472 1.509 . . . . 0.0 109.439 -174.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.35 138.17 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tt -127.67 136.54 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -129.85 105.86 8.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.92 141.51 42.28 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.864 0.866 . . . . 0.0 110.359 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.41 136.86 41.73 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.553 1.141 . . . . 0.0 108.499 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -156.16 171.65 19.8 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.02 0.827 . . . . 0.0 110.885 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.0 p -66.94 -11.67 57.22 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.861 -1.149 . . . . 0.0 113.177 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.96 121.92 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -58.17 -44.23 87.87 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 110.597 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -37.57 -29.15 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 C-N-CA 130.655 3.582 . . . . 0.0 117.514 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 m -125.59 -74.69 0.6 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.634 0.774 . . . . 0.0 109.859 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -60.46 -47.9 84.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.924 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -65.95 -46.53 77.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.712 0.687 . . . . 0.0 110.165 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -57.38 -42.68 82.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.953 0.501 . . . . 0.0 112.107 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.0 mtp -65.99 -48.48 71.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.623 0.769 . . . . 0.0 109.623 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.48 79.08 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.341 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.47 -45.13 89.24 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.91 0.884 . . . . 0.0 110.396 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.64 93.46 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.595 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -68.95 -43.65 74.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.312 1.556 . . . . 0.0 111.217 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.49 75.28 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.06 0.391 . . . . 0.0 110.863 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.21 -35.17 69.32 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -68.91 -57.33 5.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.497 0.59 . . . . 0.0 109.984 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.04 -35.93 79.07 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.78 -37.07 10.92 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.41 175.01 49.81 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 122.006 0.781 . . . . 0.0 113.048 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.29 -15.56 63.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.024 1.33 . . . . 0.0 114.181 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.92 -16.36 17.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.934 -0.479 . . . . 0.0 112.251 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -112.71 165.4 12.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.21 1.004 . . . . 0.0 109.068 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.1 145.34 46.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.14 119.7 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.95 169.34 17.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.485 0.659 . . . . 0.0 110.254 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -135.34 140.02 44.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.085 1.354 . . . . 0.0 109.418 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.06 -175.08 4.28 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.793 1.237 . . . . 0.0 108.801 169.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.75 176.03 42.52 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.83 -41.8 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.33 179.79 7.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 109.737 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.05 152.98 40.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.011 2.124 . . . . 0.0 106.393 171.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -129.47 -14.14 4.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.889 0.875 . . . . 0.0 111.619 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.77 -175.92 34.96 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -85.39 106.05 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -62.76 125.8 87.18 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.905 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 -34.37 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.152 2.568 . . . . 0.0 113.659 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -38.46 88.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.859 0.754 . . . . 0.0 110.768 176.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.79 73.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.85 -52.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -65.76 -42.43 90.9 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 118.951 0.796 . . . . 0.0 110.781 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.52 81.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.898 0.772 . . . . 0.0 110.993 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.8 mmm -75.86 -38.82 57.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.403 0.281 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -65.06 -33.97 77.3 Favored 'General case' 0 N--CA 1.461 0.105 0 O-C-N 121.061 -1.025 . . . . 0.0 111.036 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -65.02 -21.16 66.8 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.001 0.92 . . . . 0.0 112.158 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.71 -7.76 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.565 1.146 . . . . 0.0 110.294 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.76 21.16 34.68 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.931 -1.106 . . . . 0.0 111.987 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.21 91.83 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -78.12 85.95 4.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.198 0.523 . . . . 0.0 110.169 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -77.67 2.25 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.27 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -59.75 -23.13 62.97 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.107 1.776 . . . . 0.0 112.08 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -71.44 -18.39 62.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 112.907 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -72.52 173.28 9.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.102 0.961 . . . . 0.0 109.96 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -149.17 163.12 38.52 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.529 1.531 . . . . 0.0 108.606 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.4 m -107.08 155.4 19.88 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.179 0.992 . . . . 0.0 110.279 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -154.56 162.23 41.24 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.716 2.406 . . . . 0.0 108.411 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 pt -92.64 164.02 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.58 133.61 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 112.04 -169.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -122.42 102.56 8.17 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.011 1.724 . . . . 0.0 106.952 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -15.08 40.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.595 0.758 . . . . 0.0 112.194 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.2 -42.74 88.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.515 1.052 . . . . 0.0 111.249 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.92 -43.05 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tt -53.05 -47.15 68.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.976 0.51 . . . . 0.0 110.576 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -67.92 -18.77 64.87 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -96.53 -16.78 20.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.435 1.016 . . . . 0.0 111.484 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.61 153.91 40.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.406 0.548 . . . . 0.0 110.879 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.94 -38.2 66.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.09 166.48 30.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.243 1.02 . . . . 0.0 112.125 170.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.06 143.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.0 131.06 64.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -84.89 142.67 29.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -107.51 -1.75 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.31 0.644 . . . . 0.0 110.595 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.55 156.5 41.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.9 -38.19 88.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.3 -30.12 69.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.824 0.812 . . . . 0.0 111.933 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.66 78.35 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.146 0.43 . . . . 0.0 111.445 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.51 66.94 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.98 -39.3 93.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 111.783 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -81.96 -40.02 22.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 117.798 -1.096 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.8 m -47.6 108.11 0.84 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.565 1.146 . . . . 0.0 109.27 -173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.1 165.96 22.46 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.451 2.101 . . . . 0.0 113.289 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.9 111.45 2.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.37 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -72.89 122.46 87.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.864 1.266 . . . . 0.0 108.046 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.16 168.66 22.67 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.188 1.926 . . . . 0.0 110.356 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.03 -22.93 15.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.091 3.194 . . . . 0.0 116.017 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -68.08 -6.35 22.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.3 154.58 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.226 2.211 . . . . 0.0 106.62 -169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 173.69 9.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.355 -0.841 . . . . 0.0 110.734 169.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -127.89 155.04 44.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.256 1.422 . . . . 0.0 109.373 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.99 160.22 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 169.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -145.82 113.64 6.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -111.94 176.95 4.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.928 1.291 . . . . 0.0 109.314 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.59 94.69 0.21 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.999 -0.89 . . . . 0.0 112.439 -169.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.5 126.74 33.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.655 0.727 . . . . 0.0 111.481 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -74.34 153.23 39.4 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 169.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.93 120.83 83.28 Favored Pre-proline 0 C--O 1.236 0.395 0 O-C-N 121.915 -0.491 . . . . 0.0 111.131 -170.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.43 -32.22 20.38 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.631 1.554 . . . . 0.0 113.063 -169.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.53 -20.79 65.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -118.01 14.69 14.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 111.345 -177.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.98 144.46 45.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -142.66 156.66 45.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.527 0.731 . . . . 0.0 109.272 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.94 -56.52 0.38 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.1 p -146.09 170.14 17.29 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 127.012 2.125 . . . . 0.0 105.499 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.71 -42.38 86.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.659 -0.65 . . . . 0.0 110.994 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.47 -28.84 64.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.126 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.19 -44.35 72.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.111 0.868 . . . . 0.0 109.462 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -55.82 -52.23 64.71 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 109.94 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -59.6 -45.02 93.15 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.953 0.342 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.85 77.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.14 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.46 -37.21 80.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.675 1.125 . . . . 0.0 111.32 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -57.48 -47.94 80.55 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -60.67 -45.48 93.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.176 0.59 . . . . 0.0 111.986 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -60.12 -50.95 71.66 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.702 0.683 . . . . 0.0 109.754 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.09 -42.73 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.626 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -61.7 -43.44 98.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.638 2.017 . . . . 0.0 110.879 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.99 -44.9 95.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.93 -33.74 62.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.184 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.11 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.805 1.639 . . . . 0.0 108.36 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.8 -42.94 99.69 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.493 ' ND2' HH22 ' A' ' 130' ' ' ARG . 56.1 t30 -61.16 -43.13 99.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.258 1.023 . . . . 0.0 111.874 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.493 HH22 ' ND2' ' A' ' 129' ' ' ASN . 13.3 mmp_? -61.83 -41.55 97.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.689 -0.632 . . . . 0.0 110.214 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.0 mt -72.98 -34.74 66.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.672 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -48.56 79.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.179 0.992 . . . . 0.0 109.961 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.15 -50.62 72.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 118.936 0.789 . . . . 0.0 109.7 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.24 -38.9 71.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.493 1.042 . . . . 0.0 111.166 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.39 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.161 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.0 -38.92 31.08 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 110.934 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.5 p -89.61 -24.61 21.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.431 1.092 . . . . 0.0 110.188 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.9 97.86 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.963 -170.51 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -160.34 163.25 33.42 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.149 1.38 . . . . 0.0 108.762 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -164.35 -37.27 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.215 1.006 . . . . 0.0 111.438 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.8 mtmt -132.51 171.58 13.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.963 1.705 . . . . 0.0 107.631 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.63 141.71 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -127.58 140.48 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -131.35 100.16 5.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.39 148.95 46.45 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.17 139.46 41.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.759 1.624 . . . . 0.0 107.422 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.22 171.78 18.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.079 0.552 . . . . 0.0 110.338 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -74.7 -5.83 45.39 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.14 95.43 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.0 t-20 -60.16 99.39 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.873 1.269 . . . . 0.0 110.095 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.6 p -160.21 -42.9 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.422 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 p -132.47 -71.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.993 0.917 . . . . 0.0 110.434 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -52.32 -50.59 61.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.349 0.977 . . . . 0.0 111.782 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.9 -42.31 97.48 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.175 0.59 . . . . 0.0 111.221 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -67.99 -39.9 83.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.841 0.857 . . . . 0.0 111.286 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 81.6 mtp -65.09 -48.6 73.11 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.394 1.078 . . . . 0.0 108.695 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.53 81.97 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.911 0.323 . . . . 0.0 110.475 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -56.85 -44.84 82.53 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.99 -47.44 88.74 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.96 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CD1' ' HE2' ' A' ' 52' ' ' MET . 94.1 m95 -66.74 -38.01 85.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.956 1.878 . . . . 0.0 110.525 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.09 82.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.291 0.496 . . . . 0.0 110.723 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.28 -26.36 66.43 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.033 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -74.95 -56.85 4.32 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.116 0.871 . . . . 0.0 110.272 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -71.37 -29.57 65.11 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -92.08 -145.08 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.285 1.434 . . . . 0.0 107.905 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.28 -164.77 38.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.33 -19.77 37.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.785 1.634 . . . . 0.0 113.419 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.97 -12.15 4.24 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.17 1.388 . . . . 0.0 111.825 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.403 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 17.3 m95 -142.77 171.54 13.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.923 1.689 . . . . 0.0 110.819 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -129.76 140.92 50.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.645 2.378 . . . . 0.0 104.785 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.71 124.97 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 170.92 15.16 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.7 p -142.61 143.26 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.523 0.729 . . . . 0.0 109.642 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -171.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.702 1.601 . . . . 0.0 109.029 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.52 173.8 40.49 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 121.681 -0.637 . . . . 0.0 111.768 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.88 -41.02 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.103 1.361 . . . . 0.0 108.225 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.77 -176.57 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.324 1.85 . . . . 0.0 106.846 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.9 165.36 25.18 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.189 1.396 . . . . 0.0 109.172 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -129.18 -36.56 1.73 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.351 0.66 . . . . 0.0 110.322 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.65 169.2 12.97 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -58.68 109.91 0.9 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -69.43 125.8 92.21 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.97 -32.78 59.26 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.555 2.17 . . . . 0.0 113.316 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -42.39 98.69 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.84 0.746 . . . . 0.0 110.458 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -39.36 71.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.94 -54.03 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -65.3 -43.29 91.56 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.51 1.05 . . . . 0.0 110.126 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.93 -45.03 67.47 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.43 0.692 . . . . 0.0 111.597 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.407 ' HE2' ' CD1' ' A' ' 23' ' ' TRP . 98.6 mmm -80.0 -38.6 31.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.543 0.737 . . . . 0.0 111.354 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.71 -31.01 71.76 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.088 -1.008 . . . . 0.0 110.821 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.89 -20.57 65.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.086 0.954 . . . . 0.0 112.109 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.15 -26.74 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.596 1.089 . . . . 0.0 109.337 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.7 15.86 12.71 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.279 1.419 . . . . 0.0 111.677 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.99 95.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -77.83 88.75 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.31 -0.92 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.247 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -27.38 66.46 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.503 1.501 . . . . 0.0 111.325 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.34 -20.4 63.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.686 1.595 . . . . 0.0 113.007 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -70.58 175.13 5.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.932 0.893 . . . . 0.0 109.853 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -141.06 148.92 40.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.088 1.355 . . . . 0.0 108.751 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -89.07 154.66 20.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 109.689 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.1 t0 -152.65 160.07 43.18 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.545 1.938 . . . . 0.0 107.317 169.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.42 161.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 132.93 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.855 0.862 . . . . 0.0 110.972 -171.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -116.97 109.78 17.45 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.813 1.645 . . . . 0.0 107.121 174.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -59.26 -20.59 55.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.206 1.002 . . . . 0.0 112.398 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.84 -45.94 69.81 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.433 1.015 . . . . 0.0 111.059 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.71 -41.1 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.91 -49.86 58.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.068 0.547 . . . . 0.0 109.868 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -68.64 -14.65 63.15 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -96.14 -20.39 18.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.502 1.046 . . . . 0.0 110.884 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.33 140.42 55.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 118.198 0.454 . . . . 0.0 110.139 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.32 -33.95 76.33 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.632 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 35.6 tp -145.32 142.32 29.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.963 1.305 . . . . 0.0 108.925 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.15 139.8 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.61 110.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -94.06 101.52 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.15 -6.45 23.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.66 159.83 42.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.24 1.382 . . . . 0.0 109.187 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.81 99.7 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.327 -169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.49 -33.53 74.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.017 0.908 . . . . 0.0 111.177 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.49 -21.12 66.6 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.308 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.53 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.849 0.75 . . . . 0.0 112.792 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.23 -30.6 66.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.309 0.504 . . . . 0.0 111.903 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.97 62.49 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 91.7 m -125.5 79.18 67.49 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -50.69 -37.3 53.52 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.588 2.858 . . . . 0.0 114.969 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 36.6 tpp -159.72 128.39 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.2 p -140.56 85.92 12.71 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.62 171.18 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.238 3.292 . . . . 0.0 112.976 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.59 -28.64 29.62 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.577 2.852 . . . . 0.0 114.84 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -70.52 -3.8 19.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.684 1.194 . . . . 0.0 113.143 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.47 79.41 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 105.531 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -68.1 163.04 23.36 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -130.34 153.88 48.24 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.08 -0.388 . . . . 0.0 110.312 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.46 157.29 46.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -143.36 140.08 30.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.665 0.786 . . . . 0.0 109.573 -169.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -137.32 -168.54 2.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.447 1.099 . . . . 0.0 108.959 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.71 39.37 1.41 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.054 -169.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -76.62 111.11 11.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.213 1.006 . . . . 0.0 110.698 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.79 153.63 39.39 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.906 0.882 . . . . 0.0 108.988 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.71 118.97 74.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 119.192 -0.432 . . . . 0.0 112.061 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.29 -31.21 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.227 1.951 . . . . 0.0 112.584 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.6 -21.3 66.13 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.017 0.826 . . . . 0.0 111.959 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -99.38 7.45 45.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.672 1.189 . . . . 0.0 111.56 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.75 15.89 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.761 1.225 . . . . 0.0 114.303 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -51.93 153.73 2.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.18 1.392 . . . . 0.0 112.627 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 -51.94 0.22 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -154.37 153.09 31.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 168.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.36 -38.12 85.81 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 121.403 -0.811 . . . . 0.0 110.781 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.07 -31.45 72.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.23 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.76 -47.66 52.15 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -54.83 -52.54 62.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 110.143 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -63.51 -42.34 98.49 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.55 0.74 . . . . 0.0 111.036 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -35.96 71.23 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.076 0.853 . . . . 0.0 110.607 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.11 -39.15 82.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.22 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.1 -46.46 79.09 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -59.91 -49.89 75.92 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.586 0.754 . . . . 0.0 111.235 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -60.17 -49.51 77.35 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.49 -45.45 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 116.691 -1.623 . . . . 0.0 110.027 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -61.05 -43.84 98.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 122.134 2.243 . . . . 0.0 110.645 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.63 -45.98 91.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.39 -33.65 63.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.21 -44.45 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.544 1.52 . . . . 0.0 108.095 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.02 -44.48 96.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.77 -40.54 96.92 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.393 1.077 . . . . 0.0 112.506 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -56.7 -48.15 78.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.524 0.73 . . . . 0.0 109.305 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.15 -40.61 64.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.98 0.512 . . . . 0.0 109.823 -171.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -56.38 -46.24 80.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.083 0.953 . . . . 0.0 110.943 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.7 -56.04 23.92 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.486 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.31 -28.23 69.57 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.675 1.579 . . . . 0.0 111.372 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.17 63.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.672 0.669 . . . . 0.0 111.633 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -85.78 -31.87 22.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -95.49 -15.24 23.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.742 0.817 . . . . 0.0 111.544 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.26 29.73 74.67 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.405 1.482 . . . . 0.0 110.638 -178.08 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.76 146.95 44.26 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -159.5 -42.35 0.05 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.401 0.546 . . . . 0.0 112.167 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.4 mtmt -135.75 169.99 16.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.397 1.479 . . . . 0.0 108.608 170.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.99 130.61 48.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.37 132.08 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.6 107.1 9.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.452 0.701 . . . . 0.0 109.32 -169.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -77.16 142.21 39.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.23 135.01 35.15 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.229 1.812 . . . . 0.0 107.14 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.88 168.57 26.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.478 0.581 . . . . 0.0 110.436 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -68.03 -11.4 58.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.037 -1.039 . . . . 0.0 113.29 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 115.09 0.64 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 105.928 -2.869 . . . . 0.0 105.928 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.21 -40.48 90.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 0.0 111.831 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -38.13 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.534 3.134 . . . . 0.0 117.451 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.25 -62.64 0.79 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.341 0.973 . . . . 0.0 111.983 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -54.69 -51.7 64.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.234 0.925 . . . . 0.0 112.269 -169.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -63.24 -48.05 79.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.499 0.59 . . . . 0.0 110.475 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -60.06 -39.63 86.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.593 0.757 . . . . 0.0 112.033 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.81 -48.43 68.96 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.962 0.905 . . . . 0.0 109.562 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.15 81.55 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.134 0.425 . . . . 0.0 111.176 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.38 -48.41 80.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.0 0.92 . . . . 0.0 110.437 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.11 94.24 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.73 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.432 ' CD1' ' HE3' ' A' ' 52' ' ' MET . 94.3 m95 -67.92 -40.87 83.33 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.879 1.839 . . . . 0.0 110.551 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.91 79.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.524 0.602 . . . . 0.0 111.549 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.8 -32.75 67.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.725 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.6 -58.24 4.18 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.546 0.612 . . . . 0.0 110.096 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -71.41 -33.84 69.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 32.8 mt -95.82 -37.12 10.88 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.261 0.624 . . . . 0.0 112.679 -169.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.26 -176.34 44.61 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.001 0.81 . . . . 0.0 112.789 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 -8.96 34.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.004 1.322 . . . . 0.0 113.672 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.28 -11.26 2.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.368 1.867 . . . . 0.0 111.18 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.7 m95 -139.82 150.27 44.48 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.792 1.237 . . . . 0.0 109.642 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 5.3 mmpt? -98.43 139.42 34.21 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 167.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.83 117.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -168.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.47 170.31 16.26 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.378 0.609 . . . . 0.0 110.187 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.8 m -135.81 144.94 45.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.24 1.416 . . . . 0.0 109.441 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.91 -173.61 4.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.01 175.62 44.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.56 -40.17 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.43 175.58 10.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.287 0.635 . . . . 0.0 110.876 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.37 156.86 44.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.244 2.618 . . . . 0.0 106.628 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -135.74 -35.67 0.79 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.027 0.931 . . . . 0.0 110.246 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.2 179.04 46.45 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.45 102.14 6.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -60.4 124.7 79.47 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.964 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.95 -34.27 45.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.266 2.644 . . . . 0.0 113.711 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -39.29 91.84 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.844 0.747 . . . . 0.0 110.734 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.49 73.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.54 -54.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.13 -42.91 83.64 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.956 0.798 . . . . 0.0 110.744 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.32 -44.09 79.62 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.529 0.604 . . . . 0.0 110.799 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.432 ' HE3' ' CD1' ' A' ' 23' ' ' TRP . 98.3 mmm -76.57 -39.83 51.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.551 0.74 . . . . 0.0 111.372 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -34.18 76.77 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -67.91 -20.17 65.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.004 0.922 . . . . 0.0 112.612 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -78.07 -24.34 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.479 1.036 . . . . 0.0 109.586 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.49 19.21 11.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.108 1.337 . . . . 0.0 111.08 -169.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -117.17 92.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.23 87.58 3.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.77 4.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 117.738 -1.125 . . . . 0.0 111.92 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.6 m -58.02 -25.88 61.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.01 1.732 . . . . 0.0 112.057 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.19 -21.51 62.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 112.68 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.3 169.31 15.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.667 0.787 . . . . 0.0 109.412 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -145.92 156.14 43.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.489 1.116 . . . . 0.0 109.326 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.1 m -95.32 148.53 22.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.251 1.02 . . . . 0.0 111.123 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -156.8 159.75 38.55 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.45 1.5 . . . . 0.0 108.528 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.6 164.39 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.52 117.83 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.598 0.713 . . . . 0.0 112.395 -169.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.27 121.97 36.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -73.04 -23.8 60.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.71 0.804 . . . . 0.0 112.826 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.09 -41.21 62.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.608 0.64 . . . . 0.0 110.105 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.76 -44.63 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -48.98 71.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.332 0.515 . . . . 0.0 110.037 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -69.76 -5.48 25.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -107.02 -20.62 13.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.868 1.213 . . . . 0.0 111.946 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.9 148.22 51.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.389 0.541 . . . . 0.0 111.244 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 39.0 tp -147.0 143.37 28.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 110.072 -169.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.06 138.4 49.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.62 108.4 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.8 p -88.9 90.6 8.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.1 -9.78 34.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.952 0.901 . . . . 0.0 112.812 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.04 156.09 44.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.06 -41.87 94.89 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -170.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -31.74 72.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.608 0.704 . . . . 0.0 111.737 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.68 -27.99 69.62 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.437 0.562 . . . . 0.0 111.902 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 -14.55 62.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.57 -30.43 69.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.009 0.822 . . . . 0.0 112.108 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.27 -35.97 58.65 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 118.052 -0.975 . . . . 0.0 113.288 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.6 m -40.38 105.1 0.36 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.898 1.679 . . . . 0.0 113.48 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.58 71.6 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.056 3.171 . . . . 0.0 111.255 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.8 mtt 79.58 110.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 129.283 3.033 . . . . 0.0 111.673 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.2 p -117.67 81.2 14.51 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.94 173.16 7.41 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.479 2.786 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.4 -28.55 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.829 3.019 . . . . 0.0 116.445 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.39 -8.3 45.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.133 0.973 . . . . 0.0 113.034 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.7 t -134.91 82.95 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 128.47 2.708 . . . . 0.0 105.125 -169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.3 pttt -66.12 167.68 9.64 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -141.14 150.04 42.29 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.507 -0.745 . . . . 0.0 109.412 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -136.4 162.33 33.36 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -144.68 147.21 32.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.2 1.0 . . . . 0.0 112.006 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -142.72 -168.52 2.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 108.301 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.16 42.51 1.13 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.227 0.921 . . . . 0.0 113.848 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -78.57 115.92 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.555 1.177 . . . . 0.0 111.925 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -66.11 150.6 48.48 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.743 1.217 . . . . 0.0 109.525 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.19 116.65 51.02 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.31 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.45 -33.96 27.85 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.966 1.778 . . . . 0.0 112.661 -171.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.27 -16.68 64.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.439 0.563 . . . . 0.0 112.288 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -105.4 8.62 33.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.11 -38.8 71.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.243 0.929 . . . . 0.0 112.613 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 53.42 -170.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.887 2.075 . . . . 0.0 113.434 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.96 -65.71 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.205 1.86 . . . . 0.0 108.942 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -162.32 161.45 27.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.929 2.092 . . . . 0.0 105.579 170.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.03 -40.18 73.07 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.118 0.872 . . . . 0.0 111.243 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.17 -28.41 66.39 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.487 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.84 -39.45 66.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.863 0.756 . . . . 0.0 109.598 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -60.23 -53.16 60.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -57.83 -41.14 81.68 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.329 0.393 . . . . 0.0 110.58 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.66 77.53 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.074 -0.391 . . . . 0.0 110.878 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -74.42 -35.83 63.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.33 0.652 . . . . 0.0 111.512 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -56.18 -43.58 78.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.339 0.972 . . . . 0.0 108.689 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.47 -48.77 78.31 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.071 0.548 . . . . 0.0 111.386 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.02 -49.4 77.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.156 0.434 . . . . 0.0 110.069 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.11 -46.19 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.976 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -60.95 -43.31 98.9 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 121.776 2.08 . . . . 0.0 110.699 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.44 -45.37 94.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.31 -30.87 62.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.005 -0.997 . . . . 0.0 112.765 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -41.27 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.837 1.199 . . . . 0.0 108.712 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.73 -47.01 90.48 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -59.63 -37.05 77.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.595 1.158 . . . . 0.0 111.411 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -52.77 64.28 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.713 0.805 . . . . 0.0 109.735 173.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.73 -34.5 76.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.918 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -60.08 -49.84 76.05 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.748 0.819 . . . . 0.0 111.065 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.31 -51.37 69.83 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 119.364 0.983 . . . . 0.0 108.867 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -55.89 -39.53 71.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.283 0.633 . . . . 0.0 111.063 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.65 55.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 111.848 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.24 -39.8 65.18 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.389 -173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.6 p -92.41 -21.8 20.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.105 0.962 . . . . 0.0 110.825 -171.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.75 42.88 99.81 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 126.735 2.014 . . . . 0.0 111.16 -174.314 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.1 139.77 40.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.621 0.769 . . . . 0.0 110.129 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -157.4 -36.6 0.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -124.67 169.26 12.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.406 1.882 . . . . 0.0 108.129 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -141.95 139.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.03 137.53 55.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -132.95 105.91 7.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.015 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -80.0 149.28 30.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.913 0.485 . . . . 0.0 110.592 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.05 129.71 15.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.946 1.299 . . . . 0.0 107.543 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.94 172.63 15.38 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.983 0.913 . . . . 0.0 109.993 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -66.34 -8.91 28.38 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.649 -1.282 . . . . 0.0 113.449 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.77 125.17 1.41 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.086 -2.805 . . . . 0.0 106.086 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.2 t-20 -61.16 -46.77 89.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.099 0.56 . . . . 0.0 110.384 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -42.85 -22.37 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 130.178 3.391 . . . . 0.0 117.412 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -119.69 -84.2 0.66 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.476 1.11 . . . . 0.0 109.683 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -60.14 -46.75 88.58 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.384 1.074 . . . . 0.0 111.669 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 -40.76 76.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.098 0.863 . . . . 0.0 110.796 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -60.94 -43.84 98.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.676 0.671 . . . . 0.0 111.431 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 85.3 mtp -65.77 -48.58 71.36 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.389 0.676 . . . . 0.0 109.487 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.31 -42.13 81.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.086 0.554 . . . . 0.0 111.309 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.61 -48.55 79.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 110.044 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.61 97.99 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.616 -1.102 . . . . 0.0 112.584 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' CD1' ' HE3' ' A' ' 52' ' ' MET . 95.7 m95 -68.66 -40.84 80.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.722 1.761 . . . . 0.0 110.937 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.99 81.51 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.526 0.603 . . . . 0.0 111.417 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -57.53 -33.66 68.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.812 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.35 -58.59 3.81 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.408 0.549 . . . . 0.0 110.101 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -70.11 -37.7 75.42 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -90.31 -36.65 14.56 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -169.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 179.09 50.84 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 121.999 0.777 . . . . 0.0 112.829 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.28 -16.4 63.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.738 1.615 . . . . 0.0 113.998 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.24 -24.64 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.311 1.044 . . . . 0.0 110.875 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -120.93 140.53 51.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.243 0.617 . . . . 0.0 110.226 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -89.75 144.06 26.28 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.95 124.1 52.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 170.72 15.62 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 p -140.14 142.75 35.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.43 -174.9 4.01 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.338 1.455 . . . . 0.0 108.768 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.57 174.67 41.34 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.3 -42.02 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 170.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.65 178.36 8.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.839 0.856 . . . . 0.0 109.892 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.69 122.59 11.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.568 1.547 . . . . 0.0 107.042 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.67 -32.35 47.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.983 0.513 . . . . 0.0 109.95 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.94 -158.25 28.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -94.4 111.98 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -67.27 125.37 90.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.258 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.37 -34.38 50.08 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.163 2.575 . . . . 0.0 113.624 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -37.54 85.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.698 0.681 . . . . 0.0 110.915 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.66 75.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.17 -53.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -67.63 -41.68 83.52 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.32 -45.17 84.52 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.007 0.821 . . . . 0.0 110.784 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.425 ' HE3' ' CD1' ' A' ' 23' ' ' TRP . 98.8 mmm -73.53 -39.83 64.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.889 0.476 . . . . 0.0 110.92 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -64.5 -32.11 73.61 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.288 -0.883 . . . . 0.0 111.617 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.92 -19.59 65.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.77 0.828 . . . . 0.0 112.145 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.67 -9.39 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.469 1.108 . . . . 0.0 110.174 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 16.28 53.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.691 1.139 . . . . 0.0 111.927 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.1 mt -107.96 92.22 2.01 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -76.54 85.21 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.032 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 pt -78.13 3.47 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.269 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.6 p -61.07 -23.2 65.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 121.267 1.848 . . . . 0.0 112.202 -175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -70.67 -21.29 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.064 1.345 . . . . 0.0 112.7 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -70.05 170.18 11.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 109.57 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -145.71 161.47 39.83 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.26 1.424 . . . . 0.0 107.98 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -104.16 155.74 18.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.739 0.816 . . . . 0.0 110.116 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.538 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -150.83 161.31 42.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.12 2.168 . . . . 0.0 108.125 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 pt -92.44 164.56 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 135.43 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.591 0.756 . . . . 0.0 112.426 -169.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -127.07 110.07 12.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 108.212 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -61.08 -19.67 61.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.926 -0.483 . . . . 0.0 111.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.34 -2.66 14.26 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 113.638 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -115.97 -45.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.43 -51.64 14.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.488 1.115 . . . . 0.0 111.525 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -66.7 -5.97 13.89 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -134.36 5.47 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 112.664 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.1 155.08 40.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.939 0.791 . . . . 0.0 109.936 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.61 -33.86 73.27 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.975 -1.078 . . . . 0.0 108.389 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -147.55 143.8 28.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 109.509 -170.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.01 133.7 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.88 119.02 56.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -172.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 p -96.57 92.77 6.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -68.14 -12.6 61.19 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.538 -0.726 . . . . 0.0 112.805 -169.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.57 156.63 45.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.74 1.155 . . . . 0.0 108.174 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.81 -41.33 83.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -169.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.96 -35.88 82.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.76 0.78 . . . . 0.0 111.318 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.44 -28.84 70.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.59 -22.56 65.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.37 -32.64 74.16 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.529 0.732 . . . . 0.0 112.227 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -99.29 -22.74 15.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.8 t -55.32 106.42 0.67 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.72 174.88 3.32 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.472 2.781 . . . . 0.0 113.169 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -58.88 143.23 48.34 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.572 -0.705 . . . . 0.0 110.544 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -133.0 119.13 15.59 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.541 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 169.23 20.61 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.38 -25.79 19.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.957 3.105 . . . . 0.0 115.969 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -65.91 -9.02 25.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.956 . . . . 0.0 112.839 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 t -133.68 89.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 127.539 2.336 . . . . 0.0 105.5 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -69.11 164.3 22.82 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.299 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -126.25 148.77 49.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.577 1.151 . . . . 0.0 108.679 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -143.94 160.18 41.27 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 145.14 30.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.377 1.071 . . . . 0.0 111.717 -169.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -143.8 -170.16 3.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.405 1.882 . . . . 0.0 108.436 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.92 41.19 1.24 Allowed Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.484 -0.76 . . . . 0.0 113.241 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -76.21 114.96 15.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.354 1.077 . . . . 0.0 110.953 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -67.65 151.52 47.15 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.406 1.082 . . . . 0.0 109.926 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.32 126.72 92.55 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.48 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.88 -30.83 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.462 2.108 . . . . 0.0 114.049 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.49 -24.55 67.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.937 0.895 . . . . 0.0 112.933 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 25.43 10.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 112.557 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.75 -36.42 57.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 56.45 -168.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.373 1.869 . . . . 0.0 112.843 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.54 -61.14 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.428 1.966 . . . . 0.0 108.338 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 t -166.43 167.72 15.47 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 105.313 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.88 -40.35 84.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.386 -0.822 . . . . 0.0 110.626 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -29.94 66.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.429 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.62 -42.73 61.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.751 0.705 . . . . 0.0 109.287 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -58.29 -49.31 77.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.883 0.873 . . . . 0.0 109.814 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -61.78 -44.18 97.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.769 0.259 . . . . 0.0 110.503 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.97 75.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.457 0.571 . . . . 0.0 110.401 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.52 -39.02 93.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.187 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -55.95 -48.31 75.99 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.563 1.074 . . . . 0.0 108.859 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -60.56 -44.23 96.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.575 0.35 . . . . 0.0 111.113 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.95 -48.99 77.91 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.066 0.394 . . . . 0.0 110.519 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.13 -45.28 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 117.208 -1.377 . . . . 0.0 109.91 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -60.39 -42.38 95.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 121.395 1.907 . . . . 0.0 110.709 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.08 -45.0 95.46 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.84 -31.64 63.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.98 -41.01 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 119.847 1.203 . . . . 0.0 108.867 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.47 88.22 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.79 -35.82 75.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.12 1.368 . . . . 0.0 111.513 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -53.97 52.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.842 0.857 . . . . 0.0 109.595 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.02 -34.68 78.26 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.851 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -50.52 73.55 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.133 0.973 . . . . 0.0 111.116 173.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -61.01 -51.66 68.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 122.832 0.453 . . . . 0.0 111.163 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.78 58.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.072 0.949 . . . . 0.0 111.789 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.32 -38.13 60.39 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.865 0.866 . . . . 0.0 111.243 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.9 p -94.83 -20.85 19.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.357 1.063 . . . . 0.0 111.189 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.61 36.98 93.81 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -172.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.693 1.597 . . . . 0.0 111.353 -173.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.6 mtmt -134.31 167.62 20.38 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.663 1.585 . . . . 0.0 107.744 169.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -136.38 132.9 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -124.84 127.94 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -125.61 104.15 8.24 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -169.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.79 147.49 45.46 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 122.026 -0.421 . . . . 0.0 109.926 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -147.5 126.36 12.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -146.88 175.57 10.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.515 0.598 . . . . 0.0 109.814 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -67.67 -11.76 58.97 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.72 -1.238 . . . . 0.0 112.972 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.16 121.1 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 49.7 t-20 -57.63 -45.16 85.78 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.637 0.775 . . . . 0.0 109.991 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m -40.07 -34.65 0.31 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 129.746 3.218 . . . . 0.0 115.175 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.1 m -112.81 -72.47 0.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.32 0.648 . . . . 0.0 111.165 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -48.28 61.58 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.348 -169.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -63.04 -45.62 91.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.288 0.494 . . . . 0.0 109.779 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -56.55 -44.7 81.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.847 -0.596 . . . . 0.0 112.368 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.2 mtm -69.83 -45.58 67.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.615 0.643 . . . . 0.0 110.333 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.72 73.79 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.93 0.786 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -61.17 -47.3 86.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.673 1.189 . . . . 0.0 110.673 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.82 95.47 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.033 -0.87 . . . . 0.0 111.676 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 98.1 m95 -65.22 -38.59 90.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.871 1.836 . . . . 0.0 110.79 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.1 82.65 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.447 -0.783 . . . . 0.0 111.604 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.48 -26.66 68.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.13 0.877 . . . . 0.0 112.348 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.53 -46.15 13.75 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.602 0.761 . . . . 0.0 109.622 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -80.9 -26.33 36.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 mt -99.08 -140.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 107.387 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -174.6 45.73 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.86 -13.91 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 113.349 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.52 -13.53 2.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.14 2.176 . . . . 0.0 111.267 169.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.449 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 8.5 m95 -133.23 162.49 31.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.965 1.706 . . . . 0.0 108.813 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.41 139.19 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 167.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.03 118.68 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.7 173.57 11.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.334 0.587 . . . . 0.0 110.413 172.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -132.24 144.22 50.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 110.175 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 67' ' ' ILE . . . -137.03 179.45 6.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.055 2.142 . . . . 0.0 108.225 169.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.77 170.31 39.04 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.67 -41.64 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -142.6 179.52 6.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.521 0.729 . . . . 0.0 109.827 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.897 2.079 . . . . 0.0 107.202 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -135.57 -36.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.694 1.197 . . . . 0.0 109.238 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.89 178.57 39.44 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.98 100.79 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.93 127.85 92.23 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 117.883 -1.055 . . . . 0.0 109.257 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 -35.17 38.27 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.523 2.815 . . . . 0.0 113.946 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -59.61 -51.64 68.94 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.741 0.7 . . . . 0.0 109.886 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.35 80.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.496 0.589 . . . . 0.0 109.923 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -61.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -63.26 -40.02 96.24 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.999 0.818 . . . . 0.0 111.103 -169.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.15 83.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.583 0.753 . . . . 0.0 110.853 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -40.22 66.41 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.065 0.393 . . . . 0.0 110.715 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -68.3 -30.5 69.51 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.024 0.93 . . . . 0.0 111.287 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.47 -21.24 66.19 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.534 1.134 . . . . 0.0 111.879 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 t -89.89 -6.28 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.78 1.232 . . . . 0.0 110.193 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.57 19.97 52.83 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.764 -1.21 . . . . 0.0 112.258 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.3 mt -111.94 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.051 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -79.59 84.84 5.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.66 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.23 7.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.286 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.7 m -56.15 -25.16 45.26 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 120.667 1.576 . . . . 0.0 112.236 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.63 -20.34 59.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.696 1.198 . . . . 0.0 113.222 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.78 169.81 13.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.838 0.745 . . . . 0.0 110.511 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -145.8 155.4 42.9 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.412 1.485 . . . . 0.0 108.825 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 p -89.65 163.57 15.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.591 1.156 . . . . 0.0 110.409 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 41.2 t0 -158.15 158.78 35.28 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.818 2.047 . . . . 0.0 107.773 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.84 161.63 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -57.19 141.65 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 111.544 -170.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -130.7 112.77 13.4 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.19 -26.88 41.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.872 1.269 . . . . 0.0 111.445 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.38 -23.03 66.86 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 125.066 1.347 . . . . 0.0 112.859 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -100.43 -42.44 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.157 0.89 . . . . 0.0 108.689 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tp -48.13 -51.73 23.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.896 1.278 . . . . 0.0 111.122 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -67.23 -13.57 62.09 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -106.82 -14.69 14.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.141 0.977 . . . . 0.0 111.281 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 148.86 47.35 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.32 -31.6 71.99 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 27.1 tp -152.73 144.37 23.48 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.763 1.225 . . . . 0.0 109.981 -169.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 135.63 58.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.71 108.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -86.29 93.18 9.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.03 -13.31 62.09 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.593 0.757 . . . . 0.0 112.328 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.3 t -144.33 145.89 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.868 1.213 . . . . 0.0 107.923 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.8 -34.77 89.69 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.568 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.22 -25.84 67.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.161 0.981 . . . . 0.0 111.402 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 -26.54 60.24 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.031 0.532 . . . . 0.0 111.841 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.65 65.72 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.78 -33.69 70.61 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.863 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -85.52 60.53 6.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.119 0.968 . . . . 0.0 110.577 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 74.7 m -120.95 74.78 27.58 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.355 1.062 . . . . 0.0 108.6 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.15 -29.08 89.52 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.126 2.551 . . . . 0.0 115.146 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.9 ptp -162.73 115.91 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 110.217 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -132.83 77.56 68.38 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.5 171.76 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.995 3.13 . . . . 0.0 112.959 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.7 -17.77 10.74 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.011 3.141 . . . . 0.0 115.795 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.53 -13.2 38.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.059 0.943 . . . . 0.0 112.419 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -127.16 159.43 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 128.81 2.844 . . . . 0.0 106.828 -169.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.1 pttt -138.48 167.7 21.36 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -127.42 153.06 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.644 0.657 . . . . 0.0 109.418 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -135.18 156.43 49.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.51 135.45 30.21 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.78 0.832 . . . . 0.0 111.766 -168.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -137.98 -170.01 2.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.472 1.909 . . . . 0.0 108.735 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.93 40.27 1.37 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.305 -0.872 . . . . 0.0 113.43 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -79.1 112.01 15.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.255 1.027 . . . . 0.0 111.978 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.62 158.39 18.35 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.983 0.913 . . . . 0.0 109.567 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.12 118.91 74.73 Favored Pre-proline 0 CA--C 1.534 0.339 0 O-C-N 121.526 -0.733 . . . . 0.0 111.142 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.98 -30.23 21.6 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.818 1.678 . . . . 0.0 112.633 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.59 -18.12 65.09 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.54 1.064 . . . . 0.0 112.408 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -99.37 -1.13 39.54 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.911 1.284 . . . . 0.0 111.618 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 146.1 36.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.03 164.39 36.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.97 0.508 . . . . 0.0 110.797 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.82 -48.58 0.66 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -165.36 166.66 18.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.243 2.217 . . . . 0.0 105.595 169.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.29 -40.82 82.97 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.726 -0.609 . . . . 0.0 110.507 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -28.35 64.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.1 -45.07 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.893 0.769 . . . . 0.0 109.105 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -56.24 -50.46 71.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.648 0.779 . . . . 0.0 109.915 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -62.3 -43.95 97.63 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.119 0.418 . . . . 0.0 110.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.39 79.83 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.886 0.766 . . . . 0.0 110.26 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.2 -40.43 97.48 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.681 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -54.85 -49.46 71.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.096 0.862 . . . . 0.0 109.352 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -61.51 -44.16 97.56 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.947 0.499 . . . . 0.0 111.282 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.47 -50.34 73.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 119.167 -0.445 . . . . 0.0 110.098 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.43 -43.73 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 117.406 -1.283 . . . . 0.0 110.164 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -61.63 -42.04 98.33 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 121.144 1.793 . . . . 0.0 111.016 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.17 -42.63 99.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.342 0.519 . . . . 0.0 110.339 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.22 -38.95 71.98 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -65.53 -40.45 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.528 1.058 . . . . 0.0 109.3 177.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.62 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -52.38 -44.37 65.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.77 0.828 . . . . 0.0 111.137 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -47.52 84.96 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 109.933 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 131' ' ' LEU . 3.9 mm? -68.96 -34.91 76.1 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.167 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -49.7 76.73 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.933 0.788 . . . . 0.0 110.865 173.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.26 -52.07 66.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.18 -39.97 73.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.696 0.68 . . . . 0.0 111.388 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.8 67.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.688 0.795 . . . . 0.0 111.708 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -76.14 -43.49 42.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.049 0.94 . . . . 0.0 110.915 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.2 p -85.09 -22.33 28.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.373 1.069 . . . . 0.0 110.021 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.24 38.12 95.68 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.569 -169.948 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 119.8 -0.143 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -144.44 173.11 12.08 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.014 1.326 . . . . 0.0 108.567 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -131.14 142.81 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.7 141.37 46.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.868 1.267 . . . . 0.0 107.783 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.14 107.06 7.05 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.17 141.37 38.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.752 0.421 . . . . 0.0 110.083 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.81 133.81 34.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.394 1.478 . . . . 0.0 108.038 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.3 p -152.68 179.23 8.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 110.116 169.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.06 -3.68 17.57 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.85 104.43 0.21 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 54.3 t-20 -41.93 -48.16 4.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.793 1.637 . . . . 0.0 111.599 -170.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -41.89 -31.58 0.34 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.196 2.999 . . . . 0.0 115.118 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.91 -85.33 0.48 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.456 1.026 . . . . 0.0 111.185 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -45.01 95.81 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.68 -168.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -68.13 -39.24 82.76 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.997 1.272 . . . . 0.0 110.761 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -62.18 -46.2 89.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.92 0.782 . . . . 0.0 111.383 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.46 -47.86 74.68 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.88 -45.13 78.63 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.453 0.701 . . . . 0.0 110.627 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.03 -46.22 85.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.924 0.489 . . . . 0.0 110.32 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.77 97.6 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -67.16 -38.78 86.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.321 1.561 . . . . 0.0 110.536 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.8 85.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.097 0.408 . . . . 0.0 110.771 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -57.35 -31.49 65.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.417 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.99 -59.97 2.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.612 0.642 . . . . 0.0 110.514 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -70.57 -42.8 70.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -168.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.5 mt -82.2 -37.98 25.26 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 122.315 0.246 . . . . 0.0 110.825 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.2 174.66 49.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.024 0.821 . . . . 0.0 112.072 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.48 -15.37 63.31 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.809 1.244 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.13 -27.26 19.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 110.911 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -112.28 134.46 53.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 131.65 35.29 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 168.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -111.44 142.81 22.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -140.83 167.25 22.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.851 1.26 . . . . 0.0 108.815 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.0 p -139.47 134.07 31.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.237 1.415 . . . . 0.0 108.113 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.66 -175.2 4.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.972 1.709 . . . . 0.0 108.495 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 178.05 41.97 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.05 -42.31 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.793 1.237 . . . . 0.0 108.256 172.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.41 -179.45 6.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.87 125.4 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.72 1.608 . . . . 0.0 107.026 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.87 -35.01 38.72 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.013 0.525 . . . . 0.0 109.91 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.72 -161.41 31.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.53 108.96 18.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.21 131.83 95.16 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.637 -0.696 . . . . 0.0 110.265 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.29 -32.27 33.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.975 1.784 . . . . 0.0 112.88 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.76 -38.33 83.28 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.571 1.078 . . . . 0.0 110.497 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.19 89.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.648 1.113 . . . . 0.0 109.254 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.88 -58.71 6.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.81 -47.1 82.2 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.693 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.41 81.89 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 119.096 0.862 . . . . 0.0 110.677 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.17 -41.68 76.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.148 0.431 . . . . 0.0 110.29 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -67.78 -27.56 66.86 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.991 0.916 . . . . 0.0 111.818 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -67.47 -18.62 65.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.518 1.127 . . . . 0.0 111.708 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.54 -13.07 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.012 0.925 . . . . 0.0 109.972 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.86 6.39 54.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.299 1.428 . . . . 0.0 112.045 -173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.61 89.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.71 78.41 2.67 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.306 1.042 . . . . 0.0 110.651 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.27 6.09 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.452 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.0 p -57.4 -24.82 57.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.601 1.546 . . . . 0.0 112.271 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.21 -19.14 60.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.568 1.147 . . . . 0.0 112.885 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.32 169.43 15.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.777 0.717 . . . . 0.0 109.939 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -145.02 161.42 39.44 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.985 1.714 . . . . 0.0 107.986 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 m -111.57 155.35 23.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 109.831 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.55 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.2 t0 -154.44 160.57 41.69 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.838 2.055 . . . . 0.0 108.484 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 pt -94.26 163.08 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.39 119.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.563 0.697 . . . . 0.0 112.825 -169.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -100.51 111.57 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -15.61 63.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.697 0.799 . . . . 0.0 112.195 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.06 -40.14 75.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.588 1.085 . . . . 0.0 111.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.9 mt -63.41 -48.35 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.88 -46.27 74.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.413 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -66.46 -5.86 12.59 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.47 3.55 3.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.078 1.308 . . . . 0.0 113.603 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 147.74 52.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.839 0.745 . . . . 0.0 109.487 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.17 -34.64 71.13 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.063 0.847 . . . . 0.0 108.932 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.0 tp -145.27 142.73 29.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.31 132.01 69.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.4 t -114.23 113.17 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.9 p -92.39 92.98 8.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.88 -10.56 54.14 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.639 -169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -147.71 162.68 38.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.979 1.718 . . . . 0.0 110.741 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.11 -55.94 27.92 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.551 1.072 . . . . 0.0 112.522 -169.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.12 -31.92 70.94 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -171.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.95 80.12 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.49 -26.43 63.42 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.68 0.792 . . . . 0.0 112.92 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.67 -38.49 80.42 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.742 0.817 . . . . 0.0 111.755 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.26 -34.47 42.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.048 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.76 114.47 4.2 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 118.155 -0.926 . . . . 0.0 108.618 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.36 173.76 10.14 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.82 2.347 . . . . 0.0 111.875 -173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 65.8 ttp -53.79 125.07 17.15 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.208 1.003 . . . . 0.0 110.994 -170.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 p -107.1 105.59 56.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.63 1.572 . . . . 0.0 107.208 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -53.89 166.59 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.719 2.946 . . . . 0.0 112.961 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.69 -28.09 36.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.438 2.759 . . . . 0.0 114.788 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -68.19 -7.49 30.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.376 1.07 . . . . 0.0 112.981 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.75 85.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.752 2.421 . . . . 0.0 105.591 -169.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.1 pttt -69.7 167.09 17.78 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.169 -0.957 . . . . 0.0 108.973 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -123.8 160.35 27.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.036 0.534 . . . . 0.0 109.85 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.68 155.03 46.6 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -143.78 137.21 27.89 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.665 0.386 . . . . 0.0 111.731 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -140.53 -172.83 3.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.869 1.668 . . . . 0.0 109.311 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.55 44.39 1.05 Allowed Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.744 -0.597 . . . . 0.0 112.954 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -76.36 114.16 14.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.852 0.826 . . . . 0.0 110.487 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.58 162.46 20.88 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.275 0.63 . . . . 0.0 109.739 169.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.412 ' CG ' ' HE ' ' A' ' 108' ' ' ARG . 13.3 t70 -68.32 130.65 92.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.791 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.8 -44.48 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.458 2.106 . . . . 0.0 113.106 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.42 70.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.858 0.863 . . . . 0.0 111.428 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HE ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -99.14 5.89 46.67 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.636 1.575 . . . . 0.0 111.507 -177.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.71 140.07 48.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -143.36 158.65 43.46 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.687 0.795 . . . . 0.0 110.168 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.19 -51.97 0.46 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -160.41 162.06 33.18 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.57 -40.92 88.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.619 -0.675 . . . . 0.0 110.696 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.02 -29.08 67.17 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.467 -0.302 . . . . 0.0 111.069 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.93 -42.23 40.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.285 0.634 . . . . 0.0 109.994 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -54.32 -51.7 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.025 0.93 . . . . 0.0 109.639 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -60.55 -46.51 89.92 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.57 75.89 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.036 -0.415 . . . . 0.0 110.662 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.67 -37.49 87.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.667 0.787 . . . . 0.0 111.022 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -54.55 -51.74 64.25 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.118 0.872 . . . . 0.0 108.706 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.495 ' NE2' HH21 ' A' ' 124' ' ' ARG . 5.3 mm-40 -61.21 -42.72 99.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 111.666 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.27 -48.15 82.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.242 0.474 . . . . 0.0 110.113 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.1 -47.26 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 117.459 -1.257 . . . . 0.0 110.022 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.495 HH21 ' NE2' ' A' ' 121' ' ' GLN . 49.1 ptt85 -63.01 -41.65 99.62 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.898 1.681 . . . . 0.0 111.027 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.23 -42.46 98.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.21 0.459 . . . . 0.0 110.082 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -76.63 -33.76 58.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.466 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.01 -46.29 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 119.977 1.262 . . . . 0.0 107.646 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.7 -47.71 87.02 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.81 -37.91 71.84 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.8 1.24 . . . . 0.0 112.125 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -42.76 85.32 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.48 -0.763 . . . . 0.0 111.526 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 mt -68.22 -41.44 81.27 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -48.07 73.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.666 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.97 -57.9 11.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.605 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.298 5.2 p90 -68.63 -21.56 64.47 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 121.111 1.778 . . . . 0.0 112.681 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.99 64.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.38 0.991 . . . . 0.0 111.798 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -77.52 -39.58 45.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.402 1.081 . . . . 0.0 111.17 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.6 p -90.7 -22.42 21.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.932 0.893 . . . . 0.0 110.838 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.27 41.64 99.49 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.314 1.846 . . . . 0.0 111.331 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.264 0.078 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.0 mtmt -134.99 166.25 23.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.983 1.713 . . . . 0.0 106.519 169.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.0 140.16 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.2 tt -130.44 135.22 61.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.69 102.95 6.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.693 0.797 . . . . 0.0 108.981 -170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -76.91 144.96 38.53 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.205 0.602 . . . . 0.0 110.166 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 137.32 37.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.758 1.623 . . . . 0.0 108.138 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.2 p -154.76 175.23 13.98 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -67.81 -7.84 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.82 97.31 0.14 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -41.41 -40.94 1.88 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.453 1.901 . . . . 0.0 113.204 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.6 m -38.07 -36.67 0.22 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.903 3.281 . . . . 0.0 115.329 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -117.23 -74.92 0.59 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.966 0.803 . . . . 0.0 112.137 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -56.29 -50.74 70.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.738 0.699 . . . . 0.0 111.614 -169.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -70.27 -34.61 73.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.612 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -63.6 -42.22 98.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.415 0.552 . . . . 0.0 110.772 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.6 mtp -65.72 -47.54 74.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.806 0.442 . . . . 0.0 109.828 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.08 86.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.031 0.532 . . . . 0.0 110.871 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -57.86 -45.65 85.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.611 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.72 -52.44 53.09 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.074 0.845 . . . . 0.0 112.709 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -65.37 -34.57 78.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.592 1.696 . . . . 0.0 110.61 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.53 83.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.605 -0.684 . . . . 0.0 110.56 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.94 -22.11 64.1 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.223 -0.923 . . . . 0.0 112.557 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.46 -47.18 8.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.872 0.76 . . . . 0.0 110.116 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -78.92 -26.71 43.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.91 -142.78 0.25 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.46 -174.26 46.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.67 -13.74 55.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.95 -14.62 3.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.721 2.008 . . . . 0.0 111.147 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.471 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 7.8 m95 -133.18 167.06 21.04 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.021 1.728 . . . . 0.0 108.844 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -123.07 130.66 53.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 167.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.26 118.8 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.22 174.61 10.45 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.6 1.16 . . . . 0.0 108.653 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 82.4 p -137.59 160.41 39.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.372 0.606 . . . . 0.0 111.157 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.47 -162.25 1.49 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.496 1.518 . . . . 0.0 108.546 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.7 176.37 44.88 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -41.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.4 -179.88 6.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.596 1.159 . . . . 0.0 109.17 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.58 149.96 36.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.755 2.422 . . . . 0.0 106.156 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -13.93 1.9 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.961 0.904 . . . . 0.0 111.446 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.71 170.24 20.91 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 171.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.64 102.12 1.8 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -64.42 125.67 88.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.678 -170.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.97 -35.46 50.16 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.383 2.722 . . . . 0.0 113.881 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -40.96 96.61 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.631 0.651 . . . . 0.0 110.515 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.92 -41.58 82.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.54 -55.99 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -65.25 -41.33 94.4 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 119.378 0.99 . . . . 0.0 110.664 -173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.21 71.4 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.862 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.0 mmm -86.51 -38.16 17.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.451 0.569 . . . . 0.0 111.427 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.42 -33.29 75.22 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.969 0.908 . . . . 0.0 110.3 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.77 -19.2 65.08 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 112.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.67 -10.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.221 1.008 . . . . 0.0 109.906 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.62 23.31 47.28 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.121 -0.987 . . . . 0.0 111.039 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.6 mt -114.32 91.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -78.49 74.25 5.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.991 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.03 3.32 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.322 -0.861 . . . . 0.0 112.129 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -27.12 10.38 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.497 1.044 . . . . 0.0 111.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -71.83 -19.59 61.96 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 113.852 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -78.29 170.38 16.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.963 . . . . 0.0 109.681 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.05 160.75 41.46 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.418 1.487 . . . . 0.0 108.462 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 p -101.64 153.55 19.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.419 1.088 . . . . 0.0 110.958 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -156.48 160.84 39.92 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.841 1.256 . . . . 0.0 108.944 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.09 161.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.22 129.29 18.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 123.397 0.679 . . . . 0.0 111.586 -169.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -106.59 114.84 29.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.31 1.444 . . . . 0.0 107.655 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -66.71 -23.1 66.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.63 -41.25 46.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.368 0.985 . . . . 0.0 110.268 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.67 -44.75 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.33 -48.71 65.31 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.948 0.499 . . . . 0.0 109.942 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -71.15 -14.81 62.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -94.75 -17.91 21.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.578 1.081 . . . . 0.0 111.003 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.01 150.25 49.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.164 0.438 . . . . 0.0 111.071 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.04 -32.71 51.11 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.42 141.04 29.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.562 1.145 . . . . 0.0 109.662 -174.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.74 124.67 59.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.95 118.44 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -102.66 97.34 7.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.8 mt -71.84 -3.15 20.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.903 1.681 . . . . 0.0 114.487 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.7 p -151.26 163.91 37.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.584 1.538 . . . . 0.0 110.327 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.76 -64.84 3.19 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.719 1.628 . . . . 0.0 113.338 -169.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.36 -29.25 67.93 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.712 -0.287 . . . . 0.0 111.754 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.55 66.94 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.85 64.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.45 -31.75 72.13 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.109 0.564 . . . . 0.0 112.109 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -85.36 63.17 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.319 0.647 . . . . 0.0 110.633 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -124.94 76.23 66.54 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.153 0.981 . . . . 0.0 108.401 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.51 85.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.635 2.89 . . . . 0.0 111.234 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.0 tpt 70.1 111.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.383 2.673 . . . . 0.0 111.196 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -134.55 81.71 47.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.87 171.5 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.444 2.763 . . . . 0.0 110.965 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.25 -25.47 13.47 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.43 3.42 . . . . 0.0 117.448 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -56.97 -36.93 70.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.669 1.122 . . . . 0.0 110.836 170.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.75 82.96 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.91 2.484 . . . . 0.0 106.87 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -66.63 165.27 15.09 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.49 -0.756 . . . . 0.0 108.975 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -133.77 134.07 42.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.963 0.905 . . . . 0.0 110.147 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.99 155.75 45.59 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -151.3 139.08 19.8 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -141.22 178.86 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.949 1.7 . . . . 0.0 108.537 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.22 103.82 0.4 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -135.58 143.64 45.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.668 0.787 . . . . 0.0 110.579 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -73.28 169.99 15.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -73.46 117.23 58.87 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.86 -32.08 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.677 1.585 . . . . 0.0 112.818 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.35 65.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.962 0.801 . . . . 0.0 112.209 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -101.64 2.31 38.65 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 111.786 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.41 144.98 40.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.13 165.28 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.055 0.455 . . . . 0.0 111.191 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.03 -47.65 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.54 166.41 18.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.509 2.324 . . . . 0.0 105.2 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.12 -40.57 81.58 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.533 -0.729 . . . . 0.0 110.52 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -27.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.562 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.96 -45.3 51.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.007 0.822 . . . . 0.0 109.171 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -55.69 -49.42 73.04 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.73 0.812 . . . . 0.0 109.882 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -64.68 -41.78 95.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.14 -0.35 . . . . 0.0 110.96 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.06 72.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.964 0.802 . . . . 0.0 110.62 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.78 -40.8 92.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.621 -0.674 . . . . 0.0 110.629 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.03 -45.41 83.15 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 119.191 0.905 . . . . 0.0 109.04 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.76 -50.01 75.5 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.351 0.66 . . . . 0.0 111.322 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.01 -48.78 80.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 119.488 -0.292 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.98 -45.81 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.927 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -62.3 -42.95 99.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 121.414 1.916 . . . . 0.0 110.764 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.2 -42.42 98.56 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.449 0.3 . . . . 0.0 110.696 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.44 -36.92 52.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.597 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -43.61 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.79 81.41 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.903 0.851 . . . . 0.0 112.083 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -49.41 76.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.542 0.61 . . . . 0.0 110.302 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 -43.45 70.64 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.267 0.627 . . . . 0.0 109.354 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -46.42 75.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.283 1.033 . . . . 0.0 110.934 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -60.79 -55.61 31.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.382 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.272 3.1 p90 -67.72 -24.3 65.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 121.492 1.951 . . . . 0.0 111.992 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.52 67.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.059 0.845 . . . . 0.0 111.732 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -76.58 -41.67 45.47 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.671 1.189 . . . . 0.0 111.153 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.0 p -84.92 -21.09 29.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.098 0.959 . . . . 0.0 110.343 -174.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.78 21.62 79.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.108 0.861 . . . . 0.0 111.881 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.251 1.158 0 CA-C-N 117.928 0.864 . . . . 0.0 109.673 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -126.83 164.15 22.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.629 1.972 . . . . 0.0 106.553 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -135.37 124.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -169.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tt -122.98 133.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -135.95 105.2 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -77.35 151.36 34.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 111.297 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -149.62 130.7 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.025 0.93 . . . . 0.0 108.651 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -148.69 178.68 8.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 111.01 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -66.81 -8.7 30.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 113.787 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.85 102.62 0.19 Allowed Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.1 t-20 -42.83 -46.07 5.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.222 1.809 . . . . 0.0 111.87 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -35.27 -35.95 0.05 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.148 3.379 . . . . 0.0 115.302 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.0 p -111.77 -74.06 0.65 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.362 0.983 . . . . 0.0 112.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.688 1.131 . . . . 0.0 111.95 -169.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.5 m -64.62 -36.18 83.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.223 0.465 . . . . 0.0 110.845 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.73 -44.48 90.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.535 0.607 . . . . 0.0 111.465 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.4 mtp -65.46 -48.24 73.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 109.704 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.64 84.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.233 0.613 . . . . 0.0 111.209 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.78 -45.08 90.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.026 0.53 . . . . 0.0 110.274 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.1 90.88 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.914 -0.937 . . . . 0.0 112.607 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.15 -40.46 82.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.276 1.538 . . . . 0.0 111.39 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.04 79.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.936 0.335 . . . . 0.0 111.592 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.67 -33.26 68.15 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.858 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -71.54 -58.17 3.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.422 0.555 . . . . 0.0 110.332 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.39 -39.38 68.04 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.3 mt -86.55 -39.97 15.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.174 0.443 . . . . 0.0 111.811 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.56 -173.93 55.16 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.114 0.864 . . . . 0.0 113.207 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.87 -17.01 62.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.307 1.843 . . . . 0.0 113.867 -170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -60.38 -10.94 5.43 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.242 1.417 . . . . 0.0 111.672 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -133.9 166.92 21.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.662 1.185 . . . . 0.0 110.597 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.05 137.84 51.53 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 168.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -114.42 142.42 27.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -137.82 159.43 42.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 108.636 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -137.6 124.59 21.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.24 -174.13 3.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.336 1.054 . . . . 0.0 109.109 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.84 175.03 42.2 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.18 -42.65 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -144.82 179.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.876 1.27 . . . . 0.0 109.027 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.71 44.13 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.683 1.993 . . . . 0.0 106.941 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -133.33 -30.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.005 0.922 . . . . 0.0 110.68 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 169.08 -176.64 43.13 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -76.1 104.15 6.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.28 125.77 87.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.449 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.76 -34.57 44.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.372 2.715 . . . . 0.0 113.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -42.69 96.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.693 0.679 . . . . 0.0 110.53 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.64 87.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -61.27 -56.07 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -65.76 -40.69 92.3 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.549 1.068 . . . . 0.0 110.51 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.18 -39.6 79.33 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.822 0.737 . . . . 0.0 111.871 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.3 mmm -82.37 -40.36 21.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.659 0.384 . . . . 0.0 111.093 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.99 -36.09 82.36 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.087 0.955 . . . . 0.0 110.497 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.0 -18.86 65.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.184 0.594 . . . . 0.0 111.894 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.42 -2.96 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.582 1.153 . . . . 0.0 109.934 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.36 20.91 53.64 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.898 -1.127 . . . . 0.0 111.901 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.9 mt -113.29 90.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.71 79.03 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.69 0.796 . . . . 0.0 110.627 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.09 4.57 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.008 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 m -54.18 -25.8 24.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.785 1.175 . . . . 0.0 112.592 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -78.35 -17.35 56.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.637 1.175 . . . . 0.0 113.186 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -70.69 169.25 14.82 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.863 0.756 . . . . 0.0 110.131 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 p -145.96 163.76 34.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.594 1.557 . . . . 0.0 108.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -111.37 150.85 29.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.13 0.972 . . . . 0.0 109.703 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.5 t0 -149.62 160.18 43.71 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.141 2.176 . . . . 0.0 108.746 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -89.77 164.51 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.56 139.74 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.649 0.738 . . . . 0.0 111.846 -170.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -128.64 104.71 7.81 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 107.99 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 p -57.07 -24.76 56.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.842 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.41 -22.06 66.66 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.951 1.251 . . . . 0.0 112.286 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -108.57 -45.8 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 92' ' ' THR . 0.6 OUTLIER -54.48 -40.97 69.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.183 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.06 -15.56 63.48 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.953 1.251 . . . . 0.0 113.575 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -106.02 -6.99 18.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.522 1.129 . . . . 0.0 111.137 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.97 155.09 35.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.311 0.505 . . . . 0.0 110.101 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.05 -32.73 44.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.307 -0.871 . . . . 0.0 108.885 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -144.28 140.4 29.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.536 1.134 . . . . 0.0 109.714 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.22 134.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.21 106.94 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 p -76.54 147.89 37.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.16 2.63 13.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.868 0.467 . . . . 0.0 110.953 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -151.86 147.73 26.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.18 -45.39 96.62 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.87 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.19 -32.85 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.409 0.604 . . . . 0.0 111.662 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.8 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.31 -18.77 64.92 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.62 -35.61 81.07 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.064 0.946 . . . . 0.0 111.927 172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.26 -36.83 66.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.13 110.26 1.26 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.902 1.281 . . . . 0.0 110.938 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.552 2.834 . . . . 0.0 109.743 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -43.76 110.34 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.011 1.724 . . . . 0.0 111.765 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.413 HG23 HD21 ' A' ' 72' ' ' LEU . 1.1 p -133.16 72.49 75.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.93 168.07 12.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.479 2.786 . . . . 0.0 110.752 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -49.99 -23.79 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.53 3.487 . . . . 0.0 117.87 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -54.69 -40.86 69.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.605 1.093 . . . . 0.0 110.356 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.66 97.7 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.746 2.019 . . . . 0.0 107.556 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -72.02 159.59 33.95 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -131.22 148.51 52.71 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.386 0.675 . . . . 0.0 109.271 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.81 148.45 37.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -132.91 106.88 7.96 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -102.52 170.01 8.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.211 1.404 . . . . 0.0 108.081 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.27 106.68 0.5 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.432 -168.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -138.52 140.82 39.29 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.868 0.867 . . . . 0.0 111.73 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.79 168.99 10.43 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.546 0.738 . . . . 0.0 109.286 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -74.43 112.64 18.12 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.77 -34.07 51.38 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.547 1.498 . . . . 0.0 112.311 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.13 -15.18 62.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.029 0.831 . . . . 0.0 112.513 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -118.95 20.79 12.67 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.201 1.401 . . . . 0.0 110.979 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.1 67.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 55.07 -160.59 0.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.027 1.731 . . . . 0.0 112.237 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.95 -70.33 0.68 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -159.95 163.72 33.96 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -59.17 -40.63 86.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.828 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.05 -31.56 70.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.603 -0.237 . . . . 0.0 111.09 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -75.57 -38.02 59.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.355 0.662 . . . . 0.0 110.195 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -60.27 -50.01 75.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.154 0.982 . . . . 0.0 109.491 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -60.77 -42.9 98.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.069 0.395 . . . . 0.0 110.727 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.65 -37.51 76.13 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.919 0.488 . . . . 0.0 110.622 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.31 -35.46 76.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.56 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -54.94 -44.29 74.16 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.104 1.32 . . . . 0.0 108.485 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -60.58 -41.82 95.42 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.957 0.344 . . . . 0.0 111.197 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -64.03 -51.22 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.28 -46.45 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.784 -1.103 . . . . 0.0 109.67 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -62.73 -41.65 99.27 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.551 1.523 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.77 -44.67 96.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.001 0.364 . . . . 0.0 110.168 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.16 -42.26 76.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.275 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.06 -45.7 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.613 1.097 . . . . 0.0 108.719 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.14 94.35 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -57.28 -45.93 83.62 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.933 0.893 . . . . 0.0 111.781 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.63 -35.23 79.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.612 1.096 . . . . 0.0 111.91 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 131' ' ' LEU . 4.0 mm? -69.49 -41.46 76.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.757 1.162 . . . . 0.0 110.816 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.63 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 110.578 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.77 -52.86 63.74 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.643 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -55.25 -46.41 76.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 120.249 1.386 . . . . 0.0 109.966 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.78 90.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.245 0.618 . . . . 0.0 111.555 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -84.52 -37.46 21.24 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.534 0.734 . . . . 0.0 111.777 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.2 p -92.88 -23.66 18.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.597 0.759 . . . . 0.0 111.081 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.9 42.43 99.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.808 2.043 . . . . 0.0 112.468 -169.934 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 t30 . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 110.775 -0.083 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 48.0 mtmt -134.61 169.3 17.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.846 1.659 . . . . 0.0 107.577 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.92 134.36 53.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -124.39 132.74 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -129.1 105.54 8.25 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.835 0.854 . . . . 0.0 108.714 -170.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -75.59 147.54 39.52 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.941 -0.474 . . . . 0.0 110.216 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.4 127.11 15.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.95 174.52 11.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.335 0.654 . . . . 0.0 110.104 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -66.86 -12.77 60.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.73 -1.231 . . . . 0.0 112.997 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.42 122.82 1.21 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 106.326 -2.709 . . . . 0.0 106.326 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -59.69 -45.92 90.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.876 0.87 . . . . 0.0 110.744 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -38.18 -30.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 130.089 3.356 . . . . 0.0 117.279 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.3 m -120.51 -71.21 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.431 0.693 . . . . 0.0 110.195 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -66.74 -49.77 64.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.77 -169.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -63.87 -43.99 94.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.402 0.547 . . . . 0.0 109.623 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.73 -45.88 85.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.317 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 45.1 mtm -67.29 -45.34 76.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.258 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.14 -44.6 75.24 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.715 0.689 . . . . 0.0 111.048 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.88 -44.71 94.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.586 0.754 . . . . 0.0 110.468 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.97 -50.8 53.51 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.178 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -68.21 -37.21 80.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.752 1.776 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.96 79.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.553 -0.717 . . . . 0.0 111.247 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -59.09 -32.72 70.06 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.658 -0.651 . . . . 0.0 112.072 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.82 -49.43 18.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.43 0.692 . . . . 0.0 109.359 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -79.76 -34.88 39.46 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -170.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.77 -35.54 12.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.499 0.59 . . . . 0.0 112.017 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.22 -178.72 49.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.195 0.902 . . . . 0.0 112.793 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.02 -6.04 25.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.56 -8.69 4.64 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.044 1.738 . . . . 0.0 110.729 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.421 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 4.3 m95 -138.15 157.94 45.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 108.561 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -111.95 142.09 44.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 168.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.8 126.83 67.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 171.11 14.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 109.668 172.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.4 m -135.52 142.34 45.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.753 1.221 . . . . 0.0 110.261 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.69 -174.72 4.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.279 1.432 . . . . 0.0 108.925 169.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.44 175.95 41.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.01 -41.87 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.23 179.34 7.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.543 0.737 . . . . 0.0 110.083 170.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.8 42.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.295 2.238 . . . . 0.0 106.306 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -136.7 -19.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.58 0.752 . . . . 0.0 111.686 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.1 -178.0 40.91 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -77.75 100.72 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.57 122.77 73.29 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.33 -171.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.5 -32.01 41.6 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.183 2.588 . . . . 0.0 113.521 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -39.84 92.79 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.812 0.733 . . . . 0.0 110.801 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.84 75.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.11 -54.78 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -66.89 -41.58 86.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.588 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.53 -46.09 84.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.516 0.598 . . . . 0.0 110.818 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 84.4 mmm -73.81 -37.44 64.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.462 0.574 . . . . 0.0 111.326 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.336 -0.852 . . . . 0.0 111.342 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -66.22 -19.35 65.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.669 0.788 . . . . 0.0 112.177 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.37 -4.6 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.862 1.265 . . . . 0.0 110.374 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.76 23.03 65.24 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.763 -1.211 . . . . 0.0 111.916 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -111.98 93.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.15 86.45 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.441 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.31 5.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.275 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -57.01 -26.18 59.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.851 1.659 . . . . 0.0 112.345 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -74.77 -17.65 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.406 1.082 . . . . 0.0 112.807 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.03 170.27 14.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.59 0.756 . . . . 0.0 110.109 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 p -146.68 160.36 42.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.49 1.516 . . . . 0.0 108.554 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.9 m -108.34 151.74 25.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.049 0.94 . . . . 0.0 109.729 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.563 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.0 t0 -153.05 161.16 42.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.205 2.202 . . . . 0.0 108.378 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 pt -91.54 163.65 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.12 133.98 20.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.394 0.678 . . . . 0.0 111.942 -169.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -123.11 112.67 18.02 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 107.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.8 p -57.06 -24.21 52.25 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 111.508 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.88 -22.58 67.02 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.67 1.188 . . . . 0.0 112.873 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.82 -43.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.956 0.798 . . . . 0.0 108.937 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -48.6 -51.11 29.64 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.251 1.02 . . . . 0.0 110.782 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.1 -15.77 62.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -104.19 -16.91 15.08 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.18 0.992 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.96 58.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.775 0.43 . . . . 0.0 109.868 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.24 -33.74 76.43 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.9 tp -144.33 141.62 29.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.202 1.401 . . . . 0.0 109.702 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.35 132.3 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 109.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.08 88.24 7.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.67 -10.55 19.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.087 1.755 . . . . 0.0 114.357 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.0 t -148.66 157.71 43.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.834 1.652 . . . . 0.0 110.197 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.98 -59.29 9.59 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.259 1.885 . . . . 0.0 112.191 -170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.48 -26.9 66.59 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.536 0.334 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.29 72.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.795 0.438 . . . . 0.0 111.592 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.11 -20.11 65.07 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.05 -29.8 70.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.691 0.678 . . . . 0.0 112.277 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -77.4 -32.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 117.303 -1.332 . . . . 0.0 113.344 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -47.23 108.44 0.88 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.297 1.039 . . . . 0.0 111.031 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.17 -34.99 26.36 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.901 1.734 . . . . 0.0 113.011 -169.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 125.79 1.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.9 p -128.15 82.4 68.55 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.53 173.31 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.633 2.889 . . . . 0.0 110.79 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.21 -29.35 16.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.882 3.054 . . . . 0.0 116.104 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -68.77 -8.04 39.46 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.185 0.994 . . . . 0.0 113.064 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.31 80.95 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.945 2.498 . . . . 0.0 104.732 -170.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.7 pttt -64.94 164.99 11.59 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.736 0.779 . . . . 0.0 108.948 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -127.53 150.1 49.84 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 109.561 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.37 153.17 44.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -147.59 139.15 23.88 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -139.52 -169.27 2.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.658 1.583 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.0 41.58 1.29 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.098 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -80.34 119.17 22.7 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.958 1.379 . . . . 0.0 112.597 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.21 150.64 43.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.062 0.945 . . . . 0.0 109.603 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -74.2 121.12 84.47 Favored Pre-proline 0 C--O 1.236 0.373 0 O-C-N 121.999 -0.438 . . . . 0.0 111.858 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.43 -32.14 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.834 1.69 . . . . 0.0 112.678 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.76 65.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.767 0.712 . . . . 0.0 112.362 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -100.18 -0.96 37.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.688 1.195 . . . . 0.0 111.594 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.9 148.68 29.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -159.01 164.47 35.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.817 0.447 . . . . 0.0 110.655 -171.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.24 -48.66 0.64 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -164.99 165.68 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.277 2.231 . . . . 0.0 105.416 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.14 -40.51 81.53 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.556 -0.715 . . . . 0.0 110.638 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.38 -28.48 65.12 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.377 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.32 -44.94 58.03 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.92 0.782 . . . . 0.0 109.194 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -56.02 -50.37 71.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.588 0.755 . . . . 0.0 109.75 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.93 -44.86 95.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.989 0.359 . . . . 0.0 110.505 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.9 75.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.602 0.637 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.57 -36.92 85.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.342 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -54.95 -53.37 56.56 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.634 1.106 . . . . 0.0 108.274 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.516 ' NE2' HH21 ' A' ' 124' ' ' ARG . 6.3 mm100 -58.1 -43.22 87.01 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.864 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -61.15 -49.41 77.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.58 0.627 . . . . 0.0 110.606 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.28 -45.89 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.891 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.516 HH21 ' NE2' ' A' ' 121' ' ' GLN . 47.6 ptt85 -61.88 -40.81 96.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.44 1.927 . . . . 0.0 111.087 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.48 -44.72 95.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.25 0.477 . . . . 0.0 109.793 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.28 -32.51 61.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.045 -0.979 . . . . 0.0 112.858 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -65.32 -42.82 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.697 1.135 . . . . 0.0 108.644 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.78 -46.46 82.85 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -58.56 -36.23 73.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.303 1.041 . . . . 0.0 111.41 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -51.41 70.05 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.587 0.755 . . . . 0.0 109.379 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.8 mt -72.89 -31.78 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.251 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -51.91 67.53 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.777 0.831 . . . . 0.0 110.828 169.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.68 -49.21 75.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 119.299 0.954 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -55.32 -39.35 69.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.584 0.629 . . . . 0.0 111.055 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.43 -47.42 49.17 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.767 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.51 -37.5 71.22 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.612 1.165 . . . . 0.0 110.91 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.0 p -90.61 -22.63 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.001 0.92 . . . . 0.0 110.163 -175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.68 41.48 99.6 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.083 1.353 . . . . 0.0 111.015 -175.252 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 119.954 -0.07 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -124.69 167.74 14.13 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.724 0.81 . . . . 0.0 110.631 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.7 138.45 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tt -121.57 138.83 50.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -132.04 106.21 7.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -75.82 146.64 39.75 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.565 0.746 . . . . 0.0 110.546 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.02 130.19 20.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -148.46 171.21 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.984 0.811 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -67.58 -9.64 44.66 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.148 -0.97 . . . . 0.0 113.4 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 118.36 0.82 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 106.652 -2.579 . . . . 0.0 106.652 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.61 -43.19 99.42 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.811 0.844 . . . . 0.0 112.107 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -43.33 -22.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.06 3.344 . . . . 0.0 117.336 -169.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -128.78 -71.7 0.63 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.295 0.952 . . . . 0.0 110.947 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -58.68 -49.14 78.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.371 0.532 . . . . 0.0 111.336 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -72.01 -36.15 69.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.863 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -62.73 -42.07 99.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.897 0.479 . . . . 0.0 111.313 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.6 mtm -66.2 -46.62 76.66 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.693 0.679 . . . . 0.0 110.258 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.45 77.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.898 0.479 . . . . 0.0 110.64 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -57.2 -44.6 83.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.528 1.131 . . . . 0.0 110.559 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.08 90.15 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.889 -0.95 . . . . 0.0 112.59 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.61 -38.43 83.94 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.468 1.634 . . . . 0.0 110.613 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.71 85.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.652 0.381 . . . . 0.0 111.701 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -58.64 -29.12 66.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.858 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -73.67 -59.6 2.64 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.685 0.675 . . . . 0.0 110.559 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -71.28 -42.52 68.62 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.05 -39.59 33.5 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.643 0.377 . . . . 0.0 110.694 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.76 53.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.481 1.039 . . . . 0.0 112.858 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.41 -17.1 58.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.601 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.36 -21.21 5.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.595 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -127.04 161.92 27.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 110.711 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -112.0 144.43 41.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.1 t -134.21 124.52 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.3 172.59 12.6 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 74.8 p -141.74 154.82 45.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.71 -163.81 1.74 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.79 1.236 . . . . 0.0 108.15 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.78 175.01 44.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.86 -41.36 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.4 173.72 11.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.791 0.836 . . . . 0.0 110.163 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.35 157.14 42.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.677 1.991 . . . . 0.0 107.989 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -134.79 -32.67 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.767 1.227 . . . . 0.0 110.707 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.89 -173.41 33.9 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.47 109.63 9.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 170.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -70.03 132.79 88.22 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.64 -28.48 60.72 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.018 1.812 . . . . 0.0 112.997 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -39.13 91.54 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.972 0.806 . . . . 0.0 110.847 174.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.87 65.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.78 -59.72 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -63.32 -40.99 98.85 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.96 0.8 . . . . 0.0 110.513 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.1 -46.51 72.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 111.362 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.4 mmm -77.48 -38.58 48.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.173 0.589 . . . . 0.0 111.495 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -60.95 -34.6 74.98 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.579 -0.701 . . . . 0.0 110.051 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -68.94 -22.01 64.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.6 t -76.08 -26.2 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 119.53 1.059 . . . . 0.0 109.371 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.04 23.63 9.64 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.796 1.189 . . . . 0.0 110.511 -169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.2 mt -118.75 101.93 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.98 129.92 40.78 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.33 -2.02 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.584 0.753 . . . . 0.0 110.714 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -29.15 69.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.421 1.01 . . . . 0.0 110.695 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.67 -16.68 64.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.752 1.621 . . . . 0.0 113.537 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -75.29 176.1 7.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.952 0.901 . . . . 0.0 109.037 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -141.93 153.54 44.44 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.843 1.257 . . . . 0.0 108.744 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -107.44 147.24 30.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 109.87 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.87 158.47 40.82 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.851 1.261 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 pt -88.7 162.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 137.66 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.73 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -126.28 114.85 18.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.22 1.408 . . . . 0.0 108.058 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -56.4 -28.6 59.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.723 0.809 . . . . 0.0 111.377 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.72 0.5 8.7 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.786 1.634 . . . . 0.0 113.475 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.88 -46.99 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp -45.79 -52.76 10.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.468 1.107 . . . . 0.0 111.395 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -5.78 22.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -132.51 5.16 4.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.675 1.19 . . . . 0.0 112.541 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.7 47.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.37 -33.2 67.06 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.8 tp -143.03 142.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.062 1.345 . . . . 0.0 109.18 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.31 134.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.49 134.12 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 118.958 0.799 . . . . 0.0 108.861 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 86' ' ' ALA . 9.7 p -98.53 98.27 9.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.5 -12.26 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.256 1.422 . . . . 0.0 113.598 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.65 147.37 33.0 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.34 95.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.405 0.526 . . . . 0.0 112.342 -169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.95 -25.23 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.164 0.982 . . . . 0.0 111.731 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.7 -23.96 60.94 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.284 0.634 . . . . 0.0 111.689 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -64.14 -20.69 66.16 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.8 -32.63 70.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.096 0.558 . . . . 0.0 111.949 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -86.79 62.09 7.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.875 0.87 . . . . 0.0 110.588 -173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 77.0 m -120.21 75.15 22.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 108.391 172.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.04 -28.48 80.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.436 2.091 . . . . 0.0 114.659 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 ttp -158.76 99.28 1.55 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.939 0.896 . . . . 0.0 109.942 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p -128.37 73.7 80.07 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.452 1.101 . . . . 0.0 108.351 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.93 171.07 10.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.3 2.666 . . . . 0.0 110.856 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.34 -21.99 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.193 3.262 . . . . 0.0 116.456 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -63.27 -11.82 24.49 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 112.897 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.3 94.39 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 128.015 2.526 . . . . 0.0 105.273 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -70.81 165.25 23.55 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 98' ' ' ARG . 3.5 mtp85 -135.47 153.81 51.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.243 0.617 . . . . 0.0 111.671 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.54 167.08 23.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.58 6.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.844 0.858 . . . . 0.0 110.369 -169.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -115.27 -174.11 2.44 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.824 1.249 . . . . 0.0 109.405 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.63 43.64 1.19 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.239 -0.913 . . . . 0.0 114.231 -168.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -84.31 108.04 16.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.261 1.03 . . . . 0.0 111.819 -172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.37 152.6 37.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.018 0.927 . . . . 0.0 109.734 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -71.5 116.43 47.46 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 122.915 0.486 . . . . 0.0 111.713 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.21 -34.42 16.45 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.089 1.86 . . . . 0.0 112.1 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.47 -16.35 64.05 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.46 0.573 . . . . 0.0 112.076 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -111.53 14.95 21.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.978 1.311 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.83 -43.8 90.74 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.651 0.659 . . . . 0.0 111.684 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 50.36 -161.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.095 1.758 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.49 -69.83 0.21 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.877 1.703 . . . . 0.0 109.122 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -154.1 156.53 37.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.29 -38.76 84.6 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.264 0.938 . . . . 0.0 111.105 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.71 -32.34 72.91 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.257 -0.277 . . . . 0.0 111.106 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.09 -42.12 60.62 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.382 0.673 . . . . 0.0 109.877 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -58.46 -50.47 73.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.367 1.467 . . . . 0.0 110.149 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -62.01 -42.57 99.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.875 0.47 . . . . 0.0 110.619 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.03 72.7 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.784 0.72 . . . . 0.0 110.813 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.86 -40.27 83.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.737 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -56.41 -46.44 80.19 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.48 -48.74 79.78 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.663 0.785 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -59.55 -50.09 75.24 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.077 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.32 -44.6 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.223 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.05 -44.09 97.43 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.992 2.178 . . . . 0.0 110.627 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.74 -43.3 99.12 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.95 -38.03 66.91 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.604 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -42.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.774 1.625 . . . . 0.0 108.617 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.78 93.72 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.428 ' ND2' HH21 ' A' ' 130' ' ' ARG . 45.5 t30 -59.23 -43.04 92.35 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.276 1.03 . . . . 0.0 112.008 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.428 HH21 ' ND2' ' A' ' 129' ' ' ASN . 4.3 mmp_? -60.84 -46.04 92.15 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.612 -0.68 . . . . 0.0 110.29 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.12 -41.11 90.96 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.258 0.481 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.34 -48.58 73.98 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.857 0.863 . . . . 0.0 110.246 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.88 -48.32 82.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.31 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.5 -44.5 85.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.873 1.215 . . . . 0.0 109.852 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.33 85.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.776 0.431 . . . . 0.0 111.148 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -82.15 -38.95 23.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.418 1.087 . . . . 0.0 111.226 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 47.5 p -94.05 -22.95 18.2 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.203 0.601 . . . . 0.0 111.115 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.57 43.0 98.0 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.964 1.706 . . . . 0.0 112.707 -169.923 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 119.452 -0.308 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -141.99 170.67 15.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.62 142.59 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 118.758 0.708 . . . . 0.0 109.791 -168.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.25 135.76 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.86 104.16 6.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.33 0.652 . . . . 0.0 109.38 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -77.4 149.54 35.15 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.795 0.838 . . . . 0.0 110.532 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.77 132.42 14.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -149.95 171.96 15.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.264 1.393 . . . . 0.0 110.916 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -64.18 -13.32 47.79 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.948 -1.095 . . . . 0.0 112.93 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 119.21 0.9 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 105.367 -3.093 . . . . 0.0 105.367 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.3 t-20 -56.3 -43.01 78.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.771 0.828 . . . . 0.0 110.46 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -30.8 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 132.626 4.37 . . . . 0.0 118.06 -169.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.82 -58.83 0.76 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.654 0.661 . . . . 0.0 111.659 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -61.69 -50.54 72.04 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.025 0.83 . . . . 0.0 110.973 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -68.74 -38.28 80.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.226 0.466 . . . . 0.0 110.815 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -61.59 -43.7 98.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.776 0.716 . . . . 0.0 111.817 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 74.7 mtm -67.41 -46.85 72.01 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.27 0.486 . . . . 0.0 109.814 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.59 -42.0 74.18 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.274 0.488 . . . . 0.0 111.055 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.25 -48.15 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.051 0.54 . . . . 0.0 110.186 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.99 -50.86 53.37 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.574 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.8 m95 -67.18 -37.71 84.17 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.632 1.716 . . . . 0.0 110.851 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.05 82.72 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.219 0.918 . . . . 0.0 111.627 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -60.45 -27.17 67.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.192 0.906 . . . . 0.0 112.255 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.42 -47.1 13.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.615 0.766 . . . . 0.0 109.872 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -77.61 -28.63 51.55 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.07 -145.69 0.31 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.162 1.385 . . . . 0.0 108.297 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 -170.58 42.89 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.22 0.918 . . . . 0.0 111.857 -171.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.85 -19.07 63.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.707 1.603 . . . . 0.0 113.668 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.91 -12.12 10.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.859 1.264 . . . . 0.0 112.013 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -129.24 162.32 28.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.014 1.326 . . . . 0.0 110.782 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.2 132.13 53.05 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.15 137.05 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -137.25 163.88 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.548 0.739 . . . . 0.0 109.307 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -140.14 128.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.79 -173.11 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.757 1.223 . . . . 0.0 108.585 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.38 171.44 41.38 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.84 -41.02 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.93 179.36 7.23 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.005 0.922 . . . . 0.0 109.257 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.85 121.82 10.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.76 1.624 . . . . 0.0 106.652 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.25 -34.78 36.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.41 -173.82 37.04 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.902 2.191 . . . . 0.0 107.693 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.28 105.29 11.44 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.93 130.87 86.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.969 -169.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.85 -34.34 75.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.53 2.82 . . . . 0.0 113.724 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.38 78.42 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.43 0.559 . . . . 0.0 111.181 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.47 63.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.42 -53.5 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -65.72 -42.88 90.56 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 119.065 0.848 . . . . 0.0 110.383 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.52 72.15 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.64 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 83.4 mmm -83.22 -37.52 23.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.713 0.688 . . . . 0.0 111.526 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -65.68 -29.83 70.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.302 -0.874 . . . . 0.0 110.934 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.53 -18.77 65.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.111 0.964 . . . . 0.0 112.248 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.12 -9.71 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.48 1.112 . . . . 0.0 109.99 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.55 21.45 56.28 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -111.75 90.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.83 77.76 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 110.245 -172.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.05 3.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 111.868 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -53.86 -26.42 24.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.462 1.105 . . . . 0.0 112.46 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -79.79 -12.04 59.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.003 1.321 . . . . 0.0 113.593 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -74.32 172.79 11.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.259 0.936 . . . . 0.0 109.238 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -146.84 161.58 40.4 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 107.783 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.2 m -104.06 151.45 23.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.643 0.777 . . . . 0.0 109.628 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -147.39 159.81 43.27 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.945 2.098 . . . . 0.0 108.496 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -89.6 165.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 142.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.037 0.935 . . . . 0.0 112.31 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -132.22 104.24 6.67 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.364 1.865 . . . . 0.0 108.383 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 p -56.9 -26.34 58.89 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -69.8 -4.86 21.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.24 1.016 . . . . 0.0 112.79 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.82 -48.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.61 -44.49 57.08 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.815 0.734 . . . . 0.0 112.158 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -3.68 17.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -135.48 10.65 3.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.984 1.314 . . . . 0.0 112.185 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.32 152.93 36.5 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.07 -36.26 79.55 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.866 1.212 . . . . 0.0 108.629 170.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.54 155.42 43.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.872 0.844 . . . . 0.0 112.28 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -113.56 138.87 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 102.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.7 p -76.08 147.96 38.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 3.13 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.01 0.524 . . . . 0.0 112.127 -169.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.81 162.19 40.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.357 0.981 . . . . 0.0 108.396 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.07 97.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.44 -35.63 73.47 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.096 0.948 . . . . 0.0 111.18 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.67 -23.66 67.23 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.066 0.546 . . . . 0.0 112.405 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.56 -29.44 59.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.466 0.707 . . . . 0.0 112.373 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.36 -32.7 74.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.209 0.604 . . . . 0.0 112.261 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -86.9 58.61 5.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.389 0.676 . . . . 0.0 110.59 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.96 81.21 12.04 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.76 -35.46 98.6 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.828 2.352 . . . . 0.0 114.384 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -159.31 125.36 4.39 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.153 0.981 . . . . 0.0 108.356 169.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -138.94 79.96 25.75 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.35 169.87 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.073 2.515 . . . . 0.0 110.846 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.66 -18.95 6.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.407 3.405 . . . . 0.0 116.378 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -61.56 -13.81 24.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.15 0.98 . . . . 0.0 112.691 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 t -127.95 109.25 19.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.177 2.191 . . . . 0.0 106.542 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.04 167.75 20.04 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -135.62 150.37 49.62 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.529 0.732 . . . . 0.0 109.846 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 153.8 43.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 169.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -138.3 84.57 2.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -169.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -79.53 176.45 9.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.943 1.297 . . . . 0.0 109.446 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.3 93.96 0.19 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.327 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -131.93 121.43 23.99 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.831 0.853 . . . . 0.0 111.131 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -64.77 152.25 43.14 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.621 1.168 . . . . 0.0 109.92 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.76 114.91 28.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.057 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -31.67 29.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.018 1.812 . . . . 0.0 112.707 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.9 -15.21 62.74 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.592 0.633 . . . . 0.0 112.053 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -115.63 22.15 13.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.617 1.567 . . . . 0.0 110.732 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.01 -27.04 69.15 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 43.51 -147.53 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.985 2.114 . . . . 0.0 113.275 -175.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.6 -73.12 1.43 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.5 166.17 16.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.534 2.334 . . . . 0.0 105.623 172.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.84 -40.21 79.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.353 0.979 . . . . 0.0 111.447 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.65 -28.97 63.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.442 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.45 -39.78 67.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.981 0.809 . . . . 0.0 109.322 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.22 -48.14 82.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 109.832 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -61.03 -43.06 99.45 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.299 0.5 . . . . 0.0 110.573 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.19 -32.9 70.33 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.597 -0.689 . . . . 0.0 110.911 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -74.75 -35.51 62.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.023 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -53.57 -45.42 69.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.96 1.254 . . . . 0.0 108.809 169.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.25 -46.92 85.09 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 123.027 0.531 . . . . 0.0 111.3 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -61.39 -50.96 70.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.949 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.21 -44.3 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.206 -1.378 . . . . 0.0 109.903 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -63.15 -43.28 98.77 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 121.565 1.984 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.38 -42.74 99.2 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.514 0.325 . . . . 0.0 110.266 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.72 -45.44 71.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.343 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -61.27 -40.7 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.034 1.288 . . . . 0.0 108.87 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.12 85.36 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -56.98 -41.5 78.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.251 1.02 . . . . 0.0 112.218 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -65.16 -41.46 94.67 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.35 -0.844 . . . . 0.0 110.174 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.76 -36.74 78.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.476 1.035 . . . . 0.0 111.475 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -49.6 76.47 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.679 0.792 . . . . 0.0 110.092 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.77 -48.32 81.18 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.757 0.708 . . . . 0.0 109.915 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.01 -38.6 70.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.212 0.915 . . . . 0.0 111.154 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.57 -45.86 61.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.49 -38.62 54.97 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.244 1.018 . . . . 0.0 111.72 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.4 p -94.35 -16.81 23.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.576 1.15 . . . . 0.0 111.05 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.06 92.0 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.906 1.283 . . . . 0.0 112.037 -169.698 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 42.4 mtmt -133.05 171.14 14.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.477 1.511 . . . . 0.0 108.679 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -136.1 139.28 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tt -125.76 135.48 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -130.92 111.88 12.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.87 141.01 31.62 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.6 140.67 52.72 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -154.86 169.68 23.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.298 0.639 . . . . 0.0 109.445 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -71.03 -7.83 49.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.77 119.17 0.85 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 57.7 t-20 -77.36 72.53 3.91 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.352 1.061 . . . . 0.0 109.017 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.1 p -134.13 -30.96 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.311 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 m -134.75 -67.69 0.56 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.911 0.778 . . . . 0.0 111.63 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -57.79 -50.55 72.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.927 0.491 . . . . 0.0 111.74 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -64.43 -36.81 85.39 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.25 0.477 . . . . 0.0 111.618 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.51 -42.5 71.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.822 . . . . 0.0 110.85 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -62.06 -51.63 67.17 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.56 76.69 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.929 0.492 . . . . 0.0 110.969 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.68 -48.55 81.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.287 0.635 . . . . 0.0 109.97 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.82 -46.78 93.49 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.616 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.7 m95 -66.87 -41.87 86.55 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.065 1.433 . . . . 0.0 110.908 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.45 80.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.514 0.597 . . . . 0.0 111.055 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -57.45 -34.33 68.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.805 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.66 -58.62 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.366 0.53 . . . . 0.0 110.132 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -70.72 -36.44 73.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -169.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 42.8 mt -91.49 -36.69 13.6 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.78 -177.84 46.82 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.856 0.741 . . . . 0.0 112.723 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.54 -8.66 49.13 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.89 -9.79 2.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 110.972 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 9.6 m95 -136.36 166.42 23.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.835 1.654 . . . . 0.0 108.945 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.05 146.35 47.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 167.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.2 121.77 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -168.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.01 165.88 24.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.459 0.647 . . . . 0.0 109.841 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p -132.34 139.03 47.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.879 1.272 . . . . 0.0 108.427 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.59 -175.66 4.45 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.491 1.517 . . . . 0.0 108.565 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.04 177.19 46.39 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 121.802 -0.562 . . . . 0.0 111.891 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.53 -41.64 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.812 1.245 . . . . 0.0 108.569 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.89 177.42 8.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.82 0.848 . . . . 0.0 109.546 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.98 166.62 29.08 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.981 1.712 . . . . 0.0 108.714 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.26 -46.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.587 1.155 . . . . 0.0 108.12 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.74 25.91 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.62 122.53 14.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -74.24 141.44 77.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.661 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.11 -34.69 69.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.922 2.415 . . . . 0.0 113.715 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -35.43 78.96 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.719 0.691 . . . . 0.0 111.812 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.55 -42.1 68.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.01 -55.51 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.37 -44.41 96.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.4 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.13 88.74 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.087 0.858 . . . . 0.0 111.215 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.6 mmm -73.46 -39.93 64.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.7 0.4 . . . . 0.0 110.403 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -64.78 -33.5 76.14 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.141 0.976 . . . . 0.0 110.977 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.54 -15.29 62.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.791 1.236 . . . . 0.0 112.232 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.64 1.91 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.174 1.39 . . . . 0.0 109.781 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.29 72.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.661 -1.274 . . . . 0.0 112.299 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.57 93.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.09 77.8 5.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.46 0.704 . . . . 0.0 110.515 -172.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.4 pt -73.99 1.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.904 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -53.68 -27.94 30.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.99 1.268 . . . . 0.0 112.511 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.91 -22.37 61.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.061 1.344 . . . . 0.0 113.054 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -71.51 168.03 18.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.083 0.953 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -145.23 164.98 29.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.492 1.917 . . . . 0.0 108.115 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.2 m -108.68 158.26 17.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.531 0.681 . . . . 0.0 110.773 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 47.3 t0 -153.2 159.75 42.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.918 2.087 . . . . 0.0 107.499 172.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -88.44 166.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.02 108.52 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.152 0.981 . . . . 0.0 111.274 -170.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -94.03 114.56 26.76 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -18.76 62.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.245 1.418 . . . . 0.0 112.559 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.07 -47.7 60.83 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.121 0.873 . . . . 0.0 110.974 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.9 -42.65 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -48.85 -49.31 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.21 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -76.26 -12.96 60.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -92.75 -17.63 23.96 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.283 0.947 . . . . 0.0 110.903 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.74 50.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.168 0.44 . . . . 0.0 111.568 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 -37.5 75.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.71 162.59 39.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.931 0.872 . . . . 0.0 112.811 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.72 141.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.03 111.49 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 86' ' ' ALA . 52.0 p -90.18 103.08 15.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.25 -8.97 50.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.328 0.651 . . . . 0.0 112.287 -172.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -143.6 154.21 43.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.51 95.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.26 -32.07 73.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.591 0.695 . . . . 0.0 111.557 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.75 70.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.258 0.481 . . . . 0.0 111.794 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -67.0 -17.5 64.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.3 -31.54 72.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.568 0.622 . . . . 0.0 111.811 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.2 -28.51 57.28 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.175 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 m -47.06 108.01 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.4 1.08 . . . . 0.0 111.016 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.25 -38.73 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.957 1.771 . . . . 0.0 114.526 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.7 tpt -165.74 132.01 2.64 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.316 1.046 . . . . 0.0 109.166 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.7 p -137.88 96.42 10.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.74 168.39 20.28 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.889 2.393 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -50.86 -26.17 17.39 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.037 3.158 . . . . 0.0 115.85 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -66.17 -7.14 16.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.365 1.066 . . . . 0.0 113.077 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.65 97.03 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.96 2.104 . . . . 0.0 105.58 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 163.62 27.12 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.254 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -141.84 128.53 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.45 155.67 45.34 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.072 1.349 . . . . 0.0 108.054 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -137.64 143.23 41.29 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.506 0.722 . . . . 0.0 111.665 -169.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -139.28 -170.99 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.724 1.609 . . . . 0.0 108.553 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.91 45.2 0.98 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-N 119.11 0.868 . . . . 0.0 113.379 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -80.93 122.97 27.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.062 0.931 . . . . 0.0 111.576 -173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -78.19 152.65 32.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.66 127.76 76.89 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.698 -0.626 . . . . 0.0 112.47 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.35 -34.22 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.164 1.909 . . . . 0.0 113.375 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -22.05 66.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.282 0.946 . . . . 0.0 112.235 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -100.12 -0.9 38.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.419 1.088 . . . . 0.0 111.146 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.75 152.35 23.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -160.81 164.1 31.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.29 0.636 . . . . 0.0 110.358 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.52 -49.53 0.61 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.14 166.23 19.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.051 2.14 . . . . 0.0 105.649 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.36 -40.69 82.89 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.753 -0.592 . . . . 0.0 110.579 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.94 -29.05 64.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.346 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.3 -45.05 61.68 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -56.94 -49.85 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.661 0.784 . . . . 0.0 109.964 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -61.59 -44.22 97.41 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.34 0.518 . . . . 0.0 110.398 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -40.28 80.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.321 0.509 . . . . 0.0 110.293 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -62.59 -36.92 84.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.191 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.89 -50.59 70.26 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.327 0.967 . . . . 0.0 108.595 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -61.62 -45.45 94.0 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.045 0.538 . . . . 0.0 110.834 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -59.91 -50.01 75.45 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.271 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.4 -47.41 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 117.449 -1.262 . . . . 0.0 109.945 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -61.73 -41.55 97.78 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.828 1.649 . . . . 0.0 110.806 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.74 -41.74 99.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.074 0.397 . . . . 0.0 110.017 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -76.61 -33.8 58.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.619 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.62 -42.11 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.702 1.137 . . . . 0.0 108.069 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.75 -47.11 79.06 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -53.65 -44.48 69.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.883 1.273 . . . . 0.0 111.166 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -47.49 85.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 119.249 -0.405 . . . . 0.0 110.908 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.02 -37.24 83.79 Favored 'General case' 0 C--O 1.229 -0.023 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -59.15 -49.07 79.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.782 0.833 . . . . 0.0 110.407 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.61 -45.63 82.38 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.371 0.987 . . . . 0.0 109.65 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -55.39 -38.5 68.97 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.024 0.829 . . . . 0.0 111.016 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.98 34.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.601 0.76 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.76 -38.96 73.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.762 1.225 . . . . 0.0 111.32 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 p -90.34 -16.07 29.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.856 0.862 . . . . 0.0 110.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.78 40.63 89.65 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.78 1.232 . . . . 0.0 111.789 -169.927 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -142.55 169.37 17.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.381 1.472 . . . . 0.0 109.026 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.3 mt -135.98 147.31 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 tt -134.64 142.9 39.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.484 1.114 . . . . 0.0 108.387 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.27 107.22 7.08 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.71 143.39 48.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.991 0.517 . . . . 0.0 109.934 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.08 143.22 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.083 1.753 . . . . 0.0 106.536 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 1.3 t -157.91 170.29 22.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 118.674 0.67 . . . . 0.0 109.53 170.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -66.82 -10.67 50.34 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.118 -0.989 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.98 119.82 0.93 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.4 t-20 -56.9 -46.58 81.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.632 0.773 . . . . 0.0 110.355 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 m -42.33 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 130.191 3.396 . . . . 0.0 117.733 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -119.5 -78.31 0.59 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.002 0.819 . . . . 0.0 109.499 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -61.89 -47.77 83.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.109 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -68.98 -38.25 79.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.063 0.847 . . . . 0.0 110.901 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -43.77 96.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.646 0.657 . . . . 0.0 111.484 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.4 mtp -66.18 -47.32 74.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.366 0.666 . . . . 0.0 109.546 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.9 78.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.388 0.675 . . . . 0.0 110.979 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.43 -45.85 80.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.62 0.768 . . . . 0.0 110.129 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.95 -47.29 91.41 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -69.97 -39.14 76.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.38 1.59 . . . . 0.0 111.055 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.1 79.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.744 0.417 . . . . 0.0 111.554 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.5 -33.91 64.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.82 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -74.48 -57.33 4.01 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.27 0.486 . . . . 0.0 110.603 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -73.58 -45.0 55.89 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -73.84 -35.71 64.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.486 0.584 . . . . 0.0 111.348 -169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.9 167.99 42.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.973 0.797 . . . . 0.0 111.78 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.78 -12.04 61.31 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -52.81 -31.6 39.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.384 0.611 . . . . 0.0 110.055 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -100.91 150.45 22.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -110.41 125.8 53.63 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 167.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.18 127.2 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -168.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.0 172.0 13.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.629 1.172 . . . . 0.0 108.768 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -137.47 139.67 40.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.118 0.967 . . . . 0.0 109.507 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.09 -175.15 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.344 1.458 . . . . 0.0 109.022 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 10' ' ' CYS . . . -165.03 175.79 40.88 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -42.1 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.51 179.48 7.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.84 0.856 . . . . 0.0 109.815 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.33 151.16 37.88 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.613 1.965 . . . . 0.0 106.964 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -127.84 10.35 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.769 1.227 . . . . 0.0 111.797 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.84 -173.54 18.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 126.113 1.816 . . . . 0.0 109.035 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.76 109.3 20.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -63.49 124.55 84.86 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.286 -172.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.18 -34.16 38.44 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.288 2.658 . . . . 0.0 113.657 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -38.64 87.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.77 0.714 . . . . 0.0 110.913 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.13 75.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.61 -52.14 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -65.97 -41.89 90.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.87 0.759 . . . . 0.0 110.827 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.83 -45.58 82.24 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.839 0.745 . . . . 0.0 110.954 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.7 mmm -75.78 -38.91 57.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.467 0.307 . . . . 0.0 110.903 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.96 -34.02 77.43 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.01 -1.056 . . . . 0.0 110.993 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.84 -20.4 66.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 112.238 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.83 -10.06 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 110.281 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.15 20.05 28.98 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.629 1.109 . . . . 0.0 111.925 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.56 91.35 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -77.49 76.79 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.751 1.22 . . . . 0.0 110.089 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.69 2.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 121.381 -0.824 . . . . 0.0 112.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.68 -28.9 16.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.348 1.859 . . . . 0.0 112.802 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.22 -16.62 57.67 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.847 1.259 . . . . 0.0 112.922 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -70.67 171.83 9.71 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.826 0.85 . . . . 0.0 109.7 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -147.1 158.95 44.11 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 107.819 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -98.43 156.33 16.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 110.043 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 43.1 t0 -150.26 162.7 39.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.891 2.076 . . . . 0.0 108.088 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -94.21 160.9 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 133.23 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 112.515 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -116.89 111.64 19.93 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.559 1.944 . . . . 0.0 106.83 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -62.0 -19.56 62.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.993 0.917 . . . . 0.0 112.719 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.78 -43.42 84.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.772 1.169 . . . . 0.0 111.322 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.99 -48.7 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.81 -52.35 24.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.237 1.015 . . . . 0.0 110.409 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -68.96 -10.19 56.05 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.23 6.49 7.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.001 1.273 . . . . 0.0 112.812 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 154.0 39.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.49 -32.43 54.26 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.553 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 33.5 tp -145.43 145.84 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.153 1.381 . . . . 0.0 109.104 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -126.5 140.41 48.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.53 134.05 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 86' ' ' ALA . 30.6 p -95.19 118.93 32.82 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.69 -0.76 31.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.153 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -147.22 163.03 37.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.695 1.134 . . . . 0.0 109.104 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.76 -38.99 77.11 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.852 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.52 -35.84 78.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.533 1.166 . . . . 0.0 110.925 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.72 -18.96 65.71 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.603 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -60.62 -23.97 65.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.935 0.789 . . . . 0.0 112.147 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.1 -34.05 76.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 111.979 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.56 63.95 8.26 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.06 0.944 . . . . 0.0 110.119 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.5 m -122.53 72.94 40.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.89 -48.43 7.52 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.08 3.186 . . . . 0.0 115.315 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 138.23 6.48 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -132.46 80.67 62.16 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.67 168.07 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.502 2.802 . . . . 0.0 110.916 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.9 -22.04 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.824 3.683 . . . . 0.0 118.655 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.21 -41.47 93.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.986 1.267 . . . . 0.0 110.615 170.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 156.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 127.785 2.434 . . . . 0.0 108.37 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.9 pttt -140.59 170.41 15.83 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.555 1.542 . . . . 0.0 107.777 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -134.02 157.07 47.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 112.417 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.97 158.39 43.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.189 2.196 . . . . 0.0 105.204 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -145.19 117.85 8.63 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.48 -0.763 . . . . 0.0 109.291 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -109.33 -174.13 2.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.019 1.327 . . . . 0.0 109.795 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.66 43.51 1.11 Allowed Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.418 -0.801 . . . . 0.0 114.534 -168.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -85.83 121.52 28.59 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.543 1.172 . . . . 0.0 111.168 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.06 155.12 40.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.78 120.89 83.75 Favored Pre-proline 0 C--O 1.235 0.318 0 O-C-N 121.833 -0.542 . . . . 0.0 111.417 -170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.85 -33.75 42.0 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.556 1.504 . . . . 0.0 112.754 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.14 -20.47 66.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.522 0.601 . . . . 0.0 112.526 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.13 -0.02 34.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.527 1.131 . . . . 0.0 111.568 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 150.18 24.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.67 164.52 33.94 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.183 0.593 . . . . 0.0 110.085 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.11 -48.21 0.69 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -164.11 162.69 23.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.904 2.082 . . . . 0.0 105.449 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.01 -40.86 86.23 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.693 -0.629 . . . . 0.0 110.495 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.22 -29.35 68.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.319 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -76.38 -40.22 51.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.988 0.813 . . . . 0.0 109.913 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.03 -51.37 69.53 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -60.21 -44.57 95.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.47 79.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -61.2 -34.84 75.73 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.97 0.805 . . . . 0.0 111.621 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -57.39 -48.46 79.02 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -61.23 -44.17 97.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.403 0.681 . . . . 0.0 111.919 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -61.27 -53.08 61.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.64 0.654 . . . . 0.0 109.578 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.23 -43.02 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.638 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -61.16 -43.87 98.21 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.941 1.7 . . . . 0.0 110.992 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.49 -43.66 96.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.35 -39.89 71.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.01 -45.24 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.565 1.075 . . . . 0.0 108.37 175.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.89 95.18 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -62.19 -39.52 92.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.221 1.01 . . . . 0.0 111.719 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -38.6 85.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.98 0.809 . . . . 0.0 110.685 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.96 -38.98 66.54 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.925 -0.484 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -56.87 -47.15 81.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.119 0.968 . . . . 0.0 110.138 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.61 -52.22 66.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 117.324 -1.322 . . . . 0.0 109.519 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.02 -44.08 82.48 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.457 1.48 . . . . 0.0 110.196 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.21 92.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.264 0.626 . . . . 0.0 111.642 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.45 -37.68 22.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.994 0.918 . . . . 0.0 111.416 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 p -94.62 -22.77 17.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.592 0.757 . . . . 0.0 111.345 -170.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.249 1.05 0 C-N-CA 127.443 2.297 . . . . 0.0 112.443 -170.045 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.31 176.68 9.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.183 0.993 . . . . 0.0 109.474 169.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.9 mt -133.25 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.33 132.93 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -127.78 101.62 6.44 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.145 0.978 . . . . 0.0 108.387 -171.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -73.11 145.77 46.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.62 131.58 21.64 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.58 -178.1 6.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.131 0.423 . . . . 0.0 111.214 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -7.41 36.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.713 -1.242 . . . . 0.0 114.07 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.65 129.92 2.08 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.696 HD22 ' H ' ' A' ' 65' ' ' ASP . 45.4 t-20 -81.22 40.17 0.54 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.276 1.031 . . . . 0.0 112.062 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.4 p -122.46 -20.91 5.91 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 111.765 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.1 m -134.66 -73.37 0.47 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.948 0.899 . . . . 0.0 110.866 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -60.21 3.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.909 0.777 . . . . 0.0 111.038 -169.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 m -62.68 -42.34 99.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.656 0.382 . . . . 0.0 110.468 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -61.01 -45.58 94.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.219 0.608 . . . . 0.0 111.405 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 43.2 mtm -66.77 -46.17 76.18 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.933 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.03 -44.99 79.3 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.368 0.531 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.25 -45.24 91.71 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.773 0.829 . . . . 0.0 110.082 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.48 -46.58 92.93 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.474 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -69.63 -39.82 76.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.554 1.677 . . . . 0.0 110.822 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.84 78.83 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.358 0.526 . . . . 0.0 110.844 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -57.2 -33.06 67.12 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.727 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -71.56 -57.7 4.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.465 0.575 . . . . 0.0 110.148 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -70.24 -37.81 75.04 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.93 -38.74 12.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.095 0.558 . . . . 0.0 111.839 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 177.45 48.41 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.267 0.937 . . . . 0.0 112.391 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.48 -10.15 53.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.697 1.199 . . . . 0.0 113.585 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.9 -10.69 6.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.282 1.433 . . . . 0.0 111.379 169.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.61 146.11 50.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.607 1.563 . . . . 0.0 108.095 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -100.76 138.46 37.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 167.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.18 127.54 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -168.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.33 169.82 16.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -134.81 143.05 46.85 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 109.766 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.26 -177.11 4.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.282 1.433 . . . . 0.0 108.838 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.91 167.36 35.92 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.64 -40.78 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.42 179.77 6.9 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.997 . . . . 0.0 109.852 170.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.11 159.43 43.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.256 1.822 . . . . 0.0 108.017 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -147.74 -31.37 0.3 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.365 0.666 . . . . 0.0 111.833 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.91 173.61 34.55 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.19 107.27 2.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -72.4 130.9 85.36 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.02 -27.09 65.92 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.866 1.711 . . . . 0.0 112.956 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -39.1 93.22 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.996 0.816 . . . . 0.0 111.2 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.37 62.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.91 -58.36 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -64.03 -39.58 94.42 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 118.644 0.656 . . . . 0.0 110.557 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.52 68.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.709 0.686 . . . . 0.0 110.935 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.72 -38.49 67.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.022 0.529 . . . . 0.0 111.108 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -68.97 -29.02 67.15 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.304 -0.873 . . . . 0.0 111.6 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.94 -18.55 65.43 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.464 1.105 . . . . 0.0 111.874 170.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.04 -2.96 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.769 1.228 . . . . 0.0 109.798 172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.27 18.93 54.55 Favored Glycine 0 CA--C 1.531 1.031 0 O-C-N 120.79 -1.194 . . . . 0.0 112.307 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 mt -114.16 95.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.07 78.69 4.55 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.279 1.032 . . . . 0.0 110.168 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -72.83 -3.21 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.44 -0.787 . . . . 0.0 112.017 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -29.2 63.33 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.815 1.189 . . . . 0.0 112.077 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -73.02 -16.02 61.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.827 1.251 . . . . 0.0 112.533 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.61 171.01 9.63 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.707 0.803 . . . . 0.0 109.027 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -138.99 162.99 33.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.88 1.272 . . . . 0.0 109.086 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 p -116.83 144.66 44.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 109.451 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.696 ' H ' HD22 ' A' ' 13' ' ' ASN . 45.8 t0 -153.46 155.58 36.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.091 2.156 . . . . 0.0 107.999 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.78 164.44 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tt -54.34 134.33 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 111.265 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -128.95 112.05 13.67 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.688 1.195 . . . . 0.0 108.493 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 p -54.83 -28.75 51.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.592 0.757 . . . . 0.0 111.28 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.69 -1.23 15.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.364 1.465 . . . . 0.0 113.66 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.22 -46.54 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -45.46 -54.33 7.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.864 1.266 . . . . 0.0 111.456 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -2.15 9.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -133.56 3.76 3.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.612 1.165 . . . . 0.0 112.758 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.07 151.01 48.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.22 -34.27 75.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tp -145.66 143.14 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.117 1.367 . . . . 0.0 109.726 -171.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.58 138.13 52.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.13 111.81 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -90.97 91.26 8.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.45 -9.43 12.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.284 1.033 . . . . 0.0 113.307 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.3 133.66 21.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.8 -32.93 66.63 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.717 0.675 . . . . 0.0 112.687 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.2 -30.68 71.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.33 1.065 . . . . 0.0 111.884 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 -30.92 68.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.266 0.626 . . . . 0.0 111.576 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.79 -20.12 64.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.16 -34.49 66.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.965 0.906 . . . . 0.0 112.129 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 -32.56 61.67 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.661 -171.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.0 m -48.8 108.11 0.89 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.992 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.76 -28.01 14.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.323 2.015 . . . . 0.0 114.239 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.9 ptp -163.61 131.34 3.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.271 1.028 . . . . 0.0 110.086 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -140.23 80.48 19.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.78 169.19 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.214 3.276 . . . . 0.0 113.23 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.21 -28.12 32.62 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.463 2.776 . . . . 0.0 115.047 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.57 -7.22 30.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.262 1.025 . . . . 0.0 112.968 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.11 81.7 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.931 2.492 . . . . 0.0 105.271 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.8 pttt -65.58 166.16 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -131.68 155.07 48.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.92 0.488 . . . . 0.0 110.384 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.74 159.74 41.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 149.21 31.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.4 0.68 . . . . 0.0 112.429 -168.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -143.06 -160.2 1.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.197 1.399 . . . . 0.0 109.084 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.65 41.28 0.99 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.84 1.2 . . . . 0.0 113.874 -169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -85.65 107.88 17.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.586 1.193 . . . . 0.0 111.999 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.25 154.37 35.26 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.586 1.155 . . . . 0.0 110.105 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.98 120.67 82.48 Favored Pre-proline 0 C--O 1.236 0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.974 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.32 -32.04 27.12 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.906 1.737 . . . . 0.0 112.372 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.37 -19.86 66.13 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.371 0.987 . . . . 0.0 112.24 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.87 1.59 34.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.708 1.203 . . . . 0.0 111.3 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.14 138.87 57.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -145.75 156.28 43.5 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.27 -55.18 0.41 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 t -155.75 158.5 38.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.23 -39.0 88.64 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.569 -0.707 . . . . 0.0 110.815 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.22 -30.88 70.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.2 -0.313 . . . . 0.0 111.049 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.75 -42.55 58.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.205 0.602 . . . . 0.0 109.848 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 20.3 tttt -55.42 -52.27 64.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.702 1.201 . . . . 0.0 110.1 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -60.29 -45.2 94.17 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 117.962 0.346 . . . . 0.0 110.322 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.82 79.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.284 0.493 . . . . 0.0 110.427 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.72 -39.82 92.88 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.589 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.31 -50.57 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.037 0.835 . . . . 0.0 108.802 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -60.21 -45.08 94.43 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 122.912 0.485 . . . . 0.0 111.165 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.54 -48.86 79.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.85 0.46 . . . . 0.0 110.384 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.93 -44.69 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.021 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -60.85 -42.33 97.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 121.496 1.953 . . . . 0.0 110.753 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.03 -44.61 96.33 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.42 -31.65 62.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.526 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.91 -43.38 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.246 . . . . 0.0 108.592 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.29 88.82 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.91 -35.96 75.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.935 1.294 . . . . 0.0 111.562 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -50.98 71.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 123.614 0.766 . . . . 0.0 109.197 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.18 -32.17 66.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.004 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -52.02 67.26 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.942 0.897 . . . . 0.0 110.521 169.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.19 -47.42 79.84 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 119.609 1.095 . . . . 0.0 109.349 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -55.83 -38.6 70.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.607 -0.683 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -48.56 37.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.572 0.749 . . . . 0.0 111.611 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.97 -38.34 72.77 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.558 1.143 . . . . 0.0 111.143 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.4 p -90.97 -18.48 24.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 110.27 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.13 39.31 95.66 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -173.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm . . . . . 0 C--O 1.25 1.102 0 C-N-CA 125.158 1.383 . . . . 0.0 111.665 -171.767 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.54 175.93 10.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.457 0.703 . . . . 0.0 110.552 169.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.97 136.19 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.52 135.29 64.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -132.26 105.37 7.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -74.06 147.43 42.84 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.637 -0.665 . . . . 0.0 110.137 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.73 130.14 17.75 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.95 173.56 14.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.68 0.673 . . . . 0.0 110.093 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -66.06 -9.2 28.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.928 -1.107 . . . . 0.0 113.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.58 1.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 53.9 t-20 -62.67 -49.09 76.49 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.469 0.707 . . . . 0.0 110.786 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.1 m -41.69 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 130.321 3.448 . . . . 0.0 117.816 -168.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.8 -73.61 0.64 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.812 1.187 . . . . 0.0 110.09 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -61.65 -49.45 76.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.125 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -69.69 -38.83 77.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.655 0.661 . . . . 0.0 111.005 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -61.36 -45.28 95.04 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.836 0.744 . . . . 0.0 111.697 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -65.08 -48.69 72.83 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.45 78.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.859 0.463 . . . . 0.0 111.047 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.18 -50.93 71.29 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 109.927 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.28 -46.86 92.34 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.113 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.4 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.9 m95 -66.74 -42.39 86.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.655 1.728 . . . . 0.0 110.711 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.04 75.6 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.591 0.632 . . . . 0.0 111.313 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -57.31 -33.99 68.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.45 -57.2 5.55 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.455 0.571 . . . . 0.0 110.1 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -69.67 -34.38 73.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.66 -38.11 9.65 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.255 0.622 . . . . 0.0 112.456 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 178.97 51.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.216 0.912 . . . . 0.0 112.761 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.53 -12.32 60.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.934 1.294 . . . . 0.0 113.759 -170.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.7 -7.54 2.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.76 1.624 . . . . 0.0 112.063 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -131.55 145.39 51.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.48 1.512 . . . . 0.0 108.681 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 7.4 mmpt? -98.43 136.21 38.9 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 167.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.51 116.71 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -168.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.28 171.84 13.19 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -139.84 142.67 36.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.278 1.031 . . . . 0.0 108.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.93 -176.43 4.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.766 1.626 . . . . 0.0 108.544 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.63 173.84 40.59 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.19 -40.85 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.08 177.41 8.79 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.896 0.878 . . . . 0.0 110.099 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.04 126.3 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.847 1.659 . . . . 0.0 107.207 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -77.6 -46.12 23.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.339 0.656 . . . . 0.0 109.428 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.1 -166.7 39.37 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -78.18 99.62 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -62.68 131.01 94.11 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.64 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.71 -28.5 82.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.232 1.954 . . . . 0.0 112.891 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -58.9 -50.1 75.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.377 0.989 . . . . 0.0 109.324 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.22 -42.24 85.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.451 0.569 . . . . 0.0 110.233 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.64 -54.4 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.438 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -64.21 -46.64 82.99 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.318 0.963 . . . . 0.0 110.33 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.5 70.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.011 0.924 . . . . 0.0 111.436 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -79.97 -36.39 36.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.365 0.666 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.32 -31.72 72.95 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.918 -1.113 . . . . 0.0 109.801 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -72.79 6.72 2.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.672 1.989 . . . . 0.0 112.122 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.75 -6.68 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.795 2.038 . . . . 0.0 108.669 169.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.65 25.46 56.38 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 120.574 -1.328 . . . . 0.0 111.202 -169.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -116.76 90.49 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -78.78 80.72 5.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.578 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -75.25 6.82 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.246 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.9 m -53.98 -27.15 29.76 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.04 1.291 . . . . 0.0 112.168 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.68 -18.09 58.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.569 1.147 . . . . 0.0 113.161 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -71.81 170.72 13.04 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.878 0.763 . . . . 0.0 109.895 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 156.0 43.55 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.748 1.619 . . . . 0.0 107.648 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -102.44 151.95 21.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.75 . . . . 0.0 109.381 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.6 t0 -152.11 161.24 42.92 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.733 2.013 . . . . 0.0 108.251 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 pt -93.16 162.86 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -57.37 113.21 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.72 118.37 29.27 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 m -72.08 -22.53 61.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.539 -170.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.54 -42.75 51.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.044 0.838 . . . . 0.0 110.051 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.74 -44.88 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.88 -49.12 74.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.188 0.449 . . . . 0.0 110.281 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -65.85 -18.47 65.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -98.15 -14.81 20.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.342 0.974 . . . . 0.0 110.682 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.68 159.98 33.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 118.399 0.545 . . . . 0.0 110.946 -169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.37 -30.59 42.65 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 168.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 tp -152.02 145.69 25.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.621 1.568 . . . . 0.0 109.872 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.6 t -123.05 140.01 48.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.51 111.47 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.5 p -90.66 94.03 9.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.11 -10.78 33.33 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.038 0.935 . . . . 0.0 112.499 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.67 135.87 23.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.92 -34.02 76.5 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.758 0.694 . . . . 0.0 112.815 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.68 -29.28 70.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.356 1.078 . . . . 0.0 111.681 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.67 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 111.531 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.43 65.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.78 -34.29 71.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.233 1.013 . . . . 0.0 112.066 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -73.66 -32.12 63.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.883 -171.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 80.8 m -46.77 107.15 0.66 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.949 1.299 . . . . 0.0 109.627 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -64.26 -44.41 12.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.553 1.502 . . . . 0.0 114.239 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.8 ttt -167.26 123.66 1.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.291 1.036 . . . . 0.0 108.527 169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -109.24 85.48 3.48 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.7 166.62 17.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.984 2.456 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.23 -19.57 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.709 3.606 . . . . 0.0 118.279 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.18 -40.22 89.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.039 1.291 . . . . 0.0 110.051 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.26 162.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 127.881 2.472 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -142.58 169.27 17.88 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.586 1.555 . . . . 0.0 107.262 169.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -132.65 145.6 51.2 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.863 0.756 . . . . 0.0 111.156 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 152.18 43.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.301 2.24 . . . . 0.0 105.115 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.17 141.12 42.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.363 0.665 . . . . 0.0 110.284 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -138.26 -166.34 1.96 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.416 1.486 . . . . 0.0 109.076 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.54 1.13 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 119.197 0.908 . . . . 0.0 112.796 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.87 112.86 12.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.867 0.833 . . . . 0.0 110.728 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -69.14 153.56 43.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.354 0.662 . . . . 0.0 109.663 169.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.19 118.2 68.81 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 111.505 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.73 -33.7 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.005 1.804 . . . . 0.0 112.385 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.1 -19.14 64.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.745 0.702 . . . . 0.0 112.072 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -100.27 -2.95 32.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.766 1.226 . . . . 0.0 111.377 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.09 136.77 58.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 168.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.07 22.3 0.66 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -168.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.34 -51.58 42.32 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -172.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -160.17 163.62 33.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.81 2.444 . . . . 0.0 104.863 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.85 -40.02 83.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.09 1.314 . . . . 0.0 111.123 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.75 -32.75 72.73 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.282 -0.261 . . . . 0.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -75.32 -37.84 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.066 0.546 . . . . 0.0 110.144 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 41.7 tttt -59.26 -51.22 70.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.769 1.228 . . . . 0.0 109.415 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -61.96 -41.69 98.28 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.803 0.274 . . . . 0.0 110.644 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.59 73.64 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.48 -0.762 . . . . 0.0 110.859 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.2 -42.07 89.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.545 0.738 . . . . 0.0 110.385 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -56.05 -47.39 77.99 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -59.7 -48.63 80.91 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.96 0.904 . . . . 0.0 111.513 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.94 -45.06 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 116.619 -1.658 . . . . 0.0 110.262 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -61.19 -44.25 97.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 121.985 2.175 . . . . 0.0 110.48 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.71 -43.71 98.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -79.93 -27.31 39.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.255 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -65.88 -42.26 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 107.883 171.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.03 90.14 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -57.34 -40.79 78.73 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.403 1.081 . . . . 0.0 111.14 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -46.67 87.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.744 -0.598 . . . . 0.0 111.027 175.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.66 -34.31 77.91 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.588 0.631 . . . . 0.0 111.086 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -50.55 73.6 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.89 -47.36 83.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 119.712 1.142 . . . . 0.0 109.643 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.38 -39.19 72.52 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 118.394 0.543 . . . . 0.0 110.832 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.04 -48.21 46.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.907 0.883 . . . . 0.0 111.777 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -69.47 -39.6 77.61 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.726 1.21 . . . . 0.0 111.186 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -87.35 -17.66 31.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.315 1.046 . . . . 0.0 110.122 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.53 41.36 93.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.168 1.366 . . . . 0.0 110.71 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.763 0.825 . . . . 0.0 112.207 -170.771 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -146.52 173.62 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.648 1.179 . . . . 0.0 108.358 169.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.39 142.36 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -169.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.71 135.85 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.416 1.486 . . . . 0.0 107.149 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -129.01 103.43 7.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.963 0.905 . . . . 0.0 108.727 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.58 146.19 42.74 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 122.044 -0.41 . . . . 0.0 109.933 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.92 132.25 20.66 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -148.62 173.71 12.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.292 0.637 . . . . 0.0 110.116 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -68.17 -9.11 44.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.556 -1.34 . . . . 0.0 113.689 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.19 123.7 1.3 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.25 -41.04 97.15 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.219 0.509 . . . . 0.0 111.279 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -38.57 -28.94 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.77 3.228 . . . . 0.0 116.861 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -127.93 -74.93 0.57 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.206 0.912 . . . . 0.0 112.335 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mpp_? -53.87 -50.73 65.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.21 0.914 . . . . 0.0 113.436 -168.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 22.3 p -80.26 -27.81 38.56 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.979 0.809 . . . . 0.0 111.662 -175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -62.1 -41.39 98.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.643 1.11 . . . . 0.0 110.943 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 79.0 mtp -65.89 -49.37 68.29 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.64 73.66 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.938 0.495 . . . . 0.0 111.357 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -56.11 -48.91 75.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.081 0.952 . . . . 0.0 109.952 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.63 99.67 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.157 -0.801 . . . . 0.0 112.823 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 94.3 m95 -68.13 -44.11 76.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.168 1.484 . . . . 0.0 110.16 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.48 83.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.618 0.367 . . . . 0.0 110.358 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -59.14 -26.1 64.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.266 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -74.07 -59.21 2.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 110.438 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -69.81 -38.15 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 34.6 mt -87.19 -39.37 15.54 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.249 0.619 . . . . 0.0 112.176 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.39 -178.87 49.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.092 0.853 . . . . 0.0 112.834 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.93 -15.65 62.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.291 1.436 . . . . 0.0 113.567 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.76 -16.11 3.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.905 1.282 . . . . 0.0 111.534 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 11.4 m95 -129.08 140.54 51.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 110.083 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -89.57 131.15 35.73 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.54 119.21 54.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 171.59 14.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 171.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 59.2 p -136.78 152.37 50.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.238 1.015 . . . . 0.0 109.356 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.89 -168.86 3.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.076 1.351 . . . . 0.0 107.572 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.23 37.82 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.52 -40.18 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.07 179.52 6.85 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.467 1.107 . . . . 0.0 109.532 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.01 157.37 43.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.424 2.29 . . . . 0.0 106.574 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -132.5 -29.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.456 1.102 . . . . 0.0 110.185 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.53 -179.25 37.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.9 tp -75.81 101.47 5.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -62.0 124.8 83.39 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.374 -171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -51.08 -33.54 43.73 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.272 2.648 . . . . 0.0 113.719 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -39.54 90.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.651 0.659 . . . . 0.0 110.691 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.35 73.56 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -58.23 -53.35 47.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -67.62 -41.59 83.7 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.778 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.08 -49.05 74.89 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 118.886 0.766 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -71.02 -40.3 71.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.076 0.55 . . . . 0.0 110.84 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -64.57 -29.96 70.99 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.195 -0.941 . . . . 0.0 111.014 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -68.99 -22.37 64.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.963 0.905 . . . . 0.0 112.06 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.03 -30.44 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.214 0.915 . . . . 0.0 109.113 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.29 14.48 11.71 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.462 1.505 . . . . 0.0 111.471 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.87 97.25 5.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.15 85.44 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.294 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.55 4.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.277 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -56.48 -26.16 53.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.891 1.678 . . . . 0.0 112.132 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -72.93 -22.07 60.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.055 1.342 . . . . 0.0 113.013 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -71.25 167.5 19.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.73 0.812 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.49 156.45 43.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.41 1.484 . . . . 0.0 108.419 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 m -102.7 153.92 19.66 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.161 0.585 . . . . 0.0 111.599 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -154.48 154.86 33.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.718 1.607 . . . . 0.0 109.056 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 pt -84.83 163.28 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.94 134.1 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.397 1.079 . . . . 0.0 110.927 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -119.88 110.18 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.427 1.491 . . . . 0.0 107.451 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 m -54.7 -24.77 23.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.152 1.381 . . . . 0.0 112.676 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.28 -45.48 63.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.07 0.85 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.06 -42.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.55 -50.21 43.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.931 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -75.89 -12.01 60.07 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -92.57 -19.89 21.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.386 0.994 . . . . 0.0 110.783 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.15 140.45 57.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.083 0.401 . . . . 0.0 110.291 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.19 -33.47 75.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.3 tp -145.44 143.88 30.3 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.238 1.415 . . . . 0.0 109.918 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.36 136.99 55.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.24 108.48 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.2 p -88.33 95.67 10.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.75 -13.48 55.14 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 50.2 t -141.99 139.67 32.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.02 -36.64 90.96 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.493 0.568 . . . . 0.0 112.59 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.72 -27.24 68.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.193 0.997 . . . . 0.0 111.659 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -24.83 61.12 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.328 0.651 . . . . 0.0 111.651 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.31 -14.91 62.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.88 -33.6 75.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.179 0.592 . . . . 0.0 111.677 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -87.59 75.46 9.07 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.471 0.709 . . . . 0.0 109.394 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.2 m -135.99 80.95 40.66 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.13 88.31 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.519 3.48 . . . . 0.0 110.882 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . 0.263 24.1 ptt? 51.57 130.62 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 131.16 3.784 . . . . 0.0 114.643 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p -137.76 84.59 21.81 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -53.87 171.85 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.67 3.58 . . . . 0.0 113.203 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.56 -27.86 26.79 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.722 2.948 . . . . 0.0 115.199 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.44 -14.13 55.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 112.853 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.28 82.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.529 2.332 . . . . 0.0 106.423 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.6 pttt -67.08 164.35 18.08 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -129.75 155.74 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.742 -0.599 . . . . 0.0 109.718 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.15 154.56 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -140.12 143.28 36.15 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.9 0.48 . . . . 0.0 111.139 -168.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -140.08 -169.88 2.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.286 1.434 . . . . 0.0 109.19 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.02 42.77 1.28 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.018 0.818 . . . . 0.0 112.992 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -77.33 101.05 6.13 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 111.455 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -60.89 158.27 13.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.372 1.069 . . . . 0.0 110.124 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.07 124.21 86.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.368 -169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.98 -44.44 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.858 2.372 . . . . 0.0 111.84 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.59 69.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.423 0.689 . . . . 0.0 111.024 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.37 12.16 31.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.039 1.335 . . . . 0.0 111.21 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.52 72.08 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.597 0.635 . . . . 0.0 112.692 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 55.86 -176.98 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.865 2.066 . . . . 0.0 113.281 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -65.84 0.49 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 126.179 1.847 . . . . 0.0 108.784 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 t -160.92 159.88 30.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.98 -39.76 75.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.014 0.825 . . . . 0.0 111.333 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.1 -28.98 66.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.358 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.36 -41.45 69.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.732 0.697 . . . . 0.0 109.32 174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -59.41 -53.73 54.85 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -57.65 -42.1 82.8 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.528 0.517 . . . . 0.0 110.022 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.2 87.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.157 0.435 . . . . 0.0 110.295 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.91 -38.74 92.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.626 0.77 . . . . 0.0 111.144 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -58.91 -47.38 85.21 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.292 0.951 . . . . 0.0 108.721 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -61.44 -42.89 99.46 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.149 0.58 . . . . 0.0 111.149 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.47 -50.55 64.93 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.305 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.01 -44.37 99.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.191 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -44.53 97.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 121.149 1.795 . . . . 0.0 110.628 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.67 -43.02 99.65 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.84 -29.35 44.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.806 -1.093 . . . . 0.0 112.222 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.05 -44.54 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.4 -46.71 93.83 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.71 -42.18 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.848 0.824 . . . . 0.0 110.429 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -46.05 91.8 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.2 mt -72.71 -34.38 67.08 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 110.149 -175.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.65 -51.6 69.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 110.752 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.42 -49.25 76.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.982 0.81 . . . . 0.0 109.296 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.37 -39.93 67.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.686 0.675 . . . . 0.0 111.082 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.2 -46.94 54.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.745 0.818 . . . . 0.0 111.854 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.79 -38.45 67.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.606 1.163 . . . . 0.0 111.182 -173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.2 p -89.3 -22.41 22.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 110.114 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.26 44.45 97.46 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.105 1.362 . . . . 0.0 111.301 -175.488 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.4 mtmt -136.67 166.3 23.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.73 171.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.76 132.08 67.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 172.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -122.73 133.98 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -129.6 106.34 8.67 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.81 0.844 . . . . 0.0 109.155 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -75.42 146.91 40.38 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.057 -0.402 . . . . 0.0 110.084 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.95 127.51 15.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -149.44 172.84 14.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.995 0.518 . . . . 0.0 110.237 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -66.83 -10.37 47.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.885 -1.134 . . . . 0.0 113.314 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.43 118.77 0.85 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.926 -2.87 . . . . 0.0 105.926 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 56.2 t-20 -56.22 -47.48 78.35 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.611 0.764 . . . . 0.0 110.347 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -45.1 -24.61 0.26 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.679 3.192 . . . . 0.0 116.397 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 m -112.67 -88.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -60.71 -43.59 97.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.908 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -70.62 -40.56 73.07 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.914 1.234 . . . . 0.0 111.238 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.89 -44.52 96.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.079 0.854 . . . . 0.0 111.007 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.6 mtp -65.44 -45.51 83.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.78 89.41 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.316 0.647 . . . . 0.0 111.092 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -57.17 -45.46 83.62 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.79 -55.11 27.16 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.15 -0.806 . . . . 0.0 113.106 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -68.74 -36.76 78.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.911 1.856 . . . . 0.0 111.144 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.53 76.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.258 -0.902 . . . . 0.0 111.253 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.64 -35.29 70.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.623 0.647 . . . . 0.0 111.904 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.16 -49.93 25.44 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.481 0.712 . . . . 0.0 109.273 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -76.61 -31.51 57.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.22 -36.89 8.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 -171.26 49.35 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 122.116 0.842 . . . . 0.0 113.856 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.69 -14.32 57.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.746 2.019 . . . . 0.0 114.098 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.09 -10.15 2.49 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.774 1.629 . . . . 0.0 111.839 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 2.8 m95 -141.58 157.79 44.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.757 1.223 . . . . 0.0 110.261 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -109.95 139.13 45.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 167.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.02 124.94 67.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -169.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.94 170.51 15.88 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -138.65 142.2 39.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 108.507 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.92 -176.65 4.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.721 1.608 . . . . 0.0 108.466 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.16 173.69 40.19 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -41.42 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.51 179.85 6.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.814 0.846 . . . . 0.0 109.388 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.47 120.95 12.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -73.09 -38.69 66.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.642 0.777 . . . . 0.0 109.364 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.82 -167.47 35.9 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 127.961 2.696 . . . . 0.0 107.798 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.43 100.14 9.12 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -62.59 121.32 66.73 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.539 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.86 -32.82 48.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.032 2.488 . . . . 0.0 113.228 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.98 89.35 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.73 0.695 . . . . 0.0 111.035 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.47 71.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.81 -54.36 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.1 -43.12 93.08 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.127 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.68 -50.11 63.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.661 0.664 . . . . 0.0 110.431 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.4 mmm -75.42 -35.94 60.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.799 0.272 . . . . 0.0 111.578 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.68 -32.94 73.15 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -67.36 -19.85 65.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.872 0.869 . . . . 0.0 112.443 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.74 -10.68 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.504 1.047 . . . . 0.0 110.132 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.28 25.37 44.03 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.035 -1.041 . . . . 0.0 110.666 -169.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.69 89.49 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -78.6 81.44 4.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.288 -171.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.41 6.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.57 -0.728 . . . . 0.0 112.197 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 m -55.0 -27.04 41.14 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.228 1.376 . . . . 0.0 112.09 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.02 -20.72 60.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.939 1.296 . . . . 0.0 112.95 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.45 171.45 10.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.737 0.779 . . . . 0.0 109.994 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -143.65 152.41 41.32 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.539 1.536 . . . . 0.0 107.325 172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -96.12 152.51 18.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.545 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -152.06 160.51 43.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.608 1.963 . . . . 0.0 108.274 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 pt -93.96 160.5 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.64 116.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.724 0.773 . . . . 0.0 112.955 -169.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.51 113.27 25.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 m -61.43 -24.22 66.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.576 1.15 . . . . 0.0 112.56 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.15 -39.31 82.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.013 0.824 . . . . 0.0 111.222 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.0 mt -66.29 -48.19 81.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.52 -48.71 68.78 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 109.954 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.84 -2.89 8.08 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -132.96 1.43 3.57 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.535 1.516 . . . . 0.0 114.199 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.15 47.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.209 0.913 . . . . 0.0 109.599 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.27 -34.75 78.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.2 tp -147.36 144.2 28.55 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.969 1.308 . . . . 0.0 110.596 -171.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.77 136.51 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 109.82 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.4 p -88.88 101.09 13.7 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.84 -10.48 59.85 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.14 158.96 43.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.103 0.865 . . . . 0.0 109.005 169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.4 -42.67 93.73 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.104 -169.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.36 -32.39 74.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.844 0.822 . . . . 0.0 111.364 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.96 69.41 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.749 0.419 . . . . 0.0 112.053 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.41 -33.85 73.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.898 0.772 . . . . 0.0 111.599 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -89.16 59.65 5.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.404 1.082 . . . . 0.0 110.069 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.9 83.82 30.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.8 70.64 2.78 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.451 3.434 . . . . 0.0 112.134 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.6 mtt 78.55 100.18 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 129.294 3.038 . . . . 0.0 112.001 172.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -105.53 84.34 1.15 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.83 172.69 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.297 2.665 . . . . 0.0 110.775 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -49.49 -27.97 15.26 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.805 3.003 . . . . 0.0 116.365 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -68.44 -8.56 41.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.112 0.965 . . . . 0.0 113.042 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.54 86.96 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 128.421 2.688 . . . . 0.0 105.304 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -66.93 164.94 16.48 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -143.07 145.88 33.29 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.349 -0.845 . . . . 0.0 109.234 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -132.8 157.1 45.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.418 1.487 . . . . 0.0 107.576 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -141.29 138.51 33.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.843 . . . . 0.0 110.747 -168.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.52 -171.85 2.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.813 1.645 . . . . 0.0 108.43 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.63 77.68 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 O-C-N 121.174 -0.953 . . . . 0.0 113.214 -169.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.14 151.14 45.05 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.088 0.944 . . . . 0.0 111.372 170.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.51 160.32 32.65 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.444 1.898 . . . . 0.0 113.265 -169.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.85 129.36 71.0 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.096 0.959 . . . . 0.0 111.712 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.55 -30.19 4.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.188 1.925 . . . . 0.0 114.009 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.29 -13.23 57.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.27 9.65 10.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.758 1.223 . . . . 0.0 111.435 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.11 141.9 52.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.39 162.14 37.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.97 0.908 . . . . 0.0 109.708 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.54 -50.07 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.88 165.37 22.86 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.557 2.343 . . . . 0.0 105.272 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.97 -40.01 83.46 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.51 -0.744 . . . . 0.0 110.641 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.97 -29.06 66.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.411 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.06 -44.5 60.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.826 0.739 . . . . 0.0 109.128 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -56.43 -51.04 69.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.778 0.831 . . . . 0.0 109.825 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -62.85 -42.53 99.78 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.625 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.36 78.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.914 0.779 . . . . 0.0 110.142 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.37 -38.34 90.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.043 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.21 -50.9 68.22 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -60.39 -43.7 96.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.02 0.528 . . . . 0.0 111.516 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -60.52 -50.01 75.27 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.281 0.491 . . . . 0.0 110.305 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.82 -39.41 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.669 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -56.65 -51.97 66.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.696 1.134 . . . . 0.0 109.602 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.29 -41.33 96.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.456 0.702 . . . . 0.0 110.005 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.84 -26.85 44.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.618 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -45.96 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.46 -44.15 93.62 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -60.4 -39.65 88.12 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.205 1.402 . . . . 0.0 111.179 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.53 79.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.69 -32.69 64.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.518 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -51.42 69.81 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.226 1.011 . . . . 0.0 110.56 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.64 -47.18 82.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.557 1.071 . . . . 0.0 109.582 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.08 -39.03 71.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.403 0.547 . . . . 0.0 111.071 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.45 33.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.706 0.803 . . . . 0.0 111.624 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.76 -38.78 76.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.62 1.168 . . . . 0.0 111.183 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 31.4 p -89.14 -17.87 28.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.28 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.11 40.89 94.24 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -172.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.615 1.166 . . . . 0.0 111.702 -169.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.7 mtmt -134.41 165.74 24.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.031 1.333 . . . . 0.0 108.332 169.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.74 134.31 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.3 135.06 63.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -131.77 104.4 6.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.562 0.745 . . . . 0.0 109.53 -169.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.67 142.53 38.77 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.07 1.348 . . . . 0.0 110.141 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? -143.92 129.49 19.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.51 175.12 11.09 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.318 0.508 . . . . 0.0 110.774 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -6.64 21.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.64 133.7 3.09 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.98 33.12 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.064 0.932 . . . . 0.0 112.23 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 m -116.21 -1.94 12.28 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.796 1.239 . . . . 0.0 110.97 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -150.27 -94.61 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.968 0.804 . . . . 0.0 111.988 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -58.08 -46.41 85.49 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.883 1.273 . . . . 0.0 112.16 -169.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.8 p -72.38 -28.08 62.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.95 0.796 . . . . 0.0 112.055 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -68.92 -42.26 77.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.882 0.764 . . . . 0.0 110.249 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.45 -46.4 80.02 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.35 81.29 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.164 0.586 . . . . 0.0 111.104 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -57.81 -47.97 81.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.334 1.054 . . . . 0.0 109.546 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.66 -50.96 60.89 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.745 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.1 m95 -64.83 -38.3 90.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.844 1.822 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.15 79.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.642 -0.661 . . . . 0.0 111.567 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.73 -27.01 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.398 0.999 . . . . 0.0 112.475 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -46.58 13.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.452 0.701 . . . . 0.0 109.586 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -78.89 -27.2 43.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.62 -140.23 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.887 1.275 . . . . 0.0 108.101 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.16 -175.79 47.8 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.85 -12.37 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -58.14 -10.99 2.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.754 2.022 . . . . 0.0 111.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.44 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 10.2 m95 -134.98 166.36 23.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.131 1.772 . . . . 0.0 108.913 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -124.59 135.68 53.32 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 167.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 118.39 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -168.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 173.25 11.91 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.48 1.112 . . . . 0.0 109.346 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 56.8 p -136.03 159.82 40.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.225 1.01 . . . . 0.0 110.163 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.03 -169.4 3.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.755 1.622 . . . . 0.0 107.199 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.59 173.49 42.64 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.333 -0.854 . . . . 0.0 111.221 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.97 -39.23 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.555 1.142 . . . . 0.0 108.905 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.12 -178.74 6.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 108.51 170.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.11 43.55 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.545 1.538 . . . . 0.0 108.384 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -144.76 -39.22 0.27 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.063 0.945 . . . . 0.0 110.123 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.6 140.74 2.97 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.78 114.74 2.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.821 1.31 . . . . 0.0 108.062 169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.47 157.35 80.32 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.312 -169.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.7 -36.58 73.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.703 2.935 . . . . 0.0 113.866 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -36.86 85.28 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.168 0.895 . . . . 0.0 111.325 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.98 67.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.33 -52.52 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.15 -42.1 96.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.89 0.768 . . . . 0.0 110.587 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.55 -45.62 84.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.499 0.59 . . . . 0.0 110.792 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 93.3 mmm -75.94 -37.98 58.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.503 0.138 . . . . 0.0 111.112 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -61.95 -36.42 81.37 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.88 -22.32 63.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.835 0.854 . . . . 0.0 112.509 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -77.79 -26.06 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.365 0.984 . . . . 0.0 109.601 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.97 23.62 6.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.116 1.341 . . . . 0.0 111.489 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.5 mt -124.71 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 -171.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -79.85 75.69 6.55 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.276 0.63 . . . . 0.0 110.866 -170.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -70.98 0.24 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.927 -1.035 . . . . 0.0 112.071 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -51.87 -28.03 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.208 1.367 . . . . 0.0 111.78 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.18 -20.23 64.84 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.519 1.528 . . . . 0.0 113.6 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -77.45 169.29 18.57 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.059 . . . . 0.0 109.698 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 p -143.82 167.46 22.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.584 1.953 . . . . 0.0 107.876 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.6 p -118.97 151.64 37.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.358 0.663 . . . . 0.0 111.257 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.35 154.88 35.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.724 1.61 . . . . 0.0 109.028 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.96 165.85 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 tt -57.12 106.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.186 0.994 . . . . 0.0 111.816 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -89.11 102.22 14.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -16.37 49.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.138 0.975 . . . . 0.0 112.222 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.91 -37.25 62.13 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.999 1.272 . . . . 0.0 111.871 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.07 -48.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.1 -47.46 65.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.686 0.795 . . . . 0.0 110.52 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -67.45 -8.26 31.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -128.75 3.39 5.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.274 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.33 148.1 51.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.45 -32.9 72.12 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.5 tp -147.41 144.35 28.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.225 1.41 . . . . 0.0 110.428 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.49 139.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 m -128.45 129.25 68.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -88.65 138.24 31.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.5 mt -110.62 0.7 17.65 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 112.511 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -152.19 161.79 42.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.595 1.089 . . . . 0.0 109.22 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.46 -51.43 57.81 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 123.897 0.761 . . . . 0.0 112.017 -171.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.09 -31.45 70.18 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.15 -30.01 70.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.478 0.581 . . . . 0.0 112.425 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.26 67.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.88 -38.08 89.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.045 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.59 -42.85 24.09 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.056 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.8 t -47.72 106.52 0.61 Allowed Pre-proline 0 CA--C 1.547 0.861 0 O-C-N 124.76 1.288 . . . . 0.0 110.275 -169.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.45 174.68 7.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.682 3.588 . . . . 0.0 111.461 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 99.0 mmm -58.63 135.7 57.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.152 0.581 . . . . 0.0 111.041 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 p -120.53 105.22 41.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.945 1.698 . . . . 0.0 106.675 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.27 168.88 18.13 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.813 2.342 . . . . 0.0 110.693 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.32 -24.48 15.9 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.009 3.139 . . . . 0.0 116.288 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.29 -10.34 31.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.033 0.933 . . . . 0.0 112.847 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 93.92 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 128.007 2.523 . . . . 0.0 105.621 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -70.64 164.31 25.22 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.17 144.2 31.45 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.626 0.771 . . . . 0.0 109.062 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.12 164.66 29.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -144.55 113.0 6.57 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.772 0.829 . . . . 0.0 109.283 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -115.55 169.18 9.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.662 1.585 . . . . 0.0 107.851 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.9 107.94 0.63 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.784 -169.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.87 118.86 17.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.953 0.901 . . . . 0.0 111.765 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -66.52 153.41 43.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.4 1.08 . . . . 0.0 109.542 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.64 121.36 82.19 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.522 -172.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.03 -32.92 8.14 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.837 1.691 . . . . 0.0 112.588 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 -19.93 65.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.029 0.831 . . . . 0.0 112.189 -172.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.26 -2.03 43.53 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.712 1.205 . . . . 0.0 111.811 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 142.71 45.36 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -156.51 164.69 37.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.777 0.431 . . . . 0.0 110.94 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -47.91 0.69 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -165.24 166.01 19.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.245 2.218 . . . . 0.0 105.391 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.92 -40.51 80.56 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.546 -0.721 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.09 -27.42 64.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.188 -0.434 . . . . 0.0 111.473 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.76 -44.59 55.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 109.192 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -56.63 -49.88 73.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.457 0.703 . . . . 0.0 109.892 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -64.64 -39.36 93.56 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.097 -0.377 . . . . 0.0 111.089 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.61 74.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 110.655 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -68.41 -40.56 81.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.244 0.474 . . . . 0.0 110.503 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -58.36 -39.79 80.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.712 0.687 . . . . 0.0 109.841 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -63.11 -49.71 73.34 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.576 0.625 . . . . 0.0 110.208 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -59.77 -49.96 75.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.118 0.417 . . . . 0.0 110.37 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.54 -46.24 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.099 -1.429 . . . . 0.0 110.039 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -62.54 -42.17 99.36 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 121.683 2.038 . . . . 0.0 110.916 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.87 -44.66 96.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.45 -36.04 65.82 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.065 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -63.75 -40.55 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.528 1.513 . . . . 0.0 108.984 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.64 -44.34 97.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.95 -37.1 85.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.53 1.132 . . . . 0.0 112.036 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -56.27 -52.05 65.91 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 -35.77 77.38 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 119.024 -0.513 . . . . 0.0 111.918 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -49.33 77.89 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.589 0.755 . . . . 0.0 110.477 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -61.08 -50.78 71.9 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -54.87 -41.45 70.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.222 0.609 . . . . 0.0 111.321 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.33 -47.48 56.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.007 0.923 . . . . 0.0 111.505 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -73.24 -38.34 66.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.143 0.977 . . . . 0.0 111.642 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.1 p -92.23 -21.57 20.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.381 1.073 . . . . 0.0 110.6 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.06 42.46 99.73 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.438 1.495 . . . . 0.0 111.153 -175.315 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.2 mtmt -138.12 171.47 14.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.577 1.551 . . . . 0.0 108.464 169.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.7 131.28 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.83 133.67 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.52 107.11 9.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.84 143.74 37.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.689 1.196 . . . . 0.0 110.497 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.28 127.87 17.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 108.821 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.81 169.67 16.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.848 1.259 . . . . 0.0 111.256 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -67.22 -16.42 64.29 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.133 -0.979 . . . . 0.0 113.276 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.83 112.86 0.54 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.07 -35.81 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.643 1.177 . . . . 0.0 112.337 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -41.13 -19.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.266 3.026 . . . . 0.0 118.496 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -141.59 -54.74 0.46 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.708 1.595 . . . . 0.0 113.804 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -56.59 -53.72 54.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.342 0.974 . . . . 0.0 113.456 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -36.65 78.85 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.058 0.845 . . . . 0.0 110.257 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -58.07 -43.28 86.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.785 0.721 . . . . 0.0 111.597 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -66.2 -48.06 71.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.803 0.841 . . . . 0.0 109.415 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.24 74.2 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.192 0.597 . . . . 0.0 110.769 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.04 -45.34 93.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.47 0.708 . . . . 0.0 110.289 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.93 92.82 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.223 -0.765 . . . . 0.0 112.377 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.6 m95 -66.72 -43.81 83.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.914 1.357 . . . . 0.0 110.572 176.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.81 78.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.205 0.457 . . . . 0.0 110.84 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.56 -33.35 68.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.689 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.79 -57.98 4.84 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.809 0.732 . . . . 0.0 110.023 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -69.19 -33.38 73.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.9 mt -100.09 -37.85 8.79 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.05 -173.32 48.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.074 0.845 . . . . 0.0 113.4 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.18 -14.91 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.499 1.92 . . . . 0.0 113.753 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -57.23 -11.11 1.52 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.595 1.958 . . . . 0.0 111.794 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.8 m95 -142.24 147.47 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.255 1.022 . . . . 0.0 110.922 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -92.46 140.36 29.65 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.03 125.32 64.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.73 160.41 34.39 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.827 0.851 . . . . 0.0 111.38 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -136.46 128.6 29.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.808 1.643 . . . . 0.0 108.674 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 -168.85 3.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.9 176.83 42.97 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.61 -42.79 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.807 1.243 . . . . 0.0 107.908 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -143.45 177.15 8.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.254 0.622 . . . . 0.0 110.276 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.8 43.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.574 2.35 . . . . 0.0 107.219 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -134.77 -36.33 0.85 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.286 1.035 . . . . 0.0 110.077 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.47 179.31 44.99 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.02 102.82 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -67.74 134.09 92.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.135 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.09 -33.11 72.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.199 2.6 . . . . 0.0 113.738 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -36.6 78.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.732 0.696 . . . . 0.0 111.28 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.12 71.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.17 -54.06 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.48 -43.27 90.74 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.476 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.4 82.9 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.837 0.744 . . . . 0.0 111.345 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.3 mmm -77.6 -40.35 42.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.172 0.442 . . . . 0.0 111.359 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -63.36 -31.75 72.99 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.422 -0.799 . . . . 0.0 110.707 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.15 -21.7 64.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.424 1.089 . . . . 0.0 112.604 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -77.52 -22.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.558 1.072 . . . . 0.0 109.55 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.39 14.78 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.741 1.162 . . . . 0.0 110.774 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.36 99.64 8.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.44 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.15 4.44 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 110.705 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -27.28 63.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.141 1.337 . . . . 0.0 111.017 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -67.15 -16.62 64.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.915 2.086 . . . . 0.0 113.614 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.87 172.57 13.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.504 1.122 . . . . 0.0 109.213 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -150.14 160.19 43.85 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.256 1.422 . . . . 0.0 108.411 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.4 m -101.08 153.63 19.4 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.13 155.49 31.1 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.809 2.044 . . . . 0.0 108.335 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.38 159.89 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.41 141.35 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.141 0.976 . . . . 0.0 112.372 -169.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -119.45 111.55 18.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.738 1.615 . . . . 0.0 107.668 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -70.75 -21.75 62.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.58 -46.39 59.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.337 0.971 . . . . 0.0 110.106 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.81 -39.52 85.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.16 -47.88 71.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.929 0.786 . . . . 0.0 110.085 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -73.67 -7.12 50.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -98.59 -21.42 16.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 111.186 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.79 142.45 58.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.193 0.451 . . . . 0.0 110.054 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.84 -32.68 73.37 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.619 -0.676 . . . . 0.0 109.295 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.7 tp -144.99 145.12 31.38 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.002 1.321 . . . . 0.0 109.625 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.19 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.78 127.79 66.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 169.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 86' ' ' ALA . 2.4 p -94.23 96.85 9.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.59 -9.39 26.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.346 1.458 . . . . 0.0 114.356 -168.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 t -149.72 160.35 43.6 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 121.124 1.784 . . . . 0.0 110.352 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -44.79 -66.51 1.42 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 127.164 2.316 . . . . 0.0 113.217 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.11 -22.65 62.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.02 69.87 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.875 -0.516 . . . . 0.0 111.336 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -63.91 -17.46 63.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.94 -31.27 71.58 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.195 0.907 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -91.69 74.05 5.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.793 0.837 . . . . 0.0 109.175 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 p -123.16 74.25 49.45 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 0.0 109.391 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.59 74.07 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.608 3.538 . . . . 0.0 111.615 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.5 mmt 66.23 129.31 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.274 3.03 . . . . 0.0 112.412 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 p -141.44 81.58 15.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.94 171.69 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.7 3.6 . . . . 0.0 113.635 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.9 -29.84 28.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.47 2.78 . . . . 0.0 114.806 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.34 -4.83 28.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 113.171 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.74 78.38 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.55 2.34 . . . . 0.0 105.4 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -68.18 167.81 13.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -135.37 156.22 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.583 0.753 . . . . 0.0 111.879 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.79 162.7 38.7 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 169.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -153.21 119.34 5.46 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.087 -1.008 . . . . 0.0 110.337 -169.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -115.77 -174.82 2.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 0.0 110.06 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.87 44.26 1.19 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.365 0.983 . . . . 0.0 113.627 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -80.76 104.63 11.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.026 0.93 . . . . 0.0 111.342 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.87 152.31 36.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.808 0.843 . . . . 0.0 110.086 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.36 120.73 83.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.71 -33.66 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 112.784 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.15 65.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.996 0.817 . . . . 0.0 112.069 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.37 9.02 35.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.976 1.31 . . . . 0.0 111.633 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.88 22.35 0.05 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.313 1.445 . . . . 0.0 114.221 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.1 152.53 7.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.35 1.86 . . . . 0.0 111.825 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.89 -51.29 0.2 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -154.16 154.84 34.24 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.01 -38.29 85.53 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.505 -0.747 . . . . 0.0 110.742 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.53 -30.98 71.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.362 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -72.55 -48.34 40.95 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -53.48 -52.45 59.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 109.84 176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -64.22 -42.56 96.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.825 0.85 . . . . 0.0 111.168 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.78 72.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.992 0.815 . . . . 0.0 110.307 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -66.29 -38.19 87.18 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.564 -0.71 . . . . 0.0 111.152 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -57.45 -45.92 84.19 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.172 0.896 . . . . 0.0 108.996 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -60.1 -49.4 77.81 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.624 0.77 . . . . 0.0 110.993 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -58.68 -49.67 76.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.97 -47.65 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.328 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -64.01 -41.86 97.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 121.259 1.845 . . . . 0.0 110.673 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.32 -42.89 99.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.922 0.328 . . . . 0.0 110.259 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -75.75 -36.14 59.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.108 -0.949 . . . . 0.0 112.31 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -61.66 -46.25 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.72 92.38 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -54.82 -46.99 74.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.671 1.188 . . . . 0.0 111.879 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -39.82 88.0 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.98 -0.45 . . . . 0.0 109.904 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.74 -35.32 72.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.243 0.617 . . . . 0.0 110.99 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -60.04 -49.64 76.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.817 0.847 . . . . 0.0 110.271 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.6 -46.62 81.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.03 0.832 . . . . 0.0 109.71 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -54.3 -40.63 68.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.85 0.75 . . . . 0.0 110.916 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.77 37.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -71.82 -36.08 70.13 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.335 1.054 . . . . 0.0 111.566 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.3 p -90.28 -16.94 28.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 110.27 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.37 41.11 92.97 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.799 1.24 . . . . 0.0 111.842 -170.631 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -130.92 161.5 31.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.723 1.609 . . . . 0.0 107.107 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -136.64 130.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.82 127.03 74.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -124.8 100.11 6.46 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -169.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -73.09 147.88 44.54 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.3 143.46 37.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.313 1.845 . . . . 0.0 106.724 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.83 173.18 16.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 p -67.25 -11.52 57.7 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.326 -0.859 . . . . 0.0 113.164 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.23 116.61 0.73 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -55.36 -39.24 69.84 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.269 1.027 . . . . 0.0 111.756 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.48 -34.88 0.24 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.107 3.363 . . . . 0.0 115.777 -169.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 m -120.41 -73.92 0.63 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.069 0.547 . . . . 0.0 110.347 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -62.16 -48.52 79.73 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.211 0.604 . . . . 0.0 110.985 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -70.59 -37.17 73.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.316 -0.374 . . . . 0.0 110.741 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.38 -44.64 95.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.927 0.491 . . . . 0.0 111.127 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.3 mtm -67.0 -45.66 76.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.525 0.602 . . . . 0.0 110.287 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.71 81.47 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.748 0.704 . . . . 0.0 111.14 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -57.33 -47.04 82.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.288 1.035 . . . . 0.0 109.761 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.27 50.67 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.657 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' CD1' HG22 ' A' ' 127' ' ' ILE . 94.4 m95 -67.26 -37.49 83.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.817 1.809 . . . . 0.0 111.029 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.71 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.285 -0.884 . . . . 0.0 111.386 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.94 -24.79 67.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.957 0.799 . . . . 0.0 112.512 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.22 -46.99 12.03 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.892 0.769 . . . . 0.0 109.71 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -75.4 -30.75 60.22 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.7 -143.88 0.29 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.995 1.318 . . . . 0.0 108.091 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.2 -178.57 46.1 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.92 -13.85 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.95 -9.94 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.542 1.937 . . . . 0.0 111.642 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -125.58 161.74 26.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.376 1.87 . . . . 0.0 108.39 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.93 138.29 54.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.126 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.86 117.27 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 173.7 11.42 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -142.01 157.28 45.11 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 0.0 109.905 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.07 -163.63 1.75 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.462 1.505 . . . . 0.0 107.896 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.28 175.76 43.5 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.64 -41.8 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.05 176.43 8.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.791 0.836 . . . . 0.0 110.056 170.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.78 6.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.022 1.729 . . . . 0.0 107.139 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -74.48 -36.28 63.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.062 0.545 . . . . 0.0 109.626 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.81 -179.31 30.98 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -74.2 99.43 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -61.84 124.58 82.19 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.264 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.45 -33.51 38.26 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.269 2.646 . . . . 0.0 113.608 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -39.75 91.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.91 0.777 . . . . 0.0 110.916 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.31 75.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.95 -56.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.58 -42.06 99.32 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 119.042 0.837 . . . . 0.0 110.348 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.38 65.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.512 0.325 . . . . 0.0 110.336 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 90.1 mmm -74.44 -36.06 63.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.905 0.321 . . . . 0.0 110.873 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -61.8 -35.78 79.2 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.422 -0.799 . . . . 0.0 110.129 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.29 -24.25 63.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 112.572 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.38 -22.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.314 0.961 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.85 23.93 8.96 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.824 1.202 . . . . 0.0 111.263 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.1 mt -123.57 94.21 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -79.13 80.27 5.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -76.27 5.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.56 -0.712 . . . . 0.0 112.205 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -54.57 -26.46 32.44 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.824 1.193 . . . . 0.0 112.232 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.45 -20.06 57.42 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.99 1.316 . . . . 0.0 113.135 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.59 167.32 17.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 109.3 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -145.34 158.79 43.76 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.428 1.491 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -108.65 147.1 32.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.858 0.863 . . . . 0.0 110.103 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -155.17 159.5 40.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.026 1.331 . . . . 0.0 108.578 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.31 161.18 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.02 131.78 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.766 0.826 . . . . 0.0 111.987 -169.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.25 114.57 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.574 1.55 . . . . 0.0 107.327 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -69.37 -17.95 63.74 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.261 -171.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.06 -41.71 28.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.594 1.088 . . . . 0.0 110.504 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.42 -45.68 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -50.11 -50.85 47.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.03 0.932 . . . . 0.0 110.518 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -70.49 -19.51 62.93 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -89.94 -16.19 30.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.679 1.127 . . . . 0.0 110.976 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.53 34.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.225 0.536 . . . . 0.0 111.45 -169.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.52 -33.16 36.57 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 168.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -148.44 146.68 28.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.134 1.773 . . . . 0.0 110.374 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.43 140.04 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.32 111.67 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.6 p -93.53 108.41 20.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.57 -3.82 23.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.306 -170.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 36.3 t -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 120.881 1.673 . . . . 0.0 108.748 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.87 -35.81 92.49 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 123.674 0.654 . . . . 0.0 112.413 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.27 -25.91 64.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.683 1.242 . . . . 0.0 111.517 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -18.28 58.36 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.182 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.84 67.02 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.851 0.75 . . . . 0.0 112.505 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.24 -32.59 74.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 112.033 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -86.49 57.99 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.85 0.86 . . . . 0.0 110.983 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.7 m -124.01 78.02 58.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.25 -49.93 5.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.299 3.332 . . . . 0.0 114.872 -172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.1 mtp -152.85 137.04 16.49 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.0 1.72 . . . . 0.0 107.289 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.7 p -134.4 71.09 72.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.45 164.78 24.76 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.638 2.892 . . . . 0.0 110.82 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.04 -20.44 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.798 1 C-N-CA 125.458 4.105 . . . . 0.0 119.719 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -60.05 -44.42 94.69 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.625 1.557 . . . . 0.0 109.184 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.09 156.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 127.708 2.403 . . . . 0.0 108.075 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -134.71 167.36 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 169.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -139.2 146.65 40.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.276 0.944 . . . . 0.0 110.084 -169.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -142.61 156.33 45.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.001 1.32 . . . . 0.0 107.867 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.37 140.36 30.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.246 1.019 . . . . 0.0 110.316 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -136.19 -164.7 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.678 1.591 . . . . 0.0 109.562 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.0 40.63 1.17 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.572 1.078 . . . . 0.0 114.342 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.51 116.85 22.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.509 1.155 . . . . 0.0 111.879 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.17 152.68 43.16 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.557 0.743 . . . . 0.0 109.231 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.4 123.95 88.85 Favored Pre-proline 0 C--O 1.236 0.354 0 O-C-N 121.892 -0.505 . . . . 0.0 111.904 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.28 -31.6 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.055 1.837 . . . . 0.0 112.868 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.55 -21.37 65.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.083 0.856 . . . . 0.0 112.306 -174.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -94.56 -4.41 47.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.453 1.101 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.65 57.35 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.071 0.85 . . . . 0.0 109.304 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -144.74 161.42 39.26 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.528 1.131 . . . . 0.0 109.245 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.64 -51.05 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.23 164.01 25.24 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.083 2.153 . . . . 0.0 105.51 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.23 -39.94 84.32 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.546 -0.721 . . . . 0.0 110.598 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.84 -29.21 67.49 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.344 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -74.14 -42.35 60.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.029 0.831 . . . . 0.0 109.507 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.97 -50.46 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.181 0.592 . . . . 0.0 109.773 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -63.15 -39.47 94.75 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.105 0.411 . . . . 0.0 111.036 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.88 74.79 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.38 -0.825 . . . . 0.0 110.661 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.89 -41.43 91.52 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.07 -1.019 . . . . 0.0 110.324 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -57.08 -41.78 79.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -63.82 -49.77 71.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 111.385 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.68 -51.54 68.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.433 0.561 . . . . 0.0 109.928 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.61 -37.9 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.459 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -53.06 -57.54 10.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.546 1.521 . . . . 0.0 110.638 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.34 -42.02 94.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.171 0.919 . . . . 0.0 109.821 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.75 -26.16 37.5 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.578 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -66.96 -46.22 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.445 1.475 . . . . 0.0 107.043 169.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.71 96.66 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -58.12 -41.88 84.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.937 1.295 . . . . 0.0 111.37 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -49.1 77.83 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.43 -31.13 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.017 0.527 . . . . 0.0 110.56 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -52.4 65.33 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.182 0.993 . . . . 0.0 110.229 169.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.56 -47.29 84.49 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.394 0.997 . . . . 0.0 109.021 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.74 -37.95 66.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.968 0.507 . . . . 0.0 111.187 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.75 -47.15 32.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 122.963 0.505 . . . . 0.0 111.33 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.01 -41.51 74.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.923 0.889 . . . . 0.0 111.205 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.0 p -85.31 -17.64 36.27 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.954 0.902 . . . . 0.0 110.075 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.56 40.96 93.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 124.895 1.236 . . . . 0.0 110.539 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.049 -0.976 . . . . 0.0 111.524 -172.756 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -123.48 165.45 17.08 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.472 1.509 . . . . 0.0 109.439 -174.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.35 138.17 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tt -127.67 136.54 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -129.85 105.86 8.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.92 141.51 42.28 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.864 0.866 . . . . 0.0 110.359 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.41 136.86 41.73 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.553 1.141 . . . . 0.0 108.499 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -156.16 171.65 19.8 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.02 0.827 . . . . 0.0 110.885 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.0 p -66.94 -11.67 57.22 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.861 -1.149 . . . . 0.0 113.177 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.96 121.92 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -58.17 -44.23 87.87 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 110.597 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -37.57 -29.15 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 C-N-CA 130.655 3.582 . . . . 0.0 117.514 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 m -125.59 -74.69 0.6 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.634 0.774 . . . . 0.0 109.859 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -60.46 -47.9 84.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.924 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -65.95 -46.53 77.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.712 0.687 . . . . 0.0 110.165 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -57.38 -42.68 82.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.953 0.501 . . . . 0.0 112.107 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.0 mtp -65.99 -48.48 71.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.623 0.769 . . . . 0.0 109.623 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.48 79.08 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.341 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.47 -45.13 89.24 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.91 0.884 . . . . 0.0 110.396 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.64 93.46 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.595 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -68.95 -43.65 74.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.312 1.556 . . . . 0.0 111.217 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.49 75.28 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.06 0.391 . . . . 0.0 110.863 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.21 -35.17 69.32 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -68.91 -57.33 5.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.497 0.59 . . . . 0.0 109.984 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.04 -35.93 79.07 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.78 -37.07 10.92 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.41 175.01 49.81 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 122.006 0.781 . . . . 0.0 113.048 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.29 -15.56 63.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.024 1.33 . . . . 0.0 114.181 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.92 -16.36 17.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.934 -0.479 . . . . 0.0 112.251 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -112.71 165.4 12.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.21 1.004 . . . . 0.0 109.068 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.1 145.34 46.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.14 119.7 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.95 169.34 17.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.485 0.659 . . . . 0.0 110.254 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -135.34 140.02 44.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.085 1.354 . . . . 0.0 109.418 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.06 -175.08 4.28 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.793 1.237 . . . . 0.0 108.801 169.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.75 176.03 42.52 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.83 -41.8 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.33 179.79 7.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 109.737 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.05 152.98 40.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.011 2.124 . . . . 0.0 106.393 171.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -129.47 -14.14 4.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.889 0.875 . . . . 0.0 111.619 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.77 -175.92 34.96 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -85.39 106.05 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -62.76 125.8 87.18 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.905 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 -34.37 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.152 2.568 . . . . 0.0 113.659 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -38.46 88.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.859 0.754 . . . . 0.0 110.768 176.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.79 73.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.85 -52.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -65.76 -42.43 90.9 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 118.951 0.796 . . . . 0.0 110.781 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.52 81.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.898 0.772 . . . . 0.0 110.993 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.8 mmm -75.86 -38.82 57.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.403 0.281 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -65.06 -33.97 77.3 Favored 'General case' 0 N--CA 1.461 0.105 0 O-C-N 121.061 -1.025 . . . . 0.0 111.036 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -65.02 -21.16 66.8 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.001 0.92 . . . . 0.0 112.158 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.71 -7.76 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.565 1.146 . . . . 0.0 110.294 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.76 21.16 34.68 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.931 -1.106 . . . . 0.0 111.987 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.21 91.83 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -78.12 85.95 4.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.198 0.523 . . . . 0.0 110.169 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -77.67 2.25 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.27 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -59.75 -23.13 62.97 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.107 1.776 . . . . 0.0 112.08 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -71.44 -18.39 62.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 112.907 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -72.52 173.28 9.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.102 0.961 . . . . 0.0 109.96 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -149.17 163.12 38.52 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.529 1.531 . . . . 0.0 108.606 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.4 m -107.08 155.4 19.88 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.179 0.992 . . . . 0.0 110.279 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.567 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -154.56 162.23 41.24 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.716 2.406 . . . . 0.0 108.411 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 pt -92.64 164.02 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.58 133.61 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 112.04 -169.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -122.42 102.56 8.17 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.011 1.724 . . . . 0.0 106.952 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -15.08 40.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.595 0.758 . . . . 0.0 112.194 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.2 -42.74 88.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.515 1.052 . . . . 0.0 111.249 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.92 -43.05 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tt -53.05 -47.15 68.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.976 0.51 . . . . 0.0 110.576 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -67.92 -18.77 64.87 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -96.53 -16.78 20.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.435 1.016 . . . . 0.0 111.484 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.61 153.91 40.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.406 0.548 . . . . 0.0 110.879 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.94 -38.2 66.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.09 166.48 30.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.243 1.02 . . . . 0.0 112.125 170.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.06 143.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.0 131.06 64.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -84.89 142.67 29.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -107.51 -1.75 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.31 0.644 . . . . 0.0 110.595 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.55 156.5 41.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.9 -38.19 88.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.3 -30.12 69.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.824 0.812 . . . . 0.0 111.933 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.66 78.35 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.146 0.43 . . . . 0.0 111.445 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.51 66.94 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.98 -39.3 93.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 111.783 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -81.96 -40.02 22.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 117.798 -1.096 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.8 m -47.6 108.11 0.84 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.565 1.146 . . . . 0.0 109.27 -173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.1 165.96 22.46 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.451 2.101 . . . . 0.0 113.289 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.9 111.45 2.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.37 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -72.89 122.46 87.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.864 1.266 . . . . 0.0 108.046 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.16 168.66 22.67 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.188 1.926 . . . . 0.0 110.356 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.03 -22.93 15.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.091 3.194 . . . . 0.0 116.017 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -68.08 -6.35 22.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.3 154.58 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.226 2.211 . . . . 0.0 106.62 -169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 173.69 9.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.355 -0.841 . . . . 0.0 110.734 169.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -127.89 155.04 44.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.256 1.422 . . . . 0.0 109.373 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.99 160.22 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -145.82 113.64 6.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -111.94 176.95 4.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.928 1.291 . . . . 0.0 109.314 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.59 94.69 0.21 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.999 -0.89 . . . . 0.0 112.439 -169.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.5 126.74 33.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.655 0.727 . . . . 0.0 111.481 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -74.34 153.23 39.4 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 169.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.93 120.83 83.28 Favored Pre-proline 0 C--O 1.236 0.395 0 O-C-N 121.915 -0.491 . . . . 0.0 111.131 -170.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.43 -32.22 20.38 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.631 1.554 . . . . 0.0 113.063 -169.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.53 -20.79 65.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -118.01 14.69 14.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 111.345 -177.091 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.98 144.46 45.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -142.66 156.66 45.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.527 0.731 . . . . 0.0 109.272 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.94 -56.52 0.38 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.1 p -146.09 170.14 17.29 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 127.012 2.125 . . . . 0.0 105.499 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.71 -42.38 86.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.659 -0.65 . . . . 0.0 110.994 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.47 -28.84 64.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.126 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.19 -44.35 72.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.111 0.868 . . . . 0.0 109.462 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -55.82 -52.23 64.71 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 109.94 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -59.6 -45.02 93.15 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.953 0.342 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.85 77.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.14 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.46 -37.21 80.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.675 1.125 . . . . 0.0 111.32 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -57.48 -47.94 80.55 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -60.67 -45.48 93.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.176 0.59 . . . . 0.0 111.986 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -60.12 -50.95 71.66 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.702 0.683 . . . . 0.0 109.754 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.09 -42.73 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.626 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -61.7 -43.44 98.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.638 2.017 . . . . 0.0 110.879 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.99 -44.9 95.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.93 -33.74 62.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.184 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.11 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.805 1.639 . . . . 0.0 108.36 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.8 -42.94 99.69 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.462 ' ND2' HH22 ' A' ' 130' ' ' ARG . 56.1 t30 -61.16 -43.13 99.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.258 1.023 . . . . 0.0 111.874 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.462 HH22 ' ND2' ' A' ' 129' ' ' ASN . 13.3 mmp_? -61.83 -41.55 97.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.689 -0.632 . . . . 0.0 110.214 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.0 mt -72.98 -34.74 66.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.672 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -48.56 79.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.179 0.992 . . . . 0.0 109.961 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.15 -50.62 72.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 118.936 0.789 . . . . 0.0 109.7 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.24 -38.9 71.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.493 1.042 . . . . 0.0 111.166 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.39 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.161 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.0 -38.92 31.08 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 110.934 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.5 p -89.61 -24.61 21.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.431 1.092 . . . . 0.0 110.188 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.9 97.86 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.963 -170.51 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.8 mtmt -132.51 171.58 13.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.963 1.705 . . . . 0.0 107.631 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.63 141.71 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -127.58 140.48 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -131.35 100.16 5.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.39 148.95 46.45 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.17 139.46 41.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.759 1.624 . . . . 0.0 107.422 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.22 171.78 18.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.079 0.552 . . . . 0.0 110.338 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -74.7 -5.83 45.39 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.14 95.43 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.0 t-20 -60.16 99.39 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.873 1.269 . . . . 0.0 110.095 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.6 p -160.21 -42.9 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.422 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 p -132.47 -71.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.993 0.917 . . . . 0.0 110.434 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -52.32 -50.59 61.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.349 0.977 . . . . 0.0 111.782 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.9 -42.31 97.48 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.175 0.59 . . . . 0.0 111.221 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -67.99 -39.9 83.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.841 0.857 . . . . 0.0 111.286 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 81.6 mtp -65.09 -48.6 73.11 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.394 1.078 . . . . 0.0 108.695 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.53 81.97 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.911 0.323 . . . . 0.0 110.475 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -56.85 -44.84 82.53 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.99 -47.44 88.74 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.96 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -66.74 -38.01 85.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.956 1.878 . . . . 0.0 110.525 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.09 82.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.291 0.496 . . . . 0.0 110.723 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.28 -26.36 66.43 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.033 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -74.95 -56.85 4.32 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.116 0.871 . . . . 0.0 110.272 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -71.37 -29.57 65.11 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -92.08 -145.08 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.285 1.434 . . . . 0.0 107.905 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.28 -164.77 38.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.33 -19.77 37.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.785 1.634 . . . . 0.0 113.419 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.97 -12.15 4.24 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.17 1.388 . . . . 0.0 111.825 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.405 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 17.3 m95 -142.77 171.54 13.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.923 1.689 . . . . 0.0 110.819 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -129.76 140.92 50.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.645 2.378 . . . . 0.0 104.785 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.71 124.97 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 170.92 15.16 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.7 p -142.61 143.26 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.523 0.729 . . . . 0.0 109.642 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -171.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.702 1.601 . . . . 0.0 109.029 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.52 173.8 40.49 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 121.681 -0.637 . . . . 0.0 111.768 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.88 -41.02 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.103 1.361 . . . . 0.0 108.225 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.77 -176.57 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.324 1.85 . . . . 0.0 106.846 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.9 165.36 25.18 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.189 1.396 . . . . 0.0 109.172 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -129.18 -36.56 1.73 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.351 0.66 . . . . 0.0 110.322 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.65 169.2 12.97 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -58.68 109.91 0.9 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -69.43 125.8 92.21 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.97 -32.78 59.26 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.555 2.17 . . . . 0.0 113.316 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -42.39 98.69 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.84 0.746 . . . . 0.0 110.458 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -39.36 71.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.94 -54.03 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -65.3 -43.29 91.56 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.51 1.05 . . . . 0.0 110.126 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.93 -45.03 67.47 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.43 0.692 . . . . 0.0 111.597 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -80.0 -38.6 31.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.543 0.737 . . . . 0.0 111.354 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.71 -31.01 71.76 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.088 -1.008 . . . . 0.0 110.821 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.89 -20.57 65.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.086 0.954 . . . . 0.0 112.109 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.15 -26.74 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.596 1.089 . . . . 0.0 109.337 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.7 15.86 12.71 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.279 1.419 . . . . 0.0 111.677 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.99 95.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -77.83 88.75 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.31 -0.92 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.247 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -27.38 66.46 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.503 1.501 . . . . 0.0 111.325 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.34 -20.4 63.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.686 1.595 . . . . 0.0 113.007 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -70.58 175.13 5.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.932 0.893 . . . . 0.0 109.853 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -141.06 148.92 40.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.088 1.355 . . . . 0.0 108.751 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -89.07 154.66 20.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 109.689 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.1 t0 -152.65 160.07 43.18 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.545 1.938 . . . . 0.0 107.317 169.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.42 161.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 132.93 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.855 0.862 . . . . 0.0 110.972 -171.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -116.97 109.78 17.45 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.813 1.645 . . . . 0.0 107.121 174.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -59.26 -20.59 55.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.206 1.002 . . . . 0.0 112.398 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.84 -45.94 69.81 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.433 1.015 . . . . 0.0 111.059 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.71 -41.1 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.91 -49.86 58.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.068 0.547 . . . . 0.0 109.868 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -68.64 -14.65 63.15 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -96.14 -20.39 18.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.502 1.046 . . . . 0.0 110.884 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.33 140.42 55.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 118.198 0.454 . . . . 0.0 110.139 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.32 -33.95 76.33 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.632 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 35.6 tp -145.32 142.32 29.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.963 1.305 . . . . 0.0 108.925 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.15 139.8 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.61 110.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -94.06 101.52 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.15 -6.45 23.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.66 159.83 42.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.24 1.382 . . . . 0.0 109.187 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.81 99.7 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.327 -169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.49 -33.53 74.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.017 0.908 . . . . 0.0 111.177 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.49 -21.12 66.6 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.308 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.53 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.849 0.75 . . . . 0.0 112.792 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.23 -30.6 66.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.309 0.504 . . . . 0.0 111.903 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.97 62.49 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 91.7 m -125.5 79.18 67.49 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -50.69 -37.3 53.52 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.588 2.858 . . . . 0.0 114.969 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 36.6 tpp -159.72 128.39 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.2 p -140.56 85.92 12.71 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.62 171.18 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.238 3.292 . . . . 0.0 112.976 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.59 -28.64 29.62 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.577 2.852 . . . . 0.0 114.84 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -70.52 -3.8 19.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.684 1.194 . . . . 0.0 113.143 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.47 79.41 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 105.531 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -68.1 163.04 23.36 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -130.34 153.88 48.24 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.08 -0.388 . . . . 0.0 110.312 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.46 157.29 46.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -143.36 140.08 30.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.665 0.786 . . . . 0.0 109.573 -169.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -137.32 -168.54 2.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.447 1.099 . . . . 0.0 108.959 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.71 39.37 1.41 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.054 -169.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -76.62 111.11 11.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.213 1.006 . . . . 0.0 110.698 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.79 153.63 39.39 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.906 0.882 . . . . 0.0 108.988 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.71 118.97 74.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 119.192 -0.432 . . . . 0.0 112.061 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.29 -31.21 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.227 1.951 . . . . 0.0 112.584 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.6 -21.3 66.13 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.017 0.826 . . . . 0.0 111.959 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -99.38 7.45 45.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.672 1.189 . . . . 0.0 111.56 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.75 15.89 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.761 1.225 . . . . 0.0 114.303 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -51.93 153.73 2.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.18 1.392 . . . . 0.0 112.627 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 -51.94 0.22 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -154.37 153.09 31.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 168.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.36 -38.12 85.81 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 121.403 -0.811 . . . . 0.0 110.781 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.07 -31.45 72.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.23 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.76 -47.66 52.15 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -54.83 -52.54 62.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 110.143 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -63.51 -42.34 98.49 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.55 0.74 . . . . 0.0 111.036 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -35.96 71.23 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.076 0.853 . . . . 0.0 110.607 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.11 -39.15 82.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.22 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.1 -46.46 79.09 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -59.91 -49.89 75.92 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.586 0.754 . . . . 0.0 111.235 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -60.17 -49.51 77.35 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.49 -45.45 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 116.691 -1.623 . . . . 0.0 110.027 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -61.05 -43.84 98.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 122.134 2.243 . . . . 0.0 110.645 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.63 -45.98 91.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.39 -33.65 63.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.21 -44.45 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.544 1.52 . . . . 0.0 108.095 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.02 -44.48 96.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.77 -40.54 96.92 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.393 1.077 . . . . 0.0 112.506 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -56.7 -48.15 78.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.524 0.73 . . . . 0.0 109.305 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.15 -40.61 64.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.98 0.512 . . . . 0.0 109.823 -171.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -56.38 -46.24 80.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.083 0.953 . . . . 0.0 110.943 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.7 -56.04 23.92 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.486 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.31 -28.23 69.57 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.675 1.579 . . . . 0.0 111.372 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.17 63.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.672 0.669 . . . . 0.0 111.633 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -85.78 -31.87 22.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -95.49 -15.24 23.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.742 0.817 . . . . 0.0 111.544 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.26 29.73 74.67 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.405 1.482 . . . . 0.0 110.638 -178.08 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.8 t30 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.467 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.4 mtmt -135.75 169.99 16.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.397 1.479 . . . . 0.0 108.608 170.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.99 130.61 48.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.37 132.08 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.6 107.1 9.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.452 0.701 . . . . 0.0 109.32 -169.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -77.16 142.21 39.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.23 135.01 35.15 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.229 1.812 . . . . 0.0 107.14 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.88 168.57 26.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.478 0.581 . . . . 0.0 110.436 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -68.03 -11.4 58.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.037 -1.039 . . . . 0.0 113.29 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 115.09 0.64 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 105.928 -2.869 . . . . 0.0 105.928 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.21 -40.48 90.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 0.0 111.831 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -38.13 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.534 3.134 . . . . 0.0 117.451 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.25 -62.64 0.79 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.341 0.973 . . . . 0.0 111.983 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -54.69 -51.7 64.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.234 0.925 . . . . 0.0 112.269 -169.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -63.24 -48.05 79.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.499 0.59 . . . . 0.0 110.475 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -60.06 -39.63 86.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.593 0.757 . . . . 0.0 112.033 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.81 -48.43 68.96 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.962 0.905 . . . . 0.0 109.562 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.15 81.55 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.134 0.425 . . . . 0.0 111.176 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.38 -48.41 80.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.0 0.92 . . . . 0.0 110.437 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.11 94.24 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.73 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -67.92 -40.87 83.33 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.879 1.839 . . . . 0.0 110.551 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.91 79.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.524 0.602 . . . . 0.0 111.549 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.8 -32.75 67.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.725 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.6 -58.24 4.18 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.546 0.612 . . . . 0.0 110.096 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -71.41 -33.84 69.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 32.8 mt -95.82 -37.12 10.88 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.261 0.624 . . . . 0.0 112.679 -169.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.26 -176.34 44.61 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.001 0.81 . . . . 0.0 112.789 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 -8.96 34.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.004 1.322 . . . . 0.0 113.672 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.28 -11.26 2.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.368 1.867 . . . . 0.0 111.18 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.467 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.7 m95 -139.82 150.27 44.48 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.792 1.237 . . . . 0.0 109.642 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 5.3 mmpt? -98.43 139.42 34.21 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 167.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.83 117.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -168.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.47 170.31 16.26 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.378 0.609 . . . . 0.0 110.187 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.8 m -135.81 144.94 45.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.24 1.416 . . . . 0.0 109.441 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.91 -173.61 4.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.01 175.62 44.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.56 -40.17 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.43 175.58 10.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.287 0.635 . . . . 0.0 110.876 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.37 156.86 44.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.244 2.618 . . . . 0.0 106.628 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -135.74 -35.67 0.79 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.027 0.931 . . . . 0.0 110.246 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.2 179.04 46.45 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.45 102.14 6.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -60.4 124.7 79.47 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.964 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.95 -34.27 45.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.266 2.644 . . . . 0.0 113.711 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -39.29 91.84 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.844 0.747 . . . . 0.0 110.734 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.49 73.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.54 -54.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.13 -42.91 83.64 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.956 0.798 . . . . 0.0 110.744 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.32 -44.09 79.62 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.529 0.604 . . . . 0.0 110.799 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.3 mmm -76.57 -39.83 51.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.551 0.74 . . . . 0.0 111.372 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -34.18 76.77 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -67.91 -20.17 65.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.004 0.922 . . . . 0.0 112.612 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -78.07 -24.34 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.479 1.036 . . . . 0.0 109.586 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.49 19.21 11.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.108 1.337 . . . . 0.0 111.08 -169.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -117.17 92.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.23 87.58 3.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.77 4.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 117.738 -1.125 . . . . 0.0 111.92 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.6 m -58.02 -25.88 61.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.01 1.732 . . . . 0.0 112.057 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.19 -21.51 62.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 112.68 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.3 169.31 15.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.667 0.787 . . . . 0.0 109.412 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -145.92 156.14 43.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.489 1.116 . . . . 0.0 109.326 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.1 m -95.32 148.53 22.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.251 1.02 . . . . 0.0 111.123 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -156.8 159.75 38.55 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.45 1.5 . . . . 0.0 108.528 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.6 164.39 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.52 117.83 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.598 0.713 . . . . 0.0 112.395 -169.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.27 121.97 36.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -73.04 -23.8 60.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.71 0.804 . . . . 0.0 112.826 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.09 -41.21 62.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.608 0.64 . . . . 0.0 110.105 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.76 -44.63 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -48.98 71.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.332 0.515 . . . . 0.0 110.037 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -69.76 -5.48 25.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -107.02 -20.62 13.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.868 1.213 . . . . 0.0 111.946 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.9 148.22 51.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.389 0.541 . . . . 0.0 111.244 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 39.0 tp -147.0 143.37 28.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 110.072 -169.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.06 138.4 49.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.62 108.4 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.8 p -88.9 90.6 8.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.1 -9.78 34.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.952 0.901 . . . . 0.0 112.812 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.04 156.09 44.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.06 -41.87 94.89 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -170.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -31.74 72.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.608 0.704 . . . . 0.0 111.737 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.68 -27.99 69.62 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.437 0.562 . . . . 0.0 111.902 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 -14.55 62.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.57 -30.43 69.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.009 0.822 . . . . 0.0 112.108 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.27 -35.97 58.65 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 118.052 -0.975 . . . . 0.0 113.288 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.6 m -40.38 105.1 0.36 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.898 1.679 . . . . 0.0 113.48 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.58 71.6 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.056 3.171 . . . . 0.0 111.255 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.8 mtt 79.58 110.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 129.283 3.033 . . . . 0.0 111.673 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.2 p -117.67 81.2 14.51 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.94 173.16 7.41 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.479 2.786 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.4 -28.55 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.829 3.019 . . . . 0.0 116.445 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.39 -8.3 45.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.133 0.973 . . . . 0.0 113.034 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.7 t -134.91 82.95 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 128.47 2.708 . . . . 0.0 105.125 -169.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.3 pttt -66.12 167.68 9.64 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -141.14 150.04 42.29 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.507 -0.745 . . . . 0.0 109.412 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -136.4 162.33 33.36 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -144.68 147.21 32.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.2 1.0 . . . . 0.0 112.006 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -142.72 -168.52 2.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 108.301 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.16 42.51 1.13 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.227 0.921 . . . . 0.0 113.848 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -78.57 115.92 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.555 1.177 . . . . 0.0 111.925 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -66.11 150.6 48.48 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.743 1.217 . . . . 0.0 109.525 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.19 116.65 51.02 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.31 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.45 -33.96 27.85 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.966 1.778 . . . . 0.0 112.661 -171.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.27 -16.68 64.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.439 0.563 . . . . 0.0 112.288 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -105.4 8.62 33.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.11 -38.8 71.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.243 0.929 . . . . 0.0 112.613 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 53.42 -170.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.887 2.075 . . . . 0.0 113.434 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.96 -65.71 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.205 1.86 . . . . 0.0 108.942 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -162.32 161.45 27.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.929 2.092 . . . . 0.0 105.579 170.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.03 -40.18 73.07 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.118 0.872 . . . . 0.0 111.243 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.17 -28.41 66.39 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.487 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.84 -39.45 66.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.863 0.756 . . . . 0.0 109.598 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -60.23 -53.16 60.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -57.83 -41.14 81.68 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.329 0.393 . . . . 0.0 110.58 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.66 77.53 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.074 -0.391 . . . . 0.0 110.878 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -74.42 -35.83 63.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.33 0.652 . . . . 0.0 111.512 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -56.18 -43.58 78.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.339 0.972 . . . . 0.0 108.689 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.47 -48.77 78.31 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.071 0.548 . . . . 0.0 111.386 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.02 -49.4 77.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.156 0.434 . . . . 0.0 110.069 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.11 -46.19 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.976 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -60.95 -43.31 98.9 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 121.776 2.08 . . . . 0.0 110.699 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.44 -45.37 94.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.31 -30.87 62.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.005 -0.997 . . . . 0.0 112.765 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -41.27 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.837 1.199 . . . . 0.0 108.712 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.73 -47.01 90.48 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -59.63 -37.05 77.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.595 1.158 . . . . 0.0 111.411 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -52.77 64.28 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.713 0.805 . . . . 0.0 109.735 173.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.73 -34.5 76.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.918 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -60.08 -49.84 76.05 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.748 0.819 . . . . 0.0 111.065 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.31 -51.37 69.83 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 119.364 0.983 . . . . 0.0 108.867 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -55.89 -39.53 71.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.283 0.633 . . . . 0.0 111.063 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.65 55.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 111.848 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.24 -39.8 65.18 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.389 -173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.6 p -92.41 -21.8 20.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.105 0.962 . . . . 0.0 110.825 -171.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.75 42.88 99.81 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 126.735 2.014 . . . . 0.0 111.16 -174.314 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -124.67 169.26 12.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.406 1.882 . . . . 0.0 108.129 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -141.95 139.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.03 137.53 55.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -132.95 105.91 7.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.015 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -80.0 149.28 30.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.913 0.485 . . . . 0.0 110.592 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.05 129.71 15.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.946 1.299 . . . . 0.0 107.543 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.94 172.63 15.38 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.983 0.913 . . . . 0.0 109.993 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -66.34 -8.91 28.38 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.649 -1.282 . . . . 0.0 113.449 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.77 125.17 1.41 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.086 -2.805 . . . . 0.0 106.086 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.2 t-20 -61.16 -46.77 89.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.099 0.56 . . . . 0.0 110.384 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -42.85 -22.37 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 130.178 3.391 . . . . 0.0 117.412 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -119.69 -84.2 0.66 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.476 1.11 . . . . 0.0 109.683 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -60.14 -46.75 88.58 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.384 1.074 . . . . 0.0 111.669 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 -40.76 76.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.098 0.863 . . . . 0.0 110.796 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -60.94 -43.84 98.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.676 0.671 . . . . 0.0 111.431 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 85.3 mtp -65.77 -48.58 71.36 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.389 0.676 . . . . 0.0 109.487 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.31 -42.13 81.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.086 0.554 . . . . 0.0 111.309 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.61 -48.55 79.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 110.044 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.61 97.99 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.616 -1.102 . . . . 0.0 112.584 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.66 -40.84 80.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.722 1.761 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.99 81.51 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.526 0.603 . . . . 0.0 111.417 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -57.53 -33.66 68.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.812 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.35 -58.59 3.81 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.408 0.549 . . . . 0.0 110.101 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -70.11 -37.7 75.42 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -169.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -90.31 -36.65 14.56 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -169.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 179.09 50.84 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 121.999 0.777 . . . . 0.0 112.829 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.28 -16.4 63.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.738 1.615 . . . . 0.0 113.998 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.24 -24.64 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.311 1.044 . . . . 0.0 110.875 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -120.93 140.53 51.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.243 0.617 . . . . 0.0 110.226 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -89.75 144.06 26.28 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.95 124.1 52.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 170.72 15.62 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 p -140.14 142.75 35.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.43 -174.9 4.01 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.338 1.455 . . . . 0.0 108.768 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.57 174.67 41.34 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.3 -42.02 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 170.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.65 178.36 8.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.839 0.856 . . . . 0.0 109.892 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.69 122.59 11.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.568 1.547 . . . . 0.0 107.042 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.67 -32.35 47.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.983 0.513 . . . . 0.0 109.95 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.94 -158.25 28.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -94.4 111.98 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -67.27 125.37 90.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.258 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.37 -34.38 50.08 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.163 2.575 . . . . 0.0 113.624 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -37.54 85.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.698 0.681 . . . . 0.0 110.915 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.66 75.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.17 -53.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -67.63 -41.68 83.52 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.32 -45.17 84.52 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.007 0.821 . . . . 0.0 110.784 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.53 -39.83 64.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.889 0.476 . . . . 0.0 110.92 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -64.5 -32.11 73.61 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.288 -0.883 . . . . 0.0 111.617 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.92 -19.59 65.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.77 0.828 . . . . 0.0 112.145 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.67 -9.39 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.469 1.108 . . . . 0.0 110.174 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 16.28 53.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.691 1.139 . . . . 0.0 111.927 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.1 mt -107.96 92.22 2.01 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -76.54 85.21 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.032 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 pt -78.13 3.47 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.269 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.6 p -61.07 -23.2 65.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 121.267 1.848 . . . . 0.0 112.202 -175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -70.67 -21.29 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.064 1.345 . . . . 0.0 112.7 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -70.05 170.18 11.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 109.57 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -145.71 161.47 39.83 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.26 1.424 . . . . 0.0 107.98 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -104.16 155.74 18.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.739 0.816 . . . . 0.0 110.116 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -150.83 161.31 42.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.12 2.168 . . . . 0.0 108.125 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 pt -92.44 164.56 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 135.43 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.591 0.756 . . . . 0.0 112.426 -169.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -127.07 110.07 12.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 108.212 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.5 p -61.08 -19.67 61.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.926 -0.483 . . . . 0.0 111.653 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.34 -2.66 14.26 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 113.638 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -115.97 -45.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -46.43 -51.64 14.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.488 1.115 . . . . 0.0 111.525 178.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -66.7 -5.97 13.89 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -134.36 5.47 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 112.664 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.1 155.08 40.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.939 0.791 . . . . 0.0 109.936 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.61 -33.86 73.27 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.975 -1.078 . . . . 0.0 108.389 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -147.55 143.8 28.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 109.509 -170.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.01 133.7 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.88 119.02 56.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -172.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 p -96.57 92.77 6.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -68.14 -12.6 61.19 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.538 -0.726 . . . . 0.0 112.805 -169.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.57 156.63 45.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.74 1.155 . . . . 0.0 108.174 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.81 -41.33 83.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -169.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.96 -35.88 82.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.76 0.78 . . . . 0.0 111.318 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.44 -28.84 70.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.59 -22.56 65.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.37 -32.64 74.16 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.529 0.732 . . . . 0.0 112.227 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -99.29 -22.74 15.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.8 t -55.32 106.42 0.67 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.72 174.88 3.32 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.472 2.781 . . . . 0.0 113.169 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -58.88 143.23 48.34 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.572 -0.705 . . . . 0.0 110.544 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -133.0 119.13 15.59 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.541 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 169.23 20.61 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.38 -25.79 19.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.957 3.105 . . . . 0.0 115.969 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -65.91 -9.02 25.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.956 . . . . 0.0 112.839 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 t -133.68 89.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 127.539 2.336 . . . . 0.0 105.5 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -69.11 164.3 22.82 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.299 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -126.25 148.77 49.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.577 1.151 . . . . 0.0 108.679 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -143.94 160.18 41.27 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 145.14 30.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.377 1.071 . . . . 0.0 111.717 -169.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -143.8 -170.16 3.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.405 1.882 . . . . 0.0 108.436 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.92 41.19 1.24 Allowed Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.484 -0.76 . . . . 0.0 113.241 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -76.21 114.96 15.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.354 1.077 . . . . 0.0 110.953 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -67.65 151.52 47.15 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.406 1.082 . . . . 0.0 109.926 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.32 126.72 92.55 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.48 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.88 -30.83 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.462 2.108 . . . . 0.0 114.049 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.49 -24.55 67.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.937 0.895 . . . . 0.0 112.933 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 25.43 10.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 112.557 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.75 -36.42 57.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 56.45 -168.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.373 1.869 . . . . 0.0 112.843 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.54 -61.14 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.428 1.966 . . . . 0.0 108.338 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 t -166.43 167.72 15.47 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 105.313 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.88 -40.35 84.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.386 -0.822 . . . . 0.0 110.626 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -29.94 66.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.429 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.62 -42.73 61.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.751 0.705 . . . . 0.0 109.287 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -58.29 -49.31 77.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.883 0.873 . . . . 0.0 109.814 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -61.78 -44.18 97.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.769 0.259 . . . . 0.0 110.503 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.97 75.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.457 0.571 . . . . 0.0 110.401 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.52 -39.02 93.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.187 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -55.95 -48.31 75.99 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.563 1.074 . . . . 0.0 108.859 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -60.56 -44.23 96.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.575 0.35 . . . . 0.0 111.113 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.95 -48.99 77.91 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.066 0.394 . . . . 0.0 110.519 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.13 -45.28 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 117.208 -1.377 . . . . 0.0 109.91 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -60.39 -42.38 95.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 121.395 1.907 . . . . 0.0 110.709 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.08 -45.0 95.46 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.84 -31.64 63.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.98 -41.01 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 119.847 1.203 . . . . 0.0 108.867 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.47 88.22 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.79 -35.82 75.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.12 1.368 . . . . 0.0 111.513 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -53.97 52.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.842 0.857 . . . . 0.0 109.595 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.02 -34.68 78.26 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.851 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -50.52 73.55 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.133 0.973 . . . . 0.0 111.116 173.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -61.01 -51.66 68.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 122.832 0.453 . . . . 0.0 111.163 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.78 58.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.072 0.949 . . . . 0.0 111.789 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.32 -38.13 60.39 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.865 0.866 . . . . 0.0 111.243 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.9 p -94.83 -20.85 19.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.357 1.063 . . . . 0.0 111.189 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.61 36.98 93.81 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -172.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.693 1.597 . . . . 0.0 111.353 -173.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -143.72 147.45 34.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -155.97 -38.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.794 0.838 . . . . 0.0 111.406 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.6 mtmt -134.31 167.62 20.38 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.663 1.585 . . . . 0.0 107.744 169.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -136.38 132.9 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -124.84 127.94 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -125.61 104.15 8.24 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -169.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.79 147.49 45.46 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 122.026 -0.421 . . . . 0.0 109.926 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -147.5 126.36 12.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -146.88 175.57 10.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.515 0.598 . . . . 0.0 109.814 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -67.67 -11.76 58.97 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.72 -1.238 . . . . 0.0 112.972 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.16 121.1 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 49.7 t-20 -57.63 -45.16 85.78 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.637 0.775 . . . . 0.0 109.991 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m -40.07 -34.65 0.31 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 129.746 3.218 . . . . 0.0 115.175 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.1 m -112.81 -72.47 0.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.32 0.648 . . . . 0.0 111.165 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -48.28 61.58 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.348 -169.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -63.04 -45.62 91.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.288 0.494 . . . . 0.0 109.779 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -56.55 -44.7 81.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.847 -0.596 . . . . 0.0 112.368 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.2 mtm -69.83 -45.58 67.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.615 0.643 . . . . 0.0 110.333 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.72 73.79 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.93 0.786 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -61.17 -47.3 86.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.673 1.189 . . . . 0.0 110.673 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.82 95.47 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.033 -0.87 . . . . 0.0 111.676 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 98.1 m95 -65.22 -38.59 90.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.871 1.836 . . . . 0.0 110.79 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.1 82.65 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.447 -0.783 . . . . 0.0 111.604 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.48 -26.66 68.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.13 0.877 . . . . 0.0 112.348 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.53 -46.15 13.75 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.602 0.761 . . . . 0.0 109.622 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -80.9 -26.33 36.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 mt -99.08 -140.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 107.387 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -174.6 45.73 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.86 -13.91 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 113.349 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.52 -13.53 2.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.14 2.176 . . . . 0.0 111.267 169.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.449 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 8.5 m95 -133.23 162.49 31.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.965 1.706 . . . . 0.0 108.813 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.41 139.19 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 167.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.03 118.68 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.7 173.57 11.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.334 0.587 . . . . 0.0 110.413 172.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -132.24 144.22 50.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 110.175 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 67' ' ' ILE . . . -137.03 179.45 6.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.055 2.142 . . . . 0.0 108.225 169.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.77 170.31 39.04 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.67 -41.64 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -142.6 179.52 6.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.521 0.729 . . . . 0.0 109.827 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.897 2.079 . . . . 0.0 107.202 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -135.57 -36.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.694 1.197 . . . . 0.0 109.238 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.89 178.57 39.44 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.98 100.79 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.93 127.85 92.23 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 117.883 -1.055 . . . . 0.0 109.257 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 -35.17 38.27 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.523 2.815 . . . . 0.0 113.946 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -59.61 -51.64 68.94 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.741 0.7 . . . . 0.0 109.886 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.35 80.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.496 0.589 . . . . 0.0 109.923 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -61.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -63.26 -40.02 96.24 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.999 0.818 . . . . 0.0 111.103 -169.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.15 83.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.583 0.753 . . . . 0.0 110.853 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -40.22 66.41 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.065 0.393 . . . . 0.0 110.715 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -68.3 -30.5 69.51 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.024 0.93 . . . . 0.0 111.287 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.47 -21.24 66.19 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.534 1.134 . . . . 0.0 111.879 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 t -89.89 -6.28 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.78 1.232 . . . . 0.0 110.193 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.57 19.97 52.83 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.764 -1.21 . . . . 0.0 112.258 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.3 mt -111.94 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.051 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -79.59 84.84 5.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.66 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.23 7.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.286 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.7 m -56.15 -25.16 45.26 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 120.667 1.576 . . . . 0.0 112.236 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.63 -20.34 59.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.696 1.198 . . . . 0.0 113.222 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.78 169.81 13.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.838 0.745 . . . . 0.0 110.511 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -145.8 155.4 42.9 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.412 1.485 . . . . 0.0 108.825 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 p -89.65 163.57 15.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.591 1.156 . . . . 0.0 110.409 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 41.2 t0 -158.15 158.78 35.28 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.818 2.047 . . . . 0.0 107.773 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.84 161.63 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -57.19 141.65 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 111.544 -170.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -130.7 112.77 13.4 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.19 -26.88 41.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.872 1.269 . . . . 0.0 111.445 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.38 -23.03 66.86 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 125.066 1.347 . . . . 0.0 112.859 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -100.43 -42.44 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.157 0.89 . . . . 0.0 108.689 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tp -48.13 -51.73 23.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.896 1.278 . . . . 0.0 111.122 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -67.23 -13.57 62.09 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -106.82 -14.69 14.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.141 0.977 . . . . 0.0 111.281 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 148.86 47.35 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.32 -31.6 71.99 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 27.1 tp -152.73 144.37 23.48 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.763 1.225 . . . . 0.0 109.981 -169.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 135.63 58.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.71 108.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -86.29 93.18 9.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.03 -13.31 62.09 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.593 0.757 . . . . 0.0 112.328 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.3 t -144.33 145.89 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.868 1.213 . . . . 0.0 107.923 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.8 -34.77 89.69 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.568 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.22 -25.84 67.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.161 0.981 . . . . 0.0 111.402 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 -26.54 60.24 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.031 0.532 . . . . 0.0 111.841 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.65 65.72 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.78 -33.69 70.61 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.863 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -85.52 60.53 6.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.119 0.968 . . . . 0.0 110.577 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 74.7 m -120.95 74.78 27.58 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.355 1.062 . . . . 0.0 108.6 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.15 -29.08 89.52 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.126 2.551 . . . . 0.0 115.146 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.9 ptp -162.73 115.91 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 110.217 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -132.83 77.56 68.38 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.5 171.76 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.995 3.13 . . . . 0.0 112.959 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.7 -17.77 10.74 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.011 3.141 . . . . 0.0 115.795 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.53 -13.2 38.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.059 0.943 . . . . 0.0 112.419 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -127.16 159.43 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 128.81 2.844 . . . . 0.0 106.828 -169.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.1 pttt -138.48 167.7 21.36 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -127.42 153.06 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.644 0.657 . . . . 0.0 109.418 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -135.18 156.43 49.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.51 135.45 30.21 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.78 0.832 . . . . 0.0 111.766 -168.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -137.98 -170.01 2.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.472 1.909 . . . . 0.0 108.735 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.93 40.27 1.37 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.305 -0.872 . . . . 0.0 113.43 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -79.1 112.01 15.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.255 1.027 . . . . 0.0 111.978 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.62 158.39 18.35 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.983 0.913 . . . . 0.0 109.567 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.12 118.91 74.73 Favored Pre-proline 0 CA--C 1.534 0.339 0 O-C-N 121.526 -0.733 . . . . 0.0 111.142 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.98 -30.23 21.6 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.818 1.678 . . . . 0.0 112.633 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.59 -18.12 65.09 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.54 1.064 . . . . 0.0 112.408 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -99.37 -1.13 39.54 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.911 1.284 . . . . 0.0 111.618 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 146.1 36.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.03 164.39 36.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.97 0.508 . . . . 0.0 110.797 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.82 -48.58 0.66 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -165.36 166.66 18.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.243 2.217 . . . . 0.0 105.595 169.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.29 -40.82 82.97 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.726 -0.609 . . . . 0.0 110.507 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -28.35 64.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.1 -45.07 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.893 0.769 . . . . 0.0 109.105 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -56.24 -50.46 71.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.648 0.779 . . . . 0.0 109.915 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -62.3 -43.95 97.63 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.119 0.418 . . . . 0.0 110.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.39 79.83 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.886 0.766 . . . . 0.0 110.26 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.2 -40.43 97.48 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.681 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -54.85 -49.46 71.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.096 0.862 . . . . 0.0 109.352 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -61.51 -44.16 97.56 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.947 0.499 . . . . 0.0 111.282 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.47 -50.34 73.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 119.167 -0.445 . . . . 0.0 110.098 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.43 -43.73 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 117.406 -1.283 . . . . 0.0 110.164 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -61.63 -42.04 98.33 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 121.144 1.793 . . . . 0.0 111.016 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.17 -42.63 99.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.342 0.519 . . . . 0.0 110.339 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.22 -38.95 71.98 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -65.53 -40.45 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.528 1.058 . . . . 0.0 109.3 177.083 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.62 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -52.38 -44.37 65.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.77 0.828 . . . . 0.0 111.137 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -47.52 84.96 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 109.933 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 131' ' ' LEU . 3.9 mm? -68.96 -34.91 76.1 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.167 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -49.7 76.73 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.933 0.788 . . . . 0.0 110.865 173.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.26 -52.07 66.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.18 -39.97 73.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.696 0.68 . . . . 0.0 111.388 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.8 67.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.688 0.795 . . . . 0.0 111.708 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -76.14 -43.49 42.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.049 0.94 . . . . 0.0 110.915 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.2 p -85.09 -22.33 28.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.373 1.069 . . . . 0.0 110.021 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.24 38.12 95.68 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.569 -169.948 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -60.86 155.57 19.31 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.734 0.814 . . . . 0.0 111.594 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.45 -29.99 0.79 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.882 1.273 . . . . 0.0 111.096 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -144.44 173.11 12.08 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.014 1.326 . . . . 0.0 108.567 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -131.14 142.81 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.7 141.37 46.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.868 1.267 . . . . 0.0 107.783 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.14 107.06 7.05 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.17 141.37 38.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.752 0.421 . . . . 0.0 110.083 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.81 133.81 34.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.394 1.478 . . . . 0.0 108.038 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.3 p -152.68 179.23 8.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 110.116 169.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.06 -3.68 17.57 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.85 104.43 0.21 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 54.3 t-20 -41.93 -48.16 4.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.793 1.637 . . . . 0.0 111.599 -170.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -41.89 -31.58 0.34 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.196 2.999 . . . . 0.0 115.118 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.91 -85.33 0.48 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.456 1.026 . . . . 0.0 111.185 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -45.01 95.81 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.68 -168.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -68.13 -39.24 82.76 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.997 1.272 . . . . 0.0 110.761 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -62.18 -46.2 89.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.92 0.782 . . . . 0.0 111.383 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.46 -47.86 74.68 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.88 -45.13 78.63 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.453 0.701 . . . . 0.0 110.627 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.03 -46.22 85.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.924 0.489 . . . . 0.0 110.32 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.77 97.6 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -67.16 -38.78 86.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.321 1.561 . . . . 0.0 110.536 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.8 85.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.097 0.408 . . . . 0.0 110.771 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -57.35 -31.49 65.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.417 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.99 -59.97 2.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.612 0.642 . . . . 0.0 110.514 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -70.57 -42.8 70.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -168.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.5 mt -82.2 -37.98 25.26 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 122.315 0.246 . . . . 0.0 110.825 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.2 174.66 49.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.024 0.821 . . . . 0.0 112.072 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.48 -15.37 63.31 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.809 1.244 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.13 -27.26 19.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 110.911 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -112.28 134.46 53.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 131.65 35.29 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 168.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -111.44 142.81 22.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -140.83 167.25 22.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.851 1.26 . . . . 0.0 108.815 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.0 p -139.47 134.07 31.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.237 1.415 . . . . 0.0 108.113 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.66 -175.2 4.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.972 1.709 . . . . 0.0 108.495 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 178.05 41.97 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.05 -42.31 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.793 1.237 . . . . 0.0 108.256 172.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.41 -179.45 6.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.87 125.4 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.72 1.608 . . . . 0.0 107.026 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.87 -35.01 38.72 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.013 0.525 . . . . 0.0 109.91 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.72 -161.41 31.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.53 108.96 18.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.21 131.83 95.16 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.637 -0.696 . . . . 0.0 110.265 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.29 -32.27 33.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.975 1.784 . . . . 0.0 112.88 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.76 -38.33 83.28 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.571 1.078 . . . . 0.0 110.497 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.19 89.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.648 1.113 . . . . 0.0 109.254 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.88 -58.71 6.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.81 -47.1 82.2 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.693 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.41 81.89 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 119.096 0.862 . . . . 0.0 110.677 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.17 -41.68 76.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.148 0.431 . . . . 0.0 110.29 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -67.78 -27.56 66.86 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.991 0.916 . . . . 0.0 111.818 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -67.47 -18.62 65.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.518 1.127 . . . . 0.0 111.708 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.54 -13.07 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.012 0.925 . . . . 0.0 109.972 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.86 6.39 54.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.299 1.428 . . . . 0.0 112.045 -173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.61 89.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.71 78.41 2.67 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.306 1.042 . . . . 0.0 110.651 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.27 6.09 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.452 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.0 p -57.4 -24.82 57.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.601 1.546 . . . . 0.0 112.271 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.21 -19.14 60.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.568 1.147 . . . . 0.0 112.885 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.32 169.43 15.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.777 0.717 . . . . 0.0 109.939 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -145.02 161.42 39.44 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.985 1.714 . . . . 0.0 107.986 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 m -111.57 155.35 23.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 109.831 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.55 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.2 t0 -154.44 160.57 41.69 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.838 2.055 . . . . 0.0 108.484 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 pt -94.26 163.08 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.39 119.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.563 0.697 . . . . 0.0 112.825 -169.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -100.51 111.57 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -15.61 63.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.697 0.799 . . . . 0.0 112.195 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.06 -40.14 75.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.588 1.085 . . . . 0.0 111.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.9 mt -63.41 -48.35 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.88 -46.27 74.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.413 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -66.46 -5.86 12.59 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.47 3.55 3.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.078 1.308 . . . . 0.0 113.603 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 147.74 52.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.839 0.745 . . . . 0.0 109.487 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.17 -34.64 71.13 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.063 0.847 . . . . 0.0 108.932 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.0 tp -145.27 142.73 29.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.31 132.01 69.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.4 t -114.23 113.17 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.9 p -92.39 92.98 8.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.88 -10.56 54.14 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.639 -169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -147.71 162.68 38.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.979 1.718 . . . . 0.0 110.741 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.11 -55.94 27.92 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.551 1.072 . . . . 0.0 112.522 -169.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.12 -31.92 70.94 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -171.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.95 80.12 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.49 -26.43 63.42 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.68 0.792 . . . . 0.0 112.92 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.67 -38.49 80.42 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.742 0.817 . . . . 0.0 111.755 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.26 -34.47 42.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.048 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.76 114.47 4.2 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 118.155 -0.926 . . . . 0.0 108.618 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.36 173.76 10.14 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.82 2.347 . . . . 0.0 111.875 -173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 65.8 ttp -53.79 125.07 17.15 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.208 1.003 . . . . 0.0 110.994 -170.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 p -107.1 105.59 56.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.63 1.572 . . . . 0.0 107.208 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -53.89 166.59 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.719 2.946 . . . . 0.0 112.961 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.69 -28.09 36.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.438 2.759 . . . . 0.0 114.788 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -68.19 -7.49 30.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.376 1.07 . . . . 0.0 112.981 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.75 85.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.752 2.421 . . . . 0.0 105.591 -169.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.1 pttt -69.7 167.09 17.78 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.169 -0.957 . . . . 0.0 108.973 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -123.8 160.35 27.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.036 0.534 . . . . 0.0 109.85 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.68 155.03 46.6 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -143.78 137.21 27.89 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.665 0.386 . . . . 0.0 111.731 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -140.53 -172.83 3.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.869 1.668 . . . . 0.0 109.311 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.55 44.39 1.05 Allowed Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.744 -0.597 . . . . 0.0 112.954 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -76.36 114.16 14.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.852 0.826 . . . . 0.0 110.487 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.58 162.46 20.88 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.275 0.63 . . . . 0.0 109.739 169.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.412 ' CG ' ' HE ' ' A' ' 108' ' ' ARG . 13.3 t70 -68.32 130.65 92.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.791 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.8 -44.48 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.458 2.106 . . . . 0.0 113.106 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.42 70.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.858 0.863 . . . . 0.0 111.428 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HE ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -99.14 5.89 46.67 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.636 1.575 . . . . 0.0 111.507 -177.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.71 140.07 48.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -143.36 158.65 43.46 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.687 0.795 . . . . 0.0 110.168 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.19 -51.97 0.46 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -160.41 162.06 33.18 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.57 -40.92 88.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.619 -0.675 . . . . 0.0 110.696 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.02 -29.08 67.17 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.467 -0.302 . . . . 0.0 111.069 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.93 -42.23 40.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.285 0.634 . . . . 0.0 109.994 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -54.32 -51.7 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.025 0.93 . . . . 0.0 109.639 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -60.55 -46.51 89.92 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.57 75.89 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.036 -0.415 . . . . 0.0 110.662 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.67 -37.49 87.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.667 0.787 . . . . 0.0 111.022 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -54.55 -51.74 64.25 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.118 0.872 . . . . 0.0 108.706 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.495 ' NE2' HH21 ' A' ' 124' ' ' ARG . 5.3 mm-40 -61.21 -42.72 99.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 111.666 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.27 -48.15 82.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.242 0.474 . . . . 0.0 110.113 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.1 -47.26 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 117.459 -1.257 . . . . 0.0 110.022 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.495 HH21 ' NE2' ' A' ' 121' ' ' GLN . 49.1 ptt85 -63.01 -41.65 99.62 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.898 1.681 . . . . 0.0 111.027 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.23 -42.46 98.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.21 0.459 . . . . 0.0 110.082 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -76.63 -33.76 58.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.466 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.01 -46.29 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 119.977 1.262 . . . . 0.0 107.646 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.7 -47.71 87.02 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.81 -37.91 71.84 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.8 1.24 . . . . 0.0 112.125 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -42.76 85.32 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.48 -0.763 . . . . 0.0 111.526 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 mt -68.22 -41.44 81.27 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -48.07 73.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.666 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.97 -57.9 11.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.605 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.298 5.2 p90 -68.63 -21.56 64.47 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 121.111 1.778 . . . . 0.0 112.681 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.99 64.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.38 0.991 . . . . 0.0 111.798 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -77.52 -39.58 45.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.402 1.081 . . . . 0.0 111.17 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.6 p -90.7 -22.42 21.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.932 0.893 . . . . 0.0 110.838 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.27 41.64 99.49 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.314 1.846 . . . . 0.0 111.331 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -148.45 148.37 30.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -150.43 -35.78 0.15 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.362 1.065 . . . . 0.0 111.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.0 mtmt -134.99 166.25 23.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.983 1.713 . . . . 0.0 106.519 169.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.0 140.16 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.2 tt -130.44 135.22 61.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.69 102.95 6.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.693 0.797 . . . . 0.0 108.981 -170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -76.91 144.96 38.53 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.205 0.602 . . . . 0.0 110.166 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 137.32 37.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.758 1.623 . . . . 0.0 108.138 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.2 p -154.76 175.23 13.98 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -67.81 -7.84 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.82 97.31 0.14 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -41.41 -40.94 1.88 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.453 1.901 . . . . 0.0 113.204 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.6 m -38.07 -36.67 0.22 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.903 3.281 . . . . 0.0 115.329 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -117.23 -74.92 0.59 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.966 0.803 . . . . 0.0 112.137 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -56.29 -50.74 70.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.738 0.699 . . . . 0.0 111.614 -169.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -70.27 -34.61 73.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.612 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -63.6 -42.22 98.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.415 0.552 . . . . 0.0 110.772 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.6 mtp -65.72 -47.54 74.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.806 0.442 . . . . 0.0 109.828 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.08 86.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.031 0.532 . . . . 0.0 110.871 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -57.86 -45.65 85.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.611 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.72 -52.44 53.09 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.074 0.845 . . . . 0.0 112.709 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -65.37 -34.57 78.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.592 1.696 . . . . 0.0 110.61 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.53 83.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.605 -0.684 . . . . 0.0 110.56 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.94 -22.11 64.1 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.223 -0.923 . . . . 0.0 112.557 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.46 -47.18 8.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.872 0.76 . . . . 0.0 110.116 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -78.92 -26.71 43.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.91 -142.78 0.25 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.46 -174.26 46.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.67 -13.74 55.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.95 -14.62 3.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.721 2.008 . . . . 0.0 111.147 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.471 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 7.8 m95 -133.18 167.06 21.04 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.021 1.728 . . . . 0.0 108.844 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -123.07 130.66 53.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 167.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.26 118.8 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.22 174.61 10.45 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.6 1.16 . . . . 0.0 108.653 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 82.4 p -137.59 160.41 39.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.372 0.606 . . . . 0.0 111.157 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.47 -162.25 1.49 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.496 1.518 . . . . 0.0 108.546 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.7 176.37 44.88 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -41.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.4 -179.88 6.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.596 1.159 . . . . 0.0 109.17 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.58 149.96 36.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.755 2.422 . . . . 0.0 106.156 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -13.93 1.9 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.961 0.904 . . . . 0.0 111.446 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.71 170.24 20.91 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 171.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.64 102.12 1.8 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -64.42 125.67 88.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.678 -170.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.97 -35.46 50.16 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.383 2.722 . . . . 0.0 113.881 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -40.96 96.61 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.631 0.651 . . . . 0.0 110.515 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.92 -41.58 82.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.54 -55.99 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -65.25 -41.33 94.4 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 119.378 0.99 . . . . 0.0 110.664 -173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.21 71.4 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.862 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.0 mmm -86.51 -38.16 17.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.451 0.569 . . . . 0.0 111.427 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.42 -33.29 75.22 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.969 0.908 . . . . 0.0 110.3 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.77 -19.2 65.08 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 112.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.67 -10.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.221 1.008 . . . . 0.0 109.906 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.62 23.31 47.28 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.121 -0.987 . . . . 0.0 111.039 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.6 mt -114.32 91.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -78.49 74.25 5.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.991 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.03 3.32 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.322 -0.861 . . . . 0.0 112.129 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -27.12 10.38 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.497 1.044 . . . . 0.0 111.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -71.83 -19.59 61.96 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 113.852 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -78.29 170.38 16.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.963 . . . . 0.0 109.681 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.05 160.75 41.46 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.418 1.487 . . . . 0.0 108.462 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 p -101.64 153.55 19.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.419 1.088 . . . . 0.0 110.958 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -156.48 160.84 39.92 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.841 1.256 . . . . 0.0 108.944 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.09 161.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.22 129.29 18.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 123.397 0.679 . . . . 0.0 111.586 -169.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -106.59 114.84 29.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.31 1.444 . . . . 0.0 107.655 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -66.71 -23.1 66.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.63 -41.25 46.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.368 0.985 . . . . 0.0 110.268 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.67 -44.75 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.33 -48.71 65.31 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.948 0.499 . . . . 0.0 109.942 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -71.15 -14.81 62.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -94.75 -17.91 21.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.578 1.081 . . . . 0.0 111.003 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.01 150.25 49.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.164 0.438 . . . . 0.0 111.071 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.04 -32.71 51.11 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.42 141.04 29.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.562 1.145 . . . . 0.0 109.662 -174.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.74 124.67 59.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.95 118.44 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -102.66 97.34 7.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.8 mt -71.84 -3.15 20.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.903 1.681 . . . . 0.0 114.487 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.7 p -151.26 163.91 37.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.584 1.538 . . . . 0.0 110.327 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.76 -64.84 3.19 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.719 1.628 . . . . 0.0 113.338 -169.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.36 -29.25 67.93 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.712 -0.287 . . . . 0.0 111.754 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.55 66.94 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.85 64.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.45 -31.75 72.13 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.109 0.564 . . . . 0.0 112.109 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -85.36 63.17 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.319 0.647 . . . . 0.0 110.633 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -124.94 76.23 66.54 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.153 0.981 . . . . 0.0 108.401 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.51 85.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.635 2.89 . . . . 0.0 111.234 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.0 tpt 70.1 111.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.383 2.673 . . . . 0.0 111.196 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -134.55 81.71 47.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.87 171.5 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.444 2.763 . . . . 0.0 110.965 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.25 -25.47 13.47 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.43 3.42 . . . . 0.0 117.448 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -56.97 -36.93 70.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.669 1.122 . . . . 0.0 110.836 170.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.75 82.96 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.91 2.484 . . . . 0.0 106.87 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -66.63 165.27 15.09 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.49 -0.756 . . . . 0.0 108.975 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -133.77 134.07 42.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.963 0.905 . . . . 0.0 110.147 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.99 155.75 45.59 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -151.3 139.08 19.8 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -141.22 178.86 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.949 1.7 . . . . 0.0 108.537 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.22 103.82 0.4 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -135.58 143.64 45.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.668 0.787 . . . . 0.0 110.579 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -73.28 169.99 15.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -73.46 117.23 58.87 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.86 -32.08 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.677 1.585 . . . . 0.0 112.818 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.35 65.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.962 0.801 . . . . 0.0 112.209 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -101.64 2.31 38.65 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 111.786 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.41 144.98 40.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.13 165.28 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.055 0.455 . . . . 0.0 111.191 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.03 -47.65 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.54 166.41 18.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.509 2.324 . . . . 0.0 105.2 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.12 -40.57 81.58 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.533 -0.729 . . . . 0.0 110.52 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -27.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.562 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.96 -45.3 51.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.007 0.822 . . . . 0.0 109.171 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -55.69 -49.42 73.04 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.73 0.812 . . . . 0.0 109.882 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -64.68 -41.78 95.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.14 -0.35 . . . . 0.0 110.96 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.06 72.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.964 0.802 . . . . 0.0 110.62 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.78 -40.8 92.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.621 -0.674 . . . . 0.0 110.629 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.03 -45.41 83.15 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 119.191 0.905 . . . . 0.0 109.04 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.76 -50.01 75.5 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.351 0.66 . . . . 0.0 111.322 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.01 -48.78 80.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 119.488 -0.292 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.98 -45.81 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.927 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -62.3 -42.95 99.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 121.414 1.916 . . . . 0.0 110.764 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.2 -42.42 98.56 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.449 0.3 . . . . 0.0 110.696 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.44 -36.92 52.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.597 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -43.61 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.79 81.41 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.903 0.851 . . . . 0.0 112.083 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -49.41 76.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.542 0.61 . . . . 0.0 110.302 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 -43.45 70.64 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.267 0.627 . . . . 0.0 109.354 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -46.42 75.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.283 1.033 . . . . 0.0 110.934 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -60.79 -55.61 31.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.382 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.272 3.1 p90 -67.72 -24.3 65.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 121.492 1.951 . . . . 0.0 111.992 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.52 67.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.059 0.845 . . . . 0.0 111.732 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -76.58 -41.67 45.47 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.671 1.189 . . . . 0.0 111.153 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.0 p -84.92 -21.09 29.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.098 0.959 . . . . 0.0 110.343 -174.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.78 21.62 79.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.108 0.861 . . . . 0.0 111.881 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.251 1.158 0 CA-C-N 117.928 0.864 . . . . 0.0 109.673 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -153.04 150.38 29.11 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.03 -44.66 0.11 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.292 1.037 . . . . 0.0 110.094 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -126.83 164.15 22.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.629 1.972 . . . . 0.0 106.553 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -135.37 124.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -169.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tt -122.98 133.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -135.95 105.2 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -77.35 151.36 34.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 111.297 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -149.62 130.7 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.025 0.93 . . . . 0.0 108.651 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -148.69 178.68 8.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 111.01 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -66.81 -8.7 30.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 113.787 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.85 102.62 0.19 Allowed Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.1 t-20 -42.83 -46.07 5.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.222 1.809 . . . . 0.0 111.87 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -35.27 -35.95 0.05 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.148 3.379 . . . . 0.0 115.302 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.0 p -111.77 -74.06 0.65 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.362 0.983 . . . . 0.0 112.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.688 1.131 . . . . 0.0 111.95 -169.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.5 m -64.62 -36.18 83.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.223 0.465 . . . . 0.0 110.845 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.73 -44.48 90.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.535 0.607 . . . . 0.0 111.465 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.4 mtp -65.46 -48.24 73.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 109.704 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.64 84.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.233 0.613 . . . . 0.0 111.209 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.78 -45.08 90.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.026 0.53 . . . . 0.0 110.274 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.1 90.88 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.914 -0.937 . . . . 0.0 112.607 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.15 -40.46 82.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.276 1.538 . . . . 0.0 111.39 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.04 79.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.936 0.335 . . . . 0.0 111.592 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.67 -33.26 68.15 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.858 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -71.54 -58.17 3.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.422 0.555 . . . . 0.0 110.332 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.39 -39.38 68.04 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.3 mt -86.55 -39.97 15.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.174 0.443 . . . . 0.0 111.811 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.56 -173.93 55.16 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.114 0.864 . . . . 0.0 113.207 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.87 -17.01 62.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.307 1.843 . . . . 0.0 113.867 -170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -60.38 -10.94 5.43 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.242 1.417 . . . . 0.0 111.672 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -133.9 166.92 21.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.662 1.185 . . . . 0.0 110.597 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.05 137.84 51.53 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 168.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -114.42 142.42 27.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -137.82 159.43 42.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 108.636 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -137.6 124.59 21.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.24 -174.13 3.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.336 1.054 . . . . 0.0 109.109 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.84 175.03 42.2 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.18 -42.65 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -144.82 179.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.876 1.27 . . . . 0.0 109.027 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.71 44.13 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.683 1.993 . . . . 0.0 106.941 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -133.33 -30.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.005 0.922 . . . . 0.0 110.68 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 169.08 -176.64 43.13 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -76.1 104.15 6.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.28 125.77 87.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.449 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.76 -34.57 44.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.372 2.715 . . . . 0.0 113.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -42.69 96.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.693 0.679 . . . . 0.0 110.53 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.64 87.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -61.27 -56.07 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -65.76 -40.69 92.3 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.549 1.068 . . . . 0.0 110.51 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.18 -39.6 79.33 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.822 0.737 . . . . 0.0 111.871 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.3 mmm -82.37 -40.36 21.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.659 0.384 . . . . 0.0 111.093 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.99 -36.09 82.36 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.087 0.955 . . . . 0.0 110.497 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.0 -18.86 65.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.184 0.594 . . . . 0.0 111.894 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.42 -2.96 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.582 1.153 . . . . 0.0 109.934 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.36 20.91 53.64 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.898 -1.127 . . . . 0.0 111.901 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.9 mt -113.29 90.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.71 79.03 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.69 0.796 . . . . 0.0 110.627 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.09 4.57 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.008 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 m -54.18 -25.8 24.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.785 1.175 . . . . 0.0 112.592 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -78.35 -17.35 56.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.637 1.175 . . . . 0.0 113.186 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -70.69 169.25 14.82 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.863 0.756 . . . . 0.0 110.131 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 p -145.96 163.76 34.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.594 1.557 . . . . 0.0 108.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -111.37 150.85 29.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.13 0.972 . . . . 0.0 109.703 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.5 t0 -149.62 160.18 43.71 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.141 2.176 . . . . 0.0 108.746 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -89.77 164.51 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.56 139.74 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.649 0.738 . . . . 0.0 111.846 -170.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -128.64 104.71 7.81 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 107.99 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 p -57.07 -24.76 56.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.842 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.41 -22.06 66.66 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.951 1.251 . . . . 0.0 112.286 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -108.57 -45.8 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 92' ' ' THR . 0.6 OUTLIER -54.48 -40.97 69.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.183 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.06 -15.56 63.48 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.953 1.251 . . . . 0.0 113.575 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -106.02 -6.99 18.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.522 1.129 . . . . 0.0 111.137 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.97 155.09 35.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.311 0.505 . . . . 0.0 110.101 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.05 -32.73 44.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.307 -0.871 . . . . 0.0 108.885 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -144.28 140.4 29.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.536 1.134 . . . . 0.0 109.714 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.22 134.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.21 106.94 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 p -76.54 147.89 37.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.16 2.63 13.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.868 0.467 . . . . 0.0 110.953 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -151.86 147.73 26.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.18 -45.39 96.62 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.87 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.19 -32.85 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.409 0.604 . . . . 0.0 111.662 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.8 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.31 -18.77 64.92 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.62 -35.61 81.07 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.064 0.946 . . . . 0.0 111.927 172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.26 -36.83 66.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.13 110.26 1.26 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.902 1.281 . . . . 0.0 110.938 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.552 2.834 . . . . 0.0 109.743 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -43.76 110.34 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.011 1.724 . . . . 0.0 111.765 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.413 HG23 HD21 ' A' ' 72' ' ' LEU . 1.1 p -133.16 72.49 75.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.93 168.07 12.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.479 2.786 . . . . 0.0 110.752 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -49.99 -23.79 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.53 3.487 . . . . 0.0 117.87 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -54.69 -40.86 69.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.605 1.093 . . . . 0.0 110.356 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.66 97.7 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.746 2.019 . . . . 0.0 107.556 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -72.02 159.59 33.95 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -131.22 148.51 52.71 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.386 0.675 . . . . 0.0 109.271 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.81 148.45 37.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -132.91 106.88 7.96 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -102.52 170.01 8.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.211 1.404 . . . . 0.0 108.081 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.27 106.68 0.5 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.432 -168.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -138.52 140.82 39.29 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.868 0.867 . . . . 0.0 111.73 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.79 168.99 10.43 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.546 0.738 . . . . 0.0 109.286 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -74.43 112.64 18.12 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.77 -34.07 51.38 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.547 1.498 . . . . 0.0 112.311 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.13 -15.18 62.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.029 0.831 . . . . 0.0 112.513 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -118.95 20.79 12.67 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.201 1.401 . . . . 0.0 110.979 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.1 67.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 55.07 -160.59 0.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.027 1.731 . . . . 0.0 112.237 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.95 -70.33 0.68 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -159.95 163.72 33.96 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -59.17 -40.63 86.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.828 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.05 -31.56 70.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.603 -0.237 . . . . 0.0 111.09 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -75.57 -38.02 59.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.355 0.662 . . . . 0.0 110.195 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -60.27 -50.01 75.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.154 0.982 . . . . 0.0 109.491 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -60.77 -42.9 98.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.069 0.395 . . . . 0.0 110.727 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.65 -37.51 76.13 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.919 0.488 . . . . 0.0 110.622 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.31 -35.46 76.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.56 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -54.94 -44.29 74.16 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.104 1.32 . . . . 0.0 108.485 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -60.58 -41.82 95.42 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.957 0.344 . . . . 0.0 111.197 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -64.03 -51.22 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.28 -46.45 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.784 -1.103 . . . . 0.0 109.67 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -62.73 -41.65 99.27 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.551 1.523 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.77 -44.67 96.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.001 0.364 . . . . 0.0 110.168 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.16 -42.26 76.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.275 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.06 -45.7 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.613 1.097 . . . . 0.0 108.719 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.14 94.35 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -57.28 -45.93 83.62 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.933 0.893 . . . . 0.0 111.781 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.63 -35.23 79.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.612 1.096 . . . . 0.0 111.91 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 131' ' ' LEU . 4.0 mm? -69.49 -41.46 76.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.757 1.162 . . . . 0.0 110.816 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.63 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 110.578 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.77 -52.86 63.74 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.643 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -55.25 -46.41 76.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 120.249 1.386 . . . . 0.0 109.966 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.78 90.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.245 0.618 . . . . 0.0 111.555 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -84.52 -37.46 21.24 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.534 0.734 . . . . 0.0 111.777 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.2 p -92.88 -23.66 18.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.597 0.759 . . . . 0.0 111.081 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.9 42.43 99.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.808 2.043 . . . . 0.0 112.468 -169.934 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -141.02 157.29 45.53 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 106.851 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -153.68 -43.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.445 0.698 . . . . 0.0 110.775 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 48.0 mtmt -134.61 169.3 17.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.846 1.659 . . . . 0.0 107.577 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.92 134.36 53.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -124.39 132.74 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -129.1 105.54 8.25 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.835 0.854 . . . . 0.0 108.714 -170.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -75.59 147.54 39.52 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.941 -0.474 . . . . 0.0 110.216 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.4 127.11 15.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.95 174.52 11.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.335 0.654 . . . . 0.0 110.104 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -66.86 -12.77 60.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.73 -1.231 . . . . 0.0 112.997 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.42 122.82 1.21 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 106.326 -2.709 . . . . 0.0 106.326 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -59.69 -45.92 90.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.876 0.87 . . . . 0.0 110.744 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -38.18 -30.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 130.089 3.356 . . . . 0.0 117.279 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.3 m -120.51 -71.21 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.431 0.693 . . . . 0.0 110.195 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -66.74 -49.77 64.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.77 -169.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -63.87 -43.99 94.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.402 0.547 . . . . 0.0 109.623 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.73 -45.88 85.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.317 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 45.1 mtm -67.29 -45.34 76.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.258 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.14 -44.6 75.24 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.715 0.689 . . . . 0.0 111.048 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.88 -44.71 94.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.586 0.754 . . . . 0.0 110.468 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.97 -50.8 53.51 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.178 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -68.21 -37.21 80.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.752 1.776 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.96 79.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.553 -0.717 . . . . 0.0 111.247 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -59.09 -32.72 70.06 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.658 -0.651 . . . . 0.0 112.072 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.82 -49.43 18.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.43 0.692 . . . . 0.0 109.359 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -79.76 -34.88 39.46 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -170.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.77 -35.54 12.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.499 0.59 . . . . 0.0 112.017 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.22 -178.72 49.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.195 0.902 . . . . 0.0 112.793 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.02 -6.04 25.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.56 -8.69 4.64 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.044 1.738 . . . . 0.0 110.729 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.421 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 4.3 m95 -138.15 157.94 45.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 108.561 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -111.95 142.09 44.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 168.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.8 126.83 67.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 171.11 14.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 109.668 172.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.4 m -135.52 142.34 45.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.753 1.221 . . . . 0.0 110.261 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.69 -174.72 4.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.279 1.432 . . . . 0.0 108.925 169.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.44 175.95 41.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.01 -41.87 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.23 179.34 7.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.543 0.737 . . . . 0.0 110.083 170.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.8 42.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.295 2.238 . . . . 0.0 106.306 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -136.7 -19.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.58 0.752 . . . . 0.0 111.686 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.1 -178.0 40.91 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -77.75 100.72 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.57 122.77 73.29 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.33 -171.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.5 -32.01 41.6 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.183 2.588 . . . . 0.0 113.521 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -39.84 92.79 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.812 0.733 . . . . 0.0 110.801 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.84 75.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.11 -54.78 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -66.89 -41.58 86.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.588 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.53 -46.09 84.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.516 0.598 . . . . 0.0 110.818 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 84.4 mmm -73.81 -37.44 64.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.462 0.574 . . . . 0.0 111.326 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.336 -0.852 . . . . 0.0 111.342 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -66.22 -19.35 65.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.669 0.788 . . . . 0.0 112.177 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.37 -4.6 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.862 1.265 . . . . 0.0 110.374 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.76 23.03 65.24 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.763 -1.211 . . . . 0.0 111.916 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -111.98 93.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.15 86.45 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.441 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.31 5.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.275 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -57.01 -26.18 59.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.851 1.659 . . . . 0.0 112.345 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -74.77 -17.65 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.406 1.082 . . . . 0.0 112.807 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.03 170.27 14.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.59 0.756 . . . . 0.0 110.109 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 p -146.68 160.36 42.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.49 1.516 . . . . 0.0 108.554 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.9 m -108.34 151.74 25.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.049 0.94 . . . . 0.0 109.729 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.0 t0 -153.05 161.16 42.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.205 2.202 . . . . 0.0 108.378 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 pt -91.54 163.65 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.12 133.98 20.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.394 0.678 . . . . 0.0 111.942 -169.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -123.11 112.67 18.02 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 107.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.8 p -57.06 -24.21 52.25 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 111.508 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.88 -22.58 67.02 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.67 1.188 . . . . 0.0 112.873 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.82 -43.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.956 0.798 . . . . 0.0 108.937 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -48.6 -51.11 29.64 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.251 1.02 . . . . 0.0 110.782 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.1 -15.77 62.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -104.19 -16.91 15.08 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.18 0.992 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.96 58.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.775 0.43 . . . . 0.0 109.868 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.24 -33.74 76.43 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.9 tp -144.33 141.62 29.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.202 1.401 . . . . 0.0 109.702 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.35 132.3 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 109.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.08 88.24 7.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.67 -10.55 19.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.087 1.755 . . . . 0.0 114.357 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.0 t -148.66 157.71 43.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.834 1.652 . . . . 0.0 110.197 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.98 -59.29 9.59 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.259 1.885 . . . . 0.0 112.191 -170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.48 -26.9 66.59 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.536 0.334 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.29 72.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.795 0.438 . . . . 0.0 111.592 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.11 -20.11 65.07 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.05 -29.8 70.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.691 0.678 . . . . 0.0 112.277 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -77.4 -32.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 117.303 -1.332 . . . . 0.0 113.344 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -47.23 108.44 0.88 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.297 1.039 . . . . 0.0 111.031 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.17 -34.99 26.36 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.901 1.734 . . . . 0.0 113.011 -169.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 125.79 1.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.9 p -128.15 82.4 68.55 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.53 173.31 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.633 2.889 . . . . 0.0 110.79 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.21 -29.35 16.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.882 3.054 . . . . 0.0 116.104 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -68.77 -8.04 39.46 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.185 0.994 . . . . 0.0 113.064 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.31 80.95 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.945 2.498 . . . . 0.0 104.732 -170.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.7 pttt -64.94 164.99 11.59 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.736 0.779 . . . . 0.0 108.948 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -127.53 150.1 49.84 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 109.561 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.37 153.17 44.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -147.59 139.15 23.88 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -139.52 -169.27 2.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.658 1.583 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.0 41.58 1.29 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.098 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -80.34 119.17 22.7 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.958 1.379 . . . . 0.0 112.597 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.21 150.64 43.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.062 0.945 . . . . 0.0 109.603 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -74.2 121.12 84.47 Favored Pre-proline 0 C--O 1.236 0.373 0 O-C-N 121.999 -0.438 . . . . 0.0 111.858 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.43 -32.14 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.834 1.69 . . . . 0.0 112.678 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.76 65.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.767 0.712 . . . . 0.0 112.362 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -100.18 -0.96 37.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.688 1.195 . . . . 0.0 111.594 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.9 148.68 29.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -159.01 164.47 35.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.817 0.447 . . . . 0.0 110.655 -171.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.24 -48.66 0.64 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -164.99 165.68 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.277 2.231 . . . . 0.0 105.416 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.14 -40.51 81.53 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.556 -0.715 . . . . 0.0 110.638 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.38 -28.48 65.12 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.377 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.32 -44.94 58.03 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.92 0.782 . . . . 0.0 109.194 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -56.02 -50.37 71.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.588 0.755 . . . . 0.0 109.75 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.93 -44.86 95.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.989 0.359 . . . . 0.0 110.505 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.9 75.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.602 0.637 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.57 -36.92 85.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.342 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -54.95 -53.37 56.56 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.634 1.106 . . . . 0.0 108.274 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.516 ' NE2' HH21 ' A' ' 124' ' ' ARG . 6.3 mm100 -58.1 -43.22 87.01 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.864 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -61.15 -49.41 77.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.58 0.627 . . . . 0.0 110.606 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.28 -45.89 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.891 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.516 HH21 ' NE2' ' A' ' 121' ' ' GLN . 47.6 ptt85 -61.88 -40.81 96.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.44 1.927 . . . . 0.0 111.087 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.48 -44.72 95.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.25 0.477 . . . . 0.0 109.793 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.28 -32.51 61.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.045 -0.979 . . . . 0.0 112.858 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -65.32 -42.82 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.697 1.135 . . . . 0.0 108.644 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.78 -46.46 82.85 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -58.56 -36.23 73.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.303 1.041 . . . . 0.0 111.41 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -51.41 70.05 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.587 0.755 . . . . 0.0 109.379 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.8 mt -72.89 -31.78 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.251 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -51.91 67.53 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.777 0.831 . . . . 0.0 110.828 169.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.68 -49.21 75.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 119.299 0.954 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -55.32 -39.35 69.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.584 0.629 . . . . 0.0 111.055 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.43 -47.42 49.17 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.767 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.51 -37.5 71.22 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.612 1.165 . . . . 0.0 110.91 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.0 p -90.61 -22.63 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.001 0.92 . . . . 0.0 110.163 -175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.68 41.48 99.6 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.083 1.353 . . . . 0.0 111.015 -175.252 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.92 151.34 45.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 111.17 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -143.76 -41.24 0.28 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.994 0.918 . . . . 0.0 111.022 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -124.69 167.74 14.13 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.724 0.81 . . . . 0.0 110.631 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.7 138.45 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tt -121.57 138.83 50.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -132.04 106.21 7.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -75.82 146.64 39.75 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.565 0.746 . . . . 0.0 110.546 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.02 130.19 20.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -148.46 171.21 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.984 0.811 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -67.58 -9.64 44.66 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.148 -0.97 . . . . 0.0 113.4 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 118.36 0.82 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 106.652 -2.579 . . . . 0.0 106.652 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.61 -43.19 99.42 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.811 0.844 . . . . 0.0 112.107 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -43.33 -22.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.06 3.344 . . . . 0.0 117.336 -169.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -128.78 -71.7 0.63 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.295 0.952 . . . . 0.0 110.947 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -58.68 -49.14 78.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.371 0.532 . . . . 0.0 111.336 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -72.01 -36.15 69.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.863 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -62.73 -42.07 99.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.897 0.479 . . . . 0.0 111.313 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.6 mtm -66.2 -46.62 76.66 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.693 0.679 . . . . 0.0 110.258 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.45 77.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.898 0.479 . . . . 0.0 110.64 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -57.2 -44.6 83.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.528 1.131 . . . . 0.0 110.559 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.08 90.15 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.889 -0.95 . . . . 0.0 112.59 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.61 -38.43 83.94 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.468 1.634 . . . . 0.0 110.613 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.71 85.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.652 0.381 . . . . 0.0 111.701 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -58.64 -29.12 66.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.858 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -73.67 -59.6 2.64 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.685 0.675 . . . . 0.0 110.559 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -71.28 -42.52 68.62 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.05 -39.59 33.5 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.643 0.377 . . . . 0.0 110.694 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.76 53.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.481 1.039 . . . . 0.0 112.858 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.41 -17.1 58.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.601 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.36 -21.21 5.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.595 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -127.04 161.92 27.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 110.711 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -112.0 144.43 41.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.1 t -134.21 124.52 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.3 172.59 12.6 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 74.8 p -141.74 154.82 45.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.71 -163.81 1.74 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.79 1.236 . . . . 0.0 108.15 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.78 175.01 44.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.86 -41.36 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.4 173.72 11.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.791 0.836 . . . . 0.0 110.163 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.35 157.14 42.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.677 1.991 . . . . 0.0 107.989 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -134.79 -32.67 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.767 1.227 . . . . 0.0 110.707 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.89 -173.41 33.9 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.47 109.63 9.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 170.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -70.03 132.79 88.22 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.64 -28.48 60.72 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.018 1.812 . . . . 0.0 112.997 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -39.13 91.54 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.972 0.806 . . . . 0.0 110.847 174.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.87 65.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.78 -59.72 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -63.32 -40.99 98.85 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.96 0.8 . . . . 0.0 110.513 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.1 -46.51 72.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 111.362 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.4 mmm -77.48 -38.58 48.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.173 0.589 . . . . 0.0 111.495 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -60.95 -34.6 74.98 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.579 -0.701 . . . . 0.0 110.051 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -68.94 -22.01 64.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.6 t -76.08 -26.2 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 119.53 1.059 . . . . 0.0 109.371 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.04 23.63 9.64 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.796 1.189 . . . . 0.0 110.511 -169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.2 mt -118.75 101.93 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.98 129.92 40.78 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.33 -2.02 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.584 0.753 . . . . 0.0 110.714 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -29.15 69.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.421 1.01 . . . . 0.0 110.695 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.67 -16.68 64.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.752 1.621 . . . . 0.0 113.537 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -75.29 176.1 7.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.952 0.901 . . . . 0.0 109.037 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -141.93 153.54 44.44 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.843 1.257 . . . . 0.0 108.744 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -107.44 147.24 30.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 109.87 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.87 158.47 40.82 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.851 1.261 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 pt -88.7 162.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 137.66 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.73 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -126.28 114.85 18.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.22 1.408 . . . . 0.0 108.058 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -56.4 -28.6 59.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.723 0.809 . . . . 0.0 111.377 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.72 0.5 8.7 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.786 1.634 . . . . 0.0 113.475 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.88 -46.99 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp -45.79 -52.76 10.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.468 1.107 . . . . 0.0 111.395 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -5.78 22.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -132.51 5.16 4.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.675 1.19 . . . . 0.0 112.541 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.7 47.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.37 -33.2 67.06 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.8 tp -143.03 142.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.062 1.345 . . . . 0.0 109.18 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.31 134.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.49 134.12 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 118.958 0.799 . . . . 0.0 108.861 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 86' ' ' ALA . 9.7 p -98.53 98.27 9.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.5 -12.26 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.256 1.422 . . . . 0.0 113.598 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.65 147.37 33.0 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.34 95.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.405 0.526 . . . . 0.0 112.342 -169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.95 -25.23 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.164 0.982 . . . . 0.0 111.731 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.7 -23.96 60.94 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.284 0.634 . . . . 0.0 111.689 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -64.14 -20.69 66.16 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.8 -32.63 70.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.096 0.558 . . . . 0.0 111.949 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -86.79 62.09 7.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.875 0.87 . . . . 0.0 110.588 -173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 77.0 m -120.21 75.15 22.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 108.391 172.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.04 -28.48 80.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.436 2.091 . . . . 0.0 114.659 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 ttp -158.76 99.28 1.55 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.939 0.896 . . . . 0.0 109.942 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p -128.37 73.7 80.07 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.452 1.101 . . . . 0.0 108.351 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.93 171.07 10.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.3 2.666 . . . . 0.0 110.856 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.34 -21.99 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.193 3.262 . . . . 0.0 116.456 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -63.27 -11.82 24.49 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 112.897 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.3 94.39 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 128.015 2.526 . . . . 0.0 105.273 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -70.81 165.25 23.55 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 98' ' ' ARG . 3.5 mtp85 -135.47 153.81 51.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.243 0.617 . . . . 0.0 111.671 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.54 167.08 23.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.58 6.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.844 0.858 . . . . 0.0 110.369 -169.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -115.27 -174.11 2.44 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.824 1.249 . . . . 0.0 109.405 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.63 43.64 1.19 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.239 -0.913 . . . . 0.0 114.231 -168.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -84.31 108.04 16.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.261 1.03 . . . . 0.0 111.819 -172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.37 152.6 37.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.018 0.927 . . . . 0.0 109.734 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -71.5 116.43 47.46 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 122.915 0.486 . . . . 0.0 111.713 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.21 -34.42 16.45 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.089 1.86 . . . . 0.0 112.1 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.47 -16.35 64.05 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.46 0.573 . . . . 0.0 112.076 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -111.53 14.95 21.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.978 1.311 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.83 -43.8 90.74 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.651 0.659 . . . . 0.0 111.684 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 50.36 -161.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.095 1.758 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.49 -69.83 0.21 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.877 1.703 . . . . 0.0 109.122 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -154.1 156.53 37.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.29 -38.76 84.6 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.264 0.938 . . . . 0.0 111.105 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.71 -32.34 72.91 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.257 -0.277 . . . . 0.0 111.106 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.09 -42.12 60.62 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.382 0.673 . . . . 0.0 109.877 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -58.46 -50.47 73.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.367 1.467 . . . . 0.0 110.149 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -62.01 -42.57 99.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.875 0.47 . . . . 0.0 110.619 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.03 72.7 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.784 0.72 . . . . 0.0 110.813 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.86 -40.27 83.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.737 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -56.41 -46.44 80.19 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.48 -48.74 79.78 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.663 0.785 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -59.55 -50.09 75.24 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.077 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.32 -44.6 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.223 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.05 -44.09 97.43 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.992 2.178 . . . . 0.0 110.627 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.74 -43.3 99.12 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.95 -38.03 66.91 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.604 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -42.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.774 1.625 . . . . 0.0 108.617 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.78 93.72 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.428 ' ND2' HH21 ' A' ' 130' ' ' ARG . 45.5 t30 -59.23 -43.04 92.35 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.276 1.03 . . . . 0.0 112.008 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.428 HH21 ' ND2' ' A' ' 129' ' ' ASN . 4.3 mmp_? -60.84 -46.04 92.15 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.612 -0.68 . . . . 0.0 110.29 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.12 -41.11 90.96 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.258 0.481 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.34 -48.58 73.98 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.857 0.863 . . . . 0.0 110.246 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.88 -48.32 82.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.31 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.5 -44.5 85.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.873 1.215 . . . . 0.0 109.852 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.33 85.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.776 0.431 . . . . 0.0 111.148 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -82.15 -38.95 23.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.418 1.087 . . . . 0.0 111.226 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 47.5 p -94.05 -22.95 18.2 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.203 0.601 . . . . 0.0 111.115 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.57 43.0 98.0 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.964 1.706 . . . . 0.0 112.707 -169.923 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -136.54 170.95 15.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.055 1.342 . . . . 0.0 108.234 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -144.49 -46.96 0.25 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.031 0.533 . . . . 0.0 110.687 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -141.99 170.67 15.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.62 142.59 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 118.758 0.708 . . . . 0.0 109.791 -168.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.25 135.76 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.86 104.16 6.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.33 0.652 . . . . 0.0 109.38 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -77.4 149.54 35.15 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.795 0.838 . . . . 0.0 110.532 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.77 132.42 14.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -149.95 171.96 15.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.264 1.393 . . . . 0.0 110.916 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -64.18 -13.32 47.79 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.948 -1.095 . . . . 0.0 112.93 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 119.21 0.9 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 105.367 -3.093 . . . . 0.0 105.367 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.3 t-20 -56.3 -43.01 78.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.771 0.828 . . . . 0.0 110.46 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -30.8 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 132.626 4.37 . . . . 0.0 118.06 -169.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.82 -58.83 0.76 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.654 0.661 . . . . 0.0 111.659 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -61.69 -50.54 72.04 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.025 0.83 . . . . 0.0 110.973 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -68.74 -38.28 80.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.226 0.466 . . . . 0.0 110.815 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -61.59 -43.7 98.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.776 0.716 . . . . 0.0 111.817 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 74.7 mtm -67.41 -46.85 72.01 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.27 0.486 . . . . 0.0 109.814 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.59 -42.0 74.18 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.274 0.488 . . . . 0.0 111.055 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.25 -48.15 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.051 0.54 . . . . 0.0 110.186 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.99 -50.86 53.37 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.574 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.8 m95 -67.18 -37.71 84.17 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.632 1.716 . . . . 0.0 110.851 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.05 82.72 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.219 0.918 . . . . 0.0 111.627 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -60.45 -27.17 67.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.192 0.906 . . . . 0.0 112.255 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.42 -47.1 13.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.615 0.766 . . . . 0.0 109.872 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -77.61 -28.63 51.55 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.07 -145.69 0.31 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.162 1.385 . . . . 0.0 108.297 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 -170.58 42.89 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.22 0.918 . . . . 0.0 111.857 -171.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.85 -19.07 63.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.707 1.603 . . . . 0.0 113.668 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.91 -12.12 10.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.859 1.264 . . . . 0.0 112.013 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -129.24 162.32 28.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.014 1.326 . . . . 0.0 110.782 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.2 132.13 53.05 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.15 137.05 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -137.25 163.88 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.548 0.739 . . . . 0.0 109.307 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -140.14 128.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.79 -173.11 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.757 1.223 . . . . 0.0 108.585 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.38 171.44 41.38 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.84 -41.02 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.93 179.36 7.23 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.005 0.922 . . . . 0.0 109.257 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.85 121.82 10.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.76 1.624 . . . . 0.0 106.652 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.25 -34.78 36.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.41 -173.82 37.04 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.902 2.191 . . . . 0.0 107.693 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.28 105.29 11.44 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.93 130.87 86.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.969 -169.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.85 -34.34 75.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.53 2.82 . . . . 0.0 113.724 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.38 78.42 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.43 0.559 . . . . 0.0 111.181 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.47 63.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.42 -53.5 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -65.72 -42.88 90.56 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 119.065 0.848 . . . . 0.0 110.383 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.52 72.15 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.64 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 83.4 mmm -83.22 -37.52 23.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.713 0.688 . . . . 0.0 111.526 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -65.68 -29.83 70.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.302 -0.874 . . . . 0.0 110.934 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.53 -18.77 65.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.111 0.964 . . . . 0.0 112.248 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.12 -9.71 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.48 1.112 . . . . 0.0 109.99 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.55 21.45 56.28 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -111.75 90.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.83 77.76 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 110.245 -172.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.05 3.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 111.868 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -53.86 -26.42 24.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.462 1.105 . . . . 0.0 112.46 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -79.79 -12.04 59.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.003 1.321 . . . . 0.0 113.593 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -74.32 172.79 11.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.259 0.936 . . . . 0.0 109.238 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -146.84 161.58 40.4 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 107.783 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.2 m -104.06 151.45 23.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.643 0.777 . . . . 0.0 109.628 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -147.39 159.81 43.27 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.945 2.098 . . . . 0.0 108.496 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -89.6 165.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 142.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.037 0.935 . . . . 0.0 112.31 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -132.22 104.24 6.67 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.364 1.865 . . . . 0.0 108.383 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 p -56.9 -26.34 58.89 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -69.8 -4.86 21.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.24 1.016 . . . . 0.0 112.79 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.82 -48.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.61 -44.49 57.08 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.815 0.734 . . . . 0.0 112.158 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -3.68 17.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -135.48 10.65 3.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.984 1.314 . . . . 0.0 112.185 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.32 152.93 36.5 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.07 -36.26 79.55 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.866 1.212 . . . . 0.0 108.629 170.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.54 155.42 43.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.872 0.844 . . . . 0.0 112.28 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -113.56 138.87 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 102.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.7 p -76.08 147.96 38.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 3.13 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.01 0.524 . . . . 0.0 112.127 -169.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.81 162.19 40.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.357 0.981 . . . . 0.0 108.396 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.07 97.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.44 -35.63 73.47 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.096 0.948 . . . . 0.0 111.18 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.67 -23.66 67.23 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.066 0.546 . . . . 0.0 112.405 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.56 -29.44 59.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.466 0.707 . . . . 0.0 112.373 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.36 -32.7 74.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.209 0.604 . . . . 0.0 112.261 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -86.9 58.61 5.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.389 0.676 . . . . 0.0 110.59 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.96 81.21 12.04 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.76 -35.46 98.6 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.828 2.352 . . . . 0.0 114.384 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -159.31 125.36 4.39 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.153 0.981 . . . . 0.0 108.356 169.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -138.94 79.96 25.75 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.35 169.87 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.073 2.515 . . . . 0.0 110.846 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.66 -18.95 6.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.407 3.405 . . . . 0.0 116.378 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -61.56 -13.81 24.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.15 0.98 . . . . 0.0 112.691 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 t -127.95 109.25 19.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.177 2.191 . . . . 0.0 106.542 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.04 167.75 20.04 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -135.62 150.37 49.62 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.529 0.732 . . . . 0.0 109.846 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 153.8 43.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 169.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -138.3 84.57 2.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -169.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -79.53 176.45 9.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.943 1.297 . . . . 0.0 109.446 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.3 93.96 0.19 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.327 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -131.93 121.43 23.99 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.831 0.853 . . . . 0.0 111.131 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -64.77 152.25 43.14 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.621 1.168 . . . . 0.0 109.92 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.76 114.91 28.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.057 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -31.67 29.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.018 1.812 . . . . 0.0 112.707 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.9 -15.21 62.74 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.592 0.633 . . . . 0.0 112.053 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -115.63 22.15 13.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.617 1.567 . . . . 0.0 110.732 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.01 -27.04 69.15 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 43.51 -147.53 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.985 2.114 . . . . 0.0 113.275 -175.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.6 -73.12 1.43 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.5 166.17 16.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.534 2.334 . . . . 0.0 105.623 172.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.84 -40.21 79.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.353 0.979 . . . . 0.0 111.447 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.65 -28.97 63.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.442 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.45 -39.78 67.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.981 0.809 . . . . 0.0 109.322 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.22 -48.14 82.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 109.832 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -61.03 -43.06 99.45 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.299 0.5 . . . . 0.0 110.573 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.19 -32.9 70.33 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.597 -0.689 . . . . 0.0 110.911 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -74.75 -35.51 62.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.023 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -53.57 -45.42 69.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.96 1.254 . . . . 0.0 108.809 169.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.25 -46.92 85.09 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 123.027 0.531 . . . . 0.0 111.3 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -61.39 -50.96 70.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.949 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.21 -44.3 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.206 -1.378 . . . . 0.0 109.903 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -63.15 -43.28 98.77 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 121.565 1.984 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.38 -42.74 99.2 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.514 0.325 . . . . 0.0 110.266 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.72 -45.44 71.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.343 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -61.27 -40.7 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.034 1.288 . . . . 0.0 108.87 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.12 85.36 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -56.98 -41.5 78.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.251 1.02 . . . . 0.0 112.218 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -65.16 -41.46 94.67 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.35 -0.844 . . . . 0.0 110.174 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.76 -36.74 78.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.476 1.035 . . . . 0.0 111.475 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -49.6 76.47 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.679 0.792 . . . . 0.0 110.092 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.77 -48.32 81.18 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.757 0.708 . . . . 0.0 109.915 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.01 -38.6 70.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.212 0.915 . . . . 0.0 111.154 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.57 -45.86 61.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.49 -38.62 54.97 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.244 1.018 . . . . 0.0 111.72 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.4 p -94.35 -16.81 23.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.576 1.15 . . . . 0.0 111.05 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.06 92.0 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.906 1.283 . . . . 0.0 112.037 -169.698 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.36 160.46 43.3 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.444 1.098 . . . . 0.0 108.141 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -161.3 -38.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.559 0.744 . . . . 0.0 111.825 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 42.4 mtmt -133.05 171.14 14.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.477 1.511 . . . . 0.0 108.679 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -136.1 139.28 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tt -125.76 135.48 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -130.92 111.88 12.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.87 141.01 31.62 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.6 140.67 52.72 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -154.86 169.68 23.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.298 0.639 . . . . 0.0 109.445 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -71.03 -7.83 49.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.77 119.17 0.85 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 57.7 t-20 -77.36 72.53 3.91 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.352 1.061 . . . . 0.0 109.017 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.1 p -134.13 -30.96 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.311 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 m -134.75 -67.69 0.56 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.911 0.778 . . . . 0.0 111.63 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -57.79 -50.55 72.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.927 0.491 . . . . 0.0 111.74 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -64.43 -36.81 85.39 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.25 0.477 . . . . 0.0 111.618 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.51 -42.5 71.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.822 . . . . 0.0 110.85 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -62.06 -51.63 67.17 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.56 76.69 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.929 0.492 . . . . 0.0 110.969 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.68 -48.55 81.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.287 0.635 . . . . 0.0 109.97 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.82 -46.78 93.49 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.616 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.7 m95 -66.87 -41.87 86.55 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.065 1.433 . . . . 0.0 110.908 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.45 80.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.514 0.597 . . . . 0.0 111.055 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -57.45 -34.33 68.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.805 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.66 -58.62 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.366 0.53 . . . . 0.0 110.132 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -70.72 -36.44 73.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -169.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 42.8 mt -91.49 -36.69 13.6 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.78 -177.84 46.82 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.856 0.741 . . . . 0.0 112.723 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.54 -8.66 49.13 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.89 -9.79 2.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 110.972 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 9.6 m95 -136.36 166.42 23.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.835 1.654 . . . . 0.0 108.945 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.05 146.35 47.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 167.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.2 121.77 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -168.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.01 165.88 24.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.459 0.647 . . . . 0.0 109.841 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p -132.34 139.03 47.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.879 1.272 . . . . 0.0 108.427 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.59 -175.66 4.45 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.491 1.517 . . . . 0.0 108.565 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.04 177.19 46.39 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 121.802 -0.562 . . . . 0.0 111.891 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.53 -41.64 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.812 1.245 . . . . 0.0 108.569 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.89 177.42 8.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.82 0.848 . . . . 0.0 109.546 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.98 166.62 29.08 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.981 1.712 . . . . 0.0 108.714 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.26 -46.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.587 1.155 . . . . 0.0 108.12 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.74 25.91 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.62 122.53 14.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -74.24 141.44 77.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.661 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.11 -34.69 69.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.922 2.415 . . . . 0.0 113.715 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -35.43 78.96 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.719 0.691 . . . . 0.0 111.812 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.55 -42.1 68.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.01 -55.51 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.37 -44.41 96.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.4 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.13 88.74 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.087 0.858 . . . . 0.0 111.215 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.6 mmm -73.46 -39.93 64.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.7 0.4 . . . . 0.0 110.403 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -64.78 -33.5 76.14 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.141 0.976 . . . . 0.0 110.977 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.54 -15.29 62.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.791 1.236 . . . . 0.0 112.232 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.64 1.91 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.174 1.39 . . . . 0.0 109.781 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.29 72.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.661 -1.274 . . . . 0.0 112.299 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.57 93.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.09 77.8 5.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.46 0.704 . . . . 0.0 110.515 -172.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.4 pt -73.99 1.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.904 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -53.68 -27.94 30.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.99 1.268 . . . . 0.0 112.511 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.91 -22.37 61.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.061 1.344 . . . . 0.0 113.054 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -71.51 168.03 18.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.083 0.953 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -145.23 164.98 29.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.492 1.917 . . . . 0.0 108.115 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.2 m -108.68 158.26 17.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.531 0.681 . . . . 0.0 110.773 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 47.3 t0 -153.2 159.75 42.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.918 2.087 . . . . 0.0 107.499 172.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -88.44 166.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.02 108.52 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.152 0.981 . . . . 0.0 111.274 -170.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -94.03 114.56 26.76 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -18.76 62.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.245 1.418 . . . . 0.0 112.559 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.07 -47.7 60.83 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.121 0.873 . . . . 0.0 110.974 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.9 -42.65 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -48.85 -49.31 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.21 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -76.26 -12.96 60.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -92.75 -17.63 23.96 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.283 0.947 . . . . 0.0 110.903 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.74 50.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.168 0.44 . . . . 0.0 111.568 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 -37.5 75.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.71 162.59 39.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.931 0.872 . . . . 0.0 112.811 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.72 141.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.03 111.49 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 86' ' ' ALA . 52.0 p -90.18 103.08 15.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.25 -8.97 50.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.328 0.651 . . . . 0.0 112.287 -172.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -143.6 154.21 43.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.51 95.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.26 -32.07 73.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.591 0.695 . . . . 0.0 111.557 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.75 70.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.258 0.481 . . . . 0.0 111.794 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -67.0 -17.5 64.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.3 -31.54 72.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.568 0.622 . . . . 0.0 111.811 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.2 -28.51 57.28 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.175 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 m -47.06 108.01 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.4 1.08 . . . . 0.0 111.016 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.25 -38.73 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.957 1.771 . . . . 0.0 114.526 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.7 tpt -165.74 132.01 2.64 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.316 1.046 . . . . 0.0 109.166 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.7 p -137.88 96.42 10.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.74 168.39 20.28 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.889 2.393 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -50.86 -26.17 17.39 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.037 3.158 . . . . 0.0 115.85 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -66.17 -7.14 16.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.365 1.066 . . . . 0.0 113.077 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.65 97.03 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.96 2.104 . . . . 0.0 105.58 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 163.62 27.12 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.254 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -141.84 128.53 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.45 155.67 45.34 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.072 1.349 . . . . 0.0 108.054 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -137.64 143.23 41.29 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.506 0.722 . . . . 0.0 111.665 -169.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -139.28 -170.99 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.724 1.609 . . . . 0.0 108.553 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.91 45.2 0.98 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-N 119.11 0.868 . . . . 0.0 113.379 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -80.93 122.97 27.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.062 0.931 . . . . 0.0 111.576 -173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -78.19 152.65 32.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.66 127.76 76.89 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.698 -0.626 . . . . 0.0 112.47 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.35 -34.22 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.164 1.909 . . . . 0.0 113.375 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -22.05 66.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.282 0.946 . . . . 0.0 112.235 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -100.12 -0.9 38.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.419 1.088 . . . . 0.0 111.146 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.75 152.35 23.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -160.81 164.1 31.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.29 0.636 . . . . 0.0 110.358 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.52 -49.53 0.61 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.14 166.23 19.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.051 2.14 . . . . 0.0 105.649 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.36 -40.69 82.89 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.753 -0.592 . . . . 0.0 110.579 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.94 -29.05 64.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.346 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.3 -45.05 61.68 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -56.94 -49.85 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.661 0.784 . . . . 0.0 109.964 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -61.59 -44.22 97.41 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.34 0.518 . . . . 0.0 110.398 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -40.28 80.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.321 0.509 . . . . 0.0 110.293 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -62.59 -36.92 84.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.191 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.89 -50.59 70.26 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.327 0.967 . . . . 0.0 108.595 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -61.62 -45.45 94.0 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.045 0.538 . . . . 0.0 110.834 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -59.91 -50.01 75.45 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.271 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.4 -47.41 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 117.449 -1.262 . . . . 0.0 109.945 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -61.73 -41.55 97.78 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.828 1.649 . . . . 0.0 110.806 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.74 -41.74 99.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.074 0.397 . . . . 0.0 110.017 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -76.61 -33.8 58.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.619 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.62 -42.11 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.702 1.137 . . . . 0.0 108.069 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.75 -47.11 79.06 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -53.65 -44.48 69.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.883 1.273 . . . . 0.0 111.166 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -47.49 85.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 119.249 -0.405 . . . . 0.0 110.908 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.02 -37.24 83.79 Favored 'General case' 0 C--O 1.229 -0.023 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -59.15 -49.07 79.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.782 0.833 . . . . 0.0 110.407 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.61 -45.63 82.38 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.371 0.987 . . . . 0.0 109.65 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -55.39 -38.5 68.97 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.024 0.829 . . . . 0.0 111.016 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.98 34.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.601 0.76 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.76 -38.96 73.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.762 1.225 . . . . 0.0 111.32 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 p -90.34 -16.07 29.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.856 0.862 . . . . 0.0 110.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.78 40.63 89.65 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.78 1.232 . . . . 0.0 111.789 -169.927 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.78 164.28 37.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.319 1.047 . . . . 0.0 108.778 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -158.1 -36.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.464 1.506 . . . . 0.0 111.322 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -142.55 169.37 17.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.381 1.472 . . . . 0.0 109.026 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.3 mt -135.98 147.31 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 tt -134.64 142.9 39.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.484 1.114 . . . . 0.0 108.387 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.27 107.22 7.08 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.71 143.39 48.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.991 0.517 . . . . 0.0 109.934 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.08 143.22 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.083 1.753 . . . . 0.0 106.536 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 1.3 t -157.91 170.29 22.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 118.674 0.67 . . . . 0.0 109.53 170.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -66.82 -10.67 50.34 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.118 -0.989 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.98 119.82 0.93 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.4 t-20 -56.9 -46.58 81.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.632 0.773 . . . . 0.0 110.355 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 m -42.33 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 130.191 3.396 . . . . 0.0 117.733 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -119.5 -78.31 0.59 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.002 0.819 . . . . 0.0 109.499 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -61.89 -47.77 83.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.109 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -68.98 -38.25 79.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.063 0.847 . . . . 0.0 110.901 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -43.77 96.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.646 0.657 . . . . 0.0 111.484 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.4 mtp -66.18 -47.32 74.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.366 0.666 . . . . 0.0 109.546 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.9 78.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.388 0.675 . . . . 0.0 110.979 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.43 -45.85 80.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.62 0.768 . . . . 0.0 110.129 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.95 -47.29 91.41 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -69.97 -39.14 76.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.38 1.59 . . . . 0.0 111.055 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.1 79.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.744 0.417 . . . . 0.0 111.554 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.5 -33.91 64.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.82 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -74.48 -57.33 4.01 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.27 0.486 . . . . 0.0 110.603 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -73.58 -45.0 55.89 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -73.84 -35.71 64.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.486 0.584 . . . . 0.0 111.348 -169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.9 167.99 42.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.973 0.797 . . . . 0.0 111.78 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.78 -12.04 61.31 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -52.81 -31.6 39.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.384 0.611 . . . . 0.0 110.055 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -100.91 150.45 22.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -110.41 125.8 53.63 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 167.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.18 127.2 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -168.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.0 172.0 13.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.629 1.172 . . . . 0.0 108.768 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -137.47 139.67 40.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.118 0.967 . . . . 0.0 109.507 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.09 -175.15 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.344 1.458 . . . . 0.0 109.022 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 10' ' ' CYS . . . -165.03 175.79 40.88 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -42.1 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.51 179.48 7.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.84 0.856 . . . . 0.0 109.815 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.33 151.16 37.88 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.613 1.965 . . . . 0.0 106.964 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -127.84 10.35 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.769 1.227 . . . . 0.0 111.797 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.84 -173.54 18.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 126.113 1.816 . . . . 0.0 109.035 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.76 109.3 20.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -63.49 124.55 84.86 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.286 -172.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.18 -34.16 38.44 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.288 2.658 . . . . 0.0 113.657 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -38.64 87.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.77 0.714 . . . . 0.0 110.913 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.13 75.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.61 -52.14 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -65.97 -41.89 90.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.87 0.759 . . . . 0.0 110.827 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.83 -45.58 82.24 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.839 0.745 . . . . 0.0 110.954 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.7 mmm -75.78 -38.91 57.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.467 0.307 . . . . 0.0 110.903 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.96 -34.02 77.43 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.01 -1.056 . . . . 0.0 110.993 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.84 -20.4 66.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 112.238 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.83 -10.06 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 110.281 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.15 20.05 28.98 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.629 1.109 . . . . 0.0 111.925 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.56 91.35 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -77.49 76.79 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.751 1.22 . . . . 0.0 110.089 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.69 2.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 121.381 -0.824 . . . . 0.0 112.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.68 -28.9 16.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.348 1.859 . . . . 0.0 112.802 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.22 -16.62 57.67 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.847 1.259 . . . . 0.0 112.922 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -70.67 171.83 9.71 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.826 0.85 . . . . 0.0 109.7 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -147.1 158.95 44.11 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 107.819 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -98.43 156.33 16.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 110.043 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 43.1 t0 -150.26 162.7 39.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.891 2.076 . . . . 0.0 108.088 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -94.21 160.9 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 133.23 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 112.515 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -116.89 111.64 19.93 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.559 1.944 . . . . 0.0 106.83 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -62.0 -19.56 62.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.993 0.917 . . . . 0.0 112.719 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.78 -43.42 84.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.772 1.169 . . . . 0.0 111.322 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.99 -48.7 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.81 -52.35 24.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.237 1.015 . . . . 0.0 110.409 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -68.96 -10.19 56.05 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.23 6.49 7.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.001 1.273 . . . . 0.0 112.812 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 154.0 39.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.49 -32.43 54.26 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.553 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 33.5 tp -145.43 145.84 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.153 1.381 . . . . 0.0 109.104 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -126.5 140.41 48.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.53 134.05 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 86' ' ' ALA . 30.6 p -95.19 118.93 32.82 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.69 -0.76 31.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.153 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -147.22 163.03 37.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.695 1.134 . . . . 0.0 109.104 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.76 -38.99 77.11 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.852 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.52 -35.84 78.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.533 1.166 . . . . 0.0 110.925 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.72 -18.96 65.71 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.603 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -60.62 -23.97 65.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.935 0.789 . . . . 0.0 112.147 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.1 -34.05 76.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 111.979 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.56 63.95 8.26 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.06 0.944 . . . . 0.0 110.119 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.5 m -122.53 72.94 40.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.89 -48.43 7.52 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.08 3.186 . . . . 0.0 115.315 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 138.23 6.48 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -132.46 80.67 62.16 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.67 168.07 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.502 2.802 . . . . 0.0 110.916 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.9 -22.04 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.824 3.683 . . . . 0.0 118.655 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.21 -41.47 93.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.986 1.267 . . . . 0.0 110.615 170.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 156.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 127.785 2.434 . . . . 0.0 108.37 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.9 pttt -140.59 170.41 15.83 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.555 1.542 . . . . 0.0 107.777 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -134.02 157.07 47.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 112.417 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.97 158.39 43.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.189 2.196 . . . . 0.0 105.204 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -145.19 117.85 8.63 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.48 -0.763 . . . . 0.0 109.291 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -109.33 -174.13 2.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.019 1.327 . . . . 0.0 109.795 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.66 43.51 1.11 Allowed Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.418 -0.801 . . . . 0.0 114.534 -168.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -85.83 121.52 28.59 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.543 1.172 . . . . 0.0 111.168 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.06 155.12 40.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.78 120.89 83.75 Favored Pre-proline 0 C--O 1.235 0.318 0 O-C-N 121.833 -0.542 . . . . 0.0 111.417 -170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.85 -33.75 42.0 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.556 1.504 . . . . 0.0 112.754 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.14 -20.47 66.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.522 0.601 . . . . 0.0 112.526 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.13 -0.02 34.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.527 1.131 . . . . 0.0 111.568 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 150.18 24.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.67 164.52 33.94 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.183 0.593 . . . . 0.0 110.085 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.11 -48.21 0.69 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -164.11 162.69 23.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.904 2.082 . . . . 0.0 105.449 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.01 -40.86 86.23 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.693 -0.629 . . . . 0.0 110.495 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.22 -29.35 68.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.319 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -76.38 -40.22 51.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.988 0.813 . . . . 0.0 109.913 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.03 -51.37 69.53 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -60.21 -44.57 95.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.47 79.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -61.2 -34.84 75.73 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.97 0.805 . . . . 0.0 111.621 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -57.39 -48.46 79.02 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -61.23 -44.17 97.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.403 0.681 . . . . 0.0 111.919 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -61.27 -53.08 61.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.64 0.654 . . . . 0.0 109.578 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.23 -43.02 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.638 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -61.16 -43.87 98.21 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.941 1.7 . . . . 0.0 110.992 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.49 -43.66 96.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.35 -39.89 71.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.01 -45.24 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.565 1.075 . . . . 0.0 108.37 175.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.89 95.18 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -62.19 -39.52 92.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.221 1.01 . . . . 0.0 111.719 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -38.6 85.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.98 0.809 . . . . 0.0 110.685 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.96 -38.98 66.54 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.925 -0.484 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -56.87 -47.15 81.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.119 0.968 . . . . 0.0 110.138 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.61 -52.22 66.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 117.324 -1.322 . . . . 0.0 109.519 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.02 -44.08 82.48 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.457 1.48 . . . . 0.0 110.196 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.21 92.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.264 0.626 . . . . 0.0 111.642 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.45 -37.68 22.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.994 0.918 . . . . 0.0 111.416 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 p -94.62 -22.77 17.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.592 0.757 . . . . 0.0 111.345 -170.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.249 1.05 0 C-N-CA 127.443 2.297 . . . . 0.0 112.443 -170.045 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -159.37 171.24 20.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.629 1.572 . . . . 0.0 107.544 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.59 -39.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.48 0.712 . . . . 0.0 110.176 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.31 176.68 9.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.183 0.993 . . . . 0.0 109.474 169.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.9 mt -133.25 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.33 132.93 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -127.78 101.62 6.44 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.145 0.978 . . . . 0.0 108.387 -171.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -73.11 145.77 46.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.62 131.58 21.64 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.58 -178.1 6.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.131 0.423 . . . . 0.0 111.214 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -7.41 36.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.713 -1.242 . . . . 0.0 114.07 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.65 129.92 2.08 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.696 HD22 ' H ' ' A' ' 65' ' ' ASP . 45.4 t-20 -81.22 40.17 0.54 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.276 1.031 . . . . 0.0 112.062 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.4 p -122.46 -20.91 5.91 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 111.765 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.1 m -134.66 -73.37 0.47 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.948 0.899 . . . . 0.0 110.866 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -60.21 3.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.909 0.777 . . . . 0.0 111.038 -169.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 m -62.68 -42.34 99.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.656 0.382 . . . . 0.0 110.468 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -61.01 -45.58 94.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.219 0.608 . . . . 0.0 111.405 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 43.2 mtm -66.77 -46.17 76.18 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.933 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.03 -44.99 79.3 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.368 0.531 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.25 -45.24 91.71 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.773 0.829 . . . . 0.0 110.082 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.48 -46.58 92.93 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.474 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -69.63 -39.82 76.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.554 1.677 . . . . 0.0 110.822 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.84 78.83 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.358 0.526 . . . . 0.0 110.844 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -57.2 -33.06 67.12 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.727 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -71.56 -57.7 4.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.465 0.575 . . . . 0.0 110.148 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -70.24 -37.81 75.04 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.93 -38.74 12.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.095 0.558 . . . . 0.0 111.839 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 177.45 48.41 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.267 0.937 . . . . 0.0 112.391 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.48 -10.15 53.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.697 1.199 . . . . 0.0 113.585 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.9 -10.69 6.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.282 1.433 . . . . 0.0 111.379 169.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.61 146.11 50.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.607 1.563 . . . . 0.0 108.095 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -100.76 138.46 37.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 167.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.18 127.54 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -168.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.33 169.82 16.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -134.81 143.05 46.85 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 109.766 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.26 -177.11 4.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.282 1.433 . . . . 0.0 108.838 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.91 167.36 35.92 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.64 -40.78 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.42 179.77 6.9 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.997 . . . . 0.0 109.852 170.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.11 159.43 43.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.256 1.822 . . . . 0.0 108.017 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -147.74 -31.37 0.3 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.365 0.666 . . . . 0.0 111.833 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.91 173.61 34.55 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.19 107.27 2.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -72.4 130.9 85.36 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.02 -27.09 65.92 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.866 1.711 . . . . 0.0 112.956 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -39.1 93.22 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.996 0.816 . . . . 0.0 111.2 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.37 62.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.91 -58.36 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -64.03 -39.58 94.42 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 118.644 0.656 . . . . 0.0 110.557 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.52 68.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.709 0.686 . . . . 0.0 110.935 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.72 -38.49 67.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.022 0.529 . . . . 0.0 111.108 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -68.97 -29.02 67.15 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.304 -0.873 . . . . 0.0 111.6 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.94 -18.55 65.43 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.464 1.105 . . . . 0.0 111.874 170.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.04 -2.96 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.769 1.228 . . . . 0.0 109.798 172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.27 18.93 54.55 Favored Glycine 0 CA--C 1.531 1.031 0 O-C-N 120.79 -1.194 . . . . 0.0 112.307 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 mt -114.16 95.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.07 78.69 4.55 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.279 1.032 . . . . 0.0 110.168 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -72.83 -3.21 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.44 -0.787 . . . . 0.0 112.017 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -29.2 63.33 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.815 1.189 . . . . 0.0 112.077 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -73.02 -16.02 61.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.827 1.251 . . . . 0.0 112.533 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.61 171.01 9.63 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.707 0.803 . . . . 0.0 109.027 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -138.99 162.99 33.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.88 1.272 . . . . 0.0 109.086 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 p -116.83 144.66 44.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 109.451 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.696 ' H ' HD22 ' A' ' 13' ' ' ASN . 45.8 t0 -153.46 155.58 36.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.091 2.156 . . . . 0.0 107.999 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.78 164.44 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tt -54.34 134.33 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 111.265 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -128.95 112.05 13.67 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.688 1.195 . . . . 0.0 108.493 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 p -54.83 -28.75 51.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.592 0.757 . . . . 0.0 111.28 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.69 -1.23 15.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.364 1.465 . . . . 0.0 113.66 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.22 -46.54 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -45.46 -54.33 7.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.864 1.266 . . . . 0.0 111.456 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -2.15 9.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -133.56 3.76 3.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.612 1.165 . . . . 0.0 112.758 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.07 151.01 48.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.22 -34.27 75.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tp -145.66 143.14 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.117 1.367 . . . . 0.0 109.726 -171.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.58 138.13 52.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.13 111.81 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -90.97 91.26 8.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.45 -9.43 12.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.284 1.033 . . . . 0.0 113.307 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.3 133.66 21.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.8 -32.93 66.63 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.717 0.675 . . . . 0.0 112.687 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.2 -30.68 71.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.33 1.065 . . . . 0.0 111.884 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 -30.92 68.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.266 0.626 . . . . 0.0 111.576 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.79 -20.12 64.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.16 -34.49 66.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.965 0.906 . . . . 0.0 112.129 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 -32.56 61.67 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.661 -171.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.0 m -48.8 108.11 0.89 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.992 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.76 -28.01 14.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.323 2.015 . . . . 0.0 114.239 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.9 ptp -163.61 131.34 3.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.271 1.028 . . . . 0.0 110.086 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -140.23 80.48 19.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.78 169.19 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.214 3.276 . . . . 0.0 113.23 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.21 -28.12 32.62 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.463 2.776 . . . . 0.0 115.047 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.57 -7.22 30.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.262 1.025 . . . . 0.0 112.968 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.11 81.7 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.931 2.492 . . . . 0.0 105.271 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.8 pttt -65.58 166.16 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -131.68 155.07 48.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.92 0.488 . . . . 0.0 110.384 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.74 159.74 41.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 149.21 31.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.4 0.68 . . . . 0.0 112.429 -168.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -143.06 -160.2 1.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.197 1.399 . . . . 0.0 109.084 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.65 41.28 0.99 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.84 1.2 . . . . 0.0 113.874 -169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -85.65 107.88 17.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.586 1.193 . . . . 0.0 111.999 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.25 154.37 35.26 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.586 1.155 . . . . 0.0 110.105 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.98 120.67 82.48 Favored Pre-proline 0 C--O 1.236 0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.974 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.32 -32.04 27.12 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.906 1.737 . . . . 0.0 112.372 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.37 -19.86 66.13 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.371 0.987 . . . . 0.0 112.24 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.87 1.59 34.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.708 1.203 . . . . 0.0 111.3 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.14 138.87 57.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -145.75 156.28 43.5 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.27 -55.18 0.41 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 t -155.75 158.5 38.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.23 -39.0 88.64 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.569 -0.707 . . . . 0.0 110.815 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.22 -30.88 70.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.2 -0.313 . . . . 0.0 111.049 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.75 -42.55 58.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.205 0.602 . . . . 0.0 109.848 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 20.3 tttt -55.42 -52.27 64.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.702 1.201 . . . . 0.0 110.1 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -60.29 -45.2 94.17 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 117.962 0.346 . . . . 0.0 110.322 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.82 79.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.284 0.493 . . . . 0.0 110.427 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.72 -39.82 92.88 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.589 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.31 -50.57 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.037 0.835 . . . . 0.0 108.802 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -60.21 -45.08 94.43 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 122.912 0.485 . . . . 0.0 111.165 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.54 -48.86 79.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.85 0.46 . . . . 0.0 110.384 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.93 -44.69 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.021 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -60.85 -42.33 97.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 121.496 1.953 . . . . 0.0 110.753 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.03 -44.61 96.33 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.42 -31.65 62.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.526 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.91 -43.38 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.246 . . . . 0.0 108.592 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.29 88.82 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.91 -35.96 75.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.935 1.294 . . . . 0.0 111.562 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -50.98 71.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 123.614 0.766 . . . . 0.0 109.197 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.18 -32.17 66.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.004 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -52.02 67.26 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.942 0.897 . . . . 0.0 110.521 169.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.19 -47.42 79.84 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 119.609 1.095 . . . . 0.0 109.349 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -55.83 -38.6 70.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.607 -0.683 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -48.56 37.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.572 0.749 . . . . 0.0 111.611 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.97 -38.34 72.77 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.558 1.143 . . . . 0.0 111.143 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.4 p -90.97 -18.48 24.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 110.27 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.13 39.31 95.66 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -173.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm . . . . . 0 C--O 1.25 1.102 0 C-N-CA 125.158 1.383 . . . . 0.0 111.665 -171.767 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.74 166.71 32.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.612 1.565 . . . . 0.0 107.541 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -159.36 -42.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.012 0.525 . . . . 0.0 110.712 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.54 175.93 10.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.457 0.703 . . . . 0.0 110.552 169.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.97 136.19 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.52 135.29 64.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -132.26 105.37 7.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -74.06 147.43 42.84 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.637 -0.665 . . . . 0.0 110.137 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.73 130.14 17.75 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.95 173.56 14.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.68 0.673 . . . . 0.0 110.093 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -66.06 -9.2 28.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.928 -1.107 . . . . 0.0 113.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.58 1.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 53.9 t-20 -62.67 -49.09 76.49 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.469 0.707 . . . . 0.0 110.786 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.1 m -41.69 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 130.321 3.448 . . . . 0.0 117.816 -168.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.8 -73.61 0.64 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.812 1.187 . . . . 0.0 110.09 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -61.65 -49.45 76.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.125 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -69.69 -38.83 77.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.655 0.661 . . . . 0.0 111.005 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -61.36 -45.28 95.04 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.836 0.744 . . . . 0.0 111.697 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -65.08 -48.69 72.83 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.45 78.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.859 0.463 . . . . 0.0 111.047 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.18 -50.93 71.29 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 109.927 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.28 -46.86 92.34 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.113 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.4 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.9 m95 -66.74 -42.39 86.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.655 1.728 . . . . 0.0 110.711 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.04 75.6 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.591 0.632 . . . . 0.0 111.313 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -57.31 -33.99 68.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.45 -57.2 5.55 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.455 0.571 . . . . 0.0 110.1 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -69.67 -34.38 73.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.66 -38.11 9.65 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.255 0.622 . . . . 0.0 112.456 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 178.97 51.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.216 0.912 . . . . 0.0 112.761 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.53 -12.32 60.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.934 1.294 . . . . 0.0 113.759 -170.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.7 -7.54 2.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.76 1.624 . . . . 0.0 112.063 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -131.55 145.39 51.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.48 1.512 . . . . 0.0 108.681 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 7.4 mmpt? -98.43 136.21 38.9 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 167.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.51 116.71 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -168.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.28 171.84 13.19 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -139.84 142.67 36.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.278 1.031 . . . . 0.0 108.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.93 -176.43 4.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.766 1.626 . . . . 0.0 108.544 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.63 173.84 40.59 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.19 -40.85 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.08 177.41 8.79 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.896 0.878 . . . . 0.0 110.099 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.04 126.3 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.847 1.659 . . . . 0.0 107.207 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -77.6 -46.12 23.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.339 0.656 . . . . 0.0 109.428 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.1 -166.7 39.37 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -78.18 99.62 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -62.68 131.01 94.11 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.64 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.71 -28.5 82.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.232 1.954 . . . . 0.0 112.891 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -58.9 -50.1 75.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.377 0.989 . . . . 0.0 109.324 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.22 -42.24 85.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.451 0.569 . . . . 0.0 110.233 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.64 -54.4 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.438 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -64.21 -46.64 82.99 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.318 0.963 . . . . 0.0 110.33 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.5 70.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.011 0.924 . . . . 0.0 111.436 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -79.97 -36.39 36.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.365 0.666 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.32 -31.72 72.95 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.918 -1.113 . . . . 0.0 109.801 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -72.79 6.72 2.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.672 1.989 . . . . 0.0 112.122 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.75 -6.68 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.795 2.038 . . . . 0.0 108.669 169.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.65 25.46 56.38 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 120.574 -1.328 . . . . 0.0 111.202 -169.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -116.76 90.49 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -78.78 80.72 5.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.578 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -75.25 6.82 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.246 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.9 m -53.98 -27.15 29.76 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.04 1.291 . . . . 0.0 112.168 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.68 -18.09 58.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.569 1.147 . . . . 0.0 113.161 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -71.81 170.72 13.04 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.878 0.763 . . . . 0.0 109.895 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 156.0 43.55 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.748 1.619 . . . . 0.0 107.648 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -102.44 151.95 21.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.75 . . . . 0.0 109.381 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.6 t0 -152.11 161.24 42.92 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.733 2.013 . . . . 0.0 108.251 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 pt -93.16 162.86 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -57.37 113.21 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.72 118.37 29.27 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 m -72.08 -22.53 61.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.539 -170.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.54 -42.75 51.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.044 0.838 . . . . 0.0 110.051 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.74 -44.88 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.88 -49.12 74.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.188 0.449 . . . . 0.0 110.281 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -65.85 -18.47 65.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -98.15 -14.81 20.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.342 0.974 . . . . 0.0 110.682 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.68 159.98 33.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 118.399 0.545 . . . . 0.0 110.946 -169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.37 -30.59 42.65 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 168.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 tp -152.02 145.69 25.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.621 1.568 . . . . 0.0 109.872 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.6 t -123.05 140.01 48.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.51 111.47 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.5 p -90.66 94.03 9.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.11 -10.78 33.33 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.038 0.935 . . . . 0.0 112.499 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.67 135.87 23.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.92 -34.02 76.5 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.758 0.694 . . . . 0.0 112.815 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.68 -29.28 70.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.356 1.078 . . . . 0.0 111.681 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.67 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 111.531 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.43 65.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.78 -34.29 71.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.233 1.013 . . . . 0.0 112.066 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -73.66 -32.12 63.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.883 -171.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 80.8 m -46.77 107.15 0.66 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.949 1.299 . . . . 0.0 109.627 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -64.26 -44.41 12.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.553 1.502 . . . . 0.0 114.239 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.8 ttt -167.26 123.66 1.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.291 1.036 . . . . 0.0 108.527 169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -109.24 85.48 3.48 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.7 166.62 17.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.984 2.456 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.23 -19.57 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.709 3.606 . . . . 0.0 118.279 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.18 -40.22 89.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.039 1.291 . . . . 0.0 110.051 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.26 162.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 127.881 2.472 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -142.58 169.27 17.88 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.586 1.555 . . . . 0.0 107.262 169.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -132.65 145.6 51.2 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.863 0.756 . . . . 0.0 111.156 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 152.18 43.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.301 2.24 . . . . 0.0 105.115 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.17 141.12 42.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.363 0.665 . . . . 0.0 110.284 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -138.26 -166.34 1.96 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.416 1.486 . . . . 0.0 109.076 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.54 1.13 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 119.197 0.908 . . . . 0.0 112.796 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.87 112.86 12.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.867 0.833 . . . . 0.0 110.728 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -69.14 153.56 43.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.354 0.662 . . . . 0.0 109.663 169.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.19 118.2 68.81 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 111.505 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.73 -33.7 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.005 1.804 . . . . 0.0 112.385 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.1 -19.14 64.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.745 0.702 . . . . 0.0 112.072 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -100.27 -2.95 32.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.766 1.226 . . . . 0.0 111.377 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.09 136.77 58.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 168.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.07 22.3 0.66 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -168.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.34 -51.58 42.32 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -172.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -160.17 163.62 33.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.81 2.444 . . . . 0.0 104.863 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.85 -40.02 83.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.09 1.314 . . . . 0.0 111.123 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.75 -32.75 72.73 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.282 -0.261 . . . . 0.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -75.32 -37.84 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.066 0.546 . . . . 0.0 110.144 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 41.7 tttt -59.26 -51.22 70.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.769 1.228 . . . . 0.0 109.415 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -61.96 -41.69 98.28 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.803 0.274 . . . . 0.0 110.644 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.59 73.64 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.48 -0.762 . . . . 0.0 110.859 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.2 -42.07 89.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.545 0.738 . . . . 0.0 110.385 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -56.05 -47.39 77.99 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -59.7 -48.63 80.91 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.96 0.904 . . . . 0.0 111.513 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.94 -45.06 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 116.619 -1.658 . . . . 0.0 110.262 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -61.19 -44.25 97.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 121.985 2.175 . . . . 0.0 110.48 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.71 -43.71 98.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -79.93 -27.31 39.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.255 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -65.88 -42.26 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 107.883 171.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.03 90.14 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -57.34 -40.79 78.73 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.403 1.081 . . . . 0.0 111.14 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -46.67 87.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.744 -0.598 . . . . 0.0 111.027 175.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.66 -34.31 77.91 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.588 0.631 . . . . 0.0 111.086 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -50.55 73.6 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.89 -47.36 83.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 119.712 1.142 . . . . 0.0 109.643 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.38 -39.19 72.52 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 118.394 0.543 . . . . 0.0 110.832 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.04 -48.21 46.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.907 0.883 . . . . 0.0 111.777 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -69.47 -39.6 77.61 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.726 1.21 . . . . 0.0 111.186 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -87.35 -17.66 31.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.315 1.046 . . . . 0.0 110.122 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.53 41.36 93.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.168 1.366 . . . . 0.0 110.71 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.763 0.825 . . . . 0.0 112.207 -170.771 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -58.96 147.46 34.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.619 0.767 . . . . 0.0 109.759 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -153.03 -51.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.364 0.666 . . . . 0.0 110.037 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -146.52 173.62 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.648 1.179 . . . . 0.0 108.358 169.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.39 142.36 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -169.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.71 135.85 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.416 1.486 . . . . 0.0 107.149 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -129.01 103.43 7.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.963 0.905 . . . . 0.0 108.727 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.58 146.19 42.74 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 122.044 -0.41 . . . . 0.0 109.933 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.92 132.25 20.66 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -148.62 173.71 12.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.292 0.637 . . . . 0.0 110.116 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -68.17 -9.11 44.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.556 -1.34 . . . . 0.0 113.689 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.19 123.7 1.3 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.25 -41.04 97.15 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.219 0.509 . . . . 0.0 111.279 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -38.57 -28.94 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.77 3.228 . . . . 0.0 116.861 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -127.93 -74.93 0.57 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.206 0.912 . . . . 0.0 112.335 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mpp_? -53.87 -50.73 65.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.21 0.914 . . . . 0.0 113.436 -168.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 22.3 p -80.26 -27.81 38.56 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.979 0.809 . . . . 0.0 111.662 -175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -62.1 -41.39 98.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.643 1.11 . . . . 0.0 110.943 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 79.0 mtp -65.89 -49.37 68.29 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.64 73.66 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.938 0.495 . . . . 0.0 111.357 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -56.11 -48.91 75.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.081 0.952 . . . . 0.0 109.952 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.63 99.67 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.157 -0.801 . . . . 0.0 112.823 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 94.3 m95 -68.13 -44.11 76.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.168 1.484 . . . . 0.0 110.16 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.48 83.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.618 0.367 . . . . 0.0 110.358 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -59.14 -26.1 64.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.266 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -74.07 -59.21 2.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 110.438 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -69.81 -38.15 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 34.6 mt -87.19 -39.37 15.54 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.249 0.619 . . . . 0.0 112.176 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.39 -178.87 49.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.092 0.853 . . . . 0.0 112.834 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.93 -15.65 62.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.291 1.436 . . . . 0.0 113.567 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.76 -16.11 3.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.905 1.282 . . . . 0.0 111.534 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 11.4 m95 -129.08 140.54 51.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 110.083 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -89.57 131.15 35.73 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.54 119.21 54.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 171.59 14.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 171.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 59.2 p -136.78 152.37 50.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.238 1.015 . . . . 0.0 109.356 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.89 -168.86 3.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.076 1.351 . . . . 0.0 107.572 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.23 37.82 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.52 -40.18 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.07 179.52 6.85 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.467 1.107 . . . . 0.0 109.532 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.01 157.37 43.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.424 2.29 . . . . 0.0 106.574 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -132.5 -29.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.456 1.102 . . . . 0.0 110.185 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.53 -179.25 37.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.9 tp -75.81 101.47 5.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -62.0 124.8 83.39 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.374 -171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -51.08 -33.54 43.73 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.272 2.648 . . . . 0.0 113.719 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -39.54 90.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.651 0.659 . . . . 0.0 110.691 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.35 73.56 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -58.23 -53.35 47.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -67.62 -41.59 83.7 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.778 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.08 -49.05 74.89 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 118.886 0.766 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -71.02 -40.3 71.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.076 0.55 . . . . 0.0 110.84 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -64.57 -29.96 70.99 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.195 -0.941 . . . . 0.0 111.014 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -68.99 -22.37 64.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.963 0.905 . . . . 0.0 112.06 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.03 -30.44 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.214 0.915 . . . . 0.0 109.113 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.29 14.48 11.71 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.462 1.505 . . . . 0.0 111.471 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.87 97.25 5.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.15 85.44 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.294 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.55 4.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.277 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -56.48 -26.16 53.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.891 1.678 . . . . 0.0 112.132 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -72.93 -22.07 60.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.055 1.342 . . . . 0.0 113.013 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -71.25 167.5 19.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.73 0.812 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.49 156.45 43.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.41 1.484 . . . . 0.0 108.419 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 m -102.7 153.92 19.66 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.161 0.585 . . . . 0.0 111.599 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -154.48 154.86 33.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.718 1.607 . . . . 0.0 109.056 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 pt -84.83 163.28 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.94 134.1 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.397 1.079 . . . . 0.0 110.927 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -119.88 110.18 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.427 1.491 . . . . 0.0 107.451 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 m -54.7 -24.77 23.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.152 1.381 . . . . 0.0 112.676 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.28 -45.48 63.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.07 0.85 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.06 -42.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.55 -50.21 43.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.931 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -75.89 -12.01 60.07 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -92.57 -19.89 21.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.386 0.994 . . . . 0.0 110.783 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.15 140.45 57.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.083 0.401 . . . . 0.0 110.291 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.19 -33.47 75.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.3 tp -145.44 143.88 30.3 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.238 1.415 . . . . 0.0 109.918 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.36 136.99 55.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.24 108.48 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.2 p -88.33 95.67 10.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.75 -13.48 55.14 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 50.2 t -141.99 139.67 32.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.02 -36.64 90.96 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.493 0.568 . . . . 0.0 112.59 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.72 -27.24 68.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.193 0.997 . . . . 0.0 111.659 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -24.83 61.12 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.328 0.651 . . . . 0.0 111.651 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.31 -14.91 62.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.88 -33.6 75.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.179 0.592 . . . . 0.0 111.677 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -87.59 75.46 9.07 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.471 0.709 . . . . 0.0 109.394 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.2 m -135.99 80.95 40.66 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.13 88.31 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.519 3.48 . . . . 0.0 110.882 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . 0.263 24.1 ptt? 51.57 130.62 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 131.16 3.784 . . . . 0.0 114.643 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p -137.76 84.59 21.81 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -53.87 171.85 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.67 3.58 . . . . 0.0 113.203 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.56 -27.86 26.79 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.722 2.948 . . . . 0.0 115.199 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.44 -14.13 55.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 112.853 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.28 82.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.529 2.332 . . . . 0.0 106.423 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.6 pttt -67.08 164.35 18.08 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -129.75 155.74 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.742 -0.599 . . . . 0.0 109.718 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.15 154.56 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -140.12 143.28 36.15 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.9 0.48 . . . . 0.0 111.139 -168.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -140.08 -169.88 2.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.286 1.434 . . . . 0.0 109.19 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.02 42.77 1.28 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.018 0.818 . . . . 0.0 112.992 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -77.33 101.05 6.13 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 111.455 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -60.89 158.27 13.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.372 1.069 . . . . 0.0 110.124 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.07 124.21 86.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.368 -169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.98 -44.44 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.858 2.372 . . . . 0.0 111.84 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.59 69.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.423 0.689 . . . . 0.0 111.024 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.37 12.16 31.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.039 1.335 . . . . 0.0 111.21 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.52 72.08 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.597 0.635 . . . . 0.0 112.692 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 55.86 -176.98 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.865 2.066 . . . . 0.0 113.281 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -65.84 0.49 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 126.179 1.847 . . . . 0.0 108.784 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 t -160.92 159.88 30.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.98 -39.76 75.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.014 0.825 . . . . 0.0 111.333 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.1 -28.98 66.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.358 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.36 -41.45 69.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.732 0.697 . . . . 0.0 109.32 174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -59.41 -53.73 54.85 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -57.65 -42.1 82.8 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.528 0.517 . . . . 0.0 110.022 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.2 87.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.157 0.435 . . . . 0.0 110.295 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.91 -38.74 92.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.626 0.77 . . . . 0.0 111.144 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -58.91 -47.38 85.21 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.292 0.951 . . . . 0.0 108.721 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -61.44 -42.89 99.46 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.149 0.58 . . . . 0.0 111.149 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.47 -50.55 64.93 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.305 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.01 -44.37 99.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.191 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -44.53 97.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 121.149 1.795 . . . . 0.0 110.628 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.67 -43.02 99.65 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.84 -29.35 44.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.806 -1.093 . . . . 0.0 112.222 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.05 -44.54 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.4 -46.71 93.83 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.71 -42.18 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.848 0.824 . . . . 0.0 110.429 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -46.05 91.8 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.2 mt -72.71 -34.38 67.08 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 110.149 -175.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.65 -51.6 69.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 110.752 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.42 -49.25 76.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.982 0.81 . . . . 0.0 109.296 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.37 -39.93 67.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.686 0.675 . . . . 0.0 111.082 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.2 -46.94 54.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.745 0.818 . . . . 0.0 111.854 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.79 -38.45 67.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.606 1.163 . . . . 0.0 111.182 -173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.2 p -89.3 -22.41 22.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 110.114 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.26 44.45 97.46 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.105 1.362 . . . . 0.0 111.301 -175.488 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -65.57 165.89 11.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 111.633 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -142.92 -38.68 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.4 mtmt -136.67 166.3 23.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.73 171.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.76 132.08 67.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 172.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -122.73 133.98 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -129.6 106.34 8.67 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.81 0.844 . . . . 0.0 109.155 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -75.42 146.91 40.38 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.057 -0.402 . . . . 0.0 110.084 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.95 127.51 15.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -149.44 172.84 14.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.995 0.518 . . . . 0.0 110.237 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -66.83 -10.37 47.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.885 -1.134 . . . . 0.0 113.314 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.43 118.77 0.85 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.926 -2.87 . . . . 0.0 105.926 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 56.2 t-20 -56.22 -47.48 78.35 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.611 0.764 . . . . 0.0 110.347 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -45.1 -24.61 0.26 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.679 3.192 . . . . 0.0 116.397 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 m -112.67 -88.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -60.71 -43.59 97.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.908 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -70.62 -40.56 73.07 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.914 1.234 . . . . 0.0 111.238 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.89 -44.52 96.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.079 0.854 . . . . 0.0 111.007 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.6 mtp -65.44 -45.51 83.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.78 89.41 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.316 0.647 . . . . 0.0 111.092 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -57.17 -45.46 83.62 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.79 -55.11 27.16 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.15 -0.806 . . . . 0.0 113.106 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -68.74 -36.76 78.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.911 1.856 . . . . 0.0 111.144 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.53 76.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.258 -0.902 . . . . 0.0 111.253 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.64 -35.29 70.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.623 0.647 . . . . 0.0 111.904 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.16 -49.93 25.44 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.481 0.712 . . . . 0.0 109.273 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -76.61 -31.51 57.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.22 -36.89 8.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 -171.26 49.35 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 122.116 0.842 . . . . 0.0 113.856 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.69 -14.32 57.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.746 2.019 . . . . 0.0 114.098 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.09 -10.15 2.49 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.774 1.629 . . . . 0.0 111.839 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 2.8 m95 -141.58 157.79 44.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.757 1.223 . . . . 0.0 110.261 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -109.95 139.13 45.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 167.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.02 124.94 67.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -169.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.94 170.51 15.88 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -138.65 142.2 39.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 108.507 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.92 -176.65 4.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.721 1.608 . . . . 0.0 108.466 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.16 173.69 40.19 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -41.42 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.51 179.85 6.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.814 0.846 . . . . 0.0 109.388 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.47 120.95 12.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -73.09 -38.69 66.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.642 0.777 . . . . 0.0 109.364 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.82 -167.47 35.9 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 127.961 2.696 . . . . 0.0 107.798 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.43 100.14 9.12 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -62.59 121.32 66.73 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.539 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.86 -32.82 48.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.032 2.488 . . . . 0.0 113.228 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.98 89.35 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.73 0.695 . . . . 0.0 111.035 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.47 71.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.81 -54.36 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.1 -43.12 93.08 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.127 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.68 -50.11 63.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.661 0.664 . . . . 0.0 110.431 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.4 mmm -75.42 -35.94 60.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.799 0.272 . . . . 0.0 111.578 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.68 -32.94 73.15 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -67.36 -19.85 65.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.872 0.869 . . . . 0.0 112.443 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.74 -10.68 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.504 1.047 . . . . 0.0 110.132 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.28 25.37 44.03 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.035 -1.041 . . . . 0.0 110.666 -169.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.69 89.49 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -78.6 81.44 4.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.288 -171.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.41 6.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.57 -0.728 . . . . 0.0 112.197 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 m -55.0 -27.04 41.14 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.228 1.376 . . . . 0.0 112.09 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.02 -20.72 60.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.939 1.296 . . . . 0.0 112.95 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.45 171.45 10.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.737 0.779 . . . . 0.0 109.994 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -143.65 152.41 41.32 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.539 1.536 . . . . 0.0 107.325 172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -96.12 152.51 18.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.545 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -152.06 160.51 43.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.608 1.963 . . . . 0.0 108.274 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 pt -93.96 160.5 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.64 116.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.724 0.773 . . . . 0.0 112.955 -169.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.51 113.27 25.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 m -61.43 -24.22 66.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.576 1.15 . . . . 0.0 112.56 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.15 -39.31 82.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.013 0.824 . . . . 0.0 111.222 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.0 mt -66.29 -48.19 81.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.52 -48.71 68.78 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 109.954 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.84 -2.89 8.08 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -132.96 1.43 3.57 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.535 1.516 . . . . 0.0 114.199 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.15 47.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.209 0.913 . . . . 0.0 109.599 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.27 -34.75 78.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.2 tp -147.36 144.2 28.55 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.969 1.308 . . . . 0.0 110.596 -171.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.77 136.51 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 109.82 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.4 p -88.88 101.09 13.7 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.84 -10.48 59.85 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.14 158.96 43.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.103 0.865 . . . . 0.0 109.005 169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.4 -42.67 93.73 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.104 -169.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.36 -32.39 74.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.844 0.822 . . . . 0.0 111.364 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.96 69.41 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.749 0.419 . . . . 0.0 112.053 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.41 -33.85 73.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.898 0.772 . . . . 0.0 111.599 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -89.16 59.65 5.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.404 1.082 . . . . 0.0 110.069 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.9 83.82 30.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.8 70.64 2.78 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.451 3.434 . . . . 0.0 112.134 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.6 mtt 78.55 100.18 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 129.294 3.038 . . . . 0.0 112.001 172.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -105.53 84.34 1.15 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.83 172.69 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.297 2.665 . . . . 0.0 110.775 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -49.49 -27.97 15.26 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.805 3.003 . . . . 0.0 116.365 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -68.44 -8.56 41.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.112 0.965 . . . . 0.0 113.042 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.54 86.96 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 128.421 2.688 . . . . 0.0 105.304 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -66.93 164.94 16.48 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -143.07 145.88 33.29 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.349 -0.845 . . . . 0.0 109.234 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -132.8 157.1 45.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.418 1.487 . . . . 0.0 107.576 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -141.29 138.51 33.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.843 . . . . 0.0 110.747 -168.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.52 -171.85 2.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.813 1.645 . . . . 0.0 108.43 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.63 77.68 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 O-C-N 121.174 -0.953 . . . . 0.0 113.214 -169.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.14 151.14 45.05 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.088 0.944 . . . . 0.0 111.372 170.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.51 160.32 32.65 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.444 1.898 . . . . 0.0 113.265 -169.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.85 129.36 71.0 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.096 0.959 . . . . 0.0 111.712 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.55 -30.19 4.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.188 1.925 . . . . 0.0 114.009 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.29 -13.23 57.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.27 9.65 10.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.758 1.223 . . . . 0.0 111.435 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.11 141.9 52.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.39 162.14 37.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.97 0.908 . . . . 0.0 109.708 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.54 -50.07 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.88 165.37 22.86 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.557 2.343 . . . . 0.0 105.272 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.97 -40.01 83.46 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.51 -0.744 . . . . 0.0 110.641 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.97 -29.06 66.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.411 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.06 -44.5 60.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.826 0.739 . . . . 0.0 109.128 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -56.43 -51.04 69.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.778 0.831 . . . . 0.0 109.825 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -62.85 -42.53 99.78 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.625 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.36 78.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.914 0.779 . . . . 0.0 110.142 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.37 -38.34 90.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.043 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.21 -50.9 68.22 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -60.39 -43.7 96.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.02 0.528 . . . . 0.0 111.516 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -60.52 -50.01 75.27 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.281 0.491 . . . . 0.0 110.305 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.82 -39.41 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.669 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -56.65 -51.97 66.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.696 1.134 . . . . 0.0 109.602 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.29 -41.33 96.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.456 0.702 . . . . 0.0 110.005 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.84 -26.85 44.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.618 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -45.96 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.46 -44.15 93.62 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -60.4 -39.65 88.12 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.205 1.402 . . . . 0.0 111.179 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.53 79.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.69 -32.69 64.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.518 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -51.42 69.81 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.226 1.011 . . . . 0.0 110.56 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.64 -47.18 82.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.557 1.071 . . . . 0.0 109.582 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.08 -39.03 71.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.403 0.547 . . . . 0.0 111.071 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.45 33.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.706 0.803 . . . . 0.0 111.624 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.76 -38.78 76.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.62 1.168 . . . . 0.0 111.183 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 31.4 p -89.14 -17.87 28.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.28 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.11 40.89 94.24 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -172.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.615 1.166 . . . . 0.0 111.702 -169.98 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.43 149.65 45.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -158.6 -40.97 0.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.7 mtmt -134.41 165.74 24.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.031 1.333 . . . . 0.0 108.332 169.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.74 134.31 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.3 135.06 63.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -131.77 104.4 6.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.562 0.745 . . . . 0.0 109.53 -169.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.67 142.53 38.77 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.07 1.348 . . . . 0.0 110.141 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? -143.92 129.49 19.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.51 175.12 11.09 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.318 0.508 . . . . 0.0 110.774 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -6.64 21.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.64 133.7 3.09 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.98 33.12 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.064 0.932 . . . . 0.0 112.23 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 m -116.21 -1.94 12.28 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.796 1.239 . . . . 0.0 110.97 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -150.27 -94.61 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.968 0.804 . . . . 0.0 111.988 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -58.08 -46.41 85.49 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.883 1.273 . . . . 0.0 112.16 -169.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.8 p -72.38 -28.08 62.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.95 0.796 . . . . 0.0 112.055 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -68.92 -42.26 77.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.882 0.764 . . . . 0.0 110.249 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.45 -46.4 80.02 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.35 81.29 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.164 0.586 . . . . 0.0 111.104 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -57.81 -47.97 81.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.334 1.054 . . . . 0.0 109.546 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.66 -50.96 60.89 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.745 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.1 m95 -64.83 -38.3 90.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.844 1.822 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.15 79.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.642 -0.661 . . . . 0.0 111.567 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.73 -27.01 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.398 0.999 . . . . 0.0 112.475 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -46.58 13.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.452 0.701 . . . . 0.0 109.586 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -78.89 -27.2 43.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.62 -140.23 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.887 1.275 . . . . 0.0 108.101 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.16 -175.79 47.8 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.85 -12.37 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -58.14 -10.99 2.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.754 2.022 . . . . 0.0 111.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.44 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 10.2 m95 -134.98 166.36 23.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.131 1.772 . . . . 0.0 108.913 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -124.59 135.68 53.32 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 167.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 118.39 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -168.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 173.25 11.91 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.48 1.112 . . . . 0.0 109.346 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 56.8 p -136.03 159.82 40.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.225 1.01 . . . . 0.0 110.163 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.03 -169.4 3.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.755 1.622 . . . . 0.0 107.199 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.59 173.49 42.64 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.333 -0.854 . . . . 0.0 111.221 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.97 -39.23 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.555 1.142 . . . . 0.0 108.905 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.12 -178.74 6.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 108.51 170.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.11 43.55 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.545 1.538 . . . . 0.0 108.384 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -144.76 -39.22 0.27 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.063 0.945 . . . . 0.0 110.123 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.6 140.74 2.97 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.78 114.74 2.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.821 1.31 . . . . 0.0 108.062 169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.47 157.35 80.32 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.312 -169.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.7 -36.58 73.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.703 2.935 . . . . 0.0 113.866 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -36.86 85.28 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.168 0.895 . . . . 0.0 111.325 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.98 67.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.33 -52.52 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.15 -42.1 96.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.89 0.768 . . . . 0.0 110.587 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.55 -45.62 84.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.499 0.59 . . . . 0.0 110.792 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 93.3 mmm -75.94 -37.98 58.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.503 0.138 . . . . 0.0 111.112 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -61.95 -36.42 81.37 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.88 -22.32 63.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.835 0.854 . . . . 0.0 112.509 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -77.79 -26.06 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.365 0.984 . . . . 0.0 109.601 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.97 23.62 6.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.116 1.341 . . . . 0.0 111.489 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.5 mt -124.71 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 -171.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -79.85 75.69 6.55 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.276 0.63 . . . . 0.0 110.866 -170.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -70.98 0.24 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.927 -1.035 . . . . 0.0 112.071 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -51.87 -28.03 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.208 1.367 . . . . 0.0 111.78 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.18 -20.23 64.84 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.519 1.528 . . . . 0.0 113.6 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -77.45 169.29 18.57 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.059 . . . . 0.0 109.698 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 p -143.82 167.46 22.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.584 1.953 . . . . 0.0 107.876 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.6 p -118.97 151.64 37.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.358 0.663 . . . . 0.0 111.257 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.35 154.88 35.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.724 1.61 . . . . 0.0 109.028 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.96 165.85 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 tt -57.12 106.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.186 0.994 . . . . 0.0 111.816 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -89.11 102.22 14.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -16.37 49.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.138 0.975 . . . . 0.0 112.222 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.91 -37.25 62.13 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.999 1.272 . . . . 0.0 111.871 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.07 -48.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.1 -47.46 65.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.686 0.795 . . . . 0.0 110.52 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -67.45 -8.26 31.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -128.75 3.39 5.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.274 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.33 148.1 51.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.45 -32.9 72.12 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.5 tp -147.41 144.35 28.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.225 1.41 . . . . 0.0 110.428 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.49 139.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 m -128.45 129.25 68.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -88.65 138.24 31.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.5 mt -110.62 0.7 17.65 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 112.511 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -152.19 161.79 42.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.595 1.089 . . . . 0.0 109.22 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.46 -51.43 57.81 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 123.897 0.761 . . . . 0.0 112.017 -171.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.09 -31.45 70.18 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.15 -30.01 70.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.478 0.581 . . . . 0.0 112.425 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.26 67.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.88 -38.08 89.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.045 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.59 -42.85 24.09 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.056 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.8 t -47.72 106.52 0.61 Allowed Pre-proline 0 CA--C 1.547 0.861 0 O-C-N 124.76 1.288 . . . . 0.0 110.275 -169.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.45 174.68 7.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.682 3.588 . . . . 0.0 111.461 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 99.0 mmm -58.63 135.7 57.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.152 0.581 . . . . 0.0 111.041 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 p -120.53 105.22 41.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.945 1.698 . . . . 0.0 106.675 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.27 168.88 18.13 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.813 2.342 . . . . 0.0 110.693 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.32 -24.48 15.9 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.009 3.139 . . . . 0.0 116.288 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.29 -10.34 31.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.033 0.933 . . . . 0.0 112.847 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 93.92 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 128.007 2.523 . . . . 0.0 105.621 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -70.64 164.31 25.22 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.17 144.2 31.45 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.626 0.771 . . . . 0.0 109.062 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.12 164.66 29.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -144.55 113.0 6.57 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.772 0.829 . . . . 0.0 109.283 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -115.55 169.18 9.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.662 1.585 . . . . 0.0 107.851 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.9 107.94 0.63 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.784 -169.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.87 118.86 17.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.953 0.901 . . . . 0.0 111.765 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -66.52 153.41 43.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.4 1.08 . . . . 0.0 109.542 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.64 121.36 82.19 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.522 -172.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.03 -32.92 8.14 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.837 1.691 . . . . 0.0 112.588 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 -19.93 65.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.029 0.831 . . . . 0.0 112.189 -172.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.26 -2.03 43.53 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.712 1.205 . . . . 0.0 111.811 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 142.71 45.36 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -156.51 164.69 37.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.777 0.431 . . . . 0.0 110.94 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -47.91 0.69 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -165.24 166.01 19.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.245 2.218 . . . . 0.0 105.391 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.92 -40.51 80.56 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.546 -0.721 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.09 -27.42 64.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.188 -0.434 . . . . 0.0 111.473 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.76 -44.59 55.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 109.192 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -56.63 -49.88 73.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.457 0.703 . . . . 0.0 109.892 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -64.64 -39.36 93.56 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.097 -0.377 . . . . 0.0 111.089 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.61 74.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 110.655 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -68.41 -40.56 81.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.244 0.474 . . . . 0.0 110.503 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -58.36 -39.79 80.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.712 0.687 . . . . 0.0 109.841 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -63.11 -49.71 73.34 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.576 0.625 . . . . 0.0 110.208 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -59.77 -49.96 75.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.118 0.417 . . . . 0.0 110.37 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.54 -46.24 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.099 -1.429 . . . . 0.0 110.039 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -62.54 -42.17 99.36 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 121.683 2.038 . . . . 0.0 110.916 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.87 -44.66 96.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.45 -36.04 65.82 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.065 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -63.75 -40.55 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.528 1.513 . . . . 0.0 108.984 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.64 -44.34 97.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.95 -37.1 85.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.53 1.132 . . . . 0.0 112.036 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -56.27 -52.05 65.91 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 -35.77 77.38 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 119.024 -0.513 . . . . 0.0 111.918 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -49.33 77.89 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.589 0.755 . . . . 0.0 110.477 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -61.08 -50.78 71.9 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -54.87 -41.45 70.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.222 0.609 . . . . 0.0 111.321 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.33 -47.48 56.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.007 0.923 . . . . 0.0 111.505 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -73.24 -38.34 66.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.143 0.977 . . . . 0.0 111.642 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.1 p -92.23 -21.57 20.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.381 1.073 . . . . 0.0 110.6 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.06 42.46 99.73 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.438 1.495 . . . . 0.0 111.153 -175.315 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -159.2 172.77 17.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.101 1.76 . . . . 0.0 107.869 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -140.77 -44.6 0.39 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.521 0.728 . . . . 0.0 111.718 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.2 mtmt -138.12 171.47 14.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.577 1.551 . . . . 0.0 108.464 169.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.7 131.28 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.83 133.67 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.52 107.11 9.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.84 143.74 37.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.689 1.196 . . . . 0.0 110.497 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.28 127.87 17.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 108.821 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.81 169.67 16.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.848 1.259 . . . . 0.0 111.256 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -67.22 -16.42 64.29 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.133 -0.979 . . . . 0.0 113.276 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.83 112.86 0.54 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.07 -35.81 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.643 1.177 . . . . 0.0 112.337 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -41.13 -19.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.266 3.026 . . . . 0.0 118.496 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -141.59 -54.74 0.46 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.708 1.595 . . . . 0.0 113.804 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -56.59 -53.72 54.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.342 0.974 . . . . 0.0 113.456 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -36.65 78.85 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.058 0.845 . . . . 0.0 110.257 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -58.07 -43.28 86.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.785 0.721 . . . . 0.0 111.597 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -66.2 -48.06 71.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.803 0.841 . . . . 0.0 109.415 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.24 74.2 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.192 0.597 . . . . 0.0 110.769 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.04 -45.34 93.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.47 0.708 . . . . 0.0 110.289 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.93 92.82 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.223 -0.765 . . . . 0.0 112.377 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.6 m95 -66.72 -43.81 83.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.914 1.357 . . . . 0.0 110.572 176.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.81 78.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.205 0.457 . . . . 0.0 110.84 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.56 -33.35 68.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.689 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.79 -57.98 4.84 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.809 0.732 . . . . 0.0 110.023 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -69.19 -33.38 73.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.9 mt -100.09 -37.85 8.79 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.05 -173.32 48.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.074 0.845 . . . . 0.0 113.4 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.18 -14.91 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.499 1.92 . . . . 0.0 113.753 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -57.23 -11.11 1.52 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.595 1.958 . . . . 0.0 111.794 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.8 m95 -142.24 147.47 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.255 1.022 . . . . 0.0 110.922 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -92.46 140.36 29.65 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.03 125.32 64.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.73 160.41 34.39 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.827 0.851 . . . . 0.0 111.38 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -136.46 128.6 29.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.808 1.643 . . . . 0.0 108.674 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 -168.85 3.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.9 176.83 42.97 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.61 -42.79 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.807 1.243 . . . . 0.0 107.908 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -143.45 177.15 8.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.254 0.622 . . . . 0.0 110.276 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.8 43.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.574 2.35 . . . . 0.0 107.219 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -134.77 -36.33 0.85 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.286 1.035 . . . . 0.0 110.077 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.47 179.31 44.99 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.02 102.82 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -67.74 134.09 92.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.135 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.09 -33.11 72.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.199 2.6 . . . . 0.0 113.738 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -36.6 78.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.732 0.696 . . . . 0.0 111.28 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.12 71.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.17 -54.06 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.48 -43.27 90.74 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.476 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.4 82.9 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.837 0.744 . . . . 0.0 111.345 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.3 mmm -77.6 -40.35 42.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.172 0.442 . . . . 0.0 111.359 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -63.36 -31.75 72.99 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.422 -0.799 . . . . 0.0 110.707 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.15 -21.7 64.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.424 1.089 . . . . 0.0 112.604 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -77.52 -22.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.558 1.072 . . . . 0.0 109.55 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.39 14.78 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.741 1.162 . . . . 0.0 110.774 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.36 99.64 8.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.44 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.15 4.44 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 110.705 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -27.28 63.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.141 1.337 . . . . 0.0 111.017 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -67.15 -16.62 64.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.915 2.086 . . . . 0.0 113.614 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.87 172.57 13.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.504 1.122 . . . . 0.0 109.213 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -150.14 160.19 43.85 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.256 1.422 . . . . 0.0 108.411 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.4 m -101.08 153.63 19.4 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.13 155.49 31.1 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.809 2.044 . . . . 0.0 108.335 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.38 159.89 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.41 141.35 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.141 0.976 . . . . 0.0 112.372 -169.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -119.45 111.55 18.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.738 1.615 . . . . 0.0 107.668 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -70.75 -21.75 62.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.58 -46.39 59.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.337 0.971 . . . . 0.0 110.106 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.81 -39.52 85.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.16 -47.88 71.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.929 0.786 . . . . 0.0 110.085 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -73.67 -7.12 50.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -98.59 -21.42 16.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 111.186 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.79 142.45 58.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.193 0.451 . . . . 0.0 110.054 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.84 -32.68 73.37 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.619 -0.676 . . . . 0.0 109.295 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.7 tp -144.99 145.12 31.38 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.002 1.321 . . . . 0.0 109.625 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.19 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.78 127.79 66.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 169.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 86' ' ' ALA . 2.4 p -94.23 96.85 9.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.59 -9.39 26.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.346 1.458 . . . . 0.0 114.356 -168.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 t -149.72 160.35 43.6 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 121.124 1.784 . . . . 0.0 110.352 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -44.79 -66.51 1.42 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 127.164 2.316 . . . . 0.0 113.217 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.11 -22.65 62.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.02 69.87 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.875 -0.516 . . . . 0.0 111.336 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -63.91 -17.46 63.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.94 -31.27 71.58 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.195 0.907 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -91.69 74.05 5.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.793 0.837 . . . . 0.0 109.175 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 p -123.16 74.25 49.45 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 0.0 109.391 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.59 74.07 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.608 3.538 . . . . 0.0 111.615 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.5 mmt 66.23 129.31 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.274 3.03 . . . . 0.0 112.412 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 p -141.44 81.58 15.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.94 171.69 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.7 3.6 . . . . 0.0 113.635 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.9 -29.84 28.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.47 2.78 . . . . 0.0 114.806 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.34 -4.83 28.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 113.171 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.74 78.38 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.55 2.34 . . . . 0.0 105.4 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -68.18 167.81 13.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -135.37 156.22 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.583 0.753 . . . . 0.0 111.879 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.79 162.7 38.7 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 169.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -153.21 119.34 5.46 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.087 -1.008 . . . . 0.0 110.337 -169.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -115.77 -174.82 2.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 0.0 110.06 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.87 44.26 1.19 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.365 0.983 . . . . 0.0 113.627 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -80.76 104.63 11.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.026 0.93 . . . . 0.0 111.342 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.87 152.31 36.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.808 0.843 . . . . 0.0 110.086 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.36 120.73 83.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.71 -33.66 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 112.784 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.15 65.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.996 0.817 . . . . 0.0 112.069 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.37 9.02 35.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.976 1.31 . . . . 0.0 111.633 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.88 22.35 0.05 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.313 1.445 . . . . 0.0 114.221 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.1 152.53 7.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.35 1.86 . . . . 0.0 111.825 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.89 -51.29 0.2 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -154.16 154.84 34.24 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.01 -38.29 85.53 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.505 -0.747 . . . . 0.0 110.742 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.53 -30.98 71.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.362 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -72.55 -48.34 40.95 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -53.48 -52.45 59.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 109.84 176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -64.22 -42.56 96.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.825 0.85 . . . . 0.0 111.168 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.78 72.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.992 0.815 . . . . 0.0 110.307 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -66.29 -38.19 87.18 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.564 -0.71 . . . . 0.0 111.152 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -57.45 -45.92 84.19 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.172 0.896 . . . . 0.0 108.996 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -60.1 -49.4 77.81 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.624 0.77 . . . . 0.0 110.993 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -58.68 -49.67 76.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.97 -47.65 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.328 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -64.01 -41.86 97.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 121.259 1.845 . . . . 0.0 110.673 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.32 -42.89 99.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.922 0.328 . . . . 0.0 110.259 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -75.75 -36.14 59.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.108 -0.949 . . . . 0.0 112.31 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -61.66 -46.25 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.72 92.38 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -54.82 -46.99 74.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.671 1.188 . . . . 0.0 111.879 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -39.82 88.0 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.98 -0.45 . . . . 0.0 109.904 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.74 -35.32 72.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.243 0.617 . . . . 0.0 110.99 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -60.04 -49.64 76.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.817 0.847 . . . . 0.0 110.271 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.6 -46.62 81.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.03 0.832 . . . . 0.0 109.71 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -54.3 -40.63 68.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.85 0.75 . . . . 0.0 110.916 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.77 37.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -71.82 -36.08 70.13 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.335 1.054 . . . . 0.0 111.566 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.3 p -90.28 -16.94 28.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 110.27 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.37 41.11 92.97 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.799 1.24 . . . . 0.0 111.842 -170.631 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.36 128.09 32.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.77 -41.95 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -171.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -130.92 161.5 31.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.723 1.609 . . . . 0.0 107.107 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -136.64 130.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.82 127.03 74.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -124.8 100.11 6.46 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -169.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -73.09 147.88 44.54 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.3 143.46 37.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.313 1.845 . . . . 0.0 106.724 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.83 173.18 16.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 p -67.25 -11.52 57.7 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.326 -0.859 . . . . 0.0 113.164 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.23 116.61 0.73 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -55.36 -39.24 69.84 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.269 1.027 . . . . 0.0 111.756 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.48 -34.88 0.24 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.107 3.363 . . . . 0.0 115.777 -169.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 m -120.41 -73.92 0.63 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.069 0.547 . . . . 0.0 110.347 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -62.16 -48.52 79.73 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.211 0.604 . . . . 0.0 110.985 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -70.59 -37.17 73.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.316 -0.374 . . . . 0.0 110.741 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.38 -44.64 95.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.927 0.491 . . . . 0.0 111.127 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.3 mtm -67.0 -45.66 76.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.525 0.602 . . . . 0.0 110.287 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.71 81.47 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.748 0.704 . . . . 0.0 111.14 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -57.33 -47.04 82.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.288 1.035 . . . . 0.0 109.761 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.27 50.67 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.657 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' CD1' HG22 ' A' ' 127' ' ' ILE . 94.4 m95 -67.26 -37.49 83.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.817 1.809 . . . . 0.0 111.029 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.71 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.285 -0.884 . . . . 0.0 111.386 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.94 -24.79 67.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.957 0.799 . . . . 0.0 112.512 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.22 -46.99 12.03 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.892 0.769 . . . . 0.0 109.71 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -75.4 -30.75 60.22 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.7 -143.88 0.29 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.995 1.318 . . . . 0.0 108.091 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.2 -178.57 46.1 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.92 -13.85 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.95 -9.94 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.542 1.937 . . . . 0.0 111.642 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -125.58 161.74 26.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.376 1.87 . . . . 0.0 108.39 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.93 138.29 54.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.126 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.86 117.27 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 173.7 11.42 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -142.01 157.28 45.11 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 0.0 109.905 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.07 -163.63 1.75 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.462 1.505 . . . . 0.0 107.896 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.28 175.76 43.5 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.64 -41.8 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.05 176.43 8.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.791 0.836 . . . . 0.0 110.056 170.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.78 6.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.022 1.729 . . . . 0.0 107.139 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -74.48 -36.28 63.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.062 0.545 . . . . 0.0 109.626 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.81 -179.31 30.98 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -74.2 99.43 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -61.84 124.58 82.19 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.264 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.45 -33.51 38.26 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.269 2.646 . . . . 0.0 113.608 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -39.75 91.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.91 0.777 . . . . 0.0 110.916 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.31 75.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.95 -56.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.58 -42.06 99.32 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 119.042 0.837 . . . . 0.0 110.348 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.38 65.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.512 0.325 . . . . 0.0 110.336 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 90.1 mmm -74.44 -36.06 63.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.905 0.321 . . . . 0.0 110.873 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -61.8 -35.78 79.2 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.422 -0.799 . . . . 0.0 110.129 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.29 -24.25 63.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 112.572 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.38 -22.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.314 0.961 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.85 23.93 8.96 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.824 1.202 . . . . 0.0 111.263 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.1 mt -123.57 94.21 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -79.13 80.27 5.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -76.27 5.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.56 -0.712 . . . . 0.0 112.205 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -54.57 -26.46 32.44 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.824 1.193 . . . . 0.0 112.232 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.45 -20.06 57.42 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.99 1.316 . . . . 0.0 113.135 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.59 167.32 17.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 109.3 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -145.34 158.79 43.76 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.428 1.491 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -108.65 147.1 32.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.858 0.863 . . . . 0.0 110.103 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -155.17 159.5 40.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.026 1.331 . . . . 0.0 108.578 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.31 161.18 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.02 131.78 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.766 0.826 . . . . 0.0 111.987 -169.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.25 114.57 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.574 1.55 . . . . 0.0 107.327 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -69.37 -17.95 63.74 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.261 -171.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.06 -41.71 28.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.594 1.088 . . . . 0.0 110.504 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.42 -45.68 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -50.11 -50.85 47.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.03 0.932 . . . . 0.0 110.518 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -70.49 -19.51 62.93 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -89.94 -16.19 30.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.679 1.127 . . . . 0.0 110.976 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.53 34.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.225 0.536 . . . . 0.0 111.45 -169.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.52 -33.16 36.57 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 168.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -148.44 146.68 28.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.134 1.773 . . . . 0.0 110.374 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.43 140.04 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.32 111.67 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.6 p -93.53 108.41 20.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.57 -3.82 23.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.306 -170.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 36.3 t -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 120.881 1.673 . . . . 0.0 108.748 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.87 -35.81 92.49 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 123.674 0.654 . . . . 0.0 112.413 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.27 -25.91 64.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.683 1.242 . . . . 0.0 111.517 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -18.28 58.36 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.182 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.84 67.02 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.851 0.75 . . . . 0.0 112.505 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.24 -32.59 74.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 112.033 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -86.49 57.99 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.85 0.86 . . . . 0.0 110.983 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.7 m -124.01 78.02 58.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.25 -49.93 5.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.299 3.332 . . . . 0.0 114.872 -172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.1 mtp -152.85 137.04 16.49 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.0 1.72 . . . . 0.0 107.289 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.7 p -134.4 71.09 72.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.45 164.78 24.76 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.638 2.892 . . . . 0.0 110.82 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.04 -20.44 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.798 1 C-N-CA 125.458 4.105 . . . . 0.0 119.719 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -60.05 -44.42 94.69 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.625 1.557 . . . . 0.0 109.184 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.09 156.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 127.708 2.403 . . . . 0.0 108.075 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -134.71 167.36 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 169.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -139.2 146.65 40.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.276 0.944 . . . . 0.0 110.084 -169.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -142.61 156.33 45.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.001 1.32 . . . . 0.0 107.867 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.37 140.36 30.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.246 1.019 . . . . 0.0 110.316 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -136.19 -164.7 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.678 1.591 . . . . 0.0 109.562 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.0 40.63 1.17 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.572 1.078 . . . . 0.0 114.342 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.51 116.85 22.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.509 1.155 . . . . 0.0 111.879 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.17 152.68 43.16 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.557 0.743 . . . . 0.0 109.231 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.4 123.95 88.85 Favored Pre-proline 0 C--O 1.236 0.354 0 O-C-N 121.892 -0.505 . . . . 0.0 111.904 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.28 -31.6 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.055 1.837 . . . . 0.0 112.868 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.55 -21.37 65.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.083 0.856 . . . . 0.0 112.306 -174.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -94.56 -4.41 47.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.453 1.101 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.65 57.35 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.071 0.85 . . . . 0.0 109.304 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -144.74 161.42 39.26 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.528 1.131 . . . . 0.0 109.245 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.64 -51.05 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.23 164.01 25.24 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.083 2.153 . . . . 0.0 105.51 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.23 -39.94 84.32 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.546 -0.721 . . . . 0.0 110.598 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.84 -29.21 67.49 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.344 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -74.14 -42.35 60.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.029 0.831 . . . . 0.0 109.507 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.97 -50.46 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.181 0.592 . . . . 0.0 109.773 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -63.15 -39.47 94.75 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.105 0.411 . . . . 0.0 111.036 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.88 74.79 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.38 -0.825 . . . . 0.0 110.661 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.89 -41.43 91.52 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.07 -1.019 . . . . 0.0 110.324 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -57.08 -41.78 79.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -63.82 -49.77 71.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 111.385 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.68 -51.54 68.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.433 0.561 . . . . 0.0 109.928 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.61 -37.9 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.459 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -53.06 -57.54 10.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.546 1.521 . . . . 0.0 110.638 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.34 -42.02 94.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.171 0.919 . . . . 0.0 109.821 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.75 -26.16 37.5 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.578 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -66.96 -46.22 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.445 1.475 . . . . 0.0 107.043 169.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.71 96.66 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -58.12 -41.88 84.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.937 1.295 . . . . 0.0 111.37 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -49.1 77.83 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.43 -31.13 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.017 0.527 . . . . 0.0 110.56 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -52.4 65.33 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.182 0.993 . . . . 0.0 110.229 169.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.56 -47.29 84.49 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.394 0.997 . . . . 0.0 109.021 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.74 -37.95 66.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.968 0.507 . . . . 0.0 111.187 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.75 -47.15 32.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 122.963 0.505 . . . . 0.0 111.33 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.01 -41.51 74.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.923 0.889 . . . . 0.0 111.205 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.0 p -85.31 -17.64 36.27 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.954 0.902 . . . . 0.0 110.075 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.56 40.96 93.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 124.895 1.236 . . . . 0.0 110.539 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.049 -0.976 . . . . 0.0 111.524 -172.756 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -63.95 151.52 42.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.646 0.778 . . . . 0.0 111.585 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -145.97 -39.43 0.23 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.924 1.289 . . . . 0.0 110.446 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -123.48 165.45 17.08 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.472 1.509 . . . . 0.0 109.439 -174.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.35 138.17 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tt -127.67 136.54 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -129.85 105.86 8.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.92 141.51 42.28 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.864 0.866 . . . . 0.0 110.359 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.41 136.86 41.73 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.553 1.141 . . . . 0.0 108.499 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -156.16 171.65 19.8 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.02 0.827 . . . . 0.0 110.885 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.0 p -66.94 -11.67 57.22 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.861 -1.149 . . . . 0.0 113.177 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.96 121.92 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -58.17 -44.23 87.87 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 110.597 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -37.57 -29.15 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 C-N-CA 130.655 3.582 . . . . 0.0 117.514 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 m -125.59 -74.69 0.6 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.634 0.774 . . . . 0.0 109.859 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -60.46 -47.9 84.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.924 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -65.95 -46.53 77.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.712 0.687 . . . . 0.0 110.165 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -57.38 -42.68 82.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.953 0.501 . . . . 0.0 112.107 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.0 mtp -65.99 -48.48 71.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.623 0.769 . . . . 0.0 109.623 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.48 79.08 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.341 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.47 -45.13 89.24 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.91 0.884 . . . . 0.0 110.396 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.64 93.46 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.595 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -68.95 -43.65 74.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.312 1.556 . . . . 0.0 111.217 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.49 75.28 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.06 0.391 . . . . 0.0 110.863 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.21 -35.17 69.32 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -68.91 -57.33 5.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.497 0.59 . . . . 0.0 109.984 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.04 -35.93 79.07 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.78 -37.07 10.92 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.41 175.01 49.81 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 122.006 0.781 . . . . 0.0 113.048 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.29 -15.56 63.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.024 1.33 . . . . 0.0 114.181 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.92 -16.36 17.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.934 -0.479 . . . . 0.0 112.251 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -112.71 165.4 12.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.21 1.004 . . . . 0.0 109.068 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.1 145.34 46.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.14 119.7 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.95 169.34 17.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.485 0.659 . . . . 0.0 110.254 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -135.34 140.02 44.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.085 1.354 . . . . 0.0 109.418 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.06 -175.08 4.28 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.793 1.237 . . . . 0.0 108.801 169.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.75 176.03 42.52 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.83 -41.8 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.33 179.79 7.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 109.737 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.05 152.98 40.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.011 2.124 . . . . 0.0 106.393 171.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -129.47 -14.14 4.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.889 0.875 . . . . 0.0 111.619 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.77 -175.92 34.96 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -85.39 106.05 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -62.76 125.8 87.18 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.905 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 -34.37 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.152 2.568 . . . . 0.0 113.659 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -38.46 88.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.859 0.754 . . . . 0.0 110.768 176.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.79 73.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.85 -52.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -65.76 -42.43 90.9 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 118.951 0.796 . . . . 0.0 110.781 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.52 81.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.898 0.772 . . . . 0.0 110.993 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.8 mmm -75.86 -38.82 57.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.403 0.281 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -65.06 -33.97 77.3 Favored 'General case' 0 N--CA 1.461 0.105 0 O-C-N 121.061 -1.025 . . . . 0.0 111.036 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -65.02 -21.16 66.8 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.001 0.92 . . . . 0.0 112.158 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.71 -7.76 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.565 1.146 . . . . 0.0 110.294 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.76 21.16 34.68 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.931 -1.106 . . . . 0.0 111.987 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.21 91.83 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -78.12 85.95 4.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.198 0.523 . . . . 0.0 110.169 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -77.67 2.25 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.27 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -59.75 -23.13 62.97 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.107 1.776 . . . . 0.0 112.08 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -71.44 -18.39 62.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 112.907 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -72.52 173.28 9.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.102 0.961 . . . . 0.0 109.96 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -149.17 163.12 38.52 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.529 1.531 . . . . 0.0 108.606 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.4 m -107.08 155.4 19.88 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.179 0.992 . . . . 0.0 110.279 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.567 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -154.56 162.23 41.24 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.716 2.406 . . . . 0.0 108.411 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 pt -92.64 164.02 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.58 133.61 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 112.04 -169.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -122.42 102.56 8.17 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.011 1.724 . . . . 0.0 106.952 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -15.08 40.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.595 0.758 . . . . 0.0 112.194 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.2 -42.74 88.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.515 1.052 . . . . 0.0 111.249 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.92 -43.05 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tt -53.05 -47.15 68.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.976 0.51 . . . . 0.0 110.576 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -67.92 -18.77 64.87 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -96.53 -16.78 20.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.435 1.016 . . . . 0.0 111.484 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.61 153.91 40.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.406 0.548 . . . . 0.0 110.879 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.94 -38.2 66.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.09 166.48 30.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.243 1.02 . . . . 0.0 112.125 170.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.06 143.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.0 131.06 64.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -84.89 142.67 29.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -107.51 -1.75 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.31 0.644 . . . . 0.0 110.595 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.55 156.5 41.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.9 -38.19 88.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.3 -30.12 69.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.824 0.812 . . . . 0.0 111.933 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.66 78.35 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.146 0.43 . . . . 0.0 111.445 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.51 66.94 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.98 -39.3 93.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 111.783 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -81.96 -40.02 22.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 117.798 -1.096 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.8 m -47.6 108.11 0.84 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.565 1.146 . . . . 0.0 109.27 -173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.1 165.96 22.46 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.451 2.101 . . . . 0.0 113.289 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.9 111.45 2.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.37 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -72.89 122.46 87.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.864 1.266 . . . . 0.0 108.046 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.16 168.66 22.67 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.188 1.926 . . . . 0.0 110.356 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.03 -22.93 15.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.091 3.194 . . . . 0.0 116.017 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -68.08 -6.35 22.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.3 154.58 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.226 2.211 . . . . 0.0 106.62 -169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 173.69 9.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.355 -0.841 . . . . 0.0 110.734 169.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -127.89 155.04 44.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.256 1.422 . . . . 0.0 109.373 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.99 160.22 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -145.82 113.64 6.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -111.94 176.95 4.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.928 1.291 . . . . 0.0 109.314 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.59 94.69 0.21 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.999 -0.89 . . . . 0.0 112.439 -169.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.5 126.74 33.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.655 0.727 . . . . 0.0 111.481 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -74.34 153.23 39.4 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 169.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.93 120.83 83.28 Favored Pre-proline 0 C--O 1.236 0.395 0 O-C-N 121.915 -0.491 . . . . 0.0 111.131 -170.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.43 -32.22 20.38 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.631 1.554 . . . . 0.0 113.063 -169.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.53 -20.79 65.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -118.01 14.69 14.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 111.345 -177.091 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.98 144.46 45.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -142.66 156.66 45.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.527 0.731 . . . . 0.0 109.272 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.94 -56.52 0.38 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.1 p -146.09 170.14 17.29 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 127.012 2.125 . . . . 0.0 105.499 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.71 -42.38 86.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.659 -0.65 . . . . 0.0 110.994 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.47 -28.84 64.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.126 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.19 -44.35 72.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.111 0.868 . . . . 0.0 109.462 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -55.82 -52.23 64.71 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 109.94 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -59.6 -45.02 93.15 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.953 0.342 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.85 77.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.14 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.46 -37.21 80.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.675 1.125 . . . . 0.0 111.32 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -57.48 -47.94 80.55 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -60.67 -45.48 93.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.176 0.59 . . . . 0.0 111.986 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -60.12 -50.95 71.66 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.702 0.683 . . . . 0.0 109.754 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.09 -42.73 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.626 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -61.7 -43.44 98.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.638 2.017 . . . . 0.0 110.879 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.99 -44.9 95.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.93 -33.74 62.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.184 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.11 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.805 1.639 . . . . 0.0 108.36 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.8 -42.94 99.69 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.462 ' ND2' HH22 ' A' ' 130' ' ' ARG . 56.1 t30 -61.16 -43.13 99.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.258 1.023 . . . . 0.0 111.874 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.462 HH22 ' ND2' ' A' ' 129' ' ' ASN . 13.3 mmp_? -61.83 -41.55 97.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.689 -0.632 . . . . 0.0 110.214 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.0 mt -72.98 -34.74 66.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.672 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -48.56 79.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.179 0.992 . . . . 0.0 109.961 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.15 -50.62 72.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 118.936 0.789 . . . . 0.0 109.7 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.24 -38.9 71.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.493 1.042 . . . . 0.0 111.166 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.39 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.161 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.0 -38.92 31.08 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 110.934 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.5 p -89.61 -24.61 21.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.431 1.092 . . . . 0.0 110.188 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.9 97.86 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.963 -170.51 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -160.34 163.25 33.42 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.149 1.38 . . . . 0.0 108.762 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -164.35 -37.27 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.215 1.006 . . . . 0.0 111.438 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.8 mtmt -132.51 171.58 13.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.963 1.705 . . . . 0.0 107.631 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.63 141.71 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -127.58 140.48 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -131.35 100.16 5.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.39 148.95 46.45 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.17 139.46 41.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.759 1.624 . . . . 0.0 107.422 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.22 171.78 18.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.079 0.552 . . . . 0.0 110.338 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -74.7 -5.83 45.39 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.14 95.43 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.0 t-20 -60.16 99.39 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.873 1.269 . . . . 0.0 110.095 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.6 p -160.21 -42.9 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.422 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 p -132.47 -71.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.993 0.917 . . . . 0.0 110.434 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -52.32 -50.59 61.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.349 0.977 . . . . 0.0 111.782 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.9 -42.31 97.48 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.175 0.59 . . . . 0.0 111.221 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -67.99 -39.9 83.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.841 0.857 . . . . 0.0 111.286 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 81.6 mtp -65.09 -48.6 73.11 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.394 1.078 . . . . 0.0 108.695 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.53 81.97 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.911 0.323 . . . . 0.0 110.475 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -56.85 -44.84 82.53 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.99 -47.44 88.74 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.96 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -66.74 -38.01 85.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.956 1.878 . . . . 0.0 110.525 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.09 82.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.291 0.496 . . . . 0.0 110.723 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.28 -26.36 66.43 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.033 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -74.95 -56.85 4.32 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.116 0.871 . . . . 0.0 110.272 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -71.37 -29.57 65.11 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -92.08 -145.08 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.285 1.434 . . . . 0.0 107.905 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.28 -164.77 38.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.33 -19.77 37.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.785 1.634 . . . . 0.0 113.419 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.97 -12.15 4.24 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.17 1.388 . . . . 0.0 111.825 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.405 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 17.3 m95 -142.77 171.54 13.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.923 1.689 . . . . 0.0 110.819 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -129.76 140.92 50.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.645 2.378 . . . . 0.0 104.785 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.71 124.97 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 170.92 15.16 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.7 p -142.61 143.26 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.523 0.729 . . . . 0.0 109.642 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -171.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.702 1.601 . . . . 0.0 109.029 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.52 173.8 40.49 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 121.681 -0.637 . . . . 0.0 111.768 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.88 -41.02 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.103 1.361 . . . . 0.0 108.225 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.77 -176.57 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.324 1.85 . . . . 0.0 106.846 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.9 165.36 25.18 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.189 1.396 . . . . 0.0 109.172 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -129.18 -36.56 1.73 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.351 0.66 . . . . 0.0 110.322 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.65 169.2 12.97 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -58.68 109.91 0.9 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -69.43 125.8 92.21 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.97 -32.78 59.26 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.555 2.17 . . . . 0.0 113.316 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -42.39 98.69 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.84 0.746 . . . . 0.0 110.458 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -39.36 71.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.94 -54.03 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -65.3 -43.29 91.56 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.51 1.05 . . . . 0.0 110.126 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.93 -45.03 67.47 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.43 0.692 . . . . 0.0 111.597 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -80.0 -38.6 31.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.543 0.737 . . . . 0.0 111.354 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.71 -31.01 71.76 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.088 -1.008 . . . . 0.0 110.821 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.89 -20.57 65.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.086 0.954 . . . . 0.0 112.109 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.15 -26.74 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.596 1.089 . . . . 0.0 109.337 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.7 15.86 12.71 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.279 1.419 . . . . 0.0 111.677 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.99 95.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -77.83 88.75 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.31 -0.92 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.247 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -27.38 66.46 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.503 1.501 . . . . 0.0 111.325 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.34 -20.4 63.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.686 1.595 . . . . 0.0 113.007 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -70.58 175.13 5.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.932 0.893 . . . . 0.0 109.853 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -141.06 148.92 40.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.088 1.355 . . . . 0.0 108.751 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -89.07 154.66 20.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 109.689 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.1 t0 -152.65 160.07 43.18 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.545 1.938 . . . . 0.0 107.317 169.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.42 161.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 132.93 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.855 0.862 . . . . 0.0 110.972 -171.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -116.97 109.78 17.45 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.813 1.645 . . . . 0.0 107.121 174.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -59.26 -20.59 55.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.206 1.002 . . . . 0.0 112.398 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.84 -45.94 69.81 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.433 1.015 . . . . 0.0 111.059 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.71 -41.1 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.91 -49.86 58.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.068 0.547 . . . . 0.0 109.868 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -68.64 -14.65 63.15 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -96.14 -20.39 18.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.502 1.046 . . . . 0.0 110.884 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.33 140.42 55.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 118.198 0.454 . . . . 0.0 110.139 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.32 -33.95 76.33 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.632 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 35.6 tp -145.32 142.32 29.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.963 1.305 . . . . 0.0 108.925 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.15 139.8 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.61 110.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -94.06 101.52 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.15 -6.45 23.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.66 159.83 42.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.24 1.382 . . . . 0.0 109.187 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.81 99.7 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.327 -169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.49 -33.53 74.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.017 0.908 . . . . 0.0 111.177 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.49 -21.12 66.6 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.308 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.53 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.849 0.75 . . . . 0.0 112.792 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.23 -30.6 66.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.309 0.504 . . . . 0.0 111.903 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.97 62.49 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 91.7 m -125.5 79.18 67.49 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -50.69 -37.3 53.52 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.588 2.858 . . . . 0.0 114.969 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 36.6 tpp -159.72 128.39 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.2 p -140.56 85.92 12.71 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.62 171.18 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.238 3.292 . . . . 0.0 112.976 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.59 -28.64 29.62 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.577 2.852 . . . . 0.0 114.84 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -70.52 -3.8 19.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.684 1.194 . . . . 0.0 113.143 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.47 79.41 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 105.531 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -68.1 163.04 23.36 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -130.34 153.88 48.24 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.08 -0.388 . . . . 0.0 110.312 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.46 157.29 46.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -143.36 140.08 30.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.665 0.786 . . . . 0.0 109.573 -169.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -137.32 -168.54 2.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.447 1.099 . . . . 0.0 108.959 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.71 39.37 1.41 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.054 -169.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -76.62 111.11 11.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.213 1.006 . . . . 0.0 110.698 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.79 153.63 39.39 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.906 0.882 . . . . 0.0 108.988 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.71 118.97 74.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 119.192 -0.432 . . . . 0.0 112.061 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.29 -31.21 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.227 1.951 . . . . 0.0 112.584 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.6 -21.3 66.13 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.017 0.826 . . . . 0.0 111.959 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -99.38 7.45 45.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.672 1.189 . . . . 0.0 111.56 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.75 15.89 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.761 1.225 . . . . 0.0 114.303 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -51.93 153.73 2.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.18 1.392 . . . . 0.0 112.627 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 -51.94 0.22 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -154.37 153.09 31.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 168.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.36 -38.12 85.81 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 121.403 -0.811 . . . . 0.0 110.781 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.07 -31.45 72.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.23 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.76 -47.66 52.15 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -54.83 -52.54 62.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 110.143 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -63.51 -42.34 98.49 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.55 0.74 . . . . 0.0 111.036 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -35.96 71.23 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.076 0.853 . . . . 0.0 110.607 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.11 -39.15 82.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.22 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.1 -46.46 79.09 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -59.91 -49.89 75.92 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.586 0.754 . . . . 0.0 111.235 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -60.17 -49.51 77.35 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.49 -45.45 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 116.691 -1.623 . . . . 0.0 110.027 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -61.05 -43.84 98.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 122.134 2.243 . . . . 0.0 110.645 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.63 -45.98 91.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.39 -33.65 63.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.21 -44.45 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.544 1.52 . . . . 0.0 108.095 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.02 -44.48 96.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.77 -40.54 96.92 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.393 1.077 . . . . 0.0 112.506 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -56.7 -48.15 78.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.524 0.73 . . . . 0.0 109.305 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.15 -40.61 64.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.98 0.512 . . . . 0.0 109.823 -171.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -56.38 -46.24 80.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.083 0.953 . . . . 0.0 110.943 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.7 -56.04 23.92 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.486 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.31 -28.23 69.57 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.675 1.579 . . . . 0.0 111.372 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.17 63.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.672 0.669 . . . . 0.0 111.633 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -85.78 -31.87 22.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -95.49 -15.24 23.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.742 0.817 . . . . 0.0 111.544 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.26 29.73 74.67 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.405 1.482 . . . . 0.0 110.638 -178.08 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.76 146.95 44.26 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -159.5 -42.35 0.05 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.401 0.546 . . . . 0.0 112.167 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.4 mtmt -135.75 169.99 16.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.397 1.479 . . . . 0.0 108.608 170.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.99 130.61 48.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.37 132.08 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.6 107.1 9.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.452 0.701 . . . . 0.0 109.32 -169.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -77.16 142.21 39.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.23 135.01 35.15 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.229 1.812 . . . . 0.0 107.14 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.88 168.57 26.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.478 0.581 . . . . 0.0 110.436 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -68.03 -11.4 58.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.037 -1.039 . . . . 0.0 113.29 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 115.09 0.64 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 105.928 -2.869 . . . . 0.0 105.928 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.21 -40.48 90.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 0.0 111.831 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -38.13 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.534 3.134 . . . . 0.0 117.451 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.25 -62.64 0.79 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.341 0.973 . . . . 0.0 111.983 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -54.69 -51.7 64.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.234 0.925 . . . . 0.0 112.269 -169.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -63.24 -48.05 79.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.499 0.59 . . . . 0.0 110.475 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -60.06 -39.63 86.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.593 0.757 . . . . 0.0 112.033 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.81 -48.43 68.96 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.962 0.905 . . . . 0.0 109.562 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.15 81.55 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.134 0.425 . . . . 0.0 111.176 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.38 -48.41 80.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.0 0.92 . . . . 0.0 110.437 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.11 94.24 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.73 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -67.92 -40.87 83.33 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.879 1.839 . . . . 0.0 110.551 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.91 79.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.524 0.602 . . . . 0.0 111.549 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.8 -32.75 67.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.725 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.6 -58.24 4.18 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.546 0.612 . . . . 0.0 110.096 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -71.41 -33.84 69.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 32.8 mt -95.82 -37.12 10.88 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.261 0.624 . . . . 0.0 112.679 -169.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.26 -176.34 44.61 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.001 0.81 . . . . 0.0 112.789 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 -8.96 34.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.004 1.322 . . . . 0.0 113.672 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.28 -11.26 2.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.368 1.867 . . . . 0.0 111.18 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.467 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.7 m95 -139.82 150.27 44.48 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.792 1.237 . . . . 0.0 109.642 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 5.3 mmpt? -98.43 139.42 34.21 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 167.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.83 117.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -168.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.47 170.31 16.26 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.378 0.609 . . . . 0.0 110.187 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.8 m -135.81 144.94 45.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.24 1.416 . . . . 0.0 109.441 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.91 -173.61 4.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.01 175.62 44.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.56 -40.17 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.43 175.58 10.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.287 0.635 . . . . 0.0 110.876 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.37 156.86 44.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.244 2.618 . . . . 0.0 106.628 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -135.74 -35.67 0.79 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.027 0.931 . . . . 0.0 110.246 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.2 179.04 46.45 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.45 102.14 6.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -60.4 124.7 79.47 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.964 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.95 -34.27 45.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.266 2.644 . . . . 0.0 113.711 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -39.29 91.84 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.844 0.747 . . . . 0.0 110.734 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.49 73.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.54 -54.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.13 -42.91 83.64 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.956 0.798 . . . . 0.0 110.744 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.32 -44.09 79.62 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.529 0.604 . . . . 0.0 110.799 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.3 mmm -76.57 -39.83 51.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.551 0.74 . . . . 0.0 111.372 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -34.18 76.77 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -67.91 -20.17 65.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.004 0.922 . . . . 0.0 112.612 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -78.07 -24.34 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.479 1.036 . . . . 0.0 109.586 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.49 19.21 11.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.108 1.337 . . . . 0.0 111.08 -169.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -117.17 92.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.23 87.58 3.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.77 4.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 117.738 -1.125 . . . . 0.0 111.92 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.6 m -58.02 -25.88 61.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.01 1.732 . . . . 0.0 112.057 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.19 -21.51 62.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 112.68 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.3 169.31 15.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.667 0.787 . . . . 0.0 109.412 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -145.92 156.14 43.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.489 1.116 . . . . 0.0 109.326 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.1 m -95.32 148.53 22.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.251 1.02 . . . . 0.0 111.123 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -156.8 159.75 38.55 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.45 1.5 . . . . 0.0 108.528 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.6 164.39 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.52 117.83 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.598 0.713 . . . . 0.0 112.395 -169.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.27 121.97 36.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -73.04 -23.8 60.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.71 0.804 . . . . 0.0 112.826 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.09 -41.21 62.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.608 0.64 . . . . 0.0 110.105 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.76 -44.63 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -48.98 71.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.332 0.515 . . . . 0.0 110.037 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -69.76 -5.48 25.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -107.02 -20.62 13.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.868 1.213 . . . . 0.0 111.946 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.9 148.22 51.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.389 0.541 . . . . 0.0 111.244 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 39.0 tp -147.0 143.37 28.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 110.072 -169.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.06 138.4 49.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.62 108.4 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.8 p -88.9 90.6 8.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.1 -9.78 34.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.952 0.901 . . . . 0.0 112.812 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.04 156.09 44.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.06 -41.87 94.89 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -170.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -31.74 72.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.608 0.704 . . . . 0.0 111.737 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.68 -27.99 69.62 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.437 0.562 . . . . 0.0 111.902 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 -14.55 62.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.57 -30.43 69.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.009 0.822 . . . . 0.0 112.108 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.27 -35.97 58.65 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 118.052 -0.975 . . . . 0.0 113.288 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.6 m -40.38 105.1 0.36 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.898 1.679 . . . . 0.0 113.48 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.58 71.6 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.056 3.171 . . . . 0.0 111.255 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.8 mtt 79.58 110.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 129.283 3.033 . . . . 0.0 111.673 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.2 p -117.67 81.2 14.51 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.94 173.16 7.41 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.479 2.786 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.4 -28.55 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.829 3.019 . . . . 0.0 116.445 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.39 -8.3 45.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.133 0.973 . . . . 0.0 113.034 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.7 t -134.91 82.95 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 128.47 2.708 . . . . 0.0 105.125 -169.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.3 pttt -66.12 167.68 9.64 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -141.14 150.04 42.29 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.507 -0.745 . . . . 0.0 109.412 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -136.4 162.33 33.36 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -144.68 147.21 32.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.2 1.0 . . . . 0.0 112.006 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -142.72 -168.52 2.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 108.301 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.16 42.51 1.13 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.227 0.921 . . . . 0.0 113.848 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -78.57 115.92 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.555 1.177 . . . . 0.0 111.925 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -66.11 150.6 48.48 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.743 1.217 . . . . 0.0 109.525 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.19 116.65 51.02 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.31 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.45 -33.96 27.85 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.966 1.778 . . . . 0.0 112.661 -171.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.27 -16.68 64.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.439 0.563 . . . . 0.0 112.288 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -105.4 8.62 33.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.11 -38.8 71.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.243 0.929 . . . . 0.0 112.613 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 53.42 -170.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.887 2.075 . . . . 0.0 113.434 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.96 -65.71 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.205 1.86 . . . . 0.0 108.942 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -162.32 161.45 27.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.929 2.092 . . . . 0.0 105.579 170.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.03 -40.18 73.07 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.118 0.872 . . . . 0.0 111.243 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.17 -28.41 66.39 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.487 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.84 -39.45 66.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.863 0.756 . . . . 0.0 109.598 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -60.23 -53.16 60.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -57.83 -41.14 81.68 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.329 0.393 . . . . 0.0 110.58 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.66 77.53 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.074 -0.391 . . . . 0.0 110.878 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -74.42 -35.83 63.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.33 0.652 . . . . 0.0 111.512 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -56.18 -43.58 78.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.339 0.972 . . . . 0.0 108.689 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.47 -48.77 78.31 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.071 0.548 . . . . 0.0 111.386 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.02 -49.4 77.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.156 0.434 . . . . 0.0 110.069 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.11 -46.19 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.976 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -60.95 -43.31 98.9 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 121.776 2.08 . . . . 0.0 110.699 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.44 -45.37 94.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.31 -30.87 62.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.005 -0.997 . . . . 0.0 112.765 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -41.27 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.837 1.199 . . . . 0.0 108.712 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.73 -47.01 90.48 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -59.63 -37.05 77.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.595 1.158 . . . . 0.0 111.411 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -52.77 64.28 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.713 0.805 . . . . 0.0 109.735 173.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.73 -34.5 76.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.918 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -60.08 -49.84 76.05 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.748 0.819 . . . . 0.0 111.065 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.31 -51.37 69.83 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 119.364 0.983 . . . . 0.0 108.867 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -55.89 -39.53 71.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.283 0.633 . . . . 0.0 111.063 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.65 55.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 111.848 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.24 -39.8 65.18 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.389 -173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.6 p -92.41 -21.8 20.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.105 0.962 . . . . 0.0 110.825 -171.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.75 42.88 99.81 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 126.735 2.014 . . . . 0.0 111.16 -174.314 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.1 139.77 40.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.621 0.769 . . . . 0.0 110.129 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -157.4 -36.6 0.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -124.67 169.26 12.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.406 1.882 . . . . 0.0 108.129 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -141.95 139.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.03 137.53 55.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -132.95 105.91 7.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.015 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -80.0 149.28 30.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.913 0.485 . . . . 0.0 110.592 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.05 129.71 15.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.946 1.299 . . . . 0.0 107.543 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.94 172.63 15.38 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.983 0.913 . . . . 0.0 109.993 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -66.34 -8.91 28.38 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.649 -1.282 . . . . 0.0 113.449 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.77 125.17 1.41 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.086 -2.805 . . . . 0.0 106.086 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.2 t-20 -61.16 -46.77 89.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.099 0.56 . . . . 0.0 110.384 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -42.85 -22.37 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 130.178 3.391 . . . . 0.0 117.412 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -119.69 -84.2 0.66 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.476 1.11 . . . . 0.0 109.683 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -60.14 -46.75 88.58 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.384 1.074 . . . . 0.0 111.669 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 -40.76 76.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.098 0.863 . . . . 0.0 110.796 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -60.94 -43.84 98.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.676 0.671 . . . . 0.0 111.431 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 85.3 mtp -65.77 -48.58 71.36 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.389 0.676 . . . . 0.0 109.487 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.31 -42.13 81.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.086 0.554 . . . . 0.0 111.309 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.61 -48.55 79.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 110.044 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.61 97.99 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.616 -1.102 . . . . 0.0 112.584 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.66 -40.84 80.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.722 1.761 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.99 81.51 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.526 0.603 . . . . 0.0 111.417 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -57.53 -33.66 68.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.812 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.35 -58.59 3.81 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.408 0.549 . . . . 0.0 110.101 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -70.11 -37.7 75.42 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -169.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -90.31 -36.65 14.56 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -169.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 179.09 50.84 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 121.999 0.777 . . . . 0.0 112.829 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.28 -16.4 63.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.738 1.615 . . . . 0.0 113.998 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.24 -24.64 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.311 1.044 . . . . 0.0 110.875 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -120.93 140.53 51.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.243 0.617 . . . . 0.0 110.226 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -89.75 144.06 26.28 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.95 124.1 52.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 170.72 15.62 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 p -140.14 142.75 35.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.43 -174.9 4.01 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.338 1.455 . . . . 0.0 108.768 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.57 174.67 41.34 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.3 -42.02 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 170.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.65 178.36 8.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.839 0.856 . . . . 0.0 109.892 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.69 122.59 11.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.568 1.547 . . . . 0.0 107.042 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.67 -32.35 47.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.983 0.513 . . . . 0.0 109.95 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.94 -158.25 28.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -94.4 111.98 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -67.27 125.37 90.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.258 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.37 -34.38 50.08 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.163 2.575 . . . . 0.0 113.624 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -37.54 85.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.698 0.681 . . . . 0.0 110.915 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.66 75.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.17 -53.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -67.63 -41.68 83.52 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.32 -45.17 84.52 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.007 0.821 . . . . 0.0 110.784 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.53 -39.83 64.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.889 0.476 . . . . 0.0 110.92 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -64.5 -32.11 73.61 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.288 -0.883 . . . . 0.0 111.617 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.92 -19.59 65.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.77 0.828 . . . . 0.0 112.145 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.67 -9.39 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.469 1.108 . . . . 0.0 110.174 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 16.28 53.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.691 1.139 . . . . 0.0 111.927 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.1 mt -107.96 92.22 2.01 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -76.54 85.21 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.032 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 pt -78.13 3.47 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.269 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.6 p -61.07 -23.2 65.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 121.267 1.848 . . . . 0.0 112.202 -175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -70.67 -21.29 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.064 1.345 . . . . 0.0 112.7 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -70.05 170.18 11.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 109.57 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -145.71 161.47 39.83 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.26 1.424 . . . . 0.0 107.98 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -104.16 155.74 18.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.739 0.816 . . . . 0.0 110.116 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -150.83 161.31 42.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.12 2.168 . . . . 0.0 108.125 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 pt -92.44 164.56 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 135.43 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.591 0.756 . . . . 0.0 112.426 -169.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -127.07 110.07 12.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 108.212 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.5 p -61.08 -19.67 61.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.926 -0.483 . . . . 0.0 111.653 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.34 -2.66 14.26 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 113.638 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -115.97 -45.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -46.43 -51.64 14.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.488 1.115 . . . . 0.0 111.525 178.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -66.7 -5.97 13.89 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -134.36 5.47 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 112.664 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.1 155.08 40.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.939 0.791 . . . . 0.0 109.936 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.61 -33.86 73.27 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.975 -1.078 . . . . 0.0 108.389 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -147.55 143.8 28.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 109.509 -170.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.01 133.7 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.88 119.02 56.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -172.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 p -96.57 92.77 6.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -68.14 -12.6 61.19 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.538 -0.726 . . . . 0.0 112.805 -169.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.57 156.63 45.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.74 1.155 . . . . 0.0 108.174 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.81 -41.33 83.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -169.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.96 -35.88 82.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.76 0.78 . . . . 0.0 111.318 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.44 -28.84 70.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.59 -22.56 65.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.37 -32.64 74.16 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.529 0.732 . . . . 0.0 112.227 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -99.29 -22.74 15.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.8 t -55.32 106.42 0.67 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.72 174.88 3.32 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.472 2.781 . . . . 0.0 113.169 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -58.88 143.23 48.34 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.572 -0.705 . . . . 0.0 110.544 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -133.0 119.13 15.59 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.541 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 169.23 20.61 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.38 -25.79 19.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.957 3.105 . . . . 0.0 115.969 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -65.91 -9.02 25.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.956 . . . . 0.0 112.839 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 t -133.68 89.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 127.539 2.336 . . . . 0.0 105.5 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -69.11 164.3 22.82 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.299 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -126.25 148.77 49.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.577 1.151 . . . . 0.0 108.679 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -143.94 160.18 41.27 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 145.14 30.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.377 1.071 . . . . 0.0 111.717 -169.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -143.8 -170.16 3.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.405 1.882 . . . . 0.0 108.436 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.92 41.19 1.24 Allowed Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.484 -0.76 . . . . 0.0 113.241 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -76.21 114.96 15.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.354 1.077 . . . . 0.0 110.953 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -67.65 151.52 47.15 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.406 1.082 . . . . 0.0 109.926 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.32 126.72 92.55 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.48 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.88 -30.83 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.462 2.108 . . . . 0.0 114.049 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.49 -24.55 67.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.937 0.895 . . . . 0.0 112.933 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 25.43 10.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 112.557 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.75 -36.42 57.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 56.45 -168.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.373 1.869 . . . . 0.0 112.843 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.54 -61.14 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.428 1.966 . . . . 0.0 108.338 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 t -166.43 167.72 15.47 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 105.313 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.88 -40.35 84.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.386 -0.822 . . . . 0.0 110.626 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -29.94 66.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.429 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.62 -42.73 61.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.751 0.705 . . . . 0.0 109.287 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -58.29 -49.31 77.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.883 0.873 . . . . 0.0 109.814 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -61.78 -44.18 97.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.769 0.259 . . . . 0.0 110.503 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.97 75.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.457 0.571 . . . . 0.0 110.401 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.52 -39.02 93.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.187 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -55.95 -48.31 75.99 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.563 1.074 . . . . 0.0 108.859 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -60.56 -44.23 96.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.575 0.35 . . . . 0.0 111.113 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.95 -48.99 77.91 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.066 0.394 . . . . 0.0 110.519 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.13 -45.28 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 117.208 -1.377 . . . . 0.0 109.91 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -60.39 -42.38 95.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 121.395 1.907 . . . . 0.0 110.709 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.08 -45.0 95.46 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.84 -31.64 63.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.98 -41.01 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 119.847 1.203 . . . . 0.0 108.867 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.47 88.22 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.79 -35.82 75.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.12 1.368 . . . . 0.0 111.513 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -53.97 52.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.842 0.857 . . . . 0.0 109.595 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.02 -34.68 78.26 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.851 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -50.52 73.55 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.133 0.973 . . . . 0.0 111.116 173.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -61.01 -51.66 68.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 122.832 0.453 . . . . 0.0 111.163 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.78 58.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.072 0.949 . . . . 0.0 111.789 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.32 -38.13 60.39 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.865 0.866 . . . . 0.0 111.243 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.9 p -94.83 -20.85 19.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.357 1.063 . . . . 0.0 111.189 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.61 36.98 93.81 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -172.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.693 1.597 . . . . 0.0 111.353 -173.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.6 mtmt -134.31 167.62 20.38 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.663 1.585 . . . . 0.0 107.744 169.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -136.38 132.9 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -124.84 127.94 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -125.61 104.15 8.24 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -169.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.79 147.49 45.46 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 122.026 -0.421 . . . . 0.0 109.926 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -147.5 126.36 12.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -146.88 175.57 10.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.515 0.598 . . . . 0.0 109.814 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -67.67 -11.76 58.97 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.72 -1.238 . . . . 0.0 112.972 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.16 121.1 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 49.7 t-20 -57.63 -45.16 85.78 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.637 0.775 . . . . 0.0 109.991 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m -40.07 -34.65 0.31 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 129.746 3.218 . . . . 0.0 115.175 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.1 m -112.81 -72.47 0.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.32 0.648 . . . . 0.0 111.165 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -48.28 61.58 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.348 -169.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -63.04 -45.62 91.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.288 0.494 . . . . 0.0 109.779 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -56.55 -44.7 81.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.847 -0.596 . . . . 0.0 112.368 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.2 mtm -69.83 -45.58 67.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.615 0.643 . . . . 0.0 110.333 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.72 73.79 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.93 0.786 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -61.17 -47.3 86.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.673 1.189 . . . . 0.0 110.673 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.82 95.47 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.033 -0.87 . . . . 0.0 111.676 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 98.1 m95 -65.22 -38.59 90.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.871 1.836 . . . . 0.0 110.79 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.1 82.65 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.447 -0.783 . . . . 0.0 111.604 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.48 -26.66 68.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.13 0.877 . . . . 0.0 112.348 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.53 -46.15 13.75 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.602 0.761 . . . . 0.0 109.622 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -80.9 -26.33 36.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 mt -99.08 -140.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 107.387 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -174.6 45.73 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.86 -13.91 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 113.349 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.52 -13.53 2.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.14 2.176 . . . . 0.0 111.267 169.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.449 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 8.5 m95 -133.23 162.49 31.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.965 1.706 . . . . 0.0 108.813 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.41 139.19 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 167.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.03 118.68 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.7 173.57 11.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.334 0.587 . . . . 0.0 110.413 172.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -132.24 144.22 50.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 110.175 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 67' ' ' ILE . . . -137.03 179.45 6.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.055 2.142 . . . . 0.0 108.225 169.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.77 170.31 39.04 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.67 -41.64 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -142.6 179.52 6.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.521 0.729 . . . . 0.0 109.827 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.897 2.079 . . . . 0.0 107.202 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -135.57 -36.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.694 1.197 . . . . 0.0 109.238 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.89 178.57 39.44 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.98 100.79 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.93 127.85 92.23 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 117.883 -1.055 . . . . 0.0 109.257 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 -35.17 38.27 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.523 2.815 . . . . 0.0 113.946 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -59.61 -51.64 68.94 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.741 0.7 . . . . 0.0 109.886 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.35 80.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.496 0.589 . . . . 0.0 109.923 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -61.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -63.26 -40.02 96.24 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.999 0.818 . . . . 0.0 111.103 -169.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.15 83.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.583 0.753 . . . . 0.0 110.853 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -40.22 66.41 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.065 0.393 . . . . 0.0 110.715 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -68.3 -30.5 69.51 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.024 0.93 . . . . 0.0 111.287 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.47 -21.24 66.19 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.534 1.134 . . . . 0.0 111.879 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 t -89.89 -6.28 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.78 1.232 . . . . 0.0 110.193 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.57 19.97 52.83 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.764 -1.21 . . . . 0.0 112.258 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.3 mt -111.94 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.051 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -79.59 84.84 5.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.66 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.23 7.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.286 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.7 m -56.15 -25.16 45.26 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 120.667 1.576 . . . . 0.0 112.236 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.63 -20.34 59.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.696 1.198 . . . . 0.0 113.222 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.78 169.81 13.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.838 0.745 . . . . 0.0 110.511 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -145.8 155.4 42.9 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.412 1.485 . . . . 0.0 108.825 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 p -89.65 163.57 15.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.591 1.156 . . . . 0.0 110.409 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 41.2 t0 -158.15 158.78 35.28 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.818 2.047 . . . . 0.0 107.773 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.84 161.63 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -57.19 141.65 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 111.544 -170.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -130.7 112.77 13.4 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.19 -26.88 41.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.872 1.269 . . . . 0.0 111.445 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.38 -23.03 66.86 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 125.066 1.347 . . . . 0.0 112.859 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -100.43 -42.44 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.157 0.89 . . . . 0.0 108.689 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tp -48.13 -51.73 23.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.896 1.278 . . . . 0.0 111.122 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -67.23 -13.57 62.09 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -106.82 -14.69 14.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.141 0.977 . . . . 0.0 111.281 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 148.86 47.35 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.32 -31.6 71.99 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 27.1 tp -152.73 144.37 23.48 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.763 1.225 . . . . 0.0 109.981 -169.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 135.63 58.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.71 108.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -86.29 93.18 9.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.03 -13.31 62.09 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.593 0.757 . . . . 0.0 112.328 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.3 t -144.33 145.89 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.868 1.213 . . . . 0.0 107.923 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.8 -34.77 89.69 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.568 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.22 -25.84 67.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.161 0.981 . . . . 0.0 111.402 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 -26.54 60.24 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.031 0.532 . . . . 0.0 111.841 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.65 65.72 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.78 -33.69 70.61 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.863 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -85.52 60.53 6.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.119 0.968 . . . . 0.0 110.577 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 74.7 m -120.95 74.78 27.58 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.355 1.062 . . . . 0.0 108.6 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.15 -29.08 89.52 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.126 2.551 . . . . 0.0 115.146 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.9 ptp -162.73 115.91 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 110.217 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -132.83 77.56 68.38 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.5 171.76 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.995 3.13 . . . . 0.0 112.959 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.7 -17.77 10.74 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.011 3.141 . . . . 0.0 115.795 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.53 -13.2 38.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.059 0.943 . . . . 0.0 112.419 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -127.16 159.43 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 128.81 2.844 . . . . 0.0 106.828 -169.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.1 pttt -138.48 167.7 21.36 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -127.42 153.06 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.644 0.657 . . . . 0.0 109.418 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -135.18 156.43 49.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.51 135.45 30.21 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.78 0.832 . . . . 0.0 111.766 -168.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -137.98 -170.01 2.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.472 1.909 . . . . 0.0 108.735 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.93 40.27 1.37 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.305 -0.872 . . . . 0.0 113.43 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -79.1 112.01 15.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.255 1.027 . . . . 0.0 111.978 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.62 158.39 18.35 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.983 0.913 . . . . 0.0 109.567 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.12 118.91 74.73 Favored Pre-proline 0 CA--C 1.534 0.339 0 O-C-N 121.526 -0.733 . . . . 0.0 111.142 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.98 -30.23 21.6 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.818 1.678 . . . . 0.0 112.633 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.59 -18.12 65.09 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.54 1.064 . . . . 0.0 112.408 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -99.37 -1.13 39.54 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.911 1.284 . . . . 0.0 111.618 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 146.1 36.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.03 164.39 36.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.97 0.508 . . . . 0.0 110.797 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.82 -48.58 0.66 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -165.36 166.66 18.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.243 2.217 . . . . 0.0 105.595 169.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.29 -40.82 82.97 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.726 -0.609 . . . . 0.0 110.507 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -28.35 64.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.1 -45.07 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.893 0.769 . . . . 0.0 109.105 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -56.24 -50.46 71.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.648 0.779 . . . . 0.0 109.915 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -62.3 -43.95 97.63 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.119 0.418 . . . . 0.0 110.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.39 79.83 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.886 0.766 . . . . 0.0 110.26 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.2 -40.43 97.48 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.681 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -54.85 -49.46 71.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.096 0.862 . . . . 0.0 109.352 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -61.51 -44.16 97.56 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.947 0.499 . . . . 0.0 111.282 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.47 -50.34 73.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 119.167 -0.445 . . . . 0.0 110.098 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.43 -43.73 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 117.406 -1.283 . . . . 0.0 110.164 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -61.63 -42.04 98.33 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 121.144 1.793 . . . . 0.0 111.016 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.17 -42.63 99.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.342 0.519 . . . . 0.0 110.339 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.22 -38.95 71.98 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -65.53 -40.45 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.528 1.058 . . . . 0.0 109.3 177.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.62 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -52.38 -44.37 65.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.77 0.828 . . . . 0.0 111.137 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -47.52 84.96 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 109.933 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 131' ' ' LEU . 3.9 mm? -68.96 -34.91 76.1 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.167 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -49.7 76.73 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.933 0.788 . . . . 0.0 110.865 173.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.26 -52.07 66.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.18 -39.97 73.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.696 0.68 . . . . 0.0 111.388 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.8 67.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.688 0.795 . . . . 0.0 111.708 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -76.14 -43.49 42.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.049 0.94 . . . . 0.0 110.915 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.2 p -85.09 -22.33 28.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.373 1.069 . . . . 0.0 110.021 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.24 38.12 95.68 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.569 -169.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 119.8 -0.143 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -144.44 173.11 12.08 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.014 1.326 . . . . 0.0 108.567 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -131.14 142.81 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.7 141.37 46.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.868 1.267 . . . . 0.0 107.783 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.14 107.06 7.05 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.17 141.37 38.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.752 0.421 . . . . 0.0 110.083 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.81 133.81 34.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.394 1.478 . . . . 0.0 108.038 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.3 p -152.68 179.23 8.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 110.116 169.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.06 -3.68 17.57 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.85 104.43 0.21 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 54.3 t-20 -41.93 -48.16 4.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.793 1.637 . . . . 0.0 111.599 -170.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -41.89 -31.58 0.34 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.196 2.999 . . . . 0.0 115.118 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.91 -85.33 0.48 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.456 1.026 . . . . 0.0 111.185 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -45.01 95.81 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.68 -168.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -68.13 -39.24 82.76 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.997 1.272 . . . . 0.0 110.761 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -62.18 -46.2 89.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.92 0.782 . . . . 0.0 111.383 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.46 -47.86 74.68 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.88 -45.13 78.63 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.453 0.701 . . . . 0.0 110.627 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.03 -46.22 85.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.924 0.489 . . . . 0.0 110.32 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.77 97.6 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -67.16 -38.78 86.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.321 1.561 . . . . 0.0 110.536 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.8 85.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.097 0.408 . . . . 0.0 110.771 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -57.35 -31.49 65.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.417 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.99 -59.97 2.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.612 0.642 . . . . 0.0 110.514 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -70.57 -42.8 70.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -168.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.5 mt -82.2 -37.98 25.26 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 122.315 0.246 . . . . 0.0 110.825 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.2 174.66 49.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.024 0.821 . . . . 0.0 112.072 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.48 -15.37 63.31 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.809 1.244 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.13 -27.26 19.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 110.911 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -112.28 134.46 53.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 131.65 35.29 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 168.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -111.44 142.81 22.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -140.83 167.25 22.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.851 1.26 . . . . 0.0 108.815 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.0 p -139.47 134.07 31.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.237 1.415 . . . . 0.0 108.113 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.66 -175.2 4.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.972 1.709 . . . . 0.0 108.495 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 178.05 41.97 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.05 -42.31 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.793 1.237 . . . . 0.0 108.256 172.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.41 -179.45 6.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.87 125.4 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.72 1.608 . . . . 0.0 107.026 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.87 -35.01 38.72 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.013 0.525 . . . . 0.0 109.91 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.72 -161.41 31.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.53 108.96 18.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.21 131.83 95.16 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.637 -0.696 . . . . 0.0 110.265 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.29 -32.27 33.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.975 1.784 . . . . 0.0 112.88 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.76 -38.33 83.28 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.571 1.078 . . . . 0.0 110.497 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.19 89.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.648 1.113 . . . . 0.0 109.254 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.88 -58.71 6.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.81 -47.1 82.2 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.693 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.41 81.89 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 119.096 0.862 . . . . 0.0 110.677 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.17 -41.68 76.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.148 0.431 . . . . 0.0 110.29 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -67.78 -27.56 66.86 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.991 0.916 . . . . 0.0 111.818 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -67.47 -18.62 65.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.518 1.127 . . . . 0.0 111.708 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.54 -13.07 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.012 0.925 . . . . 0.0 109.972 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.86 6.39 54.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.299 1.428 . . . . 0.0 112.045 -173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.61 89.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.71 78.41 2.67 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.306 1.042 . . . . 0.0 110.651 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.27 6.09 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.452 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.0 p -57.4 -24.82 57.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.601 1.546 . . . . 0.0 112.271 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.21 -19.14 60.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.568 1.147 . . . . 0.0 112.885 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.32 169.43 15.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.777 0.717 . . . . 0.0 109.939 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -145.02 161.42 39.44 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.985 1.714 . . . . 0.0 107.986 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 m -111.57 155.35 23.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 109.831 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.55 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.2 t0 -154.44 160.57 41.69 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.838 2.055 . . . . 0.0 108.484 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 pt -94.26 163.08 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.39 119.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.563 0.697 . . . . 0.0 112.825 -169.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -100.51 111.57 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -15.61 63.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.697 0.799 . . . . 0.0 112.195 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.06 -40.14 75.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.588 1.085 . . . . 0.0 111.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.9 mt -63.41 -48.35 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.88 -46.27 74.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.413 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -66.46 -5.86 12.59 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.47 3.55 3.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.078 1.308 . . . . 0.0 113.603 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 147.74 52.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.839 0.745 . . . . 0.0 109.487 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.17 -34.64 71.13 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.063 0.847 . . . . 0.0 108.932 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.0 tp -145.27 142.73 29.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.31 132.01 69.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.4 t -114.23 113.17 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.9 p -92.39 92.98 8.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.88 -10.56 54.14 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.639 -169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -147.71 162.68 38.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.979 1.718 . . . . 0.0 110.741 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.11 -55.94 27.92 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.551 1.072 . . . . 0.0 112.522 -169.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.12 -31.92 70.94 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -171.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.95 80.12 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.49 -26.43 63.42 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.68 0.792 . . . . 0.0 112.92 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.67 -38.49 80.42 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.742 0.817 . . . . 0.0 111.755 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.26 -34.47 42.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.048 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.76 114.47 4.2 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 118.155 -0.926 . . . . 0.0 108.618 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.36 173.76 10.14 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.82 2.347 . . . . 0.0 111.875 -173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 65.8 ttp -53.79 125.07 17.15 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.208 1.003 . . . . 0.0 110.994 -170.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 p -107.1 105.59 56.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.63 1.572 . . . . 0.0 107.208 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -53.89 166.59 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.719 2.946 . . . . 0.0 112.961 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.69 -28.09 36.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.438 2.759 . . . . 0.0 114.788 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -68.19 -7.49 30.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.376 1.07 . . . . 0.0 112.981 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.75 85.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.752 2.421 . . . . 0.0 105.591 -169.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.1 pttt -69.7 167.09 17.78 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.169 -0.957 . . . . 0.0 108.973 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -123.8 160.35 27.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.036 0.534 . . . . 0.0 109.85 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.68 155.03 46.6 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -143.78 137.21 27.89 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.665 0.386 . . . . 0.0 111.731 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -140.53 -172.83 3.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.869 1.668 . . . . 0.0 109.311 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.55 44.39 1.05 Allowed Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.744 -0.597 . . . . 0.0 112.954 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -76.36 114.16 14.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.852 0.826 . . . . 0.0 110.487 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.58 162.46 20.88 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.275 0.63 . . . . 0.0 109.739 169.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.412 ' CG ' ' HE ' ' A' ' 108' ' ' ARG . 13.3 t70 -68.32 130.65 92.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.791 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.8 -44.48 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.458 2.106 . . . . 0.0 113.106 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.42 70.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.858 0.863 . . . . 0.0 111.428 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HE ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -99.14 5.89 46.67 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.636 1.575 . . . . 0.0 111.507 -177.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.71 140.07 48.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -143.36 158.65 43.46 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.687 0.795 . . . . 0.0 110.168 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.19 -51.97 0.46 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -160.41 162.06 33.18 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.57 -40.92 88.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.619 -0.675 . . . . 0.0 110.696 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.02 -29.08 67.17 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.467 -0.302 . . . . 0.0 111.069 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.93 -42.23 40.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.285 0.634 . . . . 0.0 109.994 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -54.32 -51.7 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.025 0.93 . . . . 0.0 109.639 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -60.55 -46.51 89.92 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.57 75.89 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.036 -0.415 . . . . 0.0 110.662 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.67 -37.49 87.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.667 0.787 . . . . 0.0 111.022 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -54.55 -51.74 64.25 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.118 0.872 . . . . 0.0 108.706 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.495 ' NE2' HH21 ' A' ' 124' ' ' ARG . 5.3 mm-40 -61.21 -42.72 99.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 111.666 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.27 -48.15 82.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.242 0.474 . . . . 0.0 110.113 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.1 -47.26 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 117.459 -1.257 . . . . 0.0 110.022 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.495 HH21 ' NE2' ' A' ' 121' ' ' GLN . 49.1 ptt85 -63.01 -41.65 99.62 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.898 1.681 . . . . 0.0 111.027 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.23 -42.46 98.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.21 0.459 . . . . 0.0 110.082 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -76.63 -33.76 58.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.466 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.01 -46.29 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 119.977 1.262 . . . . 0.0 107.646 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.7 -47.71 87.02 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.81 -37.91 71.84 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.8 1.24 . . . . 0.0 112.125 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -42.76 85.32 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.48 -0.763 . . . . 0.0 111.526 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 mt -68.22 -41.44 81.27 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -48.07 73.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.666 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.97 -57.9 11.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.605 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.298 5.2 p90 -68.63 -21.56 64.47 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 121.111 1.778 . . . . 0.0 112.681 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.99 64.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.38 0.991 . . . . 0.0 111.798 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -77.52 -39.58 45.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.402 1.081 . . . . 0.0 111.17 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.6 p -90.7 -22.42 21.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.932 0.893 . . . . 0.0 110.838 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.27 41.64 99.49 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.314 1.846 . . . . 0.0 111.331 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.264 0.078 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.0 mtmt -134.99 166.25 23.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.983 1.713 . . . . 0.0 106.519 169.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.0 140.16 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.2 tt -130.44 135.22 61.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.69 102.95 6.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.693 0.797 . . . . 0.0 108.981 -170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -76.91 144.96 38.53 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.205 0.602 . . . . 0.0 110.166 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 137.32 37.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.758 1.623 . . . . 0.0 108.138 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.2 p -154.76 175.23 13.98 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -67.81 -7.84 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.82 97.31 0.14 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -41.41 -40.94 1.88 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.453 1.901 . . . . 0.0 113.204 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.6 m -38.07 -36.67 0.22 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.903 3.281 . . . . 0.0 115.329 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -117.23 -74.92 0.59 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.966 0.803 . . . . 0.0 112.137 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -56.29 -50.74 70.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.738 0.699 . . . . 0.0 111.614 -169.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -70.27 -34.61 73.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.612 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -63.6 -42.22 98.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.415 0.552 . . . . 0.0 110.772 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.6 mtp -65.72 -47.54 74.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.806 0.442 . . . . 0.0 109.828 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.08 86.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.031 0.532 . . . . 0.0 110.871 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -57.86 -45.65 85.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.611 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.72 -52.44 53.09 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.074 0.845 . . . . 0.0 112.709 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -65.37 -34.57 78.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.592 1.696 . . . . 0.0 110.61 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.53 83.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.605 -0.684 . . . . 0.0 110.56 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.94 -22.11 64.1 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.223 -0.923 . . . . 0.0 112.557 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.46 -47.18 8.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.872 0.76 . . . . 0.0 110.116 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -78.92 -26.71 43.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.91 -142.78 0.25 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.46 -174.26 46.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.67 -13.74 55.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.95 -14.62 3.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.721 2.008 . . . . 0.0 111.147 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.471 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 7.8 m95 -133.18 167.06 21.04 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.021 1.728 . . . . 0.0 108.844 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -123.07 130.66 53.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 167.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.26 118.8 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.22 174.61 10.45 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.6 1.16 . . . . 0.0 108.653 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 82.4 p -137.59 160.41 39.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.372 0.606 . . . . 0.0 111.157 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.47 -162.25 1.49 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.496 1.518 . . . . 0.0 108.546 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.7 176.37 44.88 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -41.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.4 -179.88 6.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.596 1.159 . . . . 0.0 109.17 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.58 149.96 36.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.755 2.422 . . . . 0.0 106.156 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -13.93 1.9 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.961 0.904 . . . . 0.0 111.446 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.71 170.24 20.91 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 171.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.64 102.12 1.8 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -64.42 125.67 88.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.678 -170.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.97 -35.46 50.16 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.383 2.722 . . . . 0.0 113.881 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -40.96 96.61 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.631 0.651 . . . . 0.0 110.515 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.92 -41.58 82.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.54 -55.99 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -65.25 -41.33 94.4 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 119.378 0.99 . . . . 0.0 110.664 -173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.21 71.4 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.862 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.0 mmm -86.51 -38.16 17.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.451 0.569 . . . . 0.0 111.427 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.42 -33.29 75.22 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.969 0.908 . . . . 0.0 110.3 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.77 -19.2 65.08 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 112.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.67 -10.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.221 1.008 . . . . 0.0 109.906 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.62 23.31 47.28 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.121 -0.987 . . . . 0.0 111.039 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.6 mt -114.32 91.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -78.49 74.25 5.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.991 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.03 3.32 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.322 -0.861 . . . . 0.0 112.129 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -27.12 10.38 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.497 1.044 . . . . 0.0 111.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -71.83 -19.59 61.96 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 113.852 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -78.29 170.38 16.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.963 . . . . 0.0 109.681 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.05 160.75 41.46 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.418 1.487 . . . . 0.0 108.462 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 p -101.64 153.55 19.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.419 1.088 . . . . 0.0 110.958 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -156.48 160.84 39.92 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.841 1.256 . . . . 0.0 108.944 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.09 161.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.22 129.29 18.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 123.397 0.679 . . . . 0.0 111.586 -169.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -106.59 114.84 29.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.31 1.444 . . . . 0.0 107.655 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -66.71 -23.1 66.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.63 -41.25 46.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.368 0.985 . . . . 0.0 110.268 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.67 -44.75 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.33 -48.71 65.31 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.948 0.499 . . . . 0.0 109.942 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -71.15 -14.81 62.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -94.75 -17.91 21.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.578 1.081 . . . . 0.0 111.003 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.01 150.25 49.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.164 0.438 . . . . 0.0 111.071 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.04 -32.71 51.11 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.42 141.04 29.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.562 1.145 . . . . 0.0 109.662 -174.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.74 124.67 59.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.95 118.44 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -102.66 97.34 7.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.8 mt -71.84 -3.15 20.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.903 1.681 . . . . 0.0 114.487 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.7 p -151.26 163.91 37.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.584 1.538 . . . . 0.0 110.327 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.76 -64.84 3.19 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.719 1.628 . . . . 0.0 113.338 -169.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.36 -29.25 67.93 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.712 -0.287 . . . . 0.0 111.754 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.55 66.94 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.85 64.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.45 -31.75 72.13 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.109 0.564 . . . . 0.0 112.109 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -85.36 63.17 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.319 0.647 . . . . 0.0 110.633 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -124.94 76.23 66.54 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.153 0.981 . . . . 0.0 108.401 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.51 85.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.635 2.89 . . . . 0.0 111.234 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.0 tpt 70.1 111.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.383 2.673 . . . . 0.0 111.196 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -134.55 81.71 47.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.87 171.5 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.444 2.763 . . . . 0.0 110.965 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.25 -25.47 13.47 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.43 3.42 . . . . 0.0 117.448 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -56.97 -36.93 70.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.669 1.122 . . . . 0.0 110.836 170.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.75 82.96 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.91 2.484 . . . . 0.0 106.87 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -66.63 165.27 15.09 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.49 -0.756 . . . . 0.0 108.975 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -133.77 134.07 42.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.963 0.905 . . . . 0.0 110.147 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.99 155.75 45.59 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -151.3 139.08 19.8 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -141.22 178.86 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.949 1.7 . . . . 0.0 108.537 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.22 103.82 0.4 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -135.58 143.64 45.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.668 0.787 . . . . 0.0 110.579 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -73.28 169.99 15.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -73.46 117.23 58.87 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.86 -32.08 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.677 1.585 . . . . 0.0 112.818 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.35 65.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.962 0.801 . . . . 0.0 112.209 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -101.64 2.31 38.65 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 111.786 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.41 144.98 40.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.13 165.28 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.055 0.455 . . . . 0.0 111.191 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.03 -47.65 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.54 166.41 18.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.509 2.324 . . . . 0.0 105.2 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.12 -40.57 81.58 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.533 -0.729 . . . . 0.0 110.52 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -27.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.562 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.96 -45.3 51.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.007 0.822 . . . . 0.0 109.171 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -55.69 -49.42 73.04 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.73 0.812 . . . . 0.0 109.882 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -64.68 -41.78 95.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.14 -0.35 . . . . 0.0 110.96 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.06 72.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.964 0.802 . . . . 0.0 110.62 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.78 -40.8 92.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.621 -0.674 . . . . 0.0 110.629 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.03 -45.41 83.15 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 119.191 0.905 . . . . 0.0 109.04 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.76 -50.01 75.5 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.351 0.66 . . . . 0.0 111.322 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.01 -48.78 80.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 119.488 -0.292 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.98 -45.81 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.927 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -62.3 -42.95 99.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 121.414 1.916 . . . . 0.0 110.764 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.2 -42.42 98.56 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.449 0.3 . . . . 0.0 110.696 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.44 -36.92 52.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.597 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -43.61 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.79 81.41 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.903 0.851 . . . . 0.0 112.083 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -49.41 76.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.542 0.61 . . . . 0.0 110.302 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 -43.45 70.64 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.267 0.627 . . . . 0.0 109.354 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -46.42 75.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.283 1.033 . . . . 0.0 110.934 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -60.79 -55.61 31.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.382 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.272 3.1 p90 -67.72 -24.3 65.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 121.492 1.951 . . . . 0.0 111.992 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.52 67.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.059 0.845 . . . . 0.0 111.732 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -76.58 -41.67 45.47 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.671 1.189 . . . . 0.0 111.153 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.0 p -84.92 -21.09 29.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.098 0.959 . . . . 0.0 110.343 -174.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.78 21.62 79.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.108 0.861 . . . . 0.0 111.881 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.251 1.158 0 CA-C-N 117.928 0.864 . . . . 0.0 109.673 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -126.83 164.15 22.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.629 1.972 . . . . 0.0 106.553 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -135.37 124.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -169.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tt -122.98 133.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -135.95 105.2 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -77.35 151.36 34.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 111.297 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -149.62 130.7 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.025 0.93 . . . . 0.0 108.651 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -148.69 178.68 8.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 111.01 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -66.81 -8.7 30.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 113.787 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.85 102.62 0.19 Allowed Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.1 t-20 -42.83 -46.07 5.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.222 1.809 . . . . 0.0 111.87 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -35.27 -35.95 0.05 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.148 3.379 . . . . 0.0 115.302 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.0 p -111.77 -74.06 0.65 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.362 0.983 . . . . 0.0 112.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.688 1.131 . . . . 0.0 111.95 -169.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.5 m -64.62 -36.18 83.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.223 0.465 . . . . 0.0 110.845 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.73 -44.48 90.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.535 0.607 . . . . 0.0 111.465 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.4 mtp -65.46 -48.24 73.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 109.704 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.64 84.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.233 0.613 . . . . 0.0 111.209 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.78 -45.08 90.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.026 0.53 . . . . 0.0 110.274 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.1 90.88 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.914 -0.937 . . . . 0.0 112.607 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.15 -40.46 82.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.276 1.538 . . . . 0.0 111.39 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.04 79.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.936 0.335 . . . . 0.0 111.592 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.67 -33.26 68.15 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.858 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -71.54 -58.17 3.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.422 0.555 . . . . 0.0 110.332 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.39 -39.38 68.04 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.3 mt -86.55 -39.97 15.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.174 0.443 . . . . 0.0 111.811 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.56 -173.93 55.16 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.114 0.864 . . . . 0.0 113.207 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.87 -17.01 62.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.307 1.843 . . . . 0.0 113.867 -170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -60.38 -10.94 5.43 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.242 1.417 . . . . 0.0 111.672 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -133.9 166.92 21.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.662 1.185 . . . . 0.0 110.597 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.05 137.84 51.53 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 168.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -114.42 142.42 27.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -137.82 159.43 42.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 108.636 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -137.6 124.59 21.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.24 -174.13 3.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.336 1.054 . . . . 0.0 109.109 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.84 175.03 42.2 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.18 -42.65 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -144.82 179.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.876 1.27 . . . . 0.0 109.027 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.71 44.13 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.683 1.993 . . . . 0.0 106.941 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -133.33 -30.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.005 0.922 . . . . 0.0 110.68 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 169.08 -176.64 43.13 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -76.1 104.15 6.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.28 125.77 87.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.449 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.76 -34.57 44.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.372 2.715 . . . . 0.0 113.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -42.69 96.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.693 0.679 . . . . 0.0 110.53 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.64 87.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -61.27 -56.07 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -65.76 -40.69 92.3 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.549 1.068 . . . . 0.0 110.51 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.18 -39.6 79.33 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.822 0.737 . . . . 0.0 111.871 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.3 mmm -82.37 -40.36 21.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.659 0.384 . . . . 0.0 111.093 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.99 -36.09 82.36 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.087 0.955 . . . . 0.0 110.497 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.0 -18.86 65.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.184 0.594 . . . . 0.0 111.894 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.42 -2.96 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.582 1.153 . . . . 0.0 109.934 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.36 20.91 53.64 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.898 -1.127 . . . . 0.0 111.901 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.9 mt -113.29 90.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.71 79.03 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.69 0.796 . . . . 0.0 110.627 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.09 4.57 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.008 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 m -54.18 -25.8 24.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.785 1.175 . . . . 0.0 112.592 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -78.35 -17.35 56.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.637 1.175 . . . . 0.0 113.186 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -70.69 169.25 14.82 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.863 0.756 . . . . 0.0 110.131 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 p -145.96 163.76 34.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.594 1.557 . . . . 0.0 108.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -111.37 150.85 29.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.13 0.972 . . . . 0.0 109.703 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.5 t0 -149.62 160.18 43.71 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.141 2.176 . . . . 0.0 108.746 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -89.77 164.51 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.56 139.74 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.649 0.738 . . . . 0.0 111.846 -170.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -128.64 104.71 7.81 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 107.99 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 p -57.07 -24.76 56.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.842 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.41 -22.06 66.66 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.951 1.251 . . . . 0.0 112.286 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -108.57 -45.8 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 92' ' ' THR . 0.6 OUTLIER -54.48 -40.97 69.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.183 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.06 -15.56 63.48 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.953 1.251 . . . . 0.0 113.575 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -106.02 -6.99 18.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.522 1.129 . . . . 0.0 111.137 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.97 155.09 35.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.311 0.505 . . . . 0.0 110.101 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.05 -32.73 44.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.307 -0.871 . . . . 0.0 108.885 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -144.28 140.4 29.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.536 1.134 . . . . 0.0 109.714 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.22 134.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.21 106.94 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 p -76.54 147.89 37.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.16 2.63 13.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.868 0.467 . . . . 0.0 110.953 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -151.86 147.73 26.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.18 -45.39 96.62 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.87 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.19 -32.85 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.409 0.604 . . . . 0.0 111.662 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.8 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.31 -18.77 64.92 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.62 -35.61 81.07 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.064 0.946 . . . . 0.0 111.927 172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.26 -36.83 66.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.13 110.26 1.26 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.902 1.281 . . . . 0.0 110.938 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.552 2.834 . . . . 0.0 109.743 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -43.76 110.34 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.011 1.724 . . . . 0.0 111.765 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.413 HG23 HD21 ' A' ' 72' ' ' LEU . 1.1 p -133.16 72.49 75.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.93 168.07 12.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.479 2.786 . . . . 0.0 110.752 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -49.99 -23.79 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.53 3.487 . . . . 0.0 117.87 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -54.69 -40.86 69.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.605 1.093 . . . . 0.0 110.356 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.66 97.7 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.746 2.019 . . . . 0.0 107.556 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -72.02 159.59 33.95 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -131.22 148.51 52.71 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.386 0.675 . . . . 0.0 109.271 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.81 148.45 37.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -132.91 106.88 7.96 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -102.52 170.01 8.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.211 1.404 . . . . 0.0 108.081 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.27 106.68 0.5 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.432 -168.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -138.52 140.82 39.29 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.868 0.867 . . . . 0.0 111.73 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.79 168.99 10.43 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.546 0.738 . . . . 0.0 109.286 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -74.43 112.64 18.12 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.77 -34.07 51.38 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.547 1.498 . . . . 0.0 112.311 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.13 -15.18 62.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.029 0.831 . . . . 0.0 112.513 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -118.95 20.79 12.67 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.201 1.401 . . . . 0.0 110.979 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.1 67.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 55.07 -160.59 0.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.027 1.731 . . . . 0.0 112.237 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.95 -70.33 0.68 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -159.95 163.72 33.96 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -59.17 -40.63 86.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.828 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.05 -31.56 70.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.603 -0.237 . . . . 0.0 111.09 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -75.57 -38.02 59.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.355 0.662 . . . . 0.0 110.195 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -60.27 -50.01 75.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.154 0.982 . . . . 0.0 109.491 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -60.77 -42.9 98.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.069 0.395 . . . . 0.0 110.727 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.65 -37.51 76.13 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.919 0.488 . . . . 0.0 110.622 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.31 -35.46 76.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.56 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -54.94 -44.29 74.16 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.104 1.32 . . . . 0.0 108.485 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -60.58 -41.82 95.42 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.957 0.344 . . . . 0.0 111.197 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -64.03 -51.22 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.28 -46.45 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.784 -1.103 . . . . 0.0 109.67 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -62.73 -41.65 99.27 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.551 1.523 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.77 -44.67 96.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.001 0.364 . . . . 0.0 110.168 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.16 -42.26 76.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.275 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.06 -45.7 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.613 1.097 . . . . 0.0 108.719 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.14 94.35 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -57.28 -45.93 83.62 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.933 0.893 . . . . 0.0 111.781 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.63 -35.23 79.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.612 1.096 . . . . 0.0 111.91 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 131' ' ' LEU . 4.0 mm? -69.49 -41.46 76.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.757 1.162 . . . . 0.0 110.816 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.63 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 110.578 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.77 -52.86 63.74 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.643 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -55.25 -46.41 76.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 120.249 1.386 . . . . 0.0 109.966 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.78 90.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.245 0.618 . . . . 0.0 111.555 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -84.52 -37.46 21.24 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.534 0.734 . . . . 0.0 111.777 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.2 p -92.88 -23.66 18.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.597 0.759 . . . . 0.0 111.081 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.9 42.43 99.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.808 2.043 . . . . 0.0 112.468 -169.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 t30 . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 110.775 -0.083 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 48.0 mtmt -134.61 169.3 17.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.846 1.659 . . . . 0.0 107.577 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.92 134.36 53.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -124.39 132.74 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -129.1 105.54 8.25 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.835 0.854 . . . . 0.0 108.714 -170.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -75.59 147.54 39.52 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.941 -0.474 . . . . 0.0 110.216 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.4 127.11 15.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.95 174.52 11.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.335 0.654 . . . . 0.0 110.104 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -66.86 -12.77 60.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.73 -1.231 . . . . 0.0 112.997 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.42 122.82 1.21 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 106.326 -2.709 . . . . 0.0 106.326 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -59.69 -45.92 90.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.876 0.87 . . . . 0.0 110.744 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -38.18 -30.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 130.089 3.356 . . . . 0.0 117.279 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.3 m -120.51 -71.21 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.431 0.693 . . . . 0.0 110.195 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -66.74 -49.77 64.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.77 -169.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -63.87 -43.99 94.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.402 0.547 . . . . 0.0 109.623 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.73 -45.88 85.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.317 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 45.1 mtm -67.29 -45.34 76.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.258 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.14 -44.6 75.24 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.715 0.689 . . . . 0.0 111.048 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.88 -44.71 94.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.586 0.754 . . . . 0.0 110.468 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.97 -50.8 53.51 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.178 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -68.21 -37.21 80.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.752 1.776 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.96 79.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.553 -0.717 . . . . 0.0 111.247 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -59.09 -32.72 70.06 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.658 -0.651 . . . . 0.0 112.072 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.82 -49.43 18.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.43 0.692 . . . . 0.0 109.359 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -79.76 -34.88 39.46 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -170.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.77 -35.54 12.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.499 0.59 . . . . 0.0 112.017 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.22 -178.72 49.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.195 0.902 . . . . 0.0 112.793 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.02 -6.04 25.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.56 -8.69 4.64 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.044 1.738 . . . . 0.0 110.729 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.421 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 4.3 m95 -138.15 157.94 45.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 108.561 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -111.95 142.09 44.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 168.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.8 126.83 67.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 171.11 14.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 109.668 172.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.4 m -135.52 142.34 45.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.753 1.221 . . . . 0.0 110.261 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.69 -174.72 4.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.279 1.432 . . . . 0.0 108.925 169.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.44 175.95 41.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.01 -41.87 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.23 179.34 7.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.543 0.737 . . . . 0.0 110.083 170.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.8 42.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.295 2.238 . . . . 0.0 106.306 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -136.7 -19.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.58 0.752 . . . . 0.0 111.686 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.1 -178.0 40.91 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -77.75 100.72 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.57 122.77 73.29 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.33 -171.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.5 -32.01 41.6 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.183 2.588 . . . . 0.0 113.521 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -39.84 92.79 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.812 0.733 . . . . 0.0 110.801 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.84 75.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.11 -54.78 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -66.89 -41.58 86.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.588 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.53 -46.09 84.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.516 0.598 . . . . 0.0 110.818 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 84.4 mmm -73.81 -37.44 64.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.462 0.574 . . . . 0.0 111.326 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.336 -0.852 . . . . 0.0 111.342 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -66.22 -19.35 65.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.669 0.788 . . . . 0.0 112.177 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.37 -4.6 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.862 1.265 . . . . 0.0 110.374 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.76 23.03 65.24 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.763 -1.211 . . . . 0.0 111.916 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -111.98 93.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.15 86.45 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.441 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.31 5.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.275 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -57.01 -26.18 59.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.851 1.659 . . . . 0.0 112.345 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -74.77 -17.65 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.406 1.082 . . . . 0.0 112.807 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.03 170.27 14.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.59 0.756 . . . . 0.0 110.109 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 p -146.68 160.36 42.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.49 1.516 . . . . 0.0 108.554 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.9 m -108.34 151.74 25.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.049 0.94 . . . . 0.0 109.729 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.563 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.0 t0 -153.05 161.16 42.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.205 2.202 . . . . 0.0 108.378 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 pt -91.54 163.65 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.12 133.98 20.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.394 0.678 . . . . 0.0 111.942 -169.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -123.11 112.67 18.02 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 107.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.8 p -57.06 -24.21 52.25 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 111.508 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.88 -22.58 67.02 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.67 1.188 . . . . 0.0 112.873 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.82 -43.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.956 0.798 . . . . 0.0 108.937 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -48.6 -51.11 29.64 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.251 1.02 . . . . 0.0 110.782 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.1 -15.77 62.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -104.19 -16.91 15.08 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.18 0.992 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.96 58.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.775 0.43 . . . . 0.0 109.868 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.24 -33.74 76.43 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.9 tp -144.33 141.62 29.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.202 1.401 . . . . 0.0 109.702 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.35 132.3 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 109.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.08 88.24 7.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.67 -10.55 19.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.087 1.755 . . . . 0.0 114.357 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.0 t -148.66 157.71 43.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.834 1.652 . . . . 0.0 110.197 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.98 -59.29 9.59 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.259 1.885 . . . . 0.0 112.191 -170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.48 -26.9 66.59 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.536 0.334 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.29 72.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.795 0.438 . . . . 0.0 111.592 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.11 -20.11 65.07 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.05 -29.8 70.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.691 0.678 . . . . 0.0 112.277 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -77.4 -32.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 117.303 -1.332 . . . . 0.0 113.344 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -47.23 108.44 0.88 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.297 1.039 . . . . 0.0 111.031 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.17 -34.99 26.36 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.901 1.734 . . . . 0.0 113.011 -169.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 125.79 1.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.9 p -128.15 82.4 68.55 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.53 173.31 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.633 2.889 . . . . 0.0 110.79 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.21 -29.35 16.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.882 3.054 . . . . 0.0 116.104 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -68.77 -8.04 39.46 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.185 0.994 . . . . 0.0 113.064 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.31 80.95 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.945 2.498 . . . . 0.0 104.732 -170.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.7 pttt -64.94 164.99 11.59 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.736 0.779 . . . . 0.0 108.948 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -127.53 150.1 49.84 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 109.561 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.37 153.17 44.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -147.59 139.15 23.88 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -139.52 -169.27 2.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.658 1.583 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.0 41.58 1.29 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.098 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -80.34 119.17 22.7 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.958 1.379 . . . . 0.0 112.597 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.21 150.64 43.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.062 0.945 . . . . 0.0 109.603 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -74.2 121.12 84.47 Favored Pre-proline 0 C--O 1.236 0.373 0 O-C-N 121.999 -0.438 . . . . 0.0 111.858 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.43 -32.14 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.834 1.69 . . . . 0.0 112.678 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.76 65.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.767 0.712 . . . . 0.0 112.362 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -100.18 -0.96 37.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.688 1.195 . . . . 0.0 111.594 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.9 148.68 29.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -159.01 164.47 35.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.817 0.447 . . . . 0.0 110.655 -171.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.24 -48.66 0.64 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -164.99 165.68 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.277 2.231 . . . . 0.0 105.416 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.14 -40.51 81.53 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.556 -0.715 . . . . 0.0 110.638 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.38 -28.48 65.12 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.377 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.32 -44.94 58.03 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.92 0.782 . . . . 0.0 109.194 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -56.02 -50.37 71.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.588 0.755 . . . . 0.0 109.75 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.93 -44.86 95.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.989 0.359 . . . . 0.0 110.505 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.9 75.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.602 0.637 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.57 -36.92 85.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.342 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -54.95 -53.37 56.56 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.634 1.106 . . . . 0.0 108.274 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.516 ' NE2' HH21 ' A' ' 124' ' ' ARG . 6.3 mm100 -58.1 -43.22 87.01 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.864 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -61.15 -49.41 77.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.58 0.627 . . . . 0.0 110.606 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.28 -45.89 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.891 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.516 HH21 ' NE2' ' A' ' 121' ' ' GLN . 47.6 ptt85 -61.88 -40.81 96.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.44 1.927 . . . . 0.0 111.087 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.48 -44.72 95.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.25 0.477 . . . . 0.0 109.793 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.28 -32.51 61.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.045 -0.979 . . . . 0.0 112.858 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -65.32 -42.82 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.697 1.135 . . . . 0.0 108.644 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.78 -46.46 82.85 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -58.56 -36.23 73.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.303 1.041 . . . . 0.0 111.41 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -51.41 70.05 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.587 0.755 . . . . 0.0 109.379 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.8 mt -72.89 -31.78 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.251 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -51.91 67.53 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.777 0.831 . . . . 0.0 110.828 169.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.68 -49.21 75.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 119.299 0.954 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -55.32 -39.35 69.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.584 0.629 . . . . 0.0 111.055 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.43 -47.42 49.17 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.767 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.51 -37.5 71.22 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.612 1.165 . . . . 0.0 110.91 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.0 p -90.61 -22.63 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.001 0.92 . . . . 0.0 110.163 -175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.68 41.48 99.6 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.083 1.353 . . . . 0.0 111.015 -175.252 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 119.954 -0.07 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -124.69 167.74 14.13 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.724 0.81 . . . . 0.0 110.631 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.7 138.45 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tt -121.57 138.83 50.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -132.04 106.21 7.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -75.82 146.64 39.75 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.565 0.746 . . . . 0.0 110.546 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.02 130.19 20.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -148.46 171.21 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.984 0.811 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -67.58 -9.64 44.66 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.148 -0.97 . . . . 0.0 113.4 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 118.36 0.82 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 106.652 -2.579 . . . . 0.0 106.652 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.61 -43.19 99.42 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.811 0.844 . . . . 0.0 112.107 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -43.33 -22.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.06 3.344 . . . . 0.0 117.336 -169.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -128.78 -71.7 0.63 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.295 0.952 . . . . 0.0 110.947 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -58.68 -49.14 78.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.371 0.532 . . . . 0.0 111.336 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -72.01 -36.15 69.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.863 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -62.73 -42.07 99.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.897 0.479 . . . . 0.0 111.313 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.6 mtm -66.2 -46.62 76.66 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.693 0.679 . . . . 0.0 110.258 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.45 77.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.898 0.479 . . . . 0.0 110.64 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -57.2 -44.6 83.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.528 1.131 . . . . 0.0 110.559 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.08 90.15 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.889 -0.95 . . . . 0.0 112.59 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.61 -38.43 83.94 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.468 1.634 . . . . 0.0 110.613 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.71 85.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.652 0.381 . . . . 0.0 111.701 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -58.64 -29.12 66.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.858 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -73.67 -59.6 2.64 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.685 0.675 . . . . 0.0 110.559 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -71.28 -42.52 68.62 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.05 -39.59 33.5 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.643 0.377 . . . . 0.0 110.694 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.76 53.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.481 1.039 . . . . 0.0 112.858 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.41 -17.1 58.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.601 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.36 -21.21 5.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.595 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -127.04 161.92 27.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 110.711 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -112.0 144.43 41.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.1 t -134.21 124.52 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.3 172.59 12.6 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 74.8 p -141.74 154.82 45.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.71 -163.81 1.74 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.79 1.236 . . . . 0.0 108.15 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.78 175.01 44.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.86 -41.36 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.4 173.72 11.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.791 0.836 . . . . 0.0 110.163 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.35 157.14 42.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.677 1.991 . . . . 0.0 107.989 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -134.79 -32.67 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.767 1.227 . . . . 0.0 110.707 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.89 -173.41 33.9 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.47 109.63 9.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 170.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -70.03 132.79 88.22 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.64 -28.48 60.72 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.018 1.812 . . . . 0.0 112.997 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -39.13 91.54 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.972 0.806 . . . . 0.0 110.847 174.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.87 65.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.78 -59.72 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -63.32 -40.99 98.85 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.96 0.8 . . . . 0.0 110.513 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.1 -46.51 72.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 111.362 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.4 mmm -77.48 -38.58 48.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.173 0.589 . . . . 0.0 111.495 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -60.95 -34.6 74.98 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.579 -0.701 . . . . 0.0 110.051 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -68.94 -22.01 64.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.6 t -76.08 -26.2 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 119.53 1.059 . . . . 0.0 109.371 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.04 23.63 9.64 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.796 1.189 . . . . 0.0 110.511 -169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.2 mt -118.75 101.93 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.98 129.92 40.78 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.33 -2.02 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.584 0.753 . . . . 0.0 110.714 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -29.15 69.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.421 1.01 . . . . 0.0 110.695 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.67 -16.68 64.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.752 1.621 . . . . 0.0 113.537 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -75.29 176.1 7.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.952 0.901 . . . . 0.0 109.037 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -141.93 153.54 44.44 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.843 1.257 . . . . 0.0 108.744 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -107.44 147.24 30.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 109.87 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.87 158.47 40.82 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.851 1.261 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 pt -88.7 162.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 137.66 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.73 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -126.28 114.85 18.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.22 1.408 . . . . 0.0 108.058 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -56.4 -28.6 59.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.723 0.809 . . . . 0.0 111.377 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.72 0.5 8.7 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.786 1.634 . . . . 0.0 113.475 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.88 -46.99 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp -45.79 -52.76 10.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.468 1.107 . . . . 0.0 111.395 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -5.78 22.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -132.51 5.16 4.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.675 1.19 . . . . 0.0 112.541 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.7 47.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.37 -33.2 67.06 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.8 tp -143.03 142.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.062 1.345 . . . . 0.0 109.18 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.31 134.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.49 134.12 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 118.958 0.799 . . . . 0.0 108.861 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 86' ' ' ALA . 9.7 p -98.53 98.27 9.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.5 -12.26 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.256 1.422 . . . . 0.0 113.598 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.65 147.37 33.0 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.34 95.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.405 0.526 . . . . 0.0 112.342 -169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.95 -25.23 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.164 0.982 . . . . 0.0 111.731 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.7 -23.96 60.94 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.284 0.634 . . . . 0.0 111.689 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -64.14 -20.69 66.16 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.8 -32.63 70.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.096 0.558 . . . . 0.0 111.949 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -86.79 62.09 7.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.875 0.87 . . . . 0.0 110.588 -173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 77.0 m -120.21 75.15 22.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 108.391 172.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.04 -28.48 80.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.436 2.091 . . . . 0.0 114.659 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 ttp -158.76 99.28 1.55 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.939 0.896 . . . . 0.0 109.942 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p -128.37 73.7 80.07 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.452 1.101 . . . . 0.0 108.351 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.93 171.07 10.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.3 2.666 . . . . 0.0 110.856 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.34 -21.99 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.193 3.262 . . . . 0.0 116.456 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -63.27 -11.82 24.49 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 112.897 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.3 94.39 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 128.015 2.526 . . . . 0.0 105.273 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -70.81 165.25 23.55 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 98' ' ' ARG . 3.5 mtp85 -135.47 153.81 51.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.243 0.617 . . . . 0.0 111.671 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.54 167.08 23.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.58 6.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.844 0.858 . . . . 0.0 110.369 -169.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -115.27 -174.11 2.44 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.824 1.249 . . . . 0.0 109.405 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.63 43.64 1.19 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.239 -0.913 . . . . 0.0 114.231 -168.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -84.31 108.04 16.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.261 1.03 . . . . 0.0 111.819 -172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.37 152.6 37.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.018 0.927 . . . . 0.0 109.734 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -71.5 116.43 47.46 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 122.915 0.486 . . . . 0.0 111.713 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.21 -34.42 16.45 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.089 1.86 . . . . 0.0 112.1 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.47 -16.35 64.05 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.46 0.573 . . . . 0.0 112.076 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -111.53 14.95 21.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.978 1.311 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.83 -43.8 90.74 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.651 0.659 . . . . 0.0 111.684 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 50.36 -161.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.095 1.758 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.49 -69.83 0.21 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.877 1.703 . . . . 0.0 109.122 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -154.1 156.53 37.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.29 -38.76 84.6 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.264 0.938 . . . . 0.0 111.105 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.71 -32.34 72.91 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.257 -0.277 . . . . 0.0 111.106 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.09 -42.12 60.62 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.382 0.673 . . . . 0.0 109.877 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -58.46 -50.47 73.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.367 1.467 . . . . 0.0 110.149 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -62.01 -42.57 99.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.875 0.47 . . . . 0.0 110.619 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.03 72.7 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.784 0.72 . . . . 0.0 110.813 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.86 -40.27 83.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.737 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -56.41 -46.44 80.19 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.48 -48.74 79.78 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.663 0.785 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -59.55 -50.09 75.24 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.077 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.32 -44.6 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.223 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.05 -44.09 97.43 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.992 2.178 . . . . 0.0 110.627 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.74 -43.3 99.12 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.95 -38.03 66.91 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.604 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -42.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.774 1.625 . . . . 0.0 108.617 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.78 93.72 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.428 ' ND2' HH21 ' A' ' 130' ' ' ARG . 45.5 t30 -59.23 -43.04 92.35 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.276 1.03 . . . . 0.0 112.008 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.428 HH21 ' ND2' ' A' ' 129' ' ' ASN . 4.3 mmp_? -60.84 -46.04 92.15 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.612 -0.68 . . . . 0.0 110.29 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.12 -41.11 90.96 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.258 0.481 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.34 -48.58 73.98 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.857 0.863 . . . . 0.0 110.246 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.88 -48.32 82.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.31 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.5 -44.5 85.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.873 1.215 . . . . 0.0 109.852 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.33 85.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.776 0.431 . . . . 0.0 111.148 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -82.15 -38.95 23.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.418 1.087 . . . . 0.0 111.226 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 47.5 p -94.05 -22.95 18.2 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.203 0.601 . . . . 0.0 111.115 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.57 43.0 98.0 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.964 1.706 . . . . 0.0 112.707 -169.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 119.452 -0.308 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -141.99 170.67 15.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.62 142.59 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 118.758 0.708 . . . . 0.0 109.791 -168.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.25 135.76 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.86 104.16 6.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.33 0.652 . . . . 0.0 109.38 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -77.4 149.54 35.15 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.795 0.838 . . . . 0.0 110.532 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.77 132.42 14.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -149.95 171.96 15.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.264 1.393 . . . . 0.0 110.916 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -64.18 -13.32 47.79 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.948 -1.095 . . . . 0.0 112.93 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 119.21 0.9 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 105.367 -3.093 . . . . 0.0 105.367 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.3 t-20 -56.3 -43.01 78.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.771 0.828 . . . . 0.0 110.46 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -30.8 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 132.626 4.37 . . . . 0.0 118.06 -169.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.82 -58.83 0.76 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.654 0.661 . . . . 0.0 111.659 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -61.69 -50.54 72.04 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.025 0.83 . . . . 0.0 110.973 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -68.74 -38.28 80.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.226 0.466 . . . . 0.0 110.815 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -61.59 -43.7 98.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.776 0.716 . . . . 0.0 111.817 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 74.7 mtm -67.41 -46.85 72.01 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.27 0.486 . . . . 0.0 109.814 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.59 -42.0 74.18 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.274 0.488 . . . . 0.0 111.055 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.25 -48.15 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.051 0.54 . . . . 0.0 110.186 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.99 -50.86 53.37 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.574 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.8 m95 -67.18 -37.71 84.17 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.632 1.716 . . . . 0.0 110.851 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.05 82.72 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.219 0.918 . . . . 0.0 111.627 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -60.45 -27.17 67.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.192 0.906 . . . . 0.0 112.255 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.42 -47.1 13.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.615 0.766 . . . . 0.0 109.872 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -77.61 -28.63 51.55 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.07 -145.69 0.31 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.162 1.385 . . . . 0.0 108.297 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 -170.58 42.89 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.22 0.918 . . . . 0.0 111.857 -171.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.85 -19.07 63.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.707 1.603 . . . . 0.0 113.668 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.91 -12.12 10.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.859 1.264 . . . . 0.0 112.013 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -129.24 162.32 28.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.014 1.326 . . . . 0.0 110.782 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.2 132.13 53.05 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.15 137.05 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -137.25 163.88 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.548 0.739 . . . . 0.0 109.307 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -140.14 128.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.79 -173.11 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.757 1.223 . . . . 0.0 108.585 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.38 171.44 41.38 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.84 -41.02 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.93 179.36 7.23 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.005 0.922 . . . . 0.0 109.257 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.85 121.82 10.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.76 1.624 . . . . 0.0 106.652 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.25 -34.78 36.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.41 -173.82 37.04 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.902 2.191 . . . . 0.0 107.693 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.28 105.29 11.44 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.93 130.87 86.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.969 -169.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.85 -34.34 75.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.53 2.82 . . . . 0.0 113.724 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.38 78.42 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.43 0.559 . . . . 0.0 111.181 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.47 63.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.42 -53.5 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -65.72 -42.88 90.56 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 119.065 0.848 . . . . 0.0 110.383 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.52 72.15 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.64 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 83.4 mmm -83.22 -37.52 23.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.713 0.688 . . . . 0.0 111.526 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -65.68 -29.83 70.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.302 -0.874 . . . . 0.0 110.934 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.53 -18.77 65.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.111 0.964 . . . . 0.0 112.248 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.12 -9.71 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.48 1.112 . . . . 0.0 109.99 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.55 21.45 56.28 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -111.75 90.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.83 77.76 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 110.245 -172.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.05 3.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 111.868 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -53.86 -26.42 24.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.462 1.105 . . . . 0.0 112.46 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -79.79 -12.04 59.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.003 1.321 . . . . 0.0 113.593 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -74.32 172.79 11.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.259 0.936 . . . . 0.0 109.238 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -146.84 161.58 40.4 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 107.783 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.2 m -104.06 151.45 23.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.643 0.777 . . . . 0.0 109.628 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -147.39 159.81 43.27 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.945 2.098 . . . . 0.0 108.496 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -89.6 165.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 142.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.037 0.935 . . . . 0.0 112.31 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -132.22 104.24 6.67 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.364 1.865 . . . . 0.0 108.383 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 p -56.9 -26.34 58.89 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -69.8 -4.86 21.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.24 1.016 . . . . 0.0 112.79 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.82 -48.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.61 -44.49 57.08 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.815 0.734 . . . . 0.0 112.158 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -3.68 17.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -135.48 10.65 3.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.984 1.314 . . . . 0.0 112.185 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.32 152.93 36.5 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.07 -36.26 79.55 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.866 1.212 . . . . 0.0 108.629 170.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.54 155.42 43.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.872 0.844 . . . . 0.0 112.28 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -113.56 138.87 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 102.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.7 p -76.08 147.96 38.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 3.13 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.01 0.524 . . . . 0.0 112.127 -169.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.81 162.19 40.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.357 0.981 . . . . 0.0 108.396 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.07 97.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.44 -35.63 73.47 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.096 0.948 . . . . 0.0 111.18 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.67 -23.66 67.23 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.066 0.546 . . . . 0.0 112.405 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.56 -29.44 59.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.466 0.707 . . . . 0.0 112.373 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.36 -32.7 74.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.209 0.604 . . . . 0.0 112.261 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -86.9 58.61 5.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.389 0.676 . . . . 0.0 110.59 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.96 81.21 12.04 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.76 -35.46 98.6 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.828 2.352 . . . . 0.0 114.384 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -159.31 125.36 4.39 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.153 0.981 . . . . 0.0 108.356 169.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -138.94 79.96 25.75 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.35 169.87 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.073 2.515 . . . . 0.0 110.846 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.66 -18.95 6.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.407 3.405 . . . . 0.0 116.378 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -61.56 -13.81 24.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.15 0.98 . . . . 0.0 112.691 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 t -127.95 109.25 19.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.177 2.191 . . . . 0.0 106.542 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.04 167.75 20.04 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -135.62 150.37 49.62 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.529 0.732 . . . . 0.0 109.846 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 153.8 43.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 169.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -138.3 84.57 2.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -169.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -79.53 176.45 9.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.943 1.297 . . . . 0.0 109.446 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.3 93.96 0.19 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.327 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -131.93 121.43 23.99 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.831 0.853 . . . . 0.0 111.131 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -64.77 152.25 43.14 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.621 1.168 . . . . 0.0 109.92 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.76 114.91 28.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.057 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -31.67 29.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.018 1.812 . . . . 0.0 112.707 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.9 -15.21 62.74 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.592 0.633 . . . . 0.0 112.053 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -115.63 22.15 13.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.617 1.567 . . . . 0.0 110.732 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.01 -27.04 69.15 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 43.51 -147.53 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.985 2.114 . . . . 0.0 113.275 -175.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.6 -73.12 1.43 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.5 166.17 16.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.534 2.334 . . . . 0.0 105.623 172.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.84 -40.21 79.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.353 0.979 . . . . 0.0 111.447 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.65 -28.97 63.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.442 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.45 -39.78 67.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.981 0.809 . . . . 0.0 109.322 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.22 -48.14 82.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 109.832 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -61.03 -43.06 99.45 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.299 0.5 . . . . 0.0 110.573 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.19 -32.9 70.33 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.597 -0.689 . . . . 0.0 110.911 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -74.75 -35.51 62.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.023 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -53.57 -45.42 69.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.96 1.254 . . . . 0.0 108.809 169.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.25 -46.92 85.09 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 123.027 0.531 . . . . 0.0 111.3 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -61.39 -50.96 70.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.949 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.21 -44.3 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.206 -1.378 . . . . 0.0 109.903 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -63.15 -43.28 98.77 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 121.565 1.984 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.38 -42.74 99.2 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.514 0.325 . . . . 0.0 110.266 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.72 -45.44 71.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.343 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -61.27 -40.7 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.034 1.288 . . . . 0.0 108.87 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.12 85.36 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -56.98 -41.5 78.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.251 1.02 . . . . 0.0 112.218 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -65.16 -41.46 94.67 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.35 -0.844 . . . . 0.0 110.174 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.76 -36.74 78.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.476 1.035 . . . . 0.0 111.475 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -49.6 76.47 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.679 0.792 . . . . 0.0 110.092 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.77 -48.32 81.18 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.757 0.708 . . . . 0.0 109.915 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.01 -38.6 70.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.212 0.915 . . . . 0.0 111.154 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.57 -45.86 61.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.49 -38.62 54.97 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.244 1.018 . . . . 0.0 111.72 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.4 p -94.35 -16.81 23.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.576 1.15 . . . . 0.0 111.05 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.06 92.0 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.906 1.283 . . . . 0.0 112.037 -169.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 42.4 mtmt -133.05 171.14 14.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.477 1.511 . . . . 0.0 108.679 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -136.1 139.28 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tt -125.76 135.48 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -130.92 111.88 12.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.87 141.01 31.62 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.6 140.67 52.72 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -154.86 169.68 23.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.298 0.639 . . . . 0.0 109.445 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -71.03 -7.83 49.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.77 119.17 0.85 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 57.7 t-20 -77.36 72.53 3.91 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.352 1.061 . . . . 0.0 109.017 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.1 p -134.13 -30.96 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.311 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 m -134.75 -67.69 0.56 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.911 0.778 . . . . 0.0 111.63 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -57.79 -50.55 72.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.927 0.491 . . . . 0.0 111.74 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -64.43 -36.81 85.39 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.25 0.477 . . . . 0.0 111.618 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.51 -42.5 71.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.822 . . . . 0.0 110.85 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -62.06 -51.63 67.17 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.56 76.69 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.929 0.492 . . . . 0.0 110.969 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.68 -48.55 81.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.287 0.635 . . . . 0.0 109.97 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.82 -46.78 93.49 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.616 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.7 m95 -66.87 -41.87 86.55 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.065 1.433 . . . . 0.0 110.908 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.45 80.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.514 0.597 . . . . 0.0 111.055 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -57.45 -34.33 68.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.805 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.66 -58.62 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.366 0.53 . . . . 0.0 110.132 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -70.72 -36.44 73.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -169.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 42.8 mt -91.49 -36.69 13.6 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.78 -177.84 46.82 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.856 0.741 . . . . 0.0 112.723 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.54 -8.66 49.13 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.89 -9.79 2.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 110.972 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 9.6 m95 -136.36 166.42 23.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.835 1.654 . . . . 0.0 108.945 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.05 146.35 47.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 167.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.2 121.77 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -168.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.01 165.88 24.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.459 0.647 . . . . 0.0 109.841 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p -132.34 139.03 47.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.879 1.272 . . . . 0.0 108.427 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.59 -175.66 4.45 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.491 1.517 . . . . 0.0 108.565 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.04 177.19 46.39 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 121.802 -0.562 . . . . 0.0 111.891 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.53 -41.64 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.812 1.245 . . . . 0.0 108.569 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.89 177.42 8.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.82 0.848 . . . . 0.0 109.546 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.98 166.62 29.08 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.981 1.712 . . . . 0.0 108.714 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.26 -46.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.587 1.155 . . . . 0.0 108.12 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.74 25.91 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.62 122.53 14.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -74.24 141.44 77.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.661 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.11 -34.69 69.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.922 2.415 . . . . 0.0 113.715 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -35.43 78.96 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.719 0.691 . . . . 0.0 111.812 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.55 -42.1 68.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.01 -55.51 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.37 -44.41 96.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.4 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.13 88.74 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.087 0.858 . . . . 0.0 111.215 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.6 mmm -73.46 -39.93 64.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.7 0.4 . . . . 0.0 110.403 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -64.78 -33.5 76.14 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.141 0.976 . . . . 0.0 110.977 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.54 -15.29 62.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.791 1.236 . . . . 0.0 112.232 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.64 1.91 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.174 1.39 . . . . 0.0 109.781 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.29 72.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.661 -1.274 . . . . 0.0 112.299 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.57 93.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.09 77.8 5.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.46 0.704 . . . . 0.0 110.515 -172.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.4 pt -73.99 1.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.904 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -53.68 -27.94 30.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.99 1.268 . . . . 0.0 112.511 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.91 -22.37 61.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.061 1.344 . . . . 0.0 113.054 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -71.51 168.03 18.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.083 0.953 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -145.23 164.98 29.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.492 1.917 . . . . 0.0 108.115 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.2 m -108.68 158.26 17.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.531 0.681 . . . . 0.0 110.773 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 47.3 t0 -153.2 159.75 42.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.918 2.087 . . . . 0.0 107.499 172.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -88.44 166.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.02 108.52 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.152 0.981 . . . . 0.0 111.274 -170.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -94.03 114.56 26.76 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -18.76 62.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.245 1.418 . . . . 0.0 112.559 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.07 -47.7 60.83 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.121 0.873 . . . . 0.0 110.974 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.9 -42.65 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -48.85 -49.31 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.21 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -76.26 -12.96 60.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -92.75 -17.63 23.96 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.283 0.947 . . . . 0.0 110.903 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.74 50.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.168 0.44 . . . . 0.0 111.568 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 -37.5 75.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.71 162.59 39.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.931 0.872 . . . . 0.0 112.811 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.72 141.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.03 111.49 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 86' ' ' ALA . 52.0 p -90.18 103.08 15.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.25 -8.97 50.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.328 0.651 . . . . 0.0 112.287 -172.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -143.6 154.21 43.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.51 95.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.26 -32.07 73.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.591 0.695 . . . . 0.0 111.557 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.75 70.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.258 0.481 . . . . 0.0 111.794 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -67.0 -17.5 64.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.3 -31.54 72.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.568 0.622 . . . . 0.0 111.811 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.2 -28.51 57.28 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.175 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 m -47.06 108.01 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.4 1.08 . . . . 0.0 111.016 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.25 -38.73 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.957 1.771 . . . . 0.0 114.526 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.7 tpt -165.74 132.01 2.64 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.316 1.046 . . . . 0.0 109.166 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.7 p -137.88 96.42 10.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.74 168.39 20.28 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.889 2.393 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -50.86 -26.17 17.39 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.037 3.158 . . . . 0.0 115.85 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -66.17 -7.14 16.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.365 1.066 . . . . 0.0 113.077 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.65 97.03 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.96 2.104 . . . . 0.0 105.58 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 163.62 27.12 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.254 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -141.84 128.53 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.45 155.67 45.34 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.072 1.349 . . . . 0.0 108.054 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -137.64 143.23 41.29 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.506 0.722 . . . . 0.0 111.665 -169.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -139.28 -170.99 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.724 1.609 . . . . 0.0 108.553 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.91 45.2 0.98 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-N 119.11 0.868 . . . . 0.0 113.379 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -80.93 122.97 27.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.062 0.931 . . . . 0.0 111.576 -173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -78.19 152.65 32.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.66 127.76 76.89 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.698 -0.626 . . . . 0.0 112.47 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.35 -34.22 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.164 1.909 . . . . 0.0 113.375 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -22.05 66.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.282 0.946 . . . . 0.0 112.235 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -100.12 -0.9 38.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.419 1.088 . . . . 0.0 111.146 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.75 152.35 23.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -160.81 164.1 31.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.29 0.636 . . . . 0.0 110.358 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.52 -49.53 0.61 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.14 166.23 19.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.051 2.14 . . . . 0.0 105.649 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.36 -40.69 82.89 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.753 -0.592 . . . . 0.0 110.579 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.94 -29.05 64.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.346 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.3 -45.05 61.68 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -56.94 -49.85 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.661 0.784 . . . . 0.0 109.964 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -61.59 -44.22 97.41 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.34 0.518 . . . . 0.0 110.398 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -40.28 80.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.321 0.509 . . . . 0.0 110.293 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -62.59 -36.92 84.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.191 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.89 -50.59 70.26 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.327 0.967 . . . . 0.0 108.595 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -61.62 -45.45 94.0 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.045 0.538 . . . . 0.0 110.834 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -59.91 -50.01 75.45 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.271 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.4 -47.41 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 117.449 -1.262 . . . . 0.0 109.945 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -61.73 -41.55 97.78 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.828 1.649 . . . . 0.0 110.806 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.74 -41.74 99.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.074 0.397 . . . . 0.0 110.017 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -76.61 -33.8 58.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.619 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.62 -42.11 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.702 1.137 . . . . 0.0 108.069 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.75 -47.11 79.06 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -53.65 -44.48 69.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.883 1.273 . . . . 0.0 111.166 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -47.49 85.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 119.249 -0.405 . . . . 0.0 110.908 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.02 -37.24 83.79 Favored 'General case' 0 C--O 1.229 -0.023 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -59.15 -49.07 79.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.782 0.833 . . . . 0.0 110.407 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.61 -45.63 82.38 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.371 0.987 . . . . 0.0 109.65 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -55.39 -38.5 68.97 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.024 0.829 . . . . 0.0 111.016 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.98 34.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.601 0.76 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.76 -38.96 73.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.762 1.225 . . . . 0.0 111.32 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 p -90.34 -16.07 29.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.856 0.862 . . . . 0.0 110.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.78 40.63 89.65 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.78 1.232 . . . . 0.0 111.789 -169.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -142.55 169.37 17.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.381 1.472 . . . . 0.0 109.026 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.3 mt -135.98 147.31 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 tt -134.64 142.9 39.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.484 1.114 . . . . 0.0 108.387 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.27 107.22 7.08 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.71 143.39 48.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.991 0.517 . . . . 0.0 109.934 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.08 143.22 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.083 1.753 . . . . 0.0 106.536 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 1.3 t -157.91 170.29 22.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 118.674 0.67 . . . . 0.0 109.53 170.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -66.82 -10.67 50.34 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.118 -0.989 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.98 119.82 0.93 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.4 t-20 -56.9 -46.58 81.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.632 0.773 . . . . 0.0 110.355 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 m -42.33 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 130.191 3.396 . . . . 0.0 117.733 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -119.5 -78.31 0.59 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.002 0.819 . . . . 0.0 109.499 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -61.89 -47.77 83.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.109 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -68.98 -38.25 79.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.063 0.847 . . . . 0.0 110.901 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -43.77 96.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.646 0.657 . . . . 0.0 111.484 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.4 mtp -66.18 -47.32 74.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.366 0.666 . . . . 0.0 109.546 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.9 78.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.388 0.675 . . . . 0.0 110.979 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.43 -45.85 80.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.62 0.768 . . . . 0.0 110.129 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.95 -47.29 91.41 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -69.97 -39.14 76.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.38 1.59 . . . . 0.0 111.055 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.1 79.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.744 0.417 . . . . 0.0 111.554 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.5 -33.91 64.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.82 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -74.48 -57.33 4.01 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.27 0.486 . . . . 0.0 110.603 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -73.58 -45.0 55.89 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -73.84 -35.71 64.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.486 0.584 . . . . 0.0 111.348 -169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.9 167.99 42.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.973 0.797 . . . . 0.0 111.78 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.78 -12.04 61.31 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -52.81 -31.6 39.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.384 0.611 . . . . 0.0 110.055 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -100.91 150.45 22.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -110.41 125.8 53.63 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 167.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.18 127.2 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -168.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.0 172.0 13.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.629 1.172 . . . . 0.0 108.768 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -137.47 139.67 40.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.118 0.967 . . . . 0.0 109.507 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.09 -175.15 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.344 1.458 . . . . 0.0 109.022 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 10' ' ' CYS . . . -165.03 175.79 40.88 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -42.1 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.51 179.48 7.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.84 0.856 . . . . 0.0 109.815 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.33 151.16 37.88 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.613 1.965 . . . . 0.0 106.964 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -127.84 10.35 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.769 1.227 . . . . 0.0 111.797 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.84 -173.54 18.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 126.113 1.816 . . . . 0.0 109.035 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.76 109.3 20.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -63.49 124.55 84.86 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.286 -172.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.18 -34.16 38.44 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.288 2.658 . . . . 0.0 113.657 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -38.64 87.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.77 0.714 . . . . 0.0 110.913 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.13 75.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.61 -52.14 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -65.97 -41.89 90.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.87 0.759 . . . . 0.0 110.827 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.83 -45.58 82.24 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.839 0.745 . . . . 0.0 110.954 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.7 mmm -75.78 -38.91 57.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.467 0.307 . . . . 0.0 110.903 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.96 -34.02 77.43 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.01 -1.056 . . . . 0.0 110.993 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.84 -20.4 66.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 112.238 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.83 -10.06 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 110.281 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.15 20.05 28.98 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.629 1.109 . . . . 0.0 111.925 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.56 91.35 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -77.49 76.79 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.751 1.22 . . . . 0.0 110.089 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.69 2.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 121.381 -0.824 . . . . 0.0 112.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.68 -28.9 16.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.348 1.859 . . . . 0.0 112.802 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.22 -16.62 57.67 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.847 1.259 . . . . 0.0 112.922 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -70.67 171.83 9.71 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.826 0.85 . . . . 0.0 109.7 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -147.1 158.95 44.11 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 107.819 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -98.43 156.33 16.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 110.043 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 43.1 t0 -150.26 162.7 39.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.891 2.076 . . . . 0.0 108.088 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -94.21 160.9 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 133.23 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 112.515 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -116.89 111.64 19.93 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.559 1.944 . . . . 0.0 106.83 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -62.0 -19.56 62.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.993 0.917 . . . . 0.0 112.719 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.78 -43.42 84.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.772 1.169 . . . . 0.0 111.322 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.99 -48.7 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.81 -52.35 24.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.237 1.015 . . . . 0.0 110.409 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -68.96 -10.19 56.05 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.23 6.49 7.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.001 1.273 . . . . 0.0 112.812 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 154.0 39.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.49 -32.43 54.26 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.553 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 33.5 tp -145.43 145.84 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.153 1.381 . . . . 0.0 109.104 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -126.5 140.41 48.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.53 134.05 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 86' ' ' ALA . 30.6 p -95.19 118.93 32.82 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.69 -0.76 31.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.153 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -147.22 163.03 37.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.695 1.134 . . . . 0.0 109.104 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.76 -38.99 77.11 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.852 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.52 -35.84 78.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.533 1.166 . . . . 0.0 110.925 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.72 -18.96 65.71 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.603 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -60.62 -23.97 65.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.935 0.789 . . . . 0.0 112.147 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.1 -34.05 76.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 111.979 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.56 63.95 8.26 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.06 0.944 . . . . 0.0 110.119 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.5 m -122.53 72.94 40.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.89 -48.43 7.52 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.08 3.186 . . . . 0.0 115.315 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 138.23 6.48 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -132.46 80.67 62.16 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.67 168.07 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.502 2.802 . . . . 0.0 110.916 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.9 -22.04 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.824 3.683 . . . . 0.0 118.655 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.21 -41.47 93.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.986 1.267 . . . . 0.0 110.615 170.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 156.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 127.785 2.434 . . . . 0.0 108.37 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.9 pttt -140.59 170.41 15.83 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.555 1.542 . . . . 0.0 107.777 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -134.02 157.07 47.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 112.417 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.97 158.39 43.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.189 2.196 . . . . 0.0 105.204 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -145.19 117.85 8.63 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.48 -0.763 . . . . 0.0 109.291 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -109.33 -174.13 2.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.019 1.327 . . . . 0.0 109.795 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.66 43.51 1.11 Allowed Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.418 -0.801 . . . . 0.0 114.534 -168.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -85.83 121.52 28.59 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.543 1.172 . . . . 0.0 111.168 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.06 155.12 40.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.78 120.89 83.75 Favored Pre-proline 0 C--O 1.235 0.318 0 O-C-N 121.833 -0.542 . . . . 0.0 111.417 -170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.85 -33.75 42.0 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.556 1.504 . . . . 0.0 112.754 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.14 -20.47 66.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.522 0.601 . . . . 0.0 112.526 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.13 -0.02 34.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.527 1.131 . . . . 0.0 111.568 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 150.18 24.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.67 164.52 33.94 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.183 0.593 . . . . 0.0 110.085 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.11 -48.21 0.69 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -164.11 162.69 23.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.904 2.082 . . . . 0.0 105.449 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.01 -40.86 86.23 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.693 -0.629 . . . . 0.0 110.495 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.22 -29.35 68.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.319 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -76.38 -40.22 51.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.988 0.813 . . . . 0.0 109.913 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.03 -51.37 69.53 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -60.21 -44.57 95.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.47 79.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -61.2 -34.84 75.73 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.97 0.805 . . . . 0.0 111.621 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -57.39 -48.46 79.02 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -61.23 -44.17 97.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.403 0.681 . . . . 0.0 111.919 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -61.27 -53.08 61.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.64 0.654 . . . . 0.0 109.578 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.23 -43.02 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.638 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -61.16 -43.87 98.21 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.941 1.7 . . . . 0.0 110.992 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.49 -43.66 96.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.35 -39.89 71.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.01 -45.24 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.565 1.075 . . . . 0.0 108.37 175.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.89 95.18 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -62.19 -39.52 92.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.221 1.01 . . . . 0.0 111.719 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -38.6 85.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.98 0.809 . . . . 0.0 110.685 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.96 -38.98 66.54 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.925 -0.484 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -56.87 -47.15 81.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.119 0.968 . . . . 0.0 110.138 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.61 -52.22 66.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 117.324 -1.322 . . . . 0.0 109.519 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.02 -44.08 82.48 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.457 1.48 . . . . 0.0 110.196 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.21 92.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.264 0.626 . . . . 0.0 111.642 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.45 -37.68 22.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.994 0.918 . . . . 0.0 111.416 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 p -94.62 -22.77 17.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.592 0.757 . . . . 0.0 111.345 -170.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.249 1.05 0 C-N-CA 127.443 2.297 . . . . 0.0 112.443 -170.045 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.31 176.68 9.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.183 0.993 . . . . 0.0 109.474 169.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.9 mt -133.25 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.33 132.93 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -127.78 101.62 6.44 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.145 0.978 . . . . 0.0 108.387 -171.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -73.11 145.77 46.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.62 131.58 21.64 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.58 -178.1 6.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.131 0.423 . . . . 0.0 111.214 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -7.41 36.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.713 -1.242 . . . . 0.0 114.07 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.65 129.92 2.08 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.696 HD22 ' H ' ' A' ' 65' ' ' ASP . 45.4 t-20 -81.22 40.17 0.54 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.276 1.031 . . . . 0.0 112.062 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.4 p -122.46 -20.91 5.91 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 111.765 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.1 m -134.66 -73.37 0.47 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.948 0.899 . . . . 0.0 110.866 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -60.21 3.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.909 0.777 . . . . 0.0 111.038 -169.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 m -62.68 -42.34 99.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.656 0.382 . . . . 0.0 110.468 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -61.01 -45.58 94.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.219 0.608 . . . . 0.0 111.405 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 43.2 mtm -66.77 -46.17 76.18 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.933 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.03 -44.99 79.3 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.368 0.531 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.25 -45.24 91.71 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.773 0.829 . . . . 0.0 110.082 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.48 -46.58 92.93 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.474 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -69.63 -39.82 76.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.554 1.677 . . . . 0.0 110.822 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.84 78.83 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.358 0.526 . . . . 0.0 110.844 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -57.2 -33.06 67.12 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.727 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -71.56 -57.7 4.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.465 0.575 . . . . 0.0 110.148 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -70.24 -37.81 75.04 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.93 -38.74 12.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.095 0.558 . . . . 0.0 111.839 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 177.45 48.41 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.267 0.937 . . . . 0.0 112.391 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.48 -10.15 53.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.697 1.199 . . . . 0.0 113.585 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.9 -10.69 6.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.282 1.433 . . . . 0.0 111.379 169.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.61 146.11 50.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.607 1.563 . . . . 0.0 108.095 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -100.76 138.46 37.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 167.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.18 127.54 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -168.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.33 169.82 16.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -134.81 143.05 46.85 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 109.766 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.26 -177.11 4.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.282 1.433 . . . . 0.0 108.838 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.91 167.36 35.92 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.64 -40.78 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.42 179.77 6.9 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.997 . . . . 0.0 109.852 170.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.11 159.43 43.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.256 1.822 . . . . 0.0 108.017 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -147.74 -31.37 0.3 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.365 0.666 . . . . 0.0 111.833 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.91 173.61 34.55 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.19 107.27 2.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -72.4 130.9 85.36 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.02 -27.09 65.92 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.866 1.711 . . . . 0.0 112.956 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -39.1 93.22 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.996 0.816 . . . . 0.0 111.2 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.37 62.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.91 -58.36 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -64.03 -39.58 94.42 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 118.644 0.656 . . . . 0.0 110.557 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.52 68.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.709 0.686 . . . . 0.0 110.935 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.72 -38.49 67.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.022 0.529 . . . . 0.0 111.108 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -68.97 -29.02 67.15 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.304 -0.873 . . . . 0.0 111.6 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.94 -18.55 65.43 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.464 1.105 . . . . 0.0 111.874 170.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.04 -2.96 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.769 1.228 . . . . 0.0 109.798 172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.27 18.93 54.55 Favored Glycine 0 CA--C 1.531 1.031 0 O-C-N 120.79 -1.194 . . . . 0.0 112.307 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 mt -114.16 95.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.07 78.69 4.55 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.279 1.032 . . . . 0.0 110.168 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -72.83 -3.21 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.44 -0.787 . . . . 0.0 112.017 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -29.2 63.33 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.815 1.189 . . . . 0.0 112.077 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -73.02 -16.02 61.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.827 1.251 . . . . 0.0 112.533 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.61 171.01 9.63 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.707 0.803 . . . . 0.0 109.027 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -138.99 162.99 33.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.88 1.272 . . . . 0.0 109.086 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 p -116.83 144.66 44.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 109.451 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.696 ' H ' HD22 ' A' ' 13' ' ' ASN . 45.8 t0 -153.46 155.58 36.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.091 2.156 . . . . 0.0 107.999 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.78 164.44 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tt -54.34 134.33 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 111.265 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -128.95 112.05 13.67 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.688 1.195 . . . . 0.0 108.493 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 p -54.83 -28.75 51.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.592 0.757 . . . . 0.0 111.28 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.69 -1.23 15.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.364 1.465 . . . . 0.0 113.66 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.22 -46.54 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -45.46 -54.33 7.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.864 1.266 . . . . 0.0 111.456 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -2.15 9.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -133.56 3.76 3.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.612 1.165 . . . . 0.0 112.758 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.07 151.01 48.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.22 -34.27 75.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tp -145.66 143.14 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.117 1.367 . . . . 0.0 109.726 -171.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.58 138.13 52.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.13 111.81 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -90.97 91.26 8.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.45 -9.43 12.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.284 1.033 . . . . 0.0 113.307 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.3 133.66 21.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.8 -32.93 66.63 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.717 0.675 . . . . 0.0 112.687 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.2 -30.68 71.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.33 1.065 . . . . 0.0 111.884 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 -30.92 68.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.266 0.626 . . . . 0.0 111.576 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.79 -20.12 64.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.16 -34.49 66.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.965 0.906 . . . . 0.0 112.129 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 -32.56 61.67 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.661 -171.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.0 m -48.8 108.11 0.89 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.992 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.76 -28.01 14.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.323 2.015 . . . . 0.0 114.239 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.9 ptp -163.61 131.34 3.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.271 1.028 . . . . 0.0 110.086 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -140.23 80.48 19.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.78 169.19 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.214 3.276 . . . . 0.0 113.23 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.21 -28.12 32.62 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.463 2.776 . . . . 0.0 115.047 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.57 -7.22 30.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.262 1.025 . . . . 0.0 112.968 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.11 81.7 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.931 2.492 . . . . 0.0 105.271 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.8 pttt -65.58 166.16 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -131.68 155.07 48.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.92 0.488 . . . . 0.0 110.384 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.74 159.74 41.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 149.21 31.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.4 0.68 . . . . 0.0 112.429 -168.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -143.06 -160.2 1.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.197 1.399 . . . . 0.0 109.084 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.65 41.28 0.99 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.84 1.2 . . . . 0.0 113.874 -169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -85.65 107.88 17.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.586 1.193 . . . . 0.0 111.999 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.25 154.37 35.26 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.586 1.155 . . . . 0.0 110.105 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.98 120.67 82.48 Favored Pre-proline 0 C--O 1.236 0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.974 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.32 -32.04 27.12 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.906 1.737 . . . . 0.0 112.372 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.37 -19.86 66.13 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.371 0.987 . . . . 0.0 112.24 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.87 1.59 34.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.708 1.203 . . . . 0.0 111.3 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.14 138.87 57.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -145.75 156.28 43.5 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.27 -55.18 0.41 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 t -155.75 158.5 38.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.23 -39.0 88.64 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.569 -0.707 . . . . 0.0 110.815 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.22 -30.88 70.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.2 -0.313 . . . . 0.0 111.049 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.75 -42.55 58.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.205 0.602 . . . . 0.0 109.848 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 20.3 tttt -55.42 -52.27 64.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.702 1.201 . . . . 0.0 110.1 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -60.29 -45.2 94.17 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 117.962 0.346 . . . . 0.0 110.322 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.82 79.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.284 0.493 . . . . 0.0 110.427 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.72 -39.82 92.88 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.589 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.31 -50.57 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.037 0.835 . . . . 0.0 108.802 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -60.21 -45.08 94.43 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 122.912 0.485 . . . . 0.0 111.165 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.54 -48.86 79.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.85 0.46 . . . . 0.0 110.384 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.93 -44.69 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.021 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -60.85 -42.33 97.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 121.496 1.953 . . . . 0.0 110.753 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.03 -44.61 96.33 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.42 -31.65 62.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.526 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.91 -43.38 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.246 . . . . 0.0 108.592 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.29 88.82 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.91 -35.96 75.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.935 1.294 . . . . 0.0 111.562 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -50.98 71.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 123.614 0.766 . . . . 0.0 109.197 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.18 -32.17 66.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.004 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -52.02 67.26 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.942 0.897 . . . . 0.0 110.521 169.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.19 -47.42 79.84 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 119.609 1.095 . . . . 0.0 109.349 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -55.83 -38.6 70.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.607 -0.683 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -48.56 37.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.572 0.749 . . . . 0.0 111.611 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.97 -38.34 72.77 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.558 1.143 . . . . 0.0 111.143 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.4 p -90.97 -18.48 24.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 110.27 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.13 39.31 95.66 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -173.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm . . . . . 0 C--O 1.25 1.102 0 C-N-CA 125.158 1.383 . . . . 0.0 111.665 -171.767 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.54 175.93 10.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.457 0.703 . . . . 0.0 110.552 169.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.97 136.19 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.52 135.29 64.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -132.26 105.37 7.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -74.06 147.43 42.84 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.637 -0.665 . . . . 0.0 110.137 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.73 130.14 17.75 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.95 173.56 14.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.68 0.673 . . . . 0.0 110.093 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -66.06 -9.2 28.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.928 -1.107 . . . . 0.0 113.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.58 1.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 53.9 t-20 -62.67 -49.09 76.49 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.469 0.707 . . . . 0.0 110.786 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.1 m -41.69 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 130.321 3.448 . . . . 0.0 117.816 -168.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.8 -73.61 0.64 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.812 1.187 . . . . 0.0 110.09 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -61.65 -49.45 76.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.125 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -69.69 -38.83 77.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.655 0.661 . . . . 0.0 111.005 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -61.36 -45.28 95.04 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.836 0.744 . . . . 0.0 111.697 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -65.08 -48.69 72.83 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.45 78.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.859 0.463 . . . . 0.0 111.047 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.18 -50.93 71.29 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 109.927 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.28 -46.86 92.34 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.113 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.4 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.9 m95 -66.74 -42.39 86.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.655 1.728 . . . . 0.0 110.711 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.04 75.6 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.591 0.632 . . . . 0.0 111.313 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -57.31 -33.99 68.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.45 -57.2 5.55 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.455 0.571 . . . . 0.0 110.1 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -69.67 -34.38 73.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.66 -38.11 9.65 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.255 0.622 . . . . 0.0 112.456 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 178.97 51.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.216 0.912 . . . . 0.0 112.761 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.53 -12.32 60.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.934 1.294 . . . . 0.0 113.759 -170.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.7 -7.54 2.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.76 1.624 . . . . 0.0 112.063 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -131.55 145.39 51.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.48 1.512 . . . . 0.0 108.681 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 7.4 mmpt? -98.43 136.21 38.9 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 167.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.51 116.71 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -168.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.28 171.84 13.19 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -139.84 142.67 36.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.278 1.031 . . . . 0.0 108.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.93 -176.43 4.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.766 1.626 . . . . 0.0 108.544 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.63 173.84 40.59 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.19 -40.85 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.08 177.41 8.79 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.896 0.878 . . . . 0.0 110.099 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.04 126.3 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.847 1.659 . . . . 0.0 107.207 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -77.6 -46.12 23.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.339 0.656 . . . . 0.0 109.428 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.1 -166.7 39.37 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -78.18 99.62 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -62.68 131.01 94.11 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.64 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.71 -28.5 82.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.232 1.954 . . . . 0.0 112.891 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -58.9 -50.1 75.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.377 0.989 . . . . 0.0 109.324 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.22 -42.24 85.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.451 0.569 . . . . 0.0 110.233 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.64 -54.4 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.438 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -64.21 -46.64 82.99 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.318 0.963 . . . . 0.0 110.33 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.5 70.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.011 0.924 . . . . 0.0 111.436 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -79.97 -36.39 36.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.365 0.666 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.32 -31.72 72.95 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.918 -1.113 . . . . 0.0 109.801 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -72.79 6.72 2.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.672 1.989 . . . . 0.0 112.122 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.75 -6.68 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.795 2.038 . . . . 0.0 108.669 169.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.65 25.46 56.38 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 120.574 -1.328 . . . . 0.0 111.202 -169.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -116.76 90.49 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -78.78 80.72 5.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.578 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -75.25 6.82 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.246 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.9 m -53.98 -27.15 29.76 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.04 1.291 . . . . 0.0 112.168 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.68 -18.09 58.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.569 1.147 . . . . 0.0 113.161 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -71.81 170.72 13.04 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.878 0.763 . . . . 0.0 109.895 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 156.0 43.55 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.748 1.619 . . . . 0.0 107.648 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -102.44 151.95 21.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.75 . . . . 0.0 109.381 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.6 t0 -152.11 161.24 42.92 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.733 2.013 . . . . 0.0 108.251 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 pt -93.16 162.86 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -57.37 113.21 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.72 118.37 29.27 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 m -72.08 -22.53 61.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.539 -170.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.54 -42.75 51.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.044 0.838 . . . . 0.0 110.051 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.74 -44.88 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.88 -49.12 74.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.188 0.449 . . . . 0.0 110.281 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -65.85 -18.47 65.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -98.15 -14.81 20.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.342 0.974 . . . . 0.0 110.682 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.68 159.98 33.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 118.399 0.545 . . . . 0.0 110.946 -169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.37 -30.59 42.65 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 168.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 tp -152.02 145.69 25.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.621 1.568 . . . . 0.0 109.872 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.6 t -123.05 140.01 48.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.51 111.47 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.5 p -90.66 94.03 9.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.11 -10.78 33.33 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.038 0.935 . . . . 0.0 112.499 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.67 135.87 23.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.92 -34.02 76.5 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.758 0.694 . . . . 0.0 112.815 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.68 -29.28 70.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.356 1.078 . . . . 0.0 111.681 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.67 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 111.531 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.43 65.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.78 -34.29 71.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.233 1.013 . . . . 0.0 112.066 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -73.66 -32.12 63.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.883 -171.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 80.8 m -46.77 107.15 0.66 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.949 1.299 . . . . 0.0 109.627 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -64.26 -44.41 12.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.553 1.502 . . . . 0.0 114.239 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.8 ttt -167.26 123.66 1.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.291 1.036 . . . . 0.0 108.527 169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -109.24 85.48 3.48 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.7 166.62 17.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.984 2.456 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.23 -19.57 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.709 3.606 . . . . 0.0 118.279 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.18 -40.22 89.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.039 1.291 . . . . 0.0 110.051 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.26 162.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 127.881 2.472 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -142.58 169.27 17.88 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.586 1.555 . . . . 0.0 107.262 169.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -132.65 145.6 51.2 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.863 0.756 . . . . 0.0 111.156 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 152.18 43.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.301 2.24 . . . . 0.0 105.115 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.17 141.12 42.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.363 0.665 . . . . 0.0 110.284 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -138.26 -166.34 1.96 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.416 1.486 . . . . 0.0 109.076 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.54 1.13 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 119.197 0.908 . . . . 0.0 112.796 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.87 112.86 12.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.867 0.833 . . . . 0.0 110.728 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -69.14 153.56 43.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.354 0.662 . . . . 0.0 109.663 169.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.19 118.2 68.81 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 111.505 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.73 -33.7 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.005 1.804 . . . . 0.0 112.385 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.1 -19.14 64.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.745 0.702 . . . . 0.0 112.072 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -100.27 -2.95 32.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.766 1.226 . . . . 0.0 111.377 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.09 136.77 58.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 168.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.07 22.3 0.66 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -168.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.34 -51.58 42.32 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -172.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -160.17 163.62 33.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.81 2.444 . . . . 0.0 104.863 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.85 -40.02 83.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.09 1.314 . . . . 0.0 111.123 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.75 -32.75 72.73 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.282 -0.261 . . . . 0.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -75.32 -37.84 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.066 0.546 . . . . 0.0 110.144 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 41.7 tttt -59.26 -51.22 70.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.769 1.228 . . . . 0.0 109.415 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -61.96 -41.69 98.28 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.803 0.274 . . . . 0.0 110.644 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.59 73.64 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.48 -0.762 . . . . 0.0 110.859 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.2 -42.07 89.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.545 0.738 . . . . 0.0 110.385 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -56.05 -47.39 77.99 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -59.7 -48.63 80.91 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.96 0.904 . . . . 0.0 111.513 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.94 -45.06 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 116.619 -1.658 . . . . 0.0 110.262 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -61.19 -44.25 97.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 121.985 2.175 . . . . 0.0 110.48 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.71 -43.71 98.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -79.93 -27.31 39.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.255 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -65.88 -42.26 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 107.883 171.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.03 90.14 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -57.34 -40.79 78.73 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.403 1.081 . . . . 0.0 111.14 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -46.67 87.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.744 -0.598 . . . . 0.0 111.027 175.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.66 -34.31 77.91 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.588 0.631 . . . . 0.0 111.086 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -50.55 73.6 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.89 -47.36 83.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 119.712 1.142 . . . . 0.0 109.643 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.38 -39.19 72.52 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 118.394 0.543 . . . . 0.0 110.832 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.04 -48.21 46.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.907 0.883 . . . . 0.0 111.777 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -69.47 -39.6 77.61 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.726 1.21 . . . . 0.0 111.186 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -87.35 -17.66 31.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.315 1.046 . . . . 0.0 110.122 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.53 41.36 93.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.168 1.366 . . . . 0.0 110.71 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.763 0.825 . . . . 0.0 112.207 -170.771 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -146.52 173.62 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.648 1.179 . . . . 0.0 108.358 169.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.39 142.36 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -169.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.71 135.85 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.416 1.486 . . . . 0.0 107.149 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -129.01 103.43 7.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.963 0.905 . . . . 0.0 108.727 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.58 146.19 42.74 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 122.044 -0.41 . . . . 0.0 109.933 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.92 132.25 20.66 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -148.62 173.71 12.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.292 0.637 . . . . 0.0 110.116 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -68.17 -9.11 44.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.556 -1.34 . . . . 0.0 113.689 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.19 123.7 1.3 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.25 -41.04 97.15 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.219 0.509 . . . . 0.0 111.279 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -38.57 -28.94 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.77 3.228 . . . . 0.0 116.861 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -127.93 -74.93 0.57 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.206 0.912 . . . . 0.0 112.335 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mpp_? -53.87 -50.73 65.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.21 0.914 . . . . 0.0 113.436 -168.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 22.3 p -80.26 -27.81 38.56 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.979 0.809 . . . . 0.0 111.662 -175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -62.1 -41.39 98.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.643 1.11 . . . . 0.0 110.943 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 79.0 mtp -65.89 -49.37 68.29 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.64 73.66 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.938 0.495 . . . . 0.0 111.357 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -56.11 -48.91 75.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.081 0.952 . . . . 0.0 109.952 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.63 99.67 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.157 -0.801 . . . . 0.0 112.823 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 94.3 m95 -68.13 -44.11 76.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.168 1.484 . . . . 0.0 110.16 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.48 83.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.618 0.367 . . . . 0.0 110.358 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -59.14 -26.1 64.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.266 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -74.07 -59.21 2.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 110.438 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -69.81 -38.15 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 34.6 mt -87.19 -39.37 15.54 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.249 0.619 . . . . 0.0 112.176 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.39 -178.87 49.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.092 0.853 . . . . 0.0 112.834 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.93 -15.65 62.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.291 1.436 . . . . 0.0 113.567 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.76 -16.11 3.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.905 1.282 . . . . 0.0 111.534 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 11.4 m95 -129.08 140.54 51.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 110.083 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -89.57 131.15 35.73 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.54 119.21 54.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 171.59 14.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 171.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 59.2 p -136.78 152.37 50.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.238 1.015 . . . . 0.0 109.356 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.89 -168.86 3.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.076 1.351 . . . . 0.0 107.572 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.23 37.82 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.52 -40.18 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.07 179.52 6.85 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.467 1.107 . . . . 0.0 109.532 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.01 157.37 43.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.424 2.29 . . . . 0.0 106.574 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -132.5 -29.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.456 1.102 . . . . 0.0 110.185 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.53 -179.25 37.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.9 tp -75.81 101.47 5.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -62.0 124.8 83.39 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.374 -171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -51.08 -33.54 43.73 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.272 2.648 . . . . 0.0 113.719 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -39.54 90.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.651 0.659 . . . . 0.0 110.691 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.35 73.56 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -58.23 -53.35 47.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -67.62 -41.59 83.7 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.778 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.08 -49.05 74.89 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 118.886 0.766 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -71.02 -40.3 71.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.076 0.55 . . . . 0.0 110.84 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -64.57 -29.96 70.99 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.195 -0.941 . . . . 0.0 111.014 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -68.99 -22.37 64.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.963 0.905 . . . . 0.0 112.06 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.03 -30.44 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.214 0.915 . . . . 0.0 109.113 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.29 14.48 11.71 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.462 1.505 . . . . 0.0 111.471 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.87 97.25 5.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.15 85.44 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.294 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.55 4.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.277 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -56.48 -26.16 53.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.891 1.678 . . . . 0.0 112.132 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -72.93 -22.07 60.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.055 1.342 . . . . 0.0 113.013 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -71.25 167.5 19.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.73 0.812 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.49 156.45 43.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.41 1.484 . . . . 0.0 108.419 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 m -102.7 153.92 19.66 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.161 0.585 . . . . 0.0 111.599 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -154.48 154.86 33.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.718 1.607 . . . . 0.0 109.056 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 pt -84.83 163.28 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.94 134.1 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.397 1.079 . . . . 0.0 110.927 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -119.88 110.18 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.427 1.491 . . . . 0.0 107.451 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 m -54.7 -24.77 23.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.152 1.381 . . . . 0.0 112.676 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.28 -45.48 63.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.07 0.85 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.06 -42.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.55 -50.21 43.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.931 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -75.89 -12.01 60.07 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -92.57 -19.89 21.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.386 0.994 . . . . 0.0 110.783 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.15 140.45 57.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.083 0.401 . . . . 0.0 110.291 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.19 -33.47 75.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.3 tp -145.44 143.88 30.3 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.238 1.415 . . . . 0.0 109.918 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.36 136.99 55.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.24 108.48 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.2 p -88.33 95.67 10.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.75 -13.48 55.14 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 50.2 t -141.99 139.67 32.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.02 -36.64 90.96 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.493 0.568 . . . . 0.0 112.59 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.72 -27.24 68.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.193 0.997 . . . . 0.0 111.659 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -24.83 61.12 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.328 0.651 . . . . 0.0 111.651 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.31 -14.91 62.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.88 -33.6 75.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.179 0.592 . . . . 0.0 111.677 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -87.59 75.46 9.07 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.471 0.709 . . . . 0.0 109.394 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.2 m -135.99 80.95 40.66 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.13 88.31 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.519 3.48 . . . . 0.0 110.882 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . 0.263 24.1 ptt? 51.57 130.62 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 131.16 3.784 . . . . 0.0 114.643 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p -137.76 84.59 21.81 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -53.87 171.85 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.67 3.58 . . . . 0.0 113.203 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.56 -27.86 26.79 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.722 2.948 . . . . 0.0 115.199 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.44 -14.13 55.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 112.853 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.28 82.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.529 2.332 . . . . 0.0 106.423 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.6 pttt -67.08 164.35 18.08 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -129.75 155.74 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.742 -0.599 . . . . 0.0 109.718 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.15 154.56 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -140.12 143.28 36.15 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.9 0.48 . . . . 0.0 111.139 -168.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -140.08 -169.88 2.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.286 1.434 . . . . 0.0 109.19 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.02 42.77 1.28 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.018 0.818 . . . . 0.0 112.992 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -77.33 101.05 6.13 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 111.455 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -60.89 158.27 13.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.372 1.069 . . . . 0.0 110.124 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.07 124.21 86.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.368 -169.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.98 -44.44 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.858 2.372 . . . . 0.0 111.84 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.59 69.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.423 0.689 . . . . 0.0 111.024 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.37 12.16 31.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.039 1.335 . . . . 0.0 111.21 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.52 72.08 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.597 0.635 . . . . 0.0 112.692 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 55.86 -176.98 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.865 2.066 . . . . 0.0 113.281 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -65.84 0.49 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 126.179 1.847 . . . . 0.0 108.784 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 t -160.92 159.88 30.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.98 -39.76 75.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.014 0.825 . . . . 0.0 111.333 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.1 -28.98 66.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.358 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.36 -41.45 69.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.732 0.697 . . . . 0.0 109.32 174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -59.41 -53.73 54.85 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -57.65 -42.1 82.8 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.528 0.517 . . . . 0.0 110.022 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.2 87.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.157 0.435 . . . . 0.0 110.295 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.91 -38.74 92.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.626 0.77 . . . . 0.0 111.144 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -58.91 -47.38 85.21 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.292 0.951 . . . . 0.0 108.721 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -61.44 -42.89 99.46 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.149 0.58 . . . . 0.0 111.149 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.47 -50.55 64.93 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.305 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.01 -44.37 99.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.191 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -44.53 97.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 121.149 1.795 . . . . 0.0 110.628 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.67 -43.02 99.65 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.84 -29.35 44.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.806 -1.093 . . . . 0.0 112.222 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.05 -44.54 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.4 -46.71 93.83 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.71 -42.18 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.848 0.824 . . . . 0.0 110.429 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -46.05 91.8 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.2 mt -72.71 -34.38 67.08 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 110.149 -175.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.65 -51.6 69.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 110.752 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.42 -49.25 76.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.982 0.81 . . . . 0.0 109.296 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.37 -39.93 67.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.686 0.675 . . . . 0.0 111.082 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.2 -46.94 54.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.745 0.818 . . . . 0.0 111.854 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.79 -38.45 67.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.606 1.163 . . . . 0.0 111.182 -173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.2 p -89.3 -22.41 22.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 110.114 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.26 44.45 97.46 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.105 1.362 . . . . 0.0 111.301 -175.488 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.4 mtmt -136.67 166.3 23.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.73 171.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.76 132.08 67.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 172.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -122.73 133.98 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -129.6 106.34 8.67 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.81 0.844 . . . . 0.0 109.155 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -75.42 146.91 40.38 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.057 -0.402 . . . . 0.0 110.084 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.95 127.51 15.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -149.44 172.84 14.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.995 0.518 . . . . 0.0 110.237 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -66.83 -10.37 47.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.885 -1.134 . . . . 0.0 113.314 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.43 118.77 0.85 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.926 -2.87 . . . . 0.0 105.926 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 56.2 t-20 -56.22 -47.48 78.35 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.611 0.764 . . . . 0.0 110.347 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -45.1 -24.61 0.26 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.679 3.192 . . . . 0.0 116.397 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 m -112.67 -88.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -60.71 -43.59 97.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.908 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -70.62 -40.56 73.07 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.914 1.234 . . . . 0.0 111.238 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.89 -44.52 96.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.079 0.854 . . . . 0.0 111.007 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.6 mtp -65.44 -45.51 83.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.78 89.41 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.316 0.647 . . . . 0.0 111.092 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -57.17 -45.46 83.62 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.79 -55.11 27.16 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.15 -0.806 . . . . 0.0 113.106 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -68.74 -36.76 78.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.911 1.856 . . . . 0.0 111.144 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.53 76.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.258 -0.902 . . . . 0.0 111.253 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.64 -35.29 70.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.623 0.647 . . . . 0.0 111.904 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.16 -49.93 25.44 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.481 0.712 . . . . 0.0 109.273 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -76.61 -31.51 57.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.22 -36.89 8.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 -171.26 49.35 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 122.116 0.842 . . . . 0.0 113.856 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.69 -14.32 57.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.746 2.019 . . . . 0.0 114.098 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.09 -10.15 2.49 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.774 1.629 . . . . 0.0 111.839 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 2.8 m95 -141.58 157.79 44.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.757 1.223 . . . . 0.0 110.261 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -109.95 139.13 45.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 167.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.02 124.94 67.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -169.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.94 170.51 15.88 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -138.65 142.2 39.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 108.507 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.92 -176.65 4.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.721 1.608 . . . . 0.0 108.466 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.16 173.69 40.19 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -41.42 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.51 179.85 6.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.814 0.846 . . . . 0.0 109.388 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.47 120.95 12.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -73.09 -38.69 66.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.642 0.777 . . . . 0.0 109.364 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.82 -167.47 35.9 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 127.961 2.696 . . . . 0.0 107.798 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.43 100.14 9.12 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -62.59 121.32 66.73 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.539 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.86 -32.82 48.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.032 2.488 . . . . 0.0 113.228 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.98 89.35 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.73 0.695 . . . . 0.0 111.035 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.47 71.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.81 -54.36 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.1 -43.12 93.08 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.127 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.68 -50.11 63.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.661 0.664 . . . . 0.0 110.431 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.4 mmm -75.42 -35.94 60.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.799 0.272 . . . . 0.0 111.578 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.68 -32.94 73.15 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -67.36 -19.85 65.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.872 0.869 . . . . 0.0 112.443 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.74 -10.68 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.504 1.047 . . . . 0.0 110.132 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.28 25.37 44.03 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.035 -1.041 . . . . 0.0 110.666 -169.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.69 89.49 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -78.6 81.44 4.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.288 -171.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.41 6.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.57 -0.728 . . . . 0.0 112.197 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 m -55.0 -27.04 41.14 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.228 1.376 . . . . 0.0 112.09 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.02 -20.72 60.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.939 1.296 . . . . 0.0 112.95 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.45 171.45 10.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.737 0.779 . . . . 0.0 109.994 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -143.65 152.41 41.32 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.539 1.536 . . . . 0.0 107.325 172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -96.12 152.51 18.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.545 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -152.06 160.51 43.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.608 1.963 . . . . 0.0 108.274 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 pt -93.96 160.5 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.64 116.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.724 0.773 . . . . 0.0 112.955 -169.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.51 113.27 25.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 m -61.43 -24.22 66.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.576 1.15 . . . . 0.0 112.56 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.15 -39.31 82.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.013 0.824 . . . . 0.0 111.222 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.0 mt -66.29 -48.19 81.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.52 -48.71 68.78 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 109.954 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.84 -2.89 8.08 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -132.96 1.43 3.57 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.535 1.516 . . . . 0.0 114.199 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.15 47.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.209 0.913 . . . . 0.0 109.599 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.27 -34.75 78.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.2 tp -147.36 144.2 28.55 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.969 1.308 . . . . 0.0 110.596 -171.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.77 136.51 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 109.82 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.4 p -88.88 101.09 13.7 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.84 -10.48 59.85 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.14 158.96 43.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.103 0.865 . . . . 0.0 109.005 169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.4 -42.67 93.73 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.104 -169.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.36 -32.39 74.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.844 0.822 . . . . 0.0 111.364 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.96 69.41 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.749 0.419 . . . . 0.0 112.053 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.41 -33.85 73.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.898 0.772 . . . . 0.0 111.599 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -89.16 59.65 5.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.404 1.082 . . . . 0.0 110.069 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.9 83.82 30.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.8 70.64 2.78 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.451 3.434 . . . . 0.0 112.134 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.6 mtt 78.55 100.18 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 129.294 3.038 . . . . 0.0 112.001 172.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -105.53 84.34 1.15 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.83 172.69 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.297 2.665 . . . . 0.0 110.775 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -49.49 -27.97 15.26 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.805 3.003 . . . . 0.0 116.365 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -68.44 -8.56 41.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.112 0.965 . . . . 0.0 113.042 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.54 86.96 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 128.421 2.688 . . . . 0.0 105.304 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -66.93 164.94 16.48 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -143.07 145.88 33.29 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.349 -0.845 . . . . 0.0 109.234 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -132.8 157.1 45.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.418 1.487 . . . . 0.0 107.576 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -141.29 138.51 33.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.843 . . . . 0.0 110.747 -168.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.52 -171.85 2.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.813 1.645 . . . . 0.0 108.43 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.63 77.68 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 O-C-N 121.174 -0.953 . . . . 0.0 113.214 -169.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.14 151.14 45.05 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.088 0.944 . . . . 0.0 111.372 170.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.51 160.32 32.65 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.444 1.898 . . . . 0.0 113.265 -169.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.85 129.36 71.0 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.096 0.959 . . . . 0.0 111.712 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.55 -30.19 4.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.188 1.925 . . . . 0.0 114.009 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.29 -13.23 57.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.27 9.65 10.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.758 1.223 . . . . 0.0 111.435 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.11 141.9 52.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.39 162.14 37.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.97 0.908 . . . . 0.0 109.708 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.54 -50.07 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.88 165.37 22.86 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.557 2.343 . . . . 0.0 105.272 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.97 -40.01 83.46 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.51 -0.744 . . . . 0.0 110.641 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.97 -29.06 66.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.411 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.06 -44.5 60.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.826 0.739 . . . . 0.0 109.128 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -56.43 -51.04 69.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.778 0.831 . . . . 0.0 109.825 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -62.85 -42.53 99.78 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.625 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.36 78.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.914 0.779 . . . . 0.0 110.142 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.37 -38.34 90.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.043 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.21 -50.9 68.22 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -60.39 -43.7 96.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.02 0.528 . . . . 0.0 111.516 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -60.52 -50.01 75.27 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.281 0.491 . . . . 0.0 110.305 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.82 -39.41 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.669 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -56.65 -51.97 66.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.696 1.134 . . . . 0.0 109.602 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.29 -41.33 96.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.456 0.702 . . . . 0.0 110.005 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.84 -26.85 44.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.618 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -45.96 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.46 -44.15 93.62 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -60.4 -39.65 88.12 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.205 1.402 . . . . 0.0 111.179 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.53 79.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.69 -32.69 64.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.518 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -51.42 69.81 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.226 1.011 . . . . 0.0 110.56 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.64 -47.18 82.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.557 1.071 . . . . 0.0 109.582 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.08 -39.03 71.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.403 0.547 . . . . 0.0 111.071 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.45 33.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.706 0.803 . . . . 0.0 111.624 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.76 -38.78 76.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.62 1.168 . . . . 0.0 111.183 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 31.4 p -89.14 -17.87 28.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.28 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.11 40.89 94.24 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -172.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.615 1.166 . . . . 0.0 111.702 -169.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.7 mtmt -134.41 165.74 24.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.031 1.333 . . . . 0.0 108.332 169.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.74 134.31 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.3 135.06 63.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -131.77 104.4 6.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.562 0.745 . . . . 0.0 109.53 -169.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.67 142.53 38.77 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.07 1.348 . . . . 0.0 110.141 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? -143.92 129.49 19.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.51 175.12 11.09 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.318 0.508 . . . . 0.0 110.774 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -6.64 21.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.64 133.7 3.09 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.98 33.12 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.064 0.932 . . . . 0.0 112.23 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 m -116.21 -1.94 12.28 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.796 1.239 . . . . 0.0 110.97 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -150.27 -94.61 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.968 0.804 . . . . 0.0 111.988 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -58.08 -46.41 85.49 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.883 1.273 . . . . 0.0 112.16 -169.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.8 p -72.38 -28.08 62.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.95 0.796 . . . . 0.0 112.055 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -68.92 -42.26 77.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.882 0.764 . . . . 0.0 110.249 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.45 -46.4 80.02 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.35 81.29 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.164 0.586 . . . . 0.0 111.104 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -57.81 -47.97 81.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.334 1.054 . . . . 0.0 109.546 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.66 -50.96 60.89 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.745 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.1 m95 -64.83 -38.3 90.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.844 1.822 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.15 79.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.642 -0.661 . . . . 0.0 111.567 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.73 -27.01 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.398 0.999 . . . . 0.0 112.475 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -46.58 13.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.452 0.701 . . . . 0.0 109.586 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -78.89 -27.2 43.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.62 -140.23 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.887 1.275 . . . . 0.0 108.101 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.16 -175.79 47.8 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.85 -12.37 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -58.14 -10.99 2.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.754 2.022 . . . . 0.0 111.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.44 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 10.2 m95 -134.98 166.36 23.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.131 1.772 . . . . 0.0 108.913 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -124.59 135.68 53.32 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 167.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 118.39 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -168.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 173.25 11.91 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.48 1.112 . . . . 0.0 109.346 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 56.8 p -136.03 159.82 40.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.225 1.01 . . . . 0.0 110.163 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.03 -169.4 3.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.755 1.622 . . . . 0.0 107.199 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.59 173.49 42.64 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.333 -0.854 . . . . 0.0 111.221 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.97 -39.23 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.555 1.142 . . . . 0.0 108.905 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.12 -178.74 6.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 108.51 170.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.11 43.55 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.545 1.538 . . . . 0.0 108.384 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -144.76 -39.22 0.27 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.063 0.945 . . . . 0.0 110.123 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.6 140.74 2.97 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.78 114.74 2.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.821 1.31 . . . . 0.0 108.062 169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.47 157.35 80.32 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.312 -169.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.7 -36.58 73.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.703 2.935 . . . . 0.0 113.866 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -36.86 85.28 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.168 0.895 . . . . 0.0 111.325 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.98 67.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.33 -52.52 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.15 -42.1 96.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.89 0.768 . . . . 0.0 110.587 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.55 -45.62 84.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.499 0.59 . . . . 0.0 110.792 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 93.3 mmm -75.94 -37.98 58.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.503 0.138 . . . . 0.0 111.112 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -61.95 -36.42 81.37 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.88 -22.32 63.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.835 0.854 . . . . 0.0 112.509 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -77.79 -26.06 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.365 0.984 . . . . 0.0 109.601 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.97 23.62 6.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.116 1.341 . . . . 0.0 111.489 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.5 mt -124.71 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 -171.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -79.85 75.69 6.55 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.276 0.63 . . . . 0.0 110.866 -170.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -70.98 0.24 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.927 -1.035 . . . . 0.0 112.071 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -51.87 -28.03 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.208 1.367 . . . . 0.0 111.78 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.18 -20.23 64.84 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.519 1.528 . . . . 0.0 113.6 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -77.45 169.29 18.57 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.059 . . . . 0.0 109.698 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 p -143.82 167.46 22.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.584 1.953 . . . . 0.0 107.876 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.6 p -118.97 151.64 37.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.358 0.663 . . . . 0.0 111.257 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.35 154.88 35.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.724 1.61 . . . . 0.0 109.028 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.96 165.85 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 tt -57.12 106.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.186 0.994 . . . . 0.0 111.816 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -89.11 102.22 14.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -16.37 49.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.138 0.975 . . . . 0.0 112.222 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.91 -37.25 62.13 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.999 1.272 . . . . 0.0 111.871 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.07 -48.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.1 -47.46 65.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.686 0.795 . . . . 0.0 110.52 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -67.45 -8.26 31.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -128.75 3.39 5.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.274 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.33 148.1 51.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.45 -32.9 72.12 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.5 tp -147.41 144.35 28.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.225 1.41 . . . . 0.0 110.428 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.49 139.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 m -128.45 129.25 68.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -88.65 138.24 31.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.5 mt -110.62 0.7 17.65 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 112.511 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -152.19 161.79 42.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.595 1.089 . . . . 0.0 109.22 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.46 -51.43 57.81 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 123.897 0.761 . . . . 0.0 112.017 -171.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.09 -31.45 70.18 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.15 -30.01 70.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.478 0.581 . . . . 0.0 112.425 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.26 67.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.88 -38.08 89.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.045 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.59 -42.85 24.09 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.056 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.8 t -47.72 106.52 0.61 Allowed Pre-proline 0 CA--C 1.547 0.861 0 O-C-N 124.76 1.288 . . . . 0.0 110.275 -169.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.45 174.68 7.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.682 3.588 . . . . 0.0 111.461 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 99.0 mmm -58.63 135.7 57.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.152 0.581 . . . . 0.0 111.041 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 p -120.53 105.22 41.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.945 1.698 . . . . 0.0 106.675 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.27 168.88 18.13 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.813 2.342 . . . . 0.0 110.693 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.32 -24.48 15.9 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.009 3.139 . . . . 0.0 116.288 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.29 -10.34 31.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.033 0.933 . . . . 0.0 112.847 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 93.92 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 128.007 2.523 . . . . 0.0 105.621 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -70.64 164.31 25.22 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.17 144.2 31.45 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.626 0.771 . . . . 0.0 109.062 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.12 164.66 29.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -144.55 113.0 6.57 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.772 0.829 . . . . 0.0 109.283 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -115.55 169.18 9.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.662 1.585 . . . . 0.0 107.851 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.9 107.94 0.63 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.784 -169.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.87 118.86 17.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.953 0.901 . . . . 0.0 111.765 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -66.52 153.41 43.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.4 1.08 . . . . 0.0 109.542 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.64 121.36 82.19 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.522 -172.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.03 -32.92 8.14 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.837 1.691 . . . . 0.0 112.588 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 -19.93 65.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.029 0.831 . . . . 0.0 112.189 -172.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.26 -2.03 43.53 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.712 1.205 . . . . 0.0 111.811 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 142.71 45.36 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -156.51 164.69 37.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.777 0.431 . . . . 0.0 110.94 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -47.91 0.69 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -165.24 166.01 19.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.245 2.218 . . . . 0.0 105.391 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.92 -40.51 80.56 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.546 -0.721 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.09 -27.42 64.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.188 -0.434 . . . . 0.0 111.473 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.76 -44.59 55.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 109.192 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -56.63 -49.88 73.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.457 0.703 . . . . 0.0 109.892 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -64.64 -39.36 93.56 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.097 -0.377 . . . . 0.0 111.089 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.61 74.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 110.655 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -68.41 -40.56 81.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.244 0.474 . . . . 0.0 110.503 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -58.36 -39.79 80.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.712 0.687 . . . . 0.0 109.841 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -63.11 -49.71 73.34 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.576 0.625 . . . . 0.0 110.208 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -59.77 -49.96 75.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.118 0.417 . . . . 0.0 110.37 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.54 -46.24 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.099 -1.429 . . . . 0.0 110.039 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -62.54 -42.17 99.36 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 121.683 2.038 . . . . 0.0 110.916 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.87 -44.66 96.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.45 -36.04 65.82 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.065 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -63.75 -40.55 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.528 1.513 . . . . 0.0 108.984 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.64 -44.34 97.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.95 -37.1 85.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.53 1.132 . . . . 0.0 112.036 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -56.27 -52.05 65.91 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 -35.77 77.38 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 119.024 -0.513 . . . . 0.0 111.918 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -49.33 77.89 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.589 0.755 . . . . 0.0 110.477 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -61.08 -50.78 71.9 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -54.87 -41.45 70.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.222 0.609 . . . . 0.0 111.321 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.33 -47.48 56.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.007 0.923 . . . . 0.0 111.505 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -73.24 -38.34 66.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.143 0.977 . . . . 0.0 111.642 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.1 p -92.23 -21.57 20.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.381 1.073 . . . . 0.0 110.6 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.06 42.46 99.73 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.438 1.495 . . . . 0.0 111.153 -175.315 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.2 mtmt -138.12 171.47 14.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.577 1.551 . . . . 0.0 108.464 169.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.7 131.28 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.83 133.67 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.52 107.11 9.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.84 143.74 37.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.689 1.196 . . . . 0.0 110.497 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.28 127.87 17.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 108.821 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.81 169.67 16.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.848 1.259 . . . . 0.0 111.256 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -67.22 -16.42 64.29 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.133 -0.979 . . . . 0.0 113.276 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.83 112.86 0.54 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.07 -35.81 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.643 1.177 . . . . 0.0 112.337 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -41.13 -19.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.266 3.026 . . . . 0.0 118.496 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -141.59 -54.74 0.46 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.708 1.595 . . . . 0.0 113.804 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -56.59 -53.72 54.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.342 0.974 . . . . 0.0 113.456 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -36.65 78.85 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.058 0.845 . . . . 0.0 110.257 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -58.07 -43.28 86.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.785 0.721 . . . . 0.0 111.597 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -66.2 -48.06 71.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.803 0.841 . . . . 0.0 109.415 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.24 74.2 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.192 0.597 . . . . 0.0 110.769 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.04 -45.34 93.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.47 0.708 . . . . 0.0 110.289 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.93 92.82 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.223 -0.765 . . . . 0.0 112.377 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.6 m95 -66.72 -43.81 83.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.914 1.357 . . . . 0.0 110.572 176.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.81 78.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.205 0.457 . . . . 0.0 110.84 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.56 -33.35 68.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.689 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.79 -57.98 4.84 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.809 0.732 . . . . 0.0 110.023 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -69.19 -33.38 73.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.9 mt -100.09 -37.85 8.79 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.05 -173.32 48.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.074 0.845 . . . . 0.0 113.4 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.18 -14.91 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.499 1.92 . . . . 0.0 113.753 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -57.23 -11.11 1.52 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.595 1.958 . . . . 0.0 111.794 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.8 m95 -142.24 147.47 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.255 1.022 . . . . 0.0 110.922 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -92.46 140.36 29.65 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.03 125.32 64.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.73 160.41 34.39 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.827 0.851 . . . . 0.0 111.38 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -136.46 128.6 29.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.808 1.643 . . . . 0.0 108.674 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 -168.85 3.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.9 176.83 42.97 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.61 -42.79 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.807 1.243 . . . . 0.0 107.908 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -143.45 177.15 8.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.254 0.622 . . . . 0.0 110.276 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.8 43.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.574 2.35 . . . . 0.0 107.219 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -134.77 -36.33 0.85 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.286 1.035 . . . . 0.0 110.077 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.47 179.31 44.99 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.02 102.82 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -67.74 134.09 92.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.135 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.09 -33.11 72.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.199 2.6 . . . . 0.0 113.738 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -36.6 78.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.732 0.696 . . . . 0.0 111.28 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.12 71.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.17 -54.06 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.48 -43.27 90.74 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.476 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.4 82.9 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.837 0.744 . . . . 0.0 111.345 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.3 mmm -77.6 -40.35 42.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.172 0.442 . . . . 0.0 111.359 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -63.36 -31.75 72.99 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.422 -0.799 . . . . 0.0 110.707 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.15 -21.7 64.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.424 1.089 . . . . 0.0 112.604 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -77.52 -22.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.558 1.072 . . . . 0.0 109.55 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.39 14.78 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.741 1.162 . . . . 0.0 110.774 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.36 99.64 8.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.44 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.15 4.44 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 110.705 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -27.28 63.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.141 1.337 . . . . 0.0 111.017 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -67.15 -16.62 64.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.915 2.086 . . . . 0.0 113.614 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.87 172.57 13.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.504 1.122 . . . . 0.0 109.213 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -150.14 160.19 43.85 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.256 1.422 . . . . 0.0 108.411 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.4 m -101.08 153.63 19.4 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.13 155.49 31.1 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.809 2.044 . . . . 0.0 108.335 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.38 159.89 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.41 141.35 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.141 0.976 . . . . 0.0 112.372 -169.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -119.45 111.55 18.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.738 1.615 . . . . 0.0 107.668 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -70.75 -21.75 62.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.58 -46.39 59.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.337 0.971 . . . . 0.0 110.106 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.81 -39.52 85.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.16 -47.88 71.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.929 0.786 . . . . 0.0 110.085 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -73.67 -7.12 50.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -98.59 -21.42 16.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 111.186 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.79 142.45 58.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.193 0.451 . . . . 0.0 110.054 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.84 -32.68 73.37 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.619 -0.676 . . . . 0.0 109.295 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.7 tp -144.99 145.12 31.38 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.002 1.321 . . . . 0.0 109.625 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.19 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.78 127.79 66.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 169.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 86' ' ' ALA . 2.4 p -94.23 96.85 9.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.59 -9.39 26.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.346 1.458 . . . . 0.0 114.356 -168.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 t -149.72 160.35 43.6 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 121.124 1.784 . . . . 0.0 110.352 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -44.79 -66.51 1.42 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 127.164 2.316 . . . . 0.0 113.217 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.11 -22.65 62.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.02 69.87 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.875 -0.516 . . . . 0.0 111.336 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -63.91 -17.46 63.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.94 -31.27 71.58 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.195 0.907 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -91.69 74.05 5.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.793 0.837 . . . . 0.0 109.175 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 p -123.16 74.25 49.45 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 0.0 109.391 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.59 74.07 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.608 3.538 . . . . 0.0 111.615 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.5 mmt 66.23 129.31 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.274 3.03 . . . . 0.0 112.412 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 p -141.44 81.58 15.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.94 171.69 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.7 3.6 . . . . 0.0 113.635 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.9 -29.84 28.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.47 2.78 . . . . 0.0 114.806 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.34 -4.83 28.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 113.171 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.74 78.38 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.55 2.34 . . . . 0.0 105.4 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -68.18 167.81 13.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -135.37 156.22 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.583 0.753 . . . . 0.0 111.879 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.79 162.7 38.7 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 169.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -153.21 119.34 5.46 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.087 -1.008 . . . . 0.0 110.337 -169.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -115.77 -174.82 2.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 0.0 110.06 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.87 44.26 1.19 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.365 0.983 . . . . 0.0 113.627 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -80.76 104.63 11.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.026 0.93 . . . . 0.0 111.342 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.87 152.31 36.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.808 0.843 . . . . 0.0 110.086 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.36 120.73 83.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.71 -33.66 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 112.784 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.15 65.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.996 0.817 . . . . 0.0 112.069 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.37 9.02 35.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.976 1.31 . . . . 0.0 111.633 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.88 22.35 0.05 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.313 1.445 . . . . 0.0 114.221 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.1 152.53 7.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.35 1.86 . . . . 0.0 111.825 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.89 -51.29 0.2 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -154.16 154.84 34.24 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.01 -38.29 85.53 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.505 -0.747 . . . . 0.0 110.742 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.53 -30.98 71.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.362 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -72.55 -48.34 40.95 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -53.48 -52.45 59.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 109.84 176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -64.22 -42.56 96.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.825 0.85 . . . . 0.0 111.168 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.78 72.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.992 0.815 . . . . 0.0 110.307 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -66.29 -38.19 87.18 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.564 -0.71 . . . . 0.0 111.152 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -57.45 -45.92 84.19 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.172 0.896 . . . . 0.0 108.996 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -60.1 -49.4 77.81 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.624 0.77 . . . . 0.0 110.993 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -58.68 -49.67 76.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.97 -47.65 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.328 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -64.01 -41.86 97.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 121.259 1.845 . . . . 0.0 110.673 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.32 -42.89 99.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.922 0.328 . . . . 0.0 110.259 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -75.75 -36.14 59.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.108 -0.949 . . . . 0.0 112.31 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -61.66 -46.25 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.72 92.38 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -54.82 -46.99 74.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.671 1.188 . . . . 0.0 111.879 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -39.82 88.0 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.98 -0.45 . . . . 0.0 109.904 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.74 -35.32 72.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.243 0.617 . . . . 0.0 110.99 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -60.04 -49.64 76.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.817 0.847 . . . . 0.0 110.271 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.6 -46.62 81.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.03 0.832 . . . . 0.0 109.71 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -54.3 -40.63 68.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.85 0.75 . . . . 0.0 110.916 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.77 37.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -71.82 -36.08 70.13 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.335 1.054 . . . . 0.0 111.566 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.3 p -90.28 -16.94 28.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 110.27 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.37 41.11 92.97 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.799 1.24 . . . . 0.0 111.842 -170.631 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -130.92 161.5 31.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.723 1.609 . . . . 0.0 107.107 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -136.64 130.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.82 127.03 74.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -124.8 100.11 6.46 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -169.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -73.09 147.88 44.54 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.3 143.46 37.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.313 1.845 . . . . 0.0 106.724 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.83 173.18 16.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 p -67.25 -11.52 57.7 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.326 -0.859 . . . . 0.0 113.164 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.23 116.61 0.73 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -55.36 -39.24 69.84 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.269 1.027 . . . . 0.0 111.756 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.48 -34.88 0.24 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.107 3.363 . . . . 0.0 115.777 -169.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 m -120.41 -73.92 0.63 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.069 0.547 . . . . 0.0 110.347 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -62.16 -48.52 79.73 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.211 0.604 . . . . 0.0 110.985 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -70.59 -37.17 73.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.316 -0.374 . . . . 0.0 110.741 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.38 -44.64 95.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.927 0.491 . . . . 0.0 111.127 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.3 mtm -67.0 -45.66 76.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.525 0.602 . . . . 0.0 110.287 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.71 81.47 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.748 0.704 . . . . 0.0 111.14 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -57.33 -47.04 82.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.288 1.035 . . . . 0.0 109.761 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.27 50.67 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.657 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' CD1' HG22 ' A' ' 127' ' ' ILE . 94.4 m95 -67.26 -37.49 83.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.817 1.809 . . . . 0.0 111.029 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.71 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.285 -0.884 . . . . 0.0 111.386 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.94 -24.79 67.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.957 0.799 . . . . 0.0 112.512 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.22 -46.99 12.03 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.892 0.769 . . . . 0.0 109.71 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -75.4 -30.75 60.22 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.7 -143.88 0.29 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.995 1.318 . . . . 0.0 108.091 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.2 -178.57 46.1 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.92 -13.85 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.95 -9.94 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.542 1.937 . . . . 0.0 111.642 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -125.58 161.74 26.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.376 1.87 . . . . 0.0 108.39 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.93 138.29 54.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.86 117.27 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 173.7 11.42 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -142.01 157.28 45.11 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 0.0 109.905 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.07 -163.63 1.75 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.462 1.505 . . . . 0.0 107.896 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.28 175.76 43.5 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.64 -41.8 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.05 176.43 8.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.791 0.836 . . . . 0.0 110.056 170.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.78 6.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.022 1.729 . . . . 0.0 107.139 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -74.48 -36.28 63.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.062 0.545 . . . . 0.0 109.626 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.81 -179.31 30.98 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -74.2 99.43 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -61.84 124.58 82.19 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.264 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.45 -33.51 38.26 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.269 2.646 . . . . 0.0 113.608 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -39.75 91.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.91 0.777 . . . . 0.0 110.916 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.31 75.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.95 -56.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.58 -42.06 99.32 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 119.042 0.837 . . . . 0.0 110.348 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.38 65.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.512 0.325 . . . . 0.0 110.336 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 90.1 mmm -74.44 -36.06 63.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.905 0.321 . . . . 0.0 110.873 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -61.8 -35.78 79.2 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.422 -0.799 . . . . 0.0 110.129 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.29 -24.25 63.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 112.572 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.38 -22.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.314 0.961 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.85 23.93 8.96 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.824 1.202 . . . . 0.0 111.263 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.1 mt -123.57 94.21 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -79.13 80.27 5.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -76.27 5.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.56 -0.712 . . . . 0.0 112.205 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -54.57 -26.46 32.44 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.824 1.193 . . . . 0.0 112.232 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.45 -20.06 57.42 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.99 1.316 . . . . 0.0 113.135 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.59 167.32 17.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 109.3 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -145.34 158.79 43.76 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.428 1.491 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -108.65 147.1 32.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.858 0.863 . . . . 0.0 110.103 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -155.17 159.5 40.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.026 1.331 . . . . 0.0 108.578 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.31 161.18 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.02 131.78 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.766 0.826 . . . . 0.0 111.987 -169.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.25 114.57 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.574 1.55 . . . . 0.0 107.327 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -69.37 -17.95 63.74 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.261 -171.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.06 -41.71 28.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.594 1.088 . . . . 0.0 110.504 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.42 -45.68 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -50.11 -50.85 47.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.03 0.932 . . . . 0.0 110.518 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -70.49 -19.51 62.93 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -89.94 -16.19 30.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.679 1.127 . . . . 0.0 110.976 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.53 34.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.225 0.536 . . . . 0.0 111.45 -169.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.52 -33.16 36.57 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 168.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -148.44 146.68 28.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.134 1.773 . . . . 0.0 110.374 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.43 140.04 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.32 111.67 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.6 p -93.53 108.41 20.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.57 -3.82 23.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.306 -170.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 36.3 t -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 120.881 1.673 . . . . 0.0 108.748 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.87 -35.81 92.49 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 123.674 0.654 . . . . 0.0 112.413 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.27 -25.91 64.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.683 1.242 . . . . 0.0 111.517 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -18.28 58.36 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.182 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.84 67.02 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.851 0.75 . . . . 0.0 112.505 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.24 -32.59 74.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 112.033 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -86.49 57.99 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.85 0.86 . . . . 0.0 110.983 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.7 m -124.01 78.02 58.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.25 -49.93 5.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.299 3.332 . . . . 0.0 114.872 -172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.1 mtp -152.85 137.04 16.49 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.0 1.72 . . . . 0.0 107.289 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.7 p -134.4 71.09 72.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.45 164.78 24.76 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.638 2.892 . . . . 0.0 110.82 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.04 -20.44 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.798 1 C-N-CA 125.458 4.105 . . . . 0.0 119.719 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -60.05 -44.42 94.69 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.625 1.557 . . . . 0.0 109.184 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.09 156.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 127.708 2.403 . . . . 0.0 108.075 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -134.71 167.36 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 169.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -139.2 146.65 40.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.276 0.944 . . . . 0.0 110.084 -169.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -142.61 156.33 45.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.001 1.32 . . . . 0.0 107.867 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.37 140.36 30.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.246 1.019 . . . . 0.0 110.316 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -136.19 -164.7 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.678 1.591 . . . . 0.0 109.562 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.0 40.63 1.17 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.572 1.078 . . . . 0.0 114.342 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.51 116.85 22.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.509 1.155 . . . . 0.0 111.879 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.17 152.68 43.16 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.557 0.743 . . . . 0.0 109.231 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.4 123.95 88.85 Favored Pre-proline 0 C--O 1.236 0.354 0 O-C-N 121.892 -0.505 . . . . 0.0 111.904 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.28 -31.6 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.055 1.837 . . . . 0.0 112.868 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.55 -21.37 65.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.083 0.856 . . . . 0.0 112.306 -174.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -94.56 -4.41 47.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.453 1.101 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.65 57.35 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.071 0.85 . . . . 0.0 109.304 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -144.74 161.42 39.26 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.528 1.131 . . . . 0.0 109.245 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.64 -51.05 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.23 164.01 25.24 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.083 2.153 . . . . 0.0 105.51 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.23 -39.94 84.32 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.546 -0.721 . . . . 0.0 110.598 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.84 -29.21 67.49 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.344 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -74.14 -42.35 60.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.029 0.831 . . . . 0.0 109.507 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.97 -50.46 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.181 0.592 . . . . 0.0 109.773 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -63.15 -39.47 94.75 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.105 0.411 . . . . 0.0 111.036 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.88 74.79 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.38 -0.825 . . . . 0.0 110.661 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.89 -41.43 91.52 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.07 -1.019 . . . . 0.0 110.324 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -57.08 -41.78 79.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -63.82 -49.77 71.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 111.385 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.68 -51.54 68.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.433 0.561 . . . . 0.0 109.928 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.61 -37.9 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.459 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -53.06 -57.54 10.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.546 1.521 . . . . 0.0 110.638 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.34 -42.02 94.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.171 0.919 . . . . 0.0 109.821 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.75 -26.16 37.5 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.578 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -66.96 -46.22 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.445 1.475 . . . . 0.0 107.043 169.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.71 96.66 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -58.12 -41.88 84.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.937 1.295 . . . . 0.0 111.37 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -49.1 77.83 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.43 -31.13 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.017 0.527 . . . . 0.0 110.56 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -52.4 65.33 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.182 0.993 . . . . 0.0 110.229 169.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.56 -47.29 84.49 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.394 0.997 . . . . 0.0 109.021 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.74 -37.95 66.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.968 0.507 . . . . 0.0 111.187 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.75 -47.15 32.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 122.963 0.505 . . . . 0.0 111.33 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.01 -41.51 74.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.923 0.889 . . . . 0.0 111.205 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.0 p -85.31 -17.64 36.27 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.954 0.902 . . . . 0.0 110.075 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.56 40.96 93.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 124.895 1.236 . . . . 0.0 110.539 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.049 -0.976 . . . . 0.0 111.524 -172.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -123.48 165.45 17.08 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.472 1.509 . . . . 0.0 109.439 -174.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.35 138.17 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tt -127.67 136.54 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -129.85 105.86 8.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.92 141.51 42.28 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.864 0.866 . . . . 0.0 110.359 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.41 136.86 41.73 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.553 1.141 . . . . 0.0 108.499 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -156.16 171.65 19.8 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.02 0.827 . . . . 0.0 110.885 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.0 p -66.94 -11.67 57.22 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.861 -1.149 . . . . 0.0 113.177 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.96 121.92 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -58.17 -44.23 87.87 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 110.597 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -37.57 -29.15 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 C-N-CA 130.655 3.582 . . . . 0.0 117.514 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 m -125.59 -74.69 0.6 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.634 0.774 . . . . 0.0 109.859 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -60.46 -47.9 84.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.924 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -65.95 -46.53 77.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.712 0.687 . . . . 0.0 110.165 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -57.38 -42.68 82.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.953 0.501 . . . . 0.0 112.107 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.0 mtp -65.99 -48.48 71.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.623 0.769 . . . . 0.0 109.623 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.48 79.08 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.341 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.47 -45.13 89.24 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.91 0.884 . . . . 0.0 110.396 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.64 93.46 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.595 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -68.95 -43.65 74.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.312 1.556 . . . . 0.0 111.217 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.49 75.28 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.06 0.391 . . . . 0.0 110.863 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.21 -35.17 69.32 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -68.91 -57.33 5.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.497 0.59 . . . . 0.0 109.984 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.04 -35.93 79.07 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.78 -37.07 10.92 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.41 175.01 49.81 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 122.006 0.781 . . . . 0.0 113.048 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.29 -15.56 63.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.024 1.33 . . . . 0.0 114.181 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.92 -16.36 17.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.934 -0.479 . . . . 0.0 112.251 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -112.71 165.4 12.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.21 1.004 . . . . 0.0 109.068 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.1 145.34 46.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.14 119.7 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.95 169.34 17.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.485 0.659 . . . . 0.0 110.254 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -135.34 140.02 44.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.085 1.354 . . . . 0.0 109.418 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.06 -175.08 4.28 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.793 1.237 . . . . 0.0 108.801 169.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.75 176.03 42.52 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.83 -41.8 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.33 179.79 7.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 109.737 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.05 152.98 40.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.011 2.124 . . . . 0.0 106.393 171.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -129.47 -14.14 4.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.889 0.875 . . . . 0.0 111.619 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.77 -175.92 34.96 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -85.39 106.05 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -62.76 125.8 87.18 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.905 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 -34.37 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.152 2.568 . . . . 0.0 113.659 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -38.46 88.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.859 0.754 . . . . 0.0 110.768 176.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.79 73.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.85 -52.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -65.76 -42.43 90.9 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 118.951 0.796 . . . . 0.0 110.781 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.52 81.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.898 0.772 . . . . 0.0 110.993 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.8 mmm -75.86 -38.82 57.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.403 0.281 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -65.06 -33.97 77.3 Favored 'General case' 0 N--CA 1.461 0.105 0 O-C-N 121.061 -1.025 . . . . 0.0 111.036 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -65.02 -21.16 66.8 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.001 0.92 . . . . 0.0 112.158 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.71 -7.76 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.565 1.146 . . . . 0.0 110.294 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.76 21.16 34.68 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.931 -1.106 . . . . 0.0 111.987 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.21 91.83 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -78.12 85.95 4.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.198 0.523 . . . . 0.0 110.169 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -77.67 2.25 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.27 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -59.75 -23.13 62.97 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.107 1.776 . . . . 0.0 112.08 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -71.44 -18.39 62.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 112.907 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -72.52 173.28 9.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.102 0.961 . . . . 0.0 109.96 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -149.17 163.12 38.52 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.529 1.531 . . . . 0.0 108.606 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.4 m -107.08 155.4 19.88 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.179 0.992 . . . . 0.0 110.279 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.567 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -154.56 162.23 41.24 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.716 2.406 . . . . 0.0 108.411 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 pt -92.64 164.02 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.58 133.61 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 112.04 -169.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -122.42 102.56 8.17 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.011 1.724 . . . . 0.0 106.952 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -15.08 40.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.595 0.758 . . . . 0.0 112.194 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.2 -42.74 88.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.515 1.052 . . . . 0.0 111.249 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.92 -43.05 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tt -53.05 -47.15 68.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.976 0.51 . . . . 0.0 110.576 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -67.92 -18.77 64.87 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -96.53 -16.78 20.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.435 1.016 . . . . 0.0 111.484 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.61 153.91 40.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.406 0.548 . . . . 0.0 110.879 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.94 -38.2 66.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.09 166.48 30.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.243 1.02 . . . . 0.0 112.125 170.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.06 143.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.0 131.06 64.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -84.89 142.67 29.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -107.51 -1.75 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.31 0.644 . . . . 0.0 110.595 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.55 156.5 41.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.9 -38.19 88.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.3 -30.12 69.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.824 0.812 . . . . 0.0 111.933 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.66 78.35 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.146 0.43 . . . . 0.0 111.445 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.51 66.94 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.98 -39.3 93.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 111.783 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -81.96 -40.02 22.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 117.798 -1.096 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.8 m -47.6 108.11 0.84 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.565 1.146 . . . . 0.0 109.27 -173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.1 165.96 22.46 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.451 2.101 . . . . 0.0 113.289 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.9 111.45 2.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.37 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -72.89 122.46 87.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.864 1.266 . . . . 0.0 108.046 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.16 168.66 22.67 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.188 1.926 . . . . 0.0 110.356 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.03 -22.93 15.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.091 3.194 . . . . 0.0 116.017 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -68.08 -6.35 22.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.3 154.58 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.226 2.211 . . . . 0.0 106.62 -169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 173.69 9.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.355 -0.841 . . . . 0.0 110.734 169.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -127.89 155.04 44.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.256 1.422 . . . . 0.0 109.373 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.99 160.22 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -145.82 113.64 6.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -111.94 176.95 4.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.928 1.291 . . . . 0.0 109.314 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.59 94.69 0.21 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.999 -0.89 . . . . 0.0 112.439 -169.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.5 126.74 33.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.655 0.727 . . . . 0.0 111.481 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -74.34 153.23 39.4 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 169.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.93 120.83 83.28 Favored Pre-proline 0 C--O 1.236 0.395 0 O-C-N 121.915 -0.491 . . . . 0.0 111.131 -170.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.43 -32.22 20.38 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.631 1.554 . . . . 0.0 113.063 -169.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.53 -20.79 65.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -118.01 14.69 14.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 111.345 -177.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.98 144.46 45.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -142.66 156.66 45.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.527 0.731 . . . . 0.0 109.272 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.94 -56.52 0.38 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.1 p -146.09 170.14 17.29 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 127.012 2.125 . . . . 0.0 105.499 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.71 -42.38 86.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.659 -0.65 . . . . 0.0 110.994 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.47 -28.84 64.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.126 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.19 -44.35 72.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.111 0.868 . . . . 0.0 109.462 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -55.82 -52.23 64.71 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 109.94 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -59.6 -45.02 93.15 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.953 0.342 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.85 77.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.14 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.46 -37.21 80.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.675 1.125 . . . . 0.0 111.32 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -57.48 -47.94 80.55 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -60.67 -45.48 93.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.176 0.59 . . . . 0.0 111.986 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -60.12 -50.95 71.66 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.702 0.683 . . . . 0.0 109.754 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.09 -42.73 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.626 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -61.7 -43.44 98.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.638 2.017 . . . . 0.0 110.879 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.99 -44.9 95.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.93 -33.74 62.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.184 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.11 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.805 1.639 . . . . 0.0 108.36 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.8 -42.94 99.69 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.462 ' ND2' HH22 ' A' ' 130' ' ' ARG . 56.1 t30 -61.16 -43.13 99.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.258 1.023 . . . . 0.0 111.874 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.462 HH22 ' ND2' ' A' ' 129' ' ' ASN . 13.3 mmp_? -61.83 -41.55 97.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.689 -0.632 . . . . 0.0 110.214 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.0 mt -72.98 -34.74 66.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.672 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -48.56 79.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.179 0.992 . . . . 0.0 109.961 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.15 -50.62 72.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 118.936 0.789 . . . . 0.0 109.7 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.24 -38.9 71.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.493 1.042 . . . . 0.0 111.166 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.39 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.161 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.0 -38.92 31.08 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 110.934 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.5 p -89.61 -24.61 21.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.431 1.092 . . . . 0.0 110.188 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.9 97.86 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.963 -170.51 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.8 mtmt -132.51 171.58 13.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.963 1.705 . . . . 0.0 107.631 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.63 141.71 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -127.58 140.48 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -131.35 100.16 5.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.39 148.95 46.45 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.17 139.46 41.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.759 1.624 . . . . 0.0 107.422 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.22 171.78 18.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.079 0.552 . . . . 0.0 110.338 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -74.7 -5.83 45.39 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.14 95.43 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.0 t-20 -60.16 99.39 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.873 1.269 . . . . 0.0 110.095 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.6 p -160.21 -42.9 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.422 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 p -132.47 -71.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.993 0.917 . . . . 0.0 110.434 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -52.32 -50.59 61.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.349 0.977 . . . . 0.0 111.782 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.9 -42.31 97.48 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.175 0.59 . . . . 0.0 111.221 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -67.99 -39.9 83.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.841 0.857 . . . . 0.0 111.286 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 81.6 mtp -65.09 -48.6 73.11 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.394 1.078 . . . . 0.0 108.695 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.53 81.97 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.911 0.323 . . . . 0.0 110.475 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -56.85 -44.84 82.53 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.99 -47.44 88.74 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.96 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -66.74 -38.01 85.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.956 1.878 . . . . 0.0 110.525 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.09 82.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.291 0.496 . . . . 0.0 110.723 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.28 -26.36 66.43 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.033 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -74.95 -56.85 4.32 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.116 0.871 . . . . 0.0 110.272 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -71.37 -29.57 65.11 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -92.08 -145.08 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.285 1.434 . . . . 0.0 107.905 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.28 -164.77 38.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.33 -19.77 37.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.785 1.634 . . . . 0.0 113.419 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.97 -12.15 4.24 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.17 1.388 . . . . 0.0 111.825 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.405 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 17.3 m95 -142.77 171.54 13.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.923 1.689 . . . . 0.0 110.819 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -129.76 140.92 50.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.645 2.378 . . . . 0.0 104.785 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.71 124.97 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 170.92 15.16 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.7 p -142.61 143.26 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.523 0.729 . . . . 0.0 109.642 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -171.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.702 1.601 . . . . 0.0 109.029 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.52 173.8 40.49 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 121.681 -0.637 . . . . 0.0 111.768 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.88 -41.02 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.103 1.361 . . . . 0.0 108.225 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.77 -176.57 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.324 1.85 . . . . 0.0 106.846 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.9 165.36 25.18 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.189 1.396 . . . . 0.0 109.172 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -129.18 -36.56 1.73 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.351 0.66 . . . . 0.0 110.322 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.65 169.2 12.97 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -58.68 109.91 0.9 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -69.43 125.8 92.21 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.97 -32.78 59.26 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.555 2.17 . . . . 0.0 113.316 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -42.39 98.69 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.84 0.746 . . . . 0.0 110.458 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -39.36 71.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.94 -54.03 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -65.3 -43.29 91.56 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.51 1.05 . . . . 0.0 110.126 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.93 -45.03 67.47 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.43 0.692 . . . . 0.0 111.597 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -80.0 -38.6 31.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.543 0.737 . . . . 0.0 111.354 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.71 -31.01 71.76 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.088 -1.008 . . . . 0.0 110.821 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.89 -20.57 65.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.086 0.954 . . . . 0.0 112.109 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.15 -26.74 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.596 1.089 . . . . 0.0 109.337 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.7 15.86 12.71 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.279 1.419 . . . . 0.0 111.677 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.99 95.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -77.83 88.75 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.31 -0.92 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.247 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -27.38 66.46 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.503 1.501 . . . . 0.0 111.325 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.34 -20.4 63.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.686 1.595 . . . . 0.0 113.007 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -70.58 175.13 5.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.932 0.893 . . . . 0.0 109.853 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -141.06 148.92 40.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.088 1.355 . . . . 0.0 108.751 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -89.07 154.66 20.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 109.689 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.1 t0 -152.65 160.07 43.18 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.545 1.938 . . . . 0.0 107.317 169.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.42 161.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 132.93 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.855 0.862 . . . . 0.0 110.972 -171.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -116.97 109.78 17.45 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.813 1.645 . . . . 0.0 107.121 174.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -59.26 -20.59 55.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.206 1.002 . . . . 0.0 112.398 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.84 -45.94 69.81 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.433 1.015 . . . . 0.0 111.059 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.71 -41.1 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.91 -49.86 58.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.068 0.547 . . . . 0.0 109.868 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -68.64 -14.65 63.15 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -96.14 -20.39 18.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.502 1.046 . . . . 0.0 110.884 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.33 140.42 55.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 118.198 0.454 . . . . 0.0 110.139 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.32 -33.95 76.33 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.632 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 35.6 tp -145.32 142.32 29.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.963 1.305 . . . . 0.0 108.925 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.15 139.8 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.61 110.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -94.06 101.52 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.15 -6.45 23.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.66 159.83 42.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.24 1.382 . . . . 0.0 109.187 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.81 99.7 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.327 -169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.49 -33.53 74.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.017 0.908 . . . . 0.0 111.177 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.49 -21.12 66.6 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.308 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.53 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.849 0.75 . . . . 0.0 112.792 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.23 -30.6 66.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.309 0.504 . . . . 0.0 111.903 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.97 62.49 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 91.7 m -125.5 79.18 67.49 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -50.69 -37.3 53.52 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.588 2.858 . . . . 0.0 114.969 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 36.6 tpp -159.72 128.39 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.2 p -140.56 85.92 12.71 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.62 171.18 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.238 3.292 . . . . 0.0 112.976 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.59 -28.64 29.62 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.577 2.852 . . . . 0.0 114.84 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -70.52 -3.8 19.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.684 1.194 . . . . 0.0 113.143 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.47 79.41 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 105.531 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -68.1 163.04 23.36 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -130.34 153.88 48.24 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.08 -0.388 . . . . 0.0 110.312 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.46 157.29 46.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -143.36 140.08 30.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.665 0.786 . . . . 0.0 109.573 -169.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -137.32 -168.54 2.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.447 1.099 . . . . 0.0 108.959 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.71 39.37 1.41 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.054 -169.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -76.62 111.11 11.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.213 1.006 . . . . 0.0 110.698 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.79 153.63 39.39 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.906 0.882 . . . . 0.0 108.988 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.71 118.97 74.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 119.192 -0.432 . . . . 0.0 112.061 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.29 -31.21 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.227 1.951 . . . . 0.0 112.584 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.6 -21.3 66.13 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.017 0.826 . . . . 0.0 111.959 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -99.38 7.45 45.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.672 1.189 . . . . 0.0 111.56 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.75 15.89 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.761 1.225 . . . . 0.0 114.303 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -51.93 153.73 2.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.18 1.392 . . . . 0.0 112.627 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 -51.94 0.22 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -154.37 153.09 31.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 168.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.36 -38.12 85.81 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 121.403 -0.811 . . . . 0.0 110.781 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.07 -31.45 72.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.23 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.76 -47.66 52.15 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -54.83 -52.54 62.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 110.143 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -63.51 -42.34 98.49 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.55 0.74 . . . . 0.0 111.036 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -35.96 71.23 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.076 0.853 . . . . 0.0 110.607 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.11 -39.15 82.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.22 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.1 -46.46 79.09 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -59.91 -49.89 75.92 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.586 0.754 . . . . 0.0 111.235 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -60.17 -49.51 77.35 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.49 -45.45 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 116.691 -1.623 . . . . 0.0 110.027 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -61.05 -43.84 98.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 122.134 2.243 . . . . 0.0 110.645 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.63 -45.98 91.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.39 -33.65 63.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.21 -44.45 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.544 1.52 . . . . 0.0 108.095 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.02 -44.48 96.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.77 -40.54 96.92 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.393 1.077 . . . . 0.0 112.506 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -56.7 -48.15 78.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.524 0.73 . . . . 0.0 109.305 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.15 -40.61 64.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.98 0.512 . . . . 0.0 109.823 -171.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -56.38 -46.24 80.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.083 0.953 . . . . 0.0 110.943 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.7 -56.04 23.92 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.486 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.31 -28.23 69.57 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.675 1.579 . . . . 0.0 111.372 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.17 63.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.672 0.669 . . . . 0.0 111.633 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -85.78 -31.87 22.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -95.49 -15.24 23.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.742 0.817 . . . . 0.0 111.544 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.26 29.73 74.67 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.405 1.482 . . . . 0.0 110.638 -178.08 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.8 t30 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.467 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.4 mtmt -135.75 169.99 16.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.397 1.479 . . . . 0.0 108.608 170.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.99 130.61 48.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.37 132.08 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.6 107.1 9.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.452 0.701 . . . . 0.0 109.32 -169.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -77.16 142.21 39.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.23 135.01 35.15 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.229 1.812 . . . . 0.0 107.14 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.88 168.57 26.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.478 0.581 . . . . 0.0 110.436 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -68.03 -11.4 58.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.037 -1.039 . . . . 0.0 113.29 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 115.09 0.64 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 105.928 -2.869 . . . . 0.0 105.928 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.21 -40.48 90.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 0.0 111.831 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -38.13 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.534 3.134 . . . . 0.0 117.451 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.25 -62.64 0.79 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.341 0.973 . . . . 0.0 111.983 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -54.69 -51.7 64.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.234 0.925 . . . . 0.0 112.269 -169.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -63.24 -48.05 79.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.499 0.59 . . . . 0.0 110.475 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -60.06 -39.63 86.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.593 0.757 . . . . 0.0 112.033 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.81 -48.43 68.96 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.962 0.905 . . . . 0.0 109.562 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.15 81.55 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.134 0.425 . . . . 0.0 111.176 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.38 -48.41 80.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.0 0.92 . . . . 0.0 110.437 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.11 94.24 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.73 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -67.92 -40.87 83.33 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.879 1.839 . . . . 0.0 110.551 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.91 79.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.524 0.602 . . . . 0.0 111.549 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.8 -32.75 67.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.725 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.6 -58.24 4.18 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.546 0.612 . . . . 0.0 110.096 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -71.41 -33.84 69.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 32.8 mt -95.82 -37.12 10.88 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.261 0.624 . . . . 0.0 112.679 -169.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.26 -176.34 44.61 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.001 0.81 . . . . 0.0 112.789 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 -8.96 34.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.004 1.322 . . . . 0.0 113.672 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.28 -11.26 2.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.368 1.867 . . . . 0.0 111.18 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.467 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.7 m95 -139.82 150.27 44.48 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.792 1.237 . . . . 0.0 109.642 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 5.3 mmpt? -98.43 139.42 34.21 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 167.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.83 117.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -168.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.47 170.31 16.26 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.378 0.609 . . . . 0.0 110.187 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.8 m -135.81 144.94 45.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.24 1.416 . . . . 0.0 109.441 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.91 -173.61 4.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.01 175.62 44.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.56 -40.17 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.43 175.58 10.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.287 0.635 . . . . 0.0 110.876 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.37 156.86 44.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.244 2.618 . . . . 0.0 106.628 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -135.74 -35.67 0.79 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.027 0.931 . . . . 0.0 110.246 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.2 179.04 46.45 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.45 102.14 6.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -60.4 124.7 79.47 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.964 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.95 -34.27 45.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.266 2.644 . . . . 0.0 113.711 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -39.29 91.84 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.844 0.747 . . . . 0.0 110.734 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.49 73.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.54 -54.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.13 -42.91 83.64 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.956 0.798 . . . . 0.0 110.744 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.32 -44.09 79.62 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.529 0.604 . . . . 0.0 110.799 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.3 mmm -76.57 -39.83 51.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.551 0.74 . . . . 0.0 111.372 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -34.18 76.77 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -67.91 -20.17 65.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.004 0.922 . . . . 0.0 112.612 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -78.07 -24.34 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.479 1.036 . . . . 0.0 109.586 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.49 19.21 11.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.108 1.337 . . . . 0.0 111.08 -169.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -117.17 92.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.23 87.58 3.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.77 4.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 117.738 -1.125 . . . . 0.0 111.92 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.6 m -58.02 -25.88 61.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.01 1.732 . . . . 0.0 112.057 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.19 -21.51 62.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 112.68 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.3 169.31 15.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.667 0.787 . . . . 0.0 109.412 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -145.92 156.14 43.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.489 1.116 . . . . 0.0 109.326 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.1 m -95.32 148.53 22.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.251 1.02 . . . . 0.0 111.123 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -156.8 159.75 38.55 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.45 1.5 . . . . 0.0 108.528 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.6 164.39 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.52 117.83 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.598 0.713 . . . . 0.0 112.395 -169.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.27 121.97 36.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -73.04 -23.8 60.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.71 0.804 . . . . 0.0 112.826 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.09 -41.21 62.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.608 0.64 . . . . 0.0 110.105 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.76 -44.63 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -48.98 71.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.332 0.515 . . . . 0.0 110.037 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -69.76 -5.48 25.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -107.02 -20.62 13.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.868 1.213 . . . . 0.0 111.946 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.9 148.22 51.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.389 0.541 . . . . 0.0 111.244 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 39.0 tp -147.0 143.37 28.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 110.072 -169.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.06 138.4 49.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.62 108.4 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.8 p -88.9 90.6 8.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.1 -9.78 34.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.952 0.901 . . . . 0.0 112.812 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.04 156.09 44.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.06 -41.87 94.89 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -170.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -31.74 72.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.608 0.704 . . . . 0.0 111.737 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.68 -27.99 69.62 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.437 0.562 . . . . 0.0 111.902 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 -14.55 62.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.57 -30.43 69.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.009 0.822 . . . . 0.0 112.108 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.27 -35.97 58.65 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 118.052 -0.975 . . . . 0.0 113.288 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.6 m -40.38 105.1 0.36 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.898 1.679 . . . . 0.0 113.48 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.58 71.6 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.056 3.171 . . . . 0.0 111.255 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.8 mtt 79.58 110.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 129.283 3.033 . . . . 0.0 111.673 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.2 p -117.67 81.2 14.51 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.94 173.16 7.41 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.479 2.786 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.4 -28.55 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.829 3.019 . . . . 0.0 116.445 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.39 -8.3 45.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.133 0.973 . . . . 0.0 113.034 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.7 t -134.91 82.95 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 128.47 2.708 . . . . 0.0 105.125 -169.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.3 pttt -66.12 167.68 9.64 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -141.14 150.04 42.29 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.507 -0.745 . . . . 0.0 109.412 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -136.4 162.33 33.36 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -144.68 147.21 32.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.2 1.0 . . . . 0.0 112.006 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -142.72 -168.52 2.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 108.301 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.16 42.51 1.13 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.227 0.921 . . . . 0.0 113.848 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -78.57 115.92 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.555 1.177 . . . . 0.0 111.925 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -66.11 150.6 48.48 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.743 1.217 . . . . 0.0 109.525 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.19 116.65 51.02 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.31 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.45 -33.96 27.85 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.966 1.778 . . . . 0.0 112.661 -171.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.27 -16.68 64.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.439 0.563 . . . . 0.0 112.288 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -105.4 8.62 33.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.11 -38.8 71.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.243 0.929 . . . . 0.0 112.613 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 53.42 -170.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.887 2.075 . . . . 0.0 113.434 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.96 -65.71 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.205 1.86 . . . . 0.0 108.942 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -162.32 161.45 27.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.929 2.092 . . . . 0.0 105.579 170.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.03 -40.18 73.07 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.118 0.872 . . . . 0.0 111.243 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.17 -28.41 66.39 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.487 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.84 -39.45 66.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.863 0.756 . . . . 0.0 109.598 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -60.23 -53.16 60.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -57.83 -41.14 81.68 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.329 0.393 . . . . 0.0 110.58 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.66 77.53 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.074 -0.391 . . . . 0.0 110.878 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -74.42 -35.83 63.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.33 0.652 . . . . 0.0 111.512 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -56.18 -43.58 78.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.339 0.972 . . . . 0.0 108.689 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.47 -48.77 78.31 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.071 0.548 . . . . 0.0 111.386 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.02 -49.4 77.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.156 0.434 . . . . 0.0 110.069 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.11 -46.19 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.976 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -60.95 -43.31 98.9 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 121.776 2.08 . . . . 0.0 110.699 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.44 -45.37 94.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.31 -30.87 62.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.005 -0.997 . . . . 0.0 112.765 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -41.27 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.837 1.199 . . . . 0.0 108.712 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.73 -47.01 90.48 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -59.63 -37.05 77.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.595 1.158 . . . . 0.0 111.411 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -52.77 64.28 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.713 0.805 . . . . 0.0 109.735 173.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.73 -34.5 76.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.918 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -60.08 -49.84 76.05 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.748 0.819 . . . . 0.0 111.065 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.31 -51.37 69.83 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 119.364 0.983 . . . . 0.0 108.867 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -55.89 -39.53 71.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.283 0.633 . . . . 0.0 111.063 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.65 55.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 111.848 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.24 -39.8 65.18 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.389 -173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.6 p -92.41 -21.8 20.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.105 0.962 . . . . 0.0 110.825 -171.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.75 42.88 99.81 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 126.735 2.014 . . . . 0.0 111.16 -174.314 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -124.67 169.26 12.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.406 1.882 . . . . 0.0 108.129 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -141.95 139.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.03 137.53 55.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -132.95 105.91 7.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.015 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -80.0 149.28 30.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.913 0.485 . . . . 0.0 110.592 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.05 129.71 15.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.946 1.299 . . . . 0.0 107.543 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.94 172.63 15.38 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.983 0.913 . . . . 0.0 109.993 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -66.34 -8.91 28.38 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.649 -1.282 . . . . 0.0 113.449 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.77 125.17 1.41 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.086 -2.805 . . . . 0.0 106.086 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.2 t-20 -61.16 -46.77 89.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.099 0.56 . . . . 0.0 110.384 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -42.85 -22.37 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 130.178 3.391 . . . . 0.0 117.412 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -119.69 -84.2 0.66 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.476 1.11 . . . . 0.0 109.683 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -60.14 -46.75 88.58 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.384 1.074 . . . . 0.0 111.669 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 -40.76 76.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.098 0.863 . . . . 0.0 110.796 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -60.94 -43.84 98.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.676 0.671 . . . . 0.0 111.431 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 85.3 mtp -65.77 -48.58 71.36 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.389 0.676 . . . . 0.0 109.487 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.31 -42.13 81.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.086 0.554 . . . . 0.0 111.309 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.61 -48.55 79.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 110.044 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.61 97.99 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.616 -1.102 . . . . 0.0 112.584 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.66 -40.84 80.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.722 1.761 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.99 81.51 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.526 0.603 . . . . 0.0 111.417 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -57.53 -33.66 68.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.812 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.35 -58.59 3.81 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.408 0.549 . . . . 0.0 110.101 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -70.11 -37.7 75.42 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -169.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -90.31 -36.65 14.56 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -169.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 179.09 50.84 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 121.999 0.777 . . . . 0.0 112.829 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.28 -16.4 63.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.738 1.615 . . . . 0.0 113.998 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.24 -24.64 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.311 1.044 . . . . 0.0 110.875 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -120.93 140.53 51.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.243 0.617 . . . . 0.0 110.226 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -89.75 144.06 26.28 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.95 124.1 52.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 170.72 15.62 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 p -140.14 142.75 35.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.43 -174.9 4.01 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.338 1.455 . . . . 0.0 108.768 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.57 174.67 41.34 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.3 -42.02 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 170.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.65 178.36 8.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.839 0.856 . . . . 0.0 109.892 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.69 122.59 11.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.568 1.547 . . . . 0.0 107.042 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.67 -32.35 47.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.983 0.513 . . . . 0.0 109.95 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.94 -158.25 28.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -94.4 111.98 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -67.27 125.37 90.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.258 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.37 -34.38 50.08 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.163 2.575 . . . . 0.0 113.624 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -37.54 85.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.698 0.681 . . . . 0.0 110.915 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.66 75.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.17 -53.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -67.63 -41.68 83.52 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.32 -45.17 84.52 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.007 0.821 . . . . 0.0 110.784 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.53 -39.83 64.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.889 0.476 . . . . 0.0 110.92 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -64.5 -32.11 73.61 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.288 -0.883 . . . . 0.0 111.617 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.92 -19.59 65.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.77 0.828 . . . . 0.0 112.145 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.67 -9.39 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.469 1.108 . . . . 0.0 110.174 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 16.28 53.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.691 1.139 . . . . 0.0 111.927 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.1 mt -107.96 92.22 2.01 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -76.54 85.21 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.032 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 pt -78.13 3.47 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.269 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.6 p -61.07 -23.2 65.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 121.267 1.848 . . . . 0.0 112.202 -175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -70.67 -21.29 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.064 1.345 . . . . 0.0 112.7 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -70.05 170.18 11.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 109.57 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -145.71 161.47 39.83 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.26 1.424 . . . . 0.0 107.98 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -104.16 155.74 18.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.739 0.816 . . . . 0.0 110.116 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -150.83 161.31 42.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.12 2.168 . . . . 0.0 108.125 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 pt -92.44 164.56 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 135.43 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.591 0.756 . . . . 0.0 112.426 -169.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -127.07 110.07 12.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 108.212 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.5 p -61.08 -19.67 61.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.926 -0.483 . . . . 0.0 111.653 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.34 -2.66 14.26 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 113.638 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -115.97 -45.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -46.43 -51.64 14.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.488 1.115 . . . . 0.0 111.525 178.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -66.7 -5.97 13.89 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -134.36 5.47 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 112.664 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.1 155.08 40.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.939 0.791 . . . . 0.0 109.936 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.61 -33.86 73.27 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.975 -1.078 . . . . 0.0 108.389 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -147.55 143.8 28.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 109.509 -170.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.01 133.7 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.88 119.02 56.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -172.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 p -96.57 92.77 6.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -68.14 -12.6 61.19 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.538 -0.726 . . . . 0.0 112.805 -169.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.57 156.63 45.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.74 1.155 . . . . 0.0 108.174 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.81 -41.33 83.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -169.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.96 -35.88 82.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.76 0.78 . . . . 0.0 111.318 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.44 -28.84 70.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.59 -22.56 65.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.37 -32.64 74.16 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.529 0.732 . . . . 0.0 112.227 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -99.29 -22.74 15.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.8 t -55.32 106.42 0.67 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.72 174.88 3.32 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.472 2.781 . . . . 0.0 113.169 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -58.88 143.23 48.34 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.572 -0.705 . . . . 0.0 110.544 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -133.0 119.13 15.59 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.541 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 169.23 20.61 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.38 -25.79 19.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.957 3.105 . . . . 0.0 115.969 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -65.91 -9.02 25.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.956 . . . . 0.0 112.839 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 t -133.68 89.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 127.539 2.336 . . . . 0.0 105.5 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -69.11 164.3 22.82 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.299 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -126.25 148.77 49.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.577 1.151 . . . . 0.0 108.679 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -143.94 160.18 41.27 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 145.14 30.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.377 1.071 . . . . 0.0 111.717 -169.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -143.8 -170.16 3.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.405 1.882 . . . . 0.0 108.436 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.92 41.19 1.24 Allowed Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.484 -0.76 . . . . 0.0 113.241 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -76.21 114.96 15.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.354 1.077 . . . . 0.0 110.953 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -67.65 151.52 47.15 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.406 1.082 . . . . 0.0 109.926 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.32 126.72 92.55 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.48 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.88 -30.83 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.462 2.108 . . . . 0.0 114.049 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.49 -24.55 67.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.937 0.895 . . . . 0.0 112.933 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 25.43 10.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 112.557 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.75 -36.42 57.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 56.45 -168.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.373 1.869 . . . . 0.0 112.843 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.54 -61.14 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.428 1.966 . . . . 0.0 108.338 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 t -166.43 167.72 15.47 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 105.313 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.88 -40.35 84.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.386 -0.822 . . . . 0.0 110.626 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -29.94 66.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.429 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.62 -42.73 61.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.751 0.705 . . . . 0.0 109.287 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -58.29 -49.31 77.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.883 0.873 . . . . 0.0 109.814 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -61.78 -44.18 97.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.769 0.259 . . . . 0.0 110.503 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.97 75.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.457 0.571 . . . . 0.0 110.401 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.52 -39.02 93.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.187 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -55.95 -48.31 75.99 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.563 1.074 . . . . 0.0 108.859 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -60.56 -44.23 96.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.575 0.35 . . . . 0.0 111.113 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.95 -48.99 77.91 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.066 0.394 . . . . 0.0 110.519 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.13 -45.28 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 117.208 -1.377 . . . . 0.0 109.91 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -60.39 -42.38 95.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 121.395 1.907 . . . . 0.0 110.709 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.08 -45.0 95.46 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.84 -31.64 63.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.98 -41.01 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 119.847 1.203 . . . . 0.0 108.867 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.47 88.22 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.79 -35.82 75.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.12 1.368 . . . . 0.0 111.513 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -53.97 52.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.842 0.857 . . . . 0.0 109.595 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.02 -34.68 78.26 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.851 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -50.52 73.55 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.133 0.973 . . . . 0.0 111.116 173.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -61.01 -51.66 68.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 122.832 0.453 . . . . 0.0 111.163 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.78 58.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.072 0.949 . . . . 0.0 111.789 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.32 -38.13 60.39 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.865 0.866 . . . . 0.0 111.243 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.9 p -94.83 -20.85 19.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.357 1.063 . . . . 0.0 111.189 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.61 36.98 93.81 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -172.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.693 1.597 . . . . 0.0 111.353 -173.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -143.72 147.45 34.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -155.97 -38.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.794 0.838 . . . . 0.0 111.406 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.6 mtmt -134.31 167.62 20.38 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.663 1.585 . . . . 0.0 107.744 169.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.8 mt -136.38 132.9 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -124.84 127.94 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -125.61 104.15 8.24 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -169.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.79 147.49 45.46 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 122.026 -0.421 . . . . 0.0 109.926 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -147.5 126.36 12.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -146.88 175.57 10.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.515 0.598 . . . . 0.0 109.814 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -67.67 -11.76 58.97 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.72 -1.238 . . . . 0.0 112.972 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.16 121.1 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.171 -2.772 . . . . 0.0 106.171 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 49.7 t-20 -57.63 -45.16 85.78 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.637 0.775 . . . . 0.0 109.991 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m -40.07 -34.65 0.31 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 129.746 3.218 . . . . 0.0 115.175 -169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.1 m -112.81 -72.47 0.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.32 0.648 . . . . 0.0 111.165 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -48.28 61.58 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.348 -169.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -63.04 -45.62 91.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.288 0.494 . . . . 0.0 109.779 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -56.55 -44.7 81.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.847 -0.596 . . . . 0.0 112.368 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.2 mtm -69.83 -45.58 67.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.615 0.643 . . . . 0.0 110.333 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.72 73.79 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.93 0.786 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -61.17 -47.3 86.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.673 1.189 . . . . 0.0 110.673 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.82 95.47 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-O 119.033 -0.87 . . . . 0.0 111.676 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 98.1 m95 -65.22 -38.59 90.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.871 1.836 . . . . 0.0 110.79 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.1 82.65 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.447 -0.783 . . . . 0.0 111.604 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.48 -26.66 68.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.13 0.877 . . . . 0.0 112.348 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.53 -46.15 13.75 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.602 0.761 . . . . 0.0 109.622 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -80.9 -26.33 36.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 mt -99.08 -140.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 107.387 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -174.6 45.73 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.86 -13.91 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 113.349 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.52 -13.53 2.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.14 2.176 . . . . 0.0 111.267 169.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.449 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 8.5 m95 -133.23 162.49 31.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.965 1.706 . . . . 0.0 108.813 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.41 139.19 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 167.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.03 118.68 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.7 173.57 11.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.334 0.587 . . . . 0.0 110.413 172.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -132.24 144.22 50.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.059 1.344 . . . . 0.0 110.175 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 67' ' ' ILE . . . -137.03 179.45 6.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.055 2.142 . . . . 0.0 108.225 169.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.77 170.31 39.04 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.67 -41.64 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -142.6 179.52 6.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.521 0.729 . . . . 0.0 109.827 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.11 40.07 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.897 2.079 . . . . 0.0 107.202 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -135.57 -36.19 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.694 1.197 . . . . 0.0 109.238 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.89 178.57 39.44 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.98 100.79 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.93 127.85 92.23 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 117.883 -1.055 . . . . 0.0 109.257 -170.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.77 -35.17 38.27 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.523 2.815 . . . . 0.0 113.946 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -59.61 -51.64 68.94 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.741 0.7 . . . . 0.0 109.886 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.35 80.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.496 0.589 . . . . 0.0 109.923 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -61.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -63.26 -40.02 96.24 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 118.999 0.818 . . . . 0.0 111.103 -169.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.15 83.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.583 0.753 . . . . 0.0 110.853 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -40.22 66.41 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.065 0.393 . . . . 0.0 110.715 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -68.3 -30.5 69.51 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.024 0.93 . . . . 0.0 111.287 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.47 -21.24 66.19 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.534 1.134 . . . . 0.0 111.879 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 t -89.89 -6.28 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.78 1.232 . . . . 0.0 110.193 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.57 19.97 52.83 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.764 -1.21 . . . . 0.0 112.258 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.3 mt -111.94 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.051 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -79.59 84.84 5.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.66 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.23 7.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.286 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.7 m -56.15 -25.16 45.26 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 120.667 1.576 . . . . 0.0 112.236 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.63 -20.34 59.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.696 1.198 . . . . 0.0 113.222 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.78 169.81 13.78 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.838 0.745 . . . . 0.0 110.511 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -145.8 155.4 42.9 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.412 1.485 . . . . 0.0 108.825 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 p -89.65 163.57 15.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.591 1.156 . . . . 0.0 110.409 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 41.2 t0 -158.15 158.78 35.28 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.818 2.047 . . . . 0.0 107.773 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.84 161.63 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -57.19 141.65 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 111.544 -170.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -130.7 112.77 13.4 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.19 -26.88 41.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.872 1.269 . . . . 0.0 111.445 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.38 -23.03 66.86 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 125.066 1.347 . . . . 0.0 112.859 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -100.43 -42.44 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 119.157 0.89 . . . . 0.0 108.689 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tp -48.13 -51.73 23.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.896 1.278 . . . . 0.0 111.122 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -67.23 -13.57 62.09 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -106.82 -14.69 14.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.141 0.977 . . . . 0.0 111.281 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 148.86 47.35 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.32 -31.6 71.99 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 27.1 tp -152.73 144.37 23.48 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.763 1.225 . . . . 0.0 109.981 -169.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 135.63 58.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.71 108.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -86.29 93.18 9.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.03 -13.31 62.09 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.593 0.757 . . . . 0.0 112.328 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.3 t -144.33 145.89 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.868 1.213 . . . . 0.0 107.923 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.8 -34.77 89.69 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.568 -170.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.22 -25.84 67.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.161 0.981 . . . . 0.0 111.402 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 -26.54 60.24 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.031 0.532 . . . . 0.0 111.841 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.65 65.72 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.78 -33.69 70.61 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.863 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -85.52 60.53 6.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.119 0.968 . . . . 0.0 110.577 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 74.7 m -120.95 74.78 27.58 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.355 1.062 . . . . 0.0 108.6 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.15 -29.08 89.52 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.126 2.551 . . . . 0.0 115.146 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.9 ptp -162.73 115.91 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 110.217 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -132.83 77.56 68.38 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.5 171.76 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.995 3.13 . . . . 0.0 112.959 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.7 -17.77 10.74 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.011 3.141 . . . . 0.0 115.795 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.53 -13.2 38.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.059 0.943 . . . . 0.0 112.419 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 t -127.16 159.43 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 128.81 2.844 . . . . 0.0 106.828 -169.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.1 pttt -138.48 167.7 21.36 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 -127.42 153.06 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.644 0.657 . . . . 0.0 109.418 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -135.18 156.43 49.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -141.51 135.45 30.21 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.78 0.832 . . . . 0.0 111.766 -168.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -137.98 -170.01 2.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.472 1.909 . . . . 0.0 108.735 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.93 40.27 1.37 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.305 -0.872 . . . . 0.0 113.43 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -79.1 112.01 15.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.255 1.027 . . . . 0.0 111.978 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.62 158.39 18.35 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.983 0.913 . . . . 0.0 109.567 169.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.12 118.91 74.73 Favored Pre-proline 0 CA--C 1.534 0.339 0 O-C-N 121.526 -0.733 . . . . 0.0 111.142 -173.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.98 -30.23 21.6 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.818 1.678 . . . . 0.0 112.633 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.59 -18.12 65.09 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.54 1.064 . . . . 0.0 112.408 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -99.37 -1.13 39.54 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.911 1.284 . . . . 0.0 111.618 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 146.1 36.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -158.03 164.39 36.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.97 0.508 . . . . 0.0 110.797 -171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.82 -48.58 0.66 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -165.36 166.66 18.44 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.243 2.217 . . . . 0.0 105.595 169.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.29 -40.82 82.97 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.726 -0.609 . . . . 0.0 110.507 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -28.35 64.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.1 -45.07 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.893 0.769 . . . . 0.0 109.105 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -56.24 -50.46 71.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.648 0.779 . . . . 0.0 109.915 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -62.3 -43.95 97.63 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.119 0.418 . . . . 0.0 110.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.81 -40.39 79.83 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.886 0.766 . . . . 0.0 110.26 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.2 -40.43 97.48 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.681 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -54.85 -49.46 71.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.096 0.862 . . . . 0.0 109.352 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -61.51 -44.16 97.56 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.947 0.499 . . . . 0.0 111.282 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.47 -50.34 73.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 119.167 -0.445 . . . . 0.0 110.098 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.43 -43.73 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 117.406 -1.283 . . . . 0.0 110.164 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -61.63 -42.04 98.33 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 121.144 1.793 . . . . 0.0 111.016 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.17 -42.63 99.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.342 0.519 . . . . 0.0 110.339 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.22 -38.95 71.98 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -65.53 -40.45 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 119.528 1.058 . . . . 0.0 109.3 177.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.62 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -52.38 -44.37 65.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.77 0.828 . . . . 0.0 111.137 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -47.52 84.96 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.097 0.559 . . . . 0.0 109.933 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 131' ' ' LEU . 3.9 mm? -68.96 -34.91 76.1 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.167 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.59 -49.7 76.73 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 118.933 0.788 . . . . 0.0 110.865 173.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.26 -52.07 66.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.18 -39.97 73.19 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.696 0.68 . . . . 0.0 111.388 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.8 67.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.688 0.795 . . . . 0.0 111.708 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -76.14 -43.49 42.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.049 0.94 . . . . 0.0 110.915 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.2 p -85.09 -22.33 28.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.373 1.069 . . . . 0.0 110.021 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.24 38.12 95.68 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.569 -169.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -60.86 155.57 19.31 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.734 0.814 . . . . 0.0 111.594 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.45 -29.99 0.79 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.882 1.273 . . . . 0.0 111.096 -170.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -144.44 173.11 12.08 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.014 1.326 . . . . 0.0 108.567 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.7 mt -131.14 142.81 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.7 141.37 46.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.868 1.267 . . . . 0.0 107.783 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.14 107.06 7.05 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.17 141.37 38.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.752 0.421 . . . . 0.0 110.083 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.81 133.81 34.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.394 1.478 . . . . 0.0 108.038 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.3 p -152.68 179.23 8.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 110.116 169.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.06 -3.68 17.57 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.85 104.43 0.21 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 54.3 t-20 -41.93 -48.16 4.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.793 1.637 . . . . 0.0 111.599 -170.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -41.89 -31.58 0.34 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.196 2.999 . . . . 0.0 115.118 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.91 -85.33 0.48 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.456 1.026 . . . . 0.0 111.185 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -45.01 95.81 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.68 -168.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -68.13 -39.24 82.76 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.997 1.272 . . . . 0.0 110.761 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -62.18 -46.2 89.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.92 0.782 . . . . 0.0 111.383 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.46 -47.86 74.68 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.88 -45.13 78.63 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.453 0.701 . . . . 0.0 110.627 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.03 -46.22 85.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.924 0.489 . . . . 0.0 110.32 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.77 97.6 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.661 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -67.16 -38.78 86.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.321 1.561 . . . . 0.0 110.536 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.8 85.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.097 0.408 . . . . 0.0 110.771 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -57.35 -31.49 65.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.417 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -72.99 -59.97 2.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.612 0.642 . . . . 0.0 110.514 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -70.57 -42.8 70.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -168.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.5 mt -82.2 -37.98 25.26 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 122.315 0.246 . . . . 0.0 110.825 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.2 174.66 49.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.024 0.821 . . . . 0.0 112.072 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.48 -15.37 63.31 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.809 1.244 . . . . 0.0 113.684 -169.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.13 -27.26 19.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 110.911 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -112.28 134.46 53.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.29 131.65 35.29 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.27 -2.492 . . . . 0.0 104.27 168.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -111.44 142.81 22.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -140.83 167.25 22.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.851 1.26 . . . . 0.0 108.815 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.0 p -139.47 134.07 31.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.237 1.415 . . . . 0.0 108.113 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.66 -175.2 4.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.972 1.709 . . . . 0.0 108.495 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 178.05 41.97 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.05 -42.31 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.793 1.237 . . . . 0.0 108.256 172.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.41 -179.45 6.66 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.847 1.259 . . . . 0.0 109.18 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.87 125.4 14.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.72 1.608 . . . . 0.0 107.026 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.87 -35.01 38.72 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.013 0.525 . . . . 0.0 109.91 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.72 -161.41 31.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.53 108.96 18.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -65.21 131.83 95.16 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.637 -0.696 . . . . 0.0 110.265 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.29 -32.27 33.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.975 1.784 . . . . 0.0 112.88 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.76 -38.33 83.28 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.571 1.078 . . . . 0.0 110.497 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.19 89.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.648 1.113 . . . . 0.0 109.254 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.88 -58.71 6.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.81 -47.1 82.2 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.693 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.41 81.89 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 119.096 0.862 . . . . 0.0 110.677 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.17 -41.68 76.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.148 0.431 . . . . 0.0 110.29 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -67.78 -27.56 66.86 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.991 0.916 . . . . 0.0 111.818 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -67.47 -18.62 65.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.518 1.127 . . . . 0.0 111.708 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -89.54 -13.07 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.012 0.925 . . . . 0.0 109.972 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.86 6.39 54.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.299 1.428 . . . . 0.0 112.045 -173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.61 89.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.71 78.41 2.67 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.306 1.042 . . . . 0.0 110.651 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -73.27 6.09 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.452 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.0 p -57.4 -24.82 57.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.601 1.546 . . . . 0.0 112.271 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.21 -19.14 60.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.568 1.147 . . . . 0.0 112.885 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.32 169.43 15.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.777 0.717 . . . . 0.0 109.939 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -145.02 161.42 39.44 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.985 1.714 . . . . 0.0 107.986 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 m -111.57 155.35 23.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 109.831 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.55 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.2 t0 -154.44 160.57 41.69 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.838 2.055 . . . . 0.0 108.484 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 pt -94.26 163.08 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.39 119.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.563 0.697 . . . . 0.0 112.825 -169.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -100.51 111.57 23.84 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -15.61 63.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.697 0.799 . . . . 0.0 112.195 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.06 -40.14 75.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.588 1.085 . . . . 0.0 111.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.9 mt -63.41 -48.35 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.88 -46.27 74.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.413 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -66.46 -5.86 12.59 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.47 3.55 3.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.078 1.308 . . . . 0.0 113.603 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 147.74 52.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.839 0.745 . . . . 0.0 109.487 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.17 -34.64 71.13 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.063 0.847 . . . . 0.0 108.932 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.0 tp -145.27 142.73 29.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.31 132.01 69.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.4 t -114.23 113.17 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.9 p -92.39 92.98 8.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.88 -10.56 54.14 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.639 -169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -147.71 162.68 38.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.979 1.718 . . . . 0.0 110.741 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.11 -55.94 27.92 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.551 1.072 . . . . 0.0 112.522 -169.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.12 -31.92 70.94 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -171.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.95 80.12 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.49 -26.43 63.42 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.68 0.792 . . . . 0.0 112.92 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.67 -38.49 80.42 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.742 0.817 . . . . 0.0 111.755 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.26 -34.47 42.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.048 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.76 114.47 4.2 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 118.155 -0.926 . . . . 0.0 108.618 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.36 173.76 10.14 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.82 2.347 . . . . 0.0 111.875 -173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 65.8 ttp -53.79 125.07 17.15 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.208 1.003 . . . . 0.0 110.994 -170.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 p -107.1 105.59 56.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.63 1.572 . . . . 0.0 107.208 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -53.89 166.59 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.719 2.946 . . . . 0.0 112.961 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.69 -28.09 36.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.438 2.759 . . . . 0.0 114.788 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -68.19 -7.49 30.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.376 1.07 . . . . 0.0 112.981 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.75 85.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.752 2.421 . . . . 0.0 105.591 -169.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.1 pttt -69.7 167.09 17.78 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.169 -0.957 . . . . 0.0 108.973 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -123.8 160.35 27.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.036 0.534 . . . . 0.0 109.85 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.68 155.03 46.6 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -143.78 137.21 27.89 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.665 0.386 . . . . 0.0 111.731 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -140.53 -172.83 3.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.869 1.668 . . . . 0.0 109.311 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.55 44.39 1.05 Allowed Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.744 -0.597 . . . . 0.0 112.954 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -76.36 114.16 14.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.852 0.826 . . . . 0.0 110.487 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.58 162.46 20.88 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.275 0.63 . . . . 0.0 109.739 169.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.412 ' CG ' ' HE ' ' A' ' 108' ' ' ARG . 13.3 t70 -68.32 130.65 92.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.791 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.8 -44.48 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.458 2.106 . . . . 0.0 113.106 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.77 -29.42 70.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.858 0.863 . . . . 0.0 111.428 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HE ' ' CG ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -99.14 5.89 46.67 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.636 1.575 . . . . 0.0 111.507 -177.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.71 140.07 48.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -143.36 158.65 43.46 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.687 0.795 . . . . 0.0 110.168 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.19 -51.97 0.46 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -160.41 162.06 33.18 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.57 -40.92 88.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.619 -0.675 . . . . 0.0 110.696 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.02 -29.08 67.17 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.467 -0.302 . . . . 0.0 111.069 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.93 -42.23 40.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.285 0.634 . . . . 0.0 109.994 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -54.32 -51.7 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.025 0.93 . . . . 0.0 109.639 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -60.55 -46.51 89.92 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.57 75.89 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.036 -0.415 . . . . 0.0 110.662 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.67 -37.49 87.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.667 0.787 . . . . 0.0 111.022 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -54.55 -51.74 64.25 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.118 0.872 . . . . 0.0 108.706 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.495 ' NE2' HH21 ' A' ' 124' ' ' ARG . 5.3 mm-40 -61.21 -42.72 99.09 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.073 0.549 . . . . 0.0 111.666 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.27 -48.15 82.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.242 0.474 . . . . 0.0 110.113 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.1 -47.26 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 117.459 -1.257 . . . . 0.0 110.022 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.495 HH21 ' NE2' ' A' ' 121' ' ' GLN . 49.1 ptt85 -63.01 -41.65 99.62 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.898 1.681 . . . . 0.0 111.027 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.23 -42.46 98.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.21 0.459 . . . . 0.0 110.082 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -76.63 -33.76 58.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.466 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.01 -46.29 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 119.977 1.262 . . . . 0.0 107.646 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.7 -47.71 87.02 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.81 -37.91 71.84 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.8 1.24 . . . . 0.0 112.125 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -42.76 85.32 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.48 -0.763 . . . . 0.0 111.526 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 mt -68.22 -41.44 81.27 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -48.07 73.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.83 1.252 . . . . 0.0 110.666 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.97 -57.9 11.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.605 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.298 5.2 p90 -68.63 -21.56 64.47 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 121.111 1.778 . . . . 0.0 112.681 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.99 64.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.38 0.991 . . . . 0.0 111.798 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -77.52 -39.58 45.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.402 1.081 . . . . 0.0 111.17 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.6 p -90.7 -22.42 21.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.932 0.893 . . . . 0.0 110.838 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.27 41.64 99.49 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.314 1.846 . . . . 0.0 111.331 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -148.45 148.37 30.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -150.43 -35.78 0.15 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.362 1.065 . . . . 0.0 111.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.0 mtmt -134.99 166.25 23.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.983 1.713 . . . . 0.0 106.519 169.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.9 mt -134.0 140.16 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.2 tt -130.44 135.22 61.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.69 102.95 6.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.693 0.797 . . . . 0.0 108.981 -170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -76.91 144.96 38.53 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.205 0.602 . . . . 0.0 110.166 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 137.32 37.23 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.758 1.623 . . . . 0.0 108.138 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.2 p -154.76 175.23 13.98 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -67.81 -7.84 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.82 97.31 0.14 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -41.41 -40.94 1.88 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.453 1.901 . . . . 0.0 113.204 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.6 m -38.07 -36.67 0.22 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.903 3.281 . . . . 0.0 115.329 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -117.23 -74.92 0.59 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.966 0.803 . . . . 0.0 112.137 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -56.29 -50.74 70.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.738 0.699 . . . . 0.0 111.614 -169.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -70.27 -34.61 73.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.612 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -63.6 -42.22 98.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.415 0.552 . . . . 0.0 110.772 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.6 mtp -65.72 -47.54 74.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.806 0.442 . . . . 0.0 109.828 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.08 86.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.031 0.532 . . . . 0.0 110.871 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -57.86 -45.65 85.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.611 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.72 -52.44 53.09 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.074 0.845 . . . . 0.0 112.709 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -65.37 -34.57 78.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.592 1.696 . . . . 0.0 110.61 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.53 83.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.605 -0.684 . . . . 0.0 110.56 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.94 -22.11 64.1 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.223 -0.923 . . . . 0.0 112.557 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -87.46 -47.18 8.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.872 0.76 . . . . 0.0 110.116 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -78.92 -26.71 43.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.91 -142.78 0.25 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.46 -174.26 46.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.67 -13.74 55.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.95 -14.62 3.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.721 2.008 . . . . 0.0 111.147 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.471 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 7.8 m95 -133.18 167.06 21.04 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.021 1.728 . . . . 0.0 108.844 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -123.07 130.66 53.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 167.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.26 118.8 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.22 174.61 10.45 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.6 1.16 . . . . 0.0 108.653 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 82.4 p -137.59 160.41 39.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.372 0.606 . . . . 0.0 111.157 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.47 -162.25 1.49 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.496 1.518 . . . . 0.0 108.546 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.7 176.37 44.88 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -41.57 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.4 -179.88 6.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.596 1.159 . . . . 0.0 109.17 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.58 149.96 36.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.755 2.422 . . . . 0.0 106.156 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 -13.93 1.9 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.961 0.904 . . . . 0.0 111.446 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.71 170.24 20.91 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 171.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.64 102.12 1.8 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -64.42 125.67 88.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.678 -170.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.97 -35.46 50.16 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.383 2.722 . . . . 0.0 113.881 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -40.96 96.61 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.631 0.651 . . . . 0.0 110.515 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.92 -41.58 82.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.54 -55.99 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -65.25 -41.33 94.4 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 119.378 0.99 . . . . 0.0 110.664 -173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.21 71.4 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.862 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.0 mmm -86.51 -38.16 17.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.451 0.569 . . . . 0.0 111.427 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -63.42 -33.29 75.22 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.969 0.908 . . . . 0.0 110.3 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -67.77 -19.2 65.08 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 112.351 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.67 -10.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.221 1.008 . . . . 0.0 109.906 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.62 23.31 47.28 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.121 -0.987 . . . . 0.0 111.039 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.6 mt -114.32 91.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -78.49 74.25 5.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.991 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.03 3.32 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.322 -0.861 . . . . 0.0 112.129 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -27.12 10.38 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.497 1.044 . . . . 0.0 111.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -71.83 -19.59 61.96 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 113.852 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -78.29 170.38 16.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.963 . . . . 0.0 109.681 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.05 160.75 41.46 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.418 1.487 . . . . 0.0 108.462 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 p -101.64 153.55 19.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.419 1.088 . . . . 0.0 110.958 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -156.48 160.84 39.92 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.841 1.256 . . . . 0.0 108.944 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.09 161.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.22 129.29 18.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 123.397 0.679 . . . . 0.0 111.586 -169.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -106.59 114.84 29.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.31 1.444 . . . . 0.0 107.655 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -66.71 -23.1 66.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.63 -41.25 46.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.368 0.985 . . . . 0.0 110.268 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.67 -44.75 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.33 -48.71 65.31 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.948 0.499 . . . . 0.0 109.942 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -71.15 -14.81 62.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -94.75 -17.91 21.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.578 1.081 . . . . 0.0 111.003 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.01 150.25 49.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.164 0.438 . . . . 0.0 111.071 -169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.04 -32.71 51.11 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.42 141.04 29.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.562 1.145 . . . . 0.0 109.662 -174.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.74 124.67 59.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.95 118.44 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -102.66 97.34 7.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.8 mt -71.84 -3.15 20.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.903 1.681 . . . . 0.0 114.487 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.7 p -151.26 163.91 37.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.584 1.538 . . . . 0.0 110.327 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.76 -64.84 3.19 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.719 1.628 . . . . 0.0 113.338 -169.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.36 -29.25 67.93 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.712 -0.287 . . . . 0.0 111.754 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.55 66.94 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.85 64.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.45 -31.75 72.13 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.109 0.564 . . . . 0.0 112.109 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -85.36 63.17 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.319 0.647 . . . . 0.0 110.633 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -124.94 76.23 66.54 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.153 0.981 . . . . 0.0 108.401 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.51 85.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.635 2.89 . . . . 0.0 111.234 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.0 tpt 70.1 111.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.383 2.673 . . . . 0.0 111.196 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -134.55 81.71 47.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.87 171.5 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.444 2.763 . . . . 0.0 110.965 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.25 -25.47 13.47 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.43 3.42 . . . . 0.0 117.448 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -56.97 -36.93 70.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.669 1.122 . . . . 0.0 110.836 170.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.75 82.96 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.91 2.484 . . . . 0.0 106.87 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -66.63 165.27 15.09 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.49 -0.756 . . . . 0.0 108.975 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -133.77 134.07 42.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.963 0.905 . . . . 0.0 110.147 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.99 155.75 45.59 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -151.3 139.08 19.8 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -141.22 178.86 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.949 1.7 . . . . 0.0 108.537 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.22 103.82 0.4 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -135.58 143.64 45.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.668 0.787 . . . . 0.0 110.579 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -73.28 169.99 15.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -73.46 117.23 58.87 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.86 -32.08 37.15 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 121.677 1.585 . . . . 0.0 112.818 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.35 65.37 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.962 0.801 . . . . 0.0 112.209 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -101.64 2.31 38.65 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 111.786 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.41 144.98 40.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -157.13 165.28 36.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.055 0.455 . . . . 0.0 111.191 -169.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.03 -47.65 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.54 166.41 18.26 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.509 2.324 . . . . 0.0 105.2 169.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.12 -40.57 81.58 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.533 -0.729 . . . . 0.0 110.52 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.26 -27.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.562 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.96 -45.3 51.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.007 0.822 . . . . 0.0 109.171 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -55.69 -49.42 73.04 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.73 0.812 . . . . 0.0 109.882 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -64.68 -41.78 95.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.14 -0.35 . . . . 0.0 110.96 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.85 -35.06 72.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.964 0.802 . . . . 0.0 110.62 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.78 -40.8 92.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.621 -0.674 . . . . 0.0 110.629 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.03 -45.41 83.15 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 119.191 0.905 . . . . 0.0 109.04 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.76 -50.01 75.5 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.351 0.66 . . . . 0.0 111.322 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.01 -48.78 80.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 119.488 -0.292 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.98 -45.81 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 117.187 -1.387 . . . . 0.0 109.927 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -62.3 -42.95 99.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 121.414 1.916 . . . . 0.0 110.764 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.2 -42.42 98.56 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.449 0.3 . . . . 0.0 110.696 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.44 -36.92 52.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.107 -0.949 . . . . 0.0 112.597 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -43.61 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.79 81.41 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.903 0.851 . . . . 0.0 112.083 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -49.41 76.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.542 0.61 . . . . 0.0 110.302 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 -43.45 70.64 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.267 0.627 . . . . 0.0 109.354 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -46.42 75.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.283 1.033 . . . . 0.0 110.934 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -60.79 -55.61 31.05 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.382 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.272 3.1 p90 -67.72 -24.3 65.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 121.492 1.951 . . . . 0.0 111.992 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -46.52 67.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.059 0.845 . . . . 0.0 111.732 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -76.58 -41.67 45.47 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.671 1.189 . . . . 0.0 111.153 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 45.0 p -84.92 -21.09 29.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.098 0.959 . . . . 0.0 110.343 -174.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.78 21.62 79.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.108 0.861 . . . . 0.0 111.881 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.251 1.158 0 CA-C-N 117.928 0.864 . . . . 0.0 109.673 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -153.04 150.38 29.11 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -152.03 -44.66 0.11 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.292 1.037 . . . . 0.0 110.094 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -126.83 164.15 22.02 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.629 1.972 . . . . 0.0 106.553 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -135.37 124.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -169.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tt -122.98 133.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -135.95 105.2 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -77.35 151.36 34.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 111.297 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -149.62 130.7 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.025 0.93 . . . . 0.0 108.651 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -148.69 178.68 8.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 111.01 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -66.81 -8.7 30.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.015 -1.053 . . . . 0.0 113.787 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.85 102.62 0.19 Allowed Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.1 t-20 -42.83 -46.07 5.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.222 1.809 . . . . 0.0 111.87 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -35.27 -35.95 0.05 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.148 3.379 . . . . 0.0 115.302 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.0 p -111.77 -74.06 0.65 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.362 0.983 . . . . 0.0 112.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.688 1.131 . . . . 0.0 111.95 -169.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.5 m -64.62 -36.18 83.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.223 0.465 . . . . 0.0 110.845 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.73 -44.48 90.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.535 0.607 . . . . 0.0 111.465 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.4 mtp -65.46 -48.24 73.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 109.704 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.64 84.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.233 0.613 . . . . 0.0 111.209 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.78 -45.08 90.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.026 0.53 . . . . 0.0 110.274 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.1 90.88 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 118.914 -0.937 . . . . 0.0 112.607 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.15 -40.46 82.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.276 1.538 . . . . 0.0 111.39 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.04 79.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.936 0.335 . . . . 0.0 111.592 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.67 -33.26 68.15 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.858 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -71.54 -58.17 3.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.422 0.555 . . . . 0.0 110.332 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.39 -39.38 68.04 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.3 mt -86.55 -39.97 15.68 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.174 0.443 . . . . 0.0 111.811 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.56 -173.93 55.16 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.114 0.864 . . . . 0.0 113.207 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.87 -17.01 62.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.307 1.843 . . . . 0.0 113.867 -170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -60.38 -10.94 5.43 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.242 1.417 . . . . 0.0 111.672 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -133.9 166.92 21.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.662 1.185 . . . . 0.0 110.597 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.05 137.84 51.53 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 168.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -114.42 142.42 27.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -137.82 159.43 42.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.932 0.893 . . . . 0.0 108.636 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -137.6 124.59 21.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.24 -174.13 3.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.336 1.054 . . . . 0.0 109.109 174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.84 175.03 42.2 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.18 -42.65 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -144.82 179.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.876 1.27 . . . . 0.0 109.027 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.71 44.13 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.683 1.993 . . . . 0.0 106.941 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -133.33 -30.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.005 0.922 . . . . 0.0 110.68 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 169.08 -176.64 43.13 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -76.1 104.15 6.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.28 125.77 87.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.449 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.76 -34.57 44.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.372 2.715 . . . . 0.0 113.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -42.69 96.21 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.693 0.679 . . . . 0.0 110.53 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.64 87.95 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -61.27 -56.07 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -65.76 -40.69 92.3 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.549 1.068 . . . . 0.0 110.51 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.18 -39.6 79.33 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.822 0.737 . . . . 0.0 111.871 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.3 mmm -82.37 -40.36 21.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.659 0.384 . . . . 0.0 111.093 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -65.99 -36.09 82.36 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.087 0.955 . . . . 0.0 110.497 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.0 -18.86 65.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.184 0.594 . . . . 0.0 111.894 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.42 -2.96 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.582 1.153 . . . . 0.0 109.934 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.36 20.91 53.64 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 120.898 -1.127 . . . . 0.0 111.901 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.9 mt -113.29 90.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.71 79.03 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.69 0.796 . . . . 0.0 110.627 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.09 4.57 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.008 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.9 m -54.18 -25.8 24.62 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.785 1.175 . . . . 0.0 112.592 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -78.35 -17.35 56.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.637 1.175 . . . . 0.0 113.186 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -70.69 169.25 14.82 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.863 0.756 . . . . 0.0 110.131 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.7 p -145.96 163.76 34.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.594 1.557 . . . . 0.0 108.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -111.37 150.85 29.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.13 0.972 . . . . 0.0 109.703 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.5 t0 -149.62 160.18 43.71 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.141 2.176 . . . . 0.0 108.746 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -89.77 164.51 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.56 139.74 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.649 0.738 . . . . 0.0 111.846 -170.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -128.64 104.71 7.81 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 107.99 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 p -57.07 -24.76 56.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.842 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.41 -22.06 66.66 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.951 1.251 . . . . 0.0 112.286 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -108.57 -45.8 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 92' ' ' THR . 0.6 OUTLIER -54.48 -40.97 69.01 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.183 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.06 -15.56 63.48 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.953 1.251 . . . . 0.0 113.575 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -106.02 -6.99 18.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.522 1.129 . . . . 0.0 111.137 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.97 155.09 35.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 118.311 0.505 . . . . 0.0 110.101 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.05 -32.73 44.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.307 -0.871 . . . . 0.0 108.885 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -144.28 140.4 29.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.536 1.134 . . . . 0.0 109.714 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.22 134.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.21 106.94 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 p -76.54 147.89 37.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.16 2.63 13.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.868 0.467 . . . . 0.0 110.953 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.3 p -151.86 147.73 26.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.18 -45.39 96.62 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.87 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.19 -32.85 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.409 0.604 . . . . 0.0 111.662 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.83 -26.8 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.31 -18.77 64.92 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.62 -35.61 81.07 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.064 0.946 . . . . 0.0 111.927 172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.26 -36.83 66.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.022 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.13 110.26 1.26 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.902 1.281 . . . . 0.0 110.938 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.552 2.834 . . . . 0.0 109.743 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -43.76 110.34 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.011 1.724 . . . . 0.0 111.765 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.413 HG23 HD21 ' A' ' 72' ' ' LEU . 1.1 p -133.16 72.49 75.97 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.93 168.07 12.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.479 2.786 . . . . 0.0 110.752 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -49.99 -23.79 9.68 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.53 3.487 . . . . 0.0 117.87 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -54.69 -40.86 69.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.605 1.093 . . . . 0.0 110.356 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.66 97.7 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.746 2.019 . . . . 0.0 107.556 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -72.02 159.59 33.95 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -131.22 148.51 52.71 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.386 0.675 . . . . 0.0 109.271 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.81 148.45 37.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -132.91 106.88 7.96 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -102.52 170.01 8.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.211 1.404 . . . . 0.0 108.081 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.27 106.68 0.5 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.432 -168.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -138.52 140.82 39.29 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.868 0.867 . . . . 0.0 111.73 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.79 168.99 10.43 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.546 0.738 . . . . 0.0 109.286 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -74.43 112.64 18.12 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.77 -34.07 51.38 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.547 1.498 . . . . 0.0 112.311 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.13 -15.18 62.89 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.029 0.831 . . . . 0.0 112.513 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -118.95 20.79 12.67 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.201 1.401 . . . . 0.0 110.979 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.1 67.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 55.07 -160.59 0.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.027 1.731 . . . . 0.0 112.237 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.95 -70.33 0.68 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -159.95 163.72 33.96 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -59.17 -40.63 86.22 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.828 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.05 -31.56 70.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.603 -0.237 . . . . 0.0 111.09 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -75.57 -38.02 59.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.355 0.662 . . . . 0.0 110.195 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -60.27 -50.01 75.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.154 0.982 . . . . 0.0 109.491 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -60.77 -42.9 98.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.069 0.395 . . . . 0.0 110.727 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.65 -37.51 76.13 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.919 0.488 . . . . 0.0 110.622 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.31 -35.46 76.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.56 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -54.94 -44.29 74.16 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.104 1.32 . . . . 0.0 108.485 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -60.58 -41.82 95.42 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.957 0.344 . . . . 0.0 111.197 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -64.03 -51.22 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.28 -46.45 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.784 -1.103 . . . . 0.0 109.67 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -62.73 -41.65 99.27 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.551 1.523 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.77 -44.67 96.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.001 0.364 . . . . 0.0 110.168 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.16 -42.26 76.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.275 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.06 -45.7 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.613 1.097 . . . . 0.0 108.719 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.14 94.35 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -57.28 -45.93 83.62 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.933 0.893 . . . . 0.0 111.781 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.63 -35.23 79.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.612 1.096 . . . . 0.0 111.91 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 131' ' ' LEU . 4.0 mm? -69.49 -41.46 76.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.757 1.162 . . . . 0.0 110.816 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.63 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 110.578 173.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.77 -52.86 63.74 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.643 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -55.25 -46.41 76.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 120.249 1.386 . . . . 0.0 109.966 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.78 90.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.245 0.618 . . . . 0.0 111.555 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -84.52 -37.46 21.24 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.534 0.734 . . . . 0.0 111.777 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 44.2 p -92.88 -23.66 18.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.597 0.759 . . . . 0.0 111.081 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.9 42.43 99.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.808 2.043 . . . . 0.0 112.468 -169.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -141.02 157.29 45.53 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 106.851 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -153.68 -43.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.445 0.698 . . . . 0.0 110.775 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 48.0 mtmt -134.61 169.3 17.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.846 1.659 . . . . 0.0 107.577 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.92 134.36 53.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -124.39 132.74 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -129.1 105.54 8.25 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.835 0.854 . . . . 0.0 108.714 -170.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -75.59 147.54 39.52 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.941 -0.474 . . . . 0.0 110.216 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -145.4 127.11 15.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.95 174.52 11.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.335 0.654 . . . . 0.0 110.104 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -66.86 -12.77 60.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.73 -1.231 . . . . 0.0 112.997 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.42 122.82 1.21 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 106.326 -2.709 . . . . 0.0 106.326 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -59.69 -45.92 90.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.876 0.87 . . . . 0.0 110.744 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -38.18 -30.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 130.089 3.356 . . . . 0.0 117.279 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.3 m -120.51 -71.21 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.431 0.693 . . . . 0.0 110.195 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -66.74 -49.77 64.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.77 -169.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -63.87 -43.99 94.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.402 0.547 . . . . 0.0 109.623 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -57.73 -45.88 85.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.317 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 45.1 mtm -67.29 -45.34 76.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.258 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.14 -44.6 75.24 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.715 0.689 . . . . 0.0 111.048 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.88 -44.71 94.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.586 0.754 . . . . 0.0 110.468 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.97 -50.8 53.51 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.178 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -68.21 -37.21 80.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.752 1.776 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.96 79.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.553 -0.717 . . . . 0.0 111.247 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -59.09 -32.72 70.06 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.658 -0.651 . . . . 0.0 112.072 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.82 -49.43 18.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.43 0.692 . . . . 0.0 109.359 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -79.76 -34.88 39.46 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -170.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.77 -35.54 12.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.499 0.59 . . . . 0.0 112.017 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.22 -178.72 49.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.195 0.902 . . . . 0.0 112.793 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.02 -6.04 25.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.56 -8.69 4.64 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.044 1.738 . . . . 0.0 110.729 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.421 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 4.3 m95 -138.15 157.94 45.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 108.561 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -111.95 142.09 44.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 168.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.8 126.83 67.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.65 171.11 14.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 109.668 172.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.4 m -135.52 142.34 45.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.753 1.221 . . . . 0.0 110.261 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.69 -174.72 4.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.279 1.432 . . . . 0.0 108.925 169.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.44 175.95 41.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.01 -41.87 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.23 179.34 7.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.543 0.737 . . . . 0.0 110.083 170.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.8 42.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.295 2.238 . . . . 0.0 106.306 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -136.7 -19.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.58 0.752 . . . . 0.0 111.686 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.1 -178.0 40.91 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 170.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -77.75 100.72 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.57 122.77 73.29 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.33 -171.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.5 -32.01 41.6 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.183 2.588 . . . . 0.0 113.521 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -39.84 92.79 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.812 0.733 . . . . 0.0 110.801 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.84 75.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.11 -54.78 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -66.89 -41.58 86.96 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.588 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.53 -46.09 84.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.516 0.598 . . . . 0.0 110.818 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 84.4 mmm -73.81 -37.44 64.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.462 0.574 . . . . 0.0 111.326 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.336 -0.852 . . . . 0.0 111.342 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -66.22 -19.35 65.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.669 0.788 . . . . 0.0 112.177 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.37 -4.6 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.862 1.265 . . . . 0.0 110.374 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.76 23.03 65.24 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.763 -1.211 . . . . 0.0 111.916 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -111.98 93.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.15 86.45 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.441 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 pt -79.31 5.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.275 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -57.01 -26.18 59.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.851 1.659 . . . . 0.0 112.345 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -74.77 -17.65 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.406 1.082 . . . . 0.0 112.807 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.03 170.27 14.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.59 0.756 . . . . 0.0 110.109 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 p -146.68 160.36 42.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.49 1.516 . . . . 0.0 108.554 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.9 m -108.34 151.74 25.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.049 0.94 . . . . 0.0 109.729 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.0 t0 -153.05 161.16 42.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.205 2.202 . . . . 0.0 108.378 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 pt -91.54 163.65 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.12 133.98 20.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.394 0.678 . . . . 0.0 111.942 -169.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -123.11 112.67 18.02 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 107.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.8 p -57.06 -24.21 52.25 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 111.508 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.88 -22.58 67.02 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.67 1.188 . . . . 0.0 112.873 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.82 -43.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.956 0.798 . . . . 0.0 108.937 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tp -48.6 -51.11 29.64 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.251 1.02 . . . . 0.0 110.782 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.1 -15.77 62.75 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -104.19 -16.91 15.08 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.18 0.992 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.96 58.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.775 0.43 . . . . 0.0 109.868 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.24 -33.74 76.43 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.9 tp -144.33 141.62 29.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.202 1.401 . . . . 0.0 109.702 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.35 132.3 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 109.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.08 88.24 7.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.67 -10.55 19.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.087 1.755 . . . . 0.0 114.357 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 35.0 t -148.66 157.71 43.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 120.834 1.652 . . . . 0.0 110.197 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.98 -59.29 9.59 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.259 1.885 . . . . 0.0 112.191 -170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.48 -26.9 66.59 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.536 0.334 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.29 72.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.795 0.438 . . . . 0.0 111.592 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.11 -20.11 65.07 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.05 -29.8 70.72 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.691 0.678 . . . . 0.0 112.277 176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -77.4 -32.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 117.303 -1.332 . . . . 0.0 113.344 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -47.23 108.44 0.88 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.297 1.039 . . . . 0.0 111.031 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.17 -34.99 26.36 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.901 1.734 . . . . 0.0 113.011 -169.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 125.79 1.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.9 p -128.15 82.4 68.55 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.53 173.31 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.633 2.889 . . . . 0.0 110.79 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.21 -29.35 16.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.882 3.054 . . . . 0.0 116.104 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -68.77 -8.04 39.46 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.185 0.994 . . . . 0.0 113.064 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.31 80.95 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.945 2.498 . . . . 0.0 104.732 -170.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 13.7 pttt -64.94 164.99 11.59 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.736 0.779 . . . . 0.0 108.948 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -127.53 150.1 49.84 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 109.561 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.37 153.17 44.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -147.59 139.15 23.88 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -139.52 -169.27 2.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.658 1.583 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.0 41.58 1.29 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.098 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -80.34 119.17 22.7 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.958 1.379 . . . . 0.0 112.597 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.21 150.64 43.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.062 0.945 . . . . 0.0 109.603 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -74.2 121.12 84.47 Favored Pre-proline 0 C--O 1.236 0.373 0 O-C-N 121.999 -0.438 . . . . 0.0 111.858 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.43 -32.14 26.14 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.834 1.69 . . . . 0.0 112.678 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.76 65.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.767 0.712 . . . . 0.0 112.362 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -100.18 -0.96 37.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.688 1.195 . . . . 0.0 111.594 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.9 148.68 29.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -159.01 164.47 35.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.817 0.447 . . . . 0.0 110.655 -171.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.24 -48.66 0.64 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -164.99 165.68 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.277 2.231 . . . . 0.0 105.416 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.14 -40.51 81.53 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.556 -0.715 . . . . 0.0 110.638 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.38 -28.48 65.12 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.377 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.32 -44.94 58.03 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.92 0.782 . . . . 0.0 109.194 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -56.02 -50.37 71.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.588 0.755 . . . . 0.0 109.75 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.93 -44.86 95.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.989 0.359 . . . . 0.0 110.505 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.9 75.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.602 0.637 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.57 -36.92 85.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.342 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -54.95 -53.37 56.56 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.634 1.106 . . . . 0.0 108.274 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.516 ' NE2' HH21 ' A' ' 124' ' ' ARG . 6.3 mm100 -58.1 -43.22 87.01 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.864 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -61.15 -49.41 77.35 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.58 0.627 . . . . 0.0 110.606 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.28 -45.89 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.891 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.516 HH21 ' NE2' ' A' ' 121' ' ' GLN . 47.6 ptt85 -61.88 -40.81 96.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.44 1.927 . . . . 0.0 111.087 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.48 -44.72 95.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.25 0.477 . . . . 0.0 109.793 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.28 -32.51 61.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.045 -0.979 . . . . 0.0 112.858 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -65.32 -42.82 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.697 1.135 . . . . 0.0 108.644 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.78 -46.46 82.85 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -58.56 -36.23 73.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.303 1.041 . . . . 0.0 111.41 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -51.41 70.05 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.587 0.755 . . . . 0.0 109.379 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 14.8 mt -72.89 -31.78 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.251 -173.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.27 -51.91 67.53 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.777 0.831 . . . . 0.0 110.828 169.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.68 -49.21 75.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 119.299 0.954 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -55.32 -39.35 69.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.584 0.629 . . . . 0.0 111.055 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.43 -47.42 49.17 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.767 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.51 -37.5 71.22 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.612 1.165 . . . . 0.0 110.91 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 39.0 p -90.61 -22.63 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.001 0.92 . . . . 0.0 110.163 -175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.68 41.48 99.6 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.083 1.353 . . . . 0.0 111.015 -175.252 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.92 151.34 45.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 111.17 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -143.76 -41.24 0.28 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.994 0.918 . . . . 0.0 111.022 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -124.69 167.74 14.13 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.724 0.81 . . . . 0.0 110.631 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.7 138.45 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tt -121.57 138.83 50.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -132.04 106.21 7.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -75.82 146.64 39.75 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.565 0.746 . . . . 0.0 110.546 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.02 130.19 20.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t -148.46 171.21 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.984 0.811 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -67.58 -9.64 44.66 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.148 -0.97 . . . . 0.0 113.4 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 118.36 0.82 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 106.652 -2.579 . . . . 0.0 106.652 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.61 -43.19 99.42 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.811 0.844 . . . . 0.0 112.107 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 m -43.33 -22.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.06 3.344 . . . . 0.0 117.336 -169.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -128.78 -71.7 0.63 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.295 0.952 . . . . 0.0 110.947 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -58.68 -49.14 78.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.371 0.532 . . . . 0.0 111.336 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 1.4 m -72.01 -36.15 69.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.863 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -62.73 -42.07 99.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.897 0.479 . . . . 0.0 111.313 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.6 mtm -66.2 -46.62 76.66 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.693 0.679 . . . . 0.0 110.258 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.45 77.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.898 0.479 . . . . 0.0 110.64 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -57.2 -44.6 83.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.528 1.131 . . . . 0.0 110.559 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.08 90.15 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.889 -0.95 . . . . 0.0 112.59 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.61 -38.43 83.94 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.468 1.634 . . . . 0.0 110.613 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.71 85.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.652 0.381 . . . . 0.0 111.701 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -58.64 -29.12 66.29 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.858 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -73.67 -59.6 2.64 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.685 0.675 . . . . 0.0 110.559 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -71.28 -42.52 68.62 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.05 -39.59 33.5 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.643 0.377 . . . . 0.0 110.694 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.76 53.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.481 1.039 . . . . 0.0 112.858 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.41 -17.1 58.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.754 1.622 . . . . 0.0 113.601 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.36 -21.21 5.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.595 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -127.04 161.92 27.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 110.711 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -112.0 144.43 41.36 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.1 t -134.21 124.52 46.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.3 172.59 12.6 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 17' ' ' SER . 74.8 p -141.74 154.82 45.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.71 -163.81 1.74 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.79 1.236 . . . . 0.0 108.15 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.78 175.01 44.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.86 -41.36 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.4 173.72 11.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.791 0.836 . . . . 0.0 110.163 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.35 157.14 42.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.677 1.991 . . . . 0.0 107.989 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -134.79 -32.67 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.767 1.227 . . . . 0.0 110.707 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.89 -173.41 33.9 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.47 109.63 9.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 170.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -70.03 132.79 88.22 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.64 -28.48 60.72 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.018 1.812 . . . . 0.0 112.997 -169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -39.13 91.54 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.972 0.806 . . . . 0.0 110.847 174.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.55 -37.87 65.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.78 -59.72 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -63.32 -40.99 98.85 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.96 0.8 . . . . 0.0 110.513 -173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.1 -46.51 72.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 111.362 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.4 mmm -77.48 -38.58 48.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.173 0.589 . . . . 0.0 111.495 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -60.95 -34.6 74.98 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.579 -0.701 . . . . 0.0 110.051 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -68.94 -22.01 64.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.6 t -76.08 -26.2 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 119.53 1.059 . . . . 0.0 109.371 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.04 23.63 9.64 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.796 1.189 . . . . 0.0 110.511 -169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.2 mt -118.75 101.93 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.98 129.92 40.78 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 pt -118.33 -2.02 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.584 0.753 . . . . 0.0 110.714 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -29.15 69.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.421 1.01 . . . . 0.0 110.695 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.67 -16.68 64.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.752 1.621 . . . . 0.0 113.537 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -75.29 176.1 7.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.952 0.901 . . . . 0.0 109.037 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -141.93 153.54 44.44 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.843 1.257 . . . . 0.0 108.744 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -107.44 147.24 30.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 109.87 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.87 158.47 40.82 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.851 1.261 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 pt -88.7 162.47 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 137.66 16.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.018 0.927 . . . . 0.0 111.73 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -126.28 114.85 18.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.22 1.408 . . . . 0.0 108.058 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -56.4 -28.6 59.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.723 0.809 . . . . 0.0 111.377 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.72 0.5 8.7 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.786 1.634 . . . . 0.0 113.475 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -120.88 -46.99 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp -45.79 -52.76 10.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.468 1.107 . . . . 0.0 111.395 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -5.78 22.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -132.51 5.16 4.01 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.675 1.19 . . . . 0.0 112.541 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.7 47.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.37 -33.2 67.06 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.8 tp -143.03 142.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.062 1.345 . . . . 0.0 109.18 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.31 134.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.49 134.12 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 118.958 0.799 . . . . 0.0 108.861 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 86' ' ' ALA . 9.7 p -98.53 98.27 9.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.5 -12.26 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.256 1.422 . . . . 0.0 113.598 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.65 147.37 33.0 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.67 -38.34 95.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.405 0.526 . . . . 0.0 112.342 -169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.95 -25.23 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.164 0.982 . . . . 0.0 111.731 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.7 -23.96 60.94 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.284 0.634 . . . . 0.0 111.689 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -64.14 -20.69 66.16 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.8 -32.63 70.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.096 0.558 . . . . 0.0 111.949 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -86.79 62.09 7.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.875 0.87 . . . . 0.0 110.588 -173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 77.0 m -120.21 75.15 22.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 108.391 172.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.04 -28.48 80.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.436 2.091 . . . . 0.0 114.659 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 ttp -158.76 99.28 1.55 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.939 0.896 . . . . 0.0 109.942 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p -128.37 73.7 80.07 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.452 1.101 . . . . 0.0 108.351 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.93 171.07 10.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.3 2.666 . . . . 0.0 110.856 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.34 -21.99 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.193 3.262 . . . . 0.0 116.456 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -63.27 -11.82 24.49 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 112.897 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.3 94.39 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 128.015 2.526 . . . . 0.0 105.273 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -70.81 165.25 23.55 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 98' ' ' ARG . 3.5 mtp85 -135.47 153.81 51.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.243 0.617 . . . . 0.0 111.671 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.54 167.08 23.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.58 6.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.844 0.858 . . . . 0.0 110.369 -169.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -115.27 -174.11 2.44 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.824 1.249 . . . . 0.0 109.405 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.63 43.64 1.19 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.239 -0.913 . . . . 0.0 114.231 -168.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -84.31 108.04 16.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.261 1.03 . . . . 0.0 111.819 -172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -63.37 152.6 37.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.018 0.927 . . . . 0.0 109.734 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -71.5 116.43 47.46 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 122.915 0.486 . . . . 0.0 111.713 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.21 -34.42 16.45 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.089 1.86 . . . . 0.0 112.1 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.47 -16.35 64.05 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.46 0.573 . . . . 0.0 112.076 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -111.53 14.95 21.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.978 1.311 . . . . 0.0 111.055 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.83 -43.8 90.74 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.651 0.659 . . . . 0.0 111.684 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 50.36 -161.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.095 1.758 . . . . 0.0 112.32 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.49 -69.83 0.21 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.877 1.703 . . . . 0.0 109.122 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -154.1 156.53 37.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -60.29 -38.76 84.6 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.264 0.938 . . . . 0.0 111.105 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.71 -32.34 72.91 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.257 -0.277 . . . . 0.0 111.106 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.09 -42.12 60.62 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.382 0.673 . . . . 0.0 109.877 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -58.46 -50.47 73.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.367 1.467 . . . . 0.0 110.149 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -62.01 -42.57 99.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 122.875 0.47 . . . . 0.0 110.619 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.03 72.7 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.784 0.72 . . . . 0.0 110.813 177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.86 -40.27 83.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.737 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -56.41 -46.44 80.19 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -58.48 -48.74 79.78 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.663 0.785 . . . . 0.0 111.117 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -59.55 -50.09 75.24 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.077 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.5 t -66.32 -44.6 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.223 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.05 -44.09 97.43 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 121.992 2.178 . . . . 0.0 110.627 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.74 -43.3 99.12 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.95 -38.03 66.91 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.604 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -42.26 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.774 1.625 . . . . 0.0 108.617 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.35 -46.78 93.72 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.428 ' ND2' HH21 ' A' ' 130' ' ' ARG . 45.5 t30 -59.23 -43.04 92.35 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.276 1.03 . . . . 0.0 112.008 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.428 HH21 ' ND2' ' A' ' 129' ' ' ASN . 4.3 mmp_? -60.84 -46.04 92.15 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.612 -0.68 . . . . 0.0 110.29 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.12 -41.11 90.96 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.258 0.481 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.34 -48.58 73.98 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.857 0.863 . . . . 0.0 110.246 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.88 -48.32 82.34 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.31 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.5 -44.5 85.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.873 1.215 . . . . 0.0 109.852 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.33 85.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.776 0.431 . . . . 0.0 111.148 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -82.15 -38.95 23.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.418 1.087 . . . . 0.0 111.226 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 47.5 p -94.05 -22.95 18.2 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.203 0.601 . . . . 0.0 111.115 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.57 43.0 98.0 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.964 1.706 . . . . 0.0 112.707 -169.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -136.54 170.95 15.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.055 1.342 . . . . 0.0 108.234 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -144.49 -46.96 0.25 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.031 0.533 . . . . 0.0 110.687 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -141.99 170.67 15.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.62 142.59 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 118.758 0.708 . . . . 0.0 109.791 -168.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.25 135.76 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.86 104.16 6.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.33 0.652 . . . . 0.0 109.38 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -77.4 149.54 35.15 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.795 0.838 . . . . 0.0 110.532 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.77 132.42 14.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -149.95 171.96 15.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.264 1.393 . . . . 0.0 110.916 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -64.18 -13.32 47.79 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.948 -1.095 . . . . 0.0 112.93 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 119.21 0.9 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 105.367 -3.093 . . . . 0.0 105.367 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.3 t-20 -56.3 -43.01 78.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.771 0.828 . . . . 0.0 110.46 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -30.8 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 132.626 4.37 . . . . 0.0 118.06 -169.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -135.82 -58.83 0.76 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.654 0.661 . . . . 0.0 111.659 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -61.69 -50.54 72.04 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.025 0.83 . . . . 0.0 110.973 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -68.74 -38.28 80.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.226 0.466 . . . . 0.0 110.815 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -61.59 -43.7 98.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.776 0.716 . . . . 0.0 111.817 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 74.7 mtm -67.41 -46.85 72.01 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.27 0.486 . . . . 0.0 109.814 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.59 -42.0 74.18 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.274 0.488 . . . . 0.0 111.055 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.25 -48.15 82.97 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.051 0.54 . . . . 0.0 110.186 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.99 -50.86 53.37 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.574 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.8 m95 -67.18 -37.71 84.17 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.632 1.716 . . . . 0.0 110.851 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.05 82.72 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.219 0.918 . . . . 0.0 111.627 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -60.45 -27.17 67.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.192 0.906 . . . . 0.0 112.255 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.42 -47.1 13.66 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.615 0.766 . . . . 0.0 109.872 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -77.61 -28.63 51.55 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.07 -145.69 0.31 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.162 1.385 . . . . 0.0 108.297 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 -170.58 42.89 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 119.22 0.918 . . . . 0.0 111.857 -171.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.85 -19.07 63.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.707 1.603 . . . . 0.0 113.668 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.91 -12.12 10.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.859 1.264 . . . . 0.0 112.013 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -129.24 162.32 28.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.014 1.326 . . . . 0.0 110.782 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.2 132.13 53.05 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 168.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.15 137.05 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -137.25 163.88 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.548 0.739 . . . . 0.0 109.307 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -140.14 128.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.79 -173.11 3.21 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.757 1.223 . . . . 0.0 108.585 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.38 171.44 41.38 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.84 -41.02 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.93 179.36 7.23 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.005 0.922 . . . . 0.0 109.257 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.85 121.82 10.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.76 1.624 . . . . 0.0 106.652 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.25 -34.78 36.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.41 -173.82 37.04 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.902 2.191 . . . . 0.0 107.693 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.28 105.29 11.44 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.93 130.87 86.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.969 -169.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -53.85 -34.34 75.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.53 2.82 . . . . 0.0 113.724 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.38 78.42 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.43 0.559 . . . . 0.0 111.181 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.47 63.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.42 -53.5 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -65.72 -42.88 90.56 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 119.065 0.848 . . . . 0.0 110.383 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.52 72.15 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.64 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 83.4 mmm -83.22 -37.52 23.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.713 0.688 . . . . 0.0 111.526 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -65.68 -29.83 70.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.302 -0.874 . . . . 0.0 110.934 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.53 -18.77 65.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.111 0.964 . . . . 0.0 112.248 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.12 -9.71 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.48 1.112 . . . . 0.0 109.99 170.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.55 21.45 56.28 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 -169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -111.75 90.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.146 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.83 77.76 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 110.245 -172.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.05 3.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 111.868 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 m -53.86 -26.42 24.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.462 1.105 . . . . 0.0 112.46 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -79.79 -12.04 59.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.003 1.321 . . . . 0.0 113.593 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -74.32 172.79 11.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.259 0.936 . . . . 0.0 109.238 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -146.84 161.58 40.4 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 107.783 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.2 m -104.06 151.45 23.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.643 0.777 . . . . 0.0 109.628 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -147.39 159.81 43.27 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.945 2.098 . . . . 0.0 108.496 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -89.6 165.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 142.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.037 0.935 . . . . 0.0 112.31 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -132.22 104.24 6.67 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.364 1.865 . . . . 0.0 108.383 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 p -56.9 -26.34 58.89 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -69.8 -4.86 21.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.24 1.016 . . . . 0.0 112.79 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.82 -48.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.61 -44.49 57.08 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.815 0.734 . . . . 0.0 112.158 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -3.68 17.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -135.48 10.65 3.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.984 1.314 . . . . 0.0 112.185 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.32 152.93 36.5 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.07 -36.26 79.55 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.866 1.212 . . . . 0.0 108.629 170.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.54 155.42 43.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.872 0.844 . . . . 0.0 112.28 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -113.56 138.87 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 102.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.7 p -76.08 147.96 38.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 3.13 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.01 0.524 . . . . 0.0 112.127 -169.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.81 162.19 40.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.357 0.981 . . . . 0.0 108.396 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.07 97.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.44 -35.63 73.47 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.096 0.948 . . . . 0.0 111.18 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.67 -23.66 67.23 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.066 0.546 . . . . 0.0 112.405 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.56 -29.44 59.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.466 0.707 . . . . 0.0 112.373 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.36 -32.7 74.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.209 0.604 . . . . 0.0 112.261 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -86.9 58.61 5.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.389 0.676 . . . . 0.0 110.59 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.96 81.21 12.04 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.76 -35.46 98.6 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.828 2.352 . . . . 0.0 114.384 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -159.31 125.36 4.39 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.153 0.981 . . . . 0.0 108.356 169.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -138.94 79.96 25.75 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.35 169.87 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.073 2.515 . . . . 0.0 110.846 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.66 -18.95 6.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.407 3.405 . . . . 0.0 116.378 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -61.56 -13.81 24.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.15 0.98 . . . . 0.0 112.691 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 t -127.95 109.25 19.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.177 2.191 . . . . 0.0 106.542 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.04 167.75 20.04 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -135.62 150.37 49.62 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.529 0.732 . . . . 0.0 109.846 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 153.8 43.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 169.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -138.3 84.57 2.04 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -169.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -79.53 176.45 9.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.943 1.297 . . . . 0.0 109.446 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.3 93.96 0.19 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.327 -168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -131.93 121.43 23.99 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.831 0.853 . . . . 0.0 111.131 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -64.77 152.25 43.14 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.621 1.168 . . . . 0.0 109.92 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -69.76 114.91 28.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.057 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -31.67 29.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.018 1.812 . . . . 0.0 112.707 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.9 -15.21 62.74 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.592 0.633 . . . . 0.0 112.053 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -115.63 22.15 13.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.617 1.567 . . . . 0.0 110.732 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.01 -27.04 69.15 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 43.51 -147.53 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.985 2.114 . . . . 0.0 113.275 -175.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.6 -73.12 1.43 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.5 166.17 16.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.534 2.334 . . . . 0.0 105.623 172.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.84 -40.21 79.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.353 0.979 . . . . 0.0 111.447 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.65 -28.97 63.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.442 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.45 -39.78 67.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.981 0.809 . . . . 0.0 109.322 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.22 -48.14 82.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 109.832 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -61.03 -43.06 99.45 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.299 0.5 . . . . 0.0 110.573 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.19 -32.9 70.33 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.597 -0.689 . . . . 0.0 110.911 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -74.75 -35.51 62.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.023 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -53.57 -45.42 69.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.96 1.254 . . . . 0.0 108.809 169.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -58.25 -46.92 85.09 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 123.027 0.531 . . . . 0.0 111.3 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -61.39 -50.96 70.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 119.003 -0.522 . . . . 0.0 109.949 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.21 -44.3 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.206 -1.378 . . . . 0.0 109.903 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -63.15 -43.28 98.77 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 121.565 1.984 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.38 -42.74 99.2 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.514 0.325 . . . . 0.0 110.266 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.72 -45.44 71.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.343 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -61.27 -40.7 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.034 1.288 . . . . 0.0 108.87 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.12 85.36 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -56.98 -41.5 78.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.251 1.02 . . . . 0.0 112.218 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -65.16 -41.46 94.67 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.35 -0.844 . . . . 0.0 110.174 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.76 -36.74 78.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.476 1.035 . . . . 0.0 111.475 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -49.6 76.47 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.679 0.792 . . . . 0.0 110.092 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.77 -48.32 81.18 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.757 0.708 . . . . 0.0 109.915 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.01 -38.6 70.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.212 0.915 . . . . 0.0 111.154 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.57 -45.86 61.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -76.49 -38.62 54.97 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.244 1.018 . . . . 0.0 111.72 -172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.4 p -94.35 -16.81 23.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.576 1.15 . . . . 0.0 111.05 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.06 92.0 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.906 1.283 . . . . 0.0 112.037 -169.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.36 160.46 43.3 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.444 1.098 . . . . 0.0 108.141 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -161.3 -38.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.559 0.744 . . . . 0.0 111.825 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 42.4 mtmt -133.05 171.14 14.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.477 1.511 . . . . 0.0 108.679 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.3 mt -136.1 139.28 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tt -125.76 135.48 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -130.92 111.88 12.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.87 141.01 31.62 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.6 140.67 52.72 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -154.86 169.68 23.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.298 0.639 . . . . 0.0 109.445 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -71.03 -7.83 49.08 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.77 119.17 0.85 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 57.7 t-20 -77.36 72.53 3.91 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.352 1.061 . . . . 0.0 109.017 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.1 p -134.13 -30.96 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.311 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 m -134.75 -67.69 0.56 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.911 0.778 . . . . 0.0 111.63 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -57.79 -50.55 72.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.927 0.491 . . . . 0.0 111.74 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -64.43 -36.81 85.39 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.25 0.477 . . . . 0.0 111.618 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.51 -42.5 71.24 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.822 . . . . 0.0 110.85 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -62.06 -51.63 67.17 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.56 76.69 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.929 0.492 . . . . 0.0 110.969 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.68 -48.55 81.22 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.287 0.635 . . . . 0.0 109.97 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.82 -46.78 93.49 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.616 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.7 m95 -66.87 -41.87 86.55 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.065 1.433 . . . . 0.0 110.908 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.45 80.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.514 0.597 . . . . 0.0 111.055 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -57.45 -34.33 68.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.805 176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -68.66 -58.62 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.366 0.53 . . . . 0.0 110.132 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -70.72 -36.44 73.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -169.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 42.8 mt -91.49 -36.69 13.6 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.78 -177.84 46.82 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.856 0.741 . . . . 0.0 112.723 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.54 -8.66 49.13 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.89 -9.79 2.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 110.972 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 9.6 m95 -136.36 166.42 23.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.835 1.654 . . . . 0.0 108.945 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.05 146.35 47.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 167.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.2 121.77 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -168.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.01 165.88 24.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.459 0.647 . . . . 0.0 109.841 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p -132.34 139.03 47.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.879 1.272 . . . . 0.0 108.427 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.59 -175.66 4.45 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.491 1.517 . . . . 0.0 108.565 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.04 177.19 46.39 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 121.802 -0.562 . . . . 0.0 111.891 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.53 -41.64 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.812 1.245 . . . . 0.0 108.569 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.89 177.42 8.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.82 0.848 . . . . 0.0 109.546 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.98 166.62 29.08 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.981 1.712 . . . . 0.0 108.714 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -148.26 -46.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.587 1.155 . . . . 0.0 108.12 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.74 25.91 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.62 122.53 14.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -74.24 141.44 77.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.661 -172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.11 -34.69 69.6 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.922 2.415 . . . . 0.0 113.715 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -35.43 78.96 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.719 0.691 . . . . 0.0 111.812 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.55 -42.1 68.29 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.01 -55.51 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.37 -44.41 96.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.4 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.13 88.74 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.087 0.858 . . . . 0.0 111.215 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 99.6 mmm -73.46 -39.93 64.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.7 0.4 . . . . 0.0 110.403 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.6 tttp -64.78 -33.5 76.14 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.141 0.976 . . . . 0.0 110.977 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.54 -15.29 62.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.791 1.236 . . . . 0.0 112.232 173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.64 1.91 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.174 1.39 . . . . 0.0 109.781 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.1 18.29 72.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.661 -1.274 . . . . 0.0 112.299 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.57 93.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.09 77.8 5.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.46 0.704 . . . . 0.0 110.515 -172.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.4 pt -73.99 1.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.904 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -53.68 -27.94 30.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.99 1.268 . . . . 0.0 112.511 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.91 -22.37 61.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.061 1.344 . . . . 0.0 113.054 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -71.51 168.03 18.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.083 0.953 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -145.23 164.98 29.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.492 1.917 . . . . 0.0 108.115 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.2 m -108.68 158.26 17.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.531 0.681 . . . . 0.0 110.773 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 47.3 t0 -153.2 159.75 42.7 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.918 2.087 . . . . 0.0 107.499 172.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -88.44 166.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.02 108.52 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.152 0.981 . . . . 0.0 111.274 -170.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -94.03 114.56 26.76 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -18.76 62.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.245 1.418 . . . . 0.0 112.559 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.07 -47.7 60.83 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.121 0.873 . . . . 0.0 110.974 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.9 -42.65 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -48.85 -49.31 40.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.21 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -76.26 -12.96 60.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -92.75 -17.63 23.96 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.283 0.947 . . . . 0.0 110.903 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.74 50.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.168 0.44 . . . . 0.0 111.568 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.16 -37.5 75.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.71 162.59 39.44 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.931 0.872 . . . . 0.0 112.811 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -119.72 141.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.7 t -131.03 111.49 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 86' ' ' ALA . 52.0 p -90.18 103.08 15.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.25 -8.97 50.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.328 0.651 . . . . 0.0 112.287 -172.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -143.6 154.21 43.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.51 95.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.26 -32.07 73.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.591 0.695 . . . . 0.0 111.557 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.75 70.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.258 0.481 . . . . 0.0 111.794 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -67.0 -17.5 64.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.3 -31.54 72.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.568 0.622 . . . . 0.0 111.811 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.2 -28.51 57.28 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.175 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 m -47.06 108.01 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.4 1.08 . . . . 0.0 111.016 -169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.25 -38.73 8.47 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.957 1.771 . . . . 0.0 114.526 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 13.7 tpt -165.74 132.01 2.64 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.316 1.046 . . . . 0.0 109.166 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.7 p -137.88 96.42 10.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.74 168.39 20.28 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.889 2.393 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -50.86 -26.17 17.39 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.037 3.158 . . . . 0.0 115.85 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -66.17 -7.14 16.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.365 1.066 . . . . 0.0 113.077 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.65 97.03 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.96 2.104 . . . . 0.0 105.58 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 163.62 27.12 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.254 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -141.84 128.53 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.45 155.67 45.34 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.072 1.349 . . . . 0.0 108.054 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -137.64 143.23 41.29 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.506 0.722 . . . . 0.0 111.665 -169.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -139.28 -170.99 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.724 1.609 . . . . 0.0 108.553 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.91 45.2 0.98 Allowed Glycine 0 N--CA 1.468 0.791 0 CA-C-N 119.11 0.868 . . . . 0.0 113.379 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -80.93 122.97 27.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.062 0.931 . . . . 0.0 111.576 -173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -78.19 152.65 32.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.66 127.76 76.89 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 121.698 -0.626 . . . . 0.0 112.47 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.35 -34.22 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.164 1.909 . . . . 0.0 113.375 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -22.05 66.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.282 0.946 . . . . 0.0 112.235 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -100.12 -0.9 38.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.419 1.088 . . . . 0.0 111.146 -177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.75 152.35 23.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -160.81 164.1 31.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.29 0.636 . . . . 0.0 110.358 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.52 -49.53 0.61 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -165.14 166.23 19.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.051 2.14 . . . . 0.0 105.649 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.36 -40.69 82.89 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.753 -0.592 . . . . 0.0 110.579 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.94 -29.05 64.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.346 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.3 -45.05 61.68 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -56.94 -49.85 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.661 0.784 . . . . 0.0 109.964 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -61.59 -44.22 97.41 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.34 0.518 . . . . 0.0 110.398 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -40.28 80.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.321 0.509 . . . . 0.0 110.293 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -62.59 -36.92 84.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.191 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.89 -50.59 70.26 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.327 0.967 . . . . 0.0 108.595 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -61.62 -45.45 94.0 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.045 0.538 . . . . 0.0 110.834 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -59.91 -50.01 75.45 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.271 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.4 -47.41 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 117.449 -1.262 . . . . 0.0 109.945 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -61.73 -41.55 97.78 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 120.828 1.649 . . . . 0.0 110.806 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.74 -41.74 99.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.074 0.397 . . . . 0.0 110.017 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -76.61 -33.8 58.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.619 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.62 -42.11 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.702 1.137 . . . . 0.0 108.069 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.75 -47.11 79.06 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -53.65 -44.48 69.66 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.883 1.273 . . . . 0.0 111.166 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -47.49 85.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 119.249 -0.405 . . . . 0.0 110.908 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.02 -37.24 83.79 Favored 'General case' 0 C--O 1.229 -0.023 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -59.15 -49.07 79.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.782 0.833 . . . . 0.0 110.407 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.61 -45.63 82.38 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.371 0.987 . . . . 0.0 109.65 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -55.39 -38.5 68.97 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.024 0.829 . . . . 0.0 111.016 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.71 -48.98 34.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.601 0.76 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.76 -38.96 73.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.762 1.225 . . . . 0.0 111.32 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 p -90.34 -16.07 29.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.856 0.862 . . . . 0.0 110.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.78 40.63 89.65 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.78 1.232 . . . . 0.0 111.789 -169.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.78 164.28 37.21 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.319 1.047 . . . . 0.0 108.778 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -158.1 -36.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.464 1.506 . . . . 0.0 111.322 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -142.55 169.37 17.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.381 1.472 . . . . 0.0 109.026 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.3 mt -135.98 147.31 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 tt -134.64 142.9 39.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.484 1.114 . . . . 0.0 108.387 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.27 107.22 7.08 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.71 143.39 48.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.991 0.517 . . . . 0.0 109.934 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.08 143.22 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.083 1.753 . . . . 0.0 106.536 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 1.3 t -157.91 170.29 22.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 118.674 0.67 . . . . 0.0 109.53 170.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -66.82 -10.67 50.34 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.118 -0.989 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.98 119.82 0.93 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 55.4 t-20 -56.9 -46.58 81.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.632 0.773 . . . . 0.0 110.355 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 m -42.33 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 130.191 3.396 . . . . 0.0 117.733 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.1 m -119.5 -78.31 0.59 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.002 0.819 . . . . 0.0 109.499 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -61.89 -47.77 83.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.109 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -68.98 -38.25 79.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.063 0.847 . . . . 0.0 110.901 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -43.77 96.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.646 0.657 . . . . 0.0 111.484 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.4 mtp -66.18 -47.32 74.34 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.366 0.666 . . . . 0.0 109.546 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.9 78.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.388 0.675 . . . . 0.0 110.979 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.43 -45.85 80.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.62 0.768 . . . . 0.0 110.129 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.95 -47.29 91.41 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -69.97 -39.14 76.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.38 1.59 . . . . 0.0 111.055 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.1 79.74 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.744 0.417 . . . . 0.0 111.554 -171.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.5 -33.91 64.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.82 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -74.48 -57.33 4.01 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.27 0.486 . . . . 0.0 110.603 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -73.58 -45.0 55.89 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -73.84 -35.71 64.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.486 0.584 . . . . 0.0 111.348 -169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.9 167.99 42.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.973 0.797 . . . . 0.0 111.78 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.78 -12.04 61.31 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -52.81 -31.6 39.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.384 0.611 . . . . 0.0 110.055 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -100.91 150.45 22.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -110.41 125.8 53.63 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 167.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.18 127.2 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -168.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.0 172.0 13.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.629 1.172 . . . . 0.0 108.768 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -137.47 139.67 40.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.118 0.967 . . . . 0.0 109.507 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.09 -175.15 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.344 1.458 . . . . 0.0 109.022 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 10' ' ' CYS . . . -165.03 175.79 40.88 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -42.1 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.51 179.48 7.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.84 0.856 . . . . 0.0 109.815 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.33 151.16 37.88 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.613 1.965 . . . . 0.0 106.964 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -127.84 10.35 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.769 1.227 . . . . 0.0 111.797 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 126.84 -173.54 18.28 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 126.113 1.816 . . . . 0.0 109.035 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.76 109.3 20.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -63.49 124.55 84.86 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.286 -172.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.18 -34.16 38.44 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.288 2.658 . . . . 0.0 113.657 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -38.64 87.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.77 0.714 . . . . 0.0 110.913 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.13 -43.13 75.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.61 -52.14 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -65.97 -41.89 90.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.87 0.759 . . . . 0.0 110.827 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.83 -45.58 82.24 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.839 0.745 . . . . 0.0 110.954 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.7 mmm -75.78 -38.91 57.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.467 0.307 . . . . 0.0 110.903 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.96 -34.02 77.43 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.01 -1.056 . . . . 0.0 110.993 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.84 -20.4 66.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 112.238 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.83 -10.06 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.408 1.083 . . . . 0.0 110.281 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.15 20.05 28.98 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.629 1.109 . . . . 0.0 111.925 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.56 91.35 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -77.49 76.79 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.751 1.22 . . . . 0.0 110.089 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.69 2.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 121.381 -0.824 . . . . 0.0 112.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.68 -28.9 16.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.348 1.859 . . . . 0.0 112.802 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.22 -16.62 57.67 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.847 1.259 . . . . 0.0 112.922 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -70.67 171.83 9.71 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.826 0.85 . . . . 0.0 109.7 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -147.1 158.95 44.11 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 107.819 169.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -98.43 156.33 16.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 0.0 110.043 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 43.1 t0 -150.26 162.7 39.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 126.891 2.076 . . . . 0.0 108.088 175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 pt -94.21 160.9 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 133.23 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 112.515 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -116.89 111.64 19.93 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.559 1.944 . . . . 0.0 106.83 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 p -62.0 -19.56 62.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.993 0.917 . . . . 0.0 112.719 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.78 -43.42 84.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.772 1.169 . . . . 0.0 111.322 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.99 -48.7 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tp -48.81 -52.35 24.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.237 1.015 . . . . 0.0 110.409 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -68.96 -10.19 56.05 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.23 6.49 7.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.001 1.273 . . . . 0.0 112.812 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.23 154.0 39.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -77.49 -32.43 54.26 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.553 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 33.5 tp -145.43 145.84 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.153 1.381 . . . . 0.0 109.104 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -126.5 140.41 48.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.53 134.05 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 86' ' ' ALA . 30.6 p -95.19 118.93 32.82 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.69 -0.76 31.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.153 -170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -147.22 163.03 37.65 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.695 1.134 . . . . 0.0 109.104 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.76 -38.99 77.11 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.852 -171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.52 -35.84 78.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.533 1.166 . . . . 0.0 110.925 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.72 -18.96 65.71 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.603 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -60.62 -23.97 65.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.935 0.789 . . . . 0.0 112.147 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.1 -34.05 76.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 111.979 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.56 63.95 8.26 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.06 0.944 . . . . 0.0 110.119 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.5 m -122.53 72.94 40.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.89 -48.43 7.52 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.08 3.186 . . . . 0.0 115.315 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 138.23 6.48 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -132.46 80.67 62.16 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.67 168.07 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.502 2.802 . . . . 0.0 110.916 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.9 -22.04 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.824 3.683 . . . . 0.0 118.655 -169.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.21 -41.47 93.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.986 1.267 . . . . 0.0 110.615 170.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.71 156.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 127.785 2.434 . . . . 0.0 108.37 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.9 pttt -140.59 170.41 15.83 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.555 1.542 . . . . 0.0 107.777 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -134.02 157.07 47.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.626 0.648 . . . . 0.0 112.417 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.97 158.39 43.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.189 2.196 . . . . 0.0 105.204 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -145.19 117.85 8.63 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.48 -0.763 . . . . 0.0 109.291 -169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -109.33 -174.13 2.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.019 1.327 . . . . 0.0 109.795 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.66 43.51 1.11 Allowed Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.418 -0.801 . . . . 0.0 114.534 -168.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -85.83 121.52 28.59 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.543 1.172 . . . . 0.0 111.168 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.06 155.12 40.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.78 120.89 83.75 Favored Pre-proline 0 C--O 1.235 0.318 0 O-C-N 121.833 -0.542 . . . . 0.0 111.417 -170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.85 -33.75 42.0 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.556 1.504 . . . . 0.0 112.754 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.14 -20.47 66.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.522 0.601 . . . . 0.0 112.526 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -102.13 -0.02 34.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.527 1.131 . . . . 0.0 111.568 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.81 150.18 24.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.67 164.52 33.94 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.183 0.593 . . . . 0.0 110.085 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.11 -48.21 0.69 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -164.11 162.69 23.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.904 2.082 . . . . 0.0 105.449 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.01 -40.86 86.23 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.693 -0.629 . . . . 0.0 110.495 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.22 -29.35 68.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.319 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -76.38 -40.22 51.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.988 0.813 . . . . 0.0 109.913 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.03 -51.37 69.53 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -60.21 -44.57 95.04 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.47 79.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -61.2 -34.84 75.73 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.97 0.805 . . . . 0.0 111.621 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -57.39 -48.46 79.02 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -61.23 -44.17 97.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.403 0.681 . . . . 0.0 111.919 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -61.27 -53.08 61.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.64 0.654 . . . . 0.0 109.578 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.23 -43.02 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.638 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -61.16 -43.87 98.21 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.941 1.7 . . . . 0.0 110.992 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.49 -43.66 96.61 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.35 -39.89 71.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.44 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.01 -45.24 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.565 1.075 . . . . 0.0 108.37 175.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.89 95.18 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -62.19 -39.52 92.98 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.221 1.01 . . . . 0.0 111.719 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -38.6 85.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.98 0.809 . . . . 0.0 110.685 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.1 mt -72.96 -38.98 66.54 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.925 -0.484 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -56.87 -47.15 81.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.119 0.968 . . . . 0.0 110.138 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.61 -52.22 66.29 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 117.324 -1.322 . . . . 0.0 109.519 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.02 -44.08 82.48 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.457 1.48 . . . . 0.0 110.196 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.21 92.25 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.264 0.626 . . . . 0.0 111.642 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.45 -37.68 22.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.994 0.918 . . . . 0.0 111.416 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.3 p -94.62 -22.77 17.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.592 0.757 . . . . 0.0 111.345 -170.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.249 1.05 0 C-N-CA 127.443 2.297 . . . . 0.0 112.443 -170.045 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -159.37 171.24 20.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.629 1.572 . . . . 0.0 107.544 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.59 -39.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.48 0.712 . . . . 0.0 110.176 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.31 176.68 9.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.183 0.993 . . . . 0.0 109.474 169.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.9 mt -133.25 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.33 132.93 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -127.78 101.62 6.44 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.145 0.978 . . . . 0.0 108.387 -171.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -73.11 145.77 46.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -143.62 131.58 21.64 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.58 -178.1 6.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.131 0.423 . . . . 0.0 111.214 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -7.41 36.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.713 -1.242 . . . . 0.0 114.07 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.65 129.92 2.08 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.696 HD22 ' H ' ' A' ' 65' ' ' ASP . 45.4 t-20 -81.22 40.17 0.54 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.276 1.031 . . . . 0.0 112.062 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.4 p -122.46 -20.91 5.91 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 111.765 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.1 m -134.66 -73.37 0.47 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.948 0.899 . . . . 0.0 110.866 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.69 -60.21 3.76 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.909 0.777 . . . . 0.0 111.038 -169.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 m -62.68 -42.34 99.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.656 0.382 . . . . 0.0 110.468 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -61.01 -45.58 94.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.219 0.608 . . . . 0.0 111.405 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 43.2 mtm -66.77 -46.17 76.18 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.933 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.03 -44.99 79.3 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.368 0.531 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.25 -45.24 91.71 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.773 0.829 . . . . 0.0 110.082 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.48 -46.58 92.93 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.474 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -69.63 -39.82 76.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.554 1.677 . . . . 0.0 110.822 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.84 78.83 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.358 0.526 . . . . 0.0 110.844 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -57.2 -33.06 67.12 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.727 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -71.56 -57.7 4.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.465 0.575 . . . . 0.0 110.148 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -70.24 -37.81 75.04 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.93 -38.74 12.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.095 0.558 . . . . 0.0 111.839 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 177.45 48.41 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.267 0.937 . . . . 0.0 112.391 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.48 -10.15 53.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.697 1.199 . . . . 0.0 113.585 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.9 -10.69 6.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.282 1.433 . . . . 0.0 111.379 169.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.61 146.11 50.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.607 1.563 . . . . 0.0 108.095 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -100.76 138.46 37.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 167.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.18 127.54 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -168.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.33 169.82 16.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -134.81 143.05 46.85 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.042 1.337 . . . . 0.0 109.766 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.26 -177.11 4.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.282 1.433 . . . . 0.0 108.838 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.91 167.36 35.92 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.64 -40.78 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.42 179.77 6.9 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.997 . . . . 0.0 109.852 170.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.11 159.43 43.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.256 1.822 . . . . 0.0 108.017 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -147.74 -31.37 0.3 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.365 0.666 . . . . 0.0 111.833 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 165.91 173.61 34.55 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.19 107.27 2.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -72.4 130.9 85.36 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.02 -27.09 65.92 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.866 1.711 . . . . 0.0 112.956 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -39.1 93.22 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.996 0.816 . . . . 0.0 111.2 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.37 62.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.91 -58.36 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -64.03 -39.58 94.42 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 118.644 0.656 . . . . 0.0 110.557 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.52 68.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.709 0.686 . . . . 0.0 110.935 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.72 -38.49 67.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.022 0.529 . . . . 0.0 111.108 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -68.97 -29.02 67.15 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 121.304 -0.873 . . . . 0.0 111.6 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.94 -18.55 65.43 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.464 1.105 . . . . 0.0 111.874 170.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.04 -2.96 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.769 1.228 . . . . 0.0 109.798 172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.27 18.93 54.55 Favored Glycine 0 CA--C 1.531 1.031 0 O-C-N 120.79 -1.194 . . . . 0.0 112.307 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.8 mt -114.16 95.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.07 78.69 4.55 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.279 1.032 . . . . 0.0 110.168 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -72.83 -3.21 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.44 -0.787 . . . . 0.0 112.017 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 -29.2 63.33 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.815 1.189 . . . . 0.0 112.077 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -73.02 -16.02 61.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.827 1.251 . . . . 0.0 112.533 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.61 171.01 9.63 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.707 0.803 . . . . 0.0 109.027 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -138.99 162.99 33.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.88 1.272 . . . . 0.0 109.086 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 p -116.83 144.66 44.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 109.451 -174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.696 ' H ' HD22 ' A' ' 13' ' ' ASN . 45.8 t0 -153.46 155.58 36.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.091 2.156 . . . . 0.0 107.999 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 pt -89.78 164.44 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tt -54.34 134.33 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 111.265 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -128.95 112.05 13.67 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.688 1.195 . . . . 0.0 108.493 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 p -54.83 -28.75 51.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.592 0.757 . . . . 0.0 111.28 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.69 -1.23 15.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.364 1.465 . . . . 0.0 113.66 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.22 -46.54 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp -45.46 -54.33 7.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.864 1.266 . . . . 0.0 111.456 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -2.15 9.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -133.56 3.76 3.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.612 1.165 . . . . 0.0 112.758 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.07 151.01 48.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.22 -34.27 75.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 34.8 tp -145.66 143.14 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.117 1.367 . . . . 0.0 109.726 -171.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.58 138.13 52.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.13 111.81 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -90.97 91.26 8.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.45 -9.43 12.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.284 1.033 . . . . 0.0 113.307 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.3 133.66 21.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.8 -32.93 66.63 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.717 0.675 . . . . 0.0 112.687 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.2 -30.68 71.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.33 1.065 . . . . 0.0 111.884 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.65 -30.92 68.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.266 0.626 . . . . 0.0 111.576 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.79 -20.12 64.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.16 -34.49 66.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.965 0.906 . . . . 0.0 112.129 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 -32.56 61.67 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.661 -171.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 81.0 m -48.8 108.11 0.89 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.992 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.76 -28.01 14.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.323 2.015 . . . . 0.0 114.239 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 21.9 ptp -163.61 131.34 3.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.271 1.028 . . . . 0.0 110.086 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -140.23 80.48 19.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.78 169.19 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.214 3.276 . . . . 0.0 113.23 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.21 -28.12 32.62 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.463 2.776 . . . . 0.0 115.047 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.57 -7.22 30.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.262 1.025 . . . . 0.0 112.968 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.11 81.7 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.931 2.492 . . . . 0.0 105.271 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 12.8 pttt -65.58 166.16 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -131.68 155.07 48.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.92 0.488 . . . . 0.0 110.384 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.74 159.74 41.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 149.21 31.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.4 0.68 . . . . 0.0 112.429 -168.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -143.06 -160.2 1.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.197 1.399 . . . . 0.0 109.084 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.65 41.28 0.99 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.84 1.2 . . . . 0.0 113.874 -169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -85.65 107.88 17.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.586 1.193 . . . . 0.0 111.999 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.25 154.37 35.26 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.586 1.155 . . . . 0.0 110.105 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.98 120.67 82.48 Favored Pre-proline 0 C--O 1.236 0.363 0 O-C-N 121.938 -0.476 . . . . 0.0 111.974 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.32 -32.04 27.12 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.906 1.737 . . . . 0.0 112.372 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.37 -19.86 66.13 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.371 0.987 . . . . 0.0 112.24 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -102.87 1.59 34.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.708 1.203 . . . . 0.0 111.3 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.14 138.87 57.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -145.75 156.28 43.5 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.27 -55.18 0.41 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 t -155.75 158.5 38.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.23 -39.0 88.64 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.569 -0.707 . . . . 0.0 110.815 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.22 -30.88 70.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.2 -0.313 . . . . 0.0 111.049 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.75 -42.55 58.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.205 0.602 . . . . 0.0 109.848 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 20.3 tttt -55.42 -52.27 64.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.702 1.201 . . . . 0.0 110.1 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -60.29 -45.2 94.17 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 117.962 0.346 . . . . 0.0 110.322 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.82 79.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.284 0.493 . . . . 0.0 110.427 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.72 -39.82 92.88 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.589 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.31 -50.57 71.05 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.037 0.835 . . . . 0.0 108.802 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -60.21 -45.08 94.43 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 122.912 0.485 . . . . 0.0 111.165 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.54 -48.86 79.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.85 0.46 . . . . 0.0 110.384 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.93 -44.69 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.021 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -60.85 -42.33 97.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 121.496 1.953 . . . . 0.0 110.753 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.03 -44.61 96.33 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.42 -31.65 62.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.526 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.91 -43.38 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.246 . . . . 0.0 108.592 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.29 88.82 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.91 -35.96 75.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.935 1.294 . . . . 0.0 111.562 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -50.98 71.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 123.614 0.766 . . . . 0.0 109.197 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.18 -32.17 66.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.004 -173.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -52.02 67.26 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.942 0.897 . . . . 0.0 110.521 169.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.19 -47.42 79.84 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 119.609 1.095 . . . . 0.0 109.349 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -55.83 -38.6 70.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.607 -0.683 . . . . 0.0 111.198 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -48.56 37.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.572 0.749 . . . . 0.0 111.611 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.97 -38.34 72.77 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.558 1.143 . . . . 0.0 111.143 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.4 p -90.97 -18.48 24.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 110.27 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.13 39.31 95.66 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -173.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm . . . . . 0 C--O 1.25 1.102 0 C-N-CA 125.158 1.383 . . . . 0.0 111.665 -171.767 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.74 166.71 32.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.612 1.565 . . . . 0.0 107.541 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -159.36 -42.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.012 0.525 . . . . 0.0 110.712 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.54 175.93 10.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.457 0.703 . . . . 0.0 110.552 169.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.97 136.19 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.52 135.29 64.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -132.26 105.37 7.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -74.06 147.43 42.84 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.637 -0.665 . . . . 0.0 110.137 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.73 130.14 17.75 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.95 173.56 14.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.68 0.673 . . . . 0.0 110.093 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -66.06 -9.2 28.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.928 -1.107 . . . . 0.0 113.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.58 1.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 53.9 t-20 -62.67 -49.09 76.49 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.469 0.707 . . . . 0.0 110.786 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.1 m -41.69 -22.17 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 130.321 3.448 . . . . 0.0 117.816 -168.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.8 -73.61 0.64 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.812 1.187 . . . . 0.0 110.09 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -61.65 -49.45 76.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.125 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -69.69 -38.83 77.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.655 0.661 . . . . 0.0 111.005 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -61.36 -45.28 95.04 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.836 0.744 . . . . 0.0 111.697 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.6 mtt -65.08 -48.69 72.83 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.45 78.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 122.859 0.463 . . . . 0.0 111.047 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.18 -50.93 71.29 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 109.927 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.28 -46.86 92.34 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.113 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.4 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 95.9 m95 -66.74 -42.39 86.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.655 1.728 . . . . 0.0 110.711 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.04 75.6 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.591 0.632 . . . . 0.0 111.313 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -57.31 -33.99 68.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.45 -57.2 5.55 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.455 0.571 . . . . 0.0 110.1 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -69.67 -34.38 73.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.66 -38.11 9.65 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.255 0.622 . . . . 0.0 112.456 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 178.97 51.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.216 0.912 . . . . 0.0 112.761 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.53 -12.32 60.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.934 1.294 . . . . 0.0 113.759 -170.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.7 -7.54 2.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.76 1.624 . . . . 0.0 112.063 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -131.55 145.39 51.71 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.48 1.512 . . . . 0.0 108.681 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 7.4 mmpt? -98.43 136.21 38.9 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 167.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.51 116.71 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -168.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.28 171.84 13.19 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -139.84 142.67 36.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.278 1.031 . . . . 0.0 108.493 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.93 -176.43 4.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.766 1.626 . . . . 0.0 108.544 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.63 173.84 40.59 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.19 -40.85 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.08 177.41 8.79 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.896 0.878 . . . . 0.0 110.099 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.04 126.3 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.847 1.659 . . . . 0.0 107.207 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -77.6 -46.12 23.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.339 0.656 . . . . 0.0 109.428 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.1 -166.7 39.37 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -78.18 99.62 6.29 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -62.68 131.01 94.11 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.64 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.71 -28.5 82.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.232 1.954 . . . . 0.0 112.891 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -58.9 -50.1 75.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.377 0.989 . . . . 0.0 109.324 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.22 -42.24 85.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.451 0.569 . . . . 0.0 110.233 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.64 -54.4 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.438 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -64.21 -46.64 82.99 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.318 0.963 . . . . 0.0 110.33 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.5 70.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.011 0.924 . . . . 0.0 111.436 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -79.97 -36.39 36.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.365 0.666 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.32 -31.72 72.95 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.918 -1.113 . . . . 0.0 109.801 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -72.79 6.72 2.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.672 1.989 . . . . 0.0 112.122 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 t -115.75 -6.68 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.795 2.038 . . . . 0.0 108.669 169.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.65 25.46 56.38 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 120.574 -1.328 . . . . 0.0 111.202 -169.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -116.76 90.49 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -78.78 80.72 5.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.578 -172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.5 pt -75.25 6.82 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.246 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.9 m -53.98 -27.15 29.76 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.04 1.291 . . . . 0.0 112.168 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.68 -18.09 58.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.569 1.147 . . . . 0.0 113.161 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -71.81 170.72 13.04 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.878 0.763 . . . . 0.0 109.895 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 156.0 43.55 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.748 1.619 . . . . 0.0 107.648 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -102.44 151.95 21.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.75 . . . . 0.0 109.381 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.6 t0 -152.11 161.24 42.92 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.733 2.013 . . . . 0.0 108.251 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 pt -93.16 162.86 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -57.37 113.21 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -169.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -89.72 118.37 29.27 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 m -72.08 -22.53 61.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.539 -170.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.54 -42.75 51.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.044 0.838 . . . . 0.0 110.051 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.74 -44.88 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.88 -49.12 74.25 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.188 0.449 . . . . 0.0 110.281 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -65.85 -18.47 65.36 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -98.15 -14.81 20.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.342 0.974 . . . . 0.0 110.682 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.68 159.98 33.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 118.399 0.545 . . . . 0.0 110.946 -169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.37 -30.59 42.65 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 168.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 tp -152.02 145.69 25.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.621 1.568 . . . . 0.0 109.872 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.6 t -123.05 140.01 48.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 169.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.51 111.47 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.5 p -90.66 94.03 9.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.11 -10.78 33.33 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.038 0.935 . . . . 0.0 112.499 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.67 135.87 23.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.92 -34.02 76.5 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.758 0.694 . . . . 0.0 112.815 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.68 -29.28 70.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.356 1.078 . . . . 0.0 111.681 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.67 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 111.531 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 -19.43 65.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.78 -34.29 71.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.233 1.013 . . . . 0.0 112.066 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -73.66 -32.12 63.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.883 -171.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 80.8 m -46.77 107.15 0.66 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.949 1.299 . . . . 0.0 109.627 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -64.26 -44.41 12.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.553 1.502 . . . . 0.0 114.239 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 25.8 ttt -167.26 123.66 1.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.291 1.036 . . . . 0.0 108.527 169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -109.24 85.48 3.48 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.7 166.62 17.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.984 2.456 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.23 -19.57 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 124.709 3.606 . . . . 0.0 118.279 -171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.18 -40.22 89.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.039 1.291 . . . . 0.0 110.051 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -87.26 162.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 127.881 2.472 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -142.58 169.27 17.88 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.586 1.555 . . . . 0.0 107.262 169.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -132.65 145.6 51.2 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 118.863 0.756 . . . . 0.0 111.156 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 152.18 43.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.301 2.24 . . . . 0.0 105.115 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.17 141.12 42.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.363 0.665 . . . . 0.0 110.284 -169.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -138.26 -166.34 1.96 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.416 1.486 . . . . 0.0 109.076 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.54 1.13 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 119.197 0.908 . . . . 0.0 112.796 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.87 112.86 12.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.867 0.833 . . . . 0.0 110.728 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -69.14 153.56 43.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.354 0.662 . . . . 0.0 109.663 169.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.19 118.2 68.81 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 111.505 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.73 -33.7 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.005 1.804 . . . . 0.0 112.385 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.1 -19.14 64.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.745 0.702 . . . . 0.0 112.072 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -100.27 -2.95 32.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.766 1.226 . . . . 0.0 111.377 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . -59.09 136.77 58.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 168.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.07 22.3 0.66 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -168.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.34 -51.58 42.32 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -172.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -160.17 163.62 33.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.81 2.444 . . . . 0.0 104.863 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.85 -40.02 83.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 120.09 1.314 . . . . 0.0 111.123 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.75 -32.75 72.73 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.282 -0.261 . . . . 0.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -75.32 -37.84 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.066 0.546 . . . . 0.0 110.144 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 109' ' ' ALA . 41.7 tttt -59.26 -51.22 70.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.769 1.228 . . . . 0.0 109.415 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -61.96 -41.69 98.28 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.803 0.274 . . . . 0.0 110.644 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.59 73.64 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.48 -0.762 . . . . 0.0 110.859 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.2 -42.07 89.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.545 0.738 . . . . 0.0 110.385 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -56.05 -47.39 77.99 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -59.7 -48.63 80.91 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.96 0.904 . . . . 0.0 111.513 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.94 -45.06 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 116.619 -1.658 . . . . 0.0 110.262 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -61.19 -44.25 97.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 121.985 2.175 . . . . 0.0 110.48 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.71 -43.71 98.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -79.93 -27.31 39.87 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.255 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -65.88 -42.26 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 107.883 171.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.03 90.14 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -57.34 -40.79 78.73 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.403 1.081 . . . . 0.0 111.14 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -46.67 87.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.744 -0.598 . . . . 0.0 111.027 175.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.66 -34.31 77.91 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.588 0.631 . . . . 0.0 111.086 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -50.55 73.6 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.909 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.89 -47.36 83.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 119.712 1.142 . . . . 0.0 109.643 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.38 -39.19 72.52 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 118.394 0.543 . . . . 0.0 110.832 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.04 -48.21 46.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.907 0.883 . . . . 0.0 111.777 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -69.47 -39.6 77.61 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.726 1.21 . . . . 0.0 111.186 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -87.35 -17.66 31.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.315 1.046 . . . . 0.0 110.122 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.53 41.36 93.44 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.168 1.366 . . . . 0.0 110.71 -173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.763 0.825 . . . . 0.0 112.207 -170.771 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -58.96 147.46 34.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.619 0.767 . . . . 0.0 109.759 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -153.03 -51.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.364 0.666 . . . . 0.0 110.037 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -146.52 173.62 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.648 1.179 . . . . 0.0 108.358 169.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.39 142.36 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -169.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tt -129.71 135.85 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.416 1.486 . . . . 0.0 107.149 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -129.01 103.43 7.0 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.963 0.905 . . . . 0.0 108.727 -173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -74.58 146.19 42.74 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 122.044 -0.41 . . . . 0.0 109.933 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.92 132.25 20.66 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -148.62 173.71 12.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.292 0.637 . . . . 0.0 110.116 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 p -68.17 -9.11 44.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.556 -1.34 . . . . 0.0 113.689 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.19 123.7 1.3 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.25 -41.04 97.15 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.219 0.509 . . . . 0.0 111.279 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -38.57 -28.94 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.77 3.228 . . . . 0.0 116.861 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -127.93 -74.93 0.57 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.206 0.912 . . . . 0.0 112.335 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mpp_? -53.87 -50.73 65.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.21 0.914 . . . . 0.0 113.436 -168.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 22.3 p -80.26 -27.81 38.56 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.979 0.809 . . . . 0.0 111.662 -175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -62.1 -41.39 98.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.643 1.11 . . . . 0.0 110.943 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 79.0 mtp -65.89 -49.37 68.29 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.64 73.66 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.938 0.495 . . . . 0.0 111.357 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -56.11 -48.91 75.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.081 0.952 . . . . 0.0 109.952 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.63 99.67 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.157 -0.801 . . . . 0.0 112.823 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 94.3 m95 -68.13 -44.11 76.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.168 1.484 . . . . 0.0 110.16 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.48 83.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.618 0.367 . . . . 0.0 110.358 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -59.14 -26.1 64.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.266 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -74.07 -59.21 2.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 110.438 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -69.81 -38.15 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 34.6 mt -87.19 -39.37 15.54 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.249 0.619 . . . . 0.0 112.176 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.39 -178.87 49.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.092 0.853 . . . . 0.0 112.834 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.93 -15.65 62.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.291 1.436 . . . . 0.0 113.567 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.76 -16.11 3.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.905 1.282 . . . . 0.0 111.534 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 11.4 m95 -129.08 140.54 51.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 110.083 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -89.57 131.15 35.73 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -125.54 119.21 54.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 171.59 14.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 171.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 59.2 p -136.78 152.37 50.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.238 1.015 . . . . 0.0 109.356 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.89 -168.86 3.15 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.076 1.351 . . . . 0.0 107.572 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.23 37.82 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.52 -40.18 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.07 179.52 6.85 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.467 1.107 . . . . 0.0 109.532 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.01 157.37 43.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.424 2.29 . . . . 0.0 106.574 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -132.5 -29.05 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.456 1.102 . . . . 0.0 110.185 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.53 -179.25 37.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.9 tp -75.81 101.47 5.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -62.0 124.8 83.39 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.374 -171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -51.08 -33.54 43.73 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.272 2.648 . . . . 0.0 113.719 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -39.54 90.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.651 0.659 . . . . 0.0 110.691 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.35 73.56 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.8 t -58.23 -53.35 47.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -67.62 -41.59 83.7 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.778 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.08 -49.05 74.89 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 118.886 0.766 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -71.02 -40.3 71.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.076 0.55 . . . . 0.0 110.84 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -64.57 -29.96 70.99 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.195 -0.941 . . . . 0.0 111.014 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -68.99 -22.37 64.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.963 0.905 . . . . 0.0 112.06 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.03 -30.44 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.214 0.915 . . . . 0.0 109.113 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.29 14.48 11.71 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.462 1.505 . . . . 0.0 111.471 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.87 97.25 5.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.15 85.44 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.294 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -78.55 4.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.277 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -56.48 -26.16 53.38 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.891 1.678 . . . . 0.0 112.132 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -72.93 -22.07 60.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.055 1.342 . . . . 0.0 113.013 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -71.25 167.5 19.3 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.73 0.812 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -146.49 156.45 43.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.41 1.484 . . . . 0.0 108.419 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 m -102.7 153.92 19.66 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.161 0.585 . . . . 0.0 111.599 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -154.48 154.86 33.86 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.718 1.607 . . . . 0.0 109.056 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 pt -84.83 163.28 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.2 tt -53.94 134.1 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.397 1.079 . . . . 0.0 110.927 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -119.88 110.18 16.44 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.427 1.491 . . . . 0.0 107.451 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 m -54.7 -24.77 23.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.152 1.381 . . . . 0.0 112.676 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.28 -45.48 63.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.07 0.85 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.06 -42.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.55 -50.21 43.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.377 0.671 . . . . 0.0 109.931 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -75.89 -12.01 60.07 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -92.57 -19.89 21.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.386 0.994 . . . . 0.0 110.783 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.15 140.45 57.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.083 0.401 . . . . 0.0 110.291 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.19 -33.47 75.45 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.3 tp -145.44 143.88 30.3 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.238 1.415 . . . . 0.0 109.918 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.36 136.99 55.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.24 108.48 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.2 p -88.33 95.67 10.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.75 -13.48 55.14 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 50.2 t -141.99 139.67 32.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.02 -36.64 90.96 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.493 0.568 . . . . 0.0 112.59 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.72 -27.24 68.18 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.193 0.997 . . . . 0.0 111.659 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -24.83 61.12 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.328 0.651 . . . . 0.0 111.651 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.31 -14.91 62.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.88 -33.6 75.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.179 0.592 . . . . 0.0 111.677 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -87.59 75.46 9.07 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.471 0.709 . . . . 0.0 109.394 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.2 m -135.99 80.95 40.66 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.13 88.31 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.519 3.48 . . . . 0.0 110.882 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . 0.263 24.1 ptt? 51.57 130.62 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 131.16 3.784 . . . . 0.0 114.643 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p -137.76 84.59 21.81 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -53.87 171.85 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.67 3.58 . . . . 0.0 113.203 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.56 -27.86 26.79 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.722 2.948 . . . . 0.0 115.199 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.44 -14.13 55.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.84 1.256 . . . . 0.0 112.853 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.28 82.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.529 2.332 . . . . 0.0 106.423 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.6 pttt -67.08 164.35 18.08 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -129.75 155.74 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.742 -0.599 . . . . 0.0 109.718 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.15 154.56 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -140.12 143.28 36.15 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.9 0.48 . . . . 0.0 111.139 -168.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -140.08 -169.88 2.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.286 1.434 . . . . 0.0 109.19 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.02 42.77 1.28 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.018 0.818 . . . . 0.0 112.992 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -77.33 101.05 6.13 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 111.455 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -60.89 158.27 13.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.372 1.069 . . . . 0.0 110.124 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.07 124.21 86.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.368 -169.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.98 -44.44 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.858 2.372 . . . . 0.0 111.84 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.59 69.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.423 0.689 . . . . 0.0 111.024 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.37 12.16 31.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.039 1.335 . . . . 0.0 111.21 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.52 72.08 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.597 0.635 . . . . 0.0 112.692 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 55.86 -176.98 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.865 2.066 . . . . 0.0 113.281 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -65.84 0.49 Allowed Glycine 0 CA--C 1.523 0.568 0 C-N-CA 126.179 1.847 . . . . 0.0 108.784 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 t -160.92 159.88 30.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.98 -39.76 75.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 119.014 0.825 . . . . 0.0 111.333 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.1 -28.98 66.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.358 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.36 -41.45 69.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.732 0.697 . . . . 0.0 109.32 174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -59.41 -53.73 54.85 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -57.65 -42.1 82.8 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.528 0.517 . . . . 0.0 110.022 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -41.2 87.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.157 0.435 . . . . 0.0 110.295 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.91 -38.74 92.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.626 0.77 . . . . 0.0 111.144 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -58.91 -47.38 85.21 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.292 0.951 . . . . 0.0 108.721 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -61.44 -42.89 99.46 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.149 0.58 . . . . 0.0 111.149 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.47 -50.55 64.93 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.305 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.01 -44.37 99.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.191 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -44.53 97.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 121.149 1.795 . . . . 0.0 110.628 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.67 -43.02 99.65 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.84 -29.35 44.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.806 -1.093 . . . . 0.0 112.222 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -64.05 -44.54 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.4 -46.71 93.83 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.71 -42.18 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.848 0.824 . . . . 0.0 110.429 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -46.05 91.8 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.2 mt -72.71 -34.38 67.08 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 110.149 -175.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.65 -51.6 69.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 110.752 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.42 -49.25 76.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.982 0.81 . . . . 0.0 109.296 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.37 -39.93 67.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.686 0.675 . . . . 0.0 111.082 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.2 -46.94 54.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.745 0.818 . . . . 0.0 111.854 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.79 -38.45 67.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.606 1.163 . . . . 0.0 111.182 -173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.2 p -89.3 -22.41 22.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.282 1.033 . . . . 0.0 110.114 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.26 44.45 97.46 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.105 1.362 . . . . 0.0 111.301 -175.488 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -65.57 165.89 11.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 111.633 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -142.92 -38.68 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 47.4 mtmt -136.67 166.3 23.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.73 171.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.76 132.08 67.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 172.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tt -122.73 133.98 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -129.6 106.34 8.67 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.81 0.844 . . . . 0.0 109.155 -169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -75.42 146.91 40.38 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.057 -0.402 . . . . 0.0 110.084 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.95 127.51 15.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -149.44 172.84 14.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.995 0.518 . . . . 0.0 110.237 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -66.83 -10.37 47.26 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.885 -1.134 . . . . 0.0 113.314 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.43 118.77 0.85 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.926 -2.87 . . . . 0.0 105.926 169.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 56.2 t-20 -56.22 -47.48 78.35 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.611 0.764 . . . . 0.0 110.347 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -45.1 -24.61 0.26 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.679 3.192 . . . . 0.0 116.397 -169.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 m -112.67 -88.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -60.71 -43.59 97.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.908 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -70.62 -40.56 73.07 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.914 1.234 . . . . 0.0 111.238 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.89 -44.52 96.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.079 0.854 . . . . 0.0 111.007 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.6 mtp -65.44 -45.51 83.55 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.78 89.41 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.316 0.647 . . . . 0.0 111.092 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -57.17 -45.46 83.62 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.79 -55.11 27.16 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.15 -0.806 . . . . 0.0 113.106 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -68.74 -36.76 78.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.911 1.856 . . . . 0.0 111.144 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.53 76.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.258 -0.902 . . . . 0.0 111.253 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.64 -35.29 70.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.623 0.647 . . . . 0.0 111.904 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.16 -49.93 25.44 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.481 0.712 . . . . 0.0 109.273 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -76.61 -31.51 57.49 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.22 -36.89 8.34 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 -171.26 49.35 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 122.116 0.842 . . . . 0.0 113.856 174.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.69 -14.32 57.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.746 2.019 . . . . 0.0 114.098 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.09 -10.15 2.49 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.774 1.629 . . . . 0.0 111.839 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 2.8 m95 -141.58 157.79 44.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.757 1.223 . . . . 0.0 110.261 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -109.95 139.13 45.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 167.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.2 t -126.02 124.94 67.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -169.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.94 170.51 15.88 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 p -138.65 142.2 39.06 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.487 1.115 . . . . 0.0 108.507 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.92 -176.65 4.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.721 1.608 . . . . 0.0 108.466 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.16 173.69 40.19 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -41.42 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.51 179.85 6.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.814 0.846 . . . . 0.0 109.388 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.47 120.95 12.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -73.09 -38.69 66.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.642 0.777 . . . . 0.0 109.364 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 160.82 -167.47 35.9 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 127.961 2.696 . . . . 0.0 107.798 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.43 100.14 9.12 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -62.59 121.32 66.73 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.539 -172.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.86 -32.82 48.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.032 2.488 . . . . 0.0 113.228 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.98 89.35 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.73 0.695 . . . . 0.0 111.035 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.47 71.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.81 -54.36 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.1 -43.12 93.08 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.127 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.68 -50.11 63.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.661 0.664 . . . . 0.0 110.431 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 81.4 mmm -75.42 -35.94 60.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.799 0.272 . . . . 0.0 111.578 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.68 -32.94 73.15 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -67.36 -19.85 65.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.872 0.869 . . . . 0.0 112.443 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.74 -10.68 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.504 1.047 . . . . 0.0 110.132 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.28 25.37 44.03 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.035 -1.041 . . . . 0.0 110.666 -169.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.6 mt -118.69 89.49 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -78.6 81.44 4.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.288 -171.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.41 6.53 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 118.57 -0.728 . . . . 0.0 112.197 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 m -55.0 -27.04 41.14 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.228 1.376 . . . . 0.0 112.09 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.02 -20.72 60.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.939 1.296 . . . . 0.0 112.95 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.45 171.45 10.06 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.737 0.779 . . . . 0.0 109.994 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -143.65 152.41 41.32 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.539 1.536 . . . . 0.0 107.325 172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -96.12 152.51 18.48 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.545 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.8 t0 -152.06 160.51 43.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.608 1.963 . . . . 0.0 108.274 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 pt -93.96 160.5 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.64 116.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.724 0.773 . . . . 0.0 112.955 -169.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.51 113.27 25.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 m -61.43 -24.22 66.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.576 1.15 . . . . 0.0 112.56 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.15 -39.31 82.66 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.013 0.824 . . . . 0.0 111.222 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.0 mt -66.29 -48.19 81.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.52 -48.71 68.78 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 109.954 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.84 -2.89 8.08 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -132.96 1.43 3.57 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.535 1.516 . . . . 0.0 114.199 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.15 47.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.209 0.913 . . . . 0.0 109.599 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.27 -34.75 78.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 38.2 tp -147.36 144.2 28.55 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.969 1.308 . . . . 0.0 110.596 -171.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.77 136.51 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 109.82 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.4 p -88.88 101.09 13.7 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.84 -10.48 59.85 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.1 p -146.14 158.96 43.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.103 0.865 . . . . 0.0 109.005 169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.4 -42.67 93.73 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.104 -169.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.36 -32.39 74.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.844 0.822 . . . . 0.0 111.364 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.96 69.41 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.749 0.419 . . . . 0.0 112.053 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.41 -33.85 73.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.898 0.772 . . . . 0.0 111.599 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -89.16 59.65 5.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.404 1.082 . . . . 0.0 110.069 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.9 83.82 30.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.8 70.64 2.78 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.451 3.434 . . . . 0.0 112.134 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.6 mtt 78.55 100.18 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 129.294 3.038 . . . . 0.0 112.001 172.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -105.53 84.34 1.15 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.83 172.69 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.297 2.665 . . . . 0.0 110.775 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -49.49 -27.97 15.26 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.805 3.003 . . . . 0.0 116.365 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -68.44 -8.56 41.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.112 0.965 . . . . 0.0 113.042 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.54 86.96 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 128.421 2.688 . . . . 0.0 105.304 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -66.93 164.94 16.48 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -143.07 145.88 33.29 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.349 -0.845 . . . . 0.0 109.234 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -132.8 157.1 45.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.418 1.487 . . . . 0.0 107.576 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -141.29 138.51 33.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.843 . . . . 0.0 110.747 -168.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.52 -171.85 2.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.813 1.645 . . . . 0.0 108.43 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.63 77.68 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 O-C-N 121.174 -0.953 . . . . 0.0 113.214 -169.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.14 151.14 45.05 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.088 0.944 . . . . 0.0 111.372 170.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.51 160.32 32.65 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.444 1.898 . . . . 0.0 113.265 -169.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -79.85 129.36 71.0 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.096 0.959 . . . . 0.0 111.712 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.55 -30.19 4.16 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.188 1.925 . . . . 0.0 114.009 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.29 -13.23 57.95 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.27 9.65 10.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.758 1.223 . . . . 0.0 111.435 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.11 141.9 52.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.39 162.14 37.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.97 0.908 . . . . 0.0 109.708 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.54 -50.07 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.88 165.37 22.86 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.557 2.343 . . . . 0.0 105.272 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.97 -40.01 83.46 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.51 -0.744 . . . . 0.0 110.641 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.97 -29.06 66.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.411 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.06 -44.5 60.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.826 0.739 . . . . 0.0 109.128 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -56.43 -51.04 69.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.778 0.831 . . . . 0.0 109.825 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -62.85 -42.53 99.78 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.625 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.36 78.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.914 0.779 . . . . 0.0 110.142 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -64.37 -38.34 90.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.043 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -55.21 -50.9 68.22 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -60.39 -43.7 96.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.02 0.528 . . . . 0.0 111.516 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -60.52 -50.01 75.27 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.281 0.491 . . . . 0.0 110.305 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.82 -39.41 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.669 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -56.65 -51.97 66.7 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.696 1.134 . . . . 0.0 109.602 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.29 -41.33 96.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.456 0.702 . . . . 0.0 110.005 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.84 -26.85 44.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.618 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -45.96 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.46 -44.15 93.62 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -60.4 -39.65 88.12 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.205 1.402 . . . . 0.0 111.179 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.53 79.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.69 -32.69 64.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.518 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -51.42 69.81 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.226 1.011 . . . . 0.0 110.56 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.64 -47.18 82.39 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.557 1.071 . . . . 0.0 109.582 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.08 -39.03 71.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.403 0.547 . . . . 0.0 111.071 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.45 33.98 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.706 0.803 . . . . 0.0 111.624 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.76 -38.78 76.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.62 1.168 . . . . 0.0 111.183 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 31.4 p -89.14 -17.87 28.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.911 0.884 . . . . 0.0 110.28 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.11 40.89 94.24 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -172.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.615 1.166 . . . . 0.0 111.702 -169.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.43 149.65 45.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -158.6 -40.97 0.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.7 mtmt -134.41 165.74 24.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.031 1.333 . . . . 0.0 108.332 169.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.74 134.31 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.3 135.06 63.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -131.77 104.4 6.87 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.562 0.745 . . . . 0.0 109.53 -169.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.67 142.53 38.77 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.07 1.348 . . . . 0.0 110.141 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 9' ' ' LEU . 2.2 tm? -143.92 129.49 19.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.51 175.12 11.09 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.318 0.508 . . . . 0.0 110.774 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -6.64 21.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.64 133.7 3.09 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.98 33.12 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.064 0.932 . . . . 0.0 112.23 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.5 m -116.21 -1.94 12.28 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.796 1.239 . . . . 0.0 110.97 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -150.27 -94.61 0.07 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.968 0.804 . . . . 0.0 111.988 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -58.08 -46.41 85.49 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.883 1.273 . . . . 0.0 112.16 -169.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.8 p -72.38 -28.08 62.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.95 0.796 . . . . 0.0 112.055 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -68.92 -42.26 77.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.882 0.764 . . . . 0.0 110.249 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.45 -46.4 80.02 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.91 -43.35 81.29 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.164 0.586 . . . . 0.0 111.104 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -57.81 -47.97 81.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.334 1.054 . . . . 0.0 109.546 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.66 -50.96 60.89 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.745 176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.1 m95 -64.83 -38.3 90.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.844 1.822 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.15 79.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.642 -0.661 . . . . 0.0 111.567 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.73 -27.01 67.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.398 0.999 . . . . 0.0 112.475 175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -46.58 13.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.452 0.701 . . . . 0.0 109.586 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -78.89 -27.2 43.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.62 -140.23 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.887 1.275 . . . . 0.0 108.101 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.16 -175.79 47.8 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.85 -12.37 53.83 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -58.14 -10.99 2.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.754 2.022 . . . . 0.0 111.137 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.44 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 10.2 m95 -134.98 166.36 23.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.131 1.772 . . . . 0.0 108.913 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -124.59 135.68 53.32 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 167.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 118.39 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -168.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 173.25 11.91 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.48 1.112 . . . . 0.0 109.346 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 56.8 p -136.03 159.82 40.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.225 1.01 . . . . 0.0 110.163 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.03 -169.4 3.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.755 1.622 . . . . 0.0 107.199 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.59 173.49 42.64 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 121.333 -0.854 . . . . 0.0 111.221 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.97 -39.23 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.555 1.142 . . . . 0.0 108.905 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.12 -178.74 6.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 108.51 170.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.11 43.55 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.545 1.538 . . . . 0.0 108.384 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -144.76 -39.22 0.27 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.063 0.945 . . . . 0.0 110.123 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.6 140.74 2.97 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.78 114.74 2.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.821 1.31 . . . . 0.0 108.062 169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.47 157.35 80.32 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.312 -169.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.7 -36.58 73.09 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.703 2.935 . . . . 0.0 113.866 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -36.86 85.28 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.168 0.895 . . . . 0.0 111.325 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.98 67.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.33 -52.52 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.15 -42.1 96.9 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.89 0.768 . . . . 0.0 110.587 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.55 -45.62 84.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.499 0.59 . . . . 0.0 110.792 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 93.3 mmm -75.94 -37.98 58.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.503 0.138 . . . . 0.0 111.112 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -61.95 -36.42 81.37 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.88 -22.32 63.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.835 0.854 . . . . 0.0 112.509 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -77.79 -26.06 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.365 0.984 . . . . 0.0 109.601 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.97 23.62 6.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.116 1.341 . . . . 0.0 111.489 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.5 mt -124.71 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 -171.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -79.85 75.69 6.55 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.276 0.63 . . . . 0.0 110.866 -170.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 pt -70.98 0.24 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 117.927 -1.035 . . . . 0.0 112.071 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -51.87 -28.03 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.208 1.367 . . . . 0.0 111.78 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.18 -20.23 64.84 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.519 1.528 . . . . 0.0 113.6 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -77.45 169.29 18.57 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.059 . . . . 0.0 109.698 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 p -143.82 167.46 22.25 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.584 1.953 . . . . 0.0 107.876 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.6 p -118.97 151.64 37.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.358 0.663 . . . . 0.0 111.257 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -153.35 154.88 35.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.724 1.61 . . . . 0.0 109.028 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.96 165.85 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 tt -57.12 106.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.186 0.994 . . . . 0.0 111.816 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -89.11 102.22 14.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -16.37 49.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.138 0.975 . . . . 0.0 112.222 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.91 -37.25 62.13 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.999 1.272 . . . . 0.0 111.871 178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.07 -48.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.1 -47.46 65.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.686 0.795 . . . . 0.0 110.52 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -67.45 -8.26 31.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -128.75 3.39 5.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.274 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.33 148.1 51.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.45 -32.9 72.12 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.5 tp -147.41 144.35 28.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.225 1.41 . . . . 0.0 110.428 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.49 139.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 m -128.45 129.25 68.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -88.65 138.24 31.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 97.5 mt -110.62 0.7 17.65 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.417 0.687 . . . . 0.0 112.511 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.1 p -152.19 161.79 42.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.595 1.089 . . . . 0.0 109.22 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.46 -51.43 57.81 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 123.897 0.761 . . . . 0.0 112.017 -171.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.09 -31.45 70.18 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.15 -30.01 70.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.478 0.581 . . . . 0.0 112.425 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.09 -24.26 67.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.88 -38.08 89.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.045 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -79.59 -42.85 24.09 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.056 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.8 t -47.72 106.52 0.61 Allowed Pre-proline 0 CA--C 1.547 0.861 0 O-C-N 124.76 1.288 . . . . 0.0 110.275 -169.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.45 174.68 7.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.682 3.588 . . . . 0.0 111.461 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 99.0 mmm -58.63 135.7 57.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.152 0.581 . . . . 0.0 111.041 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 p -120.53 105.22 41.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.945 1.698 . . . . 0.0 106.675 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.27 168.88 18.13 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.813 2.342 . . . . 0.0 110.693 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.32 -24.48 15.9 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.009 3.139 . . . . 0.0 116.288 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.29 -10.34 31.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.033 0.933 . . . . 0.0 112.847 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 93.92 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 128.007 2.523 . . . . 0.0 105.621 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -70.64 164.31 25.22 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.17 144.2 31.45 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.626 0.771 . . . . 0.0 109.062 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.12 164.66 29.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -144.55 113.0 6.57 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.772 0.829 . . . . 0.0 109.283 -170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -115.55 169.18 9.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.662 1.585 . . . . 0.0 107.851 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.9 107.94 0.63 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.784 -169.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.87 118.86 17.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.953 0.901 . . . . 0.0 111.765 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -66.52 153.41 43.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.4 1.08 . . . . 0.0 109.542 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.64 121.36 82.19 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.522 -172.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.03 -32.92 8.14 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.837 1.691 . . . . 0.0 112.588 -173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 -19.93 65.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.029 0.831 . . . . 0.0 112.189 -172.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -97.26 -2.03 43.53 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.712 1.205 . . . . 0.0 111.811 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 142.71 45.36 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -156.51 164.69 37.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.777 0.431 . . . . 0.0 110.94 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -47.91 0.69 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -165.24 166.01 19.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.245 2.218 . . . . 0.0 105.391 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.92 -40.51 80.56 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.546 -0.721 . . . . 0.0 110.666 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.09 -27.42 64.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.188 -0.434 . . . . 0.0 111.473 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.76 -44.59 55.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 109.192 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -56.63 -49.88 73.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.457 0.703 . . . . 0.0 109.892 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -64.64 -39.36 93.56 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.097 -0.377 . . . . 0.0 111.089 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.61 74.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 110.655 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -68.41 -40.56 81.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.244 0.474 . . . . 0.0 110.503 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -58.36 -39.79 80.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.712 0.687 . . . . 0.0 109.841 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -63.11 -49.71 73.34 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.576 0.625 . . . . 0.0 110.208 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -59.77 -49.96 75.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.118 0.417 . . . . 0.0 110.37 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.54 -46.24 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.099 -1.429 . . . . 0.0 110.039 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -62.54 -42.17 99.36 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 121.683 2.038 . . . . 0.0 110.916 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.87 -44.66 96.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.45 -36.04 65.82 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.065 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.416 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -63.75 -40.55 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.528 1.513 . . . . 0.0 108.984 176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.64 -44.34 97.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.95 -37.1 85.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.53 1.132 . . . . 0.0 112.036 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -56.27 -52.05 65.91 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 -35.77 77.38 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 119.024 -0.513 . . . . 0.0 111.918 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -49.33 77.89 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.589 0.755 . . . . 0.0 110.477 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -61.08 -50.78 71.9 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -54.87 -41.45 70.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.222 0.609 . . . . 0.0 111.321 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.33 -47.48 56.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.007 0.923 . . . . 0.0 111.505 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -73.24 -38.34 66.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.143 0.977 . . . . 0.0 111.642 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.1 p -92.23 -21.57 20.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.381 1.073 . . . . 0.0 110.6 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.06 42.46 99.73 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.438 1.495 . . . . 0.0 111.153 -175.315 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -159.2 172.77 17.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.101 1.76 . . . . 0.0 107.869 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -140.77 -44.6 0.39 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.521 0.728 . . . . 0.0 111.718 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 45.2 mtmt -138.12 171.47 14.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.577 1.551 . . . . 0.0 108.464 169.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.7 131.28 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -126.83 133.67 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.52 107.11 9.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.84 143.74 37.59 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.689 1.196 . . . . 0.0 110.497 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.28 127.87 17.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.942 0.897 . . . . 0.0 108.821 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.81 169.67 16.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.848 1.259 . . . . 0.0 111.256 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -67.22 -16.42 64.29 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.133 -0.979 . . . . 0.0 113.276 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.83 112.86 0.54 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.07 -35.81 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.643 1.177 . . . . 0.0 112.337 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -41.13 -19.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.266 3.026 . . . . 0.0 118.496 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -141.59 -54.74 0.46 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 120.708 1.595 . . . . 0.0 113.804 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -56.59 -53.72 54.31 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.342 0.974 . . . . 0.0 113.456 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -36.65 78.85 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.058 0.845 . . . . 0.0 110.257 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -58.07 -43.28 86.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.785 0.721 . . . . 0.0 111.597 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -66.2 -48.06 71.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.803 0.841 . . . . 0.0 109.415 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.24 74.2 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.192 0.597 . . . . 0.0 110.769 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.04 -45.34 93.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.47 0.708 . . . . 0.0 110.289 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.93 92.82 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.223 -0.765 . . . . 0.0 112.377 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CD1' ' CG2' ' A' ' 127' ' ' ILE . 96.6 m95 -66.72 -43.81 83.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.914 1.357 . . . . 0.0 110.572 176.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.81 78.16 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.205 0.457 . . . . 0.0 110.84 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.56 -33.35 68.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.689 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.79 -57.98 4.84 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.809 0.732 . . . . 0.0 110.023 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -69.19 -33.38 73.27 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.9 mt -100.09 -37.85 8.79 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.05 -173.32 48.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.074 0.845 . . . . 0.0 113.4 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.18 -14.91 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.499 1.92 . . . . 0.0 113.753 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -57.23 -11.11 1.52 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.595 1.958 . . . . 0.0 111.794 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.8 m95 -142.24 147.47 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.255 1.022 . . . . 0.0 110.922 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -92.46 140.36 29.65 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.03 125.32 64.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.73 160.41 34.39 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.827 0.851 . . . . 0.0 111.38 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.8 m -136.46 128.6 29.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.808 1.643 . . . . 0.0 108.674 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 -168.85 3.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.9 176.83 42.97 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.61 -42.79 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.807 1.243 . . . . 0.0 107.908 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -143.45 177.15 8.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.254 0.622 . . . . 0.0 110.276 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.8 43.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.574 2.35 . . . . 0.0 107.219 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -134.77 -36.33 0.85 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.286 1.035 . . . . 0.0 110.077 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.47 179.31 44.99 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 tp -79.02 102.82 8.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -67.74 134.09 92.38 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.135 -169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.09 -33.11 72.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.199 2.6 . . . . 0.0 113.738 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -36.6 78.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.732 0.696 . . . . 0.0 111.28 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.12 71.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.4 t -59.17 -54.06 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -65.48 -43.27 90.74 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.476 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.4 82.9 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.837 0.744 . . . . 0.0 111.345 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 94.3 mmm -77.6 -40.35 42.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.172 0.442 . . . . 0.0 111.359 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -63.36 -31.75 72.99 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.422 -0.799 . . . . 0.0 110.707 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.15 -21.7 64.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.424 1.089 . . . . 0.0 112.604 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -77.52 -22.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.558 1.072 . . . . 0.0 109.55 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.39 14.78 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.741 1.162 . . . . 0.0 110.774 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.36 99.64 8.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.44 128.65 37.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.15 4.44 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.333 1.053 . . . . 0.0 110.705 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -27.28 63.4 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.141 1.337 . . . . 0.0 111.017 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -67.15 -16.62 64.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.915 2.086 . . . . 0.0 113.614 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.87 172.57 13.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.504 1.122 . . . . 0.0 109.213 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -150.14 160.19 43.85 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.256 1.422 . . . . 0.0 108.411 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.4 m -101.08 153.63 19.4 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.13 155.49 31.1 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.809 2.044 . . . . 0.0 108.335 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 pt -86.38 159.89 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.41 141.35 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.141 0.976 . . . . 0.0 112.372 -169.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -119.45 111.55 18.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.738 1.615 . . . . 0.0 107.668 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -70.75 -21.75 62.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.58 -46.39 59.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.337 0.971 . . . . 0.0 110.106 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.81 -39.52 85.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.16 -47.88 71.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.929 0.786 . . . . 0.0 110.085 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -73.67 -7.12 50.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -98.59 -21.42 16.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 111.186 173.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.79 142.45 58.4 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.193 0.451 . . . . 0.0 110.054 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.84 -32.68 73.37 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.619 -0.676 . . . . 0.0 109.295 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.7 tp -144.99 145.12 31.38 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.002 1.321 . . . . 0.0 109.625 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.19 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.78 127.79 66.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 169.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 86' ' ' ALA . 2.4 p -94.23 96.85 9.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.59 -9.39 26.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.346 1.458 . . . . 0.0 114.356 -168.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.5 t -149.72 160.35 43.6 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 121.124 1.784 . . . . 0.0 110.352 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -44.79 -66.51 1.42 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 127.164 2.316 . . . . 0.0 113.217 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.11 -22.65 62.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.02 69.87 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.875 -0.516 . . . . 0.0 111.336 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -63.91 -17.46 63.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.94 -31.27 71.58 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.195 0.907 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -91.69 74.05 5.83 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.793 0.837 . . . . 0.0 109.175 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 p -123.16 74.25 49.45 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 0.0 109.391 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.59 74.07 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.608 3.538 . . . . 0.0 111.615 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.5 mmt 66.23 129.31 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.274 3.03 . . . . 0.0 112.412 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 p -141.44 81.58 15.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.94 171.69 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.7 3.6 . . . . 0.0 113.635 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.9 -29.84 28.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.47 2.78 . . . . 0.0 114.806 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.34 -4.83 28.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 113.171 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.74 78.38 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.55 2.34 . . . . 0.0 105.4 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -68.18 167.81 13.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.6 mtp85 -135.37 156.22 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.583 0.753 . . . . 0.0 111.879 -174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.79 162.7 38.7 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 169.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -153.21 119.34 5.46 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.087 -1.008 . . . . 0.0 110.337 -169.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -115.77 -174.82 2.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 0.0 110.06 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.87 44.26 1.19 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.365 0.983 . . . . 0.0 113.627 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -80.76 104.63 11.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.026 0.93 . . . . 0.0 111.342 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.87 152.31 36.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.808 0.843 . . . . 0.0 110.086 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.36 120.73 83.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.71 -33.66 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 112.784 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.15 65.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.996 0.817 . . . . 0.0 112.069 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.37 9.02 35.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.976 1.31 . . . . 0.0 111.633 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.88 22.35 0.05 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.313 1.445 . . . . 0.0 114.221 178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.1 152.53 7.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.35 1.86 . . . . 0.0 111.825 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.89 -51.29 0.2 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -154.16 154.84 34.24 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.01 -38.29 85.53 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.505 -0.747 . . . . 0.0 110.742 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.53 -30.98 71.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.362 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -72.55 -48.34 40.95 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -53.48 -52.45 59.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 109.84 176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -64.22 -42.56 96.53 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.825 0.85 . . . . 0.0 111.168 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.78 72.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.992 0.815 . . . . 0.0 110.307 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -66.29 -38.19 87.18 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.564 -0.71 . . . . 0.0 111.152 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -57.45 -45.92 84.19 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.172 0.896 . . . . 0.0 108.996 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -60.1 -49.4 77.81 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.624 0.77 . . . . 0.0 110.993 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -58.68 -49.67 76.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.97 -47.65 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.328 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -64.01 -41.86 97.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 121.259 1.845 . . . . 0.0 110.673 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.32 -42.89 99.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.922 0.328 . . . . 0.0 110.259 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -75.75 -36.14 59.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.108 -0.949 . . . . 0.0 112.31 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 23' ' ' TRP . 1.1 tp -61.66 -46.25 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.72 92.38 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -54.82 -46.99 74.63 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.671 1.188 . . . . 0.0 111.879 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -39.82 88.0 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.98 -0.45 . . . . 0.0 109.904 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.74 -35.32 72.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.243 0.617 . . . . 0.0 110.99 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -60.04 -49.64 76.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.817 0.847 . . . . 0.0 110.271 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.6 -46.62 81.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.03 0.832 . . . . 0.0 109.71 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -54.3 -40.63 68.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.85 0.75 . . . . 0.0 110.916 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.77 37.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -71.82 -36.08 70.13 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.335 1.054 . . . . 0.0 111.566 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.3 p -90.28 -16.94 28.34 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 110.27 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.37 41.11 92.97 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.799 1.24 . . . . 0.0 111.842 -170.631 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.36 128.09 32.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -150.77 -41.95 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -171.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -130.92 161.5 31.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.723 1.609 . . . . 0.0 107.107 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -136.64 130.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.82 127.03 74.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -124.8 100.11 6.46 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -169.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -73.09 147.88 44.54 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.3 143.46 37.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.313 1.845 . . . . 0.0 106.724 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.83 173.18 16.93 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 p -67.25 -11.52 57.7 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.326 -0.859 . . . . 0.0 113.164 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.23 116.61 0.73 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -55.36 -39.24 69.84 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.269 1.027 . . . . 0.0 111.756 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.48 -34.88 0.24 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.107 3.363 . . . . 0.0 115.777 -169.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 m -120.41 -73.92 0.63 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.069 0.547 . . . . 0.0 110.347 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -62.16 -48.52 79.73 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.211 0.604 . . . . 0.0 110.985 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -70.59 -37.17 73.89 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 119.316 -0.374 . . . . 0.0 110.741 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -62.38 -44.64 95.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.927 0.491 . . . . 0.0 111.127 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.3 mtm -67.0 -45.66 76.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.525 0.602 . . . . 0.0 110.287 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.71 81.47 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.748 0.704 . . . . 0.0 111.14 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -57.33 -47.04 82.58 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.288 1.035 . . . . 0.0 109.761 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.27 50.67 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.657 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' CD1' HG22 ' A' ' 127' ' ' ILE . 94.4 m95 -67.26 -37.49 83.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.817 1.809 . . . . 0.0 111.029 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.71 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.285 -0.884 . . . . 0.0 111.386 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.94 -24.79 67.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.957 0.799 . . . . 0.0 112.512 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.22 -46.99 12.03 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.892 0.769 . . . . 0.0 109.71 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -75.4 -30.75 60.22 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.7 -143.88 0.29 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.995 1.318 . . . . 0.0 108.091 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.2 -178.57 46.1 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.92 -13.85 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.95 -9.94 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.542 1.937 . . . . 0.0 111.642 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -125.58 161.74 26.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.376 1.87 . . . . 0.0 108.39 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.93 138.29 54.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.86 117.27 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 173.7 11.42 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -142.01 157.28 45.11 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 0.0 109.905 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.07 -163.63 1.75 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.462 1.505 . . . . 0.0 107.896 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.28 175.76 43.5 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.64 -41.8 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.05 176.43 8.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.791 0.836 . . . . 0.0 110.056 170.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.78 6.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.022 1.729 . . . . 0.0 107.139 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -74.48 -36.28 63.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.062 0.545 . . . . 0.0 109.626 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.81 -179.31 30.98 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -74.2 99.43 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -61.84 124.58 82.19 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.264 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.45 -33.51 38.26 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.269 2.646 . . . . 0.0 113.608 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -39.75 91.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.91 0.777 . . . . 0.0 110.916 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.31 75.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.95 -56.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.58 -42.06 99.32 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 119.042 0.837 . . . . 0.0 110.348 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.38 65.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.512 0.325 . . . . 0.0 110.336 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 90.1 mmm -74.44 -36.06 63.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.905 0.321 . . . . 0.0 110.873 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -61.8 -35.78 79.2 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.422 -0.799 . . . . 0.0 110.129 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.29 -24.25 63.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 112.572 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.38 -22.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.314 0.961 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.85 23.93 8.96 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.824 1.202 . . . . 0.0 111.263 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.1 mt -123.57 94.21 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -79.13 80.27 5.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.9 pt -76.27 5.83 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.56 -0.712 . . . . 0.0 112.205 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 m -54.57 -26.46 32.44 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.824 1.193 . . . . 0.0 112.232 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.45 -20.06 57.42 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.99 1.316 . . . . 0.0 113.135 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -69.59 167.32 17.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 109.3 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -145.34 158.79 43.76 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.428 1.491 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -108.65 147.1 32.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.858 0.863 . . . . 0.0 110.103 -173.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -155.17 159.5 40.19 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.026 1.331 . . . . 0.0 108.578 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.31 161.18 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.02 131.78 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.766 0.826 . . . . 0.0 111.987 -169.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -111.25 114.57 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.574 1.55 . . . . 0.0 107.327 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -69.37 -17.95 63.74 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.261 -171.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.06 -41.71 28.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.594 1.088 . . . . 0.0 110.504 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.42 -45.68 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -50.11 -50.85 47.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.03 0.932 . . . . 0.0 110.518 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -70.49 -19.51 62.93 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -89.94 -16.19 30.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.679 1.127 . . . . 0.0 110.976 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.53 34.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.225 0.536 . . . . 0.0 111.45 -169.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.52 -33.16 36.57 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 168.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.8 tp -148.44 146.68 28.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.134 1.773 . . . . 0.0 110.374 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.43 140.04 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.32 111.67 19.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.6 p -93.53 108.41 20.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.57 -3.82 23.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.306 -170.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 36.3 t -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 120.881 1.673 . . . . 0.0 108.748 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.87 -35.81 92.49 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 123.674 0.654 . . . . 0.0 112.413 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.27 -25.91 64.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.683 1.242 . . . . 0.0 111.517 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -18.28 58.36 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.182 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.84 67.02 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.851 0.75 . . . . 0.0 112.505 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.24 -32.59 74.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 112.033 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -86.49 57.99 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.85 0.86 . . . . 0.0 110.983 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.7 m -124.01 78.02 58.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -42.25 -49.93 5.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 124.299 3.332 . . . . 0.0 114.872 -172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.1 mtp -152.85 137.04 16.49 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 126.0 1.72 . . . . 0.0 107.289 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.7 p -134.4 71.09 72.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.45 164.78 24.76 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.638 2.892 . . . . 0.0 110.82 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.04 -20.44 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.798 1 C-N-CA 125.458 4.105 . . . . 0.0 119.719 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -60.05 -44.42 94.69 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.625 1.557 . . . . 0.0 109.184 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.09 156.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 127.708 2.403 . . . . 0.0 108.075 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -134.71 167.36 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 169.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -139.2 146.65 40.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.276 0.944 . . . . 0.0 110.084 -169.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -142.61 156.33 45.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.001 1.32 . . . . 0.0 107.867 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.37 140.36 30.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.246 1.019 . . . . 0.0 110.316 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -136.19 -164.7 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.678 1.591 . . . . 0.0 109.562 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.0 40.63 1.17 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.572 1.078 . . . . 0.0 114.342 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.51 116.85 22.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.509 1.155 . . . . 0.0 111.879 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.17 152.68 43.16 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.557 0.743 . . . . 0.0 109.231 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.4 123.95 88.85 Favored Pre-proline 0 C--O 1.236 0.354 0 O-C-N 121.892 -0.505 . . . . 0.0 111.904 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.28 -31.6 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.055 1.837 . . . . 0.0 112.868 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.55 -21.37 65.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.083 0.856 . . . . 0.0 112.306 -174.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -94.56 -4.41 47.98 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.453 1.101 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.65 57.35 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.071 0.85 . . . . 0.0 109.304 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -144.74 161.42 39.26 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.528 1.131 . . . . 0.0 109.245 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.64 -51.05 0.53 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -163.23 164.01 25.24 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.083 2.153 . . . . 0.0 105.51 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -59.23 -39.94 84.32 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.546 -0.721 . . . . 0.0 110.598 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.84 -29.21 67.49 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.344 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -74.14 -42.35 60.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.029 0.831 . . . . 0.0 109.507 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.97 -50.46 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.181 0.592 . . . . 0.0 109.773 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -63.15 -39.47 94.75 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.105 0.411 . . . . 0.0 111.036 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.88 74.79 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.38 -0.825 . . . . 0.0 110.661 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.89 -41.43 91.52 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.07 -1.019 . . . . 0.0 110.324 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -57.08 -41.78 79.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -63.82 -49.77 71.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 111.385 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.68 -51.54 68.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.433 0.561 . . . . 0.0 109.928 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.61 -37.9 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.459 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -53.06 -57.54 10.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.546 1.521 . . . . 0.0 110.638 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.34 -42.02 94.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.171 0.919 . . . . 0.0 109.821 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.75 -26.16 37.5 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.578 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -66.96 -46.22 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 120.445 1.475 . . . . 0.0 107.043 169.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.71 96.66 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -58.12 -41.88 84.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.937 1.295 . . . . 0.0 111.37 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -49.1 77.83 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.43 -31.13 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.017 0.527 . . . . 0.0 110.56 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -52.4 65.33 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.182 0.993 . . . . 0.0 110.229 169.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.56 -47.29 84.49 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.394 0.997 . . . . 0.0 109.021 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.74 -37.95 66.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.968 0.507 . . . . 0.0 111.187 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.75 -47.15 32.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 122.963 0.505 . . . . 0.0 111.33 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.01 -41.51 74.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.923 0.889 . . . . 0.0 111.205 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.0 p -85.31 -17.64 36.27 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.954 0.902 . . . . 0.0 110.075 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.56 40.96 93.24 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 124.895 1.236 . . . . 0.0 110.539 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.049 -0.976 . . . . 0.0 111.524 -172.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -63.95 151.52 42.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.646 0.778 . . . . 0.0 111.585 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -145.97 -39.43 0.23 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.924 1.289 . . . . 0.0 110.446 173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -123.48 165.45 17.08 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.472 1.509 . . . . 0.0 109.439 -174.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.35 138.17 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tt -127.67 136.54 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -129.85 105.86 8.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.92 141.51 42.28 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.864 0.866 . . . . 0.0 110.359 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.41 136.86 41.73 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.553 1.141 . . . . 0.0 108.499 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 t -156.16 171.65 19.8 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.02 0.827 . . . . 0.0 110.885 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.0 p -66.94 -11.67 57.22 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.861 -1.149 . . . . 0.0 113.177 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.96 121.92 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 59.9 t-20 -58.17 -44.23 87.87 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 110.597 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -37.57 -29.15 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 C-N-CA 130.655 3.582 . . . . 0.0 117.514 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 m -125.59 -74.69 0.6 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.634 0.774 . . . . 0.0 109.859 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -60.46 -47.9 84.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.924 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -65.95 -46.53 77.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.712 0.687 . . . . 0.0 110.165 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -57.38 -42.68 82.61 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.953 0.501 . . . . 0.0 112.107 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.0 mtp -65.99 -48.48 71.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.623 0.769 . . . . 0.0 109.623 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.48 79.08 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.27 0.628 . . . . 0.0 111.341 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.47 -45.13 89.24 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.91 0.884 . . . . 0.0 110.396 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.64 93.46 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.595 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -68.95 -43.65 74.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.312 1.556 . . . . 0.0 111.217 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.49 75.28 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.06 0.391 . . . . 0.0 110.863 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.21 -35.17 69.32 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -68.91 -57.33 5.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.497 0.59 . . . . 0.0 109.984 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.04 -35.93 79.07 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.78 -37.07 10.92 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.41 175.01 49.81 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 122.006 0.781 . . . . 0.0 113.048 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.29 -15.56 63.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.024 1.33 . . . . 0.0 114.181 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.92 -16.36 17.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.934 -0.479 . . . . 0.0 112.251 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -112.71 165.4 12.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.21 1.004 . . . . 0.0 109.068 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -120.1 145.34 46.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 167.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.14 119.7 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.95 169.34 17.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.485 0.659 . . . . 0.0 110.254 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -135.34 140.02 44.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.085 1.354 . . . . 0.0 109.418 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.06 -175.08 4.28 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.793 1.237 . . . . 0.0 108.801 169.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.75 176.03 42.52 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.83 -41.8 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.33 179.79 7.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 109.737 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.05 152.98 40.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.011 2.124 . . . . 0.0 106.393 171.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -129.47 -14.14 4.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.889 0.875 . . . . 0.0 111.619 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.77 -175.92 34.96 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -85.39 106.05 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -62.76 125.8 87.18 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.905 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 -34.37 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.152 2.568 . . . . 0.0 113.659 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -38.46 88.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.859 0.754 . . . . 0.0 110.768 176.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.75 -42.79 73.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.85 -52.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -65.76 -42.43 90.9 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 118.951 0.796 . . . . 0.0 110.781 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.72 -45.52 81.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.898 0.772 . . . . 0.0 110.993 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 95.8 mmm -75.86 -38.82 57.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.403 0.281 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -65.06 -33.97 77.3 Favored 'General case' 0 N--CA 1.461 0.105 0 O-C-N 121.061 -1.025 . . . . 0.0 111.036 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -65.02 -21.16 66.8 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.001 0.92 . . . . 0.0 112.158 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.71 -7.76 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.565 1.146 . . . . 0.0 110.294 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.76 21.16 34.68 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.931 -1.106 . . . . 0.0 111.987 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.21 91.83 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -78.12 85.95 4.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.198 0.523 . . . . 0.0 110.169 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -77.67 2.25 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.27 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 t -59.75 -23.13 62.97 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 121.107 1.776 . . . . 0.0 112.08 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -71.44 -18.39 62.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.26 1.024 . . . . 0.0 112.907 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -72.52 173.28 9.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.102 0.961 . . . . 0.0 109.96 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 p -149.17 163.12 38.52 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.529 1.531 . . . . 0.0 108.606 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.4 m -107.08 155.4 19.88 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.179 0.992 . . . . 0.0 110.279 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.567 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -154.56 162.23 41.24 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.716 2.406 . . . . 0.0 108.411 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 pt -92.64 164.02 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.58 133.61 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 112.04 -169.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -122.42 102.56 8.17 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.011 1.724 . . . . 0.0 106.952 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.92 -15.08 40.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.595 0.758 . . . . 0.0 112.194 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.2 -42.74 88.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.515 1.052 . . . . 0.0 111.249 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.92 -43.05 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tt -53.05 -47.15 68.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.976 0.51 . . . . 0.0 110.576 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -67.92 -18.77 64.87 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -96.53 -16.78 20.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.435 1.016 . . . . 0.0 111.484 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.61 153.91 40.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.406 0.548 . . . . 0.0 110.879 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.94 -38.2 66.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.09 166.48 30.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.243 1.02 . . . . 0.0 112.125 170.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.06 143.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.0 131.06 64.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -84.89 142.67 29.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -107.51 -1.75 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.31 0.644 . . . . 0.0 110.595 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.55 156.5 41.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.9 -38.19 88.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -172.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.3 -30.12 69.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.824 0.812 . . . . 0.0 111.933 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.66 78.35 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.146 0.43 . . . . 0.0 111.445 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.51 66.94 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.98 -39.3 93.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 111.783 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -81.96 -40.02 22.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 117.798 -1.096 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.8 m -47.6 108.11 0.84 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.565 1.146 . . . . 0.0 109.27 -173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.1 165.96 22.46 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.451 2.101 . . . . 0.0 113.289 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.9 111.45 2.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.37 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -72.89 122.46 87.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.864 1.266 . . . . 0.0 108.046 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.16 168.66 22.67 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.188 1.926 . . . . 0.0 110.356 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.03 -22.93 15.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.091 3.194 . . . . 0.0 116.017 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -68.08 -6.35 22.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.403 1.081 . . . . 0.0 113.085 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.3 154.58 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.226 2.211 . . . . 0.0 106.62 -169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 173.69 9.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.355 -0.841 . . . . 0.0 110.734 169.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -127.89 155.04 44.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.256 1.422 . . . . 0.0 109.373 -173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.99 160.22 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -145.82 113.64 6.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -111.94 176.95 4.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.928 1.291 . . . . 0.0 109.314 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.59 94.69 0.21 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.999 -0.89 . . . . 0.0 112.439 -169.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.5 126.74 33.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.655 0.727 . . . . 0.0 111.481 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -74.34 153.23 39.4 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 169.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.93 120.83 83.28 Favored Pre-proline 0 C--O 1.236 0.395 0 O-C-N 121.915 -0.491 . . . . 0.0 111.131 -170.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.43 -32.22 20.38 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.631 1.554 . . . . 0.0 113.063 -169.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.53 -20.79 65.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . 0.284 0.0 OUTLIER -118.01 14.69 14.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.395 1.078 . . . . 0.0 111.345 -177.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.98 144.46 45.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -142.66 156.66 45.08 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.527 0.731 . . . . 0.0 109.272 -173.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.94 -56.52 0.38 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.1 p -146.09 170.14 17.29 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 127.012 2.125 . . . . 0.0 105.499 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.71 -42.38 86.49 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.659 -0.65 . . . . 0.0 110.994 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.47 -28.84 64.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.126 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.19 -44.35 72.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.111 0.868 . . . . 0.0 109.462 174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -55.82 -52.23 64.71 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 109.94 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -59.6 -45.02 93.15 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.953 0.342 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -36.85 77.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.14 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -60.46 -37.21 80.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.675 1.125 . . . . 0.0 111.32 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -57.48 -47.94 80.55 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -60.67 -45.48 93.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.176 0.59 . . . . 0.0 111.986 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -60.12 -50.95 71.66 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.702 0.683 . . . . 0.0 109.754 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.09 -42.73 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.626 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -61.7 -43.44 98.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.638 2.017 . . . . 0.0 110.879 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.99 -44.9 95.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.93 -33.74 62.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.184 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.11 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.805 1.639 . . . . 0.0 108.36 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.8 -42.94 99.69 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.462 ' ND2' HH22 ' A' ' 130' ' ' ARG . 56.1 t30 -61.16 -43.13 99.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.258 1.023 . . . . 0.0 111.874 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.462 HH22 ' ND2' ' A' ' 129' ' ' ASN . 13.3 mmp_? -61.83 -41.55 97.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.689 -0.632 . . . . 0.0 110.214 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.0 mt -72.98 -34.74 66.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.672 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -48.56 79.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.179 0.992 . . . . 0.0 109.961 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.15 -50.62 72.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 118.936 0.789 . . . . 0.0 109.7 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.24 -38.9 71.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.493 1.042 . . . . 0.0 111.166 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.39 68.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.698 0.799 . . . . 0.0 112.161 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -80.0 -38.92 31.08 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 110.934 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 49.5 p -89.61 -24.61 21.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.431 1.092 . . . . 0.0 110.188 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.9 97.86 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.963 -170.51 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -160.34 163.25 33.42 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.149 1.38 . . . . 0.0 108.762 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -164.35 -37.27 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.215 1.006 . . . . 0.0 111.438 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.8 mtmt -132.51 171.58 13.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.963 1.705 . . . . 0.0 107.631 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.63 141.71 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -127.58 140.48 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -131.35 100.16 5.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.39 148.95 46.45 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.17 139.46 41.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.759 1.624 . . . . 0.0 107.422 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.22 171.78 18.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.079 0.552 . . . . 0.0 110.338 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -74.7 -5.83 45.39 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.14 95.43 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.0 t-20 -60.16 99.39 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.873 1.269 . . . . 0.0 110.095 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.6 p -160.21 -42.9 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.422 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 p -132.47 -71.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.993 0.917 . . . . 0.0 110.434 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -52.32 -50.59 61.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.349 0.977 . . . . 0.0 111.782 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.9 -42.31 97.48 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.175 0.59 . . . . 0.0 111.221 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -67.99 -39.9 83.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.841 0.857 . . . . 0.0 111.286 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 81.6 mtp -65.09 -48.6 73.11 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.394 1.078 . . . . 0.0 108.695 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.53 81.97 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.911 0.323 . . . . 0.0 110.475 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -56.85 -44.84 82.53 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.99 -47.44 88.74 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.96 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -66.74 -38.01 85.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.956 1.878 . . . . 0.0 110.525 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.09 82.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.291 0.496 . . . . 0.0 110.723 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.28 -26.36 66.43 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.033 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -74.95 -56.85 4.32 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.116 0.871 . . . . 0.0 110.272 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -71.37 -29.57 65.11 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -92.08 -145.08 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.285 1.434 . . . . 0.0 107.905 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.28 -164.77 38.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.33 -19.77 37.78 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.785 1.634 . . . . 0.0 113.419 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -58.97 -12.15 4.24 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.17 1.388 . . . . 0.0 111.825 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.405 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 17.3 m95 -142.77 171.54 13.91 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.923 1.689 . . . . 0.0 110.819 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -129.76 140.92 50.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.645 2.378 . . . . 0.0 104.785 168.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.71 124.97 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 170.92 15.16 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.7 p -142.61 143.26 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.523 0.729 . . . . 0.0 109.642 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.11 -171.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.702 1.601 . . . . 0.0 109.029 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.52 173.8 40.49 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 121.681 -0.637 . . . . 0.0 111.768 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.88 -41.02 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.103 1.361 . . . . 0.0 108.225 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.77 -176.57 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.324 1.85 . . . . 0.0 106.846 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.9 165.36 25.18 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.189 1.396 . . . . 0.0 109.172 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -129.18 -36.56 1.73 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.351 0.66 . . . . 0.0 110.322 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.65 169.2 12.97 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -58.68 109.91 0.9 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -69.43 125.8 92.21 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.97 -32.78 59.26 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.555 2.17 . . . . 0.0 113.316 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -42.39 98.69 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.84 0.746 . . . . 0.0 110.458 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -39.36 71.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.94 -54.03 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -65.3 -43.29 91.56 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.51 1.05 . . . . 0.0 110.126 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.93 -45.03 67.47 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.43 0.692 . . . . 0.0 111.597 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.6 mmm -80.0 -38.6 31.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.543 0.737 . . . . 0.0 111.354 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.71 -31.01 71.76 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.088 -1.008 . . . . 0.0 110.821 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.89 -20.57 65.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.086 0.954 . . . . 0.0 112.109 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.15 -26.74 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.596 1.089 . . . . 0.0 109.337 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.7 15.86 12.71 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.279 1.419 . . . . 0.0 111.677 -170.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.99 95.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -77.83 88.75 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.9 pt -80.31 -0.92 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.247 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -27.38 66.46 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.503 1.501 . . . . 0.0 111.325 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.34 -20.4 63.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.686 1.595 . . . . 0.0 113.007 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -70.58 175.13 5.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.932 0.893 . . . . 0.0 109.853 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -141.06 148.92 40.95 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.088 1.355 . . . . 0.0 108.751 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -89.07 154.66 20.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 109.689 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 46.1 t0 -152.65 160.07 43.18 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.545 1.938 . . . . 0.0 107.317 169.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 pt -88.42 161.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 132.93 22.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.855 0.862 . . . . 0.0 110.972 -171.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -116.97 109.78 17.45 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.813 1.645 . . . . 0.0 107.121 174.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -59.26 -20.59 55.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.206 1.002 . . . . 0.0 112.398 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.84 -45.94 69.81 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.433 1.015 . . . . 0.0 111.059 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.71 -41.1 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.91 -49.86 58.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.068 0.547 . . . . 0.0 109.868 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -68.64 -14.65 63.15 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -96.14 -20.39 18.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.502 1.046 . . . . 0.0 110.884 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.33 140.42 55.92 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 118.198 0.454 . . . . 0.0 110.139 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.32 -33.95 76.33 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.632 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 35.6 tp -145.32 142.32 29.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.963 1.305 . . . . 0.0 108.925 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.15 139.8 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.61 110.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -94.06 101.52 13.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.15 -6.45 23.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.66 159.83 42.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.24 1.382 . . . . 0.0 109.187 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -42.81 99.7 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.327 -169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.49 -33.53 74.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.017 0.908 . . . . 0.0 111.177 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.49 -21.12 66.6 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.308 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.76 -19.53 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.849 0.75 . . . . 0.0 112.792 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.23 -30.6 66.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.309 0.504 . . . . 0.0 111.903 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -86.97 62.49 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 91.7 m -125.5 79.18 67.49 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -50.69 -37.3 53.52 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.588 2.858 . . . . 0.0 114.969 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 36.6 tpp -159.72 128.39 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.2 p -140.56 85.92 12.71 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.62 171.18 0.72 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.238 3.292 . . . . 0.0 112.976 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.59 -28.64 29.62 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.577 2.852 . . . . 0.0 114.84 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -70.52 -3.8 19.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.684 1.194 . . . . 0.0 113.143 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.4 t -132.47 79.41 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 105.531 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 10.4 pttt -68.1 163.04 23.36 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -130.34 153.88 48.24 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.08 -0.388 . . . . 0.0 110.312 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -139.46 157.29 46.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -143.36 140.08 30.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.665 0.786 . . . . 0.0 109.573 -169.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -137.32 -168.54 2.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.447 1.099 . . . . 0.0 108.959 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.71 39.37 1.41 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.054 -169.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -76.62 111.11 11.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.213 1.006 . . . . 0.0 110.698 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.79 153.63 39.39 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.906 0.882 . . . . 0.0 108.988 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.71 118.97 74.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 119.192 -0.432 . . . . 0.0 112.061 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.29 -31.21 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.227 1.951 . . . . 0.0 112.584 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.6 -21.3 66.13 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.017 0.826 . . . . 0.0 111.959 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -99.38 7.45 45.51 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.672 1.189 . . . . 0.0 111.56 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.75 15.89 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.761 1.225 . . . . 0.0 114.303 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -51.93 153.73 2.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.18 1.392 . . . . 0.0 112.627 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 -51.94 0.22 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.009 -2.437 . . . . 0.0 107.009 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -154.37 153.09 31.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 168.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.36 -38.12 85.81 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 121.403 -0.811 . . . . 0.0 110.781 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.07 -31.45 72.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.23 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.76 -47.66 52.15 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -54.83 -52.54 62.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 110.143 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -63.51 -42.34 98.49 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.55 0.74 . . . . 0.0 111.036 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -35.96 71.23 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.076 0.853 . . . . 0.0 110.607 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.11 -39.15 82.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.22 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -56.1 -46.46 79.09 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -59.91 -49.89 75.92 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.586 0.754 . . . . 0.0 111.235 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -60.17 -49.51 77.35 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.49 -45.45 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 116.691 -1.623 . . . . 0.0 110.027 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -61.05 -43.84 98.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 122.134 2.243 . . . . 0.0 110.645 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.63 -45.98 91.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.39 -33.65 63.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.21 -44.45 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.544 1.52 . . . . 0.0 108.095 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.02 -44.48 96.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.77 -40.54 96.92 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.393 1.077 . . . . 0.0 112.506 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -56.7 -48.15 78.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.524 0.73 . . . . 0.0 109.305 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.15 -40.61 64.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.98 0.512 . . . . 0.0 109.823 -171.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -56.38 -46.24 80.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.083 0.953 . . . . 0.0 110.943 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.7 -56.04 23.92 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.486 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.31 -28.23 69.57 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.675 1.579 . . . . 0.0 111.372 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.17 63.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.672 0.669 . . . . 0.0 111.633 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -85.78 -31.87 22.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -95.49 -15.24 23.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.742 0.817 . . . . 0.0 111.544 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.26 29.73 74.67 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt . . . . . 0 C--O 1.248 0.996 0 C-N-CA 125.405 1.482 . . . . 0.0 110.638 -178.08 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.76 146.95 44.26 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -159.5 -42.35 0.05 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.401 0.546 . . . . 0.0 112.167 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' HE3' ' CD2' ' A' ' 32' ' ' TRP . 46.4 mtmt -135.75 169.99 16.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.397 1.479 . . . . 0.0 108.608 170.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.4 mt -135.99 130.61 48.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.37 132.08 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.6 107.1 9.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.452 0.701 . . . . 0.0 109.32 -169.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -77.16 142.21 39.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.23 135.01 35.15 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 126.229 1.812 . . . . 0.0 107.14 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.88 168.57 26.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.478 0.581 . . . . 0.0 110.436 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -68.03 -11.4 58.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.037 -1.039 . . . . 0.0 113.29 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.09 115.09 0.64 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 105.928 -2.869 . . . . 0.0 105.928 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -60.21 -40.48 90.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 0.0 111.831 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -38.13 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.534 3.134 . . . . 0.0 117.451 -168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.25 -62.64 0.79 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.341 0.973 . . . . 0.0 111.983 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -54.69 -51.7 64.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.234 0.925 . . . . 0.0 112.269 -169.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -63.24 -48.05 79.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.499 0.59 . . . . 0.0 110.475 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -60.06 -39.63 86.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.593 0.757 . . . . 0.0 112.033 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.81 -48.43 68.96 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.962 0.905 . . . . 0.0 109.562 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.15 81.55 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.134 0.425 . . . . 0.0 111.176 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.38 -48.41 80.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.0 0.92 . . . . 0.0 110.437 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.04 -45.11 94.24 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.73 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -67.92 -40.87 83.33 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.879 1.839 . . . . 0.0 110.551 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.91 79.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.524 0.602 . . . . 0.0 111.549 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -57.8 -32.75 67.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.725 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.6 -58.24 4.18 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.546 0.612 . . . . 0.0 110.096 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -71.41 -33.84 69.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 32.8 mt -95.82 -37.12 10.88 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.261 0.624 . . . . 0.0 112.679 -169.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.26 -176.34 44.61 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.001 0.81 . . . . 0.0 112.789 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.12 -8.96 34.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.004 1.322 . . . . 0.0 113.672 -171.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.28 -11.26 2.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.368 1.867 . . . . 0.0 111.18 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.467 ' CD2' ' HE3' ' A' ' 4' ' ' LYS . 3.7 m95 -139.82 150.27 44.48 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.792 1.237 . . . . 0.0 109.642 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 5.3 mmpt? -98.43 139.42 34.21 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 167.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.83 117.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -168.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.47 170.31 16.26 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.378 0.609 . . . . 0.0 110.187 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.8 m -135.81 144.94 45.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.24 1.416 . . . . 0.0 109.441 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.91 -173.61 4.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.01 175.62 44.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.56 -40.17 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.43 175.58 10.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.287 0.635 . . . . 0.0 110.876 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.37 156.86 44.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.244 2.618 . . . . 0.0 106.628 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -135.74 -35.67 0.79 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.027 0.931 . . . . 0.0 110.246 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.2 179.04 46.45 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.45 102.14 6.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 169.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -60.4 124.7 79.47 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.964 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.95 -34.27 45.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.266 2.644 . . . . 0.0 113.711 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -39.29 91.84 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.844 0.747 . . . . 0.0 110.734 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.49 73.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.54 -54.43 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.13 -42.91 83.64 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.956 0.798 . . . . 0.0 110.744 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.32 -44.09 79.62 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.529 0.604 . . . . 0.0 110.799 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.3 mmm -76.57 -39.83 51.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.551 0.74 . . . . 0.0 111.372 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -62.82 -34.18 76.77 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -67.91 -20.17 65.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.004 0.922 . . . . 0.0 112.612 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -78.07 -24.34 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.479 1.036 . . . . 0.0 109.586 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.49 19.21 11.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.108 1.337 . . . . 0.0 111.08 -169.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -117.17 92.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.23 87.58 3.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.77 4.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 117.738 -1.125 . . . . 0.0 111.92 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.6 m -58.02 -25.88 61.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 121.01 1.732 . . . . 0.0 112.057 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.19 -21.51 62.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.943 1.297 . . . . 0.0 112.68 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.3 169.31 15.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.667 0.787 . . . . 0.0 109.412 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -145.92 156.14 43.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.489 1.116 . . . . 0.0 109.326 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.1 m -95.32 148.53 22.34 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.251 1.02 . . . . 0.0 111.123 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -156.8 159.75 38.55 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.45 1.5 . . . . 0.0 108.528 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.6 164.39 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.52 117.83 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.598 0.713 . . . . 0.0 112.395 -169.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.27 121.97 36.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -73.04 -23.8 60.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.71 0.804 . . . . 0.0 112.826 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.09 -41.21 62.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.608 0.64 . . . . 0.0 110.105 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.76 -44.63 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -48.98 71.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.332 0.515 . . . . 0.0 110.037 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -69.76 -5.48 25.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -107.02 -20.62 13.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.868 1.213 . . . . 0.0 111.946 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.9 148.22 51.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.389 0.541 . . . . 0.0 111.244 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -35.27 78.33 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' LYS . 39.0 tp -147.0 143.37 28.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 110.072 -169.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.06 138.4 49.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.62 108.4 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.8 p -88.9 90.6 8.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.1 -9.78 34.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.952 0.901 . . . . 0.0 112.812 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 p -143.04 156.09 44.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.06 -41.87 94.89 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -170.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -31.74 72.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.608 0.704 . . . . 0.0 111.737 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.68 -27.99 69.62 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.437 0.562 . . . . 0.0 111.902 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 -14.55 62.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.57 -30.43 69.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.009 0.822 . . . . 0.0 112.108 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.27 -35.97 58.65 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 118.052 -0.975 . . . . 0.0 113.288 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.6 m -40.38 105.1 0.36 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.898 1.679 . . . . 0.0 113.48 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.58 71.6 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.056 3.171 . . . . 0.0 111.255 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.8 mtt 79.58 110.84 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 129.283 3.033 . . . . 0.0 111.673 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.2 p -117.67 81.2 14.51 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.94 173.16 7.41 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.479 2.786 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.4 -28.55 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.829 3.019 . . . . 0.0 116.445 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.39 -8.3 45.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.133 0.973 . . . . 0.0 113.034 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.7 t -134.91 82.95 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 128.47 2.708 . . . . 0.0 105.125 -169.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 77' ' ' LEU . 11.3 pttt -66.12 167.68 9.64 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -141.14 150.04 42.29 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.507 -0.745 . . . . 0.0 109.412 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -136.4 162.33 33.36 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -144.68 147.21 32.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.2 1.0 . . . . 0.0 112.006 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -142.72 -168.52 2.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 108.301 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.16 42.51 1.13 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.227 0.921 . . . . 0.0 113.848 -169.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -78.57 115.92 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.555 1.177 . . . . 0.0 111.925 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -66.11 150.6 48.48 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.743 1.217 . . . . 0.0 109.525 169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.19 116.65 51.02 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.31 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.45 -33.96 27.85 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.966 1.778 . . . . 0.0 112.661 -171.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.27 -16.68 64.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.439 0.563 . . . . 0.0 112.288 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -105.4 8.62 33.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.11 -38.8 71.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.243 0.929 . . . . 0.0 112.613 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 53.42 -170.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.887 2.075 . . . . 0.0 113.434 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.96 -65.71 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.205 1.86 . . . . 0.0 108.942 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -162.32 161.45 27.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.929 2.092 . . . . 0.0 105.579 170.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.03 -40.18 73.07 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.118 0.872 . . . . 0.0 111.243 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.17 -28.41 66.39 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.487 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.84 -39.45 66.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.863 0.756 . . . . 0.0 109.598 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -60.23 -53.16 60.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -57.83 -41.14 81.68 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.329 0.393 . . . . 0.0 110.58 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.66 77.53 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.074 -0.391 . . . . 0.0 110.878 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -74.42 -35.83 63.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.33 0.652 . . . . 0.0 111.512 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -56.18 -43.58 78.54 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.339 0.972 . . . . 0.0 108.689 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.47 -48.77 78.31 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.071 0.548 . . . . 0.0 111.386 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -60.02 -49.4 77.8 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.156 0.434 . . . . 0.0 110.069 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.11 -46.19 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.976 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -60.95 -43.31 98.9 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 121.776 2.08 . . . . 0.0 110.699 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.44 -45.37 94.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.31 -30.87 62.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.005 -0.997 . . . . 0.0 112.765 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -41.27 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.837 1.199 . . . . 0.0 108.712 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.73 -47.01 90.48 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -59.63 -37.05 77.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.595 1.158 . . . . 0.0 111.411 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -52.77 64.28 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.713 0.805 . . . . 0.0 109.735 173.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.73 -34.5 76.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.918 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -60.08 -49.84 76.05 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.748 0.819 . . . . 0.0 111.065 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.31 -51.37 69.83 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 119.364 0.983 . . . . 0.0 108.867 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -55.89 -39.53 71.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.283 0.633 . . . . 0.0 111.063 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.65 55.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.074 0.95 . . . . 0.0 111.848 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.24 -39.8 65.18 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.389 -173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.6 p -92.41 -21.8 20.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.105 0.962 . . . . 0.0 110.825 -171.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.75 42.88 99.81 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -169.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 126.735 2.014 . . . . 0.0 111.16 -174.314 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.1 139.77 40.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.621 0.769 . . . . 0.0 110.129 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -157.4 -36.6 0.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -124.67 169.26 12.14 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.406 1.882 . . . . 0.0 108.129 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -141.95 139.39 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.03 137.53 55.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -132.95 105.91 7.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.015 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -80.0 149.28 30.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.913 0.485 . . . . 0.0 110.592 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.05 129.71 15.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.946 1.299 . . . . 0.0 107.543 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.94 172.63 15.38 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.983 0.913 . . . . 0.0 109.993 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -66.34 -8.91 28.38 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.649 -1.282 . . . . 0.0 113.449 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.77 125.17 1.41 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.086 -2.805 . . . . 0.0 106.086 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 65' ' ' ASP . 60.2 t-20 -61.16 -46.77 89.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.099 0.56 . . . . 0.0 110.384 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -42.85 -22.37 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 130.178 3.391 . . . . 0.0 117.412 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 p -119.69 -84.2 0.66 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.476 1.11 . . . . 0.0 109.683 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -60.14 -46.75 88.58 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 124.384 1.074 . . . . 0.0 111.669 -169.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 -40.76 76.2 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.098 0.863 . . . . 0.0 110.796 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -60.94 -43.84 98.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.676 0.671 . . . . 0.0 111.431 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 85.3 mtp -65.77 -48.58 71.36 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.389 0.676 . . . . 0.0 109.487 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.31 -42.13 81.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.086 0.554 . . . . 0.0 111.309 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.61 -48.55 79.11 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 110.044 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.98 -43.61 97.99 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.616 -1.102 . . . . 0.0 112.584 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.66 -40.84 80.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.722 1.761 . . . . 0.0 110.937 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.99 81.51 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.526 0.603 . . . . 0.0 111.417 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -57.53 -33.66 68.31 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 118.797 -0.621 . . . . 0.0 111.812 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -69.35 -58.59 3.81 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.408 0.549 . . . . 0.0 110.101 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -70.11 -37.7 75.42 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -169.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 mt -90.31 -36.65 14.56 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -169.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 179.09 50.84 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 121.999 0.777 . . . . 0.0 112.829 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.28 -16.4 63.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.738 1.615 . . . . 0.0 113.998 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.24 -24.64 11.76 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.311 1.044 . . . . 0.0 110.875 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -120.93 140.53 51.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.243 0.617 . . . . 0.0 110.226 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -89.75 144.06 26.28 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.95 124.1 52.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 170.72 15.62 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 p -140.14 142.75 35.97 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.43 -174.9 4.01 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.338 1.455 . . . . 0.0 108.768 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.57 174.67 41.34 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.3 -42.02 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 170.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.65 178.36 8.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.839 0.856 . . . . 0.0 109.892 171.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.69 122.59 11.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.568 1.547 . . . . 0.0 107.042 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.67 -32.35 47.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.983 0.513 . . . . 0.0 109.95 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.94 -158.25 28.67 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 tp -94.4 111.98 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -67.27 125.37 90.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.258 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.37 -34.38 50.08 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.163 2.575 . . . . 0.0 113.624 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -37.54 85.27 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.698 0.681 . . . . 0.0 110.915 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.66 75.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.17 -53.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -67.63 -41.68 83.52 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.32 -45.17 84.52 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.007 0.821 . . . . 0.0 110.784 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.53 -39.83 64.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.889 0.476 . . . . 0.0 110.92 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -64.5 -32.11 73.61 Favored 'General case' 0 C--O 1.227 -0.091 0 O-C-N 121.288 -0.883 . . . . 0.0 111.617 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.92 -19.59 65.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.77 0.828 . . . . 0.0 112.145 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -89.67 -9.39 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.469 1.108 . . . . 0.0 110.174 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 16.28 53.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.691 1.139 . . . . 0.0 111.927 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.1 mt -107.96 92.22 2.01 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -76.54 85.21 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.032 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.5 pt -78.13 3.47 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.269 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.6 p -61.07 -23.2 65.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 121.267 1.848 . . . . 0.0 112.202 -175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -70.67 -21.29 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.064 1.345 . . . . 0.0 112.7 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -70.05 170.18 11.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 109.57 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 p -145.71 161.47 39.83 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.26 1.424 . . . . 0.0 107.98 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -104.16 155.74 18.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.739 0.816 . . . . 0.0 110.116 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 45.1 t0 -150.83 161.31 42.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 127.12 2.168 . . . . 0.0 108.125 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 pt -92.44 164.56 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 135.43 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.591 0.756 . . . . 0.0 112.426 -169.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -127.07 110.07 12.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.604 1.562 . . . . 0.0 108.212 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.5 p -61.08 -19.67 61.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.926 -0.483 . . . . 0.0 111.653 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.34 -2.66 14.26 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 113.638 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 87.5 mt -115.97 -45.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -46.43 -51.64 14.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.488 1.115 . . . . 0.0 111.525 178.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -66.7 -5.97 13.89 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -134.36 5.47 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 112.664 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.1 155.08 40.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.939 0.791 . . . . 0.0 109.936 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.61 -33.86 73.27 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.975 -1.078 . . . . 0.0 108.389 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -147.55 143.8 28.04 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.537 1.535 . . . . 0.0 109.509 -170.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.01 133.7 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.88 119.02 56.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -172.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 p -96.57 92.77 6.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -68.14 -12.6 61.19 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.538 -0.726 . . . . 0.0 112.805 -169.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.57 156.63 45.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.74 1.155 . . . . 0.0 108.174 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.81 -41.33 83.33 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -169.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.96 -35.88 82.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.76 0.78 . . . . 0.0 111.318 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.44 -28.84 70.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.59 -22.56 65.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.37 -32.64 74.16 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.529 0.732 . . . . 0.0 112.227 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -99.29 -22.74 15.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 118.09 -0.957 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.8 t -55.32 106.42 0.67 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.72 174.88 3.32 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.472 2.781 . . . . 0.0 113.169 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -58.88 143.23 48.34 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.572 -0.705 . . . . 0.0 110.544 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 p -133.0 119.13 15.59 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.541 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 169.23 20.61 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.38 -25.79 19.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.957 3.105 . . . . 0.0 115.969 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -65.91 -9.02 25.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.091 0.956 . . . . 0.0 112.839 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 t -133.68 89.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 127.539 2.336 . . . . 0.0 105.5 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -69.11 164.3 22.82 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.299 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -126.25 148.77 49.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.577 1.151 . . . . 0.0 108.679 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -143.94 160.18 41.27 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 145.14 30.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.377 1.071 . . . . 0.0 111.717 -169.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -143.8 -170.16 3.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.405 1.882 . . . . 0.0 108.436 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.92 41.19 1.24 Allowed Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.484 -0.76 . . . . 0.0 113.241 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -76.21 114.96 15.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.354 1.077 . . . . 0.0 110.953 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -67.65 151.52 47.15 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.406 1.082 . . . . 0.0 109.926 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.32 126.72 92.55 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.48 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.88 -30.83 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.462 2.108 . . . . 0.0 114.049 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.49 -24.55 67.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.937 0.895 . . . . 0.0 112.933 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 25.43 10.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 112.557 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.75 -36.42 57.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 56.45 -168.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.373 1.869 . . . . 0.0 112.843 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.54 -61.14 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.428 1.966 . . . . 0.0 108.338 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 t -166.43 167.72 15.47 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 105.313 169.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.88 -40.35 84.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.386 -0.822 . . . . 0.0 110.626 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.47 -29.94 66.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.429 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.62 -42.73 61.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.751 0.705 . . . . 0.0 109.287 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -58.29 -49.31 77.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.883 0.873 . . . . 0.0 109.814 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -61.78 -44.18 97.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.769 0.259 . . . . 0.0 110.503 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.97 75.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.457 0.571 . . . . 0.0 110.401 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.52 -39.02 93.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.187 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -55.95 -48.31 75.99 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.563 1.074 . . . . 0.0 108.859 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -60.56 -44.23 96.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.575 0.35 . . . . 0.0 111.113 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -61.95 -48.99 77.91 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.066 0.394 . . . . 0.0 110.519 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.13 -45.28 94.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 117.208 -1.377 . . . . 0.0 109.91 -176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -60.39 -42.38 95.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 121.395 1.907 . . . . 0.0 110.709 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.08 -45.0 95.46 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.84 -31.64 63.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.98 -41.01 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 119.847 1.203 . . . . 0.0 108.867 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.11 -46.47 88.22 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.79 -35.82 75.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.12 1.368 . . . . 0.0 111.513 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -53.97 52.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.842 0.857 . . . . 0.0 109.595 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.02 -34.68 78.26 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.851 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -50.52 73.55 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.133 0.973 . . . . 0.0 111.116 173.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -61.01 -51.66 68.28 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 122.832 0.453 . . . . 0.0 111.163 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.78 58.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.072 0.949 . . . . 0.0 111.789 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.32 -38.13 60.39 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.865 0.866 . . . . 0.0 111.243 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.9 p -94.83 -20.85 19.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.357 1.063 . . . . 0.0 111.189 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.61 36.98 93.81 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -172.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.693 1.597 . . . . 0.0 111.353 -173.996 . . . . . . . . 0 0 . 1 stop_ save_